data_5h3n_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5h3n _Structure_validation_residue.Date_analyzed 2017-10-27 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 N--CA 1.49 1.278 0 CA-C-O 121.216 0.423 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.574 ' O ' ' N ' ' A' ' 8' ' ' ALA . 16.7 mt-10 -83.34 -39.68 20.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 110.138 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.581 ' CE2' ' CG1' ' A' ' 42' ' ' VAL . 23.5 t80 -61.78 -46.81 87.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.133 -0.979 . . . . 0.0 109.866 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.495 HD13 ' H ' ' A' ' 6' ' ' LEU . 3.4 mp -71.84 -32.99 68.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.068 -1.02 . . . . 0.0 109.439 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.9 mmtm -94.78 0.88 55.3 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.257 -0.902 . . . . 0.0 109.459 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 4' ' ' GLU . . . -52.1 153.74 2.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 109.424 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 137.52 68.42 0.05 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -144.66 8.14 1.3 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.24 -1.153 . . . . 0.0 109.567 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -166.61 126.76 1.19 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 109.243 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.85 94.56 1.0 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.405 2.07 . . . . 0.0 112.213 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -174.18 -104.18 0.17 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.6 tp -156.01 134.42 11.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.366 -1.079 . . . . 0.0 109.764 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -126.55 131.93 51.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.866 . . . . 0.0 109.357 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.544 ' HA ' HG22 ' A' ' 43' ' ' ILE . 41.6 mt -108.0 137.1 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -0.799 . . . . 0.0 109.758 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -139.5 166.19 25.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.261 -0.899 . . . . 0.0 109.063 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -144.96 142.16 29.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.126 -0.984 . . . . 0.0 109.725 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.43 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 7.6 p -79.76 127.95 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.292 -0.88 . . . . 0.0 109.566 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.503 ' O ' ' CG2' ' A' ' 25' ' ' VAL . 2.6 mm-40 -164.18 134.47 4.16 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.298 -0.876 . . . . 0.0 109.267 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 29.4 tttm 75.99 41.62 0.23 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.369 -0.832 . . . . 0.0 109.56 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 48.33 43.62 19.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.173 -0.954 . . . . 0.0 109.444 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -173.33 -172.05 0.76 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.896 . . . . 0.0 109.459 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.527 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 3.9 mm? -88.49 138.15 31.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.503 ' CG2' ' O ' ' A' ' 20' ' ' GLU . 5.0 t -138.83 128.36 14.45 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.219 -0.926 . . . . 0.0 109.253 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -74.95 166.36 29.39 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.36 2.04 . . . . 0.0 112.355 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.6 t -111.12 101.3 49.86 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.367 -0.833 . . . . 0.0 109.404 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.413 ' HD2' HD11 ' A' ' 31' ' ' LEU . 33.2 Cg_exo -53.27 168.08 0.67 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.533 2.155 . . . . 0.0 112.363 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.556 ' C ' ' H ' ' A' ' 31' ' ' LEU . 24.5 m -60.16 170.56 1.23 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.342 -0.849 . . . . 0.0 109.032 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.409 ' CB ' ' O ' ' A' ' 29' ' ' THR . 0.9 OUTLIER 69.69 -40.91 0.47 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.205 -0.934 . . . . 0.0 109.195 -179.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.556 ' H ' ' C ' ' A' ' 29' ' ' THR . 96.0 mt -81.79 -44.22 17.27 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.376 -0.828 . . . . 0.0 109.209 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 33' ' ' GLY . 0.3 OUTLIER -53.42 138.33 33.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.359 -0.838 . . . . 0.0 109.138 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.498 ' N ' ' CD1' ' A' ' 32' ' ' TYR . . . 109.43 -8.99 32.86 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -121.81 115.5 22.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.351 -1.088 . . . . 0.0 109.375 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -87.86 140.07 29.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 109.589 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -102.17 146.19 28.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.334 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 p -92.42 -8.93 43.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 109.468 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.434 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -107.94 35.79 4.78 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 9.7 m-20 -167.57 171.98 9.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.333 -1.098 . . . . 0.0 109.497 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.94 141.2 48.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 109.546 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -116.24 134.75 54.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.392 -0.817 . . . . 0.0 109.472 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.581 ' CG1' ' CE2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -114.13 124.47 70.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.21 -0.931 . . . . 0.0 108.603 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.767 ' CD1' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -121.33 133.8 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.174 -0.954 . . . . 0.0 110.03 -178.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.0 tt -122.68 121.65 36.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.504 -0.747 . . . . 0.0 109.906 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -96.56 141.87 29.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.371 -0.831 . . . . 0.0 108.954 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.529 ' O ' ' N ' ' A' ' 13' ' ' GLY . 29.1 m -137.17 128.05 27.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.037 -1.039 . . . . 0.0 109.72 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -132.68 168.72 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 O-C-N 121.223 -0.923 . . . . 0.0 109.231 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -102.82 103.57 13.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.574 -0.704 . . . . 0.0 109.464 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.8 mt -72.7 169.01 17.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.282 -0.886 . . . . 0.0 109.711 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.42 ' C ' ' N ' ' A' ' 52' ' ' GLY . 14.7 mtt180 -45.52 -72.83 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.265 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -44.97 -24.18 0.2 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 109.255 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' A' ' 50' ' ' ARG . . . 84.62 32.96 20.57 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.488 ' O ' ' O ' ' A' ' 54' ' ' LEU . 1.0 OUTLIER -86.58 14.26 7.19 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.165 -1.197 . . . . 0.0 109.205 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.59 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 12.6 mt 47.15 100.27 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.544 0.688 . . . . 0.0 109.608 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.599 ' NE2' ' H ' ' A' ' 56' ' ' TYR . 3.2 tm0? -68.57 145.35 54.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.573 -0.704 . . . . 0.0 109.129 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.599 ' H ' ' NE2' ' A' ' 55' ' ' GLN . 91.3 m-85 -129.77 114.67 16.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.923 . . . . 0.0 109.925 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.502 ' OD2' HG22 ' A' ' 90' ' ' VAL . 70.7 m-20 -123.93 155.48 38.06 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -150.35 142.76 24.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.683 -1.261 . . . . 0.0 110.983 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.615 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -120.71 133.91 55.32 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.277 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.516 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -105.14 115.38 30.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.361 -0.837 . . . . 0.0 109.366 -179.653 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.539 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 36.0 t90 -106.9 135.38 48.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.212 -0.93 . . . . 0.0 109.939 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.539 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 0.1 OUTLIER -124.27 162.18 24.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.379 -0.826 . . . . 0.0 109.501 179.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -96.31 161.77 22.45 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -82.11 -11.88 58.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.277 -1.131 . . . . 0.0 109.614 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -104.26 30.83 4.99 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.516 ' SG ' ' CD ' ' A' ' 70' ' ' GLU . 1.2 m -130.73 97.53 4.38 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.162 0.982 . . . . 0.0 108.433 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 66' ' ' CYS . 1.5 m -47.09 178.05 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.694 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.718 ' H ' ' NE2' ' A' ' 68' ' ' GLN . 1.4 mp0 -61.22 -18.07 56.45 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.235 -0.915 . . . . 0.0 109.534 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -64.42 -58.78 5.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 0.0 109.359 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.516 ' CD ' ' SG ' ' A' ' 66' ' ' CYS . 25.5 mt-10 -66.02 -44.5 84.54 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 108.824 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.85 -25.69 66.54 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.523 -0.736 . . . . 0.0 109.03 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.07 -47.01 48.26 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.74 91.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.271 -1.135 . . . . 0.0 109.193 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 60' ' ' TYR . . . -61.32 -49.47 76.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.401 -0.812 . . . . 0.0 109.195 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.75 -34.73 77.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.273 -0.892 . . . . 0.0 109.537 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.4 HD12 HG21 ' A' ' 76' ' ' ILE . 14.2 mt -57.26 -54.63 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.934 . . . . 0.0 109.418 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -60.51 -33.47 72.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.108 -0.995 . . . . 0.0 109.47 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 m -69.72 -40.18 76.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.244 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 81.0 t -61.81 -42.12 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.417 -0.802 . . . . 0.0 109.319 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -60.31 -51.32 70.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.009 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.6 mt -49.29 -43.1 43.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 108.951 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' A' ' 86' ' ' ASN . 19.6 t0 -57.02 -60.32 3.77 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.222 -0.924 . . . . 0.0 109.389 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.467 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 30.7 t0 -45.0 -35.86 3.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.145 -0.972 . . . . 0.0 108.88 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -75.89 -28.87 58.27 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.617 ' C ' ' H ' ' A' ' 87' ' ' GLY . 47.8 mt -121.49 33.46 5.52 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.432 -0.792 . . . . 0.0 109.424 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.605 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.4 OUTLIER -73.13 25.62 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 109.052 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.617 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -84.4 -58.24 2.21 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.98 35.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -1.122 . . . . 0.0 109.545 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.55 179.28 7.18 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.26 -0.9 . . . . 0.0 109.269 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.502 HG22 ' OD2' ' A' ' 57' ' ' ASP . 14.9 t -114.4 91.48 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.17 -0.956 . . . . 0.0 109.37 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.454 ' CD ' ' O ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -96.93 125.45 41.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.336 -0.852 . . . . 0.0 109.206 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.482 ' CD2' ' N ' ' A' ' 92' ' ' HIS . 1.8 p80 -151.48 118.68 5.93 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.036 -1.04 . . . . 0.0 109.513 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 8.5 ptt-85 -91.71 134.63 34.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.382 -0.824 . . . . 0.0 109.792 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -112.89 155.98 23.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.424 -0.797 . . . . 0.0 109.566 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.7 t -121.41 169.51 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.335 -0.853 . . . . 0.0 109.486 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -78.31 129.35 34.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 109.425 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.4 5.21 79.61 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.48 ' O ' ' O ' ' A' ' 99' ' ' GLU . 20.2 m-85 -146.06 19.51 1.42 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -1.152 . . . . 0.0 109.463 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.48 ' O ' ' O ' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -51.68 -173.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 109.403 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.0 t -137.89 175.77 9.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 109.524 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.53 -34.53 72.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.924 . . . . 0.0 109.424 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.5 m -53.57 -47.01 70.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.53 -56.81 7.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.319 -0.863 . . . . 0.0 109.328 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.6 mt -56.36 -24.23 42.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.25 -0.906 . . . . 0.0 109.509 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.1 -30.03 26.69 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -71.01 -30.26 66.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.184 -1.186 . . . . 0.0 109.273 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -139.14 103.57 4.8 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.28 -0.888 . . . . 0.0 109.451 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -102.86 -2.72 27.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.173 -0.954 . . . . 0.0 109.52 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.5 p -66.47 -16.12 63.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.187 -0.946 . . . . 0.0 109.486 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.89 88.78 2.07 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.588 ' H ' ' CD2' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -70.1 135.44 49.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.236 -1.155 . . . . 0.0 109.379 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -90.18 142.23 27.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.331 -0.856 . . . . 0.0 109.582 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.443 ' CD2' ' N ' ' A' ' 113' ' ' TYR . 20.4 m-85 -106.23 111.78 24.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 109.442 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -94.12 145.23 24.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 109.43 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.356 -0.84 . . . . 0.0 109.52 -179.95 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo . . . . . 0 N--CA 1.491 1.361 0 CA-C-O 121.331 0.471 . . . . 0.0 112.174 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 8' ' ' ALA . 13.5 mm-40 -83.34 -46.04 13.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 109.872 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.616 ' CE1' ' O ' ' A' ' 42' ' ' VAL . 2.8 m-85 -67.17 -35.32 79.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.312 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.466 ' H ' HD11 ' A' ' 6' ' ' LEU . 4.2 mp -64.97 -35.23 80.52 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.293 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 8' ' ' ALA . 10.5 mttp -103.86 2.4 32.6 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.354 -0.842 . . . . 0.0 109.472 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.507 ' CB ' HE22 ' A' ' 15' ' ' GLN . . . -46.81 175.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.91 . . . . 0.0 109.533 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.67 10.47 21.31 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.75 6.06 9.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.27 -1.135 . . . . 0.0 109.496 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -173.28 132.89 0.62 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.926 . . . . 0.0 109.468 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.65 90.8 1.02 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.482 2.122 . . . . 0.0 112.2 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -164.33 -107.73 0.21 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.411 HD23 ' HH ' ' A' ' 106' ' ' TYR . 51.6 tp -157.83 142.24 16.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.295 -1.121 . . . . 0.0 109.67 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.507 HE22 ' CB ' ' A' ' 8' ' ' ALA . 2.7 mt-30 -126.58 136.45 52.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.422 -0.799 . . . . 0.0 109.296 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.557 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 7.1 mt -133.01 113.77 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.387 -0.821 . . . . 0.0 109.875 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.557 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 8.3 m0 -139.77 151.41 45.77 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.073 -1.017 . . . . 0.0 109.378 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.423 HH21 ' HB2' ' A' ' 18' ' ' ARG . 18.1 ttp-105 -99.17 153.11 19.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.851 . . . . 0.0 109.564 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.8 p -89.29 135.68 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.263 -0.898 . . . . 0.0 109.577 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.6 ' O ' ' N ' ' A' ' 22' ' ' PHE . 17.3 tt0 -86.93 151.03 23.66 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.169 -0.957 . . . . 0.0 109.131 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.475 ' O ' ' CD2' ' A' ' 22' ' ' PHE . 3.5 pttm -41.35 -19.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.354 -0.842 . . . . 0.0 109.515 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.6 ' N ' ' O ' ' A' ' 20' ' ' GLU . 26.2 m-85 -161.22 35.38 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.953 . . . . 0.0 109.471 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -174.65 -131.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.178 -0.951 . . . . 0.0 109.572 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.7 tp -143.33 146.23 33.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 109.526 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 t -131.09 95.07 26.04 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.463 -0.773 . . . . 0.0 109.402 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -48.18 147.78 7.91 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.58 2.187 . . . . 0.0 112.176 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.7 t -110.72 101.59 49.72 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.32 -0.862 . . . . 0.0 109.579 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -52.89 163.14 2.17 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.536 2.158 . . . . 0.0 112.402 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.618 ' C ' ' H ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -64.55 175.99 1.24 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.267 -0.896 . . . . 0.0 109.042 179.641 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.452 ' N ' ' OG1' ' A' ' 29' ' ' THR . 0.8 OUTLIER 64.54 -39.26 0.24 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.411 -0.806 . . . . 0.0 109.386 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.618 ' H ' ' C ' ' A' ' 29' ' ' THR . 21.0 mt -83.77 -42.63 16.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.21 -0.931 . . . . 0.0 109.277 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.411 ' C ' ' O ' ' A' ' 31' ' ' LEU . 4.1 p90 -42.66 140.35 1.32 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.36 -0.838 . . . . 0.0 109.448 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.33 -26.35 8.22 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -94.84 154.62 17.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.337 -1.096 . . . . 0.0 109.374 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -141.34 125.64 17.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 109.56 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.588 ' C ' ' H ' ' A' ' 38' ' ' GLY . 36.2 m-85 -84.54 115.97 22.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.932 . . . . 0.0 109.372 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 p -52.95 -4.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.516 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.588 ' H ' ' C ' ' A' ' 36' ' ' PHE . . . -111.06 32.27 6.64 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.442 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 30.6 m-20 -160.16 -173.46 4.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -1.159 . . . . 0.0 109.544 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.88 142.25 46.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.337 -0.852 . . . . 0.0 109.511 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.507 ' OH ' ' CD2' ' A' ' 36' ' ' PHE . 35.1 m-85 -121.45 138.53 54.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.331 -0.856 . . . . 0.0 109.699 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.616 ' O ' ' CE1' ' A' ' 5' ' ' PHE . 1.1 t -118.1 134.44 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.394 -0.816 . . . . 0.0 109.084 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.522 ' CD1' ' C ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -129.99 148.08 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.846 . . . . 0.0 110.206 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.484 ' CD2' ' OG1' ' A' ' 46' ' ' THR . 7.8 tt -139.33 115.87 10.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.471 -0.768 . . . . 0.0 109.597 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -93.87 120.86 34.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.435 -0.791 . . . . 0.0 109.371 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.602 ' O ' ' N ' ' A' ' 13' ' ' GLY . 2.0 m -120.6 127.56 52.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.276 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.664 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 1.4 t -134.29 168.82 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.163 -0.96 . . . . 0.0 109.394 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.427 ' H ' HG12 ' A' ' 47' ' ' VAL . 37.9 tt0 -105.5 115.63 30.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.709 -0.619 . . . . 0.0 109.44 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.492 ' O ' ' C ' ' A' ' 50' ' ' ARG . 86.5 mt -97.71 169.43 9.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 109.436 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.645 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -38.37 151.04 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.326 -0.859 . . . . 0.0 109.368 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 34.0 t30 68.04 -32.22 0.2 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.16 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.645 ' H ' ' C ' ' A' ' 50' ' ' ARG . . . 95.55 54.34 1.45 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 54' ' ' LEU . 16.3 t30 -88.05 6.25 37.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.21 -1.171 . . . . 0.0 109.197 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.664 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 14.5 mt 38.39 95.04 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.608 0.718 . . . . 0.0 109.658 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.446 ' HG2' ' H ' ' A' ' 47' ' ' VAL . 12.2 pt20 -70.0 149.17 48.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 109.065 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.437 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 38.1 m-85 -129.78 114.97 16.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.44 -0.788 . . . . 0.0 110.01 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -124.28 155.26 38.95 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.062 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 pp -151.22 150.07 30.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.822 -1.174 . . . . 0.0 110.713 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.403 ' HD1' ' CB ' ' A' ' 92' ' ' HIS . 22.6 m-70 -127.46 133.88 49.88 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.693 ' HH ' ' HB3' ' A' ' 74' ' ' ALA . 1.0 OUTLIER -108.69 115.92 31.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.402 -0.811 . . . . 0.0 109.208 -179.651 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.59 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 17.4 t90 -109.31 133.49 52.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 109.988 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.59 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 0.2 OUTLIER -127.48 162.15 27.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.397 -0.814 . . . . 0.0 109.292 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.577 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -93.68 153.73 21.38 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -82.23 -11.78 58.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.24 -1.153 . . . . 0.0 109.529 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.11 35.15 3.25 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.683 ' SG ' ' O ' ' A' ' 66' ' ' CYS . 15.9 p -130.09 98.12 4.66 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 122.471 1.129 . . . . 0.0 108.891 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 66' ' ' CYS . 18.4 m -37.0 159.28 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.045 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.553 ' O ' ' N ' ' A' ' 72' ' ' GLY . 39.4 mt-30 -52.11 -17.8 1.21 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.41 -0.806 . . . . 0.0 109.662 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -62.37 -58.56 7.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 0.0 109.386 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.68 -49.4 73.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.361 -0.837 . . . . 0.0 108.854 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.29 -22.55 66.3 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.303 -0.873 . . . . 0.0 108.947 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -73.11 -43.9 37.95 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.94 -44.84 91.64 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.216 -1.167 . . . . 0.0 109.231 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.693 ' HB3' ' HH ' ' A' ' 60' ' ' TYR . . . -62.14 -43.69 98.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.367 -0.833 . . . . 0.0 109.053 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.478 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -58.28 -44.91 88.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.254 -0.904 . . . . 0.0 109.046 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.9 mt -54.14 -50.84 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.391 -0.818 . . . . 0.0 109.074 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -53.79 -38.26 64.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.853 . . . . 0.0 109.122 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.2 m -68.97 -48.92 61.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.407 -0.808 . . . . 0.0 108.978 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.478 HG21 ' O ' ' A' ' 75' ' ' ALA . 42.2 t -57.63 -33.35 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.311 -0.868 . . . . 0.0 109.018 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -42.2 81.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.358 -0.838 . . . . 0.0 108.929 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.77 -42.89 80.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 0.0 108.96 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 85' ' ' LEU . 5.9 t0 -62.54 -56.94 13.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.105 -0.997 . . . . 0.0 108.904 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -47.3 -31.14 3.59 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.171 -0.956 . . . . 0.0 108.607 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -74.0 -30.92 62.72 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.315 -0.866 . . . . 0.0 108.7 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 82' ' ' ASP . 78.3 mt -105.73 24.38 12.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.24 -0.913 . . . . 0.0 109.302 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.458 ' C ' ' O ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER 39.75 33.44 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.437 -0.789 . . . . 0.0 109.463 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.82 73.68 0.59 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 81.9 mtm-85 -143.01 35.05 1.37 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.149 -1.207 . . . . 0.0 109.346 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 56' ' ' TYR . . . -144.02 178.66 7.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -0.88 . . . . 0.0 109.381 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.33 112.82 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.693 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -93.94 121.69 35.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.306 -0.871 . . . . 0.0 109.209 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.403 ' CB ' ' HD1' ' A' ' 59' ' ' HIS . 34.7 m-70 -107.16 104.95 14.72 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -0.946 . . . . 0.0 109.695 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.407 HH21 ' HD2' ' A' ' 93' ' ' ARG . 21.4 mtm105 -75.53 97.36 3.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 0.0 109.073 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.602 ' CD ' ' H ' ' A' ' 100' ' ' SER . 18.0 mm-40 -96.6 137.28 35.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.272 -0.893 . . . . 0.0 109.943 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.6 t -132.85 157.56 43.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.334 -0.854 . . . . 0.0 109.17 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.466 ' C ' ' OE1' ' A' ' 96' ' ' GLN . 1.0 OUTLIER -62.21 117.3 5.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.071 -1.018 . . . . 0.0 109.398 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.74 13.52 69.64 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.83 24.0 0.76 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.146 -1.208 . . . . 0.0 109.625 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.593 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 0.9 OUTLIER -52.64 137.85 29.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 0.0 109.423 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.602 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 28.7 t -64.79 165.49 10.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.294 -0.879 . . . . 0.0 109.634 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.3 -58.13 4.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.915 . . . . 0.0 109.517 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.2 m -46.89 -32.11 3.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 109.429 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.689 ' CE1' ' CE1' ' A' ' 107' ' ' PHE . 23.9 t80 -73.16 -43.3 61.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.366 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.2 mt -69.27 -19.68 63.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.166 -0.959 . . . . 0.0 109.504 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -102.71 -24.98 7.86 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.411 ' HH ' HD23 ' A' ' 14' ' ' LEU . 25.2 t80 -82.14 -36.18 27.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.177 -1.19 . . . . 0.0 109.525 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.689 ' CE1' ' CE1' ' A' ' 103' ' ' PHE . 49.1 m-85 -89.71 81.43 6.42 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.251 -0.906 . . . . 0.0 109.524 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.9 mttt -77.57 -5.43 50.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.4 t -63.96 -7.34 8.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.117 -0.99 . . . . 0.0 109.48 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.43 82.97 0.74 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.555 ' H ' ' CD2' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -67.84 158.06 33.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -1.116 . . . . 0.0 109.379 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -158.38 135.06 9.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.242 -0.911 . . . . 0.0 109.437 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -95.2 153.19 17.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.899 . . . . 0.0 109.261 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.9 tttm -133.62 112.75 11.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.247 -0.908 . . . . 0.0 109.423 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.2 mptt . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.187 -0.946 . . . . 0.0 109.367 179.954 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo . . . . . 0 N--CA 1.492 1.389 0 CA-C-O 121.256 0.44 . . . . 0.0 111.988 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.603 ' C ' ' H ' ' A' ' 6' ' ' LEU . 6.4 mt-10 -83.15 -31.67 27.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 109.72 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.546 ' CE1' ' CG1' ' A' ' 42' ' ' VAL . 13.7 t80 -50.08 -7.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.114 -0.991 . . . . 0.0 109.435 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.603 ' H ' ' C ' ' A' ' 4' ' ' GLU . 13.1 mt -85.79 -26.83 25.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.88 . . . . 0.0 109.506 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.2 pttm -130.94 13.03 5.25 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.39 -0.819 . . . . 0.0 109.566 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.93 153.04 1.93 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.175 -0.953 . . . . 0.0 109.477 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.86 50.66 0.02 OUTLIER Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -150.15 31.36 0.68 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.127 -1.219 . . . . 0.0 109.649 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 13' ' ' GLY . 26.7 mt-10 -147.62 83.26 7.65 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.911 . . . . 0.0 109.394 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.83 80.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.693 2.262 . . . . 0.0 112.398 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 11' ' ' GLU . . . 177.36 -100.18 0.14 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.1 tp -159.37 119.94 3.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.33 -1.1 . . . . 0.0 109.537 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.479 ' OE1' ' OE2' ' A' ' 11' ' ' GLU . 19.0 mt-30 -108.22 127.67 54.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.866 . . . . 0.0 109.366 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.525 ' HA ' HG22 ' A' ' 43' ' ' ILE . 53.0 mt -101.1 144.88 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.312 -0.868 . . . . 0.0 110.042 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -142.85 159.49 42.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.357 -0.84 . . . . 0.0 108.835 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -127.15 143.68 51.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.139 -0.975 . . . . 0.0 109.729 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.419 HG11 ' HB2' ' A' ' 40' ' ' ALA . 9.9 p -78.54 146.09 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.53 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.6 ' O ' ' N ' ' A' ' 22' ' ' PHE . 44.4 tt0 -92.76 154.32 18.37 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.197 -0.939 . . . . 0.0 109.222 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -44.9 -13.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.314 -0.866 . . . . 0.0 109.496 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.6 ' N ' ' O ' ' A' ' 20' ' ' GLU . 74.3 t80 -162.94 28.16 0.1 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.673 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -175.29 -136.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.172 -0.955 . . . . 0.0 109.616 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 24' ' ' LEU . 1.7 mm? -126.76 146.11 50.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.38 -0.825 . . . . 0.0 109.259 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.503 HG21 ' HB2' ' A' ' 20' ' ' GLU . 2.1 t -141.63 130.23 12.19 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 109.017 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.44 174.64 11.82 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.348 2.032 . . . . 0.0 112.313 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.8 t -139.85 121.45 9.71 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.887 . . . . 0.0 109.246 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.76 157.79 35.36 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.296 1.997 . . . . 0.0 112.301 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.64 -11.77 55.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.16 -0.962 . . . . 0.0 109.358 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -74.28 -10.91 60.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 109.387 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 32' ' ' TYR . 91.8 mt -126.56 -20.48 4.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.356 -0.84 . . . . 0.0 109.471 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.51 ' CE2' ' CD1' ' A' ' 16' ' ' ILE . 11.1 t80 -43.16 131.02 4.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.353 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.67 -14.16 8.12 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -101.61 148.18 25.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.193 -1.181 . . . . 0.0 109.627 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -142.09 116.63 9.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.376 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -94.24 125.19 38.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.923 . . . . 0.0 109.501 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.5 p -68.33 -4.84 15.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.171 -0.956 . . . . 0.0 109.301 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.454 ' O ' ' OD2' ' A' ' 39' ' ' ASP . . . -107.51 36.18 4.55 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.454 ' OD2' ' O ' ' A' ' 38' ' ' GLY . 2.1 m-20 -159.93 156.63 27.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.265 -1.138 . . . . 0.0 109.424 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.419 ' HB2' HG11 ' A' ' 19' ' ' VAL . . . -104.63 134.03 48.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.365 -0.834 . . . . 0.0 109.514 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -113.43 134.95 54.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.42 -0.8 . . . . 0.0 109.188 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.546 ' CG1' ' CE1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -111.24 126.12 68.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 O-C-N 121.217 -0.927 . . . . 0.0 108.892 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.536 ' CD1' ' C ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -126.2 134.55 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.197 -0.94 . . . . 0.0 110.417 -179.308 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.47 ' C ' ' CD2' ' A' ' 44' ' ' LEU . 6.9 tt -117.42 115.4 25.13 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -89.95 144.48 25.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 109.786 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.442 ' O ' ' N ' ' A' ' 13' ' ' GLY . 38.4 m -143.4 117.68 9.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 109.083 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.641 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -128.54 168.37 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.142 -0.974 . . . . 0.0 109.234 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -96.32 126.91 41.85 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.545 -0.722 . . . . 0.0 109.451 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.47 HD23 ' OE1' ' A' ' 55' ' ' GLN . 79.2 mt -91.06 166.77 12.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 0.0 109.495 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 49' ' ' LEU . 2.3 mtt-85 -44.67 -57.99 3.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.089 -1.007 . . . . 0.0 109.231 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -66.38 -20.51 66.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.295 -0.878 . . . . 0.0 109.188 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . 89.62 37.34 6.99 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.508 ' O ' ' O ' ' A' ' 54' ' ' LEU . 10.7 m-80 -88.62 14.37 10.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.118 -1.225 . . . . 0.0 109.403 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.641 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.7 mt 44.79 98.44 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.621 0.724 . . . . 0.0 109.418 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.47 ' OE1' HD23 ' A' ' 49' ' ' LEU . 40.3 tt0 -73.9 110.23 8.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.39 -0.819 . . . . 0.0 109.697 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.512 ' CD2' ' O ' ' A' ' 54' ' ' LEU . 85.3 m-85 -95.91 114.3 26.0 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.186 -0.946 . . . . 0.0 109.546 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.28 155.35 24.2 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.456 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 10.6 mt -129.84 133.38 46.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.171 -0.956 . . . . 0.0 109.776 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.693 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.1 OUTLIER -133.43 115.11 14.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.396 -0.815 . . . . 0.0 109.075 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.725 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -99.95 120.58 40.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.258 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 4.4 t90 -93.26 127.03 38.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.892 . . . . 0.0 109.539 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 mt -106.12 161.65 14.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.261 -0.899 . . . . 0.0 109.396 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -109.55 150.9 17.33 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.23 -12.26 61.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -1.182 . . . . 0.0 109.461 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -108.86 26.63 10.35 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.545 ' SG ' ' OE2' ' A' ' 70' ' ' GLU . 5.4 m -130.59 97.44 4.37 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.021 0.915 . . . . 0.0 108.545 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 m -60.46 -170.91 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.782 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.608 ' H ' ' NE2' ' A' ' 68' ' ' GLN . 2.0 mp0 -65.38 -17.8 64.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 0.0 109.696 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.03 -58.84 5.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.112 -0.992 . . . . 0.0 109.481 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.545 ' OE2' ' SG ' ' A' ' 66' ' ' CYS . 22.8 mt-10 -64.07 -46.25 85.18 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.261 -0.899 . . . . 0.0 109.092 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 m -65.54 -26.81 68.05 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.347 -0.846 . . . . 0.0 108.826 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -65.87 -45.86 85.71 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.86 -48.98 74.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -1.157 . . . . 0.0 109.261 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.67 -39.82 92.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.179 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.455 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -65.84 -46.27 79.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.364 -0.835 . . . . 0.0 109.316 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 76' ' ' ILE . 44.6 mt -51.47 -49.22 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.134 -0.979 . . . . 0.0 109.294 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -62.29 -35.25 78.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 109.325 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.452 ' HG1' ' HA ' ' A' ' 75' ' ' ALA . 1.3 m -69.53 -36.42 76.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.372 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 75' ' ' ALA . 63.8 t -68.14 -42.33 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.517 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -62.49 -60.59 3.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 0.0 109.26 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.536 ' CD1' ' C ' ' A' ' 81' ' ' LEU . 0.5 OUTLIER -52.57 -29.18 24.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.215 -0.928 . . . . 0.0 108.835 179.688 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.626 ' O ' ' N ' ' A' ' 86' ' ' ASN . 55.2 t0 -67.47 -57.68 6.09 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.239 -0.913 . . . . 0.0 108.815 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.469 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 88.1 m-20 -45.25 -36.14 3.79 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.201 -0.937 . . . . 0.0 108.579 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.517 ' CD1' ' O ' ' A' ' 84' ' ' TYR . 1.8 t80 -73.66 -31.57 63.55 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 82' ' ' ASP . 96.2 mt -121.65 34.44 5.18 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.461 -0.774 . . . . 0.0 109.419 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.626 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.4 OUTLIER -82.82 27.81 0.52 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.207 -0.933 . . . . 0.0 109.371 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -64.77 -51.15 54.22 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -175.94 34.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.181 -1.188 . . . . 0.0 109.377 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.11 179.02 7.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -0.947 . . . . 0.0 109.529 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 78.9 t -130.39 102.98 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.313 -0.867 . . . . 0.0 109.505 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.587 ' O ' ' NE2' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -97.04 134.83 39.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 109.145 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.615 ' NE2' ' ND1' ' A' ' 59' ' ' HIS . 3.7 p80 -144.35 161.14 39.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.121 -0.987 . . . . 0.0 109.756 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -103.38 121.7 43.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.464 -0.772 . . . . 0.0 109.585 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.561 ' OE2' ' CD2' ' A' ' 103' ' ' PHE . 42.5 mt-10 -102.32 150.58 23.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.357 -0.84 . . . . 0.0 109.164 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.6 t -140.75 161.93 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.113 -0.992 . . . . 0.0 109.567 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -60.84 134.42 57.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 109.597 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.11 -26.23 5.04 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.547 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 71.5 t80 -108.02 10.4 28.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -1.115 . . . . 0.0 109.442 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 98' ' ' PHE . 80.5 mt-10 -43.05 123.61 2.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.875 . . . . 0.0 109.508 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.1 p -55.57 179.69 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.334 -0.854 . . . . 0.0 109.501 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.1 -41.31 82.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.344 -0.847 . . . . 0.0 109.501 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.7 m -48.68 -57.58 6.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.307 -0.87 . . . . 0.0 109.529 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.561 ' CD2' ' OE2' ' A' ' 94' ' ' GLU . 5.9 m-85 -59.18 -53.57 56.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.412 -0.805 . . . . 0.0 109.56 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.58 ' O ' ' CD1' ' A' ' 107' ' ' PHE . 25.7 mt -54.36 -14.66 1.27 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.227 -0.921 . . . . 0.0 109.56 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -104.98 -27.29 5.99 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -79.49 -15.29 58.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.261 -1.14 . . . . 0.0 109.636 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.58 ' CD1' ' O ' ' A' ' 104' ' ' LEU . 3.2 p90 -55.8 128.66 36.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.92 . . . . 0.0 109.589 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -114.92 -55.6 2.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.298 -0.876 . . . . 0.0 109.417 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.5 p -103.74 -8.61 19.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.923 . . . . 0.0 109.466 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.63 109.07 3.33 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.595 ' CD1' ' H ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -53.37 120.03 5.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -1.132 . . . . 0.0 109.469 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -81.42 125.06 29.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.292 -0.88 . . . . 0.0 109.47 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -95.28 144.09 26.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.938 . . . . 0.0 109.425 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -141.7 132.03 25.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 109.407 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 69.6 mttt . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 109.513 -179.908 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.411 ' HB3' HD11 ' A' ' 6' ' ' LEU . 50.8 Cg_exo . . . . . 0 N--CA 1.493 1.483 0 CA-C-O 121.255 0.439 . . . . 0.0 112.167 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 6' ' ' LEU . 34.1 mt-10 -83.27 -46.21 12.92 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.836 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.666 ' CE1' ' CD1' ' A' ' 81' ' ' LEU . 50.2 t80 -47.64 -16.12 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.235 -0.915 . . . . 0.0 109.391 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 4' ' ' GLU . 71.7 mt -84.05 -52.03 6.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 0.0 109.439 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.468 ' O ' ' O ' ' A' ' 8' ' ' ALA . 46.3 mtpt -91.08 5.97 46.82 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.553 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -44.43 169.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.231 -0.918 . . . . 0.0 109.632 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.75 70.75 0.51 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.46 6.63 2.54 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.17 -1.194 . . . . 0.0 109.647 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -172.13 141.97 1.2 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.899 . . . . 0.0 109.409 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.02 84.13 1.53 Allowed 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.675 2.25 . . . . 0.0 112.291 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -164.96 -108.02 0.21 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.3 tt -162.54 148.03 12.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -1.114 . . . . 0.0 109.553 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.428 ' NE2' ' HB3' ' A' ' 8' ' ' ALA . 1.0 OUTLIER -136.51 131.75 34.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.242 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.496 ' HA ' HG23 ' A' ' 43' ' ' ILE . 12.2 mt -102.28 157.63 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.215 -0.928 . . . . 0.0 110.22 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -159.17 130.46 6.2 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.495 -0.753 . . . . 0.0 109.17 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -100.92 152.5 20.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.174 -0.954 . . . . 0.0 109.403 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.4 t -77.03 129.02 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.255 -0.903 . . . . 0.0 109.532 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.711 ' O ' ' N ' ' A' ' 22' ' ' PHE . 27.6 tt0 -80.49 86.82 5.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.126 -0.984 . . . . 0.0 109.479 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.599 ' O ' ' CB ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER 39.35 15.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.574 -0.704 . . . . 0.0 110.081 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.711 ' N ' ' O ' ' A' ' 20' ' ' GLU . 1.4 t80 154.82 -39.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.391 -0.818 . . . . 0.0 109.134 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.42 ' C ' ' H ' ' A' ' 20' ' ' GLU . 1.3 t0 -98.99 -146.56 0.33 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.251 -0.906 . . . . 0.0 109.341 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.426 ' CD2' ' H ' ' A' ' 5' ' ' PHE . 3.3 tp -116.1 138.83 50.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.196 -0.94 . . . . 0.0 109.714 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.2 t -137.98 144.6 44.48 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -69.69 152.04 69.6 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.527 2.151 . . . . 0.0 112.392 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.0 t -120.54 101.61 45.97 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.874 . . . . 0.0 109.376 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -49.64 158.06 2.08 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.561 2.174 . . . . 0.0 112.128 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 31' ' ' LEU . 5.9 m -59.54 -46.26 89.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.915 . . . . 0.0 109.526 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 29' ' ' THR . 3.0 m120 -43.05 -22.14 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.119 -0.988 . . . . 0.0 109.475 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 29' ' ' THR . 79.7 mt -105.63 -25.49 12.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -0.861 . . . . 0.0 109.451 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.454 ' C ' ' O ' ' A' ' 31' ' ' LEU . 2.0 t80 -42.18 129.49 3.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.328 -0.858 . . . . 0.0 109.371 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.443 ' N ' ' CD2' ' A' ' 32' ' ' TYR . . . 100.28 -20.88 46.79 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.43 ' C ' ' CD1' ' A' ' 35' ' ' PHE . 4.3 m-20 -97.83 155.62 16.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.222 -1.163 . . . . 0.0 109.501 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.43 ' CD1' ' C ' ' A' ' 34' ' ' ASP . 57.1 m-85 -146.65 136.05 22.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 109.457 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -97.42 162.83 13.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 109.406 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.7 p -97.97 -4.87 35.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 109.383 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.91 -76.93 1.28 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.97 157.81 32.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -1.085 . . . . 0.0 109.415 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.74 167.2 11.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.444 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -128.47 134.8 48.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 109.52 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.483 HG12 ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -108.7 144.52 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.254 -0.903 . . . . 0.0 109.052 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.72 ' CD1' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -143.88 139.54 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.996 -1.065 . . . . 0.0 110.097 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.52 126.09 46.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.408 -0.808 . . . . 0.0 109.149 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -104.46 130.37 52.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.326 -0.859 . . . . 0.0 109.6 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 13' ' ' GLY . 99.8 m -131.83 125.66 32.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.293 -0.88 . . . . 0.0 109.294 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -133.09 168.46 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 121.175 -0.953 . . . . 0.0 109.357 -179.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -96.29 121.76 38.42 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.681 -0.637 . . . . 0.0 109.324 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 50' ' ' ARG . 11.1 mt -82.59 168.79 16.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.949 . . . . 0.0 109.523 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 49' ' ' LEU . 1.1 tpt180 -43.21 -67.14 0.3 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.251 -0.906 . . . . 0.0 109.261 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -60.18 -26.07 66.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 109.125 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.98 40.2 3.37 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.7 m120 -87.66 14.79 7.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.11 -1.229 . . . . 0.0 109.316 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.626 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 11.7 mt 43.79 96.83 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.511 0.672 . . . . 0.0 109.444 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -69.18 153.62 43.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.528 -0.732 . . . . 0.0 109.245 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.412 ' CD2' ' O ' ' A' ' 54' ' ' LEU . 70.7 m-85 -138.0 114.86 10.7 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.171 -0.956 . . . . 0.0 109.623 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -124.78 116.7 22.72 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.669 ' CD1' ' H ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -102.84 145.72 29.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.134 -0.979 . . . . 0.0 110.076 -179.021 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.532 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 3.1 m-70 -131.34 150.52 52.12 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.469 -0.769 . . . . 0.0 109.4 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.56 ' CE1' ' OG1' ' A' ' 78' ' ' THR . 0.1 OUTLIER -129.37 121.33 27.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.352 -0.843 . . . . 0.0 109.34 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.467 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 44.8 t90 -101.84 123.77 46.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.92 . . . . 0.0 109.59 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.467 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 18.4 mt -104.55 162.04 13.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.279 -0.888 . . . . 0.0 109.382 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.581 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -112.86 162.0 12.5 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -82.14 -11.62 58.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -1.168 . . . . 0.0 109.599 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.68 33.89 4.12 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.657 ' SG ' ' O ' ' A' ' 66' ' ' CYS . 18.0 p -130.58 97.91 4.51 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 122.478 1.133 . . . . 0.0 108.951 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.49 ' O ' ' O ' ' A' ' 66' ' ' CYS . 0.5 OUTLIER -46.57 177.18 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.731 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.555 ' O ' ' N ' ' A' ' 72' ' ' GLY . 4.6 pt20 -66.52 -17.78 65.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.476 -0.765 . . . . 0.0 109.553 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.1 p30 -62.85 -58.43 7.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.263 -0.898 . . . . 0.0 109.626 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -62.04 -51.93 65.99 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.301 -0.874 . . . . 0.0 109.129 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.43 -22.87 66.22 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.405 -0.809 . . . . 0.0 108.879 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -75.16 -46.26 16.74 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.79 -39.09 87.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.186 -1.185 . . . . 0.0 109.151 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.435 ' CB ' ' CZ ' ' A' ' 60' ' ' TYR . . . -59.4 -59.49 5.36 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.394 -0.816 . . . . 0.0 108.968 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -48.25 -43.21 32.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.31 -0.869 . . . . 0.0 109.48 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.8 mt -56.67 -39.14 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.143 -0.973 . . . . 0.0 109.564 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -64.7 -50.48 66.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 109.704 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.56 ' OG1' ' CE1' ' A' ' 60' ' ' TYR . 2.7 m -63.72 -35.03 79.24 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.065 -1.022 . . . . 0.0 108.794 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.5 t -59.59 -41.9 86.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.343 -0.848 . . . . 0.0 108.729 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -62.55 -43.75 98.03 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.666 ' CD1' ' CE1' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -50.83 -45.47 59.62 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.403 -0.811 . . . . 0.0 108.921 179.5 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 85' ' ' LEU . 1.6 m-20 -60.33 -60.42 3.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.294 -0.879 . . . . 0.0 108.967 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 82' ' ' ASP . 39.6 t0 -46.94 -32.99 4.23 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.116 -0.99 . . . . 0.0 108.412 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.468 ' O ' ' CD2' ' A' ' 84' ' ' TYR . 2.8 t80 -74.49 -27.1 60.41 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.568 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.6 tp -110.24 26.47 10.64 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.475 -0.765 . . . . 0.0 109.306 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER 44.71 37.47 2.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.487 -0.758 . . . . 0.0 109.579 179.795 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 53.7 34.13 49.92 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -90.64 31.38 1.05 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -1.138 . . . . 0.0 109.138 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.472 ' HB3' HD13 ' A' ' 58' ' ' LEU . . . -145.24 179.22 7.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.434 -0.791 . . . . 0.0 109.31 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.9 t -119.13 140.83 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -0.964 . . . . 0.0 109.672 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.41 ' CD ' ' N ' ' A' ' 91' ' ' GLN . 0.2 OUTLIER -102.74 149.28 24.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.328 -0.857 . . . . 0.0 109.319 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -124.49 121.78 35.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 109.553 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.415 ' H ' ' HD2' ' A' ' 93' ' ' ARG . 1.5 mpt_? -91.5 105.42 17.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.943 . . . . 0.0 109.063 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.417 ' OE2' ' CD1' ' A' ' 103' ' ' PHE . 35.8 mt-10 -113.12 148.06 36.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.764 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.53 HG13 ' H ' ' A' ' 96' ' ' GLN . 61.5 t -151.9 174.04 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -0.869 . . . . 0.0 109.091 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.53 ' H ' HG13 ' A' ' 95' ' ' VAL . 10.2 tt0 -62.58 115.84 4.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.051 -1.031 . . . . 0.0 109.542 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.95 11.66 82.29 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.47 ' O ' ' C ' ' A' ' 99' ' ' GLU . 3.2 t80 -132.66 19.39 4.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.252 -1.146 . . . . 0.0 109.551 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.564 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 8.8 mp0 -39.63 137.6 0.84 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.549 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.85 166.91 16.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 109.654 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.27 -64.45 0.85 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 0.0 109.448 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.8 m -47.03 -54.86 9.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.207 -0.933 . . . . 0.0 109.198 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.417 ' CD1' ' OE2' ' A' ' 94' ' ' GLU . 3.3 t80 -50.81 -45.27 59.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.471 -0.768 . . . . 0.0 109.295 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.506 ' O ' ' CD1' ' A' ' 107' ' ' PHE . 5.8 mt -59.01 -30.81 68.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.913 . . . . 0.0 109.388 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.79 -19.27 48.5 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.423 ' O ' ' C ' ' A' ' 107' ' ' PHE . 35.4 t80 -76.35 -27.36 56.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.346 -1.091 . . . . 0.0 109.458 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.54 ' CD1' ' O ' ' A' ' 107' ' ' PHE . 1.3 p90 -42.42 125.83 3.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.183 -0.948 . . . . 0.0 109.494 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -110.87 -47.85 3.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.913 . . . . 0.0 109.433 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.6 m -96.67 -28.55 14.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 109.493 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 124.24 112.5 1.98 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.2 mt -57.76 176.69 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.334 -1.098 . . . . 0.0 109.47 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -159.97 122.25 3.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.352 -0.842 . . . . 0.0 109.279 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -106.75 141.66 37.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 109.414 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -146.19 126.29 13.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.887 . . . . 0.0 109.387 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.2 pttp . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.346 -0.846 . . . . 0.0 109.47 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.485 ' HB3' HD11 ' A' ' 6' ' ' LEU . 36.2 Cg_endo . . . . . 0 N--CA 1.492 1.396 0 CA-C-O 121.343 0.476 . . . . 0.0 112.077 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.554 ' H ' HD13 ' A' ' 24' ' ' LEU . 74.7 mt-10 -83.15 -46.24 12.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 109.756 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.519 ' CE2' ' CG1' ' A' ' 42' ' ' VAL . 22.8 t80 -66.95 -18.76 65.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.281 -0.887 . . . . 0.0 109.406 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.485 HD11 ' HB3' ' A' ' 3' ' ' PRO . 10.1 mt -76.61 -37.2 56.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.258 -0.901 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.453 ' O ' ' C ' ' A' ' 8' ' ' ALA . 7.4 mtpm? -86.12 -15.6 40.63 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.334 -0.854 . . . . 0.0 109.335 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -40.94 142.36 0.49 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 109.567 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.26 42.32 0.2 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -140.65 26.38 2.11 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.339 -1.095 . . . . 0.0 109.692 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -148.84 128.1 6.29 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.192 -0.943 . . . . 0.0 109.433 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.81 80.1 2.69 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.494 2.129 . . . . 0.0 112.272 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 173.32 -99.37 0.14 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.9 tt -162.25 152.26 16.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -1.131 . . . . 0.0 109.834 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.4 ' HB3' ' CZ3' ' A' ' 17' ' ' TRP . 42.1 mt-30 -135.74 141.31 44.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 109.367 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 28.5 mt -113.99 139.11 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.36 -0.838 . . . . 0.0 110.1 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.542 ' NE1' ' OE1' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -142.75 156.77 45.05 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.535 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.411 ' O ' ' CD2' ' A' ' 24' ' ' LEU . 18.8 ttt180 -116.29 140.13 49.65 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.172 -0.955 . . . . 0.0 109.62 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.497 HG11 ' HB2' ' A' ' 40' ' ' ALA . 8.4 p -85.33 131.72 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.917 . . . . 0.0 109.409 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.606 ' O ' ' N ' ' A' ' 22' ' ' PHE . 20.4 tt0 -84.06 151.36 25.01 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.165 -0.96 . . . . 0.0 109.225 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.486 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 10.8 ttmm -45.25 -11.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.271 -0.893 . . . . 0.0 109.92 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.606 ' N ' ' O ' ' A' ' 20' ' ' GLU . 20.7 m-85 -162.96 20.97 0.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.961 -1.087 . . . . 0.0 110.065 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.474 ' CG ' ' O ' ' A' ' 22' ' ' PHE . 24.5 m-20 -166.38 -116.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.193 -0.942 . . . . 0.0 109.499 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.554 HD13 ' H ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER -158.19 138.6 12.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -0.892 . . . . 0.0 109.296 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 t -119.98 132.62 24.01 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 0.0 109.282 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.1 136.87 23.07 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.428 2.085 . . . . 0.0 112.343 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.7 t -97.49 112.03 60.12 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.224 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -45.54 127.88 9.98 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.33 2.02 . . . . 0.0 112.104 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.64 -10.11 59.27 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.146 -0.971 . . . . 0.0 109.485 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -90.91 -3.06 57.62 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.237 -0.914 . . . . 0.0 109.113 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 38.4 mt -136.81 -1.93 2.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.288 -0.882 . . . . 0.0 109.801 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.426 ' O ' ' CG ' ' A' ' 32' ' ' TYR . 3.6 p90 -50.42 135.17 22.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.952 . . . . 0.0 109.507 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.94 -25.44 3.21 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.8 105.29 16.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -1.154 . . . . 0.0 109.43 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -96.5 146.26 24.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.511 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -94.46 128.36 40.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.568 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.477 ' OG1' ' OE1' ' A' ' 65' ' ' GLU . 35.7 p -72.24 -4.78 31.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.307 -0.87 . . . . 0.0 109.426 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.44 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -109.67 38.25 3.4 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 22.6 m-20 -163.52 -169.38 1.92 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -1.122 . . . . 0.0 109.465 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.497 ' HB2' HG11 ' A' ' 19' ' ' VAL . . . -136.72 138.28 40.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.401 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -126.01 139.0 53.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.332 -0.855 . . . . 0.0 109.519 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.519 ' CG1' ' CE2' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -105.95 136.97 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 121.178 -0.951 . . . . 0.0 108.767 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.519 ' CD1' ' C ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -127.84 137.17 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.269 -0.895 . . . . 0.0 110.369 -179.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.441 ' C ' ' CD2' ' A' ' 44' ' ' LEU . 6.9 tt -117.83 116.98 28.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.7 -0.625 . . . . 0.0 109.335 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -98.9 118.24 35.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.544 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.4 m -118.62 131.33 56.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.34 -0.85 . . . . 0.0 109.201 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -132.01 168.46 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.193 -0.942 . . . . 0.0 109.569 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.576 ' NE2' ' O ' ' A' ' 49' ' ' LEU . 8.4 tm0? -95.97 112.33 24.09 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.576 ' O ' ' NE2' ' A' ' 48' ' ' GLN . 63.8 mt -72.28 155.61 40.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.924 . . . . 0.0 109.748 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 49' ' ' LEU . 20.9 mtm105 -42.89 -77.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.895 . . . . 0.0 109.388 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 50' ' ' ARG . 4.1 t-20 -43.33 -31.1 0.59 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.166 -0.959 . . . . 0.0 109.259 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.64 75.47 1.16 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.481 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.1 t-20 -132.76 14.09 4.39 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.251 -1.147 . . . . 0.0 109.199 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.621 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 11.9 mt 43.22 95.98 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.386 0.612 . . . . 0.0 109.616 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 47' ' ' VAL . 17.2 tt0 -68.85 154.48 41.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.549 -0.719 . . . . 0.0 109.144 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.599 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 97.6 m-85 -134.53 121.69 21.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 0.0 109.674 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 58' ' ' LEU . 1.5 t0 -133.0 155.44 49.17 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.581 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -143.58 145.79 32.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.825 -1.172 . . . . 0.0 110.388 -179.629 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.477 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -141.06 131.93 25.94 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.401 -0.812 . . . . 0.0 108.957 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.751 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -96.64 120.74 37.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.094 -1.004 . . . . 0.0 109.463 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.517 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 31.2 t90 -89.13 123.71 33.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.876 . . . . 0.0 109.357 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.517 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 6.6 mt -106.36 162.18 13.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.321 -0.862 . . . . 0.0 109.423 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.93 156.59 15.46 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -75.79 -12.24 60.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -1.135 . . . . 0.0 109.357 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.477 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 2.7 mt-10 -106.47 26.25 10.13 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.5 m -130.85 97.51 4.35 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.136 0.969 . . . . 0.0 108.397 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 66' ' ' CYS . 39.7 p -49.82 -177.18 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.589 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.49 ' O ' ' N ' ' A' ' 72' ' ' GLY . 29.2 mt-30 -66.04 -17.82 64.94 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.304 -0.873 . . . . 0.0 109.5 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.503 ' OD2' ' N ' ' A' ' 69' ' ' ASP . 2.5 m-20 -63.75 -58.57 6.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 109.369 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -61.03 -51.02 70.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.288 -0.882 . . . . 0.0 109.131 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.0 m -64.23 -27.37 69.01 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.442 -0.786 . . . . 0.0 109.065 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -69.24 -43.05 72.96 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.04 -41.56 97.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.317 -1.108 . . . . 0.0 109.245 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.52 -47.03 87.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.398 -0.814 . . . . 0.0 109.25 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.89 -46.44 81.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.173 -0.955 . . . . 0.0 109.345 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.2 mt -51.96 -49.82 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.214 -0.929 . . . . 0.0 109.207 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -57.91 -33.92 69.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.866 . . . . 0.0 109.277 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.404 HG21 ' CE1' ' A' ' 60' ' ' TYR . 2.1 m -68.34 -46.79 69.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.231 -0.918 . . . . 0.0 109.263 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.6 t -57.26 -31.93 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.168 -0.957 . . . . 0.0 109.318 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -68.06 -54.44 18.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.913 . . . . 0.0 109.246 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.543 ' CD1' ' C ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -53.47 -29.46 35.98 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.285 -0.884 . . . . 0.0 108.981 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 85' ' ' LEU . 3.4 m-20 -66.53 -59.32 3.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.272 -0.892 . . . . 0.0 108.913 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 82' ' ' ASP . 1.0 OUTLIER -45.62 -34.51 3.48 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.294 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.595 ' CD1' ' O ' ' A' ' 84' ' ' TYR . 0.6 OUTLIER -69.55 -32.56 71.44 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.591 ' N ' ' O ' ' A' ' 82' ' ' ASP . 5.6 mp -104.51 27.39 7.95 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.417 -0.802 . . . . 0.0 109.026 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 85' ' ' LEU . 13.1 m-80 42.7 35.03 0.64 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.449 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 86' ' ' ASN . . . 43.44 85.31 0.01 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -145.61 47.73 1.27 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.202 -1.175 . . . . 0.0 109.384 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -155.1 179.15 9.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.894 . . . . 0.0 109.505 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.505 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 8.7 t -94.58 116.13 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.625 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -109.7 125.36 52.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.268 -0.895 . . . . 0.0 109.193 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.574 ' CD2' ' N ' ' A' ' 92' ' ' HIS . 1.3 p80 -151.0 136.05 17.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.028 -1.045 . . . . 0.0 110.197 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -85.85 131.43 34.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.176 -0.953 . . . . 0.0 109.713 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -100.34 121.37 41.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.95 . . . . 0.0 109.359 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' A' ' 96' ' ' GLN . 44.4 t -89.64 167.71 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 109.615 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.686 ' NE2' ' N ' ' A' ' 97' ' ' GLY . 17.5 tp60 -88.03 136.12 33.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 109.394 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.686 ' N ' ' NE2' ' A' ' 96' ' ' GLN . . . 110.41 -26.91 12.26 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.487 ' O ' ' O ' ' A' ' 99' ' ' GLU . 2.9 t80 -133.21 -30.14 1.36 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.414 -1.051 . . . . 0.0 109.413 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 98' ' ' PHE . 18.1 mp0 47.02 -176.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 109.477 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.6 t -100.92 143.88 30.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 109.53 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -47.65 -40.42 19.73 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.194 -0.941 . . . . 0.0 109.527 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.1 m -54.02 -44.5 71.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.899 . . . . 0.0 109.442 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.81 -55.35 8.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 109.268 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.443 ' O ' ' CD1' ' A' ' 107' ' ' PHE . 92.7 mt -48.15 -21.52 0.5 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.36 -0.838 . . . . 0.0 109.497 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.23 -24.29 9.74 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -84.61 -5.98 59.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -1.183 . . . . 0.0 109.549 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 5.0 p90 -54.03 118.0 3.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.492 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -114.88 -55.79 2.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 109.483 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.1 p -92.63 -14.08 28.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.541 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.15 75.62 1.23 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.707 ' H ' ' CD2' ' A' ' 111' ' ' LEU . 1.1 pt? -56.58 163.31 1.85 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -1.124 . . . . 0.0 109.608 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -141.38 179.75 6.6 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.374 -0.829 . . . . 0.0 109.432 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.99 111.43 7.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 0.0 109.333 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -75.5 110.04 9.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.43 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.9 mttp . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 109.452 179.955 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo . . . . . 0 N--CA 1.492 1.402 0 CA-C-O 121.355 0.481 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -83.24 -28.84 28.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.878 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.581 ' CD2' HG13 ' A' ' 42' ' ' VAL . 5.7 t80 -70.46 -16.05 62.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.785 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.0 mt -83.74 -38.28 21.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 109.446 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 8' ' ' ALA . 48.2 mmtt -95.25 -2.59 49.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.343 -0.848 . . . . 0.0 109.388 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -42.12 139.27 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.885 . . . . 0.0 109.529 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.23 56.83 0.06 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 pttm -137.45 18.7 2.92 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.2 -1.177 . . . . 0.0 109.514 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.469 ' O ' ' OE1' ' A' ' 11' ' ' GLU . 1.7 pp20? -165.93 127.38 1.37 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.419 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.12 85.16 1.7 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.421 2.081 . . . . 0.0 112.148 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -174.62 -103.28 0.16 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.0 tp -153.2 146.73 25.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.356 -1.085 . . . . 0.0 109.608 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -135.89 128.72 31.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.866 . . . . 0.0 109.367 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.5 mt -105.91 150.08 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 0.0 109.557 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.68 135.59 11.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.134 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -104.82 148.61 26.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.27 -0.894 . . . . 0.0 109.568 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.481 ' O ' ' OD1' ' A' ' 39' ' ' ASP . 9.5 p -83.44 146.0 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.42 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.595 ' O ' ' N ' ' A' ' 22' ' ' PHE . 22.8 tt0 -99.3 154.52 18.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 109.382 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 20' ' ' GLU . 39.3 tttm -42.31 -18.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.892 . . . . 0.0 109.599 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.595 ' N ' ' O ' ' A' ' 20' ' ' GLU . 53.5 t80 -163.42 32.67 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.186 -0.946 . . . . 0.0 109.647 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.544 ' OD2' ' N ' ' A' ' 24' ' ' LEU . 9.3 t0 -173.23 -122.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.431 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.544 ' N ' ' OD2' ' A' ' 23' ' ' ASP . 4.6 tp -152.44 146.04 24.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.57 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.62 134.03 25.83 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.398 -0.813 . . . . 0.0 109.17 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.77 146.8 49.1 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.378 2.052 . . . . 0.0 112.16 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.5 t -105.24 105.89 53.73 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.411 -0.806 . . . . 0.0 109.191 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -47.85 127.9 15.22 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.463 2.109 . . . . 0.0 112.358 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.6 m -76.37 -3.6 37.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.32 -0.862 . . . . 0.0 109.285 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.75 -15.2 59.29 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.167 -0.958 . . . . 0.0 109.358 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.465 ' CD1' ' C ' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -156.3 12.5 0.29 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 110.129 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.434 ' C ' ' O ' ' A' ' 31' ' ' LEU . 20.6 p90 -43.35 163.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.127 -0.983 . . . . 0.0 109.377 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.25 -4.71 26.81 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -96.17 102.04 13.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.184 -1.186 . . . . 0.0 109.497 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -96.21 124.43 40.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.243 -0.911 . . . . 0.0 109.511 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -92.16 146.79 23.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.443 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.425 ' OG1' ' CD ' ' A' ' 65' ' ' GLU . 13.3 p -84.46 -15.79 44.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 109.436 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.21 22.91 32.17 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.481 ' OD1' ' O ' ' A' ' 19' ' ' VAL . 3.5 t70 -164.34 150.78 11.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.205 -1.174 . . . . 0.0 109.463 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.481 ' O ' ' OD2' ' A' ' 39' ' ' ASP . . . -92.55 153.08 19.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.391 -0.818 . . . . 0.0 109.528 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -125.01 134.79 52.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.366 -0.834 . . . . 0.0 109.32 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.581 HG13 ' CD2' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -109.93 144.39 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.269 -0.894 . . . . 0.0 109.018 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.782 ' CD1' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -143.32 121.83 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.932 -1.105 . . . . 0.0 109.852 -179.438 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.5 tt -111.35 124.58 52.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.593 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.543 ' CE ' ' OH ' ' A' ' 106' ' ' TYR . 23.2 tttm -101.33 140.47 35.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -0.883 . . . . 0.0 109.225 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 13' ' ' GLY . 98.9 m -139.32 123.22 17.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.88 . . . . 0.0 109.574 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -128.55 168.32 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.171 -0.955 . . . . 0.0 108.894 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -103.64 108.88 20.35 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.58 -0.7 . . . . 0.0 109.411 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 50' ' ' ARG . 14.5 mt -72.8 169.06 17.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 109.564 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' A' ' 49' ' ' LEU . 8.9 tpp85 -43.25 -70.36 0.11 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.217 -0.927 . . . . 0.0 109.252 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -52.74 -31.22 36.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 109.207 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.35 36.74 4.53 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.495 ' O ' ' O ' ' A' ' 54' ' ' LEU . 5.8 t-20 -84.52 13.21 5.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.118 -1.225 . . . . 0.0 109.175 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.645 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.4 mt 44.37 97.63 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.573 0.701 . . . . 0.0 109.418 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -71.39 113.18 8.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.475 -0.766 . . . . 0.0 109.325 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -98.89 114.38 26.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.239 -0.913 . . . . 0.0 109.849 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.439 ' OD1' HG22 ' A' ' 90' ' ' VAL . 4.5 m-20 -118.28 154.98 31.39 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.422 HD12 HD13 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -142.68 144.59 32.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.964 -1.085 . . . . 0.0 110.674 -179.274 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.659 ' CE1' ' CD2' ' A' ' 92' ' ' HIS . 4.2 m-70 -129.62 150.21 51.05 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.614 ' CD1' ' O ' ' A' ' 60' ' ' TYR . 19.8 p90 -128.98 124.95 36.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.205 -0.934 . . . . 0.0 109.434 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.554 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 56.1 t90 -107.78 127.75 53.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.369 -0.832 . . . . 0.0 109.647 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.554 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 24.2 mt -106.65 161.98 14.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.314 -0.866 . . . . 0.0 109.405 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.577 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -109.12 157.49 15.1 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -82.29 -11.81 58.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -1.14 . . . . 0.0 109.545 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.425 ' CD ' ' OG1' ' A' ' 37' ' ' THR . 2.2 mt-10 -110.26 33.11 4.66 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.655 ' SG ' ' O ' ' A' ' 66' ' ' CYS . 18.8 p -130.44 97.66 4.46 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 122.432 1.11 . . . . 0.0 108.965 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.485 ' O ' ' OG ' ' A' ' 71' ' ' SER . 3.1 m -43.77 170.86 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.763 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.493 ' O ' ' N ' ' A' ' 72' ' ' GLY . 19.5 mt-30 -65.44 -17.78 64.81 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.422 -0.799 . . . . 0.0 109.584 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -65.07 -58.59 5.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.52 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -63.7 -47.07 82.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.378 -0.826 . . . . 0.0 109.196 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 67' ' ' SER . 0.2 OUTLIER -68.65 -24.21 64.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.386 -0.821 . . . . 0.0 109.074 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -71.46 -36.02 62.96 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.16 -42.7 62.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -1.152 . . . . 0.0 109.344 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.37 -46.59 88.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.363 -0.836 . . . . 0.0 109.234 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.512 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -59.48 -49.33 78.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.323 -0.861 . . . . 0.0 109.29 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.9 mt -49.26 -42.22 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.252 -0.905 . . . . 0.0 109.239 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -61.75 -45.75 92.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.24 -0.913 . . . . 0.0 109.307 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.9 m -63.08 -40.12 96.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.296 -0.878 . . . . 0.0 109.413 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.512 HG21 ' O ' ' A' ' 75' ' ' ALA . 24.9 t -67.32 -31.9 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.269 -0.894 . . . . 0.0 109.667 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.65 -61.46 1.88 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.261 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.479 ' C ' HD11 ' A' ' 81' ' ' LEU . 1.5 pp -54.13 -28.15 38.02 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.107 -0.996 . . . . 0.0 108.821 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.638 ' O ' ' N ' ' A' ' 86' ' ' ASN . 8.3 t70 -62.83 -54.09 44.24 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.142 -0.974 . . . . 0.0 109.022 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.56 -34.53 62.01 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -77.92 -26.17 48.84 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.658 ' C ' ' H ' ' A' ' 87' ' ' GLY . 7.3 mt -121.49 33.28 5.58 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.535 -0.728 . . . . 0.0 109.484 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.638 ' N ' ' O ' ' A' ' 82' ' ' ASP . 4.6 t-20 -70.42 25.56 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 108.956 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.658 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -68.79 25.63 0.29 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.635 ' H ' ' C ' ' A' ' 86' ' ' ASN . 0.4 OUTLIER 80.87 35.94 0.1 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.427 -1.043 . . . . 0.0 109.704 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.25 179.46 3.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.0 109.123 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.439 HG22 ' OD1' ' A' ' 57' ' ' ASP . 3.8 t -116.2 121.65 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.217 -0.927 . . . . 0.0 109.874 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -97.65 143.26 28.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.107 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.659 ' CD2' ' CE1' ' A' ' 59' ' ' HIS . 33.8 m-70 -120.6 146.61 46.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 109.519 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.405 ' CB ' ' OH ' ' A' ' 60' ' ' TYR . 5.5 ptm180 -116.6 103.01 9.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 0.0 109.617 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.548 ' OE2' ' CG ' ' A' ' 103' ' ' PHE . 42.1 mt-10 -113.78 144.64 42.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.459 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.553 ' CG1' ' H ' ' A' ' 96' ' ' GLN . 47.4 t -149.1 176.56 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.879 . . . . 0.0 109.368 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.553 ' H ' ' CG1' ' A' ' 95' ' ' VAL . 10.4 tp-100 -67.96 118.08 10.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.934 . . . . 0.0 109.453 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.13 11.6 84.93 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.441 ' O ' ' C ' ' A' ' 99' ' ' GLU . 0.3 OUTLIER -140.98 19.32 2.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.163 -1.198 . . . . 0.0 109.485 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 98' ' ' PHE . 22.0 mt-10 -43.27 163.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 109.532 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.0 m -100.12 167.79 10.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.302 -0.873 . . . . 0.0 109.418 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.73 -50.88 31.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.449 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.6 m -46.97 -59.69 2.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.147 -0.971 . . . . 0.0 109.381 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.548 ' CG ' ' OE2' ' A' ' 94' ' ' GLU . 5.4 t80 -53.69 -51.18 64.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.392 -0.818 . . . . 0.0 109.328 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.612 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 6.6 mt -53.35 -18.71 2.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 0.0 109.094 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.81 -21.98 24.62 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.543 ' OH ' ' CE ' ' A' ' 45' ' ' LYS . 3.0 m-85 -73.68 -33.74 64.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.273 -1.134 . . . . 0.0 109.247 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.691 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 1.0 OUTLIER -41.09 108.14 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.356 -0.84 . . . . 0.0 109.599 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -115.37 -47.43 2.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.146 -0.972 . . . . 0.0 109.378 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.7 m -86.11 -29.14 23.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.896 . . . . 0.0 109.522 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 120.48 111.47 2.28 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.4 pp -120.99 166.87 13.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.326 -1.103 . . . . 0.0 109.524 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -172.81 -178.17 1.81 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.638 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -93.52 139.7 30.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.286 -0.884 . . . . 0.0 109.44 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -146.46 105.05 3.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.4 pttt . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 109.402 179.971 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 N--CA 1.491 1.354 0 CA-C-O 121.219 0.425 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -83.18 -38.0 22.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.905 . . . . 0.0 110.022 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.5 ' CE1' ' CG1' ' A' ' 42' ' ' VAL . 22.4 t80 -55.17 -19.85 8.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.101 -1.0 . . . . 0.0 109.519 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.0 mt -83.77 -35.38 24.39 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.183 -0.948 . . . . 0.0 109.466 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 8' ' ' ALA . 2.2 mmmp? -89.68 -0.96 57.87 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.197 -0.939 . . . . 0.0 109.511 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.479 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -42.88 166.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.882 . . . . 0.0 109.546 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.432 ' N ' ' OE1' ' A' ' 15' ' ' GLN . . . 101.34 75.37 1.13 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -142.99 5.49 1.52 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.19 -1.182 . . . . 0.0 109.622 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -172.34 143.27 1.26 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 0.0 109.342 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.38 88.45 1.15 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.585 2.19 . . . . 0.0 112.295 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -172.37 -104.71 0.18 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 tp -156.2 143.39 19.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.263 -1.14 . . . . 0.0 109.697 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.432 ' OE1' ' N ' ' A' ' 9' ' ' GLY . 13.0 mt-30 -129.06 130.65 46.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.363 -0.835 . . . . 0.0 109.237 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.542 ' HA ' HG23 ' A' ' 43' ' ' ILE . 53.2 mt -113.37 137.66 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.263 -0.898 . . . . 0.0 109.958 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -141.61 136.51 31.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.368 -0.832 . . . . 0.0 108.82 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.403 ' HB2' ' CE2' ' A' ' 41' ' ' TYR . 2.3 ttt180 -98.03 150.71 21.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.148 -0.97 . . . . 0.0 109.671 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.473 ' CG1' ' O ' ' A' ' 19' ' ' VAL . 8.1 p -92.12 122.77 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.387 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.611 ' O ' ' N ' ' A' ' 22' ' ' PHE . 4.2 tm-20 -75.12 149.5 39.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.126 -0.984 . . . . 0.0 109.012 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 20' ' ' GLU . 57.9 mttt -40.3 -20.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.447 -0.783 . . . . 0.0 109.841 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.611 ' N ' ' O ' ' A' ' 20' ' ' GLU . 40.4 t80 -151.46 13.24 0.65 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.081 -1.012 . . . . 0.0 109.819 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 20' ' ' GLU . 35.0 m-20 -160.81 -143.06 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.938 . . . . 0.0 109.385 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.42 ' CD2' ' H ' ' A' ' 5' ' ' PHE . 0.8 OUTLIER -129.35 139.83 51.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.31 -0.869 . . . . 0.0 109.571 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 t -119.76 133.06 23.85 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.361 -0.837 . . . . 0.0 108.947 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.62 150.75 45.9 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.431 2.088 . . . . 0.0 112.495 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.8 t -148.79 101.53 3.44 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.306 -0.871 . . . . 0.0 109.214 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -50.1 139.46 34.57 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.591 2.194 . . . . 0.0 112.262 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.475 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 12.4 t -67.53 -21.08 65.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.325 -0.86 . . . . 0.0 109.347 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -77.04 -2.74 35.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.365 -0.835 . . . . 0.0 109.415 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.486 ' O ' ' O ' ' A' ' 32' ' ' TYR . 50.1 mt -124.91 -18.87 5.4 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.339 -0.851 . . . . 0.0 109.5 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.486 ' O ' ' O ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -49.24 -178.61 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.123 -0.986 . . . . 0.0 109.51 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.15 -41.01 2.09 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -98.47 102.37 14.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -1.154 . . . . 0.0 109.495 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -90.33 136.43 33.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.187 -0.946 . . . . 0.0 109.461 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.446 ' CD2' ' OH ' ' A' ' 41' ' ' TYR . 25.1 m-85 -92.9 138.72 31.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 109.435 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.423 ' OG1' ' CD ' ' A' ' 65' ' ' GLU . 55.8 p -80.45 -4.83 55.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.31 -0.869 . . . . 0.0 109.48 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.7 -74.9 1.21 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -78.7 155.05 29.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -1.126 . . . . 0.0 109.601 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.69 165.44 13.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.335 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.446 ' OH ' ' CD2' ' A' ' 36' ' ' PHE . 11.1 m-85 -126.84 136.02 51.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.296 -0.878 . . . . 0.0 109.542 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.543 ' C ' ' CD1' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -111.68 128.6 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.625 ' CD1' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -124.79 141.96 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.949 . . . . 0.0 110.494 -178.667 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.5 tt -128.21 120.6 27.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.55 -0.719 . . . . 0.0 109.081 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.421 ' HZ2' HG23 ' A' ' 47' ' ' VAL . 38.2 tttp -93.11 146.54 23.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.364 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 13' ' ' GLY . 85.1 m -143.16 129.2 19.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.094 -1.004 . . . . 0.0 109.549 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -133.33 168.49 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 121.178 -0.951 . . . . 0.0 109.262 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -101.72 111.0 23.1 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.616 -0.677 . . . . 0.0 109.376 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 52' ' ' GLY . 81.2 mt -74.92 158.28 33.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.227 -0.92 . . . . 0.0 109.572 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.661 ' CD ' ' H ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -44.85 -47.04 11.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.363 -0.836 . . . . 0.0 109.203 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.465 ' N ' ' ND2' ' A' ' 51' ' ' ASN . 0.9 OUTLIER -65.69 -28.82 69.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.279 -0.888 . . . . 0.0 109.203 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . 94.17 30.75 8.51 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.498 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.1 t-20 -89.89 12.78 16.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.085 -1.244 . . . . 0.0 109.373 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.576 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.1 mt 45.12 99.12 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.665 0.745 . . . . 0.0 109.554 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.547 ' CD ' ' N ' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -68.56 152.83 44.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.476 -0.765 . . . . 0.0 109.118 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.547 ' N ' ' CD ' ' A' ' 55' ' ' GLN . 68.4 m-85 -133.05 114.25 13.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.223 -0.923 . . . . 0.0 109.806 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.63 155.72 26.03 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.458 ' C ' ' CD2' ' A' ' 59' ' ' HIS . 1.1 mp -130.41 146.44 51.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.884 -1.135 . . . . 0.0 110.664 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.461 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 6.9 m-70 -136.22 144.19 44.75 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.439 ' CE1' ' HG ' ' A' ' 62' ' ' LEU . 13.5 t80 -129.27 128.97 44.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.245 -0.909 . . . . 0.0 109.857 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -109.2 126.0 52.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.403 -0.811 . . . . 0.0 109.587 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.439 ' HG ' ' CE1' ' A' ' 60' ' ' TYR . 7.9 mt -104.06 162.18 13.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.423 -0.798 . . . . 0.0 109.906 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.57 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -120.54 158.6 15.53 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -82.34 -11.95 58.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.158 -1.201 . . . . 0.0 109.957 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.423 ' CD ' ' OG1' ' A' ' 37' ' ' THR . 0.4 OUTLIER -109.73 35.17 3.45 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.447 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.649 ' SG ' ' O ' ' A' ' 66' ' ' CYS . 18.5 p -130.45 97.76 4.49 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 122.44 1.114 . . . . 0.0 108.916 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 66' ' ' CYS . 1.2 m -52.46 -170.91 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.645 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -76.54 -17.82 59.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 109.561 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -64.18 -58.71 5.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.236 -0.915 . . . . 0.0 109.547 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -66.54 -40.1 88.91 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.375 -0.828 . . . . 0.0 109.123 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.7 t -73.81 -22.75 59.69 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.398 -0.813 . . . . 0.0 109.251 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -75.1 -35.36 49.57 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.75 -46.78 34.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.284 -1.127 . . . . 0.0 109.297 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.423 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -60.15 -39.81 87.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.349 -0.844 . . . . 0.0 109.324 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.46 -49.58 58.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.31 -0.869 . . . . 0.0 109.425 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.413 HG21 ' OE1' ' A' ' 80' ' ' GLN . 39.3 mt -48.31 -42.18 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -0.912 . . . . 0.0 109.411 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -70.06 -36.48 75.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 109.377 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.467 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 5.7 m -68.68 -34.94 76.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.265 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 87.5 t -70.37 -46.65 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.362 -0.836 . . . . 0.0 109.424 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.413 ' OE1' HG21 ' A' ' 76' ' ' ILE . 43.6 mt-30 -64.03 -46.27 85.18 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.295 -0.878 . . . . 0.0 109.192 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.5 mt -56.63 -36.61 69.69 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.261 -0.899 . . . . 0.0 108.88 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 86' ' ' ASN . 0.7 OUTLIER -61.53 -58.12 9.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.298 -0.876 . . . . 0.0 109.154 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.49 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 10.8 m-20 -50.7 -33.11 21.47 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.993 -1.067 . . . . 0.0 108.355 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -78.14 -25.87 47.57 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.63 ' C ' ' H ' ' A' ' 87' ' ' GLY . 8.5 mt -121.38 32.09 6.05 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.497 -0.752 . . . . 0.0 109.371 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 82' ' ' ASP . 26.8 p30 -72.77 26.38 0.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.271 -0.893 . . . . 0.0 108.849 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.63 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -78.25 56.59 4.04 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 62.03 55.23 2.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.477 -1.014 . . . . 0.0 109.69 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.22 179.09 4.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.373 -0.83 . . . . 0.0 109.186 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.1 t -134.68 151.52 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.607 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -115.75 136.63 52.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.383 -0.823 . . . . 0.0 109.416 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.485 ' O ' ' OE2' ' A' ' 94' ' ' GLU . 21.2 m-70 -107.22 110.4 22.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.159 -0.963 . . . . 0.0 109.55 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.1 mtp85 -86.39 92.93 8.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.248 -0.908 . . . . 0.0 109.142 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.485 ' OE2' ' O ' ' A' ' 92' ' ' HIS . 20.2 mp0 -99.87 140.46 34.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.871 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.6 t -132.61 157.35 43.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.417 -0.802 . . . . 0.0 109.123 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.456 ' CD ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -56.99 115.98 2.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.917 . . . . 0.0 109.499 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.89 9.92 65.39 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.456 ' O ' ' C ' ' A' ' 99' ' ' GLU . 11.5 t80 -144.98 30.07 1.18 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -1.156 . . . . 0.0 109.588 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 6.7 mp0 -41.82 157.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 0.0 109.497 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.7 p -87.29 177.76 7.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -0.889 . . . . 0.0 109.564 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.35 -57.01 4.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.458 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.8 m -46.77 -51.18 16.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.189 -0.945 . . . . 0.0 109.269 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.76 -52.5 63.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.387 -0.821 . . . . 0.0 109.203 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.6 mt -49.09 -28.68 4.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.89 . . . . 0.0 109.424 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.56 -14.11 51.44 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.444 ' O ' ' C ' ' A' ' 107' ' ' PHE . 7.2 t80 -83.08 -20.29 35.19 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.269 -1.136 . . . . 0.0 109.564 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.545 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 3.3 p90 -42.31 122.97 2.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.163 -0.961 . . . . 0.0 109.549 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -103.1 -57.12 2.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 109.427 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 72.8 m -106.15 -29.2 10.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -0.874 . . . . 0.0 109.413 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 132.49 107.9 1.09 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.572 ' H ' ' CD2' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -76.42 160.27 29.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.211 -1.17 . . . . 0.0 109.449 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.1 mtpp -153.54 152.05 30.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -0.885 . . . . 0.0 109.511 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -98.28 138.68 35.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 109.421 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -142.5 154.36 44.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.894 . . . . 0.0 109.604 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 71.1 tttt . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.429 179.975 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo . . . . . 0 N--CA 1.488 1.176 0 CA-C-O 121.252 0.438 . . . . 0.0 112.086 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 67.5 tt0 -83.21 -18.02 40.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.355 -0.841 . . . . 0.0 109.999 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.465 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 2.3 m-85 -74.09 -5.91 44.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.092 -1.005 . . . . 0.0 109.541 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.514 HD21 HE21 ' A' ' 80' ' ' GLN . 11.5 mt -85.49 -39.62 17.26 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.205 -0.934 . . . . 0.0 109.417 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 8' ' ' ALA . 41.9 mtpt -97.67 -9.97 25.84 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.352 -0.843 . . . . 0.0 109.515 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -43.84 166.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 0.0 109.577 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.464 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 134.87 -29.9 2.91 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -78.94 23.7 0.34 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.245 -1.15 . . . . 0.0 109.377 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.464 ' H ' ' C ' ' A' ' 9' ' ' GLY . 55.3 mt-10 -137.01 76.77 44.84 Favored Pre-proline 0 C--N 1.305 -1.367 0 O-C-N 121.288 -0.882 . . . . 0.0 109.547 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -52.25 81.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 122.867 2.378 . . . . 0.0 112.207 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 46' ' ' THR . . . 179.65 -102.98 0.17 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.1 tt -162.53 127.53 3.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -1.179 . . . . 0.0 109.81 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.495 ' O ' HG23 ' A' ' 43' ' ' ILE . 35.1 mt-30 -114.42 146.82 40.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.346 -0.846 . . . . 0.0 109.316 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.625 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 11.8 mt -130.68 123.86 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.502 -0.749 . . . . 0.0 110.284 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.625 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 11.3 m0 -143.88 158.94 43.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.043 -1.036 . . . . 0.0 108.528 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.504 ' NE ' ' CZ ' ' A' ' 41' ' ' TYR . 20.8 ttm180 -105.76 152.48 23.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.019 -1.051 . . . . 0.0 110.001 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.6 p -88.38 139.61 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.277 -0.889 . . . . 0.0 109.422 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.595 ' O ' ' N ' ' A' ' 22' ' ' PHE . 18.8 tt0 -88.69 152.61 21.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.23 -0.919 . . . . 0.0 109.203 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 20' ' ' GLU . 24.3 tttt -40.72 -20.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.307 -0.87 . . . . 0.0 109.555 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.595 ' N ' ' O ' ' A' ' 20' ' ' GLU . 7.2 t80 -160.14 32.1 0.17 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.175 -0.953 . . . . 0.0 109.492 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -170.71 -130.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.516 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.9 tp -144.2 146.2 32.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 109.558 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 t -129.3 126.99 23.14 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.017 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -75.21 141.6 26.24 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.368 2.045 . . . . 0.0 112.383 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.5 t -104.35 122.84 42.56 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.379 -0.826 . . . . 0.0 109.242 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.32 162.08 34.14 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.514 2.143 . . . . 0.0 112.28 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.94 -24.64 67.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.216 -0.928 . . . . 0.0 109.428 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -64.02 -10.71 23.43 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 109.429 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 32' ' ' TYR . 94.9 mt -127.26 -13.16 5.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.289 -0.882 . . . . 0.0 109.531 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.531 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 4.4 t80 -41.11 131.05 2.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.372 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 112' ' ' LYS . . . 85.8 15.03 66.3 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -141.24 99.28 3.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -1.145 . . . . 0.0 109.48 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -97.04 164.94 12.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.276 -0.89 . . . . 0.0 109.494 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -105.2 136.08 45.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.449 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.449 ' OG1' ' CD ' ' A' ' 65' ' ' GLU . 4.1 p -73.35 -4.99 36.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.184 -0.948 . . . . 0.0 109.486 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.97 38.75 3.18 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 40' ' ' ALA . 5.9 t0 -171.23 171.01 5.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -1.189 . . . . 0.0 109.489 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.463 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -113.59 136.01 53.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.89 . . . . 0.0 109.546 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.504 ' CZ ' ' NE ' ' A' ' 18' ' ' ARG . 27.7 m-85 -114.91 142.64 46.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.333 -0.854 . . . . 0.0 109.345 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.465 ' HB ' ' CD1' ' A' ' 5' ' ' PHE . 0.3 OUTLIER -113.14 143.96 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.273 -0.892 . . . . 0.0 108.871 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.495 HG23 ' O ' ' A' ' 15' ' ' GLN . 1.2 mm -136.7 151.41 27.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.359 -0.937 . . . . 0.0 110.091 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.425 ' C ' ' CD2' ' A' ' 44' ' ' LEU . 4.5 tt -135.27 121.14 19.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.554 -0.716 . . . . 0.0 109.207 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.411 ' N ' HD23 ' A' ' 44' ' ' LEU . 31.5 tttt -104.96 112.48 25.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.251 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 13' ' ' GLY . 39.1 m -119.78 135.54 54.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.418 -0.801 . . . . 0.0 109.484 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.535 ' O ' HD21 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -126.95 168.29 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 121.304 -0.872 . . . . 0.0 108.907 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 40.9 tp60 -106.9 98.49 8.14 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.611 -0.68 . . . . 0.0 109.422 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.61 ' O ' ' N ' ' A' ' 51' ' ' ASN . 9.3 mt -65.03 157.75 27.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 109.239 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -51.72 84.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.12 -0.988 . . . . 0.0 109.099 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.61 ' N ' ' O ' ' A' ' 49' ' ' LEU . 6.6 m-20 51.43 43.36 29.59 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.229 -0.92 . . . . 0.0 109.192 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.82 -79.9 1.49 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 54' ' ' LEU . 1.2 t30 -174.53 26.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.079 -1.248 . . . . 0.0 109.908 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.616 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 3.9 mt 58.51 106.7 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.666 0.746 . . . . 0.0 109.118 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 46' ' ' THR . 32.1 tt0 -68.82 147.53 51.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.523 -0.735 . . . . 0.0 109.503 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.616 ' CE1' ' O ' ' A' ' 54' ' ' LEU . 97.7 m-85 -129.95 114.67 16.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.48 -0.762 . . . . 0.0 109.507 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.593 ' OD1' ' CE1' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -123.1 154.94 37.92 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.176 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.5 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 1.8 mp -132.93 150.2 52.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.958 -1.089 . . . . 0.0 110.753 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.704 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -141.96 116.93 9.93 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.36 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.667 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -103.8 121.89 43.98 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.023 -1.048 . . . . 0.0 109.52 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.553 ' NE1' ' OE1' ' A' ' 99' ' ' GLU . 71.4 t90 -98.99 136.25 39.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.866 . . . . 0.0 109.725 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.472 HD11 ' H ' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -116.63 159.04 22.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.397 -0.814 . . . . 0.0 109.4 179.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -101.07 148.34 18.1 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -70.37 -12.25 61.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -1.16 . . . . 0.0 109.49 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.449 ' CD ' ' OG1' ' A' ' 37' ' ' THR . 1.7 mt-10 -106.6 31.37 5.29 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.3 m -130.48 97.57 4.43 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.091 0.948 . . . . 0.0 108.513 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 66' ' ' CYS . 94.3 p -52.57 -170.88 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.783 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 72' ' ' GLY . 44.2 tt0 -64.63 -17.95 64.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.367 -0.833 . . . . 0.0 109.537 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -63.29 -58.69 6.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 109.473 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -68.16 -39.46 82.57 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.396 -0.815 . . . . 0.0 108.898 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 t -73.48 -20.98 60.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.515 -0.741 . . . . 0.0 109.064 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -75.66 -41.06 30.19 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.53 -42.16 71.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -1.121 . . . . 0.0 109.22 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.04 98.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.328 -0.858 . . . . 0.0 109.285 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.513 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -64.91 -47.82 76.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.308 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.2 mt -52.76 -37.14 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.348 -0.845 . . . . 0.0 109.235 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.56 -41.34 79.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.342 -0.849 . . . . 0.0 109.293 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.9 m -68.28 -34.45 76.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 109.557 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.513 HG21 ' O ' ' A' ' 75' ' ' ALA . 61.8 t -68.06 -37.99 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.223 -0.923 . . . . 0.0 109.426 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.514 HE21 HD21 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -68.39 -47.03 68.42 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.464 HD12 HD21 ' A' ' 58' ' ' LEU . 0.6 OUTLIER -55.43 -38.13 68.59 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.189 -0.945 . . . . 0.0 108.974 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.628 ' O ' ' N ' ' A' ' 86' ' ' ASN . 16.1 t70 -61.74 -58.33 8.45 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.318 -0.864 . . . . 0.0 109.109 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 82' ' ' ASP . 59.1 m-20 -45.43 -35.09 3.48 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.119 -0.988 . . . . 0.0 108.744 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -74.25 -32.66 63.04 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.361 -0.837 . . . . 0.0 108.834 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.636 ' C ' ' H ' ' A' ' 87' ' ' GLY . 7.7 mt -121.69 36.17 4.69 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.409 -0.807 . . . . 0.0 109.283 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.628 ' N ' ' O ' ' A' ' 82' ' ' ASP . 9.6 p30 -72.03 25.4 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.95 . . . . 0.0 109.143 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.636 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -80.41 -75.65 1.06 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.405 ' HG3' HH21 ' A' ' 88' ' ' ARG . 12.7 mtt85 -152.32 50.65 0.77 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.262 -1.14 . . . . 0.0 109.458 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.485 ' CB ' ' O ' ' A' ' 56' ' ' TYR . . . -96.87 179.14 5.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.404 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.0 t -135.99 96.36 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.282 -0.886 . . . . 0.0 109.532 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 7.2 pt20 -95.87 143.92 26.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.905 . . . . 0.0 109.308 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.664 ' CE1' ' HD1' ' A' ' 59' ' ' HIS . 2.0 p80 -147.09 158.6 43.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.841 -1.162 . . . . 0.0 110.144 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -91.68 126.29 36.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.456 -0.778 . . . . 0.0 109.902 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -107.49 129.91 54.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 109.229 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.491 ' O ' ' OE1' ' A' ' 99' ' ' GLU . 3.4 t -127.57 161.41 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 109.66 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.442 ' C ' ' H ' ' A' ' 98' ' ' PHE . 4.3 tt0 -62.44 145.21 54.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.328 -0.858 . . . . 0.0 109.551 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.69 4.18 6.71 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.447 ' O ' ' C ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -134.08 6.13 3.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -1.101 . . . . 0.0 109.293 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.553 ' OE1' ' NE1' ' A' ' 61' ' ' TRP . 3.5 mp0 -42.64 158.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.417 -0.802 . . . . 0.0 109.351 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.1 m -80.32 147.44 31.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.313 -0.867 . . . . 0.0 109.369 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.71 -33.26 66.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -0.964 . . . . 0.0 109.432 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 99.4 m -68.68 -33.86 74.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -0.916 . . . . 0.0 109.481 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -68.74 -46.6 68.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.361 -0.837 . . . . 0.0 109.422 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.6 mt -69.36 -23.49 63.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.466 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.14 -26.24 22.04 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -77.33 -30.9 54.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.363 -1.081 . . . . 0.0 109.559 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.46 ' CD1' HD22 ' A' ' 111' ' ' LEU . 7.2 m-85 -80.65 129.17 34.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.446 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.446 ' HB2' ' HZ2' ' A' ' 108' ' ' LYS . 1.9 mtmp? -103.21 -12.86 17.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.895 . . . . 0.0 109.457 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.9 t -97.05 -9.21 28.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.927 . . . . 0.0 109.511 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.59 104.48 0.3 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.602 ' H ' ' CD2' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -63.27 179.82 0.39 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -1.123 . . . . 0.0 109.32 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -164.54 167.13 19.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.204 -0.935 . . . . 0.0 109.459 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.5 103.24 5.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 0.0 109.316 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.635 ' HB2' ' HZ3' ' A' ' 114' ' ' LYS . 2.9 ttmp? -79.51 124.06 28.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.897 . . . . 0.0 109.536 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.125 -0.985 . . . . 0.0 109.479 -179.945 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo . . . . . 0 N--CA 1.494 1.511 0 CA-C-O 121.192 0.413 . . . . 0.0 111.994 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.417 ' CB ' ' NE1' ' A' ' 17' ' ' TRP . 6.0 mm-40 -83.42 -46.45 12.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -0.877 . . . . 0.0 109.993 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.493 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 23.1 t80 -65.29 -32.66 74.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.207 -0.933 . . . . 0.0 109.058 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.2 mt -74.01 -35.85 64.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.31 -0.869 . . . . 0.0 109.314 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.497 ' O ' ' O ' ' A' ' 8' ' ' ALA . 12.4 mmmt -82.76 -9.88 59.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.435 -0.79 . . . . 0.0 109.307 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.497 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -45.58 173.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.595 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.4 32.57 1.77 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -150.25 35.61 0.66 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.324 -1.103 . . . . 0.0 109.412 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -155.09 115.5 2.36 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.296 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.15 81.85 2.6 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.442 2.094 . . . . 0.0 112.354 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 46' ' ' THR . . . 175.44 -100.62 0.15 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 tt -161.44 145.06 12.76 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.217 -1.167 . . . . 0.0 109.652 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -133.75 135.96 44.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 109.239 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.536 ' HA ' HG22 ' A' ' 43' ' ' ILE . 13.3 mt -106.83 135.65 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.349 -0.844 . . . . 0.0 110.067 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.417 ' NE1' ' CB ' ' A' ' 4' ' ' GLU . 0.6 OUTLIER -144.34 111.38 5.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.379 -0.825 . . . . 0.0 108.948 179.466 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.569 ' NH2' ' CD1' ' A' ' 36' ' ' PHE . 28.2 ttt180 -74.79 153.03 38.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.192 -0.942 . . . . 0.0 109.473 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.9 p -77.14 145.14 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 109.792 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 22' ' ' PHE . 21.6 tt0 -108.08 154.58 21.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.405 -0.809 . . . . 0.0 109.187 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.591 ' O ' ' CD2' ' A' ' 22' ' ' PHE . 7.2 mtmp? -46.93 -10.86 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.287 -0.883 . . . . 0.0 109.513 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 21' ' ' LYS . 9.5 m-85 -169.53 28.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 109.529 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.458 ' N ' ' HB3' ' A' ' 20' ' ' GLU . 3.7 t70 -176.03 -154.17 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.918 . . . . 0.0 109.592 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.451 HD22 ' C ' ' A' ' 23' ' ' ASP . 4.5 mm? -117.83 146.01 44.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.312 -0.868 . . . . 0.0 109.425 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 18' ' ' ARG . 2.1 t -125.08 130.65 24.12 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.323 -0.861 . . . . 0.0 109.048 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.56 137.61 20.71 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.344 2.029 . . . . 0.0 112.631 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -122.25 101.68 40.88 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.428 -0.795 . . . . 0.0 108.973 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.66 166.93 23.21 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.466 2.111 . . . . 0.0 112.478 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.35 -17.8 22.73 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.22 -0.925 . . . . 0.0 109.31 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.715 HD21 ' N ' ' A' ' 30' ' ' ASN . 0.6 OUTLIER -44.45 -31.18 1.01 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.939 . . . . 0.0 109.361 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.487 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 2.3 pp -160.45 16.64 0.13 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.247 -0.908 . . . . 0.0 109.837 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -56.33 161.4 2.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.992 -1.067 . . . . 0.0 109.423 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.57 -7.77 63.69 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.487 ' OD2' ' O ' ' A' ' 31' ' ' LEU . 11.3 p-10 -93.01 98.14 11.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -1.145 . . . . 0.0 109.373 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.486 ' CE1' HD21 ' A' ' 111' ' ' LEU . 51.1 m-85 -89.61 133.71 34.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.279 -0.888 . . . . 0.0 109.508 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.569 ' CD1' ' NH2' ' A' ' 18' ' ' ARG . 28.2 m-85 -96.52 127.4 42.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 109.525 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 28.5 p -68.83 -4.87 17.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.879 . . . . 0.0 109.576 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.22 43.82 1.54 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -167.99 -168.25 0.95 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.244 -1.15 . . . . 0.0 109.49 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.83 145.25 44.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.959 . . . . 0.0 109.497 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -118.73 135.77 54.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.399 -0.813 . . . . 0.0 109.455 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.553 ' C ' ' CD1' ' A' ' 43' ' ' ILE . 0.9 OUTLIER -115.62 120.11 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.428 -0.795 . . . . 0.0 109.048 179.785 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.59 ' CD1' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -125.1 130.0 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.16 -0.962 . . . . 0.0 110.299 -179.211 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.481 HD13 ' N ' ' A' ' 45' ' ' LYS . 6.0 tp -104.79 121.0 42.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.565 -0.709 . . . . 0.0 109.166 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.513 ' NZ ' ' OH ' ' A' ' 106' ' ' TYR . 8.1 tptm -104.83 103.81 13.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.37 -0.831 . . . . 0.0 109.178 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 55' ' ' GLN . 16.9 m -117.22 139.1 51.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.331 -0.856 . . . . 0.0 109.521 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.489 ' O ' HD23 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -131.65 168.39 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.246 -0.909 . . . . 0.0 109.491 -179.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.794 HE22 ' H ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -111.69 133.49 53.89 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.651 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.626 ' O ' ' C ' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -116.06 100.33 7.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.202 -0.936 . . . . 0.0 109.554 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.626 ' C ' ' O ' ' A' ' 49' ' ' LEU . 31.0 ttt85 21.23 72.54 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.68 -0.638 . . . . 0.0 110.235 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.794 ' H ' HE22 ' A' ' 48' ' ' GLN . 1.8 m120 45.87 52.04 10.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.381 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . -97.11 -81.74 1.6 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -165.15 20.73 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.347 -1.09 . . . . 0.0 109.754 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.592 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 5.9 mt 53.77 104.65 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.489 -0.757 . . . . 0.0 109.306 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.522 ' O ' HG23 ' A' ' 46' ' ' THR . 32.1 tt0 -68.04 149.69 49.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.538 -0.726 . . . . 0.0 109.043 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.592 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 97.1 m-85 -131.47 114.89 15.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.941 . . . . 0.0 109.94 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -120.29 155.03 34.11 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.446 HD12 ' HG3' ' A' ' 91' ' ' GLN . 4.8 mp -136.25 129.78 32.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.947 -1.095 . . . . 0.0 110.162 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.586 ' ND1' ' NE2' ' A' ' 92' ' ' HIS . 3.1 m-70 -115.62 109.65 18.05 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -99.55 115.81 30.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 109.317 -179.61 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -108.16 142.31 38.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.29 -0.881 . . . . 0.0 109.752 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.52 162.21 32.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 109.526 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -87.24 154.41 26.3 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' A' ' 64' ' ' ASN . 3.5 p-10 -82.07 -12.42 58.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -1.122 . . . . 0.0 109.564 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -106.81 32.79 4.3 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.498 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.3 m -130.23 97.67 4.5 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.261 1.029 . . . . 0.0 108.438 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 66' ' ' CYS . 1.2 t -44.32 173.87 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.855 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.596 ' O ' ' N ' ' A' ' 72' ' ' GLY . 3.3 pt20 -57.25 -17.45 11.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.483 -0.761 . . . . 0.0 109.732 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -61.22 -59.1 5.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.054 -1.029 . . . . 0.0 109.384 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.28 -50.75 66.69 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 108.691 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.2 m -64.98 -20.87 66.71 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.15 -43.83 62.55 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.69 -49.07 67.31 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -1.157 . . . . 0.0 109.103 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.69 -43.9 90.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.393 -0.817 . . . . 0.0 109.211 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.553 ' O ' HG22 ' A' ' 79' ' ' VAL . . . -66.73 -47.2 73.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.353 -0.842 . . . . 0.0 109.478 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.421 HD12 HG21 ' A' ' 76' ' ' ILE . 15.9 mt -47.08 -44.12 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.888 . . . . 0.0 109.091 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -65.77 -45.92 80.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.298 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.4 m -66.14 -22.58 66.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.245 -0.909 . . . . 0.0 109.009 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 75' ' ' ALA . 66.3 t -73.57 -50.28 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.288 -0.883 . . . . 0.0 109.459 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -61.66 -49.86 74.84 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.321 -0.862 . . . . 0.0 108.92 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.15 -37.68 67.29 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.28 -0.888 . . . . 0.0 109.037 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 86' ' ' ASN . 64.5 t0 -58.07 -55.87 29.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.226 -0.921 . . . . 0.0 108.883 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.432 ' HA ' HD21 ' A' ' 86' ' ' ASN . 39.4 m-20 -50.32 -33.98 22.08 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.08 -1.012 . . . . 0.0 108.362 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -77.1 -24.27 51.8 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.492 ' C ' ' H ' ' A' ' 87' ' ' GLY . 12.6 mt -121.4 30.45 6.76 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.326 -0.859 . . . . 0.0 109.419 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.5 OUTLIER -80.13 27.99 0.31 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.309 -0.869 . . . . 0.0 108.974 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -83.17 -54.35 3.2 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.6 ptt-85 -175.81 42.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -1.112 . . . . 0.0 109.62 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 56' ' ' TYR . . . -95.53 178.88 5.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.497 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 87.4 t -123.27 91.97 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.437 -0.789 . . . . 0.0 109.337 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.496 ' CD ' ' H ' ' A' ' 91' ' ' GLN . 3.9 mp0 -96.57 125.18 40.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.342 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.586 ' NE2' ' ND1' ' A' ' 59' ' ' HIS . 2.7 p80 -133.52 143.78 48.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.143 -0.973 . . . . 0.0 109.618 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -99.32 105.29 17.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.227 -0.92 . . . . 0.0 109.69 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.483 ' OE1' ' OG ' ' A' ' 100' ' ' SER . 41.0 mt-10 -87.11 148.16 25.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.321 -0.862 . . . . 0.0 109.391 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 t -135.28 163.46 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.196 -0.94 . . . . 0.0 109.487 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 97' ' ' GLY . 6.2 tp-100 -75.4 126.35 30.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.242 -0.911 . . . . 0.0 109.557 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.548 ' N ' ' OE1' ' A' ' 96' ' ' GLN . . . 121.19 4.58 10.03 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.459 ' O ' ' C ' ' A' ' 99' ' ' GLU . 35.9 t80 -174.0 -34.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.226 -1.161 . . . . 0.0 109.448 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 98' ' ' PHE . 14.1 mt-10 41.64 -155.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.356 -0.84 . . . . 0.0 109.569 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.483 ' OG ' ' OE1' ' A' ' 94' ' ' GLU . 78.7 p -129.78 134.3 47.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 109.5 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 100' ' ' SER . . . -44.81 -37.66 3.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.292 -0.88 . . . . 0.0 109.38 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 m -55.54 -48.34 74.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.231 -0.918 . . . . 0.0 109.346 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -62.69 -55.64 25.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 0.0 109.194 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.3 mt -47.39 -26.67 1.38 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.877 . . . . 0.0 109.242 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.71 -40.16 7.83 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.513 ' OH ' ' NZ ' ' A' ' 45' ' ' LYS . 2.7 m-85 -51.87 -46.71 64.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -1.114 . . . . 0.0 109.314 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -139.27 149.71 44.61 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.387 -0.821 . . . . 0.0 109.6 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.89 -56.82 2.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 0.0 109.286 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 110' ' ' GLY . 5.0 m -103.02 -26.81 12.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.496 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 109' ' ' SER . . . -42.44 -59.93 2.94 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.486 HD21 ' CE1' ' A' ' 35' ' ' PHE . 13.9 mt -44.87 134.28 5.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.257 -1.143 . . . . 0.0 109.445 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.3 mttp -151.23 121.56 7.31 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.224 -0.923 . . . . 0.0 109.406 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.448 ' CD2' ' N ' ' A' ' 113' ' ' TYR . 0.6 OUTLIER -98.0 127.8 44.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.302 -0.874 . . . . 0.0 109.443 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -135.42 134.13 39.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 109.457 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 31.9 mtmt . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.146 -0.971 . . . . 0.0 109.506 179.991 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo . . . . . 0 N--CA 1.493 1.476 0 CA-C-O 121.272 0.447 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.707 ' HA ' ' HZ3' ' A' ' 7' ' ' LYS . 4.4 mm-40 -83.41 -37.4 23.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 109.973 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.592 ' CE1' ' CG1' ' A' ' 42' ' ' VAL . 23.5 t80 -70.07 -24.29 63.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.175 -0.953 . . . . 0.0 110.031 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 mt -80.76 -40.34 25.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.081 -1.012 . . . . 0.0 109.677 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.707 ' HZ3' ' HA ' ' A' ' 4' ' ' GLU . 4.2 pttm -96.51 3.45 52.7 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.294 -0.879 . . . . 0.0 109.587 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -54.03 -165.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.77 64.9 1.35 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.18 17.96 1.91 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.336 -1.097 . . . . 0.0 109.588 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.476 ' O ' ' OE1' ' A' ' 11' ' ' GLU . 1.9 pp20? -156.18 134.15 7.05 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.18 -0.95 . . . . 0.0 109.421 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.34 84.65 1.67 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.526 2.151 . . . . 0.0 112.286 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 46' ' ' THR . . . 178.35 -100.55 0.14 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.403 HD11 ' HG3' ' A' ' 45' ' ' LYS . 5.5 tt -162.21 152.63 17.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.24 -1.153 . . . . 0.0 109.487 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -135.36 142.24 45.7 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.272 -0.892 . . . . 0.0 109.553 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.3 mt -117.22 133.16 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.32 -0.863 . . . . 0.0 109.801 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -139.26 119.37 13.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.313 -0.867 . . . . 0.0 109.085 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.474 HH11 ' CB ' ' A' ' 39' ' ' ASP . 15.3 ttt85 -85.47 153.62 22.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.235 -0.916 . . . . 0.0 109.647 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.406 HG11 ' N ' ' A' ' 22' ' ' PHE . 38.8 t -91.99 123.49 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.218 -0.926 . . . . 0.0 110.043 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.763 ' O ' ' N ' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -71.02 85.82 0.72 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.982 -1.074 . . . . 0.0 108.482 179.405 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.652 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 48.8 tttt 43.63 6.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.361 -0.837 . . . . 0.0 109.415 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.763 ' N ' ' O ' ' A' ' 20' ' ' GLU . 0.7 OUTLIER 160.92 -30.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.849 . . . . 0.0 109.292 -179.802 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -95.08 -129.52 0.14 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.179 -0.951 . . . . 0.0 110.076 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.8 mt -139.99 142.65 36.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.127 -0.983 . . . . 0.0 110.265 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 18' ' ' ARG . 3.4 t -142.11 110.29 5.97 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.831 . . . . 0.0 108.96 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -46.27 151.59 1.63 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.067 1.845 . . . . 0.0 111.808 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.11 101.47 45.04 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.944 . . . . 0.0 109.61 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.02 162.58 1.83 Allowed 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.506 2.138 . . . . 0.0 112.257 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.6 m -78.22 -34.79 49.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 109.348 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -56.63 -16.95 7.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.405 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.458 ' O ' ' C ' ' A' ' 32' ' ' TYR . 15.6 mt -112.35 -25.96 8.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.263 -0.898 . . . . 0.0 109.551 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.566 ' OH ' ' CE2' ' A' ' 107' ' ' PHE . 19.0 t80 -41.63 137.08 1.7 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.891 . . . . 0.0 109.453 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.44 -16.71 48.27 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -100.18 121.96 42.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -1.189 . . . . 0.0 109.438 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -102.53 121.58 42.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.189 -0.945 . . . . 0.0 109.536 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -95.96 144.23 26.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.465 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.4 p -97.05 -10.22 26.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -100.22 34.23 5.69 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.474 ' CB ' HH11 ' A' ' 18' ' ' ARG . 4.8 m-20 -163.78 -177.1 4.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -1.149 . . . . 0.0 109.496 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.406 ' C ' ' CD2' ' A' ' 41' ' ' TYR . . . -140.46 146.9 38.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.256 -0.903 . . . . 0.0 109.405 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.585 ' OH ' ' CZ3' ' A' ' 61' ' ' TRP . 0.1 OUTLIER -142.56 137.88 30.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.121 -0.987 . . . . 0.0 109.793 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.592 ' CG1' ' CE1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -101.29 144.23 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.507 ' CD1' ' C ' ' A' ' 42' ' ' VAL . 0.6 OUTLIER -128.02 134.37 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.512 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.48 ' C ' ' CD2' ' A' ' 44' ' ' LEU . 4.7 tt -109.66 116.2 31.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.627 -0.671 . . . . 0.0 109.397 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.403 ' HG3' HD11 ' A' ' 14' ' ' LEU . 8.5 ttpt -92.43 139.48 30.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.219 -0.926 . . . . 0.0 109.44 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.525 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.6 OUTLIER -143.07 118.62 10.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.119 -0.988 . . . . 0.0 109.413 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.692 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -128.24 167.97 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.109 -0.995 . . . . 0.0 109.224 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -95.37 120.25 35.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.571 -0.705 . . . . 0.0 109.433 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 52' ' ' GLY . 82.2 mt -74.86 168.8 19.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -0.956 . . . . 0.0 109.487 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 49' ' ' LEU . 13.5 ttt-85 -43.31 -48.92 6.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.273 -0.892 . . . . 0.0 109.177 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 33.0 t-20 -81.49 -12.07 58.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.308 -0.87 . . . . 0.0 109.132 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . 88.77 31.85 12.09 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.499 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.8 m120 -78.65 13.92 1.48 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.13 -1.217 . . . . 0.0 109.206 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.692 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.0 mt 43.82 96.8 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 121.438 0.637 . . . . 0.0 109.566 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.507 ' HB2' HD21 ' A' ' 49' ' ' LEU . 28.1 tp60 -77.67 118.09 19.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.386 -0.821 . . . . 0.0 109.465 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -96.16 114.14 25.81 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.137 -0.977 . . . . 0.0 109.585 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.602 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -113.43 150.2 33.09 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.189 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.486 HD23 ' O ' ' A' ' 57' ' ' ASP . 4.1 mm? -117.1 136.56 52.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.089 -1.007 . . . . 0.0 110.068 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.578 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 27.2 m-70 -135.43 125.48 26.0 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.515 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 9.4 t80 -117.36 135.18 54.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 109.819 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.585 ' CZ3' ' OH ' ' A' ' 41' ' ' TYR . 27.9 t90 -120.2 124.24 45.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.413 -0.804 . . . . 0.0 109.289 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.545 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 0.2 OUTLIER -112.86 162.31 15.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.359 -0.838 . . . . 0.0 109.523 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.02 156.1 19.62 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -78.12 -11.71 59.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.391 -1.064 . . . . 0.0 109.482 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -102.25 32.41 3.54 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.498 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.0 OUTLIER -130.79 97.56 4.38 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.181 0.991 . . . . 0.0 108.359 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 66' ' ' CYS . 20.6 t -42.02 167.97 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.785 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.564 ' O ' ' N ' ' A' ' 72' ' ' GLY . 27.0 tt0 -56.59 -17.76 9.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.901 . . . . 0.0 109.592 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -62.6 -58.65 6.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 109.376 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.557 ' N ' ' CD ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -63.07 -48.63 77.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 0.0 109.079 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.43 ' HA ' ' HH ' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -68.8 -21.62 64.31 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.311 -0.868 . . . . 0.0 109.055 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -75.65 -40.5 31.76 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.59 -39.2 77.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.194 -1.18 . . . . 0.0 109.162 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.515 ' CB ' ' CZ ' ' A' ' 60' ' ' TYR . . . -65.81 -46.53 78.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.489 -0.757 . . . . 0.0 109.226 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.3 -37.52 80.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.311 -0.868 . . . . 0.0 109.337 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.8 mt -60.88 -49.25 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.41 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -65.56 -31.43 72.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.279 -0.888 . . . . 0.0 109.405 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 74' ' ' ALA . 1.1 m -72.8 -41.95 64.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.225 -0.922 . . . . 0.0 109.278 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 89.8 t -63.34 -35.83 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.243 -0.91 . . . . 0.0 109.297 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -65.67 -51.37 59.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.331 -0.856 . . . . 0.0 109.071 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 mt -51.72 -39.49 58.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.034 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 85' ' ' LEU . 13.4 t0 -60.16 -58.75 7.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.307 -0.87 . . . . 0.0 109.144 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 82' ' ' ASP . 24.0 t0 -45.14 -34.16 2.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.207 -0.933 . . . . 0.0 108.881 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -76.57 -28.25 56.17 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.309 -0.869 . . . . 0.0 108.868 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.555 ' N ' ' O ' ' A' ' 82' ' ' ASP . 11.5 mt -121.69 32.14 5.99 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.354 -0.841 . . . . 0.0 109.736 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 82' ' ' ASP . 24.2 t-20 -79.34 27.51 0.26 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.165 -0.959 . . . . 0.0 109.13 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -89.9 -49.22 3.4 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.434 ' CG ' ' O ' ' A' ' 87' ' ' GLY . 57.8 mtm-85 -158.41 41.61 0.26 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.248 -1.148 . . . . 0.0 109.462 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -127.63 165.25 20.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.399 -0.813 . . . . 0.0 109.226 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.479 ' CG1' ' N ' ' A' ' 91' ' ' GLN . 98.6 t -135.92 167.34 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.914 . . . . 0.0 109.589 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.697 ' H ' ' NE2' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -119.31 134.51 55.17 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.39 -0.819 . . . . 0.0 109.465 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.578 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 20.2 m-70 -105.72 105.14 15.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 109.582 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.2 mtm180 -77.95 102.4 7.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.946 . . . . 0.0 109.309 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.558 ' OE2' ' CD2' ' A' ' 103' ' ' PHE . 50.2 mt-10 -102.33 134.09 46.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.189 -0.944 . . . . 0.0 109.747 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.482 HG11 ' H ' ' A' ' 96' ' ' GLN . 3.1 t -132.88 168.62 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.401 -0.812 . . . . 0.0 109.269 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.482 ' H ' HG11 ' A' ' 95' ' ' VAL . 4.5 tt0 -69.94 118.34 12.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 109.57 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.514 ' O ' ' CD1' ' A' ' 98' ' ' PHE . . . 91.0 11.29 61.67 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 24.8 m-85 -152.55 24.66 0.6 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -1.161 . . . . 0.0 109.665 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 98' ' ' PHE . 27.6 mt-10 -42.82 150.96 0.14 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.173 -0.955 . . . . 0.0 109.409 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.8 p -78.24 168.14 20.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.226 -0.921 . . . . 0.0 109.553 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.45 -61.68 1.78 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -0.906 . . . . 0.0 109.485 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.4 m -47.25 -45.04 23.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.377 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.558 ' CD2' ' OE2' ' A' ' 94' ' ' GLU . 29.1 t80 -58.67 -53.49 57.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.38 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.7 mt -56.1 -28.83 59.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.89 . . . . 0.0 109.386 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -78.0 -25.54 61.9 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -77.83 -30.08 50.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -1.158 . . . . 0.0 109.338 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.566 ' CE2' ' OH ' ' A' ' 32' ' ' TYR . 54.3 m-85 -139.06 127.35 22.74 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.256 -0.902 . . . . 0.0 109.35 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.473 ' HZ3' ' HB2' ' A' ' 108' ' ' LYS . 12.6 ttmm -105.51 -57.01 2.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 109.51 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.0 t -106.03 15.2 26.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.497 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -106.33 28.42 13.68 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.406 HD21 ' N ' ' A' ' 111' ' ' LEU . 0.3 OUTLIER -140.69 54.78 1.59 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.281 -1.129 . . . . 0.0 109.558 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -73.87 135.67 43.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.317 -0.865 . . . . 0.0 109.486 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.496 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 0.9 OUTLIER -92.37 111.32 22.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.472 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -107.99 121.14 44.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.313 -0.867 . . . . 0.0 109.582 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 58.6 mttt . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.504 179.937 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo . . . . . 0 N--CA 1.493 1.475 0 CA-C-O 121.295 0.456 . . . . 0.0 112.091 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 8' ' ' ALA . 41.9 mt-10 -83.13 -45.74 13.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.126 -0.984 . . . . 0.0 109.703 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.617 ' CZ ' HG13 ' A' ' 42' ' ' VAL . 68.2 t80 -48.67 -22.57 0.8 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -0.908 . . . . 0.0 109.287 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.568 HD21 HD12 ' A' ' 81' ' ' LEU . 85.1 mt -83.61 -40.52 18.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 109.484 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' ALA . 42.8 mmtm -101.24 7.15 43.1 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.39 -0.819 . . . . 0.0 109.549 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 4' ' ' GLU . . . -56.01 -164.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.421 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 104.86 -27.67 17.94 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -75.76 21.51 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -1.152 . . . . 0.0 109.4 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.499 ' H ' ' C ' ' A' ' 9' ' ' GLY . 26.9 mm-40 -135.12 115.43 11.95 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.259 -0.9 . . . . 0.0 109.356 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.86 73.85 5.5 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.376 2.051 . . . . 0.0 112.277 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -177.28 -103.34 0.17 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.507 ' C ' ' CD2' ' A' ' 14' ' ' LEU . 3.3 tt -162.26 146.98 12.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.239 -1.153 . . . . 0.0 109.581 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.421 ' N ' HD22 ' A' ' 14' ' ' LEU . 24.0 mt-30 -139.3 145.53 39.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.28 -0.887 . . . . 0.0 109.347 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.55 HD12 ' CE1' ' A' ' 32' ' ' TYR . 10.7 mt -114.18 146.52 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.396 -0.815 . . . . 0.0 110.198 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.451 ' CZ2' ' CB ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER -149.55 138.73 21.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.435 -0.791 . . . . 0.0 109.063 179.665 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -96.67 144.64 26.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 109.473 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.4 p -81.02 143.82 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 109.494 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.58 ' O ' ' N ' ' A' ' 22' ' ' PHE . 39.9 tt0 -103.3 153.41 20.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.368 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 20' ' ' GLU . 7.6 mtmp? -41.48 -20.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.648 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.58 ' N ' ' O ' ' A' ' 20' ' ' GLU . 3.0 p90 -160.99 30.52 0.14 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.17 -0.956 . . . . 0.0 109.524 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.41 ' N ' ' HB3' ' A' ' 20' ' ' GLU . 9.8 t70 -174.07 -130.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -0.912 . . . . 0.0 109.53 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.5 mp -144.34 146.07 32.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.322 -0.861 . . . . 0.0 109.562 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 t -126.31 112.93 23.55 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.393 -0.817 . . . . 0.0 109.427 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.49 152.64 5.89 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.436 2.091 . . . . 0.0 112.313 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.9 t -110.39 101.89 49.81 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.898 . . . . 0.0 109.317 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -48.43 143.47 15.45 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.476 2.117 . . . . 0.0 112.319 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.583 ' C ' ' H ' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -55.96 -44.11 78.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.876 . . . . 0.0 109.376 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 30' ' ' ASN . 1.4 t-20 -56.72 -2.6 0.08 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 0.0 109.481 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.583 ' H ' ' C ' ' A' ' 29' ' ' THR . 86.4 mt -129.23 -10.73 4.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.202 -0.936 . . . . 0.0 109.551 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.55 ' CE1' HD12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -41.84 124.37 2.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -0.89 . . . . 0.0 109.453 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.39 -9.37 57.46 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -97.98 107.13 19.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.184 -1.186 . . . . 0.0 109.462 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -96.15 150.52 20.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.89 . . . . 0.0 109.536 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -105.03 112.14 25.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 109.402 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.1 p -58.36 -17.07 17.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 109.586 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.447 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -88.15 10.71 69.88 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.447 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 46.6 m-20 -159.49 170.56 21.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.225 -1.162 . . . . 0.0 109.511 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -109.76 152.38 25.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.387 -0.821 . . . . 0.0 109.504 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -122.12 134.9 54.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.337 -0.852 . . . . 0.0 109.239 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.617 HG13 ' CZ ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -103.19 138.38 27.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.143 -0.973 . . . . 0.0 108.91 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 42' ' ' VAL . 0.9 OUTLIER -131.25 145.62 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.615 -179.357 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.415 ' CD2' ' OG1' ' A' ' 46' ' ' THR . 3.9 tt -123.64 118.45 27.3 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -103.94 103.77 13.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.358 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.552 ' O ' ' N ' ' A' ' 13' ' ' GLY . 33.8 m -112.63 137.15 51.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 109.423 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -133.03 168.58 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 121.158 -0.964 . . . . 0.0 109.586 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -102.58 100.74 10.84 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.8 mt -69.19 168.34 14.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.739 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.535 ' CD ' ' H ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -48.23 -73.18 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.331 -0.855 . . . . 0.0 109.265 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 50' ' ' ARG . 1.9 m120 -43.63 -25.9 0.2 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.303 -0.873 . . . . 0.0 109.16 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 50' ' ' ARG . . . 89.03 36.68 7.55 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.515 ' O ' ' O ' ' A' ' 54' ' ' LEU . 51.2 m-20 -87.61 12.81 11.63 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.15 -1.206 . . . . 0.0 109.361 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.598 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 11.1 mt 42.56 97.3 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 121.455 0.645 . . . . 0.0 109.443 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.427 ' O ' ' CG2' ' A' ' 46' ' ' THR . 7.4 tt0 -68.07 154.09 42.38 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.239 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.598 ' CE1' ' O ' ' A' ' 54' ' ' LEU . 95.6 m-85 -133.74 114.82 13.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.295 -0.878 . . . . 0.0 109.66 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -121.0 155.12 35.02 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.468 HD11 ' N ' ' A' ' 58' ' ' LEU . 3.2 mp -138.78 129.06 25.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.943 -1.098 . . . . 0.0 109.972 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -121.3 127.39 51.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.415 -0.803 . . . . 0.0 109.024 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.704 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -106.15 124.9 50.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.187 -0.946 . . . . 0.0 109.537 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.498 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 39.2 t90 -102.88 123.89 47.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.216 -0.927 . . . . 0.0 109.354 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.498 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 20.1 mt -102.73 162.01 13.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.49 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.0 155.99 15.81 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -78.98 -11.97 60.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.188 -1.183 . . . . 0.0 109.448 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -106.44 24.37 12.67 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.496 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.7 m -130.95 97.56 4.35 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.163 0.982 . . . . 0.0 108.473 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 66' ' ' CYS . 9.9 m -51.48 -171.25 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.673 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.594 ' N ' ' OE1' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -70.74 -17.6 62.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.349 -0.845 . . . . 0.0 109.516 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -62.29 -58.64 6.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.13 -0.981 . . . . 0.0 109.435 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.508 ' N ' ' CD ' ' A' ' 70' ' ' GLU . 3.3 mp0 -65.87 -45.06 83.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.32 -0.863 . . . . 0.0 108.894 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.2 t -69.67 -20.97 63.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.331 -0.856 . . . . 0.0 109.041 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -73.25 -41.01 47.96 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.92 -46.09 66.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.298 -1.119 . . . . 0.0 109.247 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.46 -44.58 92.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.349 -0.844 . . . . 0.0 109.23 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.45 ' O ' HG22 ' A' ' 79' ' ' VAL . . . -61.12 -47.58 85.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.275 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.5 mt -49.62 -46.34 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 109.241 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -61.01 -40.53 93.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 109.345 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.4 m -67.02 -31.52 72.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.159 -0.963 . . . . 0.0 109.33 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 75' ' ' ALA . 91.2 t -66.0 -44.19 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.335 -0.853 . . . . 0.0 109.334 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -61.63 -50.92 70.6 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.281 -0.887 . . . . 0.0 109.192 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.568 HD12 HD21 ' A' ' 6' ' ' LEU . 4.1 mt -54.55 -41.4 69.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.341 -0.849 . . . . 0.0 109.069 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.627 ' O ' ' N ' ' A' ' 86' ' ' ASN . 27.1 t70 -61.69 -54.97 35.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.238 -0.914 . . . . 0.0 109.133 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -47.76 -32.21 5.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.081 -1.012 . . . . 0.0 108.858 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -77.64 -31.77 52.91 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.481 ' C ' ' H ' ' A' ' 87' ' ' GLY . 53.2 mt -121.59 33.49 5.5 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.369 -0.832 . . . . 0.0 109.427 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.627 ' N ' ' O ' ' A' ' 82' ' ' ASP . 38.4 t30 -79.71 27.7 0.28 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.211 -0.931 . . . . 0.0 109.16 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -78.12 -45.57 10.09 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -173.34 33.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -1.121 . . . . 0.0 109.299 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.53 179.1 7.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.182 -0.949 . . . . 0.0 109.433 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.5 t -127.11 128.03 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.843 . . . . 0.0 109.546 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -96.06 137.2 35.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.384 -0.823 . . . . 0.0 109.357 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -126.59 126.85 44.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.156 -0.965 . . . . 0.0 109.662 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 -100.74 95.99 7.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -0.874 . . . . 0.0 109.3 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.455 ' OE1' ' CD1' ' A' ' 103' ' ' PHE . 81.9 mt-10 -97.36 138.84 34.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.919 . . . . 0.0 109.712 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.4 t -145.01 163.75 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.344 -0.848 . . . . 0.0 109.305 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -53.28 117.9 3.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.43 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.09 13.88 81.38 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.439 ' O ' ' C ' ' A' ' 99' ' ' GLU . 6.4 t80 -135.54 17.49 3.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.243 -1.151 . . . . 0.0 109.443 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.586 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 11.1 mp0 -41.46 148.22 0.15 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 109.564 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.2 t -87.2 166.81 14.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -0.889 . . . . 0.0 109.488 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.53 -65.1 0.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.533 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 51.4 m -47.55 -51.56 20.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.261 -0.899 . . . . 0.0 109.422 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.455 ' CD1' ' OE1' ' A' ' 94' ' ' GLU . 14.5 t80 -54.46 -44.79 72.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.417 -0.802 . . . . 0.0 109.437 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.9 mt -60.82 -34.16 74.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.955 . . . . 0.0 109.415 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.07 -22.57 70.98 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -79.5 -29.21 41.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -1.12 . . . . 0.0 109.365 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -139.12 120.84 15.31 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.303 -0.873 . . . . 0.0 109.457 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -101.67 -56.65 2.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.512 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.5 t -103.3 -13.25 16.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 109.51 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.3 -12.82 64.02 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.4 mt -71.94 121.2 18.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.175 -1.191 . . . . 0.0 109.499 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -148.55 154.7 40.13 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.188 -0.945 . . . . 0.0 109.417 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -135.97 134.59 38.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.365 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.89 105.87 16.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 109.338 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.202 -0.936 . . . . 0.0 109.488 179.915 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo . . . . . 0 N--CA 1.492 1.416 0 CA-C-O 121.233 0.43 . . . . 0.0 112.043 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -83.08 -28.7 29.33 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.618 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.554 ' CE1' ' CG1' ' A' ' 42' ' ' VAL . 69.0 t80 -58.46 -16.55 15.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.142 -0.974 . . . . 0.0 109.354 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.405 HD23 ' HG ' ' A' ' 81' ' ' LEU . 3.3 mt -90.24 -34.88 15.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.218 -0.926 . . . . 0.0 109.553 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 8' ' ' ALA . 30.8 mttm -87.59 -15.22 37.98 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.272 -0.892 . . . . 0.0 109.672 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -42.45 128.95 3.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 0.0 109.406 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.38 30.55 0.03 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.434 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -129.64 38.36 3.86 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.308 -1.113 . . . . 0.0 109.379 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 13' ' ' GLY . 31.1 mt-10 -157.78 79.75 3.31 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.298 -0.876 . . . . 0.0 109.31 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.1 80.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.792 2.328 . . . . 0.0 112.148 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 11' ' ' GLU . . . 177.58 -99.87 0.13 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.485 ' C ' ' CD2' ' A' ' 14' ' ' LEU . 7.1 tt -156.94 125.7 5.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -1.138 . . . . 0.0 109.727 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -112.66 133.45 54.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.384 -0.822 . . . . 0.0 109.239 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.488 ' HA ' HG23 ' A' ' 43' ' ' ILE . 5.7 mt -101.25 146.68 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.365 -0.834 . . . . 0.0 110.16 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.78 139.25 27.7 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -108.45 140.32 41.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.2 -0.938 . . . . 0.0 109.404 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.9 p -84.01 138.33 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.914 . . . . 0.0 109.495 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.609 ' O ' ' N ' ' A' ' 22' ' ' PHE . 18.5 tt0 -88.19 154.32 20.53 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.327 -0.858 . . . . 0.0 109.043 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.542 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 39.9 mttp -40.39 -20.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 109.664 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.609 ' N ' ' O ' ' A' ' 20' ' ' GLU . 63.6 m-85 -160.09 21.82 0.16 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 0.0 109.679 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.434 ' N ' ' HB3' ' A' ' 20' ' ' GLU . 2.9 m-20 -160.23 -128.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 0.0 109.429 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 mt -145.53 146.09 31.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.208 -0.932 . . . . 0.0 109.584 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 t -131.31 133.81 24.97 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.316 -0.865 . . . . 0.0 108.963 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -72.63 146.9 44.53 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.367 2.045 . . . . 0.0 112.431 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -119.23 105.15 44.94 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.359 -0.838 . . . . 0.0 109.272 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.535 ' C ' ' H ' ' A' ' 30' ' ' ASN . 61.3 Cg_endo -79.93 148.81 19.91 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.417 2.078 . . . . 0.0 112.469 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.508 ' CG2' ' O ' ' A' ' 29' ' ' THR . 14.7 m -63.32 1.32 0.52 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.2 -0.938 . . . . 0.0 109.368 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.535 ' H ' ' C ' ' A' ' 28' ' ' PRO . 14.8 m120 -76.09 -19.1 58.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.334 -0.854 . . . . 0.0 109.37 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.49 ' CD1' ' C ' ' A' ' 31' ' ' LEU . 2.6 pp -148.26 2.64 0.66 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 110.289 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -55.58 173.5 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.87 -1.143 . . . . 0.0 109.366 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.76 -32.14 6.59 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -99.45 100.59 11.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.348 -1.089 . . . . 0.0 109.527 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.605 ' CZ ' ' CZ3' ' A' ' 61' ' ' TRP . 45.5 m-85 -86.93 137.51 32.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.482 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -88.34 131.21 34.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 109.441 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.4 p -73.99 -6.42 47.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.369 -0.832 . . . . 0.0 109.409 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.437 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -97.31 20.59 50.13 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 9.7 m-20 -167.35 146.15 4.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -1.112 . . . . 0.0 109.449 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.92 149.33 21.94 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.216 -0.928 . . . . 0.0 109.399 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -117.15 139.02 51.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 109.351 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.554 ' CG1' ' CE1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -105.58 129.36 58.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 121.177 -0.952 . . . . 0.0 108.623 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.529 ' CD1' ' C ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -126.21 134.25 66.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.231 -0.918 . . . . 0.0 110.421 -179.315 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.514 ' CD2' ' OG1' ' A' ' 46' ' ' THR . 7.7 tt -114.94 115.84 27.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.58 -0.7 . . . . 0.0 109.114 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -92.42 114.3 26.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.939 . . . . 0.0 109.534 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.514 ' OG1' ' CD2' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -113.89 129.23 56.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.181 -0.949 . . . . 0.0 109.524 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -132.18 168.48 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 121.071 -1.018 . . . . 0.0 109.252 -179.852 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -98.54 117.36 32.79 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.58 -0.7 . . . . 0.0 109.401 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.6 mt -81.05 160.83 24.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -0.911 . . . . 0.0 109.609 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 25.0 mtt180 -51.44 -65.49 0.55 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.336 -0.852 . . . . 0.0 109.305 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -48.27 -29.58 3.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.263 -0.898 . . . . 0.0 109.252 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.76 71.29 1.12 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 54' ' ' LEU . 4.3 t-20 -134.85 13.46 3.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.287 -1.125 . . . . 0.0 109.32 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.591 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 11.7 mt 45.71 99.69 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.579 0.704 . . . . 0.0 109.535 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -68.6 152.1 45.83 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.498 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 61.3 m-85 -129.49 116.56 19.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 109.866 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.36 155.17 36.58 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.545 ' C ' ' CD2' ' A' ' 59' ' ' HIS . 2.6 mt -132.83 150.18 52.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.913 -1.117 . . . . 0.0 110.172 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.545 ' CD2' ' C ' ' A' ' 58' ' ' LEU . 4.6 m-70 -143.26 123.09 13.43 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.71 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -100.62 129.57 46.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.082 -1.011 . . . . 0.0 109.641 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.605 ' CZ3' ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -102.85 123.83 47.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.345 -0.847 . . . . 0.0 109.314 179.835 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.7 mt -102.15 162.07 13.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.402 -0.811 . . . . 0.0 109.461 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.25 157.69 14.88 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -75.68 -12.29 60.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.324 -1.104 . . . . 0.0 109.566 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -106.84 23.21 14.71 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.9 m -131.09 97.5 4.32 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.06 0.933 . . . . 0.0 108.514 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 m -59.6 -170.98 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.593 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 72' ' ' GLY . 37.2 tt0 -61.6 -17.95 57.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 109.559 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -63.87 -58.81 5.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.955 . . . . 0.0 109.46 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.69 -42.5 91.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.446 -0.784 . . . . 0.0 108.987 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 m -71.08 -23.28 62.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.389 -0.82 . . . . 0.0 109.016 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -71.53 -40.11 60.0 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.38 -49.09 52.72 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.261 -1.141 . . . . 0.0 109.25 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.15 -45.66 83.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.374 -0.829 . . . . 0.0 109.058 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.444 ' O ' HG22 ' A' ' 79' ' ' VAL . . . -58.54 -51.29 70.53 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.406 -0.809 . . . . 0.0 109.189 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.6 mt -48.9 -41.08 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -0.942 . . . . 0.0 109.209 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.45 -43.24 99.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.222 -0.924 . . . . 0.0 109.101 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 86.3 m -61.05 -49.45 77.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.145 -0.972 . . . . 0.0 109.093 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 75' ' ' ALA . 10.6 t -51.06 -40.06 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.238 -0.913 . . . . 0.0 109.211 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.428 ' HA ' HE21 ' A' ' 80' ' ' GLN . 5.3 mm-40 -61.25 -48.21 82.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.36 -0.838 . . . . 0.0 109.082 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.521 ' CD1' ' CE1' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -50.71 -40.17 53.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.32 -0.862 . . . . 0.0 108.929 179.63 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 85' ' ' LEU . 10.3 m-20 -61.89 -61.8 2.24 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.16 -0.962 . . . . 0.0 109.069 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -47.31 -30.62 3.25 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.049 -1.032 . . . . 0.0 108.445 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -76.81 -27.06 55.04 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.562 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.9 mt -113.87 27.23 9.69 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.37 -0.831 . . . . 0.0 109.169 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 44.47 38.36 2.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.377 -0.827 . . . . 0.0 109.479 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 56.35 31.19 59.4 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 85' ' ' LEU . 21.4 ttt-85 -92.69 31.92 1.3 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.204 -1.174 . . . . 0.0 109.38 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 56' ' ' TYR . . . -141.14 161.17 38.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.526 -0.734 . . . . 0.0 109.395 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 38.8 t -96.0 146.26 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.263 -0.898 . . . . 0.0 109.426 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.615 ' CD ' ' H ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -111.4 131.59 55.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.382 -0.824 . . . . 0.0 109.314 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.472 ' CG ' ' ND1' ' A' ' 59' ' ' HIS . 20.3 m-70 -115.68 136.35 53.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.866 . . . . 0.0 109.414 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.431 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 3.9 ptp180 -102.71 92.92 4.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.22 -0.925 . . . . 0.0 109.309 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.499 ' OE1' ' CD2' ' A' ' 103' ' ' PHE . 13.6 mt-10 -92.88 128.94 38.92 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.148 -0.97 . . . . 0.0 109.538 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.5 t -132.94 163.52 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.336 -0.852 . . . . 0.0 109.241 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.621 ' OE1' ' N ' ' A' ' 97' ' ' GLY . 0.8 OUTLIER -62.22 115.59 4.27 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.238 -0.914 . . . . 0.0 109.429 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.621 ' N ' ' OE1' ' A' ' 96' ' ' GLN . . . 90.38 5.74 69.31 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.475 ' O ' ' O ' ' A' ' 99' ' ' GLU . 5.1 t80 -143.26 32.6 1.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.366 -1.079 . . . . 0.0 109.526 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.593 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 2.4 mp0 -41.51 164.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.537 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.62 161.69 19.16 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.09 -60.39 2.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.477 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 76.9 m -46.95 -41.35 15.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.145 -0.972 . . . . 0.0 109.355 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.499 ' CD2' ' OE1' ' A' ' 94' ' ' GLU . 1.6 m-85 -69.9 -41.1 75.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.352 -0.843 . . . . 0.0 109.383 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.5 mt -58.79 -23.67 60.59 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.175 -0.953 . . . . 0.0 109.451 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -105.43 -12.94 25.68 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -86.42 -37.67 18.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -1.188 . . . . 0.0 109.602 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -84.37 117.78 23.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.309 -0.869 . . . . 0.0 109.638 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -115.0 3.0 14.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.395 -0.815 . . . . 0.0 109.387 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.0 m -89.31 -4.65 58.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 109.54 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.53 97.32 0.43 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.541 ' H ' ' CD2' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -77.78 165.74 23.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.158 -1.201 . . . . 0.0 109.509 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.442 ' CG ' ' O ' ' A' ' 111' ' ' LEU . 38.3 mtmt -158.41 152.2 23.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.246 -0.908 . . . . 0.0 109.475 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.445 ' OH ' ' CD ' ' A' ' 99' ' ' GLU . 53.8 m-85 -101.51 125.2 48.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.373 -0.83 . . . . 0.0 109.438 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.0 120.04 25.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.489 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.42 -179.987 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo . . . . . 0 N--CA 1.493 1.46 0 CA-C-O 121.266 0.444 . . . . 0.0 111.857 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -83.33 -43.43 15.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.296 -0.877 . . . . 0.0 110.071 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.593 ' CE2' ' CG1' ' A' ' 42' ' ' VAL . 21.6 t80 -50.94 -41.45 59.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.134 -0.979 . . . . 0.0 109.606 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 mp -69.4 -27.83 65.63 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.121 -0.987 . . . . 0.0 109.51 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -96.4 3.84 52.59 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.237 -0.914 . . . . 0.0 109.38 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.554 ' HB3' HD13 ' A' ' 44' ' ' LEU . . . -59.52 151.9 23.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.216 -0.928 . . . . 0.0 109.517 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.9 45.19 0.07 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -149.08 24.23 0.93 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.276 -1.132 . . . . 0.0 109.564 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -146.55 117.65 4.76 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.278 -0.889 . . . . 0.0 109.338 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.7 91.25 1.2 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.387 2.058 . . . . 0.0 112.221 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.07 -95.38 0.12 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 tp -160.23 130.35 5.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.318 -1.107 . . . . 0.0 109.627 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -113.88 135.71 53.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 109.355 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.2 mt -115.56 136.01 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.345 -0.847 . . . . 0.0 109.99 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.44 134.67 31.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.425 -0.797 . . . . 0.0 108.969 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 25' ' ' VAL . 33.5 ttt180 -98.38 153.54 18.49 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.201 -0.937 . . . . 0.0 109.444 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.1 t -106.13 123.49 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.18 -0.95 . . . . 0.0 109.593 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.658 ' C ' ' H ' ' A' ' 22' ' ' PHE . 5.2 tt0 -72.06 87.04 1.05 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.107 -0.996 . . . . 0.0 108.915 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.579 ' O ' ' CB ' ' A' ' 22' ' ' PHE . 16.5 tttm 49.04 2.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.359 -0.838 . . . . 0.0 109.85 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.658 ' H ' ' C ' ' A' ' 20' ' ' GLU . 2.1 t80 158.01 -29.34 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.289 -0.882 . . . . 0.0 109.422 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.76 -157.83 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.932 . . . . 0.0 109.584 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.26 132.75 56.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.287 -0.883 . . . . 0.0 109.344 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.545 ' CG2' ' N ' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -129.9 120.81 19.58 Favored Pre-proline 0 N--CA 1.487 1.387 0 O-C-N 121.311 -0.868 . . . . 0.0 109.227 -179.686 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.88 132.0 11.52 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.303 2.002 . . . . 0.0 112.238 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.7 t -110.34 101.57 48.65 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.335 -0.853 . . . . 0.0 109.394 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -51.22 156.56 5.25 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.434 2.089 . . . . 0.0 112.208 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.3 m -66.89 -12.2 58.57 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.328 -0.857 . . . . 0.0 109.488 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.481 ' OD1' ' O ' ' A' ' 30' ' ' ASN . 23.9 t-20 -75.98 -10.03 59.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.357 -0.839 . . . . 0.0 109.522 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 32' ' ' TYR . 96.3 mt -122.83 -23.35 5.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -0.847 . . . . 0.0 109.417 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 33' ' ' GLY . 1.7 t80 -42.88 138.33 2.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.617 ' N ' ' CD1' ' A' ' 32' ' ' TYR . . . 125.95 -28.68 4.83 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -107.19 148.19 29.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -1.152 . . . . 0.0 109.531 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -142.06 114.16 8.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 109.424 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -79.39 159.05 27.25 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.529 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.1 p -97.74 -4.77 36.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 109.447 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.445 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -88.28 16.4 52.72 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 7.6 m-20 -159.23 164.07 35.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -1.163 . . . . 0.0 109.544 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -108.29 151.98 25.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 0.0 109.406 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 41' ' ' TYR . 4.0 m-85 -130.21 134.61 47.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.884 . . . . 0.0 109.667 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.593 ' CG1' ' CE2' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -105.4 139.44 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 121.182 -0.949 . . . . 0.0 108.596 179.202 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.523 ' CD1' ' C ' ' A' ' 42' ' ' VAL . 0.4 OUTLIER -128.01 134.72 64.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.27 -0.894 . . . . 0.0 110.213 -179.421 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.554 HD13 ' HB3' ' A' ' 8' ' ' ALA . 7.2 tt -115.86 109.57 17.81 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -82.42 144.31 30.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.363 -0.835 . . . . 0.0 109.098 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.2 m -143.24 129.01 19.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.09 -1.006 . . . . 0.0 109.725 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -134.18 168.56 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 O-C-N 121.143 -0.973 . . . . 0.0 109.208 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -99.31 118.04 35.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.68 -0.638 . . . . 0.0 109.422 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 93.4 mt -81.9 165.08 21.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 109.605 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -45.35 -58.39 3.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.94 . . . . 0.0 109.145 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -61.52 -27.03 68.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.915 . . . . 0.0 109.151 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.01 33.29 6.68 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.5 ' O ' ' O ' ' A' ' 54' ' ' LEU . 5.8 t30 -85.58 12.67 8.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -1.187 . . . . 0.0 109.304 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.578 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 12.3 mt 44.91 98.38 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 121.563 0.697 . . . . 0.0 109.468 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.418 ' HG3' ' N ' ' A' ' 56' ' ' TYR . 3.3 tp-100 -68.56 155.84 39.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.505 -0.747 . . . . 0.0 109.072 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 79.6 m-85 -138.16 114.35 10.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.163 -0.96 . . . . 0.0 109.803 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.425 ' O ' HD21 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -114.38 155.25 26.65 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.136 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.522 HD23 HD22 ' A' ' 81' ' ' LEU . 11.2 mt -125.16 150.29 47.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.023 -1.048 . . . . 0.0 110.372 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.483 ' HD1' ' CG ' ' A' ' 92' ' ' HIS . 10.6 m-70 -145.18 130.43 18.57 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.441 ' CE2' HG11 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -111.69 138.87 47.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.951 -1.093 . . . . 0.0 110.063 -179.297 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -111.41 123.55 50.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.392 -0.817 . . . . 0.0 108.987 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 49.6 mt -104.18 145.92 29.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.386 -0.821 . . . . 0.0 109.413 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.9 152.2 19.84 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -80.21 -12.02 59.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -1.121 . . . . 0.0 109.478 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -107.93 31.87 5.18 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.571 ' SG ' ' OE2' ' A' ' 70' ' ' GLU . 2.1 m -130.56 97.5 4.4 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 122.043 0.925 . . . . 0.0 108.533 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 66' ' ' CYS . 30.0 m -45.63 175.89 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.78 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.48 ' O ' ' N ' ' A' ' 72' ' ' GLY . 39.0 tt0 -64.63 -17.7 64.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 0.0 109.621 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -63.14 -58.59 6.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 109.344 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.571 ' OE2' ' SG ' ' A' ' 66' ' ' CYS . 11.5 mt-10 -64.84 -44.31 90.19 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.356 -0.84 . . . . 0.0 109.034 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.55 -26.85 67.33 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.429 -0.795 . . . . 0.0 109.02 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.15 -48.17 40.8 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.18 -35.36 76.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.342 -1.093 . . . . 0.0 109.098 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.28 -51.95 66.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.418 -0.801 . . . . 0.0 109.211 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.94 -46.93 68.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 109.232 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.3 mt -51.9 -47.92 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.271 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -54.61 -44.06 72.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.31 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.426 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 0.9 OUTLIER -54.08 -50.97 65.59 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.3 -0.875 . . . . 0.0 109.507 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.5 t -61.18 -35.39 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.361 -0.837 . . . . 0.0 109.63 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -64.57 -58.83 5.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.898 . . . . 0.0 109.302 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.56 ' CD1' ' C ' ' A' ' 81' ' ' LEU . 0.1 OUTLIER -53.81 -33.51 56.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 108.911 179.828 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 85' ' ' LEU . 0.9 OUTLIER -65.73 -55.13 18.93 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.22 -0.925 . . . . 0.0 108.891 179.531 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 82' ' ' ASP . 8.7 t70 -45.87 -37.47 6.3 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -68.53 -33.39 74.02 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 82' ' ' ASP . 4.8 tp -105.81 28.15 7.82 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.496 -0.752 . . . . 0.0 109.268 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 85' ' ' LEU . 26.6 m-20 42.49 36.25 0.76 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.459 -0.776 . . . . 0.0 109.436 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 46.29 35.12 6.65 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.7 mmm-85 -86.46 29.97 0.74 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.137 -1.213 . . . . 0.0 109.106 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -144.13 166.9 23.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.565 -0.71 . . . . 0.0 109.376 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 t -100.62 153.9 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.44 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -117.57 130.29 56.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.392 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.483 ' CG ' ' HD1' ' A' ' 59' ' ' HIS . 15.5 m-70 -105.5 104.93 14.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 109.521 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.84 97.99 6.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.253 -0.904 . . . . 0.0 109.229 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.476 ' OE1' ' CG ' ' A' ' 103' ' ' PHE . 39.3 mt-10 -100.47 148.76 24.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.348 -0.845 . . . . 0.0 109.722 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.2 t -137.68 166.12 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.327 -0.858 . . . . 0.0 109.27 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.5 ' O ' ' OE1' ' A' ' 96' ' ' GLN . 1.4 tm0? -59.86 116.81 4.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 109.481 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.2 12.24 81.09 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.445 ' O ' ' C ' ' A' ' 99' ' ' GLU . 2.4 t80 -137.51 20.79 2.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -1.167 . . . . 0.0 109.569 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 98' ' ' PHE . 7.5 mm-40 -42.16 156.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.918 . . . . 0.0 109.469 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.2 p -88.01 174.29 8.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -0.961 . . . . 0.0 109.491 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.09 -53.69 7.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.492 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.1 m -47.07 -46.78 22.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 0.0 109.459 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' A' ' 106' ' ' TYR . 0.2 OUTLIER -67.46 -54.07 23.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.391 -0.818 . . . . 0.0 109.397 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 103' ' ' PHE . 29.5 mt -44.57 -26.36 0.36 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.228 -0.92 . . . . 0.0 109.462 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -99.95 -17.09 26.37 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.492 ' N ' ' O ' ' A' ' 103' ' ' PHE . 14.4 t80 -81.73 -13.43 57.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.292 -1.122 . . . . 0.0 109.559 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.534 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 8.7 p90 -45.95 122.48 3.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.137 -0.977 . . . . 0.0 109.589 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -111.19 -56.41 2.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 109.349 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.4 t -90.88 0.38 57.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.891 . . . . 0.0 109.501 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 111' ' ' LEU . . . 87.3 68.96 1.31 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 110' ' ' GLY . 2.3 pp -42.96 155.24 0.06 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.305 -1.115 . . . . 0.0 109.453 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -154.23 135.99 14.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.455 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 0.0 OUTLIER -104.21 140.02 38.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.318 -0.864 . . . . 0.0 109.47 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -108.26 120.93 43.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.853 . . . . 0.0 109.333 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.2 mttm . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 109.396 180.0 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo . . . . . 0 N--CA 1.493 1.46 0 CA-C-O 121.039 0.35 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 8' ' ' ALA . 61.5 mm-40 -83.45 -46.71 12.19 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.104 -0.998 . . . . 0.0 110.259 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.508 ' CZ ' ' O ' ' A' ' 42' ' ' VAL . 21.7 m-85 -66.94 -43.35 83.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.078 -1.014 . . . . 0.0 109.151 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.747 ' CD1' ' H ' ' A' ' 6' ' ' LEU . 3.0 mp -62.36 -33.9 75.62 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.343 -0.848 . . . . 0.0 109.628 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -106.35 9.1 31.97 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.248 -0.907 . . . . 0.0 109.605 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 4' ' ' GLU . . . -62.73 -162.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.194 -0.941 . . . . 0.0 109.395 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.45 58.02 1.31 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -146.63 10.88 1.09 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.267 -1.137 . . . . 0.0 109.452 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -161.92 124.32 1.73 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.258 -0.901 . . . . 0.0 109.282 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.87 82.28 2.19 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.396 2.064 . . . . 0.0 112.348 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -164.61 -108.05 0.21 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.6 tt -162.71 143.5 9.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.326 -1.102 . . . . 0.0 109.439 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -129.48 144.0 51.07 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.235 -0.916 . . . . 0.0 109.523 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.604 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 9.2 mt -126.58 125.85 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.418 -0.801 . . . . 0.0 109.992 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.604 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 8.1 m0 -145.22 155.85 43.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.205 -0.934 . . . . 0.0 109.061 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.438 ' N ' HG21 ' A' ' 27' ' ' VAL . 7.8 ttp180 -95.94 153.17 17.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.063 -1.023 . . . . 0.0 109.386 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.0 p -94.48 133.35 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.212 -0.93 . . . . 0.0 109.739 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.636 ' O ' ' N ' ' A' ' 22' ' ' PHE . 17.9 tt0 -82.0 154.71 25.55 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.338 -0.851 . . . . 0.0 108.768 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 20' ' ' GLU . 39.7 mttt -38.35 -22.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.394 -0.816 . . . . 0.0 109.683 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.636 ' N ' ' O ' ' A' ' 20' ' ' GLU . 3.4 t80 -158.75 21.05 0.21 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.258 -0.901 . . . . 0.0 109.394 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.421 ' N ' ' HB3' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -155.58 -147.37 0.2 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.135 -0.978 . . . . 0.0 109.749 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 24' ' ' LEU . 2.9 mm? -123.29 146.4 47.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.352 -0.843 . . . . 0.0 109.447 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -131.42 99.26 17.51 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.341 -0.849 . . . . 0.0 109.173 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -47.64 132.96 21.3 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.557 2.172 . . . . 0.0 112.42 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.438 HG21 ' N ' ' A' ' 18' ' ' ARG . 61.0 t -104.51 106.2 53.3 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.317 -0.864 . . . . 0.0 109.482 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -46.64 145.89 5.98 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.484 2.123 . . . . 0.0 112.32 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.4 t -61.7 -25.63 67.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -0.882 . . . . 0.0 109.554 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -69.04 -10.98 60.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 0.0 109.509 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.467 ' O ' ' C ' ' A' ' 32' ' ' TYR . 57.7 mt -110.14 -28.25 8.75 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -0.847 . . . . 0.0 109.572 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.467 ' C ' ' O ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -40.33 143.85 0.27 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.288 -0.883 . . . . 0.0 109.458 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.05 -32.02 7.58 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -101.89 104.53 15.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -1.144 . . . . 0.0 109.398 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -102.67 140.91 36.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 109.53 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.595 ' CD2' ' OH ' ' A' ' 41' ' ' TYR . 0.7 OUTLIER -101.67 161.12 13.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.393 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.9 p -94.89 -4.88 46.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.238 -0.914 . . . . 0.0 109.614 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -101.56 34.75 5.41 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -171.52 151.53 3.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.196 -1.179 . . . . 0.0 109.51 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.23 139.25 36.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.598 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.595 ' OH ' ' CD2' ' A' ' 36' ' ' PHE . 44.2 m-85 -121.38 144.36 48.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.365 -0.834 . . . . 0.0 109.359 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.508 ' O ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -118.76 144.82 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.286 -0.884 . . . . 0.0 109.216 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.435 ' CD1' ' C ' ' A' ' 42' ' ' VAL . 1.0 OUTLIER -134.18 146.49 31.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.98 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.7 tp -129.5 118.07 21.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.46 -0.775 . . . . 0.0 109.467 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.539 ' CE ' ' CE2' ' A' ' 106' ' ' TYR . 36.3 tttt -97.39 133.96 41.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.41 -0.806 . . . . 0.0 109.046 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.605 ' O ' ' N ' ' A' ' 13' ' ' GLY . 88.8 m -142.74 118.4 10.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.099 -1.001 . . . . 0.0 109.401 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.674 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -125.98 168.2 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.226 -0.921 . . . . 0.0 109.122 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -102.88 112.41 25.2 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.512 -0.742 . . . . 0.0 109.331 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.9 mt -77.3 169.22 18.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.438 -0.789 . . . . 0.0 109.59 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.517 ' CG ' ' N ' ' A' ' 51' ' ' ASN . 5.7 ptp85 -47.69 -49.33 28.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.884 . . . . 0.0 109.299 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.517 ' N ' ' CG ' ' A' ' 50' ' ' ARG . 5.0 m120 -70.75 -27.24 63.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.271 -0.893 . . . . 0.0 109.157 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 54' ' ' LEU . . . 93.65 28.52 11.17 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.0 t-20 -80.66 12.59 3.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.072 -1.252 . . . . 0.0 109.21 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.674 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 13.8 mt 43.88 97.72 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.535 0.683 . . . . 0.0 109.562 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -74.3 111.45 9.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.491 -0.756 . . . . 0.0 109.538 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.429 ' CD2' ' O ' ' A' ' 54' ' ' LEU . 96.2 m-85 -96.55 114.75 26.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.933 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.596 ' OD1' ' NE2' ' A' ' 92' ' ' HIS . 0.4 OUTLIER -115.99 120.8 40.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.022 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.424 ' N ' HD21 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -97.77 150.61 21.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.921 -1.112 . . . . 0.0 110.778 -178.467 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.704 ' HD1' ' CG ' ' A' ' 92' ' ' HIS . 6.1 m-70 -149.19 122.19 8.82 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.408 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 10.5 p90 -113.39 131.43 55.99 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.117 -0.989 . . . . 0.0 109.846 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.565 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 55.6 t90 -103.44 124.01 47.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.488 -0.758 . . . . 0.0 109.356 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.565 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 62.8 mt -102.76 162.12 13.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.329 -0.857 . . . . 0.0 109.591 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.92 162.96 12.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -82.07 -12.37 58.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -1.168 . . . . 0.0 109.576 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.51 28.95 7.32 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.3 m -130.84 97.57 4.37 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.115 0.959 . . . . 0.0 108.54 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 64.6 m -56.19 -170.87 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.674 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -64.87 -17.81 64.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.562 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -63.13 -58.7 6.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.118 -0.989 . . . . 0.0 109.405 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -66.81 -41.59 87.29 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.15 -23.06 62.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.401 -0.812 . . . . 0.0 108.995 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -71.64 -44.24 49.73 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.97 -43.94 86.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.343 -1.092 . . . . 0.0 109.172 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.9 -49.28 77.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.415 -0.803 . . . . 0.0 109.304 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.67 -48.62 77.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.328 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.7 mt -50.09 -42.39 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.386 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -63.77 -37.15 86.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.198 -0.939 . . . . 0.0 109.328 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.6 m -65.52 -46.96 77.58 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.366 -0.834 . . . . 0.0 109.362 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.5 t -56.09 -39.85 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 0.0 109.163 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -61.52 -47.39 85.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.304 -0.873 . . . . 0.0 109.041 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.425 HD21 ' HA ' ' A' ' 81' ' ' LEU . 34.1 mt -50.59 -46.05 57.66 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.309 -0.869 . . . . 0.0 109.001 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 85' ' ' LEU . 0.8 OUTLIER -56.59 -59.01 5.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.232 -0.918 . . . . 0.0 109.177 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 82' ' ' ASP . 9.1 t0 -45.26 -30.05 1.14 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.108 -0.995 . . . . 0.0 108.611 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -75.44 -29.7 59.76 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.588 ' N ' ' O ' ' A' ' 82' ' ' ASP . 11.6 mt -116.0 30.91 7.05 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.389 -0.819 . . . . 0.0 109.412 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 46.32 34.5 2.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.293 -0.879 . . . . 0.0 109.507 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 51.29 22.2 6.89 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -90.34 30.93 1.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.102 -1.234 . . . . 0.0 109.228 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 56' ' ' TYR . . . -123.49 177.1 5.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.542 -0.724 . . . . 0.0 109.306 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 95.1 t -113.32 115.45 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 109.477 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.93 157.87 18.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.264 -0.898 . . . . 0.0 109.374 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.704 ' CG ' ' HD1' ' A' ' 59' ' ' HIS . 27.6 m-70 -132.4 131.56 41.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.338 -0.851 . . . . 0.0 109.201 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.66 ' CD ' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -98.66 103.19 15.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.112 -0.992 . . . . 0.0 109.54 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.521 ' N ' ' CD ' ' A' ' 94' ' ' GLU . 3.9 mp0 -101.91 143.44 31.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.244 -0.91 . . . . 0.0 109.403 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.519 HG12 ' NE2' ' A' ' 96' ' ' GLN . 13.8 t -141.81 169.91 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.298 -0.876 . . . . 0.0 109.62 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.586 ' CD ' ' H ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -82.11 118.95 23.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 109.384 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.83 13.07 48.09 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.446 ' O ' ' O ' ' A' ' 99' ' ' GLU . 37.5 m-85 -150.93 -37.57 0.13 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.221 -1.164 . . . . 0.0 109.37 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 98' ' ' PHE . 40.7 mt-10 40.61 -160.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.0 109.561 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.444 ' OG ' ' OE1' ' A' ' 94' ' ' GLU . 1.8 m -139.09 159.79 41.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.176 -0.953 . . . . 0.0 109.422 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.95 -65.12 0.71 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.648 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.1 m -48.56 -54.51 14.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.159 -0.963 . . . . 0.0 109.464 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -53.78 -41.87 67.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.445 -0.784 . . . . 0.0 109.534 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.4 HD11 ' O ' ' A' ' 100' ' ' SER . 7.3 mt -69.54 -31.82 70.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.17 -0.956 . . . . 0.0 109.484 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.68 -21.14 67.01 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.539 ' CE2' ' CE ' ' A' ' 45' ' ' LYS . 8.2 t80 -76.79 -54.49 6.54 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.262 -1.14 . . . . 0.0 109.477 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -96.77 79.65 2.98 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.39 -0.819 . . . . 0.0 109.607 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -78.38 1.43 22.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.383 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.7 p -67.5 -22.04 65.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 109.493 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . 92.59 64.19 1.11 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.604 ' CD1' ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -49.23 178.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -1.095 . . . . 0.0 109.546 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.48 155.32 43.03 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.226 -0.921 . . . . 0.0 109.329 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -126.47 143.68 51.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.212 -0.93 . . . . 0.0 109.451 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 44.3 mttt -140.18 134.75 31.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.875 . . . . 0.0 109.392 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.275 -0.891 . . . . 0.0 109.523 179.869 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.536 ' HB2' HD12 ' A' ' 6' ' ' LEU . 46.7 Cg_endo . . . . . 0 N--CA 1.491 1.33 0 CA-C-O 121.273 0.447 . . . . 0.0 111.893 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.459 ' C ' ' H ' ' A' ' 6' ' ' LEU . 20.3 mm-40 -83.6 -25.71 30.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.222 -0.923 . . . . 0.0 110.035 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.63 ' CD1' HG12 ' A' ' 42' ' ' VAL . 43.6 t80 -51.65 -11.96 0.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.036 -1.04 . . . . 0.0 109.747 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.536 HD12 ' HB2' ' A' ' 3' ' ' PRO . 0.3 OUTLIER -93.94 -29.97 14.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.146 -0.971 . . . . 0.0 109.032 179.582 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.506 ' O ' ' O ' ' A' ' 8' ' ' ALA . 17.0 mtpp -87.94 -6.63 57.93 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.391 -0.818 . . . . 0.0 109.264 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -43.71 170.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.351 -0.843 . . . . 0.0 109.568 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.04 76.68 1.09 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -136.04 -1.26 2.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.226 -1.161 . . . . 0.0 109.694 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -171.46 149.58 2.54 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.152 -0.968 . . . . 0.0 109.419 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.4 89.34 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.727 2.285 . . . . 0.0 112.193 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -170.29 -106.15 0.19 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.7 tt -162.33 149.17 13.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.222 -1.163 . . . . 0.0 109.665 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -135.77 132.97 37.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.368 -0.832 . . . . 0.0 109.309 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.421 ' HA ' HG23 ' A' ' 43' ' ' ILE . 42.7 mt -102.96 159.7 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 109.767 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.422 ' CZ3' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -157.87 162.17 38.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -0.867 . . . . 0.0 109.047 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -129.03 147.29 50.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.355 -0.84 . . . . 0.0 109.555 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.536 ' CG1' ' OD1' ' A' ' 39' ' ' ASP . 8.1 p -81.03 145.98 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.862 . . . . 0.0 109.548 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.58 ' O ' ' N ' ' A' ' 22' ' ' PHE . 22.3 tt0 -100.52 153.93 18.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.343 -0.848 . . . . 0.0 109.344 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 20' ' ' GLU . 18.7 tptm -40.32 -22.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 109.509 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.58 ' N ' ' O ' ' A' ' 20' ' ' GLU . 58.6 t80 -160.86 33.97 0.15 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 109.416 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -173.89 -127.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.305 -0.872 . . . . 0.0 109.526 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.405 HD21 ' H ' ' A' ' 5' ' ' PHE . 4.7 tp -148.43 146.06 28.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -0.951 . . . . 0.0 109.572 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.5 133.36 25.02 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.888 . . . . 0.0 109.225 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.26 140.91 28.27 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.453 2.102 . . . . 0.0 112.138 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.9 t -99.76 133.74 21.54 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.218 -0.926 . . . . 0.0 109.241 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -72.7 133.14 19.78 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.525 2.15 . . . . 0.0 112.308 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.559 ' C ' ' H ' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -68.25 176.01 2.98 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.239 -0.913 . . . . 0.0 109.431 179.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 29' ' ' THR . 3.1 t-20 69.91 -39.1 0.43 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.406 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.559 ' H ' ' C ' ' A' ' 29' ' ' THR . 31.6 mt -96.94 -32.75 11.87 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.287 -0.883 . . . . 0.0 109.414 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.456 ' C ' ' O ' ' A' ' 31' ' ' LEU . 14.6 p90 -41.58 160.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 109.58 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 128.82 -19.15 5.57 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -98.26 124.33 42.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -1.136 . . . . 0.0 109.604 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -105.31 131.44 52.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -0.876 . . . . 0.0 109.335 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -96.5 135.67 38.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.211 -0.931 . . . . 0.0 109.582 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.7 p -83.71 -16.58 44.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.383 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.02 30.14 8.44 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.536 ' OD1' ' CG1' ' A' ' 19' ' ' VAL . 32.8 t0 -165.03 171.66 13.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.273 -1.133 . . . . 0.0 109.518 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.4 145.56 38.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.308 -0.87 . . . . 0.0 109.396 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -122.62 134.96 54.49 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.28 -0.888 . . . . 0.0 109.421 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.63 HG12 ' CD1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -108.71 144.16 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.324 -0.86 . . . . 0.0 109.018 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.794 ' CD1' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -144.34 125.12 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.049 -1.032 . . . . 0.0 109.738 -179.644 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 tt -113.22 124.12 51.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.282 -0.886 . . . . 0.0 109.53 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.431 ' HZ3' HG21 ' A' ' 47' ' ' VAL . 29.6 tttm -97.69 145.81 25.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.316 -0.865 . . . . 0.0 109.515 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 13' ' ' GLY . 85.0 m -142.96 128.33 18.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.292 -0.88 . . . . 0.0 109.276 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -131.98 168.45 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 O-C-N 120.986 -1.071 . . . . 0.0 109.535 -179.626 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -99.66 98.46 9.3 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.547 HD12 HH11 ' A' ' 88' ' ' ARG . 10.1 mt -60.84 168.65 2.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.328 -0.858 . . . . 0.0 109.594 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 51' ' ' ASN . 34.0 ttm180 -48.95 -77.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 0.0 109.394 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 50' ' ' ARG . 1.2 m120 -42.84 -27.89 0.21 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.912 . . . . 0.0 109.214 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 50' ' ' ARG . . . 96.03 44.17 3.13 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.3 t-20 -95.35 14.05 23.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.983 -1.304 . . . . 0.0 109.288 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.574 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 11.5 mt 43.68 97.22 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.649 0.738 . . . . 0.0 109.377 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.425 ' HB2' HD13 ' A' ' 49' ' ' LEU . 9.3 tt0 -68.86 151.89 46.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.497 -0.752 . . . . 0.0 109.156 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.574 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 90.7 m-85 -136.08 114.31 11.54 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.318 -0.864 . . . . 0.0 109.419 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.73 153.94 34.89 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.3 137.62 40.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.934 -1.104 . . . . 0.0 110.324 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.595 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 1.0 OUTLIER -122.5 150.11 42.98 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.447 -0.783 . . . . 0.0 109.138 179.545 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.707 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -124.78 116.42 22.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -0.851 . . . . 0.0 109.122 179.663 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.404 ' CE3' ' O ' ' A' ' 62' ' ' LEU . 16.7 t90 -97.77 123.93 41.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.294 -0.879 . . . . 0.0 109.61 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.404 ' O ' ' CE3' ' A' ' 61' ' ' TRP . 0.7 OUTLIER -104.54 161.49 14.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.316 -0.865 . . . . 0.0 109.394 179.861 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -106.26 157.83 15.75 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -77.52 -12.25 59.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -1.126 . . . . 0.0 109.389 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -107.16 24.36 12.96 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.8 m -130.97 97.5 4.33 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 122.105 0.955 . . . . 0.0 108.496 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 66' ' ' CYS . 1.4 m -50.85 -173.52 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.315 0 CA-C-O 121.378 0.609 . . . . 0.0 109.569 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.439 ' O ' ' N ' ' A' ' 72' ' ' GLY . 54.9 mt-30 -71.49 -17.8 62.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -0.944 . . . . 0.0 109.598 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -63.82 -58.5 6.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.463 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.32 -46.99 84.1 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.369 -0.832 . . . . 0.0 109.053 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.6 m -63.79 -29.18 70.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.493 -0.755 . . . . 0.0 108.968 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -65.1 -45.92 90.21 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.22 -49.97 74.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -1.146 . . . . 0.0 109.326 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.83 -45.43 93.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 0.0 109.252 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.21 -38.54 89.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.159 -0.963 . . . . 0.0 109.425 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.416 HD13 HG21 ' A' ' 76' ' ' ILE . 25.1 mt -58.84 -44.56 90.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.189 -0.945 . . . . 0.0 109.468 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -61.75 -42.0 98.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.37 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 82.2 m -68.0 -39.96 83.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.333 -0.854 . . . . 0.0 109.232 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 68.2 t -67.87 -27.41 37.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.402 -0.811 . . . . 0.0 109.372 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.486 ' O ' ' OD2' ' A' ' 83' ' ' ASP . 40.8 mm-40 -70.4 -61.47 1.76 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.254 -0.904 . . . . 0.0 109.285 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.8 pp -58.03 -24.06 56.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 0.0 108.645 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' A' ' 86' ' ' ASN . 13.9 t70 -72.25 -54.96 8.04 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.39 -0.819 . . . . 0.0 108.912 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.486 ' OD2' ' O ' ' A' ' 80' ' ' GLN . 1.1 p30 -48.33 -35.42 12.37 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.113 -0.992 . . . . 0.0 108.368 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.457 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -72.93 -32.07 65.03 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.297 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 82' ' ' ASP . 4.6 tp -121.56 35.29 4.93 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.327 -0.858 . . . . 0.0 109.415 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.615 ' N ' ' O ' ' A' ' 82' ' ' ASP . 42.6 t30 -87.71 30.16 0.84 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.193 -0.942 . . . . 0.0 109.205 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -107.41 -21.3 8.05 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.547 HH11 HD12 ' A' ' 49' ' ' LEU . 25.3 ttt85 -159.53 64.81 0.38 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.282 -1.128 . . . . 0.0 109.41 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.13 174.43 14.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.924 . . . . 0.0 109.379 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.9 t -136.11 142.51 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 109.641 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -103.24 147.71 26.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.328 -0.858 . . . . 0.0 109.077 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -132.1 119.16 20.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 109.655 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.524 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 11.0 ptp180 -91.97 109.32 20.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.367 -0.833 . . . . 0.0 109.299 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 100' ' ' SER . 86.6 mt-10 -113.32 144.19 43.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 109.43 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 37.5 t -148.55 166.59 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.299 -0.876 . . . . 0.0 109.37 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -59.16 115.99 3.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.245 -0.91 . . . . 0.0 109.388 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.06 9.79 85.75 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.48 ' O ' ' O ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -143.17 24.71 1.78 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -1.147 . . . . 0.0 109.305 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.48 ' O ' ' O ' ' A' ' 98' ' ' PHE . 9.7 pt-20 -44.53 170.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.276 -0.89 . . . . 0.0 109.556 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.401 ' H ' ' HG2' ' A' ' 94' ' ' GLU . 4.3 t -91.51 167.8 11.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.279 -0.888 . . . . 0.0 109.573 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.66 -59.89 2.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.295 -0.878 . . . . 0.0 109.527 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.0 m -46.85 -35.59 6.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.355 -0.841 . . . . 0.0 109.373 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -68.87 -46.49 68.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.347 -0.846 . . . . 0.0 109.292 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.58 ' O ' ' CD1' ' A' ' 107' ' ' PHE . 12.0 mt -61.15 -20.57 62.85 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.252 -0.905 . . . . 0.0 109.436 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -93.74 -24.85 19.5 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.414 ' O ' ' C ' ' A' ' 107' ' ' PHE . 7.8 t80 -80.0 -21.42 43.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -1.133 . . . . 0.0 109.461 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.583 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 1.6 p90 -44.97 121.67 2.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.456 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -108.98 -50.67 2.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.979 . . . . 0.0 109.536 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 94.9 p -101.42 -9.79 20.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 109.539 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 96.29 108.48 2.44 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.619 ' H ' ' CD2' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -67.6 177.06 2.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -1.153 . . . . 0.0 109.512 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -146.88 143.7 28.74 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.288 -0.883 . . . . 0.0 109.436 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.61 ' CD2' ' N ' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -112.41 124.67 53.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.312 -0.868 . . . . 0.0 109.485 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 17.0 mtpt -97.42 160.62 14.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 109.531 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.364 -0.835 . . . . 0.0 109.364 179.979 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo . . . . . 0 N--CA 1.494 1.521 0 CA-C-O 121.286 0.453 . . . . 0.0 111.974 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.544 ' H ' HD13 ' A' ' 24' ' ' LEU . 57.2 mm-40 -83.06 -46.02 13.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.972 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.553 ' CE2' ' CG1' ' A' ' 42' ' ' VAL . 34.8 t80 -69.74 -12.54 61.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.111 -0.993 . . . . 0.0 109.558 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.4 mt -90.34 -33.71 15.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.216 -0.927 . . . . 0.0 109.381 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 8' ' ' ALA . 25.1 mttp -91.17 -11.34 38.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.229 -0.919 . . . . 0.0 109.494 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -42.73 166.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.177 -0.952 . . . . 0.0 109.47 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.523 ' H ' ' NE2' ' A' ' 15' ' ' GLN . . . 106.24 68.27 0.69 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.8 pttt -135.97 -0.87 2.49 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.211 -1.17 . . . . 0.0 109.576 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -159.02 142.48 10.81 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 109.326 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.35 89.88 1.04 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.594 2.196 . . . . 0.0 112.256 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -169.14 -105.92 0.19 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.5 tt -162.38 144.82 11.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -1.15 . . . . 0.0 109.472 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.523 ' NE2' ' H ' ' A' ' 9' ' ' GLY . 9.0 mt-30 -134.6 144.39 47.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 109.629 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.8 mt -122.89 143.96 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.455 -0.778 . . . . 0.0 109.812 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.41 ' CE2' ' HB3' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -146.68 136.07 22.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.307 -0.87 . . . . 0.0 109.019 179.738 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.552 ' O ' ' N ' ' A' ' 25' ' ' VAL . 51.5 ttt180 -94.11 153.17 18.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.124 -0.985 . . . . 0.0 109.645 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.417 ' CG1' ' O ' ' A' ' 23' ' ' ASP . 28.3 t -96.45 133.31 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.92 . . . . 0.0 109.722 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.774 ' O ' ' N ' ' A' ' 22' ' ' PHE . 6.0 tt0 -80.09 85.58 5.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.132 -0.98 . . . . 0.0 108.774 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.648 ' O ' ' CD2' ' A' ' 22' ' ' PHE . 7.5 mtpm? 40.43 9.86 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.548 -0.72 . . . . 0.0 109.792 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.774 ' N ' ' O ' ' A' ' 20' ' ' GLU . 0.7 OUTLIER 160.22 -32.35 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.225 -0.922 . . . . 0.0 109.167 -179.723 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.528 ' OD2' ' N ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -94.49 -142.38 0.24 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.273 -0.892 . . . . 0.0 110.257 -179.214 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.602 ' C ' HG22 ' A' ' 25' ' ' VAL . 8.9 mt -125.95 146.12 49.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.341 -0.849 . . . . 0.0 109.942 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.602 HG22 ' C ' ' A' ' 24' ' ' LEU . 7.8 t -142.05 132.29 12.66 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 0.0 109.15 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -76.3 144.67 26.37 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.39 2.06 . . . . 0.0 112.26 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.2 t -110.96 101.51 50.09 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.346 -0.846 . . . . 0.0 109.437 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -51.19 161.6 1.58 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.508 2.139 . . . . 0.0 112.153 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.7 m -68.64 -22.15 64.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.389 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -67.0 -11.83 58.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 109.433 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 32' ' ' TYR . 15.3 mt -122.93 -17.11 6.87 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.268 -0.895 . . . . 0.0 109.52 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.55 ' C ' ' CD2' ' A' ' 32' ' ' TYR . 4.4 t80 -42.46 133.12 3.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.907 . . . . 0.0 109.348 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.83 22.26 16.36 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -143.02 151.37 40.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -1.192 . . . . 0.0 109.444 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -141.83 137.48 31.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.231 -0.918 . . . . 0.0 109.549 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -102.04 137.63 40.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 109.325 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.4 p -78.2 -4.79 49.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.882 . . . . 0.0 109.48 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.35 30.94 8.92 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 40' ' ' ALA . 8.8 t70 -173.66 156.13 2.86 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.188 -1.184 . . . . 0.0 109.521 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.447 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -97.77 147.68 24.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.246 -0.909 . . . . 0.0 109.279 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.44 ' CD2' ' N ' ' A' ' 41' ' ' TYR . 17.1 m-85 -128.72 134.82 48.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.324 -0.86 . . . . 0.0 109.46 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.553 ' CG1' ' CE2' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -105.44 140.94 21.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.213 -0.929 . . . . 0.0 109.06 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.536 HD13 ' C ' ' A' ' 42' ' ' VAL . 1.1 mm -131.22 134.89 60.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.37 -0.831 . . . . 0.0 110.028 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 tt -120.22 120.13 35.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.536 -0.727 . . . . 0.0 109.531 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -93.79 147.91 22.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.116 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.6 OUTLIER -142.68 122.14 13.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 109.526 -179.768 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -129.97 168.18 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 O-C-N 121.249 -0.907 . . . . 0.0 108.908 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -94.51 131.29 40.39 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.533 -0.729 . . . . 0.0 109.487 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.447 HD23 HE21 ' A' ' 55' ' ' GLN . 15.8 mt -96.32 167.52 11.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 109.534 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.53 ' CG ' ' N ' ' A' ' 51' ' ' ASN . 4.6 ptm180 -47.93 -46.86 32.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.261 -0.899 . . . . 0.0 109.296 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.53 ' N ' ' CG ' ' A' ' 50' ' ' ARG . 98.6 m-20 -75.75 -27.48 58.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.316 -0.865 . . . . 0.0 109.199 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.85 28.96 7.95 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.497 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.4 t-20 -84.67 13.64 5.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.099 -1.236 . . . . 0.0 109.359 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.619 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.8 mt 47.31 100.26 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.527 0.68 . . . . 0.0 109.509 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.447 HE21 HD23 ' A' ' 49' ' ' LEU . 8.9 tt0 -68.85 117.77 10.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.534 -0.729 . . . . 0.0 109.214 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 54' ' ' LEU . 96.7 m-85 -98.07 114.71 26.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.174 -0.954 . . . . 0.0 109.865 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.21 155.76 22.46 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.553 ' C ' ' CD2' ' A' ' 59' ' ' HIS . 5.2 mp -134.36 144.7 48.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.838 -1.164 . . . . 0.0 110.517 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.603 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.5 OUTLIER -141.97 126.55 17.89 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.566 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.701 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -105.94 131.13 53.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.1 -1.0 . . . . 0.0 109.593 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -104.94 123.94 48.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.422 -0.799 . . . . 0.0 109.331 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.9 mt -104.7 162.12 13.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.863 . . . . 0.0 109.595 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -117.37 162.69 12.81 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 64' ' ' ASN . 0.6 OUTLIER -81.08 -12.57 59.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.302 -1.117 . . . . 0.0 109.614 -179.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -106.24 26.98 9.13 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.3 m -130.75 97.61 4.4 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 122.2 1.0 . . . . 0.0 108.42 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 66' ' ' CYS . 31.4 m -49.71 -176.49 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.733 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 72' ' ' GLY . 13.7 pt20 -68.17 -17.5 64.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.4 -0.812 . . . . 0.0 109.561 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -63.48 -58.57 6.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.919 . . . . 0.0 109.652 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.449 ' N ' ' CD ' ' A' ' 70' ' ' GLU . 3.8 mm-40 -62.32 -48.13 81.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.229 -0.919 . . . . 0.0 109.177 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.7 p -66.01 -27.53 68.19 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.338 -0.851 . . . . 0.0 109.231 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.89 -31.82 66.86 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.22 -51.22 18.53 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.278 -1.131 . . . . 0.0 109.342 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.92 -48.18 73.44 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.414 -0.804 . . . . 0.0 109.279 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.405 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -57.11 -48.38 78.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 109.303 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.4 mt -50.77 -47.28 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.204 -0.935 . . . . 0.0 109.319 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -58.06 -37.75 75.02 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.306 -0.871 . . . . 0.0 109.264 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 m -65.32 -46.22 81.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.33 -0.856 . . . . 0.0 109.266 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 75' ' ' ALA . 17.1 t -56.02 -36.41 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 0.0 109.451 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -64.89 -50.09 67.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.277 -0.889 . . . . 0.0 109.255 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.2 mt -53.13 -36.1 60.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.204 -0.935 . . . . 0.0 109.247 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 85' ' ' LEU . 40.6 m-20 -63.36 -58.34 7.42 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.247 -0.908 . . . . 0.0 109.109 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 82' ' ' ASP . 1.8 t70 -45.4 -34.0 2.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.212 -0.93 . . . . 0.0 108.54 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -73.7 -28.87 61.96 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 82' ' ' ASP . 6.4 mt -112.93 28.36 8.86 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.394 -0.816 . . . . 0.0 109.272 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 85' ' ' LEU . 9.6 t-20 43.56 37.22 1.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.397 -0.815 . . . . 0.0 109.429 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 48.72 32.95 11.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -89.09 30.96 0.9 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.192 -1.181 . . . . 0.0 109.22 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -129.76 179.14 6.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.423 -0.798 . . . . 0.0 109.347 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.7 128.23 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.15 -0.969 . . . . 0.0 109.5 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.586 ' N ' ' NE2' ' A' ' 91' ' ' GLN . 1.6 mp0 -88.98 144.33 26.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.932 . . . . 0.0 109.366 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.411 ' HB2' ' CG ' ' A' ' 59' ' ' HIS . 28.4 m-70 -131.31 107.27 8.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.94 . . . . 0.0 109.576 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -86.25 105.04 16.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 109.377 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.596 ' OE1' ' CD1' ' A' ' 103' ' ' PHE . 22.3 mt-10 -110.3 141.77 42.84 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.36 -0.837 . . . . 0.0 109.732 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.0 t -144.38 163.3 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.342 -0.848 . . . . 0.0 109.147 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -56.89 120.52 8.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.939 . . . . 0.0 109.442 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.42 15.76 77.54 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.438 ' O ' ' C ' ' A' ' 99' ' ' GLU . 7.0 t80 -141.7 12.13 2.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -1.145 . . . . 0.0 109.443 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 30.2 mp0 -41.52 138.4 1.33 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.506 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.445 ' H ' ' HG2' ' A' ' 94' ' ' GLU . 4.1 m -72.29 -177.36 2.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 0.0 109.402 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.2 -65.21 0.98 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.187 -0.945 . . . . 0.0 109.505 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.6 m -47.64 -36.21 10.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 109.444 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.685 ' CZ ' ' CZ ' ' A' ' 107' ' ' PHE . 2.1 t80 -67.8 -47.16 69.87 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.259 -0.901 . . . . 0.0 109.442 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.5 mt -66.83 -23.1 65.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.934 . . . . 0.0 109.508 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -93.32 -24.17 22.49 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -86.94 -33.62 19.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.225 -1.162 . . . . 0.0 109.51 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.685 ' CZ ' ' CZ ' ' A' ' 103' ' ' PHE . 24.2 m-85 -90.31 99.31 12.36 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.29 -0.881 . . . . 0.0 109.528 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.468 ' C ' ' H ' ' A' ' 110' ' ' GLY . 19.9 mtpp -99.74 -6.16 27.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.913 . . . . 0.0 109.365 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 26.0 m -77.75 22.29 0.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 109.426 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 108' ' ' LYS . . . 47.62 80.85 0.05 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.566 ' CD1' ' H ' ' A' ' 111' ' ' LEU . 0.5 OUTLIER -43.01 118.33 1.25 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -1.145 . . . . 0.0 109.441 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -82.04 123.57 29.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.28 -0.887 . . . . 0.0 109.497 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -94.93 108.73 20.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.511 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -111.43 140.12 46.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.348 -0.845 . . . . 0.0 109.556 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 30.3 pttt . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.911 . . . . 0.0 109.397 179.983 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo . . . . . 0 N--CA 1.492 1.388 0 CA-C-O 121.296 0.457 . . . . 0.0 112.099 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.458 ' C ' ' H ' ' A' ' 6' ' ' LEU . 0.4 OUTLIER -82.25 -34.83 28.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 109.698 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.513 ' CE2' ' CG1' ' A' ' 42' ' ' VAL . 15.9 t80 -56.78 -8.87 0.66 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.184 -0.948 . . . . 0.0 109.291 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.458 ' H ' ' C ' ' A' ' 4' ' ' GLU . 51.1 mt -90.24 -45.73 8.88 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.227 -0.921 . . . . 0.0 109.385 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.455 ' O ' ' C ' ' A' ' 8' ' ' ALA . 43.6 mtpt -87.27 -2.08 58.37 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.292 -0.88 . . . . 0.0 109.439 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -41.48 150.46 0.1 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.42 -0.8 . . . . 0.0 109.581 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.54 68.83 0.29 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -134.64 9.69 3.66 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.373 -1.075 . . . . 0.0 109.539 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -172.67 139.37 0.93 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.148 -0.97 . . . . 0.0 109.451 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.38 86.3 1.17 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.547 2.165 . . . . 0.0 112.265 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -166.31 -107.58 0.2 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.6 tt -162.6 151.0 14.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.291 -1.123 . . . . 0.0 109.635 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.407 ' HB3' ' CZ3' ' A' ' 17' ' ' TRP . 32.7 mt-30 -146.66 140.25 25.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 109.403 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.71 ' HA ' HG23 ' A' ' 43' ' ' ILE . 3.4 mt -114.38 149.39 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.312 -0.867 . . . . 0.0 109.923 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.407 ' CZ3' ' HB3' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -145.27 135.23 23.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.302 -0.874 . . . . 0.0 109.122 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.453 ' HD2' ' HH ' ' A' ' 41' ' ' TYR . 5.2 ttt180 -92.27 142.83 27.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.164 -0.96 . . . . 0.0 109.381 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 19' ' ' VAL . 9.9 p -80.45 119.62 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.198 -0.939 . . . . 0.0 109.501 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.614 ' O ' ' N ' ' A' ' 22' ' ' PHE . 8.6 tm-20 -74.79 147.83 40.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.234 -0.916 . . . . 0.0 109.157 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.425 ' N ' ' CD ' ' A' ' 20' ' ' GLU . 23.8 mttp -45.19 -11.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.901 . . . . 0.0 109.833 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.614 ' N ' ' O ' ' A' ' 20' ' ' GLU . 7.6 t80 -165.71 29.75 0.05 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.126 -0.984 . . . . 0.0 109.797 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . 0.464 ' N ' ' HB3' ' A' ' 20' ' ' GLU . 27.5 t70 -175.29 -116.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 109.597 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.6 tp -157.99 146.2 18.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.346 -0.846 . . . . 0.0 109.499 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -134.38 107.9 11.17 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.244 -0.91 . . . . 0.0 109.604 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.74 132.79 37.62 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.192 1.928 . . . . 0.0 111.843 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 p -75.7 121.57 85.35 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 109.572 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -78.17 166.84 24.14 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.4 2.067 . . . . 0.0 112.139 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.86 -6.25 43.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.332 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -87.19 -6.39 58.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 109.346 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 32' ' ' TYR . 56.6 mt -132.87 -11.4 3.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 109.778 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.528 ' CZ ' ' CD1' ' A' ' 16' ' ' ILE . 9.6 t80 -43.25 118.98 1.44 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 109.487 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.66 -11.91 56.45 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.514 ' C ' ' CG ' ' A' ' 35' ' ' PHE . 1.9 m-20 -110.52 150.52 28.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -1.154 . . . . 0.0 109.503 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.514 ' CG ' ' C ' ' A' ' 34' ' ' ASP . 5.2 m-85 -155.1 148.17 24.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 109.421 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 36' ' ' PHE . 2.0 m-85 -102.34 135.96 43.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 109.536 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.4 ' OG1' ' OE1' ' A' ' 65' ' ' GLU . 44.7 p -67.13 -9.57 41.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.354 -0.841 . . . . 0.0 109.289 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.52 30.36 8.9 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 40' ' ' ALA . 3.1 t70 -161.36 159.44 28.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -1.154 . . . . 0.0 109.399 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.483 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -107.46 150.71 26.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 109.392 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.453 ' HH ' ' HD2' ' A' ' 18' ' ' ARG . 24.2 m-85 -130.03 138.89 51.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.312 -0.867 . . . . 0.0 109.511 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.549 ' C ' ' CD1' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -112.81 126.52 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.25 -0.906 . . . . 0.0 108.591 179.698 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.71 HG23 ' HA ' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -123.73 137.77 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 119.319 -0.952 . . . . 0.0 110.373 -178.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.6 tt -121.09 146.96 46.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.542 -0.724 . . . . 0.0 109.396 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 57' ' ' ASP . 1.8 ttmp? -123.67 139.34 54.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.417 -0.802 . . . . 0.0 109.259 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 13' ' ' GLY . 20.4 m -136.31 117.93 14.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.342 -0.849 . . . . 0.0 109.328 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.707 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -126.52 167.86 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.317 -0.864 . . . . 0.0 109.01 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -98.48 125.44 43.68 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.498 -0.752 . . . . 0.0 109.442 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.454 HD12 ' HB2' ' A' ' 55' ' ' GLN . 11.1 mt -87.9 154.43 20.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.27 -0.894 . . . . 0.0 109.673 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.432 ' CZ ' ' CB ' ' A' ' 50' ' ' ARG . 10.3 mtp-105 -48.24 -43.39 32.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -0.916 . . . . 0.0 109.255 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -68.41 -32.85 73.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.312 -0.868 . . . . 0.0 109.3 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.09 74.67 1.18 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.508 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.1 t-20 -143.69 13.77 1.73 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.203 -1.175 . . . . 0.0 109.336 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.707 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 31.4 mt 44.52 98.26 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.536 0.684 . . . . 0.0 109.496 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.454 ' HB2' HD12 ' A' ' 49' ' ' LEU . 9.7 tt0 -73.97 121.31 20.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.559 -0.713 . . . . 0.0 109.682 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -99.54 114.54 27.59 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.248 -0.908 . . . . 0.0 109.751 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 45' ' ' LYS . 0.9 OUTLIER -127.51 122.56 33.7 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.362 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.57 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 0.5 OUTLIER -126.16 150.37 48.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.114 -0.991 . . . . 0.0 110.71 -178.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.482 ' CB ' ' CE1' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -129.53 141.71 50.92 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.34 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.549 ' CZ ' ' HB3' ' A' ' 74' ' ' ALA . 2.4 t80 -103.24 126.22 50.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.897 . . . . 0.0 109.56 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.457 ' N ' ' CD1' ' A' ' 60' ' ' TYR . 44.2 t90 -100.74 127.8 47.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.09 -1.006 . . . . 0.0 109.824 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.436 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 2.9 mp -112.53 157.0 21.68 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.491 -0.756 . . . . 0.0 109.412 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -104.78 161.68 14.99 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.507 HD22 ' NE2' ' A' ' 96' ' ' GLN . 0.5 OUTLIER -81.72 -12.05 58.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.333 -1.098 . . . . 0.0 109.474 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.4 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 1.8 mt-10 -106.66 29.59 6.82 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.552 ' SG ' ' OE2' ' A' ' 70' ' ' GLU . 1.6 m -130.78 97.51 4.36 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.591 ' OG ' ' N ' ' A' ' 68' ' ' GLN . 1.0 OUTLIER -58.67 -173.76 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.573 -179.829 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.591 ' N ' ' OG ' ' A' ' 67' ' ' SER . 8.6 pt20 -62.45 -17.97 60.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 109.66 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -65.35 -58.77 5.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.557 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.552 ' OE2' ' SG ' ' A' ' 66' ' ' CYS . 13.4 mt-10 -64.63 -43.1 94.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.336 -0.852 . . . . 0.0 109.139 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.7 t -69.33 -26.7 64.83 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.491 -0.756 . . . . 0.0 109.191 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.31 -38.89 71.18 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.02 -47.98 64.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.331 -1.1 . . . . 0.0 109.366 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.549 ' HB3' ' CZ ' ' A' ' 60' ' ' TYR . . . -60.36 -42.22 95.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.366 -0.834 . . . . 0.0 109.311 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.487 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -62.95 -44.8 95.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.883 . . . . 0.0 109.598 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.2 mt -53.45 -51.53 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 0.0 109.341 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -61.36 -33.23 73.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 109.307 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -68.81 -44.77 72.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.382 -0.824 . . . . 0.0 109.374 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 75' ' ' ALA . 42.9 t -63.34 -31.2 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.293 -0.879 . . . . 0.0 109.409 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -66.9 -60.97 2.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.334 -0.854 . . . . 0.0 109.165 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.57 ' CD1' ' C ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -50.78 -31.09 15.84 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.046 -1.034 . . . . 0.0 108.708 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' A' ' 86' ' ' ASN . 29.2 t70 -63.64 -59.57 4.44 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.418 -0.802 . . . . 0.0 108.928 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.583 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 1.3 m-20 -46.03 -34.09 3.84 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.158 -0.964 . . . . 0.0 108.46 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -74.7 -32.79 62.28 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.551 ' C ' ' H ' ' A' ' 87' ' ' GLY . 1.1 tt -121.48 35.67 4.82 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.369 -0.832 . . . . 0.0 109.532 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.609 ' N ' ' O ' ' A' ' 82' ' ' ASP . 1.7 p30 -76.89 27.03 0.14 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.125 -0.985 . . . . 0.0 109.092 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.551 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -69.9 -57.86 6.74 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -176.67 46.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.346 -1.091 . . . . 0.0 109.564 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.63 179.13 6.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 0.0 109.406 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.7 t -126.25 111.95 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 109.45 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -102.38 136.43 42.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.364 -0.835 . . . . 0.0 109.397 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.619 ' CD2' ' N ' ' A' ' 92' ' ' HIS . 0.6 OUTLIER -143.82 118.65 9.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.077 -1.014 . . . . 0.0 109.515 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.1 mtm180 -83.01 138.28 33.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 109.774 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.433 ' CD ' ' H ' ' A' ' 100' ' ' SER . 5.4 mt-10 -131.37 155.98 46.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.304 -0.873 . . . . 0.0 109.283 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.499 ' CG1' ' H ' ' A' ' 96' ' ' GLN . 48.1 t -131.66 173.8 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.219 -0.925 . . . . 0.0 109.575 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.57 ' C ' ' H ' ' A' ' 98' ' ' PHE . 3.3 tt0 -60.55 139.75 57.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.374 -0.829 . . . . 0.0 109.54 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 70.53 -18.55 0.75 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.57 ' H ' ' C ' ' A' ' 96' ' ' GLN . 7.9 t80 -106.59 4.7 28.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.301 -1.117 . . . . 0.0 109.452 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 98' ' ' PHE . 27.7 mt-10 -42.69 148.26 0.24 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.903 . . . . 0.0 109.559 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.433 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 38.4 m -81.06 168.7 18.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.9 . . . . 0.0 109.529 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.93 -35.02 78.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.153 -0.967 . . . . 0.0 109.607 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.8 m -58.03 -61.03 2.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.568 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -57.78 -41.79 82.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.35 -0.844 . . . . 0.0 109.732 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.2 mt -66.28 -28.52 68.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.189 -0.944 . . . . 0.0 109.552 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -81.7 -19.22 66.29 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.43 ' CD1' ' CZ ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -81.37 -45.55 15.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -1.121 . . . . 0.0 109.431 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.43 ' CZ ' ' CD1' ' A' ' 106' ' ' TYR . 20.4 m-85 -139.41 87.21 2.17 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.352 -0.842 . . . . 0.0 109.496 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.35 -20.76 20.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.386 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.7 t -96.94 -12.39 23.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -0.939 . . . . 0.0 109.484 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.456 ' O ' ' C ' ' A' ' 111' ' ' LEU . . . -97.65 -107.15 2.53 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.456 ' C ' ' O ' ' A' ' 110' ' ' GLY . 14.5 mt 41.52 61.64 1.77 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.329 -1.1 . . . . 0.0 109.507 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tppt? -75.59 117.04 16.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.172 -0.955 . . . . 0.0 109.479 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -84.5 114.38 21.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.297 -0.877 . . . . 0.0 109.478 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -103.05 166.28 10.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 0.0 109.355 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.854 . . . . 0.0 109.465 179.881 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo . . . . . 0 N--CA 1.488 1.152 0 CA-C-O 121.22 0.425 . . . . 0.0 112.238 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.564 ' C ' ' H ' ' A' ' 6' ' ' LEU . 1.2 tp10 -83.07 -29.35 28.86 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.26 -0.9 . . . . 0.0 109.563 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.616 ' CZ ' ' O ' ' A' ' 42' ' ' VAL . 2.9 m-85 -56.32 -4.59 0.14 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.951 . . . . 0.0 109.13 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.564 ' H ' ' C ' ' A' ' 4' ' ' GLU . 14.4 mt -84.54 -38.4 20.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.88 . . . . 0.0 109.279 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 8' ' ' ALA . 23.2 mttt -101.43 -3.37 28.79 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.393 -0.817 . . . . 0.0 109.358 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -42.01 137.52 1.81 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.31 -0.869 . . . . 0.0 109.637 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . 0.613 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 154.86 -37.45 0.66 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.567 ' CD ' ' H ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -70.78 19.83 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -1.152 . . . . 0.0 109.309 179.85 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.613 ' H ' ' C ' ' A' ' 9' ' ' GLY . 79.9 mt-10 -139.23 103.02 7.31 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.374 -0.829 . . . . 0.0 109.293 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -78.33 83.97 2.11 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.426 2.084 . . . . 0.0 112.157 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -174.22 -102.01 0.15 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.414 ' CD2' HG22 ' A' ' 43' ' ' ILE . 0.4 OUTLIER -159.97 132.47 6.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.134 . . . . 0.0 109.427 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -115.23 135.93 53.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.276 -0.89 . . . . 0.0 109.478 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.58 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 6.3 mt -130.96 110.11 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.44 -0.787 . . . . 0.0 109.91 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.58 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 6.1 m0 -139.32 149.76 44.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.176 -0.953 . . . . 0.0 108.769 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -114.83 153.27 30.73 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.122 -0.986 . . . . 0.0 110.139 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.463 ' CG1' ' O ' ' A' ' 19' ' ' VAL . 7.3 p -89.26 125.68 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -0.843 . . . . 0.0 109.13 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.511 ' CG ' ' OD1' ' A' ' 39' ' ' ASP . 5.6 mt-10 -157.45 138.02 13.02 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.214 -0.929 . . . . 0.0 109.319 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 22' ' ' PHE . 12.8 mttt 72.97 48.21 0.18 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.501 -0.75 . . . . 0.0 109.458 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.428 ' C ' ' O ' ' A' ' 21' ' ' LYS . 20.5 m-85 43.74 36.93 1.41 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.541 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -169.01 166.75 10.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.28 -0.888 . . . . 0.0 109.405 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 tp -68.15 146.16 53.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.246 -0.909 . . . . 0.0 109.431 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.487 HG22 ' N ' ' A' ' 20' ' ' GLU . 44.1 t -138.5 97.67 9.25 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.371 -0.831 . . . . 0.0 109.071 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -50.31 168.99 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.771 2.314 . . . . 0.0 112.632 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.92 107.43 22.27 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.462 -0.774 . . . . 0.0 109.173 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -45.69 144.04 5.75 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.434 2.089 . . . . 0.0 112.492 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.539 ' C ' ' H ' ' A' ' 31' ' ' LEU . 6.5 m -51.89 -50.19 61.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.266 -0.896 . . . . 0.0 109.39 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -48.11 -11.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.418 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.539 ' H ' ' C ' ' A' ' 29' ' ' THR . 94.5 mt -114.96 -17.45 11.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 109.552 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.49 ' C ' ' O ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -38.74 122.4 1.15 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.325 -0.859 . . . . 0.0 109.352 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.2 -10.9 36.89 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.477 ' C ' ' CD2' ' A' ' 35' ' ' PHE . 4.3 m-20 -93.5 156.71 16.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.151 -1.205 . . . . 0.0 109.381 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.477 ' CD2' ' C ' ' A' ' 34' ' ' ASP . 77.2 m-85 -146.83 134.38 20.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.201 -0.937 . . . . 0.0 109.6 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.598 ' CD2' ' NZ ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -103.63 120.02 40.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 109.329 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.495 ' HG1' ' HA ' ' A' ' 115' ' ' LYS . 59.1 p -61.9 -23.05 66.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 109.44 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.451 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -88.33 24.97 9.85 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.511 ' OD1' ' CG ' ' A' ' 20' ' ' GLU . 7.1 m-20 -159.52 135.34 8.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.283 -1.128 . . . . 0.0 109.334 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.534 ' HB1' ' HE1' ' A' ' 60' ' ' TYR . . . -77.83 140.6 39.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -0.901 . . . . 0.0 109.318 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -116.33 135.04 54.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -0.859 . . . . 0.0 109.383 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.616 ' O ' ' CZ ' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -118.92 136.37 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.414 -0.804 . . . . 0.0 109.265 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.497 ' CD1' ' C ' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -130.64 141.58 45.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.776 179.81 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.451 ' C ' ' CD2' ' A' ' 44' ' ' LEU . 4.6 tt -129.32 117.31 20.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.311 -0.868 . . . . 0.0 109.688 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.503 ' NZ ' ' OH ' ' A' ' 106' ' ' TYR . 4.6 ttmm -89.07 134.65 33.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.842 . . . . 0.0 109.38 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.6 OUTLIER -140.81 116.33 10.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.159 -0.963 . . . . 0.0 109.432 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -125.58 168.44 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.18 -0.95 . . . . 0.0 109.183 -179.816 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.765 HE22 ' H ' ' A' ' 51' ' ' ASN . 1.0 OUTLIER -115.56 123.33 48.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.564 -0.71 . . . . 0.0 109.163 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.594 ' N ' ' OE1' ' A' ' 48' ' ' GLN . 0.5 OUTLIER -103.46 100.41 10.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.285 -0.885 . . . . 0.0 109.532 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.584 ' C ' ' O ' ' A' ' 49' ' ' LEU . 19.7 mtp180 25.89 58.99 0.06 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.654 -0.654 . . . . 0.0 110.032 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.765 ' H ' HE22 ' A' ' 48' ' ' GLN . 1.8 m-20 55.23 50.54 14.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.351 -0.843 . . . . 0.0 109.382 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . -93.53 -79.71 1.45 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.419 ' O ' ' O ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -164.61 22.06 0.06 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -1.171 . . . . 0.0 109.515 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.603 ' O ' ' CD2' ' A' ' 56' ' ' TYR . 11.4 mt 56.35 104.81 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.641 0.734 . . . . 0.0 109.359 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 46' ' ' THR . 4.5 tt0 -68.71 116.29 9.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.55 -0.719 . . . . 0.0 109.236 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.603 ' CD2' ' O ' ' A' ' 54' ' ' LEU . 96.3 m-85 -104.39 115.24 30.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.364 -0.835 . . . . 0.0 109.964 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.89 155.05 36.25 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.439 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 4.3 tp -142.63 137.91 30.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.936 -1.102 . . . . 0.0 110.521 -179.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.653 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -130.02 119.55 23.32 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.524 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.552 ' HH ' HD23 ' A' ' 62' ' ' LEU . 3.6 t80 -101.57 124.44 47.23 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.01 -1.056 . . . . 0.0 109.387 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -103.81 126.64 51.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.11 -0.994 . . . . 0.0 109.799 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.552 HD23 ' HH ' ' A' ' 60' ' ' TYR . 6.4 mt -97.28 162.07 13.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.449 -0.782 . . . . 0.0 109.657 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.97 154.59 16.87 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -74.62 -12.34 60.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.056 -1.261 . . . . 0.0 109.52 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.471 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 1.2 mt-10 -109.23 30.35 6.68 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 2.1 m -130.49 97.42 4.39 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 122.075 0.94 . . . . 0.0 108.586 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.2 p -73.27 -170.88 0.85 Allowed 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.665 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -55.49 -28.18 52.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.792 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.31 -58.87 4.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 0.0 109.571 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.451 ' OE2' ' O ' ' A' ' 65' ' ' GLU . 24.3 mt-10 -62.95 -43.02 99.93 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.264 -0.898 . . . . 0.0 108.998 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.0 t -64.69 -34.68 78.88 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.454 -0.779 . . . . 0.0 108.953 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.03 -43.15 99.81 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.23 -50.33 73.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -1.125 . . . . 0.0 109.116 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.479 ' O ' ' OG1' ' A' ' 78' ' ' THR . . . -61.63 -40.02 93.38 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.469 -0.769 . . . . 0.0 109.267 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.488 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -64.37 -42.7 96.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.866 . . . . 0.0 109.428 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.2 mt -55.4 -53.88 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.183 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -57.87 -32.19 67.44 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.187 -0.946 . . . . 0.0 109.228 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -69.44 -52.42 27.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.008 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.488 HG21 ' O ' ' A' ' 75' ' ' ALA . 37.7 t -56.92 -26.55 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.289 -0.882 . . . . 0.0 109.097 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -70.11 -55.9 8.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.383 -0.823 . . . . 0.0 109.295 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.497 ' CD1' ' C ' ' A' ' 81' ' ' LEU . 0.5 OUTLIER -54.17 -29.82 47.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.035 -1.041 . . . . 0.0 109.04 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 85' ' ' LEU . 72.7 m-20 -68.94 -58.77 3.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.244 -0.91 . . . . 0.0 108.806 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 82' ' ' ASP . 52.9 t0 -46.86 -29.6 2.07 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.124 -0.985 . . . . 0.0 108.465 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -75.15 -33.79 61.55 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.9 tp -107.63 25.72 11.15 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.424 -0.797 . . . . 0.0 109.375 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 85' ' ' LEU . 2.9 m120 39.09 33.9 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.582 -0.699 . . . . 0.0 109.476 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . 53.98 84.6 0.03 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 45.0 mtp85 -140.22 43.08 1.91 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.318 -1.107 . . . . 0.0 109.391 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.501 ' CB ' ' O ' ' A' ' 56' ' ' TYR . . . -150.67 170.68 18.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.858 . . . . 0.0 109.404 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.1 t -91.26 91.87 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 109.266 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.475 ' H ' ' CD ' ' A' ' 91' ' ' GLN . 2.3 mp0 -94.34 120.07 34.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -0.885 . . . . 0.0 109.49 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.603 ' NE2' ' ND1' ' A' ' 59' ' ' HIS . 3.9 p80 -127.94 134.09 49.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.359 -0.838 . . . . 0.0 109.381 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.496 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 0.8 OUTLIER -90.52 117.82 29.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.718 -179.753 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.477 ' OE2' ' OG ' ' A' ' 100' ' ' SER . 11.3 mt-10 -108.28 161.13 15.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 109.354 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.7 t -132.53 158.03 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.184 -0.947 . . . . 0.0 109.538 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . 0.548 ' C ' ' NE2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -61.98 143.79 56.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 109.443 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.53 ' N ' HE21 ' A' ' 96' ' ' GLN . . . 73.95 7.71 76.51 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -151.39 22.01 0.73 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.316 -1.108 . . . . 0.0 109.322 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -51.62 171.21 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.569 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.477 ' OG ' ' OE2' ' A' ' 94' ' ' GLU . 67.5 p -101.11 165.77 11.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.328 -0.858 . . . . 0.0 109.488 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.47 -33.21 73.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 0.0 109.487 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.2 m -59.92 -42.81 94.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.479 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -66.21 -53.46 36.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.242 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.3 mt -62.58 -27.94 69.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.352 -0.843 . . . . 0.0 109.169 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -69.35 -35.65 76.73 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.522 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 1.9 m-85 -70.13 -54.92 10.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -1.101 . . . . 0.0 109.251 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.522 ' CD2' ' O ' ' A' ' 106' ' ' TYR . 10.0 m-85 -139.36 115.57 10.4 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.425 -0.797 . . . . 0.0 109.562 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.8 tttp -98.72 -52.02 3.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.313 -0.867 . . . . 0.0 109.52 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 m -92.61 23.11 4.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 109.467 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -119.16 -30.27 1.62 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.0 mt -63.8 123.39 18.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.221 -1.164 . . . . 0.0 109.509 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -137.12 102.65 4.9 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.305 -0.872 . . . . 0.0 109.448 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.69 136.42 35.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.905 . . . . 0.0 109.373 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.598 ' NZ ' ' CD2' ' A' ' 36' ' ' PHE . 9.5 pttp -131.54 147.38 52.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 109.464 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.495 ' HA ' ' HG1' ' A' ' 37' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.353 -0.842 . . . . 0.0 109.433 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo . . . . . 0 N--CA 1.488 1.183 0 CA-C-O 121.248 0.437 . . . . 0.0 112.085 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 6' ' ' LEU . 75.8 mt-10 -83.11 -30.77 27.66 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.275 -0.89 . . . . 0.0 109.708 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.51 ' CE1' ' CG1' ' A' ' 42' ' ' VAL . 46.8 t80 -43.88 -18.31 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.134 -0.979 . . . . 0.0 109.233 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.565 ' N ' ' O ' ' A' ' 4' ' ' GLU . 4.6 mt -81.4 -39.96 24.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.337 -0.852 . . . . 0.0 109.53 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 8' ' ' ALA . 28.3 mtpt -86.93 -12.83 46.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 109.615 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.471 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -42.23 164.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.193 -0.942 . . . . 0.0 109.509 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.12 26.95 5.28 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -102.04 12.53 36.71 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.205 -1.173 . . . . 0.0 109.653 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -158.3 133.69 5.79 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.915 . . . . 0.0 109.466 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -74.58 86.02 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.499 2.133 . . . . 0.0 112.34 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -170.18 -105.59 0.18 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.3 tt -162.2 144.69 11.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.311 -1.111 . . . . 0.0 109.517 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -138.02 134.73 35.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 109.375 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.49 ' HA ' HG22 ' A' ' 43' ' ' ILE . 27.1 mt -106.92 147.38 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.338 -0.851 . . . . 0.0 110.167 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.08 141.94 36.15 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 25' ' ' VAL . 18.7 ttt180 -110.39 144.85 38.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.177 -0.952 . . . . 0.0 109.635 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 52.0 t -72.48 133.51 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.436 -0.79 . . . . 0.0 109.502 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.684 ' C ' ' H ' ' A' ' 22' ' ' PHE . 28.0 tt0 -81.08 86.85 6.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -0.966 . . . . 0.0 109.366 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.463 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 26.2 mmtp 61.05 -33.09 0.08 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.487 -0.758 . . . . 0.0 109.994 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.684 ' H ' ' C ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER 179.34 27.31 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -0.932 . . . . 0.0 109.394 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -145.15 -113.52 0.09 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.083 -1.01 . . . . 0.0 109.626 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.7 mt -143.66 136.37 27.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.066 -1.021 . . . . 0.0 109.799 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 18' ' ' ARG . 0.9 OUTLIER -149.16 140.37 14.18 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.302 -0.874 . . . . 0.0 108.759 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.49 149.42 68.59 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.551 2.167 . . . . 0.0 112.516 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.6 t -117.94 101.82 51.56 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.492 -0.755 . . . . 0.0 109.207 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -80.84 167.91 18.0 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.655 2.237 . . . . 0.0 112.461 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.6 ' C ' ' H ' ' A' ' 31' ' ' LEU . 1.9 t -61.03 -173.91 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.546 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.464 ' N ' ' OG1' ' A' ' 29' ' ' THR . 8.1 t30 70.31 -27.71 0.17 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.861 . . . . 0.0 109.343 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.6 ' H ' ' C ' ' A' ' 29' ' ' THR . 43.5 mt -122.73 -33.41 3.39 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.392 -0.818 . . . . 0.0 109.369 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -48.59 165.13 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 0.0 109.319 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.468 ' N ' ' CD1' ' A' ' 32' ' ' TYR . . . 89.04 -24.08 14.85 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -96.71 150.76 20.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -1.182 . . . . 0.0 109.469 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -141.03 134.17 29.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.898 . . . . 0.0 109.418 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.546 ' C ' ' H ' ' A' ' 38' ' ' GLY . 25.6 m-85 -104.53 111.78 24.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.872 . . . . 0.0 109.482 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.469 ' OG1' ' OE1' ' A' ' 65' ' ' GLU . 19.6 p -51.55 -9.51 0.08 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.237 -0.915 . . . . 0.0 109.356 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 36' ' ' PHE . . . -99.51 27.12 21.64 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.443 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 50.2 m-20 -161.01 146.76 14.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -1.086 . . . . 0.0 109.368 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.437 ' C ' ' CD2' ' A' ' 41' ' ' TYR . . . -92.23 158.88 15.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.192 -0.942 . . . . 0.0 109.483 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.437 ' CD2' ' C ' ' A' ' 40' ' ' ALA . 36.4 m-85 -138.26 138.12 38.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 109.369 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.523 ' C ' ' CD1' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -108.83 128.44 64.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.129 -0.982 . . . . 0.0 108.902 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.523 ' CD1' ' C ' ' A' ' 42' ' ' VAL . 0.4 OUTLIER -125.76 136.97 59.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.242 -0.911 . . . . 0.0 110.023 -179.523 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 tt -124.55 128.85 49.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.545 -0.722 . . . . 0.0 109.582 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.51 ' HZ2' HG21 ' A' ' 102' ' ' THR . 30.3 ttpt -103.79 145.96 29.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.311 -0.868 . . . . 0.0 109.06 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 13' ' ' GLY . 1.0 OUTLIER -143.01 126.78 17.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 109.764 -179.681 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.659 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -131.94 168.09 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.29 -0.881 . . . . 0.0 109.16 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -96.82 131.86 43.13 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.597 -0.689 . . . . 0.0 109.497 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 50' ' ' ARG . 14.5 mt -96.92 166.93 11.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.301 -0.874 . . . . 0.0 109.538 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.43 ' H ' ' HD2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -45.18 -78.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.272 -0.892 . . . . 0.0 109.17 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -45.53 -28.97 1.04 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.291 -0.881 . . . . 0.0 109.252 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.55 69.07 1.03 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.499 ' O ' ' O ' ' A' ' 54' ' ' LEU . 63.5 m-20 -120.73 14.44 11.72 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.242 -1.152 . . . . 0.0 109.384 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.659 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 17.7 mt 44.1 97.05 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.509 0.671 . . . . 0.0 109.364 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -71.08 112.08 6.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.428 -0.795 . . . . 0.0 109.527 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.59 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 73.7 m-85 -95.74 114.54 26.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.136 -0.978 . . . . 0.0 109.701 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -115.78 155.38 27.92 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.452 HD11 ' N ' ' A' ' 58' ' ' LEU . 3.8 mp -132.3 141.1 48.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.815 -1.178 . . . . 0.0 110.884 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.484 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -136.7 112.43 9.46 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.233 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.735 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -94.38 126.93 39.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.086 -1.008 . . . . 0.0 109.458 -179.6 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.441 ' HE1' ' HG2' ' A' ' 99' ' ' GLU . 2.3 t90 -98.08 124.73 42.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.475 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 mt -107.64 145.86 32.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.532 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -95.01 158.87 22.59 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -76.23 -12.53 60.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.322 -1.105 . . . . 0.0 109.662 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.469 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 1.1 mt-10 -109.45 29.16 7.82 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 2.0 m -130.7 97.48 4.37 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.211 1.005 . . . . 0.0 108.579 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.8 t -57.35 -170.92 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.735 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.562 ' O ' ' N ' ' A' ' 72' ' ' GLY . 3.2 mm100 -68.99 -17.39 63.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -0.86 . . . . 0.0 109.647 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -61.02 -58.75 7.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 109.394 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -64.38 -49.08 73.0 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.237 -0.914 . . . . 0.0 108.884 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.3 m -64.43 -23.22 67.21 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.399 -0.813 . . . . 0.0 108.844 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -68.44 -47.09 59.62 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.433 ' O ' ' CE2' ' A' ' 77' ' ' PHE . . . -62.63 -49.25 75.92 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.293 -1.122 . . . . 0.0 109.138 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.62 -32.51 74.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.507 -0.746 . . . . 0.0 109.214 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.556 ' O ' HG22 ' A' ' 79' ' ' VAL . . . -71.59 -43.96 65.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.264 -0.898 . . . . 0.0 109.376 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.496 ' O ' ' OE1' ' A' ' 80' ' ' GLN . 59.4 mt -55.09 -53.17 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.188 -0.945 . . . . 0.0 109.24 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . 0.559 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -60.0 -36.57 77.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.134 179.784 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.1 m -69.2 -31.42 70.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.283 -0.886 . . . . 0.0 108.999 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 75' ' ' ALA . 55.1 t -64.83 -46.09 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.271 -0.893 . . . . 0.0 109.242 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . 0.552 ' N ' ' OE1' ' A' ' 80' ' ' GLN . 5.1 mp0 -60.97 -45.42 94.82 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.6 mt -53.27 -43.93 67.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.315 -0.866 . . . . 0.0 109.037 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.64 ' O ' ' N ' ' A' ' 86' ' ' ASN . 68.4 t0 -58.14 -58.23 9.37 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.396 -0.815 . . . . 0.0 109.145 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 82' ' ' ASP . 1.9 m-20 -44.73 -34.41 2.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.155 -0.966 . . . . 0.0 108.948 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -77.08 -30.94 55.69 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.299 -0.876 . . . . 0.0 108.98 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 82' ' ' ASP . 18.7 mt -121.56 32.39 5.91 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.315 -0.866 . . . . 0.0 109.486 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.64 ' N ' ' O ' ' A' ' 82' ' ' ASP . 60.8 t30 -81.08 28.28 0.37 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.207 -0.933 . . . . 0.0 109.097 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -110.45 -37.26 1.79 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -163.23 67.78 0.2 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.154 -1.204 . . . . 0.0 109.45 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.07 166.17 24.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.0 109.321 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.9 t -123.12 96.34 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.342 -0.849 . . . . 0.0 109.545 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.58 131.38 44.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.315 -0.865 . . . . 0.0 109.036 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.569 ' CD2' ' N ' ' A' ' 92' ' ' HIS . 1.6 p80 -150.55 157.36 42.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.006 -1.059 . . . . 0.0 110.037 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.71 121.34 40.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.407 -0.808 . . . . 0.0 109.666 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.447 ' N ' ' CD ' ' A' ' 94' ' ' GLU . 1.5 mp0 -104.69 120.93 42.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.296 -0.878 . . . . 0.0 109.407 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.9 t -101.18 166.72 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.317 -0.865 . . . . 0.0 109.581 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -76.17 140.87 41.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.493 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.424 ' O ' ' CG ' ' A' ' 98' ' ' PHE . . . 80.51 5.02 90.1 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.472 ' O ' ' O ' ' A' ' 99' ' ' GLU . 46.1 m-85 -157.64 22.42 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -1.126 . . . . 0.0 109.457 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' A' ' 98' ' ' PHE . 97.3 mt-10 -49.05 178.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.405 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.3 t -89.63 163.09 15.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.424 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.08 -26.73 67.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.404 -0.81 . . . . 0.0 109.433 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.51 HG21 ' HZ2' ' A' ' 45' ' ' LYS . 7.5 m -65.62 -41.72 92.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.485 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -75.26 -41.95 56.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.372 -0.83 . . . . 0.0 109.336 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.5 mt -62.46 -24.68 67.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.271 -0.893 . . . . 0.0 109.519 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -92.94 -24.02 23.87 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.11 -35.77 69.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.274 -1.133 . . . . 0.0 109.417 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -139.16 133.82 31.97 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.328 -0.858 . . . . 0.0 109.529 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.434 ' HG3' ' H ' ' A' ' 109' ' ' SER . 1.8 pttp -108.59 -55.45 2.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.436 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' SER . . . . . 0.434 ' H ' ' HG3' ' A' ' 108' ' ' LYS . 2.4 t -105.56 15.36 27.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 109.532 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.45 -20.01 18.84 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.5 mt -72.61 70.66 0.94 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -1.18 . . . . 0.0 109.438 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -85.4 124.04 31.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.291 -0.881 . . . . 0.0 109.581 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -105.29 152.76 22.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.485 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.4 mttt -138.83 163.65 31.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.329 -0.857 . . . . 0.0 109.416 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.8 mttt . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.313 -0.867 . . . . 0.0 109.461 -179.949 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . 0.613 ' HA ' HD21 ' A' ' 24' ' ' LEU . 54.0 Cg_exo . . . . . 0 N--CA 1.492 1.42 0 CA-C-O 121.262 0.443 . . . . 0.0 112.116 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.497 ' OE2' ' CH2' ' A' ' 17' ' ' TRP . 19.6 tt0 -83.23 -44.03 15.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 109.982 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.466 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 5.4 m-85 -49.35 -28.73 5.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.185 -0.947 . . . . 0.0 109.435 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.5 mt -74.78 -29.22 61.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 109.597 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.6 mmtm -123.76 26.38 7.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -0.911 . . . . 0.0 109.523 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 4' ' ' GLU . . . -81.35 173.3 12.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.354 -0.841 . . . . 0.0 109.568 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.32 44.8 0.17 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.92 30.54 3.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.381 -1.07 . . . . 0.0 109.497 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.542 ' OE1' ' NE2' ' A' ' 15' ' ' GLN . 1.2 pm0 -164.14 117.17 1.01 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.173 -0.955 . . . . 0.0 109.367 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -77.67 89.47 1.33 Allowed 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.432 2.088 . . . . 0.0 112.088 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -177.98 -98.34 0.11 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -162.06 138.51 7.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -1.142 . . . . 0.0 109.638 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.542 ' NE2' ' OE1' ' A' ' 11' ' ' GLU . 19.1 mt-30 -114.99 135.89 53.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.435 -0.791 . . . . 0.0 108.974 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.62 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 13.1 mt -130.19 116.53 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.345 -0.847 . . . . 0.0 110.114 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TRP . . . . . 0.62 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 7.6 m0 -144.2 152.16 40.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.054 -1.029 . . . . 0.0 109.116 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.58 ' O ' ' N ' ' A' ' 25' ' ' VAL . 0.9 OUTLIER -101.84 153.29 19.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.93 . . . . 0.0 109.801 -179.283 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.5 t -97.47 131.2 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.42 -0.8 . . . . 0.0 109.538 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.696 ' C ' ' H ' ' A' ' 22' ' ' PHE . 1.9 tm-20 -76.83 86.65 3.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.132 -0.98 . . . . 0.0 108.732 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.6 ' O ' ' CB ' ' A' ' 22' ' ' PHE . 25.2 mtmm 48.31 3.86 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.375 -0.828 . . . . 0.0 109.539 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.696 ' H ' ' C ' ' A' ' 20' ' ' GLU . 1.4 t80 155.59 -30.22 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.424 -0.797 . . . . 0.0 109.472 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -81.62 -133.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.171 -0.956 . . . . 0.0 109.844 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.613 HD21 ' HA ' ' A' ' 3' ' ' PRO . 0.2 OUTLIER -137.03 140.13 41.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -0.916 . . . . 0.0 109.607 -179.767 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.58 ' N ' ' O ' ' A' ' 18' ' ' ARG . 9.4 t -137.79 91.6 13.47 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 108.999 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -52.42 159.35 4.56 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.654 2.236 . . . . 0.0 112.574 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.1 t -145.25 112.83 4.77 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.354 -0.841 . . . . 0.0 109.077 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 29' ' ' THR . 60.0 Cg_endo -77.88 168.14 22.66 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.44 2.093 . . . . 0.0 112.468 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' THR . . . . . 0.616 ' C ' ' H ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -51.73 -174.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.389 -0.819 . . . . 0.0 109.361 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.573 ' N ' ' OG1' ' A' ' 29' ' ' THR . 0.3 OUTLIER 69.17 -36.76 0.35 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.17 -0.956 . . . . 0.0 109.222 -179.788 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.616 ' H ' ' C ' ' A' ' 29' ' ' THR . 14.4 mt -109.21 -36.36 6.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.442 -0.786 . . . . 0.0 109.198 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 31' ' ' LEU . 1.9 p90 -43.22 166.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.348 -0.845 . . . . 0.0 109.376 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.89 -12.88 15.38 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 32' ' ' TYR . 1.1 m-20 -87.3 158.81 18.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.212 -1.17 . . . . 0.0 109.481 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -144.99 108.42 4.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 109.56 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.529 ' C ' ' H ' ' A' ' 38' ' ' GLY . 2.8 m-85 -80.32 111.91 17.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 109.136 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.44 ' OG1' ' OE1' ' A' ' 65' ' ' GLU . 8.7 p -56.65 -4.97 0.18 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.185 -0.947 . . . . 0.0 109.618 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.529 ' H ' ' C ' ' A' ' 36' ' ' PHE . . . -109.7 39.09 3.03 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.529 ' N ' ' SG ' ' A' ' 66' ' ' CYS . 8.2 m-20 -169.34 -176.38 2.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -1.173 . . . . 0.0 109.622 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.51 129.37 50.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.372 -0.83 . . . . 0.0 109.343 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -114.07 137.31 51.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 109.688 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.466 ' HB ' ' CD1' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -115.24 142.82 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.297 -0.877 . . . . 0.0 109.18 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.46 HD13 HG23 ' A' ' 43' ' ' ILE . 0.7 OUTLIER -136.34 143.2 36.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.108 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.8 tt -128.05 118.97 24.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.484 -0.76 . . . . 0.0 109.238 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 50.2 tttt -88.85 138.74 31.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 109.426 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -141.64 114.37 8.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.93 . . . . 0.0 109.477 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.675 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -126.03 168.04 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 121.13 -0.981 . . . . 0.0 109.069 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -100.92 101.37 12.17 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.675 -0.641 . . . . 0.0 109.395 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.6 mt -57.04 163.86 1.87 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.933 . . . . 0.0 109.434 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.404 ' HG3' ' H ' ' A' ' 51' ' ' ASN . 21.2 ptt85 -48.82 -47.65 42.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 0.0 109.308 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.404 ' H ' ' HG3' ' A' ' 50' ' ' ARG . 4.0 m120 -70.65 -30.1 66.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.176 -0.952 . . . . 0.0 109.158 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.47 34.93 3.99 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.501 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.6 t-20 -89.97 13.39 14.85 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.183 -1.187 . . . . 0.0 109.325 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.675 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.4 mt 43.38 96.97 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.578 0.704 . . . . 0.0 109.456 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -71.17 116.16 11.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.551 -0.718 . . . . 0.0 109.581 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.54 ' CD1' ' O ' ' A' ' 54' ' ' LEU . 90.4 m-85 -100.7 114.7 28.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 0.0 109.858 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.7 155.16 34.48 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.449 ' C ' ' CG ' ' A' ' 59' ' ' HIS . 5.2 mp -132.62 147.79 52.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.967 -1.083 . . . . 0.0 110.466 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . 0.462 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 1.4 m-70 -150.34 127.17 11.03 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.628 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 1.1 p90 -115.18 132.69 56.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.045 -1.035 . . . . 0.0 109.941 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.458 ' CE3' ' O ' ' A' ' 62' ' ' LEU . 10.3 t90 -102.97 123.88 47.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.375 -0.828 . . . . 0.0 109.238 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.458 ' O ' ' CE3' ' A' ' 61' ' ' TRP . 22.7 mt -101.85 162.12 13.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 109.657 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.03 154.61 16.49 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -82.15 -12.09 58.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -1.128 . . . . 0.0 109.572 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.44 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 2.8 mt-10 -106.58 29.09 7.23 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.555 ' SG ' ' OE1' ' A' ' 70' ' ' GLU . 1.6 m -130.64 97.55 4.4 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 122.15 0.976 . . . . 0.0 108.381 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 66' ' ' CYS . 9.9 m -39.03 161.57 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.707 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 72' ' ' GLY . 15.9 mm-40 -56.2 -17.41 7.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.389 -0.819 . . . . 0.0 109.661 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -63.98 -58.56 6.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 109.371 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.555 ' OE1' ' SG ' ' A' ' 66' ' ' CYS . 24.2 mt-10 -61.06 -54.26 46.95 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.345 -0.847 . . . . 0.0 108.987 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 p -64.13 -26.22 68.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.318 -0.864 . . . . 0.0 109.043 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.38 -41.77 66.75 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.14 -46.74 82.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -1.18 . . . . 0.0 109.28 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.12 -46.31 89.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.427 -0.795 . . . . 0.0 109.07 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.39 -41.53 80.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.345 -0.847 . . . . 0.0 109.26 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 51.0 mt -57.68 -46.24 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.278 -0.889 . . . . 0.0 109.279 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -59.03 -35.34 73.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 109.143 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.7 m -72.34 -25.55 61.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.183 -0.948 . . . . 0.0 109.038 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.4 t -72.77 -48.77 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.306 -0.871 . . . . 0.0 109.541 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -65.86 -35.94 82.07 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.141 -0.975 . . . . 0.0 108.85 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.85 -42.56 98.04 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.628 ' O ' ' N ' ' A' ' 86' ' ' ASN . 51.9 t0 -61.16 -57.35 12.85 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.315 -0.865 . . . . 0.0 109.214 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -48.43 -31.38 6.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.142 -0.974 . . . . 0.0 108.707 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -78.59 -31.12 47.06 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.423 -0.798 . . . . 0.0 108.882 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.543 ' C ' ' H ' ' A' ' 87' ' ' GLY . 9.9 mt -121.71 32.7 5.77 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.435 -0.79 . . . . 0.0 109.518 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASN . . . . . 0.628 ' N ' ' O ' ' A' ' 82' ' ' ASP . 17.8 t-20 -77.35 27.03 0.16 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.243 -0.91 . . . . 0.0 109.024 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -94.34 -48.41 2.6 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -152.21 45.61 0.74 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.168 -1.196 . . . . 0.0 109.638 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 56' ' ' TYR . . . -136.95 157.46 46.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.431 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 19.2 t -136.05 141.37 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 109.466 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.423 ' CD ' ' N ' ' A' ' 91' ' ' GLN . 6.8 mm-40 -88.95 142.47 27.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.212 -0.93 . . . . 0.0 109.37 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.492 ' O ' ' OE1' ' A' ' 94' ' ' GLU . 15.3 m-70 -118.29 115.24 24.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.268 -0.895 . . . . 0.0 109.461 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.84 104.92 15.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.233 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.589 ' OE2' ' CE2' ' A' ' 103' ' ' PHE . 1.5 mp0 -104.62 124.09 48.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.877 . . . . 0.0 109.65 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.1 t -125.76 155.56 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.312 -0.867 . . . . 0.0 109.17 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -55.54 115.98 2.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.19 -0.943 . . . . 0.0 109.624 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.519 ' O ' ' CD1' ' A' ' 98' ' ' PHE . . . 93.34 10.18 59.68 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 78.8 m-85 -152.94 25.37 0.56 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.179 -1.189 . . . . 0.0 109.669 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 99' ' ' GLU . 2.1 mp0 -48.19 135.52 13.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.119 -0.988 . . . . 0.0 109.428 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.5 t -61.46 171.42 1.46 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.104 -0.998 . . . . 0.0 109.552 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.11 -65.06 0.82 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 109.593 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.0 m -50.55 -27.39 6.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 109.308 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . 0.589 ' CE2' ' OE2' ' A' ' 94' ' ' GLU . 32.0 t80 -74.82 -55.59 5.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 0.0 109.799 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.439 HD11 ' C ' ' A' ' 104' ' ' LEU . 1.6 pp -67.18 -22.08 65.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.057 -1.027 . . . . 0.0 109.372 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.76 -33.12 34.86 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -78.4 -43.82 26.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -1.127 . . . . 0.0 109.422 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.454 ' HB2' HD23 ' A' ' 111' ' ' LEU . 51.8 m-85 -102.21 105.83 16.57 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.397 -0.814 . . . . 0.0 109.579 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -111.65 -49.85 2.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.358 -0.839 . . . . 0.0 109.513 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.0 t -106.04 23.16 14.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.094 -1.003 . . . . 0.0 109.514 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.575 ' O ' ' N ' ' A' ' 112' ' ' LYS . . . -125.18 -15.41 3.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.454 HD23 ' HB2' ' A' ' 107' ' ' PHE . 95.2 mt -62.13 70.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -1.176 . . . . 0.0 109.508 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.575 ' N ' ' O ' ' A' ' 110' ' ' GLY . 29.4 tttt -93.25 108.49 20.11 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.202 -0.936 . . . . 0.0 109.565 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.66 143.79 27.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.369 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -133.54 115.99 15.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 0.0 109.426 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.87 . . . . 0.0 109.47 179.969 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.481 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 1.6 p-80 -146.2 78.35 11.34 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.212 -0.93 . . . . 0.0 109.526 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -76.84 97.06 1.12 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.747 2.298 . . . . 0.0 111.946 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.574 ' O ' ' N ' ' A' ' 8' ' ' ALA . 16.7 mt-10 -83.34 -39.68 20.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 110.138 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.581 ' CE2' ' CG1' ' A' ' 42' ' ' VAL . 23.5 t80 -61.78 -46.81 87.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.133 -0.979 . . . . 0.0 109.866 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.495 HD13 ' H ' ' A' ' 6' ' ' LEU . 3.4 mp -71.84 -32.99 68.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.068 -1.02 . . . . 0.0 109.439 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.9 mmtm -94.78 0.88 55.3 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.257 -0.902 . . . . 0.0 109.459 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 4' ' ' GLU . . . -52.1 153.74 2.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 109.424 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 137.52 68.42 0.05 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -144.66 8.14 1.3 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.24 -1.153 . . . . 0.0 109.567 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -166.61 126.76 1.19 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 109.243 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.85 94.56 1.0 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.405 2.07 . . . . 0.0 112.213 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -174.18 -104.18 0.17 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.6 tp -156.01 134.42 11.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.366 -1.079 . . . . 0.0 109.764 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -126.55 131.93 51.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.866 . . . . 0.0 109.357 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.544 ' HA ' HG22 ' A' ' 43' ' ' ILE . 41.6 mt -108.0 137.1 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -0.799 . . . . 0.0 109.758 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -139.5 166.19 25.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.261 -0.899 . . . . 0.0 109.063 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -144.96 142.16 29.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.126 -0.984 . . . . 0.0 109.725 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.43 ' O ' ' CG1' ' A' ' 19' ' ' VAL . 7.6 p -79.76 127.95 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.292 -0.88 . . . . 0.0 109.566 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.503 ' O ' ' CG2' ' A' ' 25' ' ' VAL . 2.6 mm-40 -164.18 134.47 4.16 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.298 -0.876 . . . . 0.0 109.267 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 29.4 tttm 75.99 41.62 0.23 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.369 -0.832 . . . . 0.0 109.56 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 48.33 43.62 19.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.173 -0.954 . . . . 0.0 109.444 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.481 ' OD2' ' CE1' ' A' ' 2' ' ' HIS . 26.3 t0 -173.33 -172.05 0.76 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.896 . . . . 0.0 109.459 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.527 ' CD2' ' N ' ' A' ' 24' ' ' LEU . 3.9 mm? -88.49 138.15 31.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.503 ' CG2' ' O ' ' A' ' 20' ' ' GLU . 5.0 t -138.83 128.36 14.45 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.219 -0.926 . . . . 0.0 109.253 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -74.95 166.36 29.39 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.36 2.04 . . . . 0.0 112.355 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.6 t -111.12 101.3 49.86 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.367 -0.833 . . . . 0.0 109.404 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.413 ' HD2' HD11 ' A' ' 31' ' ' LEU . 33.2 Cg_exo -53.27 168.08 0.67 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.533 2.155 . . . . 0.0 112.363 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.556 ' C ' ' H ' ' A' ' 31' ' ' LEU . 24.5 m -60.16 170.56 1.23 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.342 -0.849 . . . . 0.0 109.032 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.409 ' CB ' ' O ' ' A' ' 29' ' ' THR . 0.9 OUTLIER 69.69 -40.91 0.47 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.205 -0.934 . . . . 0.0 109.195 -179.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.556 ' H ' ' C ' ' A' ' 29' ' ' THR . 96.0 mt -81.79 -44.22 17.27 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.376 -0.828 . . . . 0.0 109.209 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 33' ' ' GLY . 0.3 OUTLIER -53.42 138.33 33.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.359 -0.838 . . . . 0.0 109.138 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.498 ' N ' ' CD1' ' A' ' 32' ' ' TYR . . . 109.43 -8.99 32.86 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -121.81 115.5 22.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.351 -1.088 . . . . 0.0 109.375 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -87.86 140.07 29.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 109.589 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -102.17 146.19 28.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.334 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 p -92.42 -8.93 43.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 109.468 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.434 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -107.94 35.79 4.78 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 9.7 m-20 -167.57 171.98 9.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.333 -1.098 . . . . 0.0 109.497 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.94 141.2 48.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 109.546 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -116.24 134.75 54.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.392 -0.817 . . . . 0.0 109.472 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.581 ' CG1' ' CE2' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -114.13 124.47 70.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.21 -0.931 . . . . 0.0 108.603 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.767 ' CD1' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -121.33 133.8 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.174 -0.954 . . . . 0.0 110.03 -178.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.0 tt -122.68 121.65 36.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.504 -0.747 . . . . 0.0 109.906 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -96.56 141.87 29.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.371 -0.831 . . . . 0.0 108.954 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.529 ' O ' ' N ' ' A' ' 13' ' ' GLY . 29.1 m -137.17 128.05 27.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.037 -1.039 . . . . 0.0 109.72 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -132.68 168.72 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 O-C-N 121.223 -0.923 . . . . 0.0 109.231 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -102.82 103.57 13.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.574 -0.704 . . . . 0.0 109.464 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.8 mt -72.7 169.01 17.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.282 -0.886 . . . . 0.0 109.711 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.42 ' C ' ' N ' ' A' ' 52' ' ' GLY . 14.7 mtt180 -45.52 -72.83 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.265 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -44.97 -24.18 0.2 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 109.255 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' A' ' 50' ' ' ARG . . . 84.62 32.96 20.57 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.488 ' O ' ' O ' ' A' ' 54' ' ' LEU . 1.0 OUTLIER -86.58 14.26 7.19 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.165 -1.197 . . . . 0.0 109.205 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.59 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 12.6 mt 47.15 100.27 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.544 0.688 . . . . 0.0 109.608 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.599 ' NE2' ' H ' ' A' ' 56' ' ' TYR . 3.2 tm0? -68.57 145.35 54.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.573 -0.704 . . . . 0.0 109.129 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.599 ' H ' ' NE2' ' A' ' 55' ' ' GLN . 91.3 m-85 -129.77 114.67 16.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.923 . . . . 0.0 109.925 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.502 ' OD2' HG22 ' A' ' 90' ' ' VAL . 70.7 m-20 -123.93 155.48 38.06 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -150.35 142.76 24.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.683 -1.261 . . . . 0.0 110.983 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.615 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -120.71 133.91 55.32 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.277 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.516 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -105.14 115.38 30.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.361 -0.837 . . . . 0.0 109.366 -179.653 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.539 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 36.0 t90 -106.9 135.38 48.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.212 -0.93 . . . . 0.0 109.939 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.539 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 0.1 OUTLIER -124.27 162.18 24.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.379 -0.826 . . . . 0.0 109.501 179.627 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -96.31 161.77 22.45 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -82.11 -11.88 58.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.277 -1.131 . . . . 0.0 109.614 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -104.26 30.83 4.99 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.516 ' SG ' ' CD ' ' A' ' 70' ' ' GLU . 1.2 m -130.73 97.53 4.38 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.162 0.982 . . . . 0.0 108.433 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 66' ' ' CYS . 1.5 m -47.09 178.05 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.694 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.718 ' H ' ' NE2' ' A' ' 68' ' ' GLN . 1.4 mp0 -61.22 -18.07 56.45 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.235 -0.915 . . . . 0.0 109.534 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -64.42 -58.78 5.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 0.0 109.359 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.516 ' CD ' ' SG ' ' A' ' 66' ' ' CYS . 25.5 mt-10 -66.02 -44.5 84.54 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 108.824 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.85 -25.69 66.54 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.523 -0.736 . . . . 0.0 109.03 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.07 -47.01 48.26 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.74 91.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.271 -1.135 . . . . 0.0 109.193 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.449 ' HB2' ' CZ ' ' A' ' 60' ' ' TYR . . . -61.32 -49.47 76.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.401 -0.812 . . . . 0.0 109.195 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.75 -34.73 77.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.273 -0.892 . . . . 0.0 109.537 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.4 HD12 HG21 ' A' ' 76' ' ' ILE . 14.2 mt -57.26 -54.63 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.934 . . . . 0.0 109.418 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -60.51 -33.47 72.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.108 -0.995 . . . . 0.0 109.47 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 m -69.72 -40.18 76.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.244 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 81.0 t -61.81 -42.12 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.417 -0.802 . . . . 0.0 109.319 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 6.1 mm-40 -60.31 -51.32 70.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.009 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.6 mt -49.29 -43.1 43.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 108.951 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' A' ' 86' ' ' ASN . 19.6 t0 -57.02 -60.32 3.77 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.222 -0.924 . . . . 0.0 109.389 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.467 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 30.7 t0 -45.0 -35.86 3.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.145 -0.972 . . . . 0.0 108.88 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 18.1 t80 -75.89 -28.87 58.27 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.617 ' C ' ' H ' ' A' ' 87' ' ' GLY . 47.8 mt -121.49 33.46 5.52 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.432 -0.792 . . . . 0.0 109.424 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.605 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.4 OUTLIER -73.13 25.62 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 109.052 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.617 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -84.4 -58.24 2.21 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.98 35.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -1.122 . . . . 0.0 109.545 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -78.55 179.28 7.18 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.26 -0.9 . . . . 0.0 109.269 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.502 HG22 ' OD2' ' A' ' 57' ' ' ASP . 14.9 t -114.4 91.48 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.17 -0.956 . . . . 0.0 109.37 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.454 ' CD ' ' O ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -96.93 125.45 41.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.336 -0.852 . . . . 0.0 109.206 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.482 ' CD2' ' N ' ' A' ' 92' ' ' HIS . 1.8 p80 -151.48 118.68 5.93 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.036 -1.04 . . . . 0.0 109.513 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 8.5 ptt-85 -91.71 134.63 34.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.382 -0.824 . . . . 0.0 109.792 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -112.89 155.98 23.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.424 -0.797 . . . . 0.0 109.566 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.7 t -121.41 169.51 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.335 -0.853 . . . . 0.0 109.486 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.1 tt0 -78.31 129.35 34.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 109.425 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.4 5.21 79.61 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.48 ' O ' ' O ' ' A' ' 99' ' ' GLU . 20.2 m-85 -146.06 19.51 1.42 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -1.152 . . . . 0.0 109.463 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.48 ' O ' ' O ' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -51.68 -173.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 109.403 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.0 t -137.89 175.77 9.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 109.524 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.53 -34.53 72.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.924 . . . . 0.0 109.424 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.5 m -53.57 -47.01 70.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.53 -56.81 7.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.319 -0.863 . . . . 0.0 109.328 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.6 mt -56.36 -24.23 42.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.25 -0.906 . . . . 0.0 109.509 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.1 -30.03 26.69 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -71.01 -30.26 66.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.184 -1.186 . . . . 0.0 109.273 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -139.14 103.57 4.8 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.28 -0.888 . . . . 0.0 109.451 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -102.86 -2.72 27.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.173 -0.954 . . . . 0.0 109.52 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.5 p -66.47 -16.12 63.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.187 -0.946 . . . . 0.0 109.486 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.89 88.78 2.07 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.588 ' H ' ' CD2' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -70.1 135.44 49.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.236 -1.155 . . . . 0.0 109.379 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -90.18 142.23 27.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.331 -0.856 . . . . 0.0 109.582 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.443 ' CD2' ' N ' ' A' ' 113' ' ' TYR . 20.4 m-85 -106.23 111.78 24.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 109.442 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -94.12 145.23 24.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 109.43 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm -138.28 137.67 37.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.356 -0.84 . . . . 0.0 109.52 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.4 115.01 0.07 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -100.25 74.65 0.44 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.5 t -60.82 89.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -1.139 . . . . 0.0 109.507 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -176.47 117.18 0.12 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 0.0 109.439 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.6 m -90.13 21.16 3.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.454 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.83 90.25 0.4 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -174.8 124.75 0.27 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.191 -1.182 . . . . 0.0 109.491 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.0 pttm -131.93 154.96 48.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.351 -0.843 . . . . 0.0 109.425 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -97.61 125.38 42.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.299 -0.875 . . . . 0.0 109.492 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 64.2 t -64.59 125.56 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.894 . . . . 0.0 109.412 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -95.61 153.89 39.34 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.948 . . . . 0.0 109.465 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 128' ' ' ASN . 41.5 Cg_endo -70.89 97.36 0.73 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.673 2.249 . . . . 0.0 112.142 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 127' ' ' PRO . 29.2 m-20 43.04 -164.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.257 -0.902 . . . . 0.0 109.512 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.472 ' C ' ' H ' ' A' ' 131' ' ' VAL . 35.1 mp0 -77.22 163.76 26.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.376 -0.828 . . . . 0.0 109.48 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.422 ' O ' ' C ' ' A' ' 131' ' ' VAL . 39.1 t -74.59 13.31 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.145 -0.972 . . . . 0.0 109.434 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.472 ' H ' ' C ' ' A' ' 129' ' ' GLU . 2.2 p -43.66 -42.08 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.203 -0.935 . . . . 0.0 109.439 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 37.1 t -73.52 142.93 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -0.948 . . . . 0.0 109.341 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 38.4 tp60 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.448 179.964 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.492 ' O ' ' CG ' ' A' ' 2' ' ' HIS . 16.5 tm-20 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.601 ' HD1' ' CG ' ' A' ' 23' ' ' ASP . 9.1 m80 -163.74 58.92 0.73 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.251 -0.906 . . . . 0.0 109.495 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -71.33 71.84 2.32 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.845 2.363 . . . . 0.0 112.174 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 8' ' ' ALA . 13.5 mm-40 -83.34 -46.04 13.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 109.872 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.616 ' CE1' ' O ' ' A' ' 42' ' ' VAL . 2.8 m-85 -67.17 -35.32 79.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.312 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.466 ' H ' HD11 ' A' ' 6' ' ' LEU . 4.2 mp -64.97 -35.23 80.52 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.293 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 8' ' ' ALA . 10.5 mttp -103.86 2.4 32.6 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.354 -0.842 . . . . 0.0 109.472 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.507 ' CB ' HE22 ' A' ' 15' ' ' GLN . . . -46.81 175.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.91 . . . . 0.0 109.533 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.67 10.47 21.31 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.75 6.06 9.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.27 -1.135 . . . . 0.0 109.496 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -173.28 132.89 0.62 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.926 . . . . 0.0 109.468 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.65 90.8 1.02 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.482 2.122 . . . . 0.0 112.2 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -164.33 -107.73 0.21 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.411 HD23 ' HH ' ' A' ' 106' ' ' TYR . 51.6 tp -157.83 142.24 16.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.295 -1.121 . . . . 0.0 109.67 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.507 HE22 ' CB ' ' A' ' 8' ' ' ALA . 2.7 mt-30 -126.58 136.45 52.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.422 -0.799 . . . . 0.0 109.296 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.557 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 7.1 mt -133.01 113.77 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.387 -0.821 . . . . 0.0 109.875 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.557 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 8.3 m0 -139.77 151.41 45.77 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.073 -1.017 . . . . 0.0 109.378 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.423 HH21 ' HB2' ' A' ' 18' ' ' ARG . 18.1 ttp-105 -99.17 153.11 19.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.851 . . . . 0.0 109.564 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.8 p -89.29 135.68 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.263 -0.898 . . . . 0.0 109.577 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.6 ' O ' ' N ' ' A' ' 22' ' ' PHE . 17.3 tt0 -86.93 151.03 23.66 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.169 -0.957 . . . . 0.0 109.131 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.475 ' O ' ' CD2' ' A' ' 22' ' ' PHE . 3.5 pttm -41.35 -19.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.354 -0.842 . . . . 0.0 109.515 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.6 ' N ' ' O ' ' A' ' 20' ' ' GLU . 26.2 m-85 -161.22 35.38 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.953 . . . . 0.0 109.471 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.601 ' CG ' ' HD1' ' A' ' 2' ' ' HIS . 16.9 t0 -174.65 -131.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.178 -0.951 . . . . 0.0 109.572 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.7 tp -143.33 146.23 33.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 109.526 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 t -131.09 95.07 26.04 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.463 -0.773 . . . . 0.0 109.402 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -48.18 147.78 7.91 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.58 2.187 . . . . 0.0 112.176 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.7 t -110.72 101.59 49.72 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.32 -0.862 . . . . 0.0 109.579 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -52.89 163.14 2.17 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.536 2.158 . . . . 0.0 112.402 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.618 ' C ' ' H ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -64.55 175.99 1.24 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.267 -0.896 . . . . 0.0 109.042 179.641 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.452 ' N ' ' OG1' ' A' ' 29' ' ' THR . 0.8 OUTLIER 64.54 -39.26 0.24 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.411 -0.806 . . . . 0.0 109.386 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.618 ' H ' ' C ' ' A' ' 29' ' ' THR . 21.0 mt -83.77 -42.63 16.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.21 -0.931 . . . . 0.0 109.277 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.411 ' C ' ' O ' ' A' ' 31' ' ' LEU . 4.1 p90 -42.66 140.35 1.32 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.36 -0.838 . . . . 0.0 109.448 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.33 -26.35 8.22 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -94.84 154.62 17.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.337 -1.096 . . . . 0.0 109.374 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -141.34 125.64 17.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 109.56 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.588 ' C ' ' H ' ' A' ' 38' ' ' GLY . 36.2 m-85 -84.54 115.97 22.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.932 . . . . 0.0 109.372 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.5 p -52.95 -4.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.516 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.588 ' H ' ' C ' ' A' ' 36' ' ' PHE . . . -111.06 32.27 6.64 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.442 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 30.6 m-20 -160.16 -173.46 4.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -1.159 . . . . 0.0 109.544 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.88 142.25 46.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.337 -0.852 . . . . 0.0 109.511 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.507 ' OH ' ' CD2' ' A' ' 36' ' ' PHE . 35.1 m-85 -121.45 138.53 54.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.331 -0.856 . . . . 0.0 109.699 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.616 ' O ' ' CE1' ' A' ' 5' ' ' PHE . 1.1 t -118.1 134.44 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.394 -0.816 . . . . 0.0 109.084 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.522 ' CD1' ' C ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -129.99 148.08 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.846 . . . . 0.0 110.206 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.484 ' CD2' ' OG1' ' A' ' 46' ' ' THR . 7.8 tt -139.33 115.87 10.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.471 -0.768 . . . . 0.0 109.597 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -93.87 120.86 34.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.435 -0.791 . . . . 0.0 109.371 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.602 ' O ' ' N ' ' A' ' 13' ' ' GLY . 2.0 m -120.6 127.56 52.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.276 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.664 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 1.4 t -134.29 168.82 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.163 -0.96 . . . . 0.0 109.394 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.427 ' H ' HG12 ' A' ' 47' ' ' VAL . 37.9 tt0 -105.5 115.63 30.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.709 -0.619 . . . . 0.0 109.44 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.492 ' O ' ' C ' ' A' ' 50' ' ' ARG . 86.5 mt -97.71 169.43 9.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 109.436 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.645 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -38.37 151.04 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.326 -0.859 . . . . 0.0 109.368 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 34.0 t30 68.04 -32.22 0.2 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.16 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.645 ' H ' ' C ' ' A' ' 50' ' ' ARG . . . 95.55 54.34 1.45 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 54' ' ' LEU . 16.3 t30 -88.05 6.25 37.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.21 -1.171 . . . . 0.0 109.197 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.664 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 14.5 mt 38.39 95.04 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.608 0.718 . . . . 0.0 109.658 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.446 ' HG2' ' H ' ' A' ' 47' ' ' VAL . 12.2 pt20 -70.0 149.17 48.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 109.065 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.437 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 38.1 m-85 -129.78 114.97 16.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.44 -0.788 . . . . 0.0 110.01 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -124.28 155.26 38.95 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.062 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 pp -151.22 150.07 30.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.822 -1.174 . . . . 0.0 110.713 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.403 ' HD1' ' CB ' ' A' ' 92' ' ' HIS . 22.6 m-70 -127.46 133.88 49.88 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.693 ' HH ' ' HB3' ' A' ' 74' ' ' ALA . 1.0 OUTLIER -108.69 115.92 31.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.402 -0.811 . . . . 0.0 109.208 -179.651 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.59 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 17.4 t90 -109.31 133.49 52.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 109.988 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.59 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 0.2 OUTLIER -127.48 162.15 27.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.397 -0.814 . . . . 0.0 109.292 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.577 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -93.68 153.73 21.38 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -82.23 -11.78 58.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.24 -1.153 . . . . 0.0 109.529 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.11 35.15 3.25 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.683 ' SG ' ' O ' ' A' ' 66' ' ' CYS . 15.9 p -130.09 98.12 4.66 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 122.471 1.129 . . . . 0.0 108.891 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 66' ' ' CYS . 18.4 m -37.0 159.28 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.045 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.553 ' O ' ' N ' ' A' ' 72' ' ' GLY . 39.4 mt-30 -52.11 -17.8 1.21 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.41 -0.806 . . . . 0.0 109.662 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -62.37 -58.56 7.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 0.0 109.386 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.68 -49.4 73.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.361 -0.837 . . . . 0.0 108.854 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.29 -22.55 66.3 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.303 -0.873 . . . . 0.0 108.947 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -73.11 -43.9 37.95 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.94 -44.84 91.64 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.216 -1.167 . . . . 0.0 109.231 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.693 ' HB3' ' HH ' ' A' ' 60' ' ' TYR . . . -62.14 -43.69 98.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.367 -0.833 . . . . 0.0 109.053 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.478 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -58.28 -44.91 88.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.254 -0.904 . . . . 0.0 109.046 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.9 mt -54.14 -50.84 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.391 -0.818 . . . . 0.0 109.074 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -53.79 -38.26 64.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.853 . . . . 0.0 109.122 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.2 m -68.97 -48.92 61.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.407 -0.808 . . . . 0.0 108.978 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.478 HG21 ' O ' ' A' ' 75' ' ' ALA . 42.2 t -57.63 -33.35 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.311 -0.868 . . . . 0.0 109.018 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -42.2 81.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.358 -0.838 . . . . 0.0 108.929 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.77 -42.89 80.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 0.0 108.96 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 85' ' ' LEU . 5.9 t0 -62.54 -56.94 13.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.105 -0.997 . . . . 0.0 108.904 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -47.3 -31.14 3.59 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.171 -0.956 . . . . 0.0 108.607 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -74.0 -30.92 62.72 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.315 -0.866 . . . . 0.0 108.7 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 82' ' ' ASP . 78.3 mt -105.73 24.38 12.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.24 -0.913 . . . . 0.0 109.302 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.458 ' C ' ' O ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER 39.75 33.44 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.437 -0.789 . . . . 0.0 109.463 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.82 73.68 0.59 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 81.9 mtm-85 -143.01 35.05 1.37 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.149 -1.207 . . . . 0.0 109.346 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.437 ' CB ' ' O ' ' A' ' 56' ' ' TYR . . . -144.02 178.66 7.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -0.88 . . . . 0.0 109.381 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.33 112.82 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.693 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -93.94 121.69 35.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.306 -0.871 . . . . 0.0 109.209 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.403 ' CB ' ' HD1' ' A' ' 59' ' ' HIS . 34.7 m-70 -107.16 104.95 14.72 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -0.946 . . . . 0.0 109.695 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.407 HH21 ' HD2' ' A' ' 93' ' ' ARG . 21.4 mtm105 -75.53 97.36 3.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 0.0 109.073 179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.602 ' CD ' ' H ' ' A' ' 100' ' ' SER . 18.0 mm-40 -96.6 137.28 35.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.272 -0.893 . . . . 0.0 109.943 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.6 t -132.85 157.56 43.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.334 -0.854 . . . . 0.0 109.17 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.466 ' C ' ' OE1' ' A' ' 96' ' ' GLN . 1.0 OUTLIER -62.21 117.3 5.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.071 -1.018 . . . . 0.0 109.398 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.74 13.52 69.64 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.83 24.0 0.76 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.146 -1.208 . . . . 0.0 109.625 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.593 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 0.9 OUTLIER -52.64 137.85 29.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 0.0 109.423 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.602 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 28.7 t -64.79 165.49 10.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.294 -0.879 . . . . 0.0 109.634 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.3 -58.13 4.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.915 . . . . 0.0 109.517 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.2 m -46.89 -32.11 3.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 109.429 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.689 ' CE1' ' CE1' ' A' ' 107' ' ' PHE . 23.9 t80 -73.16 -43.3 61.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.366 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.2 mt -69.27 -19.68 63.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.166 -0.959 . . . . 0.0 109.504 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -102.71 -24.98 7.86 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.411 ' HH ' HD23 ' A' ' 14' ' ' LEU . 25.2 t80 -82.14 -36.18 27.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.177 -1.19 . . . . 0.0 109.525 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.689 ' CE1' ' CE1' ' A' ' 103' ' ' PHE . 49.1 m-85 -89.71 81.43 6.42 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.251 -0.906 . . . . 0.0 109.524 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.9 mttt -77.57 -5.43 50.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.4 t -63.96 -7.34 8.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.117 -0.99 . . . . 0.0 109.48 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.43 82.97 0.74 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.555 ' H ' ' CD2' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -67.84 158.06 33.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -1.116 . . . . 0.0 109.379 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -158.38 135.06 9.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.242 -0.911 . . . . 0.0 109.437 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -95.2 153.19 17.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.899 . . . . 0.0 109.261 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.9 tttm -133.62 112.75 11.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.247 -0.908 . . . . 0.0 109.423 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -76.87 147.34 37.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.187 -0.946 . . . . 0.0 109.367 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -56.08 115.03 5.59 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.09 56.6 4.35 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.7 m -55.68 -17.22 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.348 -1.09 . . . . 0.0 109.515 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -44.94 -67.24 0.3 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 109.478 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.2 p 63.13 -172.47 0.16 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.193 -0.942 . . . . 0.0 109.53 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 143.92 -37.02 1.46 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.509 ' CG ' ' O ' ' A' ' 122' ' ' PHE . 37.6 p90 -153.64 121.97 6.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -1.123 . . . . 0.0 109.462 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -169.16 8.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.456 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.422 ' O ' ' CG ' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -157.31 41.92 0.32 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 109.54 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -79.7 68.19 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.298 -0.876 . . . . 0.0 109.464 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.8 t -143.59 65.02 14.18 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.168 -0.958 . . . . 0.0 109.585 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -73.81 179.5 5.6 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.757 2.304 . . . . 0.0 112.094 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -76.74 138.93 40.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.442 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -76.83 -171.91 2.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.858 . . . . 0.0 109.404 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.7 t -63.09 146.58 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.301 -0.874 . . . . 0.0 109.408 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.4 ' O ' ' CG1' ' A' ' 131' ' ' VAL . 7.1 p -59.44 99.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.0 109.572 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 67.1 t -82.49 116.51 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.226 -0.921 . . . . 0.0 109.5 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.469 -179.997 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.56 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 10.7 tt0 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.493 ' CB ' ' O ' ' A' ' 1' ' ' GLU . 1.8 t-80 75.15 60.66 0.27 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.881 . . . . 0.0 109.554 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.18 74.37 2.5 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.773 2.316 . . . . 0.0 111.988 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.603 ' C ' ' H ' ' A' ' 6' ' ' LEU . 6.4 mt-10 -83.15 -31.67 27.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 109.72 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.546 ' CE1' ' CG1' ' A' ' 42' ' ' VAL . 13.7 t80 -50.08 -7.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.114 -0.991 . . . . 0.0 109.435 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.603 ' H ' ' C ' ' A' ' 4' ' ' GLU . 13.1 mt -85.79 -26.83 25.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.88 . . . . 0.0 109.506 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.2 pttm -130.94 13.03 5.25 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.39 -0.819 . . . . 0.0 109.566 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -50.93 153.04 1.93 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.175 -0.953 . . . . 0.0 109.477 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.86 50.66 0.02 OUTLIER Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -150.15 31.36 0.68 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.127 -1.219 . . . . 0.0 109.649 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 13' ' ' GLY . 26.7 mt-10 -147.62 83.26 7.65 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.911 . . . . 0.0 109.394 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.83 80.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.693 2.262 . . . . 0.0 112.398 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 11' ' ' GLU . . . 177.36 -100.18 0.14 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.1 tp -159.37 119.94 3.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.33 -1.1 . . . . 0.0 109.537 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.479 ' OE1' ' OE2' ' A' ' 11' ' ' GLU . 19.0 mt-30 -108.22 127.67 54.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.866 . . . . 0.0 109.366 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.525 ' HA ' HG22 ' A' ' 43' ' ' ILE . 53.0 mt -101.1 144.88 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.312 -0.868 . . . . 0.0 110.042 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -142.85 159.49 42.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.357 -0.84 . . . . 0.0 108.835 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -127.15 143.68 51.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.139 -0.975 . . . . 0.0 109.729 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.419 HG11 ' HB2' ' A' ' 40' ' ' ALA . 9.9 p -78.54 146.09 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.53 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.6 ' O ' ' N ' ' A' ' 22' ' ' PHE . 44.4 tt0 -92.76 154.32 18.37 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.197 -0.939 . . . . 0.0 109.222 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -44.9 -13.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.314 -0.866 . . . . 0.0 109.496 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.6 ' N ' ' O ' ' A' ' 20' ' ' GLU . 74.3 t80 -162.94 28.16 0.1 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.673 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.56 ' OD1' ' N ' ' A' ' 1' ' ' GLU . 8.4 t70 -175.29 -136.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.172 -0.955 . . . . 0.0 109.616 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.43 HD12 ' HA ' ' A' ' 24' ' ' LEU . 1.7 mm? -126.76 146.11 50.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.38 -0.825 . . . . 0.0 109.259 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.503 HG21 ' HB2' ' A' ' 20' ' ' GLU . 2.1 t -141.63 130.23 12.19 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 109.017 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.44 174.64 11.82 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.348 2.032 . . . . 0.0 112.313 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.8 t -139.85 121.45 9.71 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.887 . . . . 0.0 109.246 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.76 157.79 35.36 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.296 1.997 . . . . 0.0 112.301 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.64 -11.77 55.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.16 -0.962 . . . . 0.0 109.358 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -74.28 -10.91 60.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 109.387 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 32' ' ' TYR . 91.8 mt -126.56 -20.48 4.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.356 -0.84 . . . . 0.0 109.471 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.51 ' CE2' ' CD1' ' A' ' 16' ' ' ILE . 11.1 t80 -43.16 131.02 4.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.353 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.67 -14.16 8.12 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -101.61 148.18 25.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.193 -1.181 . . . . 0.0 109.627 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -142.09 116.63 9.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.376 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -94.24 125.19 38.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.923 . . . . 0.0 109.501 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.5 p -68.33 -4.84 15.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.171 -0.956 . . . . 0.0 109.301 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.454 ' O ' ' OD2' ' A' ' 39' ' ' ASP . . . -107.51 36.18 4.55 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.454 ' OD2' ' O ' ' A' ' 38' ' ' GLY . 2.1 m-20 -159.93 156.63 27.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.265 -1.138 . . . . 0.0 109.424 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.419 ' HB2' HG11 ' A' ' 19' ' ' VAL . . . -104.63 134.03 48.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.365 -0.834 . . . . 0.0 109.514 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -113.43 134.95 54.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.42 -0.8 . . . . 0.0 109.188 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.546 ' CG1' ' CE1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -111.24 126.12 68.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 O-C-N 121.217 -0.927 . . . . 0.0 108.892 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.536 ' CD1' ' C ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -126.2 134.55 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.197 -0.94 . . . . 0.0 110.417 -179.308 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.47 ' C ' ' CD2' ' A' ' 44' ' ' LEU . 6.9 tt -117.42 115.4 25.13 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -89.95 144.48 25.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 109.786 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.442 ' O ' ' N ' ' A' ' 13' ' ' GLY . 38.4 m -143.4 117.68 9.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 109.083 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.641 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -128.54 168.37 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.142 -0.974 . . . . 0.0 109.234 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -96.32 126.91 41.85 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.545 -0.722 . . . . 0.0 109.451 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.47 HD23 ' OE1' ' A' ' 55' ' ' GLN . 79.2 mt -91.06 166.77 12.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 0.0 109.495 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 49' ' ' LEU . 2.3 mtt-85 -44.67 -57.99 3.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.089 -1.007 . . . . 0.0 109.231 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -66.38 -20.51 66.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.295 -0.878 . . . . 0.0 109.188 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . 89.62 37.34 6.99 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.508 ' O ' ' O ' ' A' ' 54' ' ' LEU . 10.7 m-80 -88.62 14.37 10.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.118 -1.225 . . . . 0.0 109.403 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.641 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.7 mt 44.79 98.44 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.621 0.724 . . . . 0.0 109.418 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.47 ' OE1' HD23 ' A' ' 49' ' ' LEU . 40.3 tt0 -73.9 110.23 8.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.39 -0.819 . . . . 0.0 109.697 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.512 ' CD2' ' O ' ' A' ' 54' ' ' LEU . 85.3 m-85 -95.91 114.3 26.0 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.186 -0.946 . . . . 0.0 109.546 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.28 155.35 24.2 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.456 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 10.6 mt -129.84 133.38 46.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.171 -0.956 . . . . 0.0 109.776 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.693 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.1 OUTLIER -133.43 115.11 14.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.396 -0.815 . . . . 0.0 109.075 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.725 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -99.95 120.58 40.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.258 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 4.4 t90 -93.26 127.03 38.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.892 . . . . 0.0 109.539 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 mt -106.12 161.65 14.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.261 -0.899 . . . . 0.0 109.396 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -109.55 150.9 17.33 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.23 -12.26 61.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -1.182 . . . . 0.0 109.461 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -108.86 26.63 10.35 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.545 ' SG ' ' OE2' ' A' ' 70' ' ' GLU . 5.4 m -130.59 97.44 4.37 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.021 0.915 . . . . 0.0 108.545 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 m -60.46 -170.91 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.782 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.608 ' H ' ' NE2' ' A' ' 68' ' ' GLN . 2.0 mp0 -65.38 -17.8 64.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 0.0 109.696 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.03 -58.84 5.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.112 -0.992 . . . . 0.0 109.481 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.545 ' OE2' ' SG ' ' A' ' 66' ' ' CYS . 22.8 mt-10 -64.07 -46.25 85.18 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.261 -0.899 . . . . 0.0 109.092 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 m -65.54 -26.81 68.05 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.347 -0.846 . . . . 0.0 108.826 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -65.87 -45.86 85.71 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.86 -48.98 74.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -1.157 . . . . 0.0 109.261 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.67 -39.82 92.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.179 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.455 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -65.84 -46.27 79.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.364 -0.835 . . . . 0.0 109.316 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.415 HD13 HG21 ' A' ' 76' ' ' ILE . 44.6 mt -51.47 -49.22 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.134 -0.979 . . . . 0.0 109.294 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -62.29 -35.25 78.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 109.325 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.452 ' HG1' ' HA ' ' A' ' 75' ' ' ALA . 1.3 m -69.53 -36.42 76.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.372 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 75' ' ' ALA . 63.8 t -68.14 -42.33 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.517 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -62.49 -60.59 3.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 0.0 109.26 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.536 ' CD1' ' C ' ' A' ' 81' ' ' LEU . 0.5 OUTLIER -52.57 -29.18 24.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.215 -0.928 . . . . 0.0 108.835 179.688 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.626 ' O ' ' N ' ' A' ' 86' ' ' ASN . 55.2 t0 -67.47 -57.68 6.09 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.239 -0.913 . . . . 0.0 108.815 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.469 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 88.1 m-20 -45.25 -36.14 3.79 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.201 -0.937 . . . . 0.0 108.579 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.517 ' CD1' ' O ' ' A' ' 84' ' ' TYR . 1.8 t80 -73.66 -31.57 63.55 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 82' ' ' ASP . 96.2 mt -121.65 34.44 5.18 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.461 -0.774 . . . . 0.0 109.419 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.626 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.4 OUTLIER -82.82 27.81 0.52 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.207 -0.933 . . . . 0.0 109.371 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.43 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -64.77 -51.15 54.22 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -175.94 34.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.181 -1.188 . . . . 0.0 109.377 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.11 179.02 7.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -0.947 . . . . 0.0 109.529 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 78.9 t -130.39 102.98 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.313 -0.867 . . . . 0.0 109.505 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.587 ' O ' ' NE2' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -97.04 134.83 39.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 109.145 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.615 ' NE2' ' ND1' ' A' ' 59' ' ' HIS . 3.7 p80 -144.35 161.14 39.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.121 -0.987 . . . . 0.0 109.756 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -103.38 121.7 43.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.464 -0.772 . . . . 0.0 109.585 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.561 ' OE2' ' CD2' ' A' ' 103' ' ' PHE . 42.5 mt-10 -102.32 150.58 23.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.357 -0.84 . . . . 0.0 109.164 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.6 t -140.75 161.93 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.113 -0.992 . . . . 0.0 109.567 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -60.84 134.42 57.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 109.597 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.11 -26.23 5.04 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.547 ' O ' ' CD1' ' A' ' 98' ' ' PHE . 71.5 t80 -108.02 10.4 28.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -1.115 . . . . 0.0 109.442 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 98' ' ' PHE . 80.5 mt-10 -43.05 123.61 2.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.875 . . . . 0.0 109.508 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.1 p -55.57 179.69 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.334 -0.854 . . . . 0.0 109.501 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.1 -41.31 82.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.344 -0.847 . . . . 0.0 109.501 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.7 m -48.68 -57.58 6.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.307 -0.87 . . . . 0.0 109.529 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.561 ' CD2' ' OE2' ' A' ' 94' ' ' GLU . 5.9 m-85 -59.18 -53.57 56.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.412 -0.805 . . . . 0.0 109.56 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.58 ' O ' ' CD1' ' A' ' 107' ' ' PHE . 25.7 mt -54.36 -14.66 1.27 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.227 -0.921 . . . . 0.0 109.56 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -104.98 -27.29 5.99 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -79.49 -15.29 58.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.261 -1.14 . . . . 0.0 109.636 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.58 ' CD1' ' O ' ' A' ' 104' ' ' LEU . 3.2 p90 -55.8 128.66 36.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.92 . . . . 0.0 109.589 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -114.92 -55.6 2.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.298 -0.876 . . . . 0.0 109.417 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.5 p -103.74 -8.61 19.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.923 . . . . 0.0 109.466 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.63 109.07 3.33 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.595 ' CD1' ' H ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -53.37 120.03 5.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -1.132 . . . . 0.0 109.469 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -81.42 125.06 29.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.292 -0.88 . . . . 0.0 109.47 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -95.28 144.09 26.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.938 . . . . 0.0 109.425 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -141.7 132.03 25.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 109.407 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -74.1 156.32 37.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 109.513 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -84.56 -64.92 1.53 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -159.26 -130.52 1.15 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.1 t -103.14 -77.6 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -1.16 . . . . 0.0 109.56 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.19 -152.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.464 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 18.9 t -144.2 64.09 1.32 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 109.427 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -177.73 -35.1 0.05 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 124' ' ' HIS . 8.6 m-85 -70.29 -83.86 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -1.161 . . . . 0.0 109.504 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.2 ttpt 68.9 -62.72 0.39 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.342 -0.849 . . . . 0.0 109.51 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.425 ' N ' ' O ' ' A' ' 122' ' ' PHE . 3.0 t-160 -158.71 128.06 5.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.145 -0.972 . . . . 0.0 109.523 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.2 p -93.87 148.87 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 109.432 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.4 m -142.26 83.81 11.97 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 0.0 109.482 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.16 -70.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.73 2.287 . . . . 0.0 112.321 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.54 168.51 19.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.182 -0.949 . . . . 0.0 109.515 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -90.11 104.21 16.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -0.956 . . . . 0.0 109.422 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.441 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 14.0 p -105.06 112.48 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.333 -0.855 . . . . 0.0 109.572 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 t -75.45 127.69 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.303 -0.873 . . . . 0.0 109.479 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.6 p -45.15 148.44 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.943 . . . . 0.0 109.44 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.494 -179.953 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.594 ' O ' ' N ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER 176.0 -48.11 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 109.76 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 2' ' ' HIS . 50.8 Cg_exo -52.26 70.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.575 2.183 . . . . 0.0 112.167 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.594 ' N ' ' O ' ' A' ' 2' ' ' HIS . 34.1 mt-10 -83.27 -46.21 12.92 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.836 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.666 ' CE1' ' CD1' ' A' ' 81' ' ' LEU . 50.2 t80 -47.64 -16.12 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.235 -0.915 . . . . 0.0 109.391 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 4' ' ' GLU . 71.7 mt -84.05 -52.03 6.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 0.0 109.439 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.468 ' O ' ' O ' ' A' ' 8' ' ' ALA . 46.3 mtpt -91.08 5.97 46.82 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.553 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -44.43 169.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.231 -0.918 . . . . 0.0 109.632 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.75 70.75 0.51 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.46 6.63 2.54 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.17 -1.194 . . . . 0.0 109.647 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -172.13 141.97 1.2 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.899 . . . . 0.0 109.409 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.02 84.13 1.53 Allowed 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.675 2.25 . . . . 0.0 112.291 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -164.96 -108.02 0.21 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.3 tt -162.54 148.03 12.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -1.114 . . . . 0.0 109.553 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.428 ' NE2' ' HB3' ' A' ' 8' ' ' ALA . 1.0 OUTLIER -136.51 131.75 34.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.242 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.496 ' HA ' HG23 ' A' ' 43' ' ' ILE . 12.2 mt -102.28 157.63 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.215 -0.928 . . . . 0.0 110.22 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -159.17 130.46 6.2 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.495 -0.753 . . . . 0.0 109.17 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -100.92 152.5 20.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.174 -0.954 . . . . 0.0 109.403 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.4 t -77.03 129.02 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.255 -0.903 . . . . 0.0 109.532 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.711 ' O ' ' N ' ' A' ' 22' ' ' PHE . 27.6 tt0 -80.49 86.82 5.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.126 -0.984 . . . . 0.0 109.479 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.599 ' O ' ' CB ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER 39.35 15.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.574 -0.704 . . . . 0.0 110.081 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.711 ' N ' ' O ' ' A' ' 20' ' ' GLU . 1.4 t80 154.82 -39.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.391 -0.818 . . . . 0.0 109.134 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.42 ' C ' ' H ' ' A' ' 20' ' ' GLU . 1.3 t0 -98.99 -146.56 0.33 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.251 -0.906 . . . . 0.0 109.341 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.426 ' CD2' ' H ' ' A' ' 5' ' ' PHE . 3.3 tp -116.1 138.83 50.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.196 -0.94 . . . . 0.0 109.714 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 1.2 t -137.98 144.6 44.48 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -69.69 152.04 69.6 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.527 2.151 . . . . 0.0 112.392 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.0 t -120.54 101.61 45.97 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.874 . . . . 0.0 109.376 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -49.64 158.06 2.08 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.561 2.174 . . . . 0.0 112.128 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 31' ' ' LEU . 5.9 m -59.54 -46.26 89.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.915 . . . . 0.0 109.526 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 29' ' ' THR . 3.0 m120 -43.05 -22.14 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.119 -0.988 . . . . 0.0 109.475 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 29' ' ' THR . 79.7 mt -105.63 -25.49 12.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -0.861 . . . . 0.0 109.451 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.454 ' C ' ' O ' ' A' ' 31' ' ' LEU . 2.0 t80 -42.18 129.49 3.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.328 -0.858 . . . . 0.0 109.371 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.443 ' N ' ' CD2' ' A' ' 32' ' ' TYR . . . 100.28 -20.88 46.79 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.43 ' C ' ' CD1' ' A' ' 35' ' ' PHE . 4.3 m-20 -97.83 155.62 16.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.222 -1.163 . . . . 0.0 109.501 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.43 ' CD1' ' C ' ' A' ' 34' ' ' ASP . 57.1 m-85 -146.65 136.05 22.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 109.457 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -97.42 162.83 13.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 109.406 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.7 p -97.97 -4.87 35.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 109.383 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.91 -76.93 1.28 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.97 157.81 32.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -1.085 . . . . 0.0 109.415 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.74 167.2 11.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.444 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -128.47 134.8 48.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 109.52 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.483 HG12 ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -108.7 144.52 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.254 -0.903 . . . . 0.0 109.052 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.72 ' CD1' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -143.88 139.54 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.996 -1.065 . . . . 0.0 110.097 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.52 126.09 46.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.408 -0.808 . . . . 0.0 109.149 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.3 ttpt -104.46 130.37 52.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.326 -0.859 . . . . 0.0 109.6 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 13' ' ' GLY . 99.8 m -131.83 125.66 32.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.293 -0.88 . . . . 0.0 109.294 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -133.09 168.46 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 121.175 -0.953 . . . . 0.0 109.357 -179.647 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -96.29 121.76 38.42 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.681 -0.637 . . . . 0.0 109.324 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 50' ' ' ARG . 11.1 mt -82.59 168.79 16.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.949 . . . . 0.0 109.523 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 49' ' ' LEU . 1.1 tpt180 -43.21 -67.14 0.3 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.251 -0.906 . . . . 0.0 109.261 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -60.18 -26.07 66.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 109.125 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.98 40.2 3.37 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.7 m120 -87.66 14.79 7.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.11 -1.229 . . . . 0.0 109.316 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.626 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 11.7 mt 43.79 96.83 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.511 0.672 . . . . 0.0 109.444 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -69.18 153.62 43.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.528 -0.732 . . . . 0.0 109.245 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.412 ' CD2' ' O ' ' A' ' 54' ' ' LEU . 70.7 m-85 -138.0 114.86 10.7 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.171 -0.956 . . . . 0.0 109.623 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -124.78 116.7 22.72 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.669 ' CD1' ' H ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -102.84 145.72 29.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.134 -0.979 . . . . 0.0 110.076 -179.021 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.532 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 3.1 m-70 -131.34 150.52 52.12 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.469 -0.769 . . . . 0.0 109.4 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.56 ' CE1' ' OG1' ' A' ' 78' ' ' THR . 0.1 OUTLIER -129.37 121.33 27.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.352 -0.843 . . . . 0.0 109.34 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.467 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 44.8 t90 -101.84 123.77 46.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.92 . . . . 0.0 109.59 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.467 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 18.4 mt -104.55 162.04 13.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.279 -0.888 . . . . 0.0 109.382 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.581 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -112.86 162.0 12.5 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -82.14 -11.62 58.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -1.168 . . . . 0.0 109.599 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.68 33.89 4.12 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.657 ' SG ' ' O ' ' A' ' 66' ' ' CYS . 18.0 p -130.58 97.91 4.51 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 122.478 1.133 . . . . 0.0 108.951 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.49 ' O ' ' O ' ' A' ' 66' ' ' CYS . 0.5 OUTLIER -46.57 177.18 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.731 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.555 ' O ' ' N ' ' A' ' 72' ' ' GLY . 4.6 pt20 -66.52 -17.78 65.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.476 -0.765 . . . . 0.0 109.553 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.1 p30 -62.85 -58.43 7.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.263 -0.898 . . . . 0.0 109.626 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -62.04 -51.93 65.99 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.301 -0.874 . . . . 0.0 109.129 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.43 -22.87 66.22 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.405 -0.809 . . . . 0.0 108.879 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -75.16 -46.26 16.74 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.79 -39.09 87.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.186 -1.185 . . . . 0.0 109.151 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.435 ' CB ' ' CZ ' ' A' ' 60' ' ' TYR . . . -59.4 -59.49 5.36 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.394 -0.816 . . . . 0.0 108.968 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -48.25 -43.21 32.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.31 -0.869 . . . . 0.0 109.48 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.8 mt -56.67 -39.14 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.143 -0.973 . . . . 0.0 109.564 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -64.7 -50.48 66.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 109.704 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.56 ' OG1' ' CE1' ' A' ' 60' ' ' TYR . 2.7 m -63.72 -35.03 79.24 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.065 -1.022 . . . . 0.0 108.794 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 74.5 t -59.59 -41.9 86.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.343 -0.848 . . . . 0.0 108.729 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -62.55 -43.75 98.03 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.666 ' CD1' ' CE1' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -50.83 -45.47 59.62 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.403 -0.811 . . . . 0.0 108.921 179.5 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 85' ' ' LEU . 1.6 m-20 -60.33 -60.42 3.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.294 -0.879 . . . . 0.0 108.967 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 82' ' ' ASP . 39.6 t0 -46.94 -32.99 4.23 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.116 -0.99 . . . . 0.0 108.412 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.468 ' O ' ' CD2' ' A' ' 84' ' ' TYR . 2.8 t80 -74.49 -27.1 60.41 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.568 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.6 tp -110.24 26.47 10.64 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.475 -0.765 . . . . 0.0 109.306 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER 44.71 37.47 2.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.487 -0.758 . . . . 0.0 109.579 179.795 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 53.7 34.13 49.92 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -90.64 31.38 1.05 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -1.138 . . . . 0.0 109.138 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.472 ' HB3' HD13 ' A' ' 58' ' ' LEU . . . -145.24 179.22 7.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.434 -0.791 . . . . 0.0 109.31 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.9 t -119.13 140.83 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -0.964 . . . . 0.0 109.672 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.41 ' CD ' ' N ' ' A' ' 91' ' ' GLN . 0.2 OUTLIER -102.74 149.28 24.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.328 -0.857 . . . . 0.0 109.319 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -124.49 121.78 35.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 109.553 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.415 ' H ' ' HD2' ' A' ' 93' ' ' ARG . 1.5 mpt_? -91.5 105.42 17.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.943 . . . . 0.0 109.063 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.417 ' OE2' ' CD1' ' A' ' 103' ' ' PHE . 35.8 mt-10 -113.12 148.06 36.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.764 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.53 HG13 ' H ' ' A' ' 96' ' ' GLN . 61.5 t -151.9 174.04 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -0.869 . . . . 0.0 109.091 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.53 ' H ' HG13 ' A' ' 95' ' ' VAL . 10.2 tt0 -62.58 115.84 4.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.051 -1.031 . . . . 0.0 109.542 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.95 11.66 82.29 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.47 ' O ' ' C ' ' A' ' 99' ' ' GLU . 3.2 t80 -132.66 19.39 4.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.252 -1.146 . . . . 0.0 109.551 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.564 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 8.8 mp0 -39.63 137.6 0.84 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.549 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.85 166.91 16.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 109.654 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.27 -64.45 0.85 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 0.0 109.448 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.8 m -47.03 -54.86 9.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.207 -0.933 . . . . 0.0 109.198 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.417 ' CD1' ' OE2' ' A' ' 94' ' ' GLU . 3.3 t80 -50.81 -45.27 59.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.471 -0.768 . . . . 0.0 109.295 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.506 ' O ' ' CD1' ' A' ' 107' ' ' PHE . 5.8 mt -59.01 -30.81 68.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.913 . . . . 0.0 109.388 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.79 -19.27 48.5 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.423 ' O ' ' C ' ' A' ' 107' ' ' PHE . 35.4 t80 -76.35 -27.36 56.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.346 -1.091 . . . . 0.0 109.458 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.54 ' CD1' ' O ' ' A' ' 107' ' ' PHE . 1.3 p90 -42.42 125.83 3.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.183 -0.948 . . . . 0.0 109.494 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -110.87 -47.85 3.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.913 . . . . 0.0 109.433 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.6 m -96.67 -28.55 14.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 109.493 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 124.24 112.5 1.98 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.2 mt -57.76 176.69 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.334 -1.098 . . . . 0.0 109.47 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -159.97 122.25 3.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.352 -0.842 . . . . 0.0 109.279 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -106.75 141.66 37.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 109.414 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -146.19 126.29 13.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.887 . . . . 0.0 109.387 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -114.02 131.39 56.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.346 -0.846 . . . . 0.0 109.47 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 166.79 -52.6 0.25 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.06 23.71 12.74 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.2 m -145.55 153.1 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.343 -1.093 . . . . 0.0 109.474 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.43 -80.55 0.15 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.321 -0.862 . . . . 0.0 109.471 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.5 m -147.05 -152.94 0.46 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.952 . . . . 0.0 109.423 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -175.53 169.61 42.42 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -94.11 151.8 19.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.337 -1.096 . . . . 0.0 109.446 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.417 ' HZ3' ' HG3' ' A' ' 123' ' ' LYS . 13.5 ttmm -157.39 -48.57 0.07 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.366 -0.834 . . . . 0.0 109.318 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.54 119.1 11.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.302 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.1 t -87.46 -56.79 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.307 -0.87 . . . . 0.0 109.435 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 26.1 m -50.75 147.87 7.92 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.401 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.32 178.44 5.52 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.579 2.186 . . . . 0.0 112.136 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -70.95 -73.89 0.16 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.254 -0.904 . . . . 0.0 109.405 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -131.52 151.15 51.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.436 -0.79 . . . . 0.0 109.42 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 131' ' ' VAL . 55.1 t -69.35 149.22 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.187 -0.945 . . . . 0.0 109.441 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.415 ' C ' ' O ' ' A' ' 130' ' ' VAL . 58.0 t -42.82 121.99 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.529 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.6 p -49.22 130.54 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 109.448 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.497 ' CD ' ' H ' ' A' ' 133' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.097 -0.954 . . . . 0.0 109.39 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.61 ' H1 ' ' HD1' ' A' ' 2' ' ' HIS . 10.5 mm-40 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.282 0.563 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.61 ' HD1' ' H1 ' ' A' ' 1' ' ' GLU . 8.7 m80 -146.48 57.29 3.66 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.91 . . . . 0.0 109.398 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.485 ' HB3' HD11 ' A' ' 6' ' ' LEU . 36.2 Cg_endo -68.13 66.74 0.99 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.78 2.32 . . . . 0.0 112.077 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.554 ' H ' HD13 ' A' ' 24' ' ' LEU . 74.7 mt-10 -83.15 -46.24 12.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 109.756 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.519 ' CE2' ' CG1' ' A' ' 42' ' ' VAL . 22.8 t80 -66.95 -18.76 65.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.281 -0.887 . . . . 0.0 109.406 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.485 HD11 ' HB3' ' A' ' 3' ' ' PRO . 10.1 mt -76.61 -37.2 56.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.258 -0.901 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.453 ' O ' ' C ' ' A' ' 8' ' ' ALA . 7.4 mtpm? -86.12 -15.6 40.63 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.334 -0.854 . . . . 0.0 109.335 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -40.94 142.36 0.49 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 109.567 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.26 42.32 0.2 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -140.65 26.38 2.11 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.339 -1.095 . . . . 0.0 109.692 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -148.84 128.1 6.29 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.192 -0.943 . . . . 0.0 109.433 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.81 80.1 2.69 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.494 2.129 . . . . 0.0 112.272 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 173.32 -99.37 0.14 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.9 tt -162.25 152.26 16.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -1.131 . . . . 0.0 109.834 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.4 ' HB3' ' CZ3' ' A' ' 17' ' ' TRP . 42.1 mt-30 -135.74 141.31 44.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 109.367 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 28.5 mt -113.99 139.11 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.36 -0.838 . . . . 0.0 110.1 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.542 ' NE1' ' OE1' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -142.75 156.77 45.05 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.535 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.411 ' O ' ' CD2' ' A' ' 24' ' ' LEU . 18.8 ttt180 -116.29 140.13 49.65 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.172 -0.955 . . . . 0.0 109.62 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.497 HG11 ' HB2' ' A' ' 40' ' ' ALA . 8.4 p -85.33 131.72 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.917 . . . . 0.0 109.409 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.606 ' O ' ' N ' ' A' ' 22' ' ' PHE . 20.4 tt0 -84.06 151.36 25.01 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.165 -0.96 . . . . 0.0 109.225 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.486 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 10.8 ttmm -45.25 -11.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.271 -0.893 . . . . 0.0 109.92 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.606 ' N ' ' O ' ' A' ' 20' ' ' GLU . 20.7 m-85 -162.96 20.97 0.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.961 -1.087 . . . . 0.0 110.065 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.474 ' CG ' ' O ' ' A' ' 22' ' ' PHE . 24.5 m-20 -166.38 -116.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.193 -0.942 . . . . 0.0 109.499 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.554 HD13 ' H ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER -158.19 138.6 12.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -0.892 . . . . 0.0 109.296 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 t -119.98 132.62 24.01 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 0.0 109.282 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.1 136.87 23.07 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.428 2.085 . . . . 0.0 112.343 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.7 t -97.49 112.03 60.12 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.224 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -45.54 127.88 9.98 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.33 2.02 . . . . 0.0 112.104 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.64 -10.11 59.27 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.146 -0.971 . . . . 0.0 109.485 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -90.91 -3.06 57.62 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.237 -0.914 . . . . 0.0 109.113 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 38.4 mt -136.81 -1.93 2.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.288 -0.882 . . . . 0.0 109.801 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.426 ' O ' ' CG ' ' A' ' 32' ' ' TYR . 3.6 p90 -50.42 135.17 22.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.952 . . . . 0.0 109.507 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.94 -25.44 3.21 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.8 105.29 16.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -1.154 . . . . 0.0 109.43 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -96.5 146.26 24.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.511 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -94.46 128.36 40.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.568 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.477 ' OG1' ' OE1' ' A' ' 65' ' ' GLU . 35.7 p -72.24 -4.78 31.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.307 -0.87 . . . . 0.0 109.426 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.44 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -109.67 38.25 3.4 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 22.6 m-20 -163.52 -169.38 1.92 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -1.122 . . . . 0.0 109.465 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.497 ' HB2' HG11 ' A' ' 19' ' ' VAL . . . -136.72 138.28 40.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.401 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -126.01 139.0 53.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.332 -0.855 . . . . 0.0 109.519 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.519 ' CG1' ' CE2' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -105.95 136.97 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 121.178 -0.951 . . . . 0.0 108.767 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.519 ' CD1' ' C ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -127.84 137.17 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.269 -0.895 . . . . 0.0 110.369 -179.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.441 ' C ' ' CD2' ' A' ' 44' ' ' LEU . 6.9 tt -117.83 116.98 28.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.7 -0.625 . . . . 0.0 109.335 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.8 ttpm? -98.9 118.24 35.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.544 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.4 m -118.62 131.33 56.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.34 -0.85 . . . . 0.0 109.201 179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -132.01 168.46 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.193 -0.942 . . . . 0.0 109.569 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.576 ' NE2' ' O ' ' A' ' 49' ' ' LEU . 8.4 tm0? -95.97 112.33 24.09 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.576 ' O ' ' NE2' ' A' ' 48' ' ' GLN . 63.8 mt -72.28 155.61 40.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.924 . . . . 0.0 109.748 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 49' ' ' LEU . 20.9 mtm105 -42.89 -77.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.895 . . . . 0.0 109.388 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 50' ' ' ARG . 4.1 t-20 -43.33 -31.1 0.59 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.166 -0.959 . . . . 0.0 109.259 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.64 75.47 1.16 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.481 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.1 t-20 -132.76 14.09 4.39 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.251 -1.147 . . . . 0.0 109.199 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.621 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 11.9 mt 43.22 95.98 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.386 0.612 . . . . 0.0 109.616 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 47' ' ' VAL . 17.2 tt0 -68.85 154.48 41.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.549 -0.719 . . . . 0.0 109.144 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.599 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 97.6 m-85 -134.53 121.69 21.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 0.0 109.674 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 58' ' ' LEU . 1.5 t0 -133.0 155.44 49.17 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.581 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -143.58 145.79 32.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.825 -1.172 . . . . 0.0 110.388 -179.629 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.477 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -141.06 131.93 25.94 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.401 -0.812 . . . . 0.0 108.957 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.751 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -96.64 120.74 37.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.094 -1.004 . . . . 0.0 109.463 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.517 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 31.2 t90 -89.13 123.71 33.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.876 . . . . 0.0 109.357 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.517 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 6.6 mt -106.36 162.18 13.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.321 -0.862 . . . . 0.0 109.423 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.93 156.59 15.46 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -75.79 -12.24 60.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -1.135 . . . . 0.0 109.357 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 116' ' ' GLY . 2.7 mt-10 -106.47 26.25 10.13 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.5 m -130.85 97.51 4.35 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.136 0.969 . . . . 0.0 108.397 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 66' ' ' CYS . 39.7 p -49.82 -177.18 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.589 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.49 ' O ' ' N ' ' A' ' 72' ' ' GLY . 29.2 mt-30 -66.04 -17.82 64.94 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.304 -0.873 . . . . 0.0 109.5 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.503 ' OD2' ' N ' ' A' ' 69' ' ' ASP . 2.5 m-20 -63.75 -58.57 6.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 109.369 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -61.03 -51.02 70.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.288 -0.882 . . . . 0.0 109.131 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.0 m -64.23 -27.37 69.01 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.442 -0.786 . . . . 0.0 109.065 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -69.24 -43.05 72.96 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.04 -41.56 97.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.317 -1.108 . . . . 0.0 109.245 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.52 -47.03 87.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.398 -0.814 . . . . 0.0 109.25 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.89 -46.44 81.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.173 -0.955 . . . . 0.0 109.345 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.2 mt -51.96 -49.82 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.214 -0.929 . . . . 0.0 109.207 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -57.91 -33.92 69.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.866 . . . . 0.0 109.277 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.404 HG21 ' CE1' ' A' ' 60' ' ' TYR . 2.1 m -68.34 -46.79 69.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.231 -0.918 . . . . 0.0 109.263 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.6 t -57.26 -31.93 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.168 -0.957 . . . . 0.0 109.318 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -68.06 -54.44 18.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.913 . . . . 0.0 109.246 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.543 ' CD1' ' C ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -53.47 -29.46 35.98 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.285 -0.884 . . . . 0.0 108.981 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 85' ' ' LEU . 3.4 m-20 -66.53 -59.32 3.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.272 -0.892 . . . . 0.0 108.913 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 82' ' ' ASP . 1.0 OUTLIER -45.62 -34.51 3.48 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.294 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.595 ' CD1' ' O ' ' A' ' 84' ' ' TYR . 0.6 OUTLIER -69.55 -32.56 71.44 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.591 ' N ' ' O ' ' A' ' 82' ' ' ASP . 5.6 mp -104.51 27.39 7.95 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.417 -0.802 . . . . 0.0 109.026 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 85' ' ' LEU . 13.1 m-80 42.7 35.03 0.64 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.449 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 86' ' ' ASN . . . 43.44 85.31 0.01 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -145.61 47.73 1.27 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.202 -1.175 . . . . 0.0 109.384 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -155.1 179.15 9.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.894 . . . . 0.0 109.505 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.505 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 8.7 t -94.58 116.13 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.625 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -109.7 125.36 52.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.268 -0.895 . . . . 0.0 109.193 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.574 ' CD2' ' N ' ' A' ' 92' ' ' HIS . 1.3 p80 -151.0 136.05 17.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.028 -1.045 . . . . 0.0 110.197 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -85.85 131.43 34.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.176 -0.953 . . . . 0.0 109.713 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -100.34 121.37 41.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.95 . . . . 0.0 109.359 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.4 ' CG1' ' N ' ' A' ' 96' ' ' GLN . 44.4 t -89.64 167.71 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 109.615 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.686 ' NE2' ' N ' ' A' ' 97' ' ' GLY . 17.5 tp60 -88.03 136.12 33.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 109.394 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.686 ' N ' ' NE2' ' A' ' 96' ' ' GLN . . . 110.41 -26.91 12.26 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.487 ' O ' ' O ' ' A' ' 99' ' ' GLU . 2.9 t80 -133.21 -30.14 1.36 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.414 -1.051 . . . . 0.0 109.413 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 98' ' ' PHE . 18.1 mp0 47.02 -176.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 109.477 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.6 t -100.92 143.88 30.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 109.53 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -47.65 -40.42 19.73 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.194 -0.941 . . . . 0.0 109.527 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.1 m -54.02 -44.5 71.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.899 . . . . 0.0 109.442 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.81 -55.35 8.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 109.268 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.443 ' O ' ' CD1' ' A' ' 107' ' ' PHE . 92.7 mt -48.15 -21.52 0.5 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.36 -0.838 . . . . 0.0 109.497 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.23 -24.29 9.74 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -84.61 -5.98 59.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -1.183 . . . . 0.0 109.549 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 5.0 p90 -54.03 118.0 3.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.492 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -114.88 -55.79 2.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 109.483 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.1 p -92.63 -14.08 28.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.541 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.15 75.62 1.23 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.707 ' H ' ' CD2' ' A' ' 111' ' ' LEU . 1.1 pt? -56.58 163.31 1.85 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -1.124 . . . . 0.0 109.608 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -141.38 179.75 6.6 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.374 -0.829 . . . . 0.0 109.432 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.99 111.43 7.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 0.0 109.333 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -75.5 110.04 9.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.43 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -77.44 114.86 16.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 109.452 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.549 ' N ' ' OE1' ' A' ' 65' ' ' GLU . . . -72.27 -125.12 0.07 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -176.24 120.17 0.74 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.516 ' C ' ' H ' ' A' ' 120' ' ' SER . 16.5 m -88.05 -159.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -1.126 . . . . 0.0 109.442 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.22 33.36 0.1 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.91 . . . . 0.0 109.392 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.516 ' H ' ' C ' ' A' ' 118' ' ' VAL . 3.5 t 56.15 178.57 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.423 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.597 ' O ' ' CG ' ' A' ' 122' ' ' PHE . . . -179.33 120.01 0.67 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.597 ' CG ' ' O ' ' A' ' 121' ' ' GLY . 4.9 m-85 -177.07 -165.87 0.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.265 -1.138 . . . . 0.0 109.374 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.499 ' O ' ' O ' ' A' ' 122' ' ' PHE . 3.3 mptp? 57.47 122.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.382 -0.824 . . . . 0.0 109.701 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.533 ' O ' ' C ' ' A' ' 125' ' ' VAL . 16.4 m170 -66.51 -151.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.3 -0.875 . . . . 0.0 109.45 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.533 ' C ' ' O ' ' A' ' 124' ' ' HIS . 1.3 p -34.48 105.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.574 -0.703 . . . . 0.0 109.73 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.624 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -83.66 -41.42 0.79 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.849 . . . . 0.0 109.924 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 126' ' ' VAL . 73.1 Cg_endo -83.52 -102.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.513 2.142 . . . . 0.0 112.359 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.58 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 14.9 m120 -160.12 -159.05 0.68 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.133 -0.98 . . . . 0.0 109.528 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.422 ' O ' ' CG2' ' A' ' 130' ' ' VAL . 2.8 tm-20 -173.87 100.51 0.11 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.357 -0.84 . . . . 0.0 109.312 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.434 ' O ' ' C ' ' A' ' 131' ' ' VAL . 56.1 t -157.49 -61.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.168 -0.958 . . . . 0.0 109.596 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.434 ' C ' ' O ' ' A' ' 130' ' ' VAL . 11.6 t -42.61 113.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.208 -0.933 . . . . 0.0 109.506 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.02 51.01 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.885 . . . . 0.0 109.573 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.066 -0.969 . . . . 0.0 109.433 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.662 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -100.38 -40.93 0.22 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.863 . . . . 0.0 109.572 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.662 ' CD ' ' N ' ' A' ' 2' ' ' HIS . 25.8 Cg_exo -59.82 86.03 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.711 2.274 . . . . 0.0 111.965 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -83.24 -28.84 28.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.878 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.581 ' CD2' HG13 ' A' ' 42' ' ' VAL . 5.7 t80 -70.46 -16.05 62.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.785 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.0 mt -83.74 -38.28 21.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 109.446 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 8' ' ' ALA . 48.2 mmtt -95.25 -2.59 49.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.343 -0.848 . . . . 0.0 109.388 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.45 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -42.12 139.27 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.885 . . . . 0.0 109.529 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.23 56.83 0.06 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 pttm -137.45 18.7 2.92 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.2 -1.177 . . . . 0.0 109.514 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.469 ' O ' ' OE1' ' A' ' 11' ' ' GLU . 1.7 pp20? -165.93 127.38 1.37 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.419 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.12 85.16 1.7 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.421 2.081 . . . . 0.0 112.148 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -174.62 -103.28 0.16 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.0 tp -153.2 146.73 25.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.356 -1.085 . . . . 0.0 109.608 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -135.89 128.72 31.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.866 . . . . 0.0 109.367 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.5 mt -105.91 150.08 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 0.0 109.557 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -156.68 135.59 11.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.134 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -104.82 148.61 26.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.27 -0.894 . . . . 0.0 109.568 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.481 ' O ' ' OD1' ' A' ' 39' ' ' ASP . 9.5 p -83.44 146.0 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.42 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.595 ' O ' ' N ' ' A' ' 22' ' ' PHE . 22.8 tt0 -99.3 154.52 18.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 109.382 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 20' ' ' GLU . 39.3 tttm -42.31 -18.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.892 . . . . 0.0 109.599 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.595 ' N ' ' O ' ' A' ' 20' ' ' GLU . 53.5 t80 -163.42 32.67 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.186 -0.946 . . . . 0.0 109.647 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.544 ' OD2' ' N ' ' A' ' 24' ' ' LEU . 9.3 t0 -173.23 -122.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.431 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.544 ' N ' ' OD2' ' A' ' 23' ' ' ASP . 4.6 tp -152.44 146.04 24.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.57 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.62 134.03 25.83 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.398 -0.813 . . . . 0.0 109.17 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.77 146.8 49.1 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.378 2.052 . . . . 0.0 112.16 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.5 t -105.24 105.89 53.73 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.411 -0.806 . . . . 0.0 109.191 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -47.85 127.9 15.22 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.463 2.109 . . . . 0.0 112.358 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.6 m -76.37 -3.6 37.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.32 -0.862 . . . . 0.0 109.285 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.75 -15.2 59.29 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.167 -0.958 . . . . 0.0 109.358 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.465 ' CD1' ' C ' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -156.3 12.5 0.29 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 110.129 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.434 ' C ' ' O ' ' A' ' 31' ' ' LEU . 20.6 p90 -43.35 163.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.127 -0.983 . . . . 0.0 109.377 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.25 -4.71 26.81 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -96.17 102.04 13.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.184 -1.186 . . . . 0.0 109.497 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -96.21 124.43 40.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.243 -0.911 . . . . 0.0 109.511 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -92.16 146.79 23.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.443 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.425 ' OG1' ' CD ' ' A' ' 65' ' ' GLU . 13.3 p -84.46 -15.79 44.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 109.436 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.21 22.91 32.17 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.481 ' OD1' ' O ' ' A' ' 19' ' ' VAL . 3.5 t70 -164.34 150.78 11.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.205 -1.174 . . . . 0.0 109.463 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.481 ' O ' ' OD2' ' A' ' 39' ' ' ASP . . . -92.55 153.08 19.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.391 -0.818 . . . . 0.0 109.528 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -125.01 134.79 52.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.366 -0.834 . . . . 0.0 109.32 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.581 HG13 ' CD2' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -109.93 144.39 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.269 -0.894 . . . . 0.0 109.018 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.782 ' CD1' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -143.32 121.83 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.932 -1.105 . . . . 0.0 109.852 -179.438 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.5 tt -111.35 124.58 52.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.593 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.543 ' CE ' ' OH ' ' A' ' 106' ' ' TYR . 23.2 tttm -101.33 140.47 35.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -0.883 . . . . 0.0 109.225 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.465 ' O ' ' N ' ' A' ' 13' ' ' GLY . 98.9 m -139.32 123.22 17.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.88 . . . . 0.0 109.574 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -128.55 168.32 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.171 -0.955 . . . . 0.0 108.894 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -103.64 108.88 20.35 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.58 -0.7 . . . . 0.0 109.411 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 50' ' ' ARG . 14.5 mt -72.8 169.06 17.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 109.564 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' A' ' 49' ' ' LEU . 8.9 tpp85 -43.25 -70.36 0.11 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.217 -0.927 . . . . 0.0 109.252 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -52.74 -31.22 36.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 109.207 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.35 36.74 4.53 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.495 ' O ' ' O ' ' A' ' 54' ' ' LEU . 5.8 t-20 -84.52 13.21 5.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.118 -1.225 . . . . 0.0 109.175 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.645 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.4 mt 44.37 97.63 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.573 0.701 . . . . 0.0 109.418 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -71.39 113.18 8.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.475 -0.766 . . . . 0.0 109.325 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 92.6 m-85 -98.89 114.38 26.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.239 -0.913 . . . . 0.0 109.849 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.439 ' OD1' HG22 ' A' ' 90' ' ' VAL . 4.5 m-20 -118.28 154.98 31.39 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.422 HD12 HD13 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -142.68 144.59 32.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.964 -1.085 . . . . 0.0 110.674 -179.274 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.659 ' CE1' ' CD2' ' A' ' 92' ' ' HIS . 4.2 m-70 -129.62 150.21 51.05 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.614 ' CD1' ' O ' ' A' ' 60' ' ' TYR . 19.8 p90 -128.98 124.95 36.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.205 -0.934 . . . . 0.0 109.434 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.554 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 56.1 t90 -107.78 127.75 53.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.369 -0.832 . . . . 0.0 109.647 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.554 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 24.2 mt -106.65 161.98 14.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.314 -0.866 . . . . 0.0 109.405 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.577 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -109.12 157.49 15.1 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -82.29 -11.81 58.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -1.14 . . . . 0.0 109.545 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.425 ' CD ' ' OG1' ' A' ' 37' ' ' THR . 2.2 mt-10 -110.26 33.11 4.66 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.655 ' SG ' ' O ' ' A' ' 66' ' ' CYS . 18.8 p -130.44 97.66 4.46 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 122.432 1.11 . . . . 0.0 108.965 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.485 ' O ' ' OG ' ' A' ' 71' ' ' SER . 3.1 m -43.77 170.86 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.763 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.493 ' O ' ' N ' ' A' ' 72' ' ' GLY . 19.5 mt-30 -65.44 -17.78 64.81 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.422 -0.799 . . . . 0.0 109.584 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -65.07 -58.59 5.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.52 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -63.7 -47.07 82.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.378 -0.826 . . . . 0.0 109.196 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 67' ' ' SER . 0.2 OUTLIER -68.65 -24.21 64.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.386 -0.821 . . . . 0.0 109.074 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -71.46 -36.02 62.96 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.16 -42.7 62.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -1.152 . . . . 0.0 109.344 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.37 -46.59 88.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.363 -0.836 . . . . 0.0 109.234 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.512 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -59.48 -49.33 78.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.323 -0.861 . . . . 0.0 109.29 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.9 mt -49.26 -42.22 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.252 -0.905 . . . . 0.0 109.239 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -61.75 -45.75 92.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.24 -0.913 . . . . 0.0 109.307 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.9 m -63.08 -40.12 96.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.296 -0.878 . . . . 0.0 109.413 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.512 HG21 ' O ' ' A' ' 75' ' ' ALA . 24.9 t -67.32 -31.9 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.269 -0.894 . . . . 0.0 109.667 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.65 -61.46 1.88 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.261 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.479 ' C ' HD11 ' A' ' 81' ' ' LEU . 1.5 pp -54.13 -28.15 38.02 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.107 -0.996 . . . . 0.0 108.821 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.638 ' O ' ' N ' ' A' ' 86' ' ' ASN . 8.3 t70 -62.83 -54.09 44.24 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.142 -0.974 . . . . 0.0 109.022 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.56 -34.53 62.01 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -77.92 -26.17 48.84 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.658 ' C ' ' H ' ' A' ' 87' ' ' GLY . 7.3 mt -121.49 33.28 5.58 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.535 -0.728 . . . . 0.0 109.484 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.638 ' N ' ' O ' ' A' ' 82' ' ' ASP . 4.6 t-20 -70.42 25.56 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 108.956 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.658 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -68.79 25.63 0.29 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.635 ' H ' ' C ' ' A' ' 86' ' ' ASN . 0.4 OUTLIER 80.87 35.94 0.1 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.427 -1.043 . . . . 0.0 109.704 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -73.25 179.46 3.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.0 109.123 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.439 HG22 ' OD1' ' A' ' 57' ' ' ASP . 3.8 t -116.2 121.65 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.217 -0.927 . . . . 0.0 109.874 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -97.65 143.26 28.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.107 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.659 ' CD2' ' CE1' ' A' ' 59' ' ' HIS . 33.8 m-70 -120.6 146.61 46.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 109.519 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.405 ' CB ' ' OH ' ' A' ' 60' ' ' TYR . 5.5 ptm180 -116.6 103.01 9.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 0.0 109.617 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.548 ' OE2' ' CG ' ' A' ' 103' ' ' PHE . 42.1 mt-10 -113.78 144.64 42.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.459 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.553 ' CG1' ' H ' ' A' ' 96' ' ' GLN . 47.4 t -149.1 176.56 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.879 . . . . 0.0 109.368 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.553 ' H ' ' CG1' ' A' ' 95' ' ' VAL . 10.4 tp-100 -67.96 118.08 10.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.934 . . . . 0.0 109.453 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.13 11.6 84.93 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.441 ' O ' ' C ' ' A' ' 99' ' ' GLU . 0.3 OUTLIER -140.98 19.32 2.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.163 -1.198 . . . . 0.0 109.485 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 98' ' ' PHE . 22.0 mt-10 -43.27 163.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 109.532 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.0 m -100.12 167.79 10.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.302 -0.873 . . . . 0.0 109.418 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.73 -50.88 31.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.449 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.6 m -46.97 -59.69 2.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.147 -0.971 . . . . 0.0 109.381 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.548 ' CG ' ' OE2' ' A' ' 94' ' ' GLU . 5.4 t80 -53.69 -51.18 64.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.392 -0.818 . . . . 0.0 109.328 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.612 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 6.6 mt -53.35 -18.71 2.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 0.0 109.094 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.81 -21.98 24.62 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.543 ' OH ' ' CE ' ' A' ' 45' ' ' LYS . 3.0 m-85 -73.68 -33.74 64.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.273 -1.134 . . . . 0.0 109.247 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.691 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 1.0 OUTLIER -41.09 108.14 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.356 -0.84 . . . . 0.0 109.599 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -115.37 -47.43 2.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.146 -0.972 . . . . 0.0 109.378 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.7 m -86.11 -29.14 23.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.896 . . . . 0.0 109.522 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 120.48 111.47 2.28 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.4 pp -120.99 166.87 13.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.326 -1.103 . . . . 0.0 109.524 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -172.81 -178.17 1.81 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.638 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -93.52 139.7 30.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.286 -0.884 . . . . 0.0 109.44 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -146.46 105.05 3.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -88.95 150.97 22.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 109.402 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.06 150.1 37.11 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.52 87.81 0.23 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.7 p -101.29 154.66 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.161 -1.199 . . . . 0.0 109.418 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 174.87 -76.36 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.0 109.426 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -93.09 -61.55 1.55 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -0.872 . . . . 0.0 109.494 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 48.45 -155.86 1.34 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -85.13 -34.56 22.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -1.159 . . . . 0.0 109.504 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.532 ' CG ' ' H ' ' A' ' 124' ' ' HIS . 23.0 tptt 54.22 -138.78 1.07 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.218 -0.926 . . . . 0.0 109.41 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.532 ' H ' ' CG ' ' A' ' 123' ' ' LYS . 33.4 m170 52.87 59.35 4.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.343 -0.848 . . . . 0.0 109.489 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.43 ' C ' ' O ' ' A' ' 124' ' ' HIS . 12.7 p -42.79 150.29 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.183 -0.948 . . . . 0.0 109.461 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -79.12 153.04 77.11 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.922 . . . . 0.0 109.433 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.52 -159.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.7 2.267 . . . . 0.0 112.096 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -134.96 84.58 2.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.9 . . . . 0.0 109.462 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -140.54 152.45 45.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.458 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.405 HG11 ' H ' ' A' ' 131' ' ' VAL . 2.1 t -72.69 -133.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.441 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.405 ' H ' HG11 ' A' ' 130' ' ' VAL . 2.3 t -62.32 154.6 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.47 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.7 t -73.5 134.55 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.501 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 118.058 -0.972 . . . . 0.0 109.477 -179.991 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.477 ' C ' ' CG ' ' A' ' 2' ' ' HIS . 18.3 tt0 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.287 0.565 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.477 ' CG ' ' C ' ' A' ' 1' ' ' GLU . 0.2 OUTLIER 171.71 81.24 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.24 -0.913 . . . . 0.0 109.52 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.21 89.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.702 2.268 . . . . 0.0 111.966 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -83.18 -38.0 22.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.905 . . . . 0.0 110.022 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.5 ' CE1' ' CG1' ' A' ' 42' ' ' VAL . 22.4 t80 -55.17 -19.85 8.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.101 -1.0 . . . . 0.0 109.519 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.0 mt -83.77 -35.38 24.39 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.183 -0.948 . . . . 0.0 109.466 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 8' ' ' ALA . 2.2 mmmp? -89.68 -0.96 57.87 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.197 -0.939 . . . . 0.0 109.511 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.479 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -42.88 166.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.882 . . . . 0.0 109.546 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.432 ' N ' ' OE1' ' A' ' 15' ' ' GLN . . . 101.34 75.37 1.13 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -142.99 5.49 1.52 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.19 -1.182 . . . . 0.0 109.622 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -172.34 143.27 1.26 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 0.0 109.342 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.38 88.45 1.15 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.585 2.19 . . . . 0.0 112.295 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -172.37 -104.71 0.18 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 tp -156.2 143.39 19.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.263 -1.14 . . . . 0.0 109.697 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.432 ' OE1' ' N ' ' A' ' 9' ' ' GLY . 13.0 mt-30 -129.06 130.65 46.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.363 -0.835 . . . . 0.0 109.237 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.542 ' HA ' HG23 ' A' ' 43' ' ' ILE . 53.2 mt -113.37 137.66 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.263 -0.898 . . . . 0.0 109.958 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -141.61 136.51 31.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.368 -0.832 . . . . 0.0 108.82 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.403 ' HB2' ' CE2' ' A' ' 41' ' ' TYR . 2.3 ttt180 -98.03 150.71 21.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.148 -0.97 . . . . 0.0 109.671 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.473 ' CG1' ' O ' ' A' ' 19' ' ' VAL . 8.1 p -92.12 122.77 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.387 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.611 ' O ' ' N ' ' A' ' 22' ' ' PHE . 4.2 tm-20 -75.12 149.5 39.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.126 -0.984 . . . . 0.0 109.012 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 20' ' ' GLU . 57.9 mttt -40.3 -20.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.447 -0.783 . . . . 0.0 109.841 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.611 ' N ' ' O ' ' A' ' 20' ' ' GLU . 40.4 t80 -151.46 13.24 0.65 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.081 -1.012 . . . . 0.0 109.819 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 20' ' ' GLU . 35.0 m-20 -160.81 -143.06 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.938 . . . . 0.0 109.385 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.42 ' CD2' ' H ' ' A' ' 5' ' ' PHE . 0.8 OUTLIER -129.35 139.83 51.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.31 -0.869 . . . . 0.0 109.571 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 t -119.76 133.06 23.85 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.361 -0.837 . . . . 0.0 108.947 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.62 150.75 45.9 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.431 2.088 . . . . 0.0 112.495 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.8 t -148.79 101.53 3.44 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.306 -0.871 . . . . 0.0 109.214 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -50.1 139.46 34.57 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.591 2.194 . . . . 0.0 112.262 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.475 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 12.4 t -67.53 -21.08 65.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.325 -0.86 . . . . 0.0 109.347 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -77.04 -2.74 35.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.365 -0.835 . . . . 0.0 109.415 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.486 ' O ' ' O ' ' A' ' 32' ' ' TYR . 50.1 mt -124.91 -18.87 5.4 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.339 -0.851 . . . . 0.0 109.5 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.486 ' O ' ' O ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -49.24 -178.61 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.123 -0.986 . . . . 0.0 109.51 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.15 -41.01 2.09 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -98.47 102.37 14.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -1.154 . . . . 0.0 109.495 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -90.33 136.43 33.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.187 -0.946 . . . . 0.0 109.461 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.446 ' CD2' ' OH ' ' A' ' 41' ' ' TYR . 25.1 m-85 -92.9 138.72 31.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 109.435 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.423 ' OG1' ' CD ' ' A' ' 65' ' ' GLU . 55.8 p -80.45 -4.83 55.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.31 -0.869 . . . . 0.0 109.48 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.7 -74.9 1.21 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -78.7 155.05 29.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -1.126 . . . . 0.0 109.601 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.69 165.44 13.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.335 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.446 ' OH ' ' CD2' ' A' ' 36' ' ' PHE . 11.1 m-85 -126.84 136.02 51.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.296 -0.878 . . . . 0.0 109.542 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.543 ' C ' ' CD1' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -111.68 128.6 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.625 ' CD1' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -124.79 141.96 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.949 . . . . 0.0 110.494 -178.667 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.5 tt -128.21 120.6 27.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.55 -0.719 . . . . 0.0 109.081 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.421 ' HZ2' HG23 ' A' ' 47' ' ' VAL . 38.2 tttp -93.11 146.54 23.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.364 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 13' ' ' GLY . 85.1 m -143.16 129.2 19.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.094 -1.004 . . . . 0.0 109.549 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -133.33 168.49 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 121.178 -0.951 . . . . 0.0 109.262 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -101.72 111.0 23.1 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.616 -0.677 . . . . 0.0 109.376 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 52' ' ' GLY . 81.2 mt -74.92 158.28 33.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.227 -0.92 . . . . 0.0 109.572 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.661 ' CD ' ' H ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -44.85 -47.04 11.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.363 -0.836 . . . . 0.0 109.203 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.465 ' N ' ' ND2' ' A' ' 51' ' ' ASN . 0.9 OUTLIER -65.69 -28.82 69.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.279 -0.888 . . . . 0.0 109.203 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . 94.17 30.75 8.51 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.498 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.1 t-20 -89.89 12.78 16.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.085 -1.244 . . . . 0.0 109.373 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.576 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.1 mt 45.12 99.12 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.665 0.745 . . . . 0.0 109.554 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.547 ' CD ' ' N ' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -68.56 152.83 44.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.476 -0.765 . . . . 0.0 109.118 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.547 ' N ' ' CD ' ' A' ' 55' ' ' GLN . 68.4 m-85 -133.05 114.25 13.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.223 -0.923 . . . . 0.0 109.806 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.63 155.72 26.03 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.458 ' C ' ' CD2' ' A' ' 59' ' ' HIS . 1.1 mp -130.41 146.44 51.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.884 -1.135 . . . . 0.0 110.664 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.461 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 6.9 m-70 -136.22 144.19 44.75 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.439 ' CE1' ' HG ' ' A' ' 62' ' ' LEU . 13.5 t80 -129.27 128.97 44.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.245 -0.909 . . . . 0.0 109.857 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -109.2 126.0 52.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.403 -0.811 . . . . 0.0 109.587 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.439 ' HG ' ' CE1' ' A' ' 60' ' ' TYR . 7.9 mt -104.06 162.18 13.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.423 -0.798 . . . . 0.0 109.906 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.57 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -120.54 158.6 15.53 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -82.34 -11.95 58.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.158 -1.201 . . . . 0.0 109.957 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.423 ' CD ' ' OG1' ' A' ' 37' ' ' THR . 0.4 OUTLIER -109.73 35.17 3.45 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.447 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.649 ' SG ' ' O ' ' A' ' 66' ' ' CYS . 18.5 p -130.45 97.76 4.49 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 122.44 1.114 . . . . 0.0 108.916 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 66' ' ' CYS . 1.2 m -52.46 -170.91 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.645 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -76.54 -17.82 59.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 109.561 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -64.18 -58.71 5.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.236 -0.915 . . . . 0.0 109.547 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -66.54 -40.1 88.91 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.375 -0.828 . . . . 0.0 109.123 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.7 t -73.81 -22.75 59.69 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.398 -0.813 . . . . 0.0 109.251 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -75.1 -35.36 49.57 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.75 -46.78 34.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.284 -1.127 . . . . 0.0 109.297 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.423 ' HB3' ' CE2' ' A' ' 60' ' ' TYR . . . -60.15 -39.81 87.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.349 -0.844 . . . . 0.0 109.324 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.46 -49.58 58.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.31 -0.869 . . . . 0.0 109.425 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.413 HG21 ' OE1' ' A' ' 80' ' ' GLN . 39.3 mt -48.31 -42.18 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -0.912 . . . . 0.0 109.411 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -70.06 -36.48 75.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 109.377 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.467 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 5.7 m -68.68 -34.94 76.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.265 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 87.5 t -70.37 -46.65 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.362 -0.836 . . . . 0.0 109.424 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.413 ' OE1' HG21 ' A' ' 76' ' ' ILE . 43.6 mt-30 -64.03 -46.27 85.18 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.295 -0.878 . . . . 0.0 109.192 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.5 mt -56.63 -36.61 69.69 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.261 -0.899 . . . . 0.0 108.88 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 86' ' ' ASN . 0.7 OUTLIER -61.53 -58.12 9.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.298 -0.876 . . . . 0.0 109.154 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.49 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 10.8 m-20 -50.7 -33.11 21.47 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.993 -1.067 . . . . 0.0 108.355 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -78.14 -25.87 47.57 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.63 ' C ' ' H ' ' A' ' 87' ' ' GLY . 8.5 mt -121.38 32.09 6.05 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.497 -0.752 . . . . 0.0 109.371 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 82' ' ' ASP . 26.8 p30 -72.77 26.38 0.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.271 -0.893 . . . . 0.0 108.849 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.63 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -78.25 56.59 4.04 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 62.03 55.23 2.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.477 -1.014 . . . . 0.0 109.69 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.22 179.09 4.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.373 -0.83 . . . . 0.0 109.186 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.1 t -134.68 151.52 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.607 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -115.75 136.63 52.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.383 -0.823 . . . . 0.0 109.416 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.485 ' O ' ' OE2' ' A' ' 94' ' ' GLU . 21.2 m-70 -107.22 110.4 22.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.159 -0.963 . . . . 0.0 109.55 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.1 mtp85 -86.39 92.93 8.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.248 -0.908 . . . . 0.0 109.142 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.485 ' OE2' ' O ' ' A' ' 92' ' ' HIS . 20.2 mp0 -99.87 140.46 34.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.871 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.6 t -132.61 157.35 43.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.417 -0.802 . . . . 0.0 109.123 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.456 ' CD ' ' O ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -56.99 115.98 2.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.917 . . . . 0.0 109.499 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.89 9.92 65.39 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.456 ' O ' ' C ' ' A' ' 99' ' ' GLU . 11.5 t80 -144.98 30.07 1.18 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -1.156 . . . . 0.0 109.588 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.59 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 6.7 mp0 -41.82 157.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 0.0 109.497 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.7 p -87.29 177.76 7.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -0.889 . . . . 0.0 109.564 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.35 -57.01 4.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.458 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.8 m -46.77 -51.18 16.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.189 -0.945 . . . . 0.0 109.269 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.76 -52.5 63.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.387 -0.821 . . . . 0.0 109.203 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.6 mt -49.09 -28.68 4.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.89 . . . . 0.0 109.424 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.56 -14.11 51.44 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.444 ' O ' ' C ' ' A' ' 107' ' ' PHE . 7.2 t80 -83.08 -20.29 35.19 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.269 -1.136 . . . . 0.0 109.564 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.545 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 3.3 p90 -42.31 122.97 2.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.163 -0.961 . . . . 0.0 109.549 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -103.1 -57.12 2.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 109.427 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 72.8 m -106.15 -29.2 10.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -0.874 . . . . 0.0 109.413 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 132.49 107.9 1.09 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.572 ' H ' ' CD2' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -76.42 160.27 29.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.211 -1.17 . . . . 0.0 109.449 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.1 mtpp -153.54 152.05 30.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -0.885 . . . . 0.0 109.511 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -98.28 138.68 35.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 109.421 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -142.5 154.36 44.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.894 . . . . 0.0 109.604 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -94.91 139.29 31.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.429 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -95.47 87.61 1.03 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -155.24 -62.19 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.6 m -95.82 142.81 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -1.14 . . . . 0.0 109.547 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.65 100.92 12.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 109.442 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.1 t -89.83 79.89 6.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.396 -0.815 . . . . 0.0 109.508 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 148.58 105.15 0.36 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 48.44 -140.63 0.64 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.261 -1.14 . . . . 0.0 109.435 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.0 tttp -158.47 123.98 4.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.898 . . . . 0.0 109.389 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.752 ' HD1' ' H ' ' A' ' 125' ' ' VAL . 1.1 t-80 -59.37 153.0 19.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.164 -0.96 . . . . 0.0 109.488 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.752 ' H ' ' HD1' ' A' ' 124' ' ' HIS . 11.2 t -53.49 153.23 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.185 -0.947 . . . . 0.0 109.504 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 91.7 t -145.07 83.21 9.43 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.88 . . . . 0.0 109.459 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 128' ' ' ASN . 51.7 Cg_exo -50.59 -38.91 55.95 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.726 2.284 . . . . 0.0 112.28 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 127' ' ' PRO . 5.3 t-20 61.04 133.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.383 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -92.6 95.43 9.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.489 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' A' ' 131' ' ' VAL . 96.8 t -151.91 107.91 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.174 -0.953 . . . . 0.0 109.426 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 130' ' ' VAL . 6.5 p -43.11 -40.84 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.323 -0.861 . . . . 0.0 109.482 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.2 t -66.32 123.87 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.179 -0.951 . . . . 0.0 109.51 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.432 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.491 ' O ' ' N ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER -142.0 154.75 65.44 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.271 -0.893 . . . . 0.0 109.3 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -40.94 87.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.648 2.232 . . . . 0.0 112.086 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 2' ' ' HIS . 67.5 tt0 -83.21 -18.02 40.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.355 -0.841 . . . . 0.0 109.999 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.465 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 2.3 m-85 -74.09 -5.91 44.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.092 -1.005 . . . . 0.0 109.541 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.514 HD21 HE21 ' A' ' 80' ' ' GLN . 11.5 mt -85.49 -39.62 17.26 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.205 -0.934 . . . . 0.0 109.417 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 8' ' ' ALA . 41.9 mtpt -97.67 -9.97 25.84 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.352 -0.843 . . . . 0.0 109.515 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -43.84 166.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 0.0 109.577 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.464 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 134.87 -29.9 2.91 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -78.94 23.7 0.34 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.245 -1.15 . . . . 0.0 109.377 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.464 ' H ' ' C ' ' A' ' 9' ' ' GLY . 55.3 mt-10 -137.01 76.77 44.84 Favored Pre-proline 0 C--N 1.305 -1.367 0 O-C-N 121.288 -0.882 . . . . 0.0 109.547 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -52.25 81.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 122.867 2.378 . . . . 0.0 112.207 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 46' ' ' THR . . . 179.65 -102.98 0.17 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.1 tt -162.53 127.53 3.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -1.179 . . . . 0.0 109.81 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.495 ' O ' HG23 ' A' ' 43' ' ' ILE . 35.1 mt-30 -114.42 146.82 40.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.346 -0.846 . . . . 0.0 109.316 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.625 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 11.8 mt -130.68 123.86 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.502 -0.749 . . . . 0.0 110.284 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.625 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 11.3 m0 -143.88 158.94 43.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.043 -1.036 . . . . 0.0 108.528 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.504 ' NE ' ' CZ ' ' A' ' 41' ' ' TYR . 20.8 ttm180 -105.76 152.48 23.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.019 -1.051 . . . . 0.0 110.001 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.6 p -88.38 139.61 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.277 -0.889 . . . . 0.0 109.422 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.595 ' O ' ' N ' ' A' ' 22' ' ' PHE . 18.8 tt0 -88.69 152.61 21.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.23 -0.919 . . . . 0.0 109.203 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 20' ' ' GLU . 24.3 tttt -40.72 -20.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.307 -0.87 . . . . 0.0 109.555 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.595 ' N ' ' O ' ' A' ' 20' ' ' GLU . 7.2 t80 -160.14 32.1 0.17 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.175 -0.953 . . . . 0.0 109.492 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -170.71 -130.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.516 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.9 tp -144.2 146.2 32.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 109.558 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 t -129.3 126.99 23.14 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.017 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -75.21 141.6 26.24 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.368 2.045 . . . . 0.0 112.383 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.5 t -104.35 122.84 42.56 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.379 -0.826 . . . . 0.0 109.242 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.32 162.08 34.14 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.514 2.143 . . . . 0.0 112.28 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.94 -24.64 67.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.216 -0.928 . . . . 0.0 109.428 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -64.02 -10.71 23.43 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 109.429 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 32' ' ' TYR . 94.9 mt -127.26 -13.16 5.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.289 -0.882 . . . . 0.0 109.531 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.531 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 4.4 t80 -41.11 131.05 2.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.372 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 112' ' ' LYS . . . 85.8 15.03 66.3 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -141.24 99.28 3.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -1.145 . . . . 0.0 109.48 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -97.04 164.94 12.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.276 -0.89 . . . . 0.0 109.494 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -105.2 136.08 45.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.449 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.449 ' OG1' ' CD ' ' A' ' 65' ' ' GLU . 4.1 p -73.35 -4.99 36.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.184 -0.948 . . . . 0.0 109.486 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.97 38.75 3.18 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 40' ' ' ALA . 5.9 t0 -171.23 171.01 5.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -1.189 . . . . 0.0 109.489 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.463 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -113.59 136.01 53.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.89 . . . . 0.0 109.546 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.504 ' CZ ' ' NE ' ' A' ' 18' ' ' ARG . 27.7 m-85 -114.91 142.64 46.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.333 -0.854 . . . . 0.0 109.345 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.465 ' HB ' ' CD1' ' A' ' 5' ' ' PHE . 0.3 OUTLIER -113.14 143.96 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.273 -0.892 . . . . 0.0 108.871 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.495 HG23 ' O ' ' A' ' 15' ' ' GLN . 1.2 mm -136.7 151.41 27.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.359 -0.937 . . . . 0.0 110.091 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.425 ' C ' ' CD2' ' A' ' 44' ' ' LEU . 4.5 tt -135.27 121.14 19.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.554 -0.716 . . . . 0.0 109.207 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.411 ' N ' HD23 ' A' ' 44' ' ' LEU . 31.5 tttt -104.96 112.48 25.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.251 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.504 ' O ' ' N ' ' A' ' 13' ' ' GLY . 39.1 m -119.78 135.54 54.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.418 -0.801 . . . . 0.0 109.484 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.535 ' O ' HD21 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -126.95 168.29 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 121.304 -0.872 . . . . 0.0 108.907 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 40.9 tp60 -106.9 98.49 8.14 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.611 -0.68 . . . . 0.0 109.422 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.61 ' O ' ' N ' ' A' ' 51' ' ' ASN . 9.3 mt -65.03 157.75 27.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 109.239 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -51.72 84.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.12 -0.988 . . . . 0.0 109.099 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.61 ' N ' ' O ' ' A' ' 49' ' ' LEU . 6.6 m-20 51.43 43.36 29.59 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.229 -0.92 . . . . 0.0 109.192 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.82 -79.9 1.49 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 54' ' ' LEU . 1.2 t30 -174.53 26.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.079 -1.248 . . . . 0.0 109.908 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.616 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 3.9 mt 58.51 106.7 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.666 0.746 . . . . 0.0 109.118 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 46' ' ' THR . 32.1 tt0 -68.82 147.53 51.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.523 -0.735 . . . . 0.0 109.503 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.616 ' CE1' ' O ' ' A' ' 54' ' ' LEU . 97.7 m-85 -129.95 114.67 16.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.48 -0.762 . . . . 0.0 109.507 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.593 ' OD1' ' CE1' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -123.1 154.94 37.92 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.176 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.5 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 1.8 mp -132.93 150.2 52.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.958 -1.089 . . . . 0.0 110.753 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.704 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -141.96 116.93 9.93 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.36 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.667 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -103.8 121.89 43.98 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.023 -1.048 . . . . 0.0 109.52 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.553 ' NE1' ' OE1' ' A' ' 99' ' ' GLU . 71.4 t90 -98.99 136.25 39.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.866 . . . . 0.0 109.725 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.472 HD11 ' H ' ' A' ' 62' ' ' LEU . 0.5 OUTLIER -116.63 159.04 22.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.397 -0.814 . . . . 0.0 109.4 179.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -101.07 148.34 18.1 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -70.37 -12.25 61.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -1.16 . . . . 0.0 109.49 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.449 ' CD ' ' OG1' ' A' ' 37' ' ' THR . 1.7 mt-10 -106.6 31.37 5.29 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.3 m -130.48 97.57 4.43 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.091 0.948 . . . . 0.0 108.513 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 66' ' ' CYS . 94.3 p -52.57 -170.88 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.783 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 72' ' ' GLY . 44.2 tt0 -64.63 -17.95 64.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.367 -0.833 . . . . 0.0 109.537 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -63.29 -58.69 6.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 109.473 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -68.16 -39.46 82.57 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.396 -0.815 . . . . 0.0 108.898 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 t -73.48 -20.98 60.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.515 -0.741 . . . . 0.0 109.064 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -75.66 -41.06 30.19 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.53 -42.16 71.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -1.121 . . . . 0.0 109.22 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.05 -42.04 98.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.328 -0.858 . . . . 0.0 109.285 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.513 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -64.91 -47.82 76.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.308 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.2 mt -52.76 -37.14 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.348 -0.845 . . . . 0.0 109.235 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.56 -41.34 79.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.342 -0.849 . . . . 0.0 109.293 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.9 m -68.28 -34.45 76.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 109.557 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.513 HG21 ' O ' ' A' ' 75' ' ' ALA . 61.8 t -68.06 -37.99 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.223 -0.923 . . . . 0.0 109.426 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.514 HE21 HD21 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -68.39 -47.03 68.42 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.723 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.464 HD12 HD21 ' A' ' 58' ' ' LEU . 0.6 OUTLIER -55.43 -38.13 68.59 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.189 -0.945 . . . . 0.0 108.974 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.628 ' O ' ' N ' ' A' ' 86' ' ' ASN . 16.1 t70 -61.74 -58.33 8.45 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.318 -0.864 . . . . 0.0 109.109 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 82' ' ' ASP . 59.1 m-20 -45.43 -35.09 3.48 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.119 -0.988 . . . . 0.0 108.744 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -74.25 -32.66 63.04 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.361 -0.837 . . . . 0.0 108.834 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.636 ' C ' ' H ' ' A' ' 87' ' ' GLY . 7.7 mt -121.69 36.17 4.69 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.409 -0.807 . . . . 0.0 109.283 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.628 ' N ' ' O ' ' A' ' 82' ' ' ASP . 9.6 p30 -72.03 25.4 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.95 . . . . 0.0 109.143 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.636 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -80.41 -75.65 1.06 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.405 ' HG3' HH21 ' A' ' 88' ' ' ARG . 12.7 mtt85 -152.32 50.65 0.77 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.262 -1.14 . . . . 0.0 109.458 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.485 ' CB ' ' O ' ' A' ' 56' ' ' TYR . . . -96.87 179.14 5.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.404 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.0 t -135.99 96.36 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.282 -0.886 . . . . 0.0 109.532 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 7.2 pt20 -95.87 143.92 26.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.905 . . . . 0.0 109.308 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.664 ' CE1' ' HD1' ' A' ' 59' ' ' HIS . 2.0 p80 -147.09 158.6 43.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.841 -1.162 . . . . 0.0 110.144 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.4 ttt180 -91.68 126.29 36.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.456 -0.778 . . . . 0.0 109.902 -179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -107.49 129.91 54.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 109.229 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.491 ' O ' ' OE1' ' A' ' 99' ' ' GLU . 3.4 t -127.57 161.41 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 109.66 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.442 ' C ' ' H ' ' A' ' 98' ' ' PHE . 4.3 tt0 -62.44 145.21 54.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.328 -0.858 . . . . 0.0 109.551 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.69 4.18 6.71 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.447 ' O ' ' C ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -134.08 6.13 3.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -1.101 . . . . 0.0 109.293 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.553 ' OE1' ' NE1' ' A' ' 61' ' ' TRP . 3.5 mp0 -42.64 158.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.417 -0.802 . . . . 0.0 109.351 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.1 m -80.32 147.44 31.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.313 -0.867 . . . . 0.0 109.369 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.71 -33.26 66.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -0.964 . . . . 0.0 109.432 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 99.4 m -68.68 -33.86 74.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -0.916 . . . . 0.0 109.481 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -68.74 -46.6 68.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.361 -0.837 . . . . 0.0 109.422 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.6 mt -69.36 -23.49 63.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.466 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.14 -26.24 22.04 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -77.33 -30.9 54.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.363 -1.081 . . . . 0.0 109.559 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.46 ' CD1' HD22 ' A' ' 111' ' ' LEU . 7.2 m-85 -80.65 129.17 34.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.446 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.446 ' HB2' ' HZ2' ' A' ' 108' ' ' LYS . 1.9 mtmp? -103.21 -12.86 17.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.895 . . . . 0.0 109.457 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.9 t -97.05 -9.21 28.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.927 . . . . 0.0 109.511 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.59 104.48 0.3 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.602 ' H ' ' CD2' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -63.27 179.82 0.39 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -1.123 . . . . 0.0 109.32 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -164.54 167.13 19.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.204 -0.935 . . . . 0.0 109.459 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.5 103.24 5.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 0.0 109.316 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.635 ' HB2' ' HZ3' ' A' ' 114' ' ' LYS . 2.9 ttmp? -79.51 124.06 28.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.897 . . . . 0.0 109.536 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -92.73 144.49 25.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.125 -0.985 . . . . 0.0 109.479 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -102.01 48.81 1.05 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -161.1 95.86 0.14 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.0 p -147.64 -13.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.276 -1.132 . . . . 0.0 109.416 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.477 ' C ' ' H ' ' A' ' 121' ' ' GLY . . . -159.42 -174.44 4.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.495 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 47.0 t -75.42 37.23 0.13 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 109.46 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.477 ' H ' ' C ' ' A' ' 119' ' ' ALA . . . 77.74 123.04 0.25 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 123' ' ' LYS . 55.6 t80 -47.66 -95.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -1.141 . . . . 0.0 109.376 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.452 ' N ' ' CD1' ' A' ' 122' ' ' PHE . 14.8 ptpt -57.01 -169.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 0.0 109.492 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -94.97 94.67 8.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 109.437 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.0 p -120.48 1.06 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.909 . . . . 0.0 109.409 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 126' ' ' VAL . 8.3 p -51.95 114.26 5.13 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.175 -0.953 . . . . 0.0 109.416 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -45.59 169.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.432 2.088 . . . . 0.0 112.237 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -99.19 55.22 0.99 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.566 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -56.68 158.25 4.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 109.477 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 49.0 t -69.46 72.81 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.247 -0.908 . . . . 0.0 109.533 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.2 t -151.12 113.05 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.245 -0.91 . . . . 0.0 109.429 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 61.4 t -150.85 79.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.29 -0.881 . . . . 0.0 109.445 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.441 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.585 ' N ' ' OE2' ' A' ' 1' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.576 ' CD2' ' O ' ' A' ' 1' ' ' GLU . 20.2 m-70 -157.35 52.55 0.6 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.201 -0.937 . . . . 0.0 109.551 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 2' ' ' HIS . 34.8 Cg_endo -68.08 75.05 0.7 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.786 2.324 . . . . 0.0 111.994 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.417 ' CB ' ' NE1' ' A' ' 17' ' ' TRP . 6.0 mm-40 -83.42 -46.45 12.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -0.877 . . . . 0.0 109.993 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.493 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 23.1 t80 -65.29 -32.66 74.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.207 -0.933 . . . . 0.0 109.058 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.2 mt -74.01 -35.85 64.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.31 -0.869 . . . . 0.0 109.314 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.497 ' O ' ' O ' ' A' ' 8' ' ' ALA . 12.4 mmmt -82.76 -9.88 59.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.435 -0.79 . . . . 0.0 109.307 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.497 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -45.58 173.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.595 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.4 32.57 1.77 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -150.25 35.61 0.66 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.324 -1.103 . . . . 0.0 109.412 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -155.09 115.5 2.36 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.296 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.15 81.85 2.6 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.442 2.094 . . . . 0.0 112.354 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 46' ' ' THR . . . 175.44 -100.62 0.15 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 tt -161.44 145.06 12.76 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.217 -1.167 . . . . 0.0 109.652 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -133.75 135.96 44.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 109.239 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.536 ' HA ' HG22 ' A' ' 43' ' ' ILE . 13.3 mt -106.83 135.65 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.349 -0.844 . . . . 0.0 110.067 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.417 ' NE1' ' CB ' ' A' ' 4' ' ' GLU . 0.6 OUTLIER -144.34 111.38 5.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.379 -0.825 . . . . 0.0 108.948 179.466 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.569 ' NH2' ' CD1' ' A' ' 36' ' ' PHE . 28.2 ttt180 -74.79 153.03 38.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.192 -0.942 . . . . 0.0 109.473 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.9 p -77.14 145.14 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 109.792 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 22' ' ' PHE . 21.6 tt0 -108.08 154.58 21.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.405 -0.809 . . . . 0.0 109.187 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.591 ' O ' ' CD2' ' A' ' 22' ' ' PHE . 7.2 mtmp? -46.93 -10.86 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.287 -0.883 . . . . 0.0 109.513 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 21' ' ' LYS . 9.5 m-85 -169.53 28.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 109.529 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.585 ' OD1' ' N ' ' A' ' 1' ' ' GLU . 3.7 t70 -176.03 -154.17 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.918 . . . . 0.0 109.592 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.451 HD22 ' C ' ' A' ' 23' ' ' ASP . 4.5 mm? -117.83 146.01 44.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.312 -0.868 . . . . 0.0 109.425 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 18' ' ' ARG . 2.1 t -125.08 130.65 24.12 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.323 -0.861 . . . . 0.0 109.048 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.56 137.61 20.71 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.344 2.029 . . . . 0.0 112.631 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -122.25 101.68 40.88 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.428 -0.795 . . . . 0.0 108.973 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.66 166.93 23.21 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.466 2.111 . . . . 0.0 112.478 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.35 -17.8 22.73 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.22 -0.925 . . . . 0.0 109.31 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.715 HD21 ' N ' ' A' ' 30' ' ' ASN . 0.6 OUTLIER -44.45 -31.18 1.01 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.939 . . . . 0.0 109.361 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.487 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 2.3 pp -160.45 16.64 0.13 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.247 -0.908 . . . . 0.0 109.837 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -56.33 161.4 2.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.992 -1.067 . . . . 0.0 109.423 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.57 -7.77 63.69 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.487 ' OD2' ' O ' ' A' ' 31' ' ' LEU . 11.3 p-10 -93.01 98.14 11.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -1.145 . . . . 0.0 109.373 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.486 ' CE1' HD21 ' A' ' 111' ' ' LEU . 51.1 m-85 -89.61 133.71 34.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.279 -0.888 . . . . 0.0 109.508 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.569 ' CD1' ' NH2' ' A' ' 18' ' ' ARG . 28.2 m-85 -96.52 127.4 42.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 109.525 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 28.5 p -68.83 -4.87 17.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.879 . . . . 0.0 109.576 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.22 43.82 1.54 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -167.99 -168.25 0.95 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.244 -1.15 . . . . 0.0 109.49 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.83 145.25 44.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.959 . . . . 0.0 109.497 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -118.73 135.77 54.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.399 -0.813 . . . . 0.0 109.455 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.553 ' C ' ' CD1' ' A' ' 43' ' ' ILE . 0.9 OUTLIER -115.62 120.11 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.428 -0.795 . . . . 0.0 109.048 179.785 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.59 ' CD1' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -125.1 130.0 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.16 -0.962 . . . . 0.0 110.299 -179.211 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.481 HD13 ' N ' ' A' ' 45' ' ' LYS . 6.0 tp -104.79 121.0 42.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.565 -0.709 . . . . 0.0 109.166 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.513 ' NZ ' ' OH ' ' A' ' 106' ' ' TYR . 8.1 tptm -104.83 103.81 13.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.37 -0.831 . . . . 0.0 109.178 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 55' ' ' GLN . 16.9 m -117.22 139.1 51.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.331 -0.856 . . . . 0.0 109.521 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.489 ' O ' HD23 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -131.65 168.39 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.246 -0.909 . . . . 0.0 109.491 -179.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.794 HE22 ' H ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -111.69 133.49 53.89 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.651 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.626 ' O ' ' C ' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -116.06 100.33 7.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.202 -0.936 . . . . 0.0 109.554 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.626 ' C ' ' O ' ' A' ' 49' ' ' LEU . 31.0 ttt85 21.23 72.54 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.68 -0.638 . . . . 0.0 110.235 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.794 ' H ' HE22 ' A' ' 48' ' ' GLN . 1.8 m120 45.87 52.04 10.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.381 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . -97.11 -81.74 1.6 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -165.15 20.73 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.347 -1.09 . . . . 0.0 109.754 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.592 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 5.9 mt 53.77 104.65 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.489 -0.757 . . . . 0.0 109.306 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.522 ' O ' HG23 ' A' ' 46' ' ' THR . 32.1 tt0 -68.04 149.69 49.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.538 -0.726 . . . . 0.0 109.043 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.592 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 97.1 m-85 -131.47 114.89 15.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.941 . . . . 0.0 109.94 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -120.29 155.03 34.11 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.446 HD12 ' HG3' ' A' ' 91' ' ' GLN . 4.8 mp -136.25 129.78 32.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.947 -1.095 . . . . 0.0 110.162 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.586 ' ND1' ' NE2' ' A' ' 92' ' ' HIS . 3.1 m-70 -115.62 109.65 18.05 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.513 ' C ' ' CD1' ' A' ' 60' ' ' TYR . 0.6 OUTLIER -99.55 115.81 30.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 109.317 -179.61 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -108.16 142.31 38.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.29 -0.881 . . . . 0.0 109.752 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.52 162.21 32.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 109.526 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -87.24 154.41 26.3 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.44 ' OD1' ' N ' ' A' ' 64' ' ' ASN . 3.5 p-10 -82.07 -12.42 58.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -1.122 . . . . 0.0 109.564 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -106.81 32.79 4.3 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.498 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.3 m -130.23 97.67 4.5 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.261 1.029 . . . . 0.0 108.438 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 66' ' ' CYS . 1.2 t -44.32 173.87 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.855 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.596 ' O ' ' N ' ' A' ' 72' ' ' GLY . 3.3 pt20 -57.25 -17.45 11.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.483 -0.761 . . . . 0.0 109.732 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -61.22 -59.1 5.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.054 -1.029 . . . . 0.0 109.384 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.28 -50.75 66.69 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 108.691 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.2 m -64.98 -20.87 66.71 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.15 -43.83 62.55 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.69 -49.07 67.31 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -1.157 . . . . 0.0 109.103 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.69 -43.9 90.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.393 -0.817 . . . . 0.0 109.211 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.553 ' O ' HG22 ' A' ' 79' ' ' VAL . . . -66.73 -47.2 73.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.353 -0.842 . . . . 0.0 109.478 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.421 HD12 HG21 ' A' ' 76' ' ' ILE . 15.9 mt -47.08 -44.12 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.888 . . . . 0.0 109.091 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -65.77 -45.92 80.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.298 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.4 m -66.14 -22.58 66.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.245 -0.909 . . . . 0.0 109.009 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.553 HG22 ' O ' ' A' ' 75' ' ' ALA . 66.3 t -73.57 -50.28 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.288 -0.883 . . . . 0.0 109.459 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -61.66 -49.86 74.84 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.321 -0.862 . . . . 0.0 108.92 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.15 -37.68 67.29 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.28 -0.888 . . . . 0.0 109.037 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 86' ' ' ASN . 64.5 t0 -58.07 -55.87 29.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.226 -0.921 . . . . 0.0 108.883 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.432 ' HA ' HD21 ' A' ' 86' ' ' ASN . 39.4 m-20 -50.32 -33.98 22.08 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.08 -1.012 . . . . 0.0 108.362 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -77.1 -24.27 51.8 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.492 ' C ' ' H ' ' A' ' 87' ' ' GLY . 12.6 mt -121.4 30.45 6.76 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.326 -0.859 . . . . 0.0 109.419 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.5 OUTLIER -80.13 27.99 0.31 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.309 -0.869 . . . . 0.0 108.974 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.492 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -83.17 -54.35 3.2 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.6 ptt-85 -175.81 42.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -1.112 . . . . 0.0 109.62 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 56' ' ' TYR . . . -95.53 178.88 5.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.497 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 87.4 t -123.27 91.97 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.437 -0.789 . . . . 0.0 109.337 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.496 ' CD ' ' H ' ' A' ' 91' ' ' GLN . 3.9 mp0 -96.57 125.18 40.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.342 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.586 ' NE2' ' ND1' ' A' ' 59' ' ' HIS . 2.7 p80 -133.52 143.78 48.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.143 -0.973 . . . . 0.0 109.618 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -99.32 105.29 17.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.227 -0.92 . . . . 0.0 109.69 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.483 ' OE1' ' OG ' ' A' ' 100' ' ' SER . 41.0 mt-10 -87.11 148.16 25.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.321 -0.862 . . . . 0.0 109.391 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 t -135.28 163.46 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.196 -0.94 . . . . 0.0 109.487 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 97' ' ' GLY . 6.2 tp-100 -75.4 126.35 30.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.242 -0.911 . . . . 0.0 109.557 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.548 ' N ' ' OE1' ' A' ' 96' ' ' GLN . . . 121.19 4.58 10.03 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.459 ' O ' ' C ' ' A' ' 99' ' ' GLU . 35.9 t80 -174.0 -34.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.226 -1.161 . . . . 0.0 109.448 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 98' ' ' PHE . 14.1 mt-10 41.64 -155.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.356 -0.84 . . . . 0.0 109.569 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.483 ' OG ' ' OE1' ' A' ' 94' ' ' GLU . 78.7 p -129.78 134.3 47.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 109.5 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 100' ' ' SER . . . -44.81 -37.66 3.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.292 -0.88 . . . . 0.0 109.38 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 m -55.54 -48.34 74.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.231 -0.918 . . . . 0.0 109.346 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -62.69 -55.64 25.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 0.0 109.194 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.3 mt -47.39 -26.67 1.38 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.877 . . . . 0.0 109.242 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.71 -40.16 7.83 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.513 ' OH ' ' NZ ' ' A' ' 45' ' ' LYS . 2.7 m-85 -51.87 -46.71 64.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -1.114 . . . . 0.0 109.314 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -139.27 149.71 44.61 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.387 -0.821 . . . . 0.0 109.6 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.89 -56.82 2.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 0.0 109.286 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 110' ' ' GLY . 5.0 m -103.02 -26.81 12.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.496 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 109' ' ' SER . . . -42.44 -59.93 2.94 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.486 HD21 ' CE1' ' A' ' 35' ' ' PHE . 13.9 mt -44.87 134.28 5.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.257 -1.143 . . . . 0.0 109.445 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.3 mttp -151.23 121.56 7.31 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.224 -0.923 . . . . 0.0 109.406 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.448 ' CD2' ' N ' ' A' ' 113' ' ' TYR . 0.6 OUTLIER -98.0 127.8 44.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.302 -0.874 . . . . 0.0 109.443 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -135.42 134.13 39.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 109.457 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 31.9 mtmt -66.2 143.84 57.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.146 -0.971 . . . . 0.0 109.506 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.555 ' C ' ' H ' ' A' ' 118' ' ' VAL . . . -66.98 -9.09 52.68 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.18 -39.4 0.44 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.555 ' H ' ' C ' ' A' ' 116' ' ' GLY . 60.2 t -96.41 69.31 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -1.152 . . . . 0.0 109.416 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . -60.38 -153.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.294 -0.879 . . . . 0.0 109.422 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.99 -73.8 0.33 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 47.73 -152.6 1.88 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -75.17 -168.43 0.77 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -1.136 . . . . 0.0 109.418 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -166.5 128.12 1.77 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 109.519 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.29 124.78 37.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 109.443 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.0 t -98.49 5.72 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.884 . . . . 0.0 109.497 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 127' ' ' PRO . 2.2 t 61.01 80.82 0.25 Allowed Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.329 -0.857 . . . . 0.0 109.515 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 126' ' ' VAL . 50.9 Cg_exo -51.44 -155.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.809 2.339 . . . . 0.0 112.239 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.525 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 0.5 OUTLIER -89.29 179.18 6.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.466 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -157.02 68.19 0.55 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.207 -0.933 . . . . 0.0 109.47 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.5 t -65.19 82.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 109.583 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.5 p -75.31 93.72 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 109.536 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.6 t -56.0 125.57 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.193 -0.942 . . . . 0.0 109.506 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.418 ' OXT' ' CD ' ' A' ' 133' ' ' GLN . 1.2 tm0? . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.507 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.449 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 2.3 pm0 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.35 155.66 37.1 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.428 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -66.71 87.77 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.764 2.309 . . . . 0.0 112.007 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.707 ' HA ' ' HZ3' ' A' ' 7' ' ' LYS . 4.4 mm-40 -83.41 -37.4 23.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 109.973 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.592 ' CE1' ' CG1' ' A' ' 42' ' ' VAL . 23.5 t80 -70.07 -24.29 63.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.175 -0.953 . . . . 0.0 110.031 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 mt -80.76 -40.34 25.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.081 -1.012 . . . . 0.0 109.677 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.707 ' HZ3' ' HA ' ' A' ' 4' ' ' GLU . 4.2 pttm -96.51 3.45 52.7 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.294 -0.879 . . . . 0.0 109.587 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -54.03 -165.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.77 64.9 1.35 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.18 17.96 1.91 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.336 -1.097 . . . . 0.0 109.588 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.476 ' O ' ' OE1' ' A' ' 11' ' ' GLU . 1.9 pp20? -156.18 134.15 7.05 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.18 -0.95 . . . . 0.0 109.421 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.34 84.65 1.67 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.526 2.151 . . . . 0.0 112.286 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 46' ' ' THR . . . 178.35 -100.55 0.14 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.403 HD11 ' HG3' ' A' ' 45' ' ' LYS . 5.5 tt -162.21 152.63 17.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.24 -1.153 . . . . 0.0 109.487 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -135.36 142.24 45.7 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.272 -0.892 . . . . 0.0 109.553 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 22.3 mt -117.22 133.16 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.32 -0.863 . . . . 0.0 109.801 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -139.26 119.37 13.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.313 -0.867 . . . . 0.0 109.085 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.474 HH11 ' CB ' ' A' ' 39' ' ' ASP . 15.3 ttt85 -85.47 153.62 22.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.235 -0.916 . . . . 0.0 109.647 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.406 HG11 ' N ' ' A' ' 22' ' ' PHE . 38.8 t -91.99 123.49 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.218 -0.926 . . . . 0.0 110.043 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.763 ' O ' ' N ' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -71.02 85.82 0.72 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.982 -1.074 . . . . 0.0 108.482 179.405 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.652 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 48.8 tttt 43.63 6.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.361 -0.837 . . . . 0.0 109.415 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.763 ' N ' ' O ' ' A' ' 20' ' ' GLU . 0.7 OUTLIER 160.92 -30.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.849 . . . . 0.0 109.292 -179.802 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -95.08 -129.52 0.14 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.179 -0.951 . . . . 0.0 110.076 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.8 mt -139.99 142.65 36.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.127 -0.983 . . . . 0.0 110.265 -179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 18' ' ' ARG . 3.4 t -142.11 110.29 5.97 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.831 . . . . 0.0 108.96 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -46.27 151.59 1.63 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.067 1.845 . . . . 0.0 111.808 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.11 101.47 45.04 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.944 . . . . 0.0 109.61 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.02 162.58 1.83 Allowed 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.506 2.138 . . . . 0.0 112.257 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.6 m -78.22 -34.79 49.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 109.348 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -56.63 -16.95 7.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.405 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.458 ' O ' ' C ' ' A' ' 32' ' ' TYR . 15.6 mt -112.35 -25.96 8.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.263 -0.898 . . . . 0.0 109.551 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.566 ' OH ' ' CE2' ' A' ' 107' ' ' PHE . 19.0 t80 -41.63 137.08 1.7 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.891 . . . . 0.0 109.453 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.44 -16.71 48.27 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -100.18 121.96 42.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -1.189 . . . . 0.0 109.438 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -102.53 121.58 42.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.189 -0.945 . . . . 0.0 109.536 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -95.96 144.23 26.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.465 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.4 p -97.05 -10.22 26.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -100.22 34.23 5.69 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.474 ' CB ' HH11 ' A' ' 18' ' ' ARG . 4.8 m-20 -163.78 -177.1 4.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -1.149 . . . . 0.0 109.496 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.406 ' C ' ' CD2' ' A' ' 41' ' ' TYR . . . -140.46 146.9 38.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.256 -0.903 . . . . 0.0 109.405 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.585 ' OH ' ' CZ3' ' A' ' 61' ' ' TRP . 0.1 OUTLIER -142.56 137.88 30.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.121 -0.987 . . . . 0.0 109.793 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.592 ' CG1' ' CE1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -101.29 144.23 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.507 ' CD1' ' C ' ' A' ' 42' ' ' VAL . 0.6 OUTLIER -128.02 134.37 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.512 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.48 ' C ' ' CD2' ' A' ' 44' ' ' LEU . 4.7 tt -109.66 116.2 31.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.627 -0.671 . . . . 0.0 109.397 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.403 ' HG3' HD11 ' A' ' 14' ' ' LEU . 8.5 ttpt -92.43 139.48 30.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.219 -0.926 . . . . 0.0 109.44 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.525 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.6 OUTLIER -143.07 118.62 10.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.119 -0.988 . . . . 0.0 109.413 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.692 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -128.24 167.97 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.109 -0.995 . . . . 0.0 109.224 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -95.37 120.25 35.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.571 -0.705 . . . . 0.0 109.433 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 52' ' ' GLY . 82.2 mt -74.86 168.8 19.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -0.956 . . . . 0.0 109.487 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 49' ' ' LEU . 13.5 ttt-85 -43.31 -48.92 6.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.273 -0.892 . . . . 0.0 109.177 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.434 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 33.0 t-20 -81.49 -12.07 58.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.308 -0.87 . . . . 0.0 109.132 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . 88.77 31.85 12.09 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.499 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.8 m120 -78.65 13.92 1.48 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.13 -1.217 . . . . 0.0 109.206 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.692 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.0 mt 43.82 96.8 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 121.438 0.637 . . . . 0.0 109.566 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.507 ' HB2' HD21 ' A' ' 49' ' ' LEU . 28.1 tp60 -77.67 118.09 19.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.386 -0.821 . . . . 0.0 109.465 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -96.16 114.14 25.81 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.137 -0.977 . . . . 0.0 109.585 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.602 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -113.43 150.2 33.09 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.189 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.486 HD23 ' O ' ' A' ' 57' ' ' ASP . 4.1 mm? -117.1 136.56 52.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.089 -1.007 . . . . 0.0 110.068 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.578 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 27.2 m-70 -135.43 125.48 26.0 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.515 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 9.4 t80 -117.36 135.18 54.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 109.819 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.585 ' CZ3' ' OH ' ' A' ' 41' ' ' TYR . 27.9 t90 -120.2 124.24 45.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.413 -0.804 . . . . 0.0 109.289 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.545 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 0.2 OUTLIER -112.86 162.31 15.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.359 -0.838 . . . . 0.0 109.523 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.02 156.1 19.62 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -78.12 -11.71 59.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.391 -1.064 . . . . 0.0 109.482 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -102.25 32.41 3.54 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.498 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.0 OUTLIER -130.79 97.56 4.38 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.181 0.991 . . . . 0.0 108.359 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 66' ' ' CYS . 20.6 t -42.02 167.97 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.785 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.564 ' O ' ' N ' ' A' ' 72' ' ' GLY . 27.0 tt0 -56.59 -17.76 9.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.901 . . . . 0.0 109.592 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -62.6 -58.65 6.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 109.376 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.557 ' N ' ' CD ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -63.07 -48.63 77.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 0.0 109.079 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.43 ' HA ' ' HH ' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -68.8 -21.62 64.31 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.311 -0.868 . . . . 0.0 109.055 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -75.65 -40.5 31.76 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.59 -39.2 77.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.194 -1.18 . . . . 0.0 109.162 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.515 ' CB ' ' CZ ' ' A' ' 60' ' ' TYR . . . -65.81 -46.53 78.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.489 -0.757 . . . . 0.0 109.226 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -60.3 -37.52 80.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.311 -0.868 . . . . 0.0 109.337 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.8 mt -60.88 -49.25 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.41 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -65.56 -31.43 72.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.279 -0.888 . . . . 0.0 109.405 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.411 ' OG1' ' O ' ' A' ' 74' ' ' ALA . 1.1 m -72.8 -41.95 64.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.225 -0.922 . . . . 0.0 109.278 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 89.8 t -63.34 -35.83 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.243 -0.91 . . . . 0.0 109.297 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -65.67 -51.37 59.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.331 -0.856 . . . . 0.0 109.071 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 mt -51.72 -39.49 58.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.034 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 85' ' ' LEU . 13.4 t0 -60.16 -58.75 7.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.307 -0.87 . . . . 0.0 109.144 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 82' ' ' ASP . 24.0 t0 -45.14 -34.16 2.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.207 -0.933 . . . . 0.0 108.881 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -76.57 -28.25 56.17 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.309 -0.869 . . . . 0.0 108.868 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.555 ' N ' ' O ' ' A' ' 82' ' ' ASP . 11.5 mt -121.69 32.14 5.99 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.354 -0.841 . . . . 0.0 109.736 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 82' ' ' ASP . 24.2 t-20 -79.34 27.51 0.26 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.165 -0.959 . . . . 0.0 109.13 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.508 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -89.9 -49.22 3.4 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.434 ' CG ' ' O ' ' A' ' 87' ' ' GLY . 57.8 mtm-85 -158.41 41.61 0.26 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.248 -1.148 . . . . 0.0 109.462 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -127.63 165.25 20.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.399 -0.813 . . . . 0.0 109.226 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.479 ' CG1' ' N ' ' A' ' 91' ' ' GLN . 98.6 t -135.92 167.34 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.914 . . . . 0.0 109.589 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.697 ' H ' ' NE2' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -119.31 134.51 55.17 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.39 -0.819 . . . . 0.0 109.465 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.578 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 20.2 m-70 -105.72 105.14 15.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 109.582 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.2 mtm180 -77.95 102.4 7.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.946 . . . . 0.0 109.309 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.558 ' OE2' ' CD2' ' A' ' 103' ' ' PHE . 50.2 mt-10 -102.33 134.09 46.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.189 -0.944 . . . . 0.0 109.747 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.482 HG11 ' H ' ' A' ' 96' ' ' GLN . 3.1 t -132.88 168.62 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.401 -0.812 . . . . 0.0 109.269 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.482 ' H ' HG11 ' A' ' 95' ' ' VAL . 4.5 tt0 -69.94 118.34 12.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 109.57 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.514 ' O ' ' CD1' ' A' ' 98' ' ' PHE . . . 91.0 11.29 61.67 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 24.8 m-85 -152.55 24.66 0.6 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -1.161 . . . . 0.0 109.665 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 98' ' ' PHE . 27.6 mt-10 -42.82 150.96 0.14 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.173 -0.955 . . . . 0.0 109.409 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.8 p -78.24 168.14 20.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.226 -0.921 . . . . 0.0 109.553 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.45 -61.68 1.78 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -0.906 . . . . 0.0 109.485 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.4 m -47.25 -45.04 23.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.377 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.558 ' CD2' ' OE2' ' A' ' 94' ' ' GLU . 29.1 t80 -58.67 -53.49 57.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.38 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.7 mt -56.1 -28.83 59.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.89 . . . . 0.0 109.386 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -78.0 -25.54 61.9 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -77.83 -30.08 50.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -1.158 . . . . 0.0 109.338 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.566 ' CE2' ' OH ' ' A' ' 32' ' ' TYR . 54.3 m-85 -139.06 127.35 22.74 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.256 -0.902 . . . . 0.0 109.35 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.473 ' HZ3' ' HB2' ' A' ' 108' ' ' LYS . 12.6 ttmm -105.51 -57.01 2.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 109.51 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.0 t -106.03 15.2 26.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.497 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -106.33 28.42 13.68 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.406 HD21 ' N ' ' A' ' 111' ' ' LEU . 0.3 OUTLIER -140.69 54.78 1.59 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.281 -1.129 . . . . 0.0 109.558 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -73.87 135.67 43.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.317 -0.865 . . . . 0.0 109.486 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.496 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 0.9 OUTLIER -92.37 111.32 22.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.472 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -107.99 121.14 44.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.313 -0.867 . . . . 0.0 109.582 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -56.97 122.08 11.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.504 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -87.51 138.76 15.51 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -151.95 -61.73 0.01 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 18.6 t -83.86 118.29 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.275 -1.132 . . . . 0.0 109.522 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.51 30.45 0.71 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 109.513 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 94.4 p -172.77 107.1 0.17 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 109.396 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -169.66 14.66 0.06 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -151.69 91.12 1.61 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.282 -1.128 . . . . 0.0 109.513 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.451 ' O ' ' C ' ' A' ' 124' ' ' HIS . 42.2 mttm -68.07 -156.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.947 . . . . 0.0 109.422 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.451 ' C ' ' O ' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -42.1 162.01 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -0.865 . . . . 0.0 109.485 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.45 ' CG2' ' N ' ' A' ' 126' ' ' VAL . 7.6 p -66.99 165.4 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.122 -0.986 . . . . 0.0 109.423 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.45 ' N ' ' CG2' ' A' ' 125' ' ' VAL . 2.3 m -117.89 87.4 27.55 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.331 -0.856 . . . . 0.0 109.424 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -50.66 -69.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.704 2.27 . . . . 0.0 112.255 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -162.48 131.4 4.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 109.494 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -103.59 162.29 13.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 109.376 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.475 ' O ' ' N ' ' A' ' 132' ' ' VAL . 55.6 t -83.07 -33.95 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.254 -0.904 . . . . 0.0 109.543 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.513 ' CG1' ' O ' ' A' ' 131' ' ' VAL . 12.0 p -67.44 68.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 109.474 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.475 ' N ' ' O ' ' A' ' 130' ' ' VAL . 72.3 t -86.01 129.98 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.92 . . . . 0.0 109.514 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.549 -179.976 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.72 ' HD1' ' H ' ' A' ' 2' ' ' HIS . 0.0 OUTLIER -92.09 -38.53 0.36 Allowed Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.216 -0.927 . . . . 0.0 109.694 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' A' ' 2' ' ' HIS . 16.7 Cg_exo -64.63 49.72 0.17 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.756 2.304 . . . . 0.0 112.091 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 8' ' ' ALA . 41.9 mt-10 -83.13 -45.74 13.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.126 -0.984 . . . . 0.0 109.703 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.617 ' CZ ' HG13 ' A' ' 42' ' ' VAL . 68.2 t80 -48.67 -22.57 0.8 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -0.908 . . . . 0.0 109.287 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.568 HD21 HD12 ' A' ' 81' ' ' LEU . 85.1 mt -83.61 -40.52 18.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 109.484 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' ALA . 42.8 mmtm -101.24 7.15 43.1 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.39 -0.819 . . . . 0.0 109.549 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 4' ' ' GLU . . . -56.01 -164.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.421 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 104.86 -27.67 17.94 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -75.76 21.51 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -1.152 . . . . 0.0 109.4 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.499 ' H ' ' C ' ' A' ' 9' ' ' GLY . 26.9 mm-40 -135.12 115.43 11.95 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.259 -0.9 . . . . 0.0 109.356 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.86 73.85 5.5 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.376 2.051 . . . . 0.0 112.277 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -177.28 -103.34 0.17 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.507 ' C ' ' CD2' ' A' ' 14' ' ' LEU . 3.3 tt -162.26 146.98 12.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.239 -1.153 . . . . 0.0 109.581 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.421 ' N ' HD22 ' A' ' 14' ' ' LEU . 24.0 mt-30 -139.3 145.53 39.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.28 -0.887 . . . . 0.0 109.347 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.55 HD12 ' CE1' ' A' ' 32' ' ' TYR . 10.7 mt -114.18 146.52 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.396 -0.815 . . . . 0.0 110.198 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.451 ' CZ2' ' CB ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER -149.55 138.73 21.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.435 -0.791 . . . . 0.0 109.063 179.665 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -96.67 144.64 26.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 109.473 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.4 p -81.02 143.82 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 109.494 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.58 ' O ' ' N ' ' A' ' 22' ' ' PHE . 39.9 tt0 -103.3 153.41 20.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.368 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 20' ' ' GLU . 7.6 mtmp? -41.48 -20.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.648 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.58 ' N ' ' O ' ' A' ' 20' ' ' GLU . 3.0 p90 -160.99 30.52 0.14 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.17 -0.956 . . . . 0.0 109.524 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.41 ' N ' ' HB3' ' A' ' 20' ' ' GLU . 9.8 t70 -174.07 -130.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -0.912 . . . . 0.0 109.53 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.5 mp -144.34 146.07 32.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.322 -0.861 . . . . 0.0 109.562 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 t -126.31 112.93 23.55 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.393 -0.817 . . . . 0.0 109.427 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.49 152.64 5.89 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.436 2.091 . . . . 0.0 112.313 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.9 t -110.39 101.89 49.81 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.898 . . . . 0.0 109.317 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -48.43 143.47 15.45 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.476 2.117 . . . . 0.0 112.319 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.583 ' C ' ' H ' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -55.96 -44.11 78.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.876 . . . . 0.0 109.376 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 30' ' ' ASN . 1.4 t-20 -56.72 -2.6 0.08 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 0.0 109.481 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.583 ' H ' ' C ' ' A' ' 29' ' ' THR . 86.4 mt -129.23 -10.73 4.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.202 -0.936 . . . . 0.0 109.551 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.55 ' CE1' HD12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -41.84 124.37 2.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -0.89 . . . . 0.0 109.453 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.39 -9.37 57.46 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -97.98 107.13 19.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.184 -1.186 . . . . 0.0 109.462 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -96.15 150.52 20.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.89 . . . . 0.0 109.536 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -105.03 112.14 25.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 109.402 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.1 p -58.36 -17.07 17.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 109.586 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.447 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -88.15 10.71 69.88 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.447 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 46.6 m-20 -159.49 170.56 21.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.225 -1.162 . . . . 0.0 109.511 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -109.76 152.38 25.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.387 -0.821 . . . . 0.0 109.504 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -122.12 134.9 54.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.337 -0.852 . . . . 0.0 109.239 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.617 HG13 ' CZ ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -103.19 138.38 27.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.143 -0.973 . . . . 0.0 108.91 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 42' ' ' VAL . 0.9 OUTLIER -131.25 145.62 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.615 -179.357 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.415 ' CD2' ' OG1' ' A' ' 46' ' ' THR . 3.9 tt -123.64 118.45 27.3 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.0 tttp -103.94 103.77 13.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.358 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.552 ' O ' ' N ' ' A' ' 13' ' ' GLY . 33.8 m -112.63 137.15 51.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 109.423 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -133.03 168.58 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 121.158 -0.964 . . . . 0.0 109.586 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -102.58 100.74 10.84 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.8 mt -69.19 168.34 14.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.739 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.535 ' CD ' ' H ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -48.23 -73.18 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.331 -0.855 . . . . 0.0 109.265 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 50' ' ' ARG . 1.9 m120 -43.63 -25.9 0.2 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.303 -0.873 . . . . 0.0 109.16 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 50' ' ' ARG . . . 89.03 36.68 7.55 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.515 ' O ' ' O ' ' A' ' 54' ' ' LEU . 51.2 m-20 -87.61 12.81 11.63 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.15 -1.206 . . . . 0.0 109.361 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.598 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 11.1 mt 42.56 97.3 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 121.455 0.645 . . . . 0.0 109.443 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.427 ' O ' ' CG2' ' A' ' 46' ' ' THR . 7.4 tt0 -68.07 154.09 42.38 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.239 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.598 ' CE1' ' O ' ' A' ' 54' ' ' LEU . 95.6 m-85 -133.74 114.82 13.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.295 -0.878 . . . . 0.0 109.66 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -121.0 155.12 35.02 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.468 HD11 ' N ' ' A' ' 58' ' ' LEU . 3.2 mp -138.78 129.06 25.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.943 -1.098 . . . . 0.0 109.972 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -121.3 127.39 51.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.415 -0.803 . . . . 0.0 109.024 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.704 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -106.15 124.9 50.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.187 -0.946 . . . . 0.0 109.537 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.498 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 39.2 t90 -102.88 123.89 47.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.216 -0.927 . . . . 0.0 109.354 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.498 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 20.1 mt -102.73 162.01 13.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.49 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.0 155.99 15.81 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -78.98 -11.97 60.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.188 -1.183 . . . . 0.0 109.448 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -106.44 24.37 12.67 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.496 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.7 m -130.95 97.56 4.35 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.163 0.982 . . . . 0.0 108.473 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 66' ' ' CYS . 9.9 m -51.48 -171.25 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.673 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.594 ' N ' ' OE1' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -70.74 -17.6 62.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.349 -0.845 . . . . 0.0 109.516 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -62.29 -58.64 6.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.13 -0.981 . . . . 0.0 109.435 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.508 ' N ' ' CD ' ' A' ' 70' ' ' GLU . 3.3 mp0 -65.87 -45.06 83.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.32 -0.863 . . . . 0.0 108.894 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.2 t -69.67 -20.97 63.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.331 -0.856 . . . . 0.0 109.041 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -73.25 -41.01 47.96 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.92 -46.09 66.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.298 -1.119 . . . . 0.0 109.247 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.46 -44.58 92.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.349 -0.844 . . . . 0.0 109.23 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.45 ' O ' HG22 ' A' ' 79' ' ' VAL . . . -61.12 -47.58 85.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.275 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.5 mt -49.62 -46.34 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 109.241 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -61.01 -40.53 93.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 109.345 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.4 m -67.02 -31.52 72.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.159 -0.963 . . . . 0.0 109.33 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 75' ' ' ALA . 91.2 t -66.0 -44.19 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.335 -0.853 . . . . 0.0 109.334 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -61.63 -50.92 70.6 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.281 -0.887 . . . . 0.0 109.192 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.568 HD12 HD21 ' A' ' 6' ' ' LEU . 4.1 mt -54.55 -41.4 69.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.341 -0.849 . . . . 0.0 109.069 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.627 ' O ' ' N ' ' A' ' 86' ' ' ASN . 27.1 t70 -61.69 -54.97 35.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.238 -0.914 . . . . 0.0 109.133 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -47.76 -32.21 5.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.081 -1.012 . . . . 0.0 108.858 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -77.64 -31.77 52.91 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.481 ' C ' ' H ' ' A' ' 87' ' ' GLY . 53.2 mt -121.59 33.49 5.5 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.369 -0.832 . . . . 0.0 109.427 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.627 ' N ' ' O ' ' A' ' 82' ' ' ASP . 38.4 t30 -79.71 27.7 0.28 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.211 -0.931 . . . . 0.0 109.16 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.481 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -78.12 -45.57 10.09 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -173.34 33.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -1.121 . . . . 0.0 109.299 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.53 179.1 7.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.182 -0.949 . . . . 0.0 109.433 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.5 t -127.11 128.03 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.843 . . . . 0.0 109.546 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -96.06 137.2 35.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.384 -0.823 . . . . 0.0 109.357 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -126.59 126.85 44.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.156 -0.965 . . . . 0.0 109.662 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 -100.74 95.99 7.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -0.874 . . . . 0.0 109.3 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.455 ' OE1' ' CD1' ' A' ' 103' ' ' PHE . 81.9 mt-10 -97.36 138.84 34.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.919 . . . . 0.0 109.712 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.4 t -145.01 163.75 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.344 -0.848 . . . . 0.0 109.305 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -53.28 117.9 3.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.43 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.09 13.88 81.38 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.439 ' O ' ' C ' ' A' ' 99' ' ' GLU . 6.4 t80 -135.54 17.49 3.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.243 -1.151 . . . . 0.0 109.443 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.586 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 11.1 mp0 -41.46 148.22 0.15 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 109.564 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.2 t -87.2 166.81 14.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -0.889 . . . . 0.0 109.488 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.53 -65.1 0.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.533 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 51.4 m -47.55 -51.56 20.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.261 -0.899 . . . . 0.0 109.422 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.455 ' CD1' ' OE1' ' A' ' 94' ' ' GLU . 14.5 t80 -54.46 -44.79 72.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.417 -0.802 . . . . 0.0 109.437 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.9 mt -60.82 -34.16 74.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.955 . . . . 0.0 109.415 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.07 -22.57 70.98 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -79.5 -29.21 41.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -1.12 . . . . 0.0 109.365 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -139.12 120.84 15.31 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.303 -0.873 . . . . 0.0 109.457 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -101.67 -56.65 2.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.512 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.5 t -103.3 -13.25 16.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 109.51 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.3 -12.82 64.02 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.4 mt -71.94 121.2 18.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.175 -1.191 . . . . 0.0 109.499 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -148.55 154.7 40.13 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.188 -0.945 . . . . 0.0 109.417 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -135.97 134.59 38.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.365 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.89 105.87 16.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 109.338 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 116' ' ' GLY . 9.3 mtpm? -83.78 108.28 16.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.202 -0.936 . . . . 0.0 109.488 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . 44.06 -161.02 0.08 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 146.26 3.79 0.52 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.6 m -139.22 142.28 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.303 -1.116 . . . . 0.0 109.435 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -101.49 -76.05 0.58 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.306 -0.871 . . . . 0.0 109.537 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.5 m -90.25 169.48 11.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.18 -0.95 . . . . 0.0 109.556 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -160.91 81.13 0.14 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -92.05 -161.72 0.85 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -1.143 . . . . 0.0 109.422 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -132.88 89.77 2.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 109.407 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -77.67 82.11 4.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.315 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.9 t -52.14 -25.19 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.541 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.7 m -145.06 145.83 28.62 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.97 . . . . 0.0 109.439 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -41.88 -65.88 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.543 2.162 . . . . 0.0 112.266 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -136.37 -122.91 0.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.936 . . . . 0.0 109.471 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -105.06 130.24 53.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.344 -0.847 . . . . 0.0 109.503 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.08 4.36 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.237 -0.915 . . . . 0.0 109.539 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 64.6 t -46.93 126.72 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.943 . . . . 0.0 109.459 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.466 ' O ' ' OXT' ' A' ' 133' ' ' GLN . 11.1 t -74.65 104.79 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.342 -0.849 . . . . 0.0 109.536 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.466 ' OXT' ' O ' ' A' ' 132' ' ' VAL . 48.0 mm-40 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.572 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.417 ' C ' ' ND1' ' A' ' 2' ' ' HIS . 20.5 mt-10 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.417 ' ND1' ' C ' ' A' ' 1' ' ' GLU . 8.8 m80 -142.01 57.33 6.64 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.584 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 2' ' ' HIS . 55.4 Cg_endo -73.97 65.34 5.07 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.692 2.261 . . . . 0.0 112.043 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -83.08 -28.7 29.33 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.618 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.554 ' CE1' ' CG1' ' A' ' 42' ' ' VAL . 69.0 t80 -58.46 -16.55 15.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.142 -0.974 . . . . 0.0 109.354 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.405 HD23 ' HG ' ' A' ' 81' ' ' LEU . 3.3 mt -90.24 -34.88 15.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.218 -0.926 . . . . 0.0 109.553 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 8' ' ' ALA . 30.8 mttm -87.59 -15.22 37.98 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.272 -0.892 . . . . 0.0 109.672 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -42.45 128.95 3.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 0.0 109.406 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.38 30.55 0.03 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.434 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -129.64 38.36 3.86 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.308 -1.113 . . . . 0.0 109.379 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 13' ' ' GLY . 31.1 mt-10 -157.78 79.75 3.31 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.298 -0.876 . . . . 0.0 109.31 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.1 80.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.792 2.328 . . . . 0.0 112.148 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 11' ' ' GLU . . . 177.58 -99.87 0.13 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.485 ' C ' ' CD2' ' A' ' 14' ' ' LEU . 7.1 tt -156.94 125.7 5.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -1.138 . . . . 0.0 109.727 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -112.66 133.45 54.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.384 -0.822 . . . . 0.0 109.239 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.488 ' HA ' HG23 ' A' ' 43' ' ' ILE . 5.7 mt -101.25 146.68 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.365 -0.834 . . . . 0.0 110.16 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.78 139.25 27.7 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -108.45 140.32 41.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.2 -0.938 . . . . 0.0 109.404 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 8.9 p -84.01 138.33 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.914 . . . . 0.0 109.495 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.609 ' O ' ' N ' ' A' ' 22' ' ' PHE . 18.5 tt0 -88.19 154.32 20.53 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.327 -0.858 . . . . 0.0 109.043 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.542 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 39.9 mttp -40.39 -20.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 109.664 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.609 ' N ' ' O ' ' A' ' 20' ' ' GLU . 63.6 m-85 -160.09 21.82 0.16 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 0.0 109.679 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.434 ' N ' ' HB3' ' A' ' 20' ' ' GLU . 2.9 m-20 -160.23 -128.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 0.0 109.429 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 mt -145.53 146.09 31.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.208 -0.932 . . . . 0.0 109.584 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 t -131.31 133.81 24.97 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.316 -0.865 . . . . 0.0 108.963 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -72.63 146.9 44.53 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.367 2.045 . . . . 0.0 112.431 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -119.23 105.15 44.94 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.359 -0.838 . . . . 0.0 109.272 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.535 ' C ' ' H ' ' A' ' 30' ' ' ASN . 61.3 Cg_endo -79.93 148.81 19.91 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.417 2.078 . . . . 0.0 112.469 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.508 ' CG2' ' O ' ' A' ' 29' ' ' THR . 14.7 m -63.32 1.32 0.52 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.2 -0.938 . . . . 0.0 109.368 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.535 ' H ' ' C ' ' A' ' 28' ' ' PRO . 14.8 m120 -76.09 -19.1 58.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.334 -0.854 . . . . 0.0 109.37 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.49 ' CD1' ' C ' ' A' ' 31' ' ' LEU . 2.6 pp -148.26 2.64 0.66 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 110.289 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -55.58 173.5 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.87 -1.143 . . . . 0.0 109.366 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.76 -32.14 6.59 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -99.45 100.59 11.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.348 -1.089 . . . . 0.0 109.527 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.605 ' CZ ' ' CZ3' ' A' ' 61' ' ' TRP . 45.5 m-85 -86.93 137.51 32.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.482 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -88.34 131.21 34.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 109.441 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.4 p -73.99 -6.42 47.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.369 -0.832 . . . . 0.0 109.409 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.437 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -97.31 20.59 50.13 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 9.7 m-20 -167.35 146.15 4.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -1.112 . . . . 0.0 109.449 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.92 149.33 21.94 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.216 -0.928 . . . . 0.0 109.399 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -117.15 139.02 51.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 109.351 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.554 ' CG1' ' CE1' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -105.58 129.36 58.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 121.177 -0.952 . . . . 0.0 108.623 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.529 ' CD1' ' C ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -126.21 134.25 66.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.231 -0.918 . . . . 0.0 110.421 -179.315 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.514 ' CD2' ' OG1' ' A' ' 46' ' ' THR . 7.7 tt -114.94 115.84 27.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.58 -0.7 . . . . 0.0 109.114 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -92.42 114.3 26.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.939 . . . . 0.0 109.534 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.514 ' OG1' ' CD2' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -113.89 129.23 56.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.181 -0.949 . . . . 0.0 109.524 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -132.18 168.48 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 121.071 -1.018 . . . . 0.0 109.252 -179.852 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -98.54 117.36 32.79 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.58 -0.7 . . . . 0.0 109.401 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.6 mt -81.05 160.83 24.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -0.911 . . . . 0.0 109.609 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 25.0 mtt180 -51.44 -65.49 0.55 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.336 -0.852 . . . . 0.0 109.305 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -48.27 -29.58 3.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.263 -0.898 . . . . 0.0 109.252 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.76 71.29 1.12 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 54' ' ' LEU . 4.3 t-20 -134.85 13.46 3.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.287 -1.125 . . . . 0.0 109.32 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.591 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 11.7 mt 45.71 99.69 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.579 0.704 . . . . 0.0 109.535 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -68.6 152.1 45.83 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.498 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 61.3 m-85 -129.49 116.56 19.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 109.866 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.36 155.17 36.58 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.545 ' C ' ' CD2' ' A' ' 59' ' ' HIS . 2.6 mt -132.83 150.18 52.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.913 -1.117 . . . . 0.0 110.172 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.545 ' CD2' ' C ' ' A' ' 58' ' ' LEU . 4.6 m-70 -143.26 123.09 13.43 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.71 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -100.62 129.57 46.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.082 -1.011 . . . . 0.0 109.641 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.605 ' CZ3' ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -102.85 123.83 47.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.345 -0.847 . . . . 0.0 109.314 179.835 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.7 mt -102.15 162.07 13.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.402 -0.811 . . . . 0.0 109.461 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.25 157.69 14.88 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -75.68 -12.29 60.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.324 -1.104 . . . . 0.0 109.566 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -106.84 23.21 14.71 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.9 m -131.09 97.5 4.32 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.06 0.933 . . . . 0.0 108.514 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 m -59.6 -170.98 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.593 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.53 ' O ' ' N ' ' A' ' 72' ' ' GLY . 37.2 tt0 -61.6 -17.95 57.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 109.559 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -63.87 -58.81 5.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.955 . . . . 0.0 109.46 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.69 -42.5 91.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.446 -0.784 . . . . 0.0 108.987 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 m -71.08 -23.28 62.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.389 -0.82 . . . . 0.0 109.016 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.53 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -71.53 -40.11 60.0 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.38 -49.09 52.72 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.261 -1.141 . . . . 0.0 109.25 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.15 -45.66 83.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.374 -0.829 . . . . 0.0 109.058 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.444 ' O ' HG22 ' A' ' 79' ' ' VAL . . . -58.54 -51.29 70.53 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.406 -0.809 . . . . 0.0 109.189 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.6 mt -48.9 -41.08 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -0.942 . . . . 0.0 109.209 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.45 -43.24 99.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.222 -0.924 . . . . 0.0 109.101 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 86.3 m -61.05 -49.45 77.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.145 -0.972 . . . . 0.0 109.093 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 75' ' ' ALA . 10.6 t -51.06 -40.06 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.238 -0.913 . . . . 0.0 109.211 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.428 ' HA ' HE21 ' A' ' 80' ' ' GLN . 5.3 mm-40 -61.25 -48.21 82.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.36 -0.838 . . . . 0.0 109.082 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.521 ' CD1' ' CE1' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -50.71 -40.17 53.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.32 -0.862 . . . . 0.0 108.929 179.63 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 85' ' ' LEU . 10.3 m-20 -61.89 -61.8 2.24 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.16 -0.962 . . . . 0.0 109.069 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -47.31 -30.62 3.25 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.049 -1.032 . . . . 0.0 108.445 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -76.81 -27.06 55.04 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.562 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.9 mt -113.87 27.23 9.69 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.37 -0.831 . . . . 0.0 109.169 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 44.47 38.36 2.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.377 -0.827 . . . . 0.0 109.479 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 56.35 31.19 59.4 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 85' ' ' LEU . 21.4 ttt-85 -92.69 31.92 1.3 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.204 -1.174 . . . . 0.0 109.38 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 56' ' ' TYR . . . -141.14 161.17 38.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.526 -0.734 . . . . 0.0 109.395 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 38.8 t -96.0 146.26 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.263 -0.898 . . . . 0.0 109.426 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.615 ' CD ' ' H ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -111.4 131.59 55.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.382 -0.824 . . . . 0.0 109.314 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.472 ' CG ' ' ND1' ' A' ' 59' ' ' HIS . 20.3 m-70 -115.68 136.35 53.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.866 . . . . 0.0 109.414 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.431 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 3.9 ptp180 -102.71 92.92 4.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.22 -0.925 . . . . 0.0 109.309 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.499 ' OE1' ' CD2' ' A' ' 103' ' ' PHE . 13.6 mt-10 -92.88 128.94 38.92 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.148 -0.97 . . . . 0.0 109.538 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 10.5 t -132.94 163.52 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.336 -0.852 . . . . 0.0 109.241 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.621 ' OE1' ' N ' ' A' ' 97' ' ' GLY . 0.8 OUTLIER -62.22 115.59 4.27 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.238 -0.914 . . . . 0.0 109.429 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.621 ' N ' ' OE1' ' A' ' 96' ' ' GLN . . . 90.38 5.74 69.31 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.475 ' O ' ' O ' ' A' ' 99' ' ' GLU . 5.1 t80 -143.26 32.6 1.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.366 -1.079 . . . . 0.0 109.526 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.593 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 2.4 mp0 -41.51 164.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.537 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.62 161.69 19.16 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.09 -60.39 2.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.477 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 76.9 m -46.95 -41.35 15.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.145 -0.972 . . . . 0.0 109.355 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.499 ' CD2' ' OE1' ' A' ' 94' ' ' GLU . 1.6 m-85 -69.9 -41.1 75.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.352 -0.843 . . . . 0.0 109.383 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.5 mt -58.79 -23.67 60.59 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.175 -0.953 . . . . 0.0 109.451 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -105.43 -12.94 25.68 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -86.42 -37.67 18.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -1.188 . . . . 0.0 109.602 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -84.37 117.78 23.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.309 -0.869 . . . . 0.0 109.638 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -115.0 3.0 14.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.395 -0.815 . . . . 0.0 109.387 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.0 m -89.31 -4.65 58.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 109.54 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.53 97.32 0.43 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.541 ' H ' ' CD2' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -77.78 165.74 23.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.158 -1.201 . . . . 0.0 109.509 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.442 ' CG ' ' O ' ' A' ' 111' ' ' LEU . 38.3 mtmt -158.41 152.2 23.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.246 -0.908 . . . . 0.0 109.475 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.445 ' OH ' ' CD ' ' A' ' 99' ' ' GLU . 53.8 m-85 -101.51 125.2 48.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.373 -0.83 . . . . 0.0 109.438 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.0 120.04 25.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.489 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt -82.02 140.07 34.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.42 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -96.07 22.89 37.13 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -94.82 -127.04 4.93 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.462 HG23 ' N ' ' A' ' 119' ' ' ALA . 9.1 m -93.53 -155.08 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -1.151 . . . . 0.0 109.515 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.462 ' N ' HG23 ' A' ' 118' ' ' VAL . . . -146.88 -51.97 0.21 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 0.0 109.46 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.1 m -164.32 -65.72 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 93.95 24.31 20.39 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -48.93 -34.38 12.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.132 -1.217 . . . . 0.0 109.377 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.4 tptt -89.62 144.09 26.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.931 . . . . 0.0 109.376 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.768 ' HD1' ' H ' ' A' ' 125' ' ' VAL . 3.0 t-80 -136.65 -155.59 0.63 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.899 . . . . 0.0 109.488 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.768 ' H ' ' HD1' ' A' ' 124' ' ' HIS . 59.7 t -91.05 161.91 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.478 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 10.0 t -148.34 99.17 3.66 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.456 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -79.62 0.76 9.76 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.586 2.19 . . . . 0.0 112.227 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -101.92 94.03 5.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 109.368 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 130' ' ' VAL . 6.7 mt-10 -129.31 -159.07 0.93 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.883 . . . . 0.0 109.441 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.433 ' C ' ' O ' ' A' ' 129' ' ' GLU . 7.6 p -42.73 119.56 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.201 -0.937 . . . . 0.0 109.447 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.3 p -47.22 142.68 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.338 -0.851 . . . . 0.0 109.555 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 12.3 t -48.32 99.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.594 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.442 -179.952 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.498 ' O ' ' O ' ' A' ' 2' ' ' HIS . 7.1 mm-40 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.498 ' O ' ' O ' ' A' ' 1' ' ' GLU . 2.8 m80 56.92 156.41 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.353 -0.842 . . . . 0.0 109.374 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.21 90.34 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.726 2.284 . . . . 0.0 111.857 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -83.33 -43.43 15.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.296 -0.877 . . . . 0.0 110.071 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.593 ' CE2' ' CG1' ' A' ' 42' ' ' VAL . 21.6 t80 -50.94 -41.45 59.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.134 -0.979 . . . . 0.0 109.606 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.1 mp -69.4 -27.83 65.63 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.121 -0.987 . . . . 0.0 109.51 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -96.4 3.84 52.59 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.237 -0.914 . . . . 0.0 109.38 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.554 ' HB3' HD13 ' A' ' 44' ' ' LEU . . . -59.52 151.9 23.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.216 -0.928 . . . . 0.0 109.517 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.9 45.19 0.07 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -149.08 24.23 0.93 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.276 -1.132 . . . . 0.0 109.564 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -146.55 117.65 4.76 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.278 -0.889 . . . . 0.0 109.338 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.7 91.25 1.2 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.387 2.058 . . . . 0.0 112.221 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.07 -95.38 0.12 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 tp -160.23 130.35 5.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.318 -1.107 . . . . 0.0 109.627 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -113.88 135.71 53.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 109.355 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.2 mt -115.56 136.01 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.345 -0.847 . . . . 0.0 109.99 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.44 134.67 31.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.425 -0.797 . . . . 0.0 108.969 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 25' ' ' VAL . 33.5 ttt180 -98.38 153.54 18.49 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.201 -0.937 . . . . 0.0 109.444 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.1 t -106.13 123.49 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.18 -0.95 . . . . 0.0 109.593 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.658 ' C ' ' H ' ' A' ' 22' ' ' PHE . 5.2 tt0 -72.06 87.04 1.05 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.107 -0.996 . . . . 0.0 108.915 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.579 ' O ' ' CB ' ' A' ' 22' ' ' PHE . 16.5 tttm 49.04 2.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.359 -0.838 . . . . 0.0 109.85 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.658 ' H ' ' C ' ' A' ' 20' ' ' GLU . 2.1 t80 158.01 -29.34 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.289 -0.882 . . . . 0.0 109.422 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.76 -157.83 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.932 . . . . 0.0 109.584 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.26 132.75 56.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.287 -0.883 . . . . 0.0 109.344 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.545 ' CG2' ' N ' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -129.9 120.81 19.58 Favored Pre-proline 0 N--CA 1.487 1.387 0 O-C-N 121.311 -0.868 . . . . 0.0 109.227 -179.686 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.88 132.0 11.52 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.303 2.002 . . . . 0.0 112.238 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.7 t -110.34 101.57 48.65 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.335 -0.853 . . . . 0.0 109.394 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -51.22 156.56 5.25 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.434 2.089 . . . . 0.0 112.208 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.3 m -66.89 -12.2 58.57 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.328 -0.857 . . . . 0.0 109.488 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.481 ' OD1' ' O ' ' A' ' 30' ' ' ASN . 23.9 t-20 -75.98 -10.03 59.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.357 -0.839 . . . . 0.0 109.522 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 32' ' ' TYR . 96.3 mt -122.83 -23.35 5.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -0.847 . . . . 0.0 109.417 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 33' ' ' GLY . 1.7 t80 -42.88 138.33 2.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.617 ' N ' ' CD1' ' A' ' 32' ' ' TYR . . . 125.95 -28.68 4.83 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -107.19 148.19 29.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -1.152 . . . . 0.0 109.531 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -142.06 114.16 8.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 109.424 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -79.39 159.05 27.25 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.529 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.1 p -97.74 -4.77 36.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 109.447 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.445 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -88.28 16.4 52.72 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 7.6 m-20 -159.23 164.07 35.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -1.163 . . . . 0.0 109.544 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -108.29 151.98 25.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 0.0 109.406 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.575 ' CD1' ' N ' ' A' ' 41' ' ' TYR . 4.0 m-85 -130.21 134.61 47.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.884 . . . . 0.0 109.667 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.593 ' CG1' ' CE2' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -105.4 139.44 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 121.182 -0.949 . . . . 0.0 108.596 179.202 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.523 ' CD1' ' C ' ' A' ' 42' ' ' VAL . 0.4 OUTLIER -128.01 134.72 64.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.27 -0.894 . . . . 0.0 110.213 -179.421 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.554 HD13 ' HB3' ' A' ' 8' ' ' ALA . 7.2 tt -115.86 109.57 17.81 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -82.42 144.31 30.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.363 -0.835 . . . . 0.0 109.098 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.2 m -143.24 129.01 19.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.09 -1.006 . . . . 0.0 109.725 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -134.18 168.56 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 O-C-N 121.143 -0.973 . . . . 0.0 109.208 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -99.31 118.04 35.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.68 -0.638 . . . . 0.0 109.422 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 93.4 mt -81.9 165.08 21.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 109.605 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -45.35 -58.39 3.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.94 . . . . 0.0 109.145 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -61.52 -27.03 68.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.915 . . . . 0.0 109.151 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.01 33.29 6.68 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.5 ' O ' ' O ' ' A' ' 54' ' ' LEU . 5.8 t30 -85.58 12.67 8.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -1.187 . . . . 0.0 109.304 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.578 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 12.3 mt 44.91 98.38 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 121.563 0.697 . . . . 0.0 109.468 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.418 ' HG3' ' N ' ' A' ' 56' ' ' TYR . 3.3 tp-100 -68.56 155.84 39.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.505 -0.747 . . . . 0.0 109.072 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 79.6 m-85 -138.16 114.35 10.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.163 -0.96 . . . . 0.0 109.803 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.425 ' O ' HD21 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -114.38 155.25 26.65 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.136 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.522 HD23 HD22 ' A' ' 81' ' ' LEU . 11.2 mt -125.16 150.29 47.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.023 -1.048 . . . . 0.0 110.372 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.483 ' HD1' ' CG ' ' A' ' 92' ' ' HIS . 10.6 m-70 -145.18 130.43 18.57 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.441 ' CE2' HG11 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -111.69 138.87 47.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.951 -1.093 . . . . 0.0 110.063 -179.297 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -111.41 123.55 50.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.392 -0.817 . . . . 0.0 108.987 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 49.6 mt -104.18 145.92 29.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.386 -0.821 . . . . 0.0 109.413 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.9 152.2 19.84 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -80.21 -12.02 59.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -1.121 . . . . 0.0 109.478 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -107.93 31.87 5.18 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.571 ' SG ' ' OE2' ' A' ' 70' ' ' GLU . 2.1 m -130.56 97.5 4.4 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 122.043 0.925 . . . . 0.0 108.533 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 66' ' ' CYS . 30.0 m -45.63 175.89 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.78 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.48 ' O ' ' N ' ' A' ' 72' ' ' GLY . 39.0 tt0 -64.63 -17.7 64.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 0.0 109.621 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -63.14 -58.59 6.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 109.344 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.571 ' OE2' ' SG ' ' A' ' 66' ' ' CYS . 11.5 mt-10 -64.84 -44.31 90.19 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.356 -0.84 . . . . 0.0 109.034 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.55 -26.85 67.33 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.429 -0.795 . . . . 0.0 109.02 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.15 -48.17 40.8 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.18 -35.36 76.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.342 -1.093 . . . . 0.0 109.098 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.28 -51.95 66.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.418 -0.801 . . . . 0.0 109.211 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -52.94 -46.93 68.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 109.232 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.3 mt -51.9 -47.92 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.271 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -54.61 -44.06 72.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.31 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.426 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 0.9 OUTLIER -54.08 -50.97 65.59 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.3 -0.875 . . . . 0.0 109.507 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.5 t -61.18 -35.39 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.361 -0.837 . . . . 0.0 109.63 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -64.57 -58.83 5.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.898 . . . . 0.0 109.302 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.56 ' CD1' ' C ' ' A' ' 81' ' ' LEU . 0.1 OUTLIER -53.81 -33.51 56.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 108.911 179.828 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 85' ' ' LEU . 0.9 OUTLIER -65.73 -55.13 18.93 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.22 -0.925 . . . . 0.0 108.891 179.531 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 82' ' ' ASP . 8.7 t70 -45.87 -37.47 6.3 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -68.53 -33.39 74.02 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 82' ' ' ASP . 4.8 tp -105.81 28.15 7.82 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.496 -0.752 . . . . 0.0 109.268 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 85' ' ' LEU . 26.6 m-20 42.49 36.25 0.76 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.459 -0.776 . . . . 0.0 109.436 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 46.29 35.12 6.65 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.7 mmm-85 -86.46 29.97 0.74 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.137 -1.213 . . . . 0.0 109.106 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -144.13 166.9 23.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.565 -0.71 . . . . 0.0 109.376 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 t -100.62 153.9 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.44 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -117.57 130.29 56.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.392 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.483 ' CG ' ' HD1' ' A' ' 59' ' ' HIS . 15.5 m-70 -105.5 104.93 14.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 109.521 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.84 97.99 6.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.253 -0.904 . . . . 0.0 109.229 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.476 ' OE1' ' CG ' ' A' ' 103' ' ' PHE . 39.3 mt-10 -100.47 148.76 24.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.348 -0.845 . . . . 0.0 109.722 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 6.2 t -137.68 166.12 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.327 -0.858 . . . . 0.0 109.27 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.5 ' O ' ' OE1' ' A' ' 96' ' ' GLN . 1.4 tm0? -59.86 116.81 4.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 109.481 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.2 12.24 81.09 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.445 ' O ' ' C ' ' A' ' 99' ' ' GLU . 2.4 t80 -137.51 20.79 2.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -1.167 . . . . 0.0 109.569 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 98' ' ' PHE . 7.5 mm-40 -42.16 156.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.918 . . . . 0.0 109.469 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.2 p -88.01 174.29 8.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -0.961 . . . . 0.0 109.491 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.09 -53.69 7.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.492 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.1 m -47.07 -46.78 22.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 0.0 109.459 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' A' ' 106' ' ' TYR . 0.2 OUTLIER -67.46 -54.07 23.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.391 -0.818 . . . . 0.0 109.397 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 103' ' ' PHE . 29.5 mt -44.57 -26.36 0.36 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.228 -0.92 . . . . 0.0 109.462 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -99.95 -17.09 26.37 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.492 ' N ' ' O ' ' A' ' 103' ' ' PHE . 14.4 t80 -81.73 -13.43 57.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.292 -1.122 . . . . 0.0 109.559 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.534 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 8.7 p90 -45.95 122.48 3.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.137 -0.977 . . . . 0.0 109.589 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -111.19 -56.41 2.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 109.349 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.4 t -90.88 0.38 57.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.891 . . . . 0.0 109.501 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 111' ' ' LEU . . . 87.3 68.96 1.31 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 110' ' ' GLY . 2.3 pp -42.96 155.24 0.06 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.305 -1.115 . . . . 0.0 109.453 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -154.23 135.99 14.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.455 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 0.0 OUTLIER -104.21 140.02 38.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.318 -0.864 . . . . 0.0 109.47 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -108.26 120.93 43.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.853 . . . . 0.0 109.333 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -76.81 138.34 39.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 109.396 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -142.99 -97.69 0.26 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 48.86 65.4 2.68 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.406 ' O ' ' C ' ' A' ' 119' ' ' ALA . 24.5 m -95.8 152.7 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -1.116 . . . . 0.0 109.49 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 118' ' ' VAL . . . 45.34 75.93 0.1 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.479 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.9 t -62.87 -159.89 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.149 -0.97 . . . . 0.0 109.453 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 123' ' ' LYS . . . 174.24 -160.83 30.66 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -50.16 90.09 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.301 -1.117 . . . . 0.0 109.467 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 121' ' ' GLY . 4.7 mmtp -141.25 -59.15 0.49 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 109.492 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -83.17 99.26 9.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.7 t -114.14 100.25 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.4 -0.813 . . . . 0.0 109.435 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 47.5 t -139.96 74.13 32.0 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.447 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.95 170.21 19.26 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.82 2.347 . . . . 0.0 112.24 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.445 ' O ' ' O ' ' A' ' 129' ' ' GLU . 1.0 OUTLIER -85.63 131.19 34.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.0 109.494 -179.922 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.447 ' OE1' ' C ' ' A' ' 130' ' ' VAL . 0.2 OUTLIER 53.0 101.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.429 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.454 ' CG1' ' O ' ' A' ' 130' ' ' VAL . 8.3 p -66.28 120.19 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.225 -0.922 . . . . 0.0 109.533 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.412 ' CG1' ' N ' ' A' ' 132' ' ' VAL . 82.8 t -73.32 164.46 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.175 -0.953 . . . . 0.0 109.497 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.412 ' N ' ' CG1' ' A' ' 131' ' ' VAL . 27.4 t -146.89 59.52 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.224 -0.923 . . . . 0.0 109.483 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.957 -1.02 . . . . 0.0 109.422 -179.911 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.546 ' NE2' ' O ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -159.22 76.32 3.16 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -58.0 93.21 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.953 2.435 . . . . 0.0 112.007 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 8' ' ' ALA . 61.5 mm-40 -83.45 -46.71 12.19 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.104 -0.998 . . . . 0.0 110.259 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.508 ' CZ ' ' O ' ' A' ' 42' ' ' VAL . 21.7 m-85 -66.94 -43.35 83.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.078 -1.014 . . . . 0.0 109.151 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.747 ' CD1' ' H ' ' A' ' 6' ' ' LEU . 3.0 mp -62.36 -33.9 75.62 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.343 -0.848 . . . . 0.0 109.628 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -106.35 9.1 31.97 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.248 -0.907 . . . . 0.0 109.605 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.489 ' N ' ' O ' ' A' ' 4' ' ' GLU . . . -62.73 -162.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.194 -0.941 . . . . 0.0 109.395 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.45 58.02 1.31 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -146.63 10.88 1.09 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.267 -1.137 . . . . 0.0 109.452 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -161.92 124.32 1.73 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.258 -0.901 . . . . 0.0 109.282 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.87 82.28 2.19 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.396 2.064 . . . . 0.0 112.348 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -164.61 -108.05 0.21 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.6 tt -162.71 143.5 9.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.326 -1.102 . . . . 0.0 109.439 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -129.48 144.0 51.07 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.235 -0.916 . . . . 0.0 109.523 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.604 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 9.2 mt -126.58 125.85 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.418 -0.801 . . . . 0.0 109.992 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.604 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 8.1 m0 -145.22 155.85 43.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.205 -0.934 . . . . 0.0 109.061 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.438 ' N ' HG21 ' A' ' 27' ' ' VAL . 7.8 ttp180 -95.94 153.17 17.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.063 -1.023 . . . . 0.0 109.386 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.0 p -94.48 133.35 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.212 -0.93 . . . . 0.0 109.739 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.636 ' O ' ' N ' ' A' ' 22' ' ' PHE . 17.9 tt0 -82.0 154.71 25.55 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.338 -0.851 . . . . 0.0 108.768 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 20' ' ' GLU . 39.7 mttt -38.35 -22.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.394 -0.816 . . . . 0.0 109.683 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.636 ' N ' ' O ' ' A' ' 20' ' ' GLU . 3.4 t80 -158.75 21.05 0.21 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.258 -0.901 . . . . 0.0 109.394 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.421 ' N ' ' HB3' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -155.58 -147.37 0.2 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.135 -0.978 . . . . 0.0 109.749 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.546 ' O ' ' NE2' ' A' ' 2' ' ' HIS . 2.9 mm? -123.29 146.4 47.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.352 -0.843 . . . . 0.0 109.447 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -131.42 99.26 17.51 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.341 -0.849 . . . . 0.0 109.173 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -47.64 132.96 21.3 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.557 2.172 . . . . 0.0 112.42 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.438 HG21 ' N ' ' A' ' 18' ' ' ARG . 61.0 t -104.51 106.2 53.3 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.317 -0.864 . . . . 0.0 109.482 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -46.64 145.89 5.98 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.484 2.123 . . . . 0.0 112.32 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.4 t -61.7 -25.63 67.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -0.882 . . . . 0.0 109.554 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -69.04 -10.98 60.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 0.0 109.509 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.467 ' O ' ' C ' ' A' ' 32' ' ' TYR . 57.7 mt -110.14 -28.25 8.75 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -0.847 . . . . 0.0 109.572 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.467 ' C ' ' O ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -40.33 143.85 0.27 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.288 -0.883 . . . . 0.0 109.458 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.05 -32.02 7.58 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -101.89 104.53 15.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -1.144 . . . . 0.0 109.398 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -102.67 140.91 36.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 109.53 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.595 ' CD2' ' OH ' ' A' ' 41' ' ' TYR . 0.7 OUTLIER -101.67 161.12 13.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.393 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.9 p -94.89 -4.88 46.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.238 -0.914 . . . . 0.0 109.614 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -101.56 34.75 5.41 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -171.52 151.53 3.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.196 -1.179 . . . . 0.0 109.51 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -100.23 139.25 36.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.598 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.595 ' OH ' ' CD2' ' A' ' 36' ' ' PHE . 44.2 m-85 -121.38 144.36 48.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.365 -0.834 . . . . 0.0 109.359 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.508 ' O ' ' CZ ' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -118.76 144.82 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.286 -0.884 . . . . 0.0 109.216 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.435 ' CD1' ' C ' ' A' ' 42' ' ' VAL . 1.0 OUTLIER -134.18 146.49 31.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.98 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 15.7 tp -129.5 118.07 21.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.46 -0.775 . . . . 0.0 109.467 179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.539 ' CE ' ' CE2' ' A' ' 106' ' ' TYR . 36.3 tttt -97.39 133.96 41.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.41 -0.806 . . . . 0.0 109.046 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.605 ' O ' ' N ' ' A' ' 13' ' ' GLY . 88.8 m -142.74 118.4 10.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.099 -1.001 . . . . 0.0 109.401 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.674 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -125.98 168.2 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.226 -0.921 . . . . 0.0 109.122 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -102.88 112.41 25.2 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.512 -0.742 . . . . 0.0 109.331 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.9 mt -77.3 169.22 18.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.438 -0.789 . . . . 0.0 109.59 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.517 ' CG ' ' N ' ' A' ' 51' ' ' ASN . 5.7 ptp85 -47.69 -49.33 28.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.884 . . . . 0.0 109.299 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.517 ' N ' ' CG ' ' A' ' 50' ' ' ARG . 5.0 m120 -70.75 -27.24 63.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.271 -0.893 . . . . 0.0 109.157 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 54' ' ' LEU . . . 93.65 28.52 11.17 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.0 t-20 -80.66 12.59 3.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.072 -1.252 . . . . 0.0 109.21 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.674 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 13.8 mt 43.88 97.72 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.535 0.683 . . . . 0.0 109.562 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -74.3 111.45 9.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.491 -0.756 . . . . 0.0 109.538 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.429 ' CD2' ' O ' ' A' ' 54' ' ' LEU . 96.2 m-85 -96.55 114.75 26.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.933 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.596 ' OD1' ' NE2' ' A' ' 92' ' ' HIS . 0.4 OUTLIER -115.99 120.8 40.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.022 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.424 ' N ' HD21 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -97.77 150.61 21.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.921 -1.112 . . . . 0.0 110.778 -178.467 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.704 ' HD1' ' CG ' ' A' ' 92' ' ' HIS . 6.1 m-70 -149.19 122.19 8.82 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.408 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 10.5 p90 -113.39 131.43 55.99 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.117 -0.989 . . . . 0.0 109.846 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.565 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 55.6 t90 -103.44 124.01 47.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.488 -0.758 . . . . 0.0 109.356 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.565 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 62.8 mt -102.76 162.12 13.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.329 -0.857 . . . . 0.0 109.591 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.92 162.96 12.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -82.07 -12.37 58.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -1.168 . . . . 0.0 109.576 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.51 28.95 7.32 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.3 m -130.84 97.57 4.37 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.115 0.959 . . . . 0.0 108.54 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 64.6 m -56.19 -170.87 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.674 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -64.87 -17.81 64.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.562 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -63.13 -58.7 6.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.118 -0.989 . . . . 0.0 109.405 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -66.81 -41.59 87.29 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.15 -23.06 62.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.401 -0.812 . . . . 0.0 108.995 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -71.64 -44.24 49.73 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.97 -43.94 86.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.343 -1.092 . . . . 0.0 109.172 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.9 -49.28 77.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.415 -0.803 . . . . 0.0 109.304 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.67 -48.62 77.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.328 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.7 mt -50.09 -42.39 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.386 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -63.77 -37.15 86.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.198 -0.939 . . . . 0.0 109.328 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.6 m -65.52 -46.96 77.58 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.366 -0.834 . . . . 0.0 109.362 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.5 t -56.09 -39.85 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 0.0 109.163 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -61.52 -47.39 85.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.304 -0.873 . . . . 0.0 109.041 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.425 HD21 ' HA ' ' A' ' 81' ' ' LEU . 34.1 mt -50.59 -46.05 57.66 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.309 -0.869 . . . . 0.0 109.001 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 85' ' ' LEU . 0.8 OUTLIER -56.59 -59.01 5.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.232 -0.918 . . . . 0.0 109.177 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 82' ' ' ASP . 9.1 t0 -45.26 -30.05 1.14 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.108 -0.995 . . . . 0.0 108.611 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -75.44 -29.7 59.76 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.588 ' N ' ' O ' ' A' ' 82' ' ' ASP . 11.6 mt -116.0 30.91 7.05 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.389 -0.819 . . . . 0.0 109.412 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 46.32 34.5 2.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.293 -0.879 . . . . 0.0 109.507 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 51.29 22.2 6.89 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -90.34 30.93 1.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.102 -1.234 . . . . 0.0 109.228 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.414 ' CB ' ' O ' ' A' ' 56' ' ' TYR . . . -123.49 177.1 5.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.542 -0.724 . . . . 0.0 109.306 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 95.1 t -113.32 115.45 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 109.477 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.93 157.87 18.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.264 -0.898 . . . . 0.0 109.374 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.704 ' CG ' ' HD1' ' A' ' 59' ' ' HIS . 27.6 m-70 -132.4 131.56 41.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.338 -0.851 . . . . 0.0 109.201 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.66 ' CD ' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -98.66 103.19 15.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.112 -0.992 . . . . 0.0 109.54 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.521 ' N ' ' CD ' ' A' ' 94' ' ' GLU . 3.9 mp0 -101.91 143.44 31.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.244 -0.91 . . . . 0.0 109.403 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.519 HG12 ' NE2' ' A' ' 96' ' ' GLN . 13.8 t -141.81 169.91 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.298 -0.876 . . . . 0.0 109.62 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.586 ' CD ' ' H ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -82.11 118.95 23.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 109.384 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.83 13.07 48.09 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.446 ' O ' ' O ' ' A' ' 99' ' ' GLU . 37.5 m-85 -150.93 -37.57 0.13 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.221 -1.164 . . . . 0.0 109.37 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 98' ' ' PHE . 40.7 mt-10 40.61 -160.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.0 109.561 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.444 ' OG ' ' OE1' ' A' ' 94' ' ' GLU . 1.8 m -139.09 159.79 41.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.176 -0.953 . . . . 0.0 109.422 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.95 -65.12 0.71 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.648 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.1 m -48.56 -54.51 14.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.159 -0.963 . . . . 0.0 109.464 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -53.78 -41.87 67.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.445 -0.784 . . . . 0.0 109.534 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.4 HD11 ' O ' ' A' ' 100' ' ' SER . 7.3 mt -69.54 -31.82 70.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.17 -0.956 . . . . 0.0 109.484 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.68 -21.14 67.01 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.539 ' CE2' ' CE ' ' A' ' 45' ' ' LYS . 8.2 t80 -76.79 -54.49 6.54 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.262 -1.14 . . . . 0.0 109.477 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -96.77 79.65 2.98 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.39 -0.819 . . . . 0.0 109.607 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -78.38 1.43 22.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.383 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.7 p -67.5 -22.04 65.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 109.493 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . 92.59 64.19 1.11 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.604 ' CD1' ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -49.23 178.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -1.095 . . . . 0.0 109.546 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.48 155.32 43.03 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.226 -0.921 . . . . 0.0 109.329 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -126.47 143.68 51.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.212 -0.93 . . . . 0.0 109.451 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 44.3 mttt -140.18 134.75 31.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.875 . . . . 0.0 109.392 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm -68.28 151.75 46.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.275 -0.891 . . . . 0.0 109.523 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -143.33 63.15 0.5 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -73.67 127.11 10.26 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.5 p -155.81 151.4 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -1.127 . . . . 0.0 109.488 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.41 ' O ' ' OG ' ' A' ' 120' ' ' SER . . . -144.38 -90.77 0.11 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.878 . . . . 0.0 109.472 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 119' ' ' ALA . 4.4 m -174.57 137.81 0.49 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.297 -0.877 . . . . 0.0 109.576 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -142.85 135.42 6.5 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -72.13 49.42 0.19 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -1.16 . . . . 0.0 109.424 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -96.12 -84.03 0.36 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 109.371 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -62.04 98.84 0.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.217 -0.927 . . . . 0.0 109.441 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.2 t -75.44 -72.61 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.658 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.425 ' C ' ' H ' ' A' ' 128' ' ' ASN . 5.7 p -157.58 80.0 3.34 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.17 -0.956 . . . . 0.0 109.421 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.98 -9.91 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.846 2.364 . . . . 0.0 112.281 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.425 ' H ' ' C ' ' A' ' 126' ' ' VAL . 24.3 m120 -96.62 110.74 23.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.237 -0.914 . . . . 0.0 109.54 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -72.29 -162.97 0.1 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 51.9 t -68.52 76.43 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.27 -0.894 . . . . 0.0 109.472 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.466 HG11 ' H ' ' A' ' 132' ' ' VAL . 2.0 t -72.57 -137.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.292 -0.88 . . . . 0.0 109.503 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.466 ' H ' HG11 ' A' ' 131' ' ' VAL . 7.3 p -73.15 117.49 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 109.474 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.414 179.986 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.585 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 67.2 tt0 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.303 0.573 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.601 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 33.0 m80 -159.52 53.35 0.54 Allowed Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.22 -0.925 . . . . 0.0 109.644 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.536 ' HB2' HD12 ' A' ' 6' ' ' LEU . 46.7 Cg_endo -71.33 91.74 0.66 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.758 2.305 . . . . 0.0 111.893 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.459 ' C ' ' H ' ' A' ' 6' ' ' LEU . 20.3 mm-40 -83.6 -25.71 30.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.222 -0.923 . . . . 0.0 110.035 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.63 ' CD1' HG12 ' A' ' 42' ' ' VAL . 43.6 t80 -51.65 -11.96 0.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.036 -1.04 . . . . 0.0 109.747 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.536 HD12 ' HB2' ' A' ' 3' ' ' PRO . 0.3 OUTLIER -93.94 -29.97 14.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.146 -0.971 . . . . 0.0 109.032 179.582 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.506 ' O ' ' O ' ' A' ' 8' ' ' ALA . 17.0 mtpp -87.94 -6.63 57.93 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.391 -0.818 . . . . 0.0 109.264 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -43.71 170.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.351 -0.843 . . . . 0.0 109.568 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.04 76.68 1.09 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -136.04 -1.26 2.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.226 -1.161 . . . . 0.0 109.694 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -171.46 149.58 2.54 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.152 -0.968 . . . . 0.0 109.419 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.4 89.34 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.727 2.285 . . . . 0.0 112.193 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -170.29 -106.15 0.19 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.7 tt -162.33 149.17 13.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.222 -1.163 . . . . 0.0 109.665 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -135.77 132.97 37.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.368 -0.832 . . . . 0.0 109.309 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.421 ' HA ' HG23 ' A' ' 43' ' ' ILE . 42.7 mt -102.96 159.7 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 109.767 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.422 ' CZ3' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -157.87 162.17 38.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -0.867 . . . . 0.0 109.047 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -129.03 147.29 50.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.355 -0.84 . . . . 0.0 109.555 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.536 ' CG1' ' OD1' ' A' ' 39' ' ' ASP . 8.1 p -81.03 145.98 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.862 . . . . 0.0 109.548 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.58 ' O ' ' N ' ' A' ' 22' ' ' PHE . 22.3 tt0 -100.52 153.93 18.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.343 -0.848 . . . . 0.0 109.344 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 20' ' ' GLU . 18.7 tptm -40.32 -22.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 109.509 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.58 ' N ' ' O ' ' A' ' 20' ' ' GLU . 58.6 t80 -160.86 33.97 0.15 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 109.416 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.601 ' OD1' ' N ' ' A' ' 2' ' ' HIS . 25.9 t0 -173.89 -127.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.305 -0.872 . . . . 0.0 109.526 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.405 HD21 ' H ' ' A' ' 5' ' ' PHE . 4.7 tp -148.43 146.06 28.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -0.951 . . . . 0.0 109.572 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.5 133.36 25.02 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.888 . . . . 0.0 109.225 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.26 140.91 28.27 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.453 2.102 . . . . 0.0 112.138 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.9 t -99.76 133.74 21.54 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.218 -0.926 . . . . 0.0 109.241 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -72.7 133.14 19.78 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.525 2.15 . . . . 0.0 112.308 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.559 ' C ' ' H ' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -68.25 176.01 2.98 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.239 -0.913 . . . . 0.0 109.431 179.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 29' ' ' THR . 3.1 t-20 69.91 -39.1 0.43 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.406 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.559 ' H ' ' C ' ' A' ' 29' ' ' THR . 31.6 mt -96.94 -32.75 11.87 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.287 -0.883 . . . . 0.0 109.414 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.456 ' C ' ' O ' ' A' ' 31' ' ' LEU . 14.6 p90 -41.58 160.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 109.58 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 128.82 -19.15 5.57 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -98.26 124.33 42.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -1.136 . . . . 0.0 109.604 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -105.31 131.44 52.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -0.876 . . . . 0.0 109.335 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -96.5 135.67 38.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.211 -0.931 . . . . 0.0 109.582 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.7 p -83.71 -16.58 44.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.383 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.02 30.14 8.44 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.536 ' OD1' ' CG1' ' A' ' 19' ' ' VAL . 32.8 t0 -165.03 171.66 13.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.273 -1.133 . . . . 0.0 109.518 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.4 145.56 38.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.308 -0.87 . . . . 0.0 109.396 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -122.62 134.96 54.49 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.28 -0.888 . . . . 0.0 109.421 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.63 HG12 ' CD1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -108.71 144.16 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.324 -0.86 . . . . 0.0 109.018 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.794 ' CD1' ' N ' ' A' ' 43' ' ' ILE . 0.0 OUTLIER -144.34 125.12 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.049 -1.032 . . . . 0.0 109.738 -179.644 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 tt -113.22 124.12 51.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.282 -0.886 . . . . 0.0 109.53 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.431 ' HZ3' HG21 ' A' ' 47' ' ' VAL . 29.6 tttm -97.69 145.81 25.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.316 -0.865 . . . . 0.0 109.515 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 13' ' ' GLY . 85.0 m -142.96 128.33 18.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.292 -0.88 . . . . 0.0 109.276 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.57 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -131.98 168.45 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 O-C-N 120.986 -1.071 . . . . 0.0 109.535 -179.626 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -99.66 98.46 9.3 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.547 HD12 HH11 ' A' ' 88' ' ' ARG . 10.1 mt -60.84 168.65 2.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.328 -0.858 . . . . 0.0 109.594 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 51' ' ' ASN . 34.0 ttm180 -48.95 -77.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 0.0 109.394 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 50' ' ' ARG . 1.2 m120 -42.84 -27.89 0.21 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.912 . . . . 0.0 109.214 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 50' ' ' ARG . . . 96.03 44.17 3.13 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.3 t-20 -95.35 14.05 23.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.983 -1.304 . . . . 0.0 109.288 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.574 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 11.5 mt 43.68 97.22 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.649 0.738 . . . . 0.0 109.377 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.425 ' HB2' HD13 ' A' ' 49' ' ' LEU . 9.3 tt0 -68.86 151.89 46.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.497 -0.752 . . . . 0.0 109.156 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.574 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 90.7 m-85 -136.08 114.31 11.54 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.318 -0.864 . . . . 0.0 109.419 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.73 153.94 34.89 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.3 137.62 40.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.934 -1.104 . . . . 0.0 110.324 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.595 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 1.0 OUTLIER -122.5 150.11 42.98 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.447 -0.783 . . . . 0.0 109.138 179.545 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.707 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -124.78 116.42 22.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -0.851 . . . . 0.0 109.122 179.663 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.404 ' CE3' ' O ' ' A' ' 62' ' ' LEU . 16.7 t90 -97.77 123.93 41.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.294 -0.879 . . . . 0.0 109.61 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.404 ' O ' ' CE3' ' A' ' 61' ' ' TRP . 0.7 OUTLIER -104.54 161.49 14.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.316 -0.865 . . . . 0.0 109.394 179.861 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -106.26 157.83 15.75 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -77.52 -12.25 59.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -1.126 . . . . 0.0 109.389 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -107.16 24.36 12.96 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.8 m -130.97 97.5 4.33 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 122.105 0.955 . . . . 0.0 108.496 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 66' ' ' CYS . 1.4 m -50.85 -173.52 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.315 0 CA-C-O 121.378 0.609 . . . . 0.0 109.569 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.439 ' O ' ' N ' ' A' ' 72' ' ' GLY . 54.9 mt-30 -71.49 -17.8 62.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -0.944 . . . . 0.0 109.598 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -63.82 -58.5 6.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.463 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.32 -46.99 84.1 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.369 -0.832 . . . . 0.0 109.053 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.6 m -63.79 -29.18 70.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.493 -0.755 . . . . 0.0 108.968 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -65.1 -45.92 90.21 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.22 -49.97 74.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -1.146 . . . . 0.0 109.326 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.83 -45.43 93.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 0.0 109.252 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -62.21 -38.54 89.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.159 -0.963 . . . . 0.0 109.425 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.416 HD13 HG21 ' A' ' 76' ' ' ILE . 25.1 mt -58.84 -44.56 90.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.189 -0.945 . . . . 0.0 109.468 179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -61.75 -42.0 98.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.37 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 82.2 m -68.0 -39.96 83.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.333 -0.854 . . . . 0.0 109.232 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 68.2 t -67.87 -27.41 37.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.402 -0.811 . . . . 0.0 109.372 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.486 ' O ' ' OD2' ' A' ' 83' ' ' ASP . 40.8 mm-40 -70.4 -61.47 1.76 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.254 -0.904 . . . . 0.0 109.285 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.8 pp -58.03 -24.06 56.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 0.0 108.645 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' A' ' 86' ' ' ASN . 13.9 t70 -72.25 -54.96 8.04 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.39 -0.819 . . . . 0.0 108.912 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.486 ' OD2' ' O ' ' A' ' 80' ' ' GLN . 1.1 p30 -48.33 -35.42 12.37 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.113 -0.992 . . . . 0.0 108.368 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.457 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -72.93 -32.07 65.03 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.297 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 82' ' ' ASP . 4.6 tp -121.56 35.29 4.93 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.327 -0.858 . . . . 0.0 109.415 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.615 ' N ' ' O ' ' A' ' 82' ' ' ASP . 42.6 t30 -87.71 30.16 0.84 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.193 -0.942 . . . . 0.0 109.205 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -107.41 -21.3 8.05 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.547 HH11 HD12 ' A' ' 49' ' ' LEU . 25.3 ttt85 -159.53 64.81 0.38 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.282 -1.128 . . . . 0.0 109.41 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.13 174.43 14.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.924 . . . . 0.0 109.379 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.9 t -136.11 142.51 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 109.641 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -103.24 147.71 26.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.328 -0.858 . . . . 0.0 109.077 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 38.4 m-70 -132.1 119.16 20.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 109.655 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.524 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 11.0 ptp180 -91.97 109.32 20.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.367 -0.833 . . . . 0.0 109.299 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 100' ' ' SER . 86.6 mt-10 -113.32 144.19 43.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 109.43 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 37.5 t -148.55 166.59 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.299 -0.876 . . . . 0.0 109.37 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.7 tt0 -59.16 115.99 3.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.245 -0.91 . . . . 0.0 109.388 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.06 9.79 85.75 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.48 ' O ' ' O ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -143.17 24.71 1.78 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -1.147 . . . . 0.0 109.305 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.48 ' O ' ' O ' ' A' ' 98' ' ' PHE . 9.7 pt-20 -44.53 170.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.276 -0.89 . . . . 0.0 109.556 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.401 ' H ' ' HG2' ' A' ' 94' ' ' GLU . 4.3 t -91.51 167.8 11.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.279 -0.888 . . . . 0.0 109.573 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.66 -59.89 2.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.295 -0.878 . . . . 0.0 109.527 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.0 m -46.85 -35.59 6.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.355 -0.841 . . . . 0.0 109.373 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -68.87 -46.49 68.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.347 -0.846 . . . . 0.0 109.292 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.58 ' O ' ' CD1' ' A' ' 107' ' ' PHE . 12.0 mt -61.15 -20.57 62.85 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.252 -0.905 . . . . 0.0 109.436 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -93.74 -24.85 19.5 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.414 ' O ' ' C ' ' A' ' 107' ' ' PHE . 7.8 t80 -80.0 -21.42 43.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -1.133 . . . . 0.0 109.461 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.583 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 1.6 p90 -44.97 121.67 2.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.456 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -108.98 -50.67 2.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.979 . . . . 0.0 109.536 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 94.9 p -101.42 -9.79 20.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 109.539 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 96.29 108.48 2.44 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.619 ' H ' ' CD2' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -67.6 177.06 2.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -1.153 . . . . 0.0 109.512 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -146.88 143.7 28.74 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.288 -0.883 . . . . 0.0 109.436 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.61 ' CD2' ' N ' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -112.41 124.67 53.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.312 -0.868 . . . . 0.0 109.485 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 17.0 mtpt -97.42 160.62 14.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 109.531 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -125.35 123.98 40.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.364 -0.835 . . . . 0.0 109.364 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.69 -109.53 0.21 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.85 145.46 12.88 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.82 -156.43 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -1.179 . . . . 0.0 109.433 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.47 ' C ' ' H ' ' A' ' 121' ' ' GLY . . . -139.65 -0.31 1.75 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 0.0 109.466 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.1 m 53.33 10.29 0.19 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.47 ' H ' ' C ' ' A' ' 119' ' ' ALA . . . 59.79 -128.84 47.41 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.579 ' CD2' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -85.57 -78.67 0.26 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -1.151 . . . . 0.0 109.419 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.463 ' HG2' ' H ' ' A' ' 124' ' ' HIS . 6.0 ttpp -78.95 -152.95 0.07 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.18 -0.95 . . . . 0.0 109.324 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.463 ' H ' ' HG2' ' A' ' 123' ' ' LYS . 4.9 t-80 59.11 35.96 23.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.549 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.1 t -116.92 24.8 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.321 -0.862 . . . . 0.0 109.35 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.5 t -144.11 69.33 16.14 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.894 . . . . 0.0 109.39 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.527 ' C ' ' H ' ' A' ' 129' ' ' GLU . 55.4 Cg_endo -74.71 6.47 3.25 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.708 2.272 . . . . 0.0 112.226 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -74.3 20.43 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.946 . . . . 0.0 109.36 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' A' ' 127' ' ' PRO . 6.2 pt-20 -141.01 64.2 1.43 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.453 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.451 ' C ' ' O ' ' A' ' 129' ' ' GLU . 42.7 t -40.72 125.25 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.312 -0.868 . . . . 0.0 109.64 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 15.0 p -72.24 127.73 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.438 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.92 -27.84 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.873 . . . . 0.0 109.433 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.453 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.581 ' O ' ' ND1' ' A' ' 2' ' ' HIS . 60.1 mm-40 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.601 ' O ' ' N ' ' A' ' 4' ' ' GLU . 13.8 m-70 -156.53 81.61 3.51 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.168 -0.957 . . . . 0.0 109.627 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -54.13 67.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.774 2.316 . . . . 0.0 111.974 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 2' ' ' HIS . 57.2 mm-40 -83.06 -46.02 13.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.972 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.553 ' CE2' ' CG1' ' A' ' 42' ' ' VAL . 34.8 t80 -69.74 -12.54 61.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.111 -0.993 . . . . 0.0 109.558 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.4 mt -90.34 -33.71 15.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.216 -0.927 . . . . 0.0 109.381 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 8' ' ' ALA . 25.1 mttp -91.17 -11.34 38.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.229 -0.919 . . . . 0.0 109.494 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -42.73 166.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.177 -0.952 . . . . 0.0 109.47 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.523 ' H ' ' NE2' ' A' ' 15' ' ' GLN . . . 106.24 68.27 0.69 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.8 pttt -135.97 -0.87 2.49 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.211 -1.17 . . . . 0.0 109.576 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -159.02 142.48 10.81 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 109.326 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.35 89.88 1.04 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.594 2.196 . . . . 0.0 112.256 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -169.14 -105.92 0.19 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.5 tt -162.38 144.82 11.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -1.15 . . . . 0.0 109.472 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.523 ' NE2' ' H ' ' A' ' 9' ' ' GLY . 9.0 mt-30 -134.6 144.39 47.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 109.629 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 7.8 mt -122.89 143.96 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.455 -0.778 . . . . 0.0 109.812 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.41 ' CE2' ' HB3' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -146.68 136.07 22.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.307 -0.87 . . . . 0.0 109.019 179.738 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.552 ' O ' ' N ' ' A' ' 25' ' ' VAL . 51.5 ttt180 -94.11 153.17 18.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.124 -0.985 . . . . 0.0 109.645 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.417 ' CG1' ' O ' ' A' ' 23' ' ' ASP . 28.3 t -96.45 133.31 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.92 . . . . 0.0 109.722 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.774 ' O ' ' N ' ' A' ' 22' ' ' PHE . 6.0 tt0 -80.09 85.58 5.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.132 -0.98 . . . . 0.0 108.774 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.648 ' O ' ' CD2' ' A' ' 22' ' ' PHE . 7.5 mtpm? 40.43 9.86 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.548 -0.72 . . . . 0.0 109.792 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.774 ' N ' ' O ' ' A' ' 20' ' ' GLU . 0.7 OUTLIER 160.22 -32.35 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.225 -0.922 . . . . 0.0 109.167 -179.723 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.528 ' OD2' ' N ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -94.49 -142.38 0.24 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.273 -0.892 . . . . 0.0 110.257 -179.214 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.602 ' C ' HG22 ' A' ' 25' ' ' VAL . 8.9 mt -125.95 146.12 49.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.341 -0.849 . . . . 0.0 109.942 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.602 HG22 ' C ' ' A' ' 24' ' ' LEU . 7.8 t -142.05 132.29 12.66 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 0.0 109.15 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -76.3 144.67 26.37 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.39 2.06 . . . . 0.0 112.26 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.2 t -110.96 101.51 50.09 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.346 -0.846 . . . . 0.0 109.437 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -51.19 161.6 1.58 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.508 2.139 . . . . 0.0 112.153 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.7 m -68.64 -22.15 64.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.389 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -67.0 -11.83 58.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 109.433 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 32' ' ' TYR . 15.3 mt -122.93 -17.11 6.87 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.268 -0.895 . . . . 0.0 109.52 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.55 ' C ' ' CD2' ' A' ' 32' ' ' TYR . 4.4 t80 -42.46 133.12 3.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.907 . . . . 0.0 109.348 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.83 22.26 16.36 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -143.02 151.37 40.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -1.192 . . . . 0.0 109.444 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -141.83 137.48 31.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.231 -0.918 . . . . 0.0 109.549 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -102.04 137.63 40.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 109.325 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.4 p -78.2 -4.79 49.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.882 . . . . 0.0 109.48 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.35 30.94 8.92 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 40' ' ' ALA . 8.8 t70 -173.66 156.13 2.86 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.188 -1.184 . . . . 0.0 109.521 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.447 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -97.77 147.68 24.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.246 -0.909 . . . . 0.0 109.279 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.44 ' CD2' ' N ' ' A' ' 41' ' ' TYR . 17.1 m-85 -128.72 134.82 48.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.324 -0.86 . . . . 0.0 109.46 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.553 ' CG1' ' CE2' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -105.44 140.94 21.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.213 -0.929 . . . . 0.0 109.06 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.536 HD13 ' C ' ' A' ' 42' ' ' VAL . 1.1 mm -131.22 134.89 60.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.37 -0.831 . . . . 0.0 110.028 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 tt -120.22 120.13 35.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.536 -0.727 . . . . 0.0 109.531 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 43.6 tttt -93.79 147.91 22.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.116 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.6 OUTLIER -142.68 122.14 13.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 109.526 -179.768 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.619 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -129.97 168.18 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 O-C-N 121.249 -0.907 . . . . 0.0 108.908 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -94.51 131.29 40.39 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.533 -0.729 . . . . 0.0 109.487 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.447 HD23 HE21 ' A' ' 55' ' ' GLN . 15.8 mt -96.32 167.52 11.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 109.534 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.53 ' CG ' ' N ' ' A' ' 51' ' ' ASN . 4.6 ptm180 -47.93 -46.86 32.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.261 -0.899 . . . . 0.0 109.296 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.53 ' N ' ' CG ' ' A' ' 50' ' ' ARG . 98.6 m-20 -75.75 -27.48 58.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.316 -0.865 . . . . 0.0 109.199 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.85 28.96 7.95 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.497 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.4 t-20 -84.67 13.64 5.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.099 -1.236 . . . . 0.0 109.359 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.619 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.8 mt 47.31 100.26 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.527 0.68 . . . . 0.0 109.509 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.447 HE21 HD23 ' A' ' 49' ' ' LEU . 8.9 tt0 -68.85 117.77 10.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.534 -0.729 . . . . 0.0 109.214 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.453 ' CD1' ' O ' ' A' ' 54' ' ' LEU . 96.7 m-85 -98.07 114.71 26.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.174 -0.954 . . . . 0.0 109.865 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.21 155.76 22.46 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.553 ' C ' ' CD2' ' A' ' 59' ' ' HIS . 5.2 mp -134.36 144.7 48.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.838 -1.164 . . . . 0.0 110.517 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.603 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.5 OUTLIER -141.97 126.55 17.89 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.566 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.701 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -105.94 131.13 53.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.1 -1.0 . . . . 0.0 109.593 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -104.94 123.94 48.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.422 -0.799 . . . . 0.0 109.331 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.9 mt -104.7 162.12 13.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.863 . . . . 0.0 109.595 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -117.37 162.69 12.81 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 64' ' ' ASN . 0.6 OUTLIER -81.08 -12.57 59.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.302 -1.117 . . . . 0.0 109.614 -179.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -106.24 26.98 9.13 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.3 m -130.75 97.61 4.4 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 122.2 1.0 . . . . 0.0 108.42 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 66' ' ' CYS . 31.4 m -49.71 -176.49 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.733 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 72' ' ' GLY . 13.7 pt20 -68.17 -17.5 64.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.4 -0.812 . . . . 0.0 109.561 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -63.48 -58.57 6.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.919 . . . . 0.0 109.652 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.449 ' N ' ' CD ' ' A' ' 70' ' ' GLU . 3.8 mm-40 -62.32 -48.13 81.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.229 -0.919 . . . . 0.0 109.177 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.7 p -66.01 -27.53 68.19 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.338 -0.851 . . . . 0.0 109.231 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.89 -31.82 66.86 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.22 -51.22 18.53 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.278 -1.131 . . . . 0.0 109.342 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.92 -48.18 73.44 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.414 -0.804 . . . . 0.0 109.279 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.405 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -57.11 -48.38 78.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 109.303 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.4 mt -50.77 -47.28 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.204 -0.935 . . . . 0.0 109.319 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -58.06 -37.75 75.02 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.306 -0.871 . . . . 0.0 109.264 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 m -65.32 -46.22 81.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.33 -0.856 . . . . 0.0 109.266 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.405 HG21 ' O ' ' A' ' 75' ' ' ALA . 17.1 t -56.02 -36.41 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 0.0 109.451 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -64.89 -50.09 67.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.277 -0.889 . . . . 0.0 109.255 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.2 mt -53.13 -36.1 60.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.204 -0.935 . . . . 0.0 109.247 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 85' ' ' LEU . 40.6 m-20 -63.36 -58.34 7.42 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.247 -0.908 . . . . 0.0 109.109 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 82' ' ' ASP . 1.8 t70 -45.4 -34.0 2.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.212 -0.93 . . . . 0.0 108.54 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -73.7 -28.87 61.96 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 82' ' ' ASP . 6.4 mt -112.93 28.36 8.86 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.394 -0.816 . . . . 0.0 109.272 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 85' ' ' LEU . 9.6 t-20 43.56 37.22 1.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.397 -0.815 . . . . 0.0 109.429 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 48.72 32.95 11.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -89.09 30.96 0.9 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.192 -1.181 . . . . 0.0 109.22 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -129.76 179.14 6.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.423 -0.798 . . . . 0.0 109.347 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.7 128.23 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.15 -0.969 . . . . 0.0 109.5 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.586 ' N ' ' NE2' ' A' ' 91' ' ' GLN . 1.6 mp0 -88.98 144.33 26.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.932 . . . . 0.0 109.366 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.411 ' HB2' ' CG ' ' A' ' 59' ' ' HIS . 28.4 m-70 -131.31 107.27 8.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.94 . . . . 0.0 109.576 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -86.25 105.04 16.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 109.377 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.596 ' OE1' ' CD1' ' A' ' 103' ' ' PHE . 22.3 mt-10 -110.3 141.77 42.84 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.36 -0.837 . . . . 0.0 109.732 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 12.0 t -144.38 163.3 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.342 -0.848 . . . . 0.0 109.147 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -56.89 120.52 8.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.939 . . . . 0.0 109.442 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.42 15.76 77.54 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.438 ' O ' ' C ' ' A' ' 99' ' ' GLU . 7.0 t80 -141.7 12.13 2.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -1.145 . . . . 0.0 109.443 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.576 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 30.2 mp0 -41.52 138.4 1.33 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.506 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.445 ' H ' ' HG2' ' A' ' 94' ' ' GLU . 4.1 m -72.29 -177.36 2.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 0.0 109.402 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.2 -65.21 0.98 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.187 -0.945 . . . . 0.0 109.505 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.6 m -47.64 -36.21 10.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 109.444 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.685 ' CZ ' ' CZ ' ' A' ' 107' ' ' PHE . 2.1 t80 -67.8 -47.16 69.87 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.259 -0.901 . . . . 0.0 109.442 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 63.5 mt -66.83 -23.1 65.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.934 . . . . 0.0 109.508 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -93.32 -24.17 22.49 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -86.94 -33.62 19.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.225 -1.162 . . . . 0.0 109.51 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.685 ' CZ ' ' CZ ' ' A' ' 103' ' ' PHE . 24.2 m-85 -90.31 99.31 12.36 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.29 -0.881 . . . . 0.0 109.528 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.468 ' C ' ' H ' ' A' ' 110' ' ' GLY . 19.9 mtpp -99.74 -6.16 27.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.913 . . . . 0.0 109.365 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 26.0 m -77.75 22.29 0.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 109.426 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 108' ' ' LYS . . . 47.62 80.85 0.05 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.566 ' CD1' ' H ' ' A' ' 111' ' ' LEU . 0.5 OUTLIER -43.01 118.33 1.25 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -1.145 . . . . 0.0 109.441 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -82.04 123.57 29.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.28 -0.887 . . . . 0.0 109.497 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -94.93 108.73 20.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.511 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -111.43 140.12 46.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.348 -0.845 . . . . 0.0 109.556 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 30.3 pttt -137.57 139.91 40.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.911 . . . . 0.0 109.397 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.87 112.55 3.5 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 177.1 0.04 0.03 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.5 t -96.04 -48.56 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -1.122 . . . . 0.0 109.433 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 53.31 -117.88 1.25 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.162 -0.961 . . . . 0.0 109.384 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 t -93.67 111.96 23.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.182 -0.948 . . . . 0.0 109.422 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -155.22 19.29 0.54 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -151.66 -31.6 0.16 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.33 -1.1 . . . . 0.0 109.487 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.416 ' O ' ' CG ' ' A' ' 124' ' ' HIS . 28.6 mtmt -67.67 -29.32 68.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.903 . . . . 0.0 109.413 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.416 ' CG ' ' O ' ' A' ' 123' ' ' LYS . 80.1 m80 -153.87 100.63 2.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.29 -0.881 . . . . 0.0 109.401 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.482 ' O ' ' C ' ' A' ' 126' ' ' VAL . 2.1 t -69.64 66.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 109.532 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.482 ' C ' ' O ' ' A' ' 125' ' ' VAL . 1.2 m -38.92 103.35 0.28 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.435 -0.791 . . . . 0.0 109.574 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.99 119.58 5.03 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.461 2.107 . . . . 0.0 112.187 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.774 HD21 ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -102.55 -12.7 17.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 109.499 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -163.2 84.61 0.5 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.317 -0.864 . . . . 0.0 109.508 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.4 t -71.25 139.53 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.164 -0.96 . . . . 0.0 109.43 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 13.3 p -72.25 124.86 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.895 . . . . 0.0 109.474 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.4 t -69.15 77.5 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 109.428 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.427 -179.951 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.618 ' ND1' ' N ' ' A' ' 2' ' ' HIS . 0.0 OUTLIER -144.07 173.28 4.56 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.372 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -49.39 73.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.73 2.287 . . . . 0.0 112.099 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.592 ' N ' ' O ' ' A' ' 2' ' ' HIS . 0.4 OUTLIER -82.25 -34.83 28.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 109.698 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.513 ' CE2' ' CG1' ' A' ' 42' ' ' VAL . 15.9 t80 -56.78 -8.87 0.66 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.184 -0.948 . . . . 0.0 109.291 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.458 ' H ' ' C ' ' A' ' 4' ' ' GLU . 51.1 mt -90.24 -45.73 8.88 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.227 -0.921 . . . . 0.0 109.385 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.455 ' O ' ' C ' ' A' ' 8' ' ' ALA . 43.6 mtpt -87.27 -2.08 58.37 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.292 -0.88 . . . . 0.0 109.439 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -41.48 150.46 0.1 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.42 -0.8 . . . . 0.0 109.581 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.54 68.83 0.29 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -134.64 9.69 3.66 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.373 -1.075 . . . . 0.0 109.539 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -172.67 139.37 0.93 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.148 -0.97 . . . . 0.0 109.451 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.38 86.3 1.17 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.547 2.165 . . . . 0.0 112.265 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -166.31 -107.58 0.2 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.6 tt -162.6 151.0 14.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.291 -1.123 . . . . 0.0 109.635 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.407 ' HB3' ' CZ3' ' A' ' 17' ' ' TRP . 32.7 mt-30 -146.66 140.25 25.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 109.403 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.71 ' HA ' HG23 ' A' ' 43' ' ' ILE . 3.4 mt -114.38 149.39 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.312 -0.867 . . . . 0.0 109.923 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.407 ' CZ3' ' HB3' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -145.27 135.23 23.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.302 -0.874 . . . . 0.0 109.122 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.453 ' HD2' ' HH ' ' A' ' 41' ' ' TYR . 5.2 ttt180 -92.27 142.83 27.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.164 -0.96 . . . . 0.0 109.381 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 19' ' ' VAL . 9.9 p -80.45 119.62 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.198 -0.939 . . . . 0.0 109.501 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.614 ' O ' ' N ' ' A' ' 22' ' ' PHE . 8.6 tm-20 -74.79 147.83 40.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.234 -0.916 . . . . 0.0 109.157 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.425 ' N ' ' CD ' ' A' ' 20' ' ' GLU . 23.8 mttp -45.19 -11.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.901 . . . . 0.0 109.833 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.614 ' N ' ' O ' ' A' ' 20' ' ' GLU . 7.6 t80 -165.71 29.75 0.05 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.126 -0.984 . . . . 0.0 109.797 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.464 ' N ' ' HB3' ' A' ' 20' ' ' GLU . 27.5 t70 -175.29 -116.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 109.597 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.6 tp -157.99 146.2 18.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.346 -0.846 . . . . 0.0 109.499 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -134.38 107.9 11.17 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.244 -0.91 . . . . 0.0 109.604 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.74 132.79 37.62 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.192 1.928 . . . . 0.0 111.843 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.2 p -75.7 121.57 85.35 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 109.572 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -78.17 166.84 24.14 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.4 2.067 . . . . 0.0 112.139 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.86 -6.25 43.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.332 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -87.19 -6.39 58.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 109.346 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 32' ' ' TYR . 56.6 mt -132.87 -11.4 3.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 109.778 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.528 ' CZ ' ' CD1' ' A' ' 16' ' ' ILE . 9.6 t80 -43.25 118.98 1.44 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 109.487 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.66 -11.91 56.45 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.514 ' C ' ' CG ' ' A' ' 35' ' ' PHE . 1.9 m-20 -110.52 150.52 28.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -1.154 . . . . 0.0 109.503 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.514 ' CG ' ' C ' ' A' ' 34' ' ' ASP . 5.2 m-85 -155.1 148.17 24.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 109.421 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 36' ' ' PHE . 2.0 m-85 -102.34 135.96 43.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 109.536 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.4 ' OG1' ' OE1' ' A' ' 65' ' ' GLU . 44.7 p -67.13 -9.57 41.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.354 -0.841 . . . . 0.0 109.289 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.52 30.36 8.9 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 40' ' ' ALA . 3.1 t70 -161.36 159.44 28.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -1.154 . . . . 0.0 109.399 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.483 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -107.46 150.71 26.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 109.392 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.453 ' HH ' ' HD2' ' A' ' 18' ' ' ARG . 24.2 m-85 -130.03 138.89 51.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.312 -0.867 . . . . 0.0 109.511 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.549 ' C ' ' CD1' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -112.81 126.52 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.25 -0.906 . . . . 0.0 108.591 179.698 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.71 HG23 ' HA ' ' A' ' 16' ' ' ILE . 0.0 OUTLIER -123.73 137.77 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 119.319 -0.952 . . . . 0.0 110.373 -178.862 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.6 tt -121.09 146.96 46.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.542 -0.724 . . . . 0.0 109.396 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 57' ' ' ASP . 1.8 ttmp? -123.67 139.34 54.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.417 -0.802 . . . . 0.0 109.259 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 13' ' ' GLY . 20.4 m -136.31 117.93 14.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.342 -0.849 . . . . 0.0 109.328 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.707 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -126.52 167.86 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.317 -0.864 . . . . 0.0 109.01 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -98.48 125.44 43.68 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.498 -0.752 . . . . 0.0 109.442 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.454 HD12 ' HB2' ' A' ' 55' ' ' GLN . 11.1 mt -87.9 154.43 20.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.27 -0.894 . . . . 0.0 109.673 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.432 ' CZ ' ' CB ' ' A' ' 50' ' ' ARG . 10.3 mtp-105 -48.24 -43.39 32.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -0.916 . . . . 0.0 109.255 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -68.41 -32.85 73.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.312 -0.868 . . . . 0.0 109.3 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.09 74.67 1.18 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.508 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.1 t-20 -143.69 13.77 1.73 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.203 -1.175 . . . . 0.0 109.336 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.707 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 31.4 mt 44.52 98.26 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.536 0.684 . . . . 0.0 109.496 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.454 ' HB2' HD12 ' A' ' 49' ' ' LEU . 9.7 tt0 -73.97 121.31 20.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.559 -0.713 . . . . 0.0 109.682 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -99.54 114.54 27.59 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.248 -0.908 . . . . 0.0 109.751 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 45' ' ' LYS . 0.9 OUTLIER -127.51 122.56 33.7 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.362 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.57 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 0.5 OUTLIER -126.16 150.37 48.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.114 -0.991 . . . . 0.0 110.71 -178.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.482 ' CB ' ' CE1' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -129.53 141.71 50.92 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.34 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.549 ' CZ ' ' HB3' ' A' ' 74' ' ' ALA . 2.4 t80 -103.24 126.22 50.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.897 . . . . 0.0 109.56 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.457 ' N ' ' CD1' ' A' ' 60' ' ' TYR . 44.2 t90 -100.74 127.8 47.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.09 -1.006 . . . . 0.0 109.824 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.436 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 2.9 mp -112.53 157.0 21.68 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.491 -0.756 . . . . 0.0 109.412 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -104.78 161.68 14.99 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.507 HD22 ' NE2' ' A' ' 96' ' ' GLN . 0.5 OUTLIER -81.72 -12.05 58.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.333 -1.098 . . . . 0.0 109.474 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.4 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 1.8 mt-10 -106.66 29.59 6.82 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.552 ' SG ' ' OE2' ' A' ' 70' ' ' GLU . 1.6 m -130.78 97.51 4.36 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.591 ' OG ' ' N ' ' A' ' 68' ' ' GLN . 1.0 OUTLIER -58.67 -173.76 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.573 -179.829 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.591 ' N ' ' OG ' ' A' ' 67' ' ' SER . 8.6 pt20 -62.45 -17.97 60.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 109.66 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -65.35 -58.77 5.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.557 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.552 ' OE2' ' SG ' ' A' ' 66' ' ' CYS . 13.4 mt-10 -64.63 -43.1 94.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.336 -0.852 . . . . 0.0 109.139 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.7 t -69.33 -26.7 64.83 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.491 -0.756 . . . . 0.0 109.191 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.31 -38.89 71.18 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.02 -47.98 64.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.331 -1.1 . . . . 0.0 109.366 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.549 ' HB3' ' CZ ' ' A' ' 60' ' ' TYR . . . -60.36 -42.22 95.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.366 -0.834 . . . . 0.0 109.311 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.487 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -62.95 -44.8 95.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.883 . . . . 0.0 109.598 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.2 mt -53.45 -51.53 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 0.0 109.341 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -61.36 -33.23 73.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 109.307 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -68.81 -44.77 72.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.382 -0.824 . . . . 0.0 109.374 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 75' ' ' ALA . 42.9 t -63.34 -31.2 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.293 -0.879 . . . . 0.0 109.409 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -66.9 -60.97 2.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.334 -0.854 . . . . 0.0 109.165 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.57 ' CD1' ' C ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -50.78 -31.09 15.84 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.046 -1.034 . . . . 0.0 108.708 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' A' ' 86' ' ' ASN . 29.2 t70 -63.64 -59.57 4.44 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.418 -0.802 . . . . 0.0 108.928 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.583 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 1.3 m-20 -46.03 -34.09 3.84 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.158 -0.964 . . . . 0.0 108.46 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -74.7 -32.79 62.28 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.551 ' C ' ' H ' ' A' ' 87' ' ' GLY . 1.1 tt -121.48 35.67 4.82 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.369 -0.832 . . . . 0.0 109.532 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.609 ' N ' ' O ' ' A' ' 82' ' ' ASP . 1.7 p30 -76.89 27.03 0.14 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.125 -0.985 . . . . 0.0 109.092 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.551 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -69.9 -57.86 6.74 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -176.67 46.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.346 -1.091 . . . . 0.0 109.564 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.63 179.13 6.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 0.0 109.406 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.7 t -126.25 111.95 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 109.45 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -102.38 136.43 42.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.364 -0.835 . . . . 0.0 109.397 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.619 ' CD2' ' N ' ' A' ' 92' ' ' HIS . 0.6 OUTLIER -143.82 118.65 9.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.077 -1.014 . . . . 0.0 109.515 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.1 mtm180 -83.01 138.28 33.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 109.774 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.433 ' CD ' ' H ' ' A' ' 100' ' ' SER . 5.4 mt-10 -131.37 155.98 46.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.304 -0.873 . . . . 0.0 109.283 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.499 ' CG1' ' H ' ' A' ' 96' ' ' GLN . 48.1 t -131.66 173.8 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.219 -0.925 . . . . 0.0 109.575 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.57 ' C ' ' H ' ' A' ' 98' ' ' PHE . 3.3 tt0 -60.55 139.75 57.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.374 -0.829 . . . . 0.0 109.54 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 70.53 -18.55 0.75 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.57 ' H ' ' C ' ' A' ' 96' ' ' GLN . 7.9 t80 -106.59 4.7 28.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.301 -1.117 . . . . 0.0 109.452 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 98' ' ' PHE . 27.7 mt-10 -42.69 148.26 0.24 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.903 . . . . 0.0 109.559 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.433 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 38.4 m -81.06 168.7 18.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.9 . . . . 0.0 109.529 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.93 -35.02 78.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.153 -0.967 . . . . 0.0 109.607 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.8 m -58.03 -61.03 2.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.568 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -57.78 -41.79 82.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.35 -0.844 . . . . 0.0 109.732 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.2 mt -66.28 -28.52 68.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.189 -0.944 . . . . 0.0 109.552 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -81.7 -19.22 66.29 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.43 ' CD1' ' CZ ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -81.37 -45.55 15.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -1.121 . . . . 0.0 109.431 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.43 ' CZ ' ' CD1' ' A' ' 106' ' ' TYR . 20.4 m-85 -139.41 87.21 2.17 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.352 -0.842 . . . . 0.0 109.496 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.35 -20.76 20.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.386 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.7 t -96.94 -12.39 23.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -0.939 . . . . 0.0 109.484 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.456 ' O ' ' C ' ' A' ' 111' ' ' LEU . . . -97.65 -107.15 2.53 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.456 ' C ' ' O ' ' A' ' 110' ' ' GLY . 14.5 mt 41.52 61.64 1.77 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.329 -1.1 . . . . 0.0 109.507 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tppt? -75.59 117.04 16.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.172 -0.955 . . . . 0.0 109.479 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -84.5 114.38 21.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.297 -0.877 . . . . 0.0 109.478 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -103.05 166.28 10.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 0.0 109.355 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -127.8 156.59 42.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.854 . . . . 0.0 109.465 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.04 -162.46 12.69 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -176.04 -176.32 44.15 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 p -156.76 139.21 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.097 -1.237 . . . . 0.0 109.541 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -98.39 84.34 3.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.293 -0.879 . . . . 0.0 109.507 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.1 t -70.92 -59.96 2.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.911 . . . . 0.0 109.395 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -160.08 26.38 0.32 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -65.75 -73.08 0.14 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -1.161 . . . . 0.0 109.488 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -95.97 -64.72 1.03 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 109.607 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.457 ' CG ' ' H ' ' A' ' 125' ' ' VAL . 0.8 OUTLIER -140.3 -174.41 3.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.297 -0.877 . . . . 0.0 109.502 179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.457 ' H ' ' CG ' ' A' ' 124' ' ' HIS . 14.5 p -103.4 3.45 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.56 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.7 t 57.21 66.91 2.76 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 0.0 109.458 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -73.32 -172.58 1.06 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.73 2.287 . . . . 0.0 112.185 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.421 ' O ' ' O ' ' A' ' 129' ' ' GLU . 56.9 m-80 -85.47 -64.67 1.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.499 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' A' ' 128' ' ' ASN . 28.5 tt0 61.65 145.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.405 -0.809 . . . . 0.0 109.442 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.5 t -146.65 -78.04 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.22 -0.925 . . . . 0.0 109.458 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.423 ' C ' ' H ' ' A' ' 133' ' ' GLN . 2.0 t -71.76 146.97 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.292 -0.88 . . . . 0.0 109.481 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.436 ' O ' ' OXT' ' A' ' 133' ' ' GLN . 75.3 t -51.55 -14.38 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.927 . . . . 0.0 109.515 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.436 ' OXT' ' O ' ' A' ' 132' ' ' VAL . 24.6 mm-40 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.066 -0.969 . . . . 0.0 109.534 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.281 0.562 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.579 ' O ' ' N ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER -176.46 145.44 0.7 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.246 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -39.4 81.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.65 2.234 . . . . 0.0 112.238 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.579 ' N ' ' O ' ' A' ' 2' ' ' HIS . 1.2 tp10 -83.07 -29.35 28.86 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.26 -0.9 . . . . 0.0 109.563 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.616 ' CZ ' ' O ' ' A' ' 42' ' ' VAL . 2.9 m-85 -56.32 -4.59 0.14 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.951 . . . . 0.0 109.13 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.564 ' H ' ' C ' ' A' ' 4' ' ' GLU . 14.4 mt -84.54 -38.4 20.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.88 . . . . 0.0 109.279 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 8' ' ' ALA . 23.2 mttt -101.43 -3.37 28.79 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.393 -0.817 . . . . 0.0 109.358 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -42.01 137.52 1.81 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.31 -0.869 . . . . 0.0 109.637 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . 0.613 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 154.86 -37.45 0.66 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.567 ' CD ' ' H ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -70.78 19.83 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -1.152 . . . . 0.0 109.309 179.85 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.613 ' H ' ' C ' ' A' ' 9' ' ' GLY . 79.9 mt-10 -139.23 103.02 7.31 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.374 -0.829 . . . . 0.0 109.293 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -78.33 83.97 2.11 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.426 2.084 . . . . 0.0 112.157 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -174.22 -102.01 0.15 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.414 ' CD2' HG22 ' A' ' 43' ' ' ILE . 0.4 OUTLIER -159.97 132.47 6.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.134 . . . . 0.0 109.427 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -115.23 135.93 53.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.276 -0.89 . . . . 0.0 109.478 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.58 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 6.3 mt -130.96 110.11 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.44 -0.787 . . . . 0.0 109.91 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.58 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 6.1 m0 -139.32 149.76 44.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.176 -0.953 . . . . 0.0 108.769 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.7 ptp180 -114.83 153.27 30.73 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.122 -0.986 . . . . 0.0 110.139 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.463 ' CG1' ' O ' ' A' ' 19' ' ' VAL . 7.3 p -89.26 125.68 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -0.843 . . . . 0.0 109.13 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.511 ' CG ' ' OD1' ' A' ' 39' ' ' ASP . 5.6 mt-10 -157.45 138.02 13.02 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.214 -0.929 . . . . 0.0 109.319 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 22' ' ' PHE . 12.8 mttt 72.97 48.21 0.18 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.501 -0.75 . . . . 0.0 109.458 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.428 ' C ' ' O ' ' A' ' 21' ' ' LYS . 20.5 m-85 43.74 36.93 1.41 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.541 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -169.01 166.75 10.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.28 -0.888 . . . . 0.0 109.405 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 tp -68.15 146.16 53.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.246 -0.909 . . . . 0.0 109.431 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.487 HG22 ' N ' ' A' ' 20' ' ' GLU . 44.1 t -138.5 97.67 9.25 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.371 -0.831 . . . . 0.0 109.071 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -50.31 168.99 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.771 2.314 . . . . 0.0 112.632 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.0 t -126.92 107.43 22.27 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.462 -0.774 . . . . 0.0 109.173 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -45.69 144.04 5.75 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.434 2.089 . . . . 0.0 112.492 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.539 ' C ' ' H ' ' A' ' 31' ' ' LEU . 6.5 m -51.89 -50.19 61.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.266 -0.896 . . . . 0.0 109.39 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -48.11 -11.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.418 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.539 ' H ' ' C ' ' A' ' 29' ' ' THR . 94.5 mt -114.96 -17.45 11.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 109.552 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.49 ' C ' ' O ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -38.74 122.4 1.15 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.325 -0.859 . . . . 0.0 109.352 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.2 -10.9 36.89 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.477 ' C ' ' CD2' ' A' ' 35' ' ' PHE . 4.3 m-20 -93.5 156.71 16.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.151 -1.205 . . . . 0.0 109.381 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.477 ' CD2' ' C ' ' A' ' 34' ' ' ASP . 77.2 m-85 -146.83 134.38 20.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.201 -0.937 . . . . 0.0 109.6 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.598 ' CD2' ' NZ ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -103.63 120.02 40.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 109.329 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.495 ' HG1' ' HA ' ' A' ' 115' ' ' LYS . 59.1 p -61.9 -23.05 66.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 109.44 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.451 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -88.33 24.97 9.85 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.511 ' OD1' ' CG ' ' A' ' 20' ' ' GLU . 7.1 m-20 -159.52 135.34 8.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.283 -1.128 . . . . 0.0 109.334 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.534 ' HB1' ' HE1' ' A' ' 60' ' ' TYR . . . -77.83 140.6 39.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -0.901 . . . . 0.0 109.318 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -116.33 135.04 54.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -0.859 . . . . 0.0 109.383 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.616 ' O ' ' CZ ' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -118.92 136.37 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.414 -0.804 . . . . 0.0 109.265 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.497 ' CD1' ' C ' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -130.64 141.58 45.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.776 179.81 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.451 ' C ' ' CD2' ' A' ' 44' ' ' LEU . 4.6 tt -129.32 117.31 20.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.311 -0.868 . . . . 0.0 109.688 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.503 ' NZ ' ' OH ' ' A' ' 106' ' ' TYR . 4.6 ttmm -89.07 134.65 33.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.842 . . . . 0.0 109.38 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.6 OUTLIER -140.81 116.33 10.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.159 -0.963 . . . . 0.0 109.432 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -125.58 168.44 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.18 -0.95 . . . . 0.0 109.183 -179.816 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.765 HE22 ' H ' ' A' ' 51' ' ' ASN . 1.0 OUTLIER -115.56 123.33 48.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.564 -0.71 . . . . 0.0 109.163 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.594 ' N ' ' OE1' ' A' ' 48' ' ' GLN . 0.5 OUTLIER -103.46 100.41 10.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.285 -0.885 . . . . 0.0 109.532 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.584 ' C ' ' O ' ' A' ' 49' ' ' LEU . 19.7 mtp180 25.89 58.99 0.06 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.654 -0.654 . . . . 0.0 110.032 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.765 ' H ' HE22 ' A' ' 48' ' ' GLN . 1.8 m-20 55.23 50.54 14.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.351 -0.843 . . . . 0.0 109.382 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . -93.53 -79.71 1.45 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.419 ' O ' ' O ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -164.61 22.06 0.06 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -1.171 . . . . 0.0 109.515 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.603 ' O ' ' CD2' ' A' ' 56' ' ' TYR . 11.4 mt 56.35 104.81 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.641 0.734 . . . . 0.0 109.359 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 46' ' ' THR . 4.5 tt0 -68.71 116.29 9.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.55 -0.719 . . . . 0.0 109.236 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.603 ' CD2' ' O ' ' A' ' 54' ' ' LEU . 96.3 m-85 -104.39 115.24 30.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.364 -0.835 . . . . 0.0 109.964 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.89 155.05 36.25 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.439 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 4.3 tp -142.63 137.91 30.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.936 -1.102 . . . . 0.0 110.521 -179.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.653 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -130.02 119.55 23.32 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.524 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.552 ' HH ' HD23 ' A' ' 62' ' ' LEU . 3.6 t80 -101.57 124.44 47.23 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.01 -1.056 . . . . 0.0 109.387 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -103.81 126.64 51.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.11 -0.994 . . . . 0.0 109.799 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.552 HD23 ' HH ' ' A' ' 60' ' ' TYR . 6.4 mt -97.28 162.07 13.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.449 -0.782 . . . . 0.0 109.657 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.97 154.59 16.87 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -74.62 -12.34 60.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.056 -1.261 . . . . 0.0 109.52 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.471 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 1.2 mt-10 -109.23 30.35 6.68 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 2.1 m -130.49 97.42 4.39 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 122.075 0.94 . . . . 0.0 108.586 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.2 p -73.27 -170.88 0.85 Allowed 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.665 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -55.49 -28.18 52.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.792 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.31 -58.87 4.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 0.0 109.571 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.451 ' OE2' ' O ' ' A' ' 65' ' ' GLU . 24.3 mt-10 -62.95 -43.02 99.93 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.264 -0.898 . . . . 0.0 108.998 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.0 t -64.69 -34.68 78.88 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.454 -0.779 . . . . 0.0 108.953 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.03 -43.15 99.81 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.23 -50.33 73.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -1.125 . . . . 0.0 109.116 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.479 ' O ' ' OG1' ' A' ' 78' ' ' THR . . . -61.63 -40.02 93.38 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.469 -0.769 . . . . 0.0 109.267 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.488 ' O ' HG21 ' A' ' 79' ' ' VAL . . . -64.37 -42.7 96.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.866 . . . . 0.0 109.428 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.2 mt -55.4 -53.88 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.183 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -57.87 -32.19 67.44 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.187 -0.946 . . . . 0.0 109.228 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -69.44 -52.42 27.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.008 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.488 HG21 ' O ' ' A' ' 75' ' ' ALA . 37.7 t -56.92 -26.55 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.289 -0.882 . . . . 0.0 109.097 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -70.11 -55.9 8.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.383 -0.823 . . . . 0.0 109.295 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.497 ' CD1' ' C ' ' A' ' 81' ' ' LEU . 0.5 OUTLIER -54.17 -29.82 47.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.035 -1.041 . . . . 0.0 109.04 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 85' ' ' LEU . 72.7 m-20 -68.94 -58.77 3.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.244 -0.91 . . . . 0.0 108.806 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 82' ' ' ASP . 52.9 t0 -46.86 -29.6 2.07 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.124 -0.985 . . . . 0.0 108.465 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -75.15 -33.79 61.55 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.9 tp -107.63 25.72 11.15 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.424 -0.797 . . . . 0.0 109.375 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 85' ' ' LEU . 2.9 m120 39.09 33.9 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.582 -0.699 . . . . 0.0 109.476 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . 53.98 84.6 0.03 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 45.0 mtp85 -140.22 43.08 1.91 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.318 -1.107 . . . . 0.0 109.391 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.501 ' CB ' ' O ' ' A' ' 56' ' ' TYR . . . -150.67 170.68 18.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.858 . . . . 0.0 109.404 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.1 t -91.26 91.87 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 109.266 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.475 ' H ' ' CD ' ' A' ' 91' ' ' GLN . 2.3 mp0 -94.34 120.07 34.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -0.885 . . . . 0.0 109.49 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.603 ' NE2' ' ND1' ' A' ' 59' ' ' HIS . 3.9 p80 -127.94 134.09 49.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.359 -0.838 . . . . 0.0 109.381 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.496 ' CG ' ' O ' ' A' ' 93' ' ' ARG . 0.8 OUTLIER -90.52 117.82 29.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.718 -179.753 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.477 ' OE2' ' OG ' ' A' ' 100' ' ' SER . 11.3 mt-10 -108.28 161.13 15.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 109.354 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.7 t -132.53 158.03 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.184 -0.947 . . . . 0.0 109.538 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.548 ' C ' ' NE2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -61.98 143.79 56.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 109.443 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.53 ' N ' HE21 ' A' ' 96' ' ' GLN . . . 73.95 7.71 76.51 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -151.39 22.01 0.73 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.316 -1.108 . . . . 0.0 109.322 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -51.62 171.21 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.569 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.477 ' OG ' ' OE2' ' A' ' 94' ' ' GLU . 67.5 p -101.11 165.77 11.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.328 -0.858 . . . . 0.0 109.488 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.47 -33.21 73.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 0.0 109.487 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.2 m -59.92 -42.81 94.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.479 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -66.21 -53.46 36.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.242 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.3 mt -62.58 -27.94 69.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.352 -0.843 . . . . 0.0 109.169 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -69.35 -35.65 76.73 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.522 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 1.9 m-85 -70.13 -54.92 10.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -1.101 . . . . 0.0 109.251 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.522 ' CD2' ' O ' ' A' ' 106' ' ' TYR . 10.0 m-85 -139.36 115.57 10.4 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.425 -0.797 . . . . 0.0 109.562 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.8 tttp -98.72 -52.02 3.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.313 -0.867 . . . . 0.0 109.52 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 m -92.61 23.11 4.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 109.467 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -119.16 -30.27 1.62 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.0 mt -63.8 123.39 18.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.221 -1.164 . . . . 0.0 109.509 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -137.12 102.65 4.9 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.305 -0.872 . . . . 0.0 109.448 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.69 136.42 35.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.905 . . . . 0.0 109.373 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.598 ' NZ ' ' CD2' ' A' ' 36' ' ' PHE . 9.5 pttp -131.54 147.38 52.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 109.464 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.495 ' HA ' ' HG1' ' A' ' 37' ' ' THR . 0.1 OUTLIER -107.74 153.25 23.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.353 -0.842 . . . . 0.0 109.433 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 117' ' ' GLY . . . -163.67 143.54 8.71 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 118' ' ' VAL . . . -42.96 -55.24 4.91 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 117' ' ' GLY . 32.4 t 44.21 -105.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -1.123 . . . . 0.0 109.417 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.408 ' N ' HG11 ' A' ' 118' ' ' VAL . . . -81.44 54.52 2.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.172 -0.955 . . . . 0.0 109.508 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.9 p -58.42 -78.0 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.88 . . . . 0.0 109.533 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 158.59 100.48 0.17 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -46.16 -63.88 0.88 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -1.127 . . . . 0.0 109.539 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.41 ' HG2' ' H ' ' A' ' 124' ' ' HIS . 38.0 tttt -93.09 -133.68 0.15 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.371 -0.831 . . . . 0.0 109.492 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . 0.41 ' H ' ' HG2' ' A' ' 123' ' ' LYS . 5.1 t-80 -148.17 35.15 0.81 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 109.392 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . 0.693 HG23 ' H ' ' A' ' 126' ' ' VAL . 0.9 OUTLIER -110.37 -171.82 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.237 -0.914 . . . . 0.0 109.342 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.693 ' H ' HG23 ' A' ' 125' ' ' VAL . 7.4 p -174.32 118.17 0.35 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 109.307 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -76.94 83.5 2.11 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.274 1.983 . . . . 0.0 112.268 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.579 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 4.9 p-10 -90.27 149.87 22.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 109.473 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -172.42 62.08 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.867 . . . . 0.0 109.337 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 6.3 p -79.11 87.35 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.276 -0.89 . . . . 0.0 109.638 -179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.511 ' CG1' ' O ' ' A' ' 131' ' ' VAL . 9.5 p -83.49 118.0 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.318 -0.864 . . . . 0.0 109.477 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.1 t -77.33 -96.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.192 -0.943 . . . . 0.0 109.582 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.056 -0.974 . . . . 0.0 109.466 179.981 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.59 ' CE1' ' OE1' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -85.87 -51.3 0.49 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.941 . . . . 0.0 109.58 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 2' ' ' HIS . 65.3 Cg_endo -79.44 72.85 6.3 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.607 2.205 . . . . 0.0 112.085 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 6' ' ' LEU . 75.8 mt-10 -83.11 -30.77 27.66 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.275 -0.89 . . . . 0.0 109.708 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.51 ' CE1' ' CG1' ' A' ' 42' ' ' VAL . 46.8 t80 -43.88 -18.31 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.134 -0.979 . . . . 0.0 109.233 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.565 ' N ' ' O ' ' A' ' 4' ' ' GLU . 4.6 mt -81.4 -39.96 24.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.337 -0.852 . . . . 0.0 109.53 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 8' ' ' ALA . 28.3 mtpt -86.93 -12.83 46.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 109.615 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.471 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -42.23 164.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.193 -0.942 . . . . 0.0 109.509 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.12 26.95 5.28 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -102.04 12.53 36.71 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.205 -1.173 . . . . 0.0 109.653 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -158.3 133.69 5.79 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.915 . . . . 0.0 109.466 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -74.58 86.02 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.499 2.133 . . . . 0.0 112.34 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -170.18 -105.59 0.18 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.3 tt -162.2 144.69 11.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.311 -1.111 . . . . 0.0 109.517 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -138.02 134.73 35.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 109.375 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.49 ' HA ' HG22 ' A' ' 43' ' ' ILE . 27.1 mt -106.92 147.38 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.338 -0.851 . . . . 0.0 110.167 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.08 141.94 36.15 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 25' ' ' VAL . 18.7 ttt180 -110.39 144.85 38.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.177 -0.952 . . . . 0.0 109.635 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 52.0 t -72.48 133.51 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.436 -0.79 . . . . 0.0 109.502 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.684 ' C ' ' H ' ' A' ' 22' ' ' PHE . 28.0 tt0 -81.08 86.85 6.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -0.966 . . . . 0.0 109.366 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.463 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 26.2 mmtp 61.05 -33.09 0.08 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.487 -0.758 . . . . 0.0 109.994 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.684 ' H ' ' C ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER 179.34 27.31 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -0.932 . . . . 0.0 109.394 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -145.15 -113.52 0.09 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.083 -1.01 . . . . 0.0 109.626 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.7 mt -143.66 136.37 27.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.066 -1.021 . . . . 0.0 109.799 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 18' ' ' ARG . 0.9 OUTLIER -149.16 140.37 14.18 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.302 -0.874 . . . . 0.0 108.759 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.49 149.42 68.59 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.551 2.167 . . . . 0.0 112.516 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 71.6 t -117.94 101.82 51.56 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.492 -0.755 . . . . 0.0 109.207 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -80.84 167.91 18.0 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.655 2.237 . . . . 0.0 112.461 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.6 ' C ' ' H ' ' A' ' 31' ' ' LEU . 1.9 t -61.03 -173.91 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.546 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.464 ' N ' ' OG1' ' A' ' 29' ' ' THR . 8.1 t30 70.31 -27.71 0.17 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.861 . . . . 0.0 109.343 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.6 ' H ' ' C ' ' A' ' 29' ' ' THR . 43.5 mt -122.73 -33.41 3.39 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.392 -0.818 . . . . 0.0 109.369 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -48.59 165.13 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 0.0 109.319 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.468 ' N ' ' CD1' ' A' ' 32' ' ' TYR . . . 89.04 -24.08 14.85 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -96.71 150.76 20.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -1.182 . . . . 0.0 109.469 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -141.03 134.17 29.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.898 . . . . 0.0 109.418 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.546 ' C ' ' H ' ' A' ' 38' ' ' GLY . 25.6 m-85 -104.53 111.78 24.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.872 . . . . 0.0 109.482 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.469 ' OG1' ' OE1' ' A' ' 65' ' ' GLU . 19.6 p -51.55 -9.51 0.08 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.237 -0.915 . . . . 0.0 109.356 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 36' ' ' PHE . . . -99.51 27.12 21.64 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.443 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 50.2 m-20 -161.01 146.76 14.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -1.086 . . . . 0.0 109.368 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.437 ' C ' ' CD2' ' A' ' 41' ' ' TYR . . . -92.23 158.88 15.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.192 -0.942 . . . . 0.0 109.483 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.437 ' CD2' ' C ' ' A' ' 40' ' ' ALA . 36.4 m-85 -138.26 138.12 38.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 109.369 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.523 ' C ' ' CD1' ' A' ' 43' ' ' ILE . 0.1 OUTLIER -108.83 128.44 64.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.129 -0.982 . . . . 0.0 108.902 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.523 ' CD1' ' C ' ' A' ' 42' ' ' VAL . 0.4 OUTLIER -125.76 136.97 59.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.242 -0.911 . . . . 0.0 110.023 -179.523 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 tt -124.55 128.85 49.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.545 -0.722 . . . . 0.0 109.582 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.51 ' HZ2' HG21 ' A' ' 102' ' ' THR . 30.3 ttpt -103.79 145.96 29.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.311 -0.868 . . . . 0.0 109.06 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 13' ' ' GLY . 1.0 OUTLIER -143.01 126.78 17.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 109.764 -179.681 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.659 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -131.94 168.09 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.29 -0.881 . . . . 0.0 109.16 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -96.82 131.86 43.13 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.597 -0.689 . . . . 0.0 109.497 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 50' ' ' ARG . 14.5 mt -96.92 166.93 11.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.301 -0.874 . . . . 0.0 109.538 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.43 ' H ' ' HD2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -45.18 -78.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.272 -0.892 . . . . 0.0 109.17 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -45.53 -28.97 1.04 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.291 -0.881 . . . . 0.0 109.252 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.55 69.07 1.03 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.499 ' O ' ' O ' ' A' ' 54' ' ' LEU . 63.5 m-20 -120.73 14.44 11.72 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.242 -1.152 . . . . 0.0 109.384 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.659 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 17.7 mt 44.1 97.05 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.509 0.671 . . . . 0.0 109.364 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -71.08 112.08 6.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.428 -0.795 . . . . 0.0 109.527 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.59 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 73.7 m-85 -95.74 114.54 26.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.136 -0.978 . . . . 0.0 109.701 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -115.78 155.38 27.92 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.452 HD11 ' N ' ' A' ' 58' ' ' LEU . 3.8 mp -132.3 141.1 48.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.815 -1.178 . . . . 0.0 110.884 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.484 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -136.7 112.43 9.46 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.233 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.735 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -94.38 126.93 39.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.086 -1.008 . . . . 0.0 109.458 -179.6 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.441 ' HE1' ' HG2' ' A' ' 99' ' ' GLU . 2.3 t90 -98.08 124.73 42.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.475 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 mt -107.64 145.86 32.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.532 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -95.01 158.87 22.59 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -76.23 -12.53 60.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.322 -1.105 . . . . 0.0 109.662 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.469 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 1.1 mt-10 -109.45 29.16 7.82 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 2.0 m -130.7 97.48 4.37 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.211 1.005 . . . . 0.0 108.579 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.8 t -57.35 -170.92 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.735 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.562 ' O ' ' N ' ' A' ' 72' ' ' GLY . 3.2 mm100 -68.99 -17.39 63.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -0.86 . . . . 0.0 109.647 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -61.02 -58.75 7.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 109.394 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -64.38 -49.08 73.0 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.237 -0.914 . . . . 0.0 108.884 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.3 m -64.43 -23.22 67.21 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.399 -0.813 . . . . 0.0 108.844 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -68.44 -47.09 59.62 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.433 ' O ' ' CE2' ' A' ' 77' ' ' PHE . . . -62.63 -49.25 75.92 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.293 -1.122 . . . . 0.0 109.138 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.62 -32.51 74.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.507 -0.746 . . . . 0.0 109.214 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.556 ' O ' HG22 ' A' ' 79' ' ' VAL . . . -71.59 -43.96 65.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.264 -0.898 . . . . 0.0 109.376 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.496 ' O ' ' OE1' ' A' ' 80' ' ' GLN . 59.4 mt -55.09 -53.17 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.188 -0.945 . . . . 0.0 109.24 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . 0.559 ' CD1' ' N ' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -60.0 -36.57 77.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.134 179.784 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.1 m -69.2 -31.42 70.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.283 -0.886 . . . . 0.0 108.999 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 75' ' ' ALA . 55.1 t -64.83 -46.09 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.271 -0.893 . . . . 0.0 109.242 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . 0.552 ' N ' ' OE1' ' A' ' 80' ' ' GLN . 5.1 mp0 -60.97 -45.42 94.82 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.6 mt -53.27 -43.93 67.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.315 -0.866 . . . . 0.0 109.037 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.64 ' O ' ' N ' ' A' ' 86' ' ' ASN . 68.4 t0 -58.14 -58.23 9.37 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.396 -0.815 . . . . 0.0 109.145 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 82' ' ' ASP . 1.9 m-20 -44.73 -34.41 2.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.155 -0.966 . . . . 0.0 108.948 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -77.08 -30.94 55.69 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.299 -0.876 . . . . 0.0 108.98 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 82' ' ' ASP . 18.7 mt -121.56 32.39 5.91 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.315 -0.866 . . . . 0.0 109.486 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.64 ' N ' ' O ' ' A' ' 82' ' ' ASP . 60.8 t30 -81.08 28.28 0.37 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.207 -0.933 . . . . 0.0 109.097 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.473 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -110.45 -37.26 1.79 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -163.23 67.78 0.2 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.154 -1.204 . . . . 0.0 109.45 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.07 166.17 24.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.0 109.321 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.9 t -123.12 96.34 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.342 -0.849 . . . . 0.0 109.545 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.58 131.38 44.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.315 -0.865 . . . . 0.0 109.036 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.569 ' CD2' ' N ' ' A' ' 92' ' ' HIS . 1.6 p80 -150.55 157.36 42.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.006 -1.059 . . . . 0.0 110.037 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.71 121.34 40.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.407 -0.808 . . . . 0.0 109.666 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.447 ' N ' ' CD ' ' A' ' 94' ' ' GLU . 1.5 mp0 -104.69 120.93 42.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.296 -0.878 . . . . 0.0 109.407 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.9 t -101.18 166.72 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.317 -0.865 . . . . 0.0 109.581 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -76.17 140.87 41.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.493 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.424 ' O ' ' CG ' ' A' ' 98' ' ' PHE . . . 80.51 5.02 90.1 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.472 ' O ' ' O ' ' A' ' 99' ' ' GLU . 46.1 m-85 -157.64 22.42 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -1.126 . . . . 0.0 109.457 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' A' ' 98' ' ' PHE . 97.3 mt-10 -49.05 178.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.405 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.3 t -89.63 163.09 15.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.424 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.08 -26.73 67.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.404 -0.81 . . . . 0.0 109.433 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.51 HG21 ' HZ2' ' A' ' 45' ' ' LYS . 7.5 m -65.62 -41.72 92.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.485 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -75.26 -41.95 56.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.372 -0.83 . . . . 0.0 109.336 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.5 mt -62.46 -24.68 67.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.271 -0.893 . . . . 0.0 109.519 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -92.94 -24.02 23.87 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.11 -35.77 69.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.274 -1.133 . . . . 0.0 109.417 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -139.16 133.82 31.97 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.328 -0.858 . . . . 0.0 109.529 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.434 ' HG3' ' H ' ' A' ' 109' ' ' SER . 1.8 pttp -108.59 -55.45 2.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.436 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . 0.434 ' H ' ' HG3' ' A' ' 108' ' ' LYS . 2.4 t -105.56 15.36 27.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 109.532 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.45 -20.01 18.84 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.5 mt -72.61 70.66 0.94 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -1.18 . . . . 0.0 109.438 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -85.4 124.04 31.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.291 -0.881 . . . . 0.0 109.581 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -105.29 152.76 22.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.485 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.4 mttt -138.83 163.65 31.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.329 -0.857 . . . . 0.0 109.416 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.8 mttt -116.38 126.75 53.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.313 -0.867 . . . . 0.0 109.461 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 60.51 -100.36 0.22 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 145.2 173.25 16.29 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.3 m -144.54 140.9 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -1.127 . . . . 0.0 109.426 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . 0.403 ' O ' ' OG ' ' A' ' 120' ' ' SER . . . -157.54 134.77 10.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 109.481 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' SER . . . . . 0.403 ' OG ' ' O ' ' A' ' 119' ' ' ALA . 4.4 m -174.69 -27.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.194 -0.942 . . . . 0.0 109.519 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.34 66.24 0.98 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -53.01 -44.51 67.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -1.131 . . . . 0.0 109.496 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp -101.69 -84.39 0.44 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -0.859 . . . . 0.0 109.454 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -142.14 104.32 4.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.889 . . . . 0.0 109.544 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 7.3 p -72.98 -13.06 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.268 -0.895 . . . . 0.0 109.467 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.47 ' O ' HG23 ' A' ' 126' ' ' VAL . 6.2 p -149.7 76.67 8.91 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.875 . . . . 0.0 109.407 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.484 ' O ' ' O ' ' A' ' 128' ' ' ASN . 50.5 Cg_exo -49.19 -69.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.792 2.328 . . . . 0.0 112.192 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 127' ' ' PRO . 15.6 t30 53.43 105.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 0.0 109.38 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -138.47 -166.56 2.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -0.942 . . . . 0.0 109.397 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.9 t -65.53 -56.63 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.286 -0.884 . . . . 0.0 109.506 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 6.5 p -46.23 104.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.471 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' A' ' 133' ' ' GLN . 7.6 p -76.47 -15.71 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -0.932 . . . . 0.0 109.461 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 132' ' ' VAL . 3.6 tp-100 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.891 -1.052 . . . . 0.0 109.534 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 24' ' ' LEU . 29.3 mt-10 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -176.53 96.15 0.25 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.374 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.613 ' HA ' HD21 ' A' ' 24' ' ' LEU . 54.0 Cg_exo -48.61 90.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.563 2.176 . . . . 0.0 112.116 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.497 ' OE2' ' CH2' ' A' ' 17' ' ' TRP . 19.6 tt0 -83.23 -44.03 15.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 109.982 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.466 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 5.4 m-85 -49.35 -28.73 5.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.185 -0.947 . . . . 0.0 109.435 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.5 mt -74.78 -29.22 61.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 109.597 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.6 mmtm -123.76 26.38 7.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -0.911 . . . . 0.0 109.523 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 4' ' ' GLU . . . -81.35 173.3 12.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.354 -0.841 . . . . 0.0 109.568 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.32 44.8 0.17 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.92 30.54 3.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.381 -1.07 . . . . 0.0 109.497 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.542 ' OE1' ' NE2' ' A' ' 15' ' ' GLN . 1.2 pm0 -164.14 117.17 1.01 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.173 -0.955 . . . . 0.0 109.367 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -77.67 89.47 1.33 Allowed 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.432 2.088 . . . . 0.0 112.088 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -177.98 -98.34 0.11 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -162.06 138.51 7.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -1.142 . . . . 0.0 109.638 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.542 ' NE2' ' OE1' ' A' ' 11' ' ' GLU . 19.1 mt-30 -114.99 135.89 53.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.435 -0.791 . . . . 0.0 108.974 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.62 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 13.1 mt -130.19 116.53 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.345 -0.847 . . . . 0.0 110.114 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TRP . . . . . 0.62 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 7.6 m0 -144.2 152.16 40.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.054 -1.029 . . . . 0.0 109.116 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.58 ' O ' ' N ' ' A' ' 25' ' ' VAL . 0.9 OUTLIER -101.84 153.29 19.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.93 . . . . 0.0 109.801 -179.283 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.5 t -97.47 131.2 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.42 -0.8 . . . . 0.0 109.538 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.696 ' C ' ' H ' ' A' ' 22' ' ' PHE . 1.9 tm-20 -76.83 86.65 3.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.132 -0.98 . . . . 0.0 108.732 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.6 ' O ' ' CB ' ' A' ' 22' ' ' PHE . 25.2 mtmm 48.31 3.86 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.375 -0.828 . . . . 0.0 109.539 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.696 ' H ' ' C ' ' A' ' 20' ' ' GLU . 1.4 t80 155.59 -30.22 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.424 -0.797 . . . . 0.0 109.472 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -81.62 -133.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.171 -0.956 . . . . 0.0 109.844 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.613 HD21 ' HA ' ' A' ' 3' ' ' PRO . 0.2 OUTLIER -137.03 140.13 41.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -0.916 . . . . 0.0 109.607 -179.767 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.58 ' N ' ' O ' ' A' ' 18' ' ' ARG . 9.4 t -137.79 91.6 13.47 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 108.999 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -52.42 159.35 4.56 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.654 2.236 . . . . 0.0 112.574 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.1 t -145.25 112.83 4.77 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.354 -0.841 . . . . 0.0 109.077 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 29' ' ' THR . 60.0 Cg_endo -77.88 168.14 22.66 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.44 2.093 . . . . 0.0 112.468 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . 0.616 ' C ' ' H ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -51.73 -174.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.389 -0.819 . . . . 0.0 109.361 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.573 ' N ' ' OG1' ' A' ' 29' ' ' THR . 0.3 OUTLIER 69.17 -36.76 0.35 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.17 -0.956 . . . . 0.0 109.222 -179.788 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.616 ' H ' ' C ' ' A' ' 29' ' ' THR . 14.4 mt -109.21 -36.36 6.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.442 -0.786 . . . . 0.0 109.198 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 31' ' ' LEU . 1.9 p90 -43.22 166.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.348 -0.845 . . . . 0.0 109.376 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.89 -12.88 15.38 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 32' ' ' TYR . 1.1 m-20 -87.3 158.81 18.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.212 -1.17 . . . . 0.0 109.481 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -144.99 108.42 4.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 109.56 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.529 ' C ' ' H ' ' A' ' 38' ' ' GLY . 2.8 m-85 -80.32 111.91 17.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 109.136 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.44 ' OG1' ' OE1' ' A' ' 65' ' ' GLU . 8.7 p -56.65 -4.97 0.18 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.185 -0.947 . . . . 0.0 109.618 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.529 ' H ' ' C ' ' A' ' 36' ' ' PHE . . . -109.7 39.09 3.03 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.529 ' N ' ' SG ' ' A' ' 66' ' ' CYS . 8.2 m-20 -169.34 -176.38 2.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -1.173 . . . . 0.0 109.622 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.51 129.37 50.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.372 -0.83 . . . . 0.0 109.343 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -114.07 137.31 51.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 109.688 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.466 ' HB ' ' CD1' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -115.24 142.82 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.297 -0.877 . . . . 0.0 109.18 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.46 HD13 HG23 ' A' ' 43' ' ' ILE . 0.7 OUTLIER -136.34 143.2 36.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.108 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.8 tt -128.05 118.97 24.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.484 -0.76 . . . . 0.0 109.238 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 50.2 tttt -88.85 138.74 31.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 109.426 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -141.64 114.37 8.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.93 . . . . 0.0 109.477 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.675 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -126.03 168.04 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 121.13 -0.981 . . . . 0.0 109.069 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -100.92 101.37 12.17 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.675 -0.641 . . . . 0.0 109.395 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.6 mt -57.04 163.86 1.87 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.933 . . . . 0.0 109.434 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.404 ' HG3' ' H ' ' A' ' 51' ' ' ASN . 21.2 ptt85 -48.82 -47.65 42.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 0.0 109.308 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.404 ' H ' ' HG3' ' A' ' 50' ' ' ARG . 4.0 m120 -70.65 -30.1 66.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.176 -0.952 . . . . 0.0 109.158 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.47 34.93 3.99 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.501 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.6 t-20 -89.97 13.39 14.85 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.183 -1.187 . . . . 0.0 109.325 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.675 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.4 mt 43.38 96.97 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.578 0.704 . . . . 0.0 109.456 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -71.17 116.16 11.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.551 -0.718 . . . . 0.0 109.581 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.54 ' CD1' ' O ' ' A' ' 54' ' ' LEU . 90.4 m-85 -100.7 114.7 28.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 0.0 109.858 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.7 155.16 34.48 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.449 ' C ' ' CG ' ' A' ' 59' ' ' HIS . 5.2 mp -132.62 147.79 52.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.967 -1.083 . . . . 0.0 110.466 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . 0.462 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 1.4 m-70 -150.34 127.17 11.03 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.628 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 1.1 p90 -115.18 132.69 56.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.045 -1.035 . . . . 0.0 109.941 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.458 ' CE3' ' O ' ' A' ' 62' ' ' LEU . 10.3 t90 -102.97 123.88 47.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.375 -0.828 . . . . 0.0 109.238 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.458 ' O ' ' CE3' ' A' ' 61' ' ' TRP . 22.7 mt -101.85 162.12 13.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 109.657 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.03 154.61 16.49 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -82.15 -12.09 58.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -1.128 . . . . 0.0 109.572 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.44 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 2.8 mt-10 -106.58 29.09 7.23 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.555 ' SG ' ' OE1' ' A' ' 70' ' ' GLU . 1.6 m -130.64 97.55 4.4 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 122.15 0.976 . . . . 0.0 108.381 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 66' ' ' CYS . 9.9 m -39.03 161.57 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.707 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 72' ' ' GLY . 15.9 mm-40 -56.2 -17.41 7.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.389 -0.819 . . . . 0.0 109.661 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -63.98 -58.56 6.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 109.371 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.555 ' OE1' ' SG ' ' A' ' 66' ' ' CYS . 24.2 mt-10 -61.06 -54.26 46.95 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.345 -0.847 . . . . 0.0 108.987 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 p -64.13 -26.22 68.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.318 -0.864 . . . . 0.0 109.043 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.38 -41.77 66.75 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.14 -46.74 82.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -1.18 . . . . 0.0 109.28 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.12 -46.31 89.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.427 -0.795 . . . . 0.0 109.07 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.39 -41.53 80.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.345 -0.847 . . . . 0.0 109.26 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 51.0 mt -57.68 -46.24 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.278 -0.889 . . . . 0.0 109.279 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -59.03 -35.34 73.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 109.143 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.7 m -72.34 -25.55 61.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.183 -0.948 . . . . 0.0 109.038 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.4 t -72.77 -48.77 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.306 -0.871 . . . . 0.0 109.541 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -65.86 -35.94 82.07 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.141 -0.975 . . . . 0.0 108.85 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.85 -42.56 98.04 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.628 ' O ' ' N ' ' A' ' 86' ' ' ASN . 51.9 t0 -61.16 -57.35 12.85 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.315 -0.865 . . . . 0.0 109.214 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -48.43 -31.38 6.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.142 -0.974 . . . . 0.0 108.707 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -78.59 -31.12 47.06 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.423 -0.798 . . . . 0.0 108.882 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.543 ' C ' ' H ' ' A' ' 87' ' ' GLY . 9.9 mt -121.71 32.7 5.77 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.435 -0.79 . . . . 0.0 109.518 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.628 ' N ' ' O ' ' A' ' 82' ' ' ASP . 17.8 t-20 -77.35 27.03 0.16 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.243 -0.91 . . . . 0.0 109.024 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -94.34 -48.41 2.6 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -152.21 45.61 0.74 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.168 -1.196 . . . . 0.0 109.638 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 56' ' ' TYR . . . -136.95 157.46 46.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.431 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 19.2 t -136.05 141.37 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 109.466 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.423 ' CD ' ' N ' ' A' ' 91' ' ' GLN . 6.8 mm-40 -88.95 142.47 27.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.212 -0.93 . . . . 0.0 109.37 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.492 ' O ' ' OE1' ' A' ' 94' ' ' GLU . 15.3 m-70 -118.29 115.24 24.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.268 -0.895 . . . . 0.0 109.461 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.84 104.92 15.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.233 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.589 ' OE2' ' CE2' ' A' ' 103' ' ' PHE . 1.5 mp0 -104.62 124.09 48.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.877 . . . . 0.0 109.65 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.1 t -125.76 155.56 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.312 -0.867 . . . . 0.0 109.17 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -55.54 115.98 2.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.19 -0.943 . . . . 0.0 109.624 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.519 ' O ' ' CD1' ' A' ' 98' ' ' PHE . . . 93.34 10.18 59.68 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 78.8 m-85 -152.94 25.37 0.56 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.179 -1.189 . . . . 0.0 109.669 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.407 ' H ' ' CD ' ' A' ' 99' ' ' GLU . 2.1 mp0 -48.19 135.52 13.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.119 -0.988 . . . . 0.0 109.428 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.5 t -61.46 171.42 1.46 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.104 -0.998 . . . . 0.0 109.552 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.11 -65.06 0.82 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 109.593 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.0 m -50.55 -27.39 6.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 109.308 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.589 ' CE2' ' OE2' ' A' ' 94' ' ' GLU . 32.0 t80 -74.82 -55.59 5.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 0.0 109.799 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.439 HD11 ' C ' ' A' ' 104' ' ' LEU . 1.6 pp -67.18 -22.08 65.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.057 -1.027 . . . . 0.0 109.372 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.76 -33.12 34.86 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -78.4 -43.82 26.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -1.127 . . . . 0.0 109.422 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.454 ' HB2' HD23 ' A' ' 111' ' ' LEU . 51.8 m-85 -102.21 105.83 16.57 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.397 -0.814 . . . . 0.0 109.579 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -111.65 -49.85 2.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.358 -0.839 . . . . 0.0 109.513 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.0 t -106.04 23.16 14.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.094 -1.003 . . . . 0.0 109.514 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.575 ' O ' ' N ' ' A' ' 112' ' ' LYS . . . -125.18 -15.41 3.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.454 HD23 ' HB2' ' A' ' 107' ' ' PHE . 95.2 mt -62.13 70.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -1.176 . . . . 0.0 109.508 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.575 ' N ' ' O ' ' A' ' 110' ' ' GLY . 29.4 tttt -93.25 108.49 20.11 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.202 -0.936 . . . . 0.0 109.565 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.66 143.79 27.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.369 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -133.54 115.99 15.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 0.0 109.426 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -75.04 163.13 27.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.87 . . . . 0.0 109.47 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.08 -162.04 35.02 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -175.41 -74.45 0.05 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . 0.486 ' O ' ' CG1' ' A' ' 118' ' ' VAL . 7.6 p -79.1 116.83 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.27 -1.136 . . . . 0.0 109.427 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.75 -75.24 0.07 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.308 -0.87 . . . . 0.0 109.484 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 70.2 m -65.69 -107.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.218 -0.926 . . . . 0.0 109.409 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 140.26 -109.65 0.63 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -166.39 3.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.386 -1.067 . . . . 0.0 109.388 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -66.81 -62.28 1.53 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 0.0 109.507 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -97.21 97.74 9.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 109.489 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -104.23 79.92 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.341 -0.849 . . . . 0.0 109.449 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.512 ' O ' ' O ' ' A' ' 127' ' ' PRO . 30.6 m -143.67 81.17 12.27 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 109.433 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.512 ' O ' ' O ' ' A' ' 126' ' ' VAL . 48.5 Cg_exo -52.16 -145.72 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.747 2.298 . . . . 0.0 112.318 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 62.76 24.85 14.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.186 -0.946 . . . . 0.0 109.256 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -51.1 161.24 0.42 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.325 -0.859 . . . . 0.0 109.515 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 9.1 p -75.46 165.25 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.342 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.517 ' CG1' ' O ' ' A' ' 131' ' ' VAL . 9.2 p -64.19 116.13 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.166 -0.959 . . . . 0.0 109.466 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 69.8 t -83.17 -25.2 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.196 -0.94 . . . . 0.0 109.505 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.382 179.997 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 N--CA 1.49 1.278 0 CA-C-O 121.216 0.423 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.574 ' O ' ' N ' ' A' ' 8' ' ' ALA . 16.7 mt-10 -83.34 -39.68 20.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 110.138 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.715 ' CE2' HG12 ' A' ' 42' ' ' VAL . 23.5 t80 -61.78 -46.81 87.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.133 -0.979 . . . . 0.0 109.866 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.579 ' H ' HD12 ' A' ' 6' ' ' LEU . 3.4 mp -71.84 -32.99 68.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.068 -1.02 . . . . 0.0 109.439 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.9 mmtm -94.78 0.88 55.3 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.257 -0.902 . . . . 0.0 109.459 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 4' ' ' GLU . . . -52.1 153.74 2.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 109.424 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 137.52 68.42 0.05 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -144.66 8.14 1.3 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.24 -1.153 . . . . 0.0 109.567 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -166.61 126.76 1.19 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 109.243 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.85 94.56 1.0 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.405 2.07 . . . . 0.0 112.213 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -174.18 -104.18 0.17 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.6 tp -156.01 134.42 11.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.366 -1.079 . . . . 0.0 109.764 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -126.55 131.93 51.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.866 . . . . 0.0 109.357 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.6 mt -108.0 137.1 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -0.799 . . . . 0.0 109.758 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -139.5 166.19 25.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.261 -0.899 . . . . 0.0 109.063 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -144.96 142.16 29.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.126 -0.984 . . . . 0.0 109.725 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 19' ' ' VAL . 7.6 p -79.76 127.95 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.292 -0.88 . . . . 0.0 109.566 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.529 ' CB ' HG21 ' A' ' 25' ' ' VAL . 2.6 mm-40 -164.18 134.47 4.16 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.298 -0.876 . . . . 0.0 109.267 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 29.4 tttm 75.99 41.62 0.23 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.369 -0.832 . . . . 0.0 109.56 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 48.33 43.62 19.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.173 -0.954 . . . . 0.0 109.444 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -173.33 -172.05 0.76 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.896 . . . . 0.0 109.459 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.549 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.9 mm? -88.49 138.15 31.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.529 HG21 ' CB ' ' A' ' 20' ' ' GLU . 5.0 t -138.83 128.36 14.45 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.219 -0.926 . . . . 0.0 109.253 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -74.95 166.36 29.39 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.36 2.04 . . . . 0.0 112.355 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.6 t -111.12 101.3 49.86 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.367 -0.833 . . . . 0.0 109.404 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -53.27 168.08 0.67 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.533 2.155 . . . . 0.0 112.363 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.559 HG22 ' N ' ' A' ' 30' ' ' ASN . 24.5 m -60.16 170.56 1.23 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.342 -0.849 . . . . 0.0 109.032 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.559 ' N ' HG22 ' A' ' 29' ' ' THR . 0.9 OUTLIER 69.69 -40.91 0.47 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.205 -0.934 . . . . 0.0 109.195 -179.726 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.502 ' H ' ' C ' ' A' ' 29' ' ' THR . 96.0 mt -81.79 -44.22 17.27 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.376 -0.828 . . . . 0.0 109.209 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 33' ' ' GLY . 0.3 OUTLIER -53.42 138.33 33.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.359 -0.838 . . . . 0.0 109.138 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.498 ' N ' ' CD1' ' A' ' 32' ' ' TYR . . . 109.43 -8.99 32.86 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -121.81 115.5 22.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.351 -1.088 . . . . 0.0 109.375 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -87.86 140.07 29.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 109.589 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -102.17 146.19 28.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.334 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 p -92.42 -8.93 43.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 109.468 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.434 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -107.94 35.79 4.78 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 9.7 m-20 -167.57 171.98 9.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.333 -1.098 . . . . 0.0 109.497 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.94 141.2 48.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 109.546 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -116.24 134.75 54.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.392 -0.817 . . . . 0.0 109.472 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.034 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -114.13 124.47 70.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.21 -0.931 . . . . 0.0 108.603 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.034 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -121.33 133.8 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.174 -0.954 . . . . 0.0 110.03 -178.417 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.0 tt -122.68 121.65 36.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.504 -0.747 . . . . 0.0 109.906 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -96.56 141.87 29.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.371 -0.831 . . . . 0.0 108.954 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.529 ' O ' ' N ' ' A' ' 13' ' ' GLY . 29.1 m -137.17 128.05 27.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.037 -1.039 . . . . 0.0 109.72 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -132.68 168.72 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 O-C-N 121.223 -0.923 . . . . 0.0 109.231 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -102.82 103.57 13.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.574 -0.704 . . . . 0.0 109.464 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.8 mt -72.7 169.01 17.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.282 -0.886 . . . . 0.0 109.711 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.42 ' C ' ' N ' ' A' ' 52' ' ' GLY . 14.7 mtt180 -45.52 -72.83 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.265 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 50' ' ' ARG . 19.4 t-20 -44.97 -24.18 0.2 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 109.255 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' A' ' 50' ' ' ARG . . . 84.62 32.96 20.57 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.488 ' O ' ' O ' ' A' ' 54' ' ' LEU . 3.5 m-20 -86.58 14.26 7.19 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.165 -1.197 . . . . 0.0 109.205 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.59 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 12.6 mt 47.15 100.27 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.544 0.688 . . . . 0.0 109.608 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.597 ' NE2' ' H ' ' A' ' 56' ' ' TYR . 3.2 tm0? -68.57 145.35 54.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.573 -0.704 . . . . 0.0 109.129 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.597 ' H ' ' NE2' ' A' ' 55' ' ' GLN . 91.3 m-85 -129.77 114.67 16.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.923 . . . . 0.0 109.925 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.413 ' OD1' ' OE1' ' A' ' 55' ' ' GLN . 70.7 m-20 -123.93 155.48 38.06 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -150.35 142.76 24.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.683 -1.261 . . . . 0.0 110.983 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.418 ' ND1' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -120.71 133.91 55.32 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.277 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.649 ' CZ ' HD22 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -105.14 115.38 30.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.361 -0.837 . . . . 0.0 109.366 -179.653 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.539 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 36.0 t90 -106.9 135.38 48.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.212 -0.93 . . . . 0.0 109.939 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.649 HD22 ' CZ ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -124.27 162.18 24.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.379 -0.826 . . . . 0.0 109.501 179.627 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -96.31 161.77 22.45 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -82.11 -11.88 58.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.277 -1.131 . . . . 0.0 109.614 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -104.26 30.83 4.99 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.516 ' SG ' ' CD ' ' A' ' 70' ' ' GLU . 1.2 m -130.73 97.53 4.38 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.162 0.982 . . . . 0.0 108.433 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 66' ' ' CYS . 1.5 m -47.09 178.05 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.694 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.497 ' O ' ' N ' ' A' ' 72' ' ' GLY . 10.0 mp0 -61.22 -18.07 56.45 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.235 -0.915 . . . . 0.0 109.534 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -64.42 -58.78 5.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 0.0 109.359 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.516 ' CD ' ' SG ' ' A' ' 66' ' ' CYS . 25.5 mt-10 -66.02 -44.5 84.54 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 108.824 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.85 -25.69 66.54 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.523 -0.736 . . . . 0.0 109.03 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.07 -47.01 48.26 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.74 91.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.271 -1.135 . . . . 0.0 109.193 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.404 ' HB1' ' CE1' ' A' ' 60' ' ' TYR . . . -61.32 -49.47 76.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.401 -0.812 . . . . 0.0 109.195 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.577 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -62.75 -34.73 77.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.273 -0.892 . . . . 0.0 109.537 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.2 mt -57.26 -54.63 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.934 . . . . 0.0 109.418 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -60.51 -33.47 72.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.108 -0.995 . . . . 0.0 109.47 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 m -69.72 -40.18 76.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.244 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 75' ' ' ALA . 81.0 t -61.81 -42.12 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.417 -0.802 . . . . 0.0 109.319 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -60.31 -51.32 70.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.009 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.6 mt -49.29 -43.1 43.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 108.951 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' A' ' 86' ' ' ASN . 19.6 t0 -57.02 -60.32 3.77 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.222 -0.924 . . . . 0.0 109.389 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.467 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 30.7 t0 -45.0 -35.86 3.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.145 -0.972 . . . . 0.0 108.88 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.505 ' CE1' HD21 ' A' ' 85' ' ' LEU . 18.1 t80 -75.89 -28.87 58.27 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.563 ' C ' ' H ' ' A' ' 87' ' ' GLY . 47.8 mt -121.49 33.46 5.52 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.432 -0.792 . . . . 0.0 109.424 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.605 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.4 OUTLIER -73.13 25.62 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 109.052 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -84.4 -58.24 2.21 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.98 35.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -1.122 . . . . 0.0 109.545 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.589 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -78.55 179.28 7.18 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.26 -0.9 . . . . 0.0 109.269 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.9 t -114.4 91.48 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.17 -0.956 . . . . 0.0 109.37 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.454 ' O ' ' CD ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -96.93 125.45 41.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.336 -0.852 . . . . 0.0 109.206 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.482 ' N ' ' CD2' ' A' ' 92' ' ' HIS . 1.8 p80 -151.48 118.68 5.93 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.036 -1.04 . . . . 0.0 109.513 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 8.5 ptt-85 -91.71 134.63 34.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.382 -0.824 . . . . 0.0 109.792 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -112.89 155.98 23.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.424 -0.797 . . . . 0.0 109.566 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.498 HG12 ' H ' ' A' ' 96' ' ' GLN . 3.7 t -121.41 169.51 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.335 -0.853 . . . . 0.0 109.486 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.498 ' H ' HG12 ' A' ' 95' ' ' VAL . 14.1 tt0 -78.31 129.35 34.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 109.425 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.4 5.21 79.61 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.48 ' O ' ' O ' ' A' ' 99' ' ' GLU . 20.2 m-85 -146.06 19.51 1.42 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -1.152 . . . . 0.0 109.463 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.48 ' O ' ' O ' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -51.68 -173.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 109.403 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.0 t -137.89 175.77 9.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 109.524 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.53 -34.53 72.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.924 . . . . 0.0 109.424 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.5 m -53.57 -47.01 70.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.53 -56.81 7.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.319 -0.863 . . . . 0.0 109.328 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.6 mt -56.36 -24.23 42.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.25 -0.906 . . . . 0.0 109.509 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.1 -30.03 26.69 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -71.01 -30.26 66.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.184 -1.186 . . . . 0.0 109.273 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -139.14 103.57 4.8 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.28 -0.888 . . . . 0.0 109.451 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -102.86 -2.72 27.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.173 -0.954 . . . . 0.0 109.52 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.5 p -66.47 -16.12 63.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.187 -0.946 . . . . 0.0 109.486 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.89 88.78 2.07 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.685 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -70.1 135.44 49.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.236 -1.155 . . . . 0.0 109.379 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -90.18 142.23 27.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.331 -0.856 . . . . 0.0 109.582 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.443 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 20.4 m-85 -106.23 111.78 24.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 109.442 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -94.12 145.23 24.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 109.43 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.356 -0.84 . . . . 0.0 109.52 -179.95 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo . . . . . 0 N--CA 1.491 1.361 0 CA-C-O 121.331 0.471 . . . . 0.0 112.174 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 8' ' ' ALA . 13.5 mm-40 -83.34 -46.04 13.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 109.872 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.616 ' CE1' ' O ' ' A' ' 42' ' ' VAL . 2.8 m-85 -67.17 -35.32 79.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.312 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.51 ' H ' HD12 ' A' ' 6' ' ' LEU . 4.2 mp -64.97 -35.23 80.52 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.293 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 8' ' ' ALA . 10.5 mttp -103.86 2.4 32.6 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.354 -0.842 . . . . 0.0 109.472 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.621 ' HB1' ' OE1' ' A' ' 15' ' ' GLN . . . -46.81 175.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.91 . . . . 0.0 109.533 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.67 10.47 21.31 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.75 6.06 9.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.27 -1.135 . . . . 0.0 109.496 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -173.28 132.89 0.62 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.926 . . . . 0.0 109.468 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.65 90.8 1.02 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.482 2.122 . . . . 0.0 112.2 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -164.33 -107.73 0.21 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 51.6 tp -157.83 142.24 16.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.295 -1.121 . . . . 0.0 109.67 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.621 ' OE1' ' HB1' ' A' ' 8' ' ' ALA . 4.0 mt-30 -126.58 136.45 52.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.422 -0.799 . . . . 0.0 109.296 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.557 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 7.1 mt -133.01 113.77 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.387 -0.821 . . . . 0.0 109.875 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.557 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 8.3 m0 -139.77 151.41 45.77 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.073 -1.017 . . . . 0.0 109.378 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.434 ' HB2' HH21 ' A' ' 18' ' ' ARG . 18.1 ttp-105 -99.17 153.11 19.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.851 . . . . 0.0 109.564 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.8 p -89.29 135.68 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.263 -0.898 . . . . 0.0 109.577 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.6 ' O ' ' N ' ' A' ' 22' ' ' PHE . 17.3 tt0 -86.93 151.03 23.66 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.169 -0.957 . . . . 0.0 109.131 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.475 ' O ' ' CD2' ' A' ' 22' ' ' PHE . 3.5 pttm -41.35 -19.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.354 -0.842 . . . . 0.0 109.515 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.6 ' N ' ' O ' ' A' ' 20' ' ' GLU . 26.2 m-85 -161.22 35.38 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.953 . . . . 0.0 109.471 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -174.65 -131.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.178 -0.951 . . . . 0.0 109.572 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.7 tp -143.33 146.23 33.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 109.526 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 t -131.09 95.07 26.04 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.463 -0.773 . . . . 0.0 109.402 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -48.18 147.78 7.91 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.58 2.187 . . . . 0.0 112.176 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.7 t -110.72 101.59 49.72 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.32 -0.862 . . . . 0.0 109.579 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -52.89 163.14 2.17 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.536 2.158 . . . . 0.0 112.402 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.601 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -64.55 175.99 1.24 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.267 -0.896 . . . . 0.0 109.042 179.641 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.452 ' N ' ' OG1' ' A' ' 29' ' ' THR . 0.8 OUTLIER 64.54 -39.26 0.24 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.411 -0.806 . . . . 0.0 109.386 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.601 ' N ' ' O ' ' A' ' 29' ' ' THR . 21.0 mt -83.77 -42.63 16.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.21 -0.931 . . . . 0.0 109.277 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.411 ' C ' ' O ' ' A' ' 31' ' ' LEU . 4.1 p90 -42.66 140.35 1.32 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.36 -0.838 . . . . 0.0 109.448 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.33 -26.35 8.22 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -94.84 154.62 17.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.337 -1.096 . . . . 0.0 109.374 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -141.34 125.64 17.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 109.56 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.549 ' C ' ' H ' ' A' ' 38' ' ' GLY . 36.2 m-85 -84.54 115.97 22.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.932 . . . . 0.0 109.372 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.408 ' H ' HG23 ' A' ' 37' ' ' THR . 1.5 p -52.95 -4.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.516 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 36' ' ' PHE . . . -111.06 32.27 6.64 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.442 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 30.6 m-20 -160.16 -173.46 4.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -1.159 . . . . 0.0 109.544 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.88 142.25 46.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.337 -0.852 . . . . 0.0 109.511 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.507 ' OH ' ' CD2' ' A' ' 36' ' ' PHE . 35.1 m-85 -121.45 138.53 54.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.331 -0.856 . . . . 0.0 109.699 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.988 ' C ' HD13 ' A' ' 43' ' ' ILE . 1.1 t -118.1 134.44 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.394 -0.816 . . . . 0.0 109.084 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.988 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -129.99 148.08 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.846 . . . . 0.0 110.206 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.484 ' CD2' ' OG1' ' A' ' 46' ' ' THR . 7.8 tt -139.33 115.87 10.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.471 -0.768 . . . . 0.0 109.597 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -93.87 120.86 34.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.435 -0.791 . . . . 0.0 109.371 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.602 ' O ' ' N ' ' A' ' 13' ' ' GLY . 2.0 m -120.6 127.56 52.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.276 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 1.4 t -134.29 168.82 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.163 -0.96 . . . . 0.0 109.394 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -105.5 115.63 30.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.709 -0.619 . . . . 0.0 109.44 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.579 HD21 ' OE1' ' A' ' 55' ' ' GLN . 86.5 mt -97.71 169.43 9.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 109.436 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.589 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -38.37 151.04 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.326 -0.859 . . . . 0.0 109.368 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 34.0 t30 68.04 -32.22 0.2 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.16 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.589 ' H ' ' C ' ' A' ' 50' ' ' ARG . . . 95.55 54.34 1.45 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 54' ' ' LEU . 16.3 t30 -88.05 6.25 37.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.21 -1.171 . . . . 0.0 109.197 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.665 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 14.5 mt 38.39 95.04 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.608 0.718 . . . . 0.0 109.658 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.579 ' OE1' HD21 ' A' ' 49' ' ' LEU . 12.2 pt20 -70.0 149.17 48.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 109.065 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.497 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 38.1 m-85 -129.78 114.97 16.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.44 -0.788 . . . . 0.0 110.01 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -124.28 155.26 38.95 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.062 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 pp -151.22 150.07 30.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.822 -1.174 . . . . 0.0 110.713 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -127.46 133.88 49.88 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.62 ' CE2' HD22 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -108.69 115.92 31.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.402 -0.811 . . . . 0.0 109.208 -179.651 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.59 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 17.4 t90 -109.31 133.49 52.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 109.988 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.62 HD22 ' CE2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -127.48 162.15 27.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.397 -0.814 . . . . 0.0 109.292 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.68 153.73 21.38 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -82.23 -11.78 58.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.24 -1.153 . . . . 0.0 109.529 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.11 35.15 3.25 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.683 ' SG ' ' O ' ' A' ' 66' ' ' CYS . 15.9 p -130.09 98.12 4.66 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 122.471 1.129 . . . . 0.0 108.891 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 66' ' ' CYS . 18.4 m -37.0 159.28 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.045 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.553 ' O ' ' N ' ' A' ' 72' ' ' GLY . 39.4 mt-30 -52.11 -17.8 1.21 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.41 -0.806 . . . . 0.0 109.662 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -62.37 -58.56 7.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 0.0 109.386 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.68 -49.4 73.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.361 -0.837 . . . . 0.0 108.854 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.29 -22.55 66.3 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.303 -0.873 . . . . 0.0 108.947 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -73.11 -43.9 37.95 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.94 -44.84 91.64 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.216 -1.167 . . . . 0.0 109.231 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.14 -43.69 98.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.367 -0.833 . . . . 0.0 109.053 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.478 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -58.28 -44.91 88.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.254 -0.904 . . . . 0.0 109.046 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.9 mt -54.14 -50.84 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.391 -0.818 . . . . 0.0 109.074 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -53.79 -38.26 64.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.853 . . . . 0.0 109.122 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.2 m -68.97 -48.92 61.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.407 -0.808 . . . . 0.0 108.978 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 75' ' ' ALA . 42.2 t -57.63 -33.35 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.311 -0.868 . . . . 0.0 109.018 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -42.2 81.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.358 -0.838 . . . . 0.0 108.929 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.77 -42.89 80.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 0.0 108.96 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 85' ' ' LEU . 5.9 t0 -62.54 -56.94 13.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.105 -0.997 . . . . 0.0 108.904 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -47.3 -31.14 3.59 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.171 -0.956 . . . . 0.0 108.607 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -74.0 -30.92 62.72 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.315 -0.866 . . . . 0.0 108.7 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 82' ' ' ASP . 78.3 mt -105.73 24.38 12.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.24 -0.913 . . . . 0.0 109.302 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.458 ' C ' ' O ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER 39.75 33.44 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.437 -0.789 . . . . 0.0 109.463 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.82 73.68 0.59 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 81.9 mtm-85 -143.01 35.05 1.37 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.149 -1.207 . . . . 0.0 109.346 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.497 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -144.02 178.66 7.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -0.88 . . . . 0.0 109.381 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.33 112.82 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.693 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -93.94 121.69 35.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.306 -0.871 . . . . 0.0 109.209 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -107.16 104.95 14.72 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -0.946 . . . . 0.0 109.695 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.4 mtm105 -75.53 97.36 3.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 0.0 109.073 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.616 ' CD ' ' H ' ' A' ' 100' ' ' SER . 18.0 mm-40 -96.6 137.28 35.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.272 -0.893 . . . . 0.0 109.943 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.6 t -132.85 157.56 43.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.334 -0.854 . . . . 0.0 109.17 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.466 ' C ' ' OE1' ' A' ' 96' ' ' GLN . 1.0 OUTLIER -62.21 117.3 5.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.071 -1.018 . . . . 0.0 109.398 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.74 13.52 69.64 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.83 24.0 0.76 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.146 -1.208 . . . . 0.0 109.625 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.634 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 0.9 OUTLIER -52.64 137.85 29.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 0.0 109.423 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.616 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 28.7 t -64.79 165.49 10.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.294 -0.879 . . . . 0.0 109.634 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.3 -58.13 4.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.915 . . . . 0.0 109.517 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.2 m -46.89 -32.11 3.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 109.429 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.689 ' CE1' ' CE1' ' A' ' 107' ' ' PHE . 23.9 t80 -73.16 -43.3 61.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.366 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.2 mt -69.27 -19.68 63.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.166 -0.959 . . . . 0.0 109.504 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -102.71 -24.98 7.86 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -82.14 -36.18 27.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.177 -1.19 . . . . 0.0 109.525 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.689 ' CE1' ' CE1' ' A' ' 103' ' ' PHE . 49.1 m-85 -89.71 81.43 6.42 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.251 -0.906 . . . . 0.0 109.524 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.9 mttt -77.57 -5.43 50.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.4 t -63.96 -7.34 8.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.117 -0.99 . . . . 0.0 109.48 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.43 82.97 0.74 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.74 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -67.84 158.06 33.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -1.116 . . . . 0.0 109.379 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -158.38 135.06 9.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.242 -0.911 . . . . 0.0 109.437 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -95.2 153.19 17.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.899 . . . . 0.0 109.261 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.9 tttm -133.62 112.75 11.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.247 -0.908 . . . . 0.0 109.423 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.2 mptt . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.187 -0.946 . . . . 0.0 109.367 179.954 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo . . . . . 0 N--CA 1.492 1.389 0 CA-C-O 121.256 0.44 . . . . 0.0 111.988 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.555 ' O ' ' N ' ' A' ' 6' ' ' LEU . 6.4 mt-10 -83.15 -31.67 27.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 109.72 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.686 ' CE1' HG12 ' A' ' 42' ' ' VAL . 13.7 t80 -50.08 -7.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.114 -0.991 . . . . 0.0 109.435 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.555 ' N ' ' O ' ' A' ' 4' ' ' GLU . 13.1 mt -85.79 -26.83 25.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.88 . . . . 0.0 109.506 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.2 pttm -130.94 13.03 5.25 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.39 -0.819 . . . . 0.0 109.566 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.507 ' HB3' HD13 ' A' ' 44' ' ' LEU . . . -50.93 153.04 1.93 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.175 -0.953 . . . . 0.0 109.477 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.86 50.66 0.02 OUTLIER Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -150.15 31.36 0.68 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.127 -1.219 . . . . 0.0 109.649 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 13' ' ' GLY . 26.7 mt-10 -147.62 83.26 7.65 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.911 . . . . 0.0 109.394 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.83 80.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.693 2.262 . . . . 0.0 112.398 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 11' ' ' GLU . . . 177.36 -100.18 0.14 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.1 tp -159.37 119.94 3.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.33 -1.1 . . . . 0.0 109.537 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.479 ' OE1' ' OE2' ' A' ' 11' ' ' GLU . 19.0 mt-30 -108.22 127.67 54.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.866 . . . . 0.0 109.366 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.549 HG23 HD12 ' A' ' 43' ' ' ILE . 53.0 mt -101.1 144.88 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.312 -0.868 . . . . 0.0 110.042 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -142.85 159.49 42.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.357 -0.84 . . . . 0.0 108.835 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -127.15 143.68 51.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.139 -0.975 . . . . 0.0 109.729 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.54 146.09 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.53 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.6 ' O ' ' N ' ' A' ' 22' ' ' PHE . 44.4 tt0 -92.76 154.32 18.37 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.197 -0.939 . . . . 0.0 109.222 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -44.9 -13.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.314 -0.866 . . . . 0.0 109.496 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.6 ' N ' ' O ' ' A' ' 20' ' ' GLU . 74.3 t80 -162.94 28.16 0.1 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.673 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.666 ' O ' HD22 ' A' ' 24' ' ' LEU . 8.4 t70 -175.29 -136.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.172 -0.955 . . . . 0.0 109.616 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.666 HD22 ' O ' ' A' ' 23' ' ' ASP . 1.7 mm? -126.76 146.11 50.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.38 -0.825 . . . . 0.0 109.259 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.495 HG23 ' HB2' ' A' ' 20' ' ' GLU . 2.1 t -141.63 130.23 12.19 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 109.017 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.44 174.64 11.82 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.348 2.032 . . . . 0.0 112.313 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.8 t -139.85 121.45 9.71 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.887 . . . . 0.0 109.246 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.76 157.79 35.36 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.296 1.997 . . . . 0.0 112.301 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.64 -11.77 55.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.16 -0.962 . . . . 0.0 109.358 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -74.28 -10.91 60.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 109.387 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 32' ' ' TYR . 91.8 mt -126.56 -20.48 4.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.356 -0.84 . . . . 0.0 109.471 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.51 ' CE2' ' CD1' ' A' ' 16' ' ' ILE . 11.1 t80 -43.16 131.02 4.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.353 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.67 -14.16 8.12 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -101.61 148.18 25.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.193 -1.181 . . . . 0.0 109.627 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -142.09 116.63 9.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.376 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -94.24 125.19 38.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.923 . . . . 0.0 109.501 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.5 p -68.33 -4.84 15.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.171 -0.956 . . . . 0.0 109.301 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.454 ' O ' ' OD2' ' A' ' 39' ' ' ASP . . . -107.51 36.18 4.55 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.454 ' OD2' ' O ' ' A' ' 38' ' ' GLY . 2.1 m-20 -159.93 156.63 27.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.265 -1.138 . . . . 0.0 109.424 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.63 134.03 48.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.365 -0.834 . . . . 0.0 109.514 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.51 ' HB3' HD11 ' A' ' 43' ' ' ILE . 3.0 m-85 -113.43 134.95 54.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.42 -0.8 . . . . 0.0 109.188 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.015 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -111.24 126.12 68.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 O-C-N 121.217 -0.927 . . . . 0.0 108.892 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.015 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -126.2 134.55 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.197 -0.94 . . . . 0.0 110.417 -179.308 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.727 HD23 ' C ' ' A' ' 44' ' ' LEU . 6.9 tt -117.42 115.4 25.13 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -89.95 144.48 25.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 109.786 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.576 HG22 HD22 ' A' ' 54' ' ' LEU . 38.4 m -143.4 117.68 9.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 109.083 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -128.54 168.37 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.142 -0.974 . . . . 0.0 109.234 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -96.32 126.91 41.85 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.545 -0.722 . . . . 0.0 109.451 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.469 HD21 ' OE1' ' A' ' 55' ' ' GLN . 79.2 mt -91.06 166.77 12.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 0.0 109.495 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 49' ' ' LEU . 2.3 mtt-85 -44.67 -57.99 3.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.089 -1.007 . . . . 0.0 109.231 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -66.38 -20.51 66.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.295 -0.878 . . . . 0.0 109.188 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . 89.62 37.34 6.99 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.508 ' O ' ' O ' ' A' ' 54' ' ' LEU . 10.7 m-80 -88.62 14.37 10.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.118 -1.225 . . . . 0.0 109.403 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.642 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.7 mt 44.79 98.44 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.621 0.724 . . . . 0.0 109.418 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.469 ' OE1' HD21 ' A' ' 49' ' ' LEU . 40.3 tt0 -73.9 110.23 8.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.39 -0.819 . . . . 0.0 109.697 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.512 ' CD2' ' O ' ' A' ' 54' ' ' LEU . 85.3 m-85 -95.91 114.3 26.0 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.186 -0.946 . . . . 0.0 109.546 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.28 155.35 24.2 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.694 HD11 HD11 ' A' ' 81' ' ' LEU . 10.6 mt -129.84 133.38 46.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.171 -0.956 . . . . 0.0 109.776 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.693 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.1 OUTLIER -133.43 115.11 14.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.396 -0.815 . . . . 0.0 109.075 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.725 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -99.95 120.58 40.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.258 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 4.4 t90 -93.26 127.03 38.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.892 . . . . 0.0 109.539 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 mt -106.12 161.65 14.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.261 -0.899 . . . . 0.0 109.396 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -109.55 150.9 17.33 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.23 -12.26 61.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -1.182 . . . . 0.0 109.461 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -108.86 26.63 10.35 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.538 ' SG ' ' OE2' ' A' ' 70' ' ' GLU . 5.4 m -130.59 97.44 4.37 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.021 0.915 . . . . 0.0 108.545 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 m -60.46 -170.91 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.782 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.49 ' O ' ' N ' ' A' ' 72' ' ' GLY . 7.8 mp0 -65.38 -17.8 64.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 0.0 109.696 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.03 -58.84 5.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.112 -0.992 . . . . 0.0 109.481 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.538 ' OE2' ' SG ' ' A' ' 66' ' ' CYS . 22.8 mt-10 -64.07 -46.25 85.18 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.261 -0.899 . . . . 0.0 109.092 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 m -65.54 -26.81 68.05 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.347 -0.846 . . . . 0.0 108.826 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -65.87 -45.86 85.71 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.86 -48.98 74.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -1.157 . . . . 0.0 109.261 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.67 -39.82 92.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.179 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.454 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -65.84 -46.27 79.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.364 -0.835 . . . . 0.0 109.316 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.6 mt -51.47 -49.22 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.134 -0.979 . . . . 0.0 109.294 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -62.29 -35.25 78.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 109.325 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.3 m -69.53 -36.42 76.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.372 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 75' ' ' ALA . 63.8 t -68.14 -42.33 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.517 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -62.49 -60.59 3.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 0.0 109.26 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.728 ' C ' HD12 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -52.57 -29.18 24.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.215 -0.928 . . . . 0.0 108.835 179.688 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.626 ' O ' ' N ' ' A' ' 86' ' ' ASN . 55.2 t0 -67.47 -57.68 6.09 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.239 -0.913 . . . . 0.0 108.815 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.469 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 88.1 m-20 -45.25 -36.14 3.79 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.201 -0.937 . . . . 0.0 108.579 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.517 ' CD1' ' O ' ' A' ' 84' ' ' TYR . 1.8 t80 -73.66 -31.57 63.55 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 82' ' ' ASP . 96.2 mt -121.65 34.44 5.18 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.461 -0.774 . . . . 0.0 109.419 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.626 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.4 OUTLIER -82.82 27.81 0.52 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.207 -0.933 . . . . 0.0 109.371 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.77 -51.15 54.22 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -175.94 34.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.181 -1.188 . . . . 0.0 109.377 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.11 179.02 7.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -0.947 . . . . 0.0 109.529 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 78.9 t -130.39 102.98 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.313 -0.867 . . . . 0.0 109.505 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.66 ' H ' ' CD ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -97.04 134.83 39.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 109.145 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.601 ' NE2' ' ND1' ' A' ' 59' ' ' HIS . 3.7 p80 -144.35 161.14 39.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.121 -0.987 . . . . 0.0 109.756 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -103.38 121.7 43.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.464 -0.772 . . . . 0.0 109.585 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.561 ' OE2' ' CD2' ' A' ' 103' ' ' PHE . 42.5 mt-10 -102.32 150.58 23.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.357 -0.84 . . . . 0.0 109.164 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.6 t -140.75 161.93 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.113 -0.992 . . . . 0.0 109.567 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -60.84 134.42 57.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 109.597 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.11 -26.23 5.04 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.547 ' CD1' ' O ' ' A' ' 98' ' ' PHE . 71.5 t80 -108.02 10.4 28.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -1.115 . . . . 0.0 109.442 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 98' ' ' PHE . 80.5 mt-10 -43.05 123.61 2.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.875 . . . . 0.0 109.508 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.1 p -55.57 179.69 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.334 -0.854 . . . . 0.0 109.501 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.1 -41.31 82.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.344 -0.847 . . . . 0.0 109.501 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.7 m -48.68 -57.58 6.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.307 -0.87 . . . . 0.0 109.529 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.561 ' CD2' ' OE2' ' A' ' 94' ' ' GLU . 5.9 m-85 -59.18 -53.57 56.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.412 -0.805 . . . . 0.0 109.56 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.58 ' O ' ' CD1' ' A' ' 107' ' ' PHE . 25.7 mt -54.36 -14.66 1.27 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.227 -0.921 . . . . 0.0 109.56 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -104.98 -27.29 5.99 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -79.49 -15.29 58.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.261 -1.14 . . . . 0.0 109.636 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.58 ' CD1' ' O ' ' A' ' 104' ' ' LEU . 3.2 p90 -55.8 128.66 36.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.92 . . . . 0.0 109.589 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -114.92 -55.6 2.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.298 -0.876 . . . . 0.0 109.417 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.5 p -103.74 -8.61 19.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.923 . . . . 0.0 109.466 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.63 109.07 3.33 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.737 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -53.37 120.03 5.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -1.132 . . . . 0.0 109.469 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -81.42 125.06 29.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.292 -0.88 . . . . 0.0 109.47 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -95.28 144.09 26.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.938 . . . . 0.0 109.425 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -141.7 132.03 25.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 109.407 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 69.6 mttt . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 109.513 -179.908 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.432 ' HB3' HD12 ' A' ' 6' ' ' LEU . 50.8 Cg_exo . . . . . 0 N--CA 1.493 1.483 0 CA-C-O 121.255 0.439 . . . . 0.0 112.167 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 6' ' ' LEU . 34.1 mt-10 -83.27 -46.21 12.92 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.836 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.666 ' CE1' ' CD1' ' A' ' 81' ' ' LEU . 50.2 t80 -47.64 -16.12 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.235 -0.915 . . . . 0.0 109.391 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 4' ' ' GLU . 71.7 mt -84.05 -52.03 6.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 0.0 109.439 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.468 ' O ' ' O ' ' A' ' 8' ' ' ALA . 46.3 mtpt -91.08 5.97 46.82 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.553 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -44.43 169.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.231 -0.918 . . . . 0.0 109.632 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.75 70.75 0.51 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.46 6.63 2.54 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.17 -1.194 . . . . 0.0 109.647 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -172.13 141.97 1.2 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.899 . . . . 0.0 109.409 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.02 84.13 1.53 Allowed 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.675 2.25 . . . . 0.0 112.291 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -164.96 -108.02 0.21 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.3 tt -162.54 148.03 12.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -1.114 . . . . 0.0 109.553 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.415 ' HB3' ' CZ3' ' A' ' 17' ' ' TRP . 3.5 mt-30 -136.51 131.75 34.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.242 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.492 ' HA ' HG23 ' A' ' 43' ' ' ILE . 12.2 mt -102.28 157.63 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.215 -0.928 . . . . 0.0 110.22 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.428 ' N ' HG22 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -159.17 130.46 6.2 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.495 -0.753 . . . . 0.0 109.17 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -100.92 152.5 20.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.174 -0.954 . . . . 0.0 109.403 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 23' ' ' ASP . 41.4 t -77.03 129.02 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.255 -0.903 . . . . 0.0 109.532 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.711 ' O ' ' N ' ' A' ' 22' ' ' PHE . 27.6 tt0 -80.49 86.82 5.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.126 -0.984 . . . . 0.0 109.479 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.599 ' O ' ' CB ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER 39.35 15.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.574 -0.704 . . . . 0.0 110.081 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.711 ' N ' ' O ' ' A' ' 20' ' ' GLU . 1.4 t80 154.82 -39.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.391 -0.818 . . . . 0.0 109.134 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 20' ' ' GLU . 1.3 t0 -98.99 -146.56 0.33 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.251 -0.906 . . . . 0.0 109.341 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.43 ' CD2' ' H ' ' A' ' 5' ' ' PHE . 3.3 tp -116.1 138.83 50.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.196 -0.94 . . . . 0.0 109.714 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.533 HG23 ' CD ' ' A' ' 20' ' ' GLU . 1.2 t -137.98 144.6 44.48 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -69.69 152.04 69.6 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.527 2.151 . . . . 0.0 112.392 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.0 t -120.54 101.61 45.97 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.874 . . . . 0.0 109.376 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -49.64 158.06 2.08 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.561 2.174 . . . . 0.0 112.128 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 31' ' ' LEU . 5.9 m -59.54 -46.26 89.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.915 . . . . 0.0 109.526 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 29' ' ' THR . 3.0 m120 -43.05 -22.14 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.119 -0.988 . . . . 0.0 109.475 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 29' ' ' THR . 79.7 mt -105.63 -25.49 12.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -0.861 . . . . 0.0 109.451 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.454 ' C ' ' O ' ' A' ' 31' ' ' LEU . 2.0 t80 -42.18 129.49 3.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.328 -0.858 . . . . 0.0 109.371 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.443 ' N ' ' CD2' ' A' ' 32' ' ' TYR . . . 100.28 -20.88 46.79 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.43 ' C ' ' CD1' ' A' ' 35' ' ' PHE . 4.3 m-20 -97.83 155.62 16.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.222 -1.163 . . . . 0.0 109.501 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.43 ' CD1' ' C ' ' A' ' 34' ' ' ASP . 57.1 m-85 -146.65 136.05 22.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 109.457 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -97.42 162.83 13.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 109.406 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.7 p -97.97 -4.87 35.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 109.383 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.91 -76.93 1.28 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.97 157.81 32.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -1.085 . . . . 0.0 109.415 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.74 167.2 11.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.444 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -128.47 134.8 48.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 109.52 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.562 HG11 ' CD1' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -108.7 144.52 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.254 -0.903 . . . . 0.0 109.052 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.985 ' N ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -143.88 139.54 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.996 -1.065 . . . . 0.0 110.097 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.661 HD23 ' N ' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -123.52 126.09 46.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.408 -0.808 . . . . 0.0 109.149 179.256 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.661 ' N ' HD23 ' A' ' 44' ' ' LEU . 30.3 ttpt -104.46 130.37 52.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.326 -0.859 . . . . 0.0 109.6 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 13' ' ' GLY . 99.8 m -131.83 125.66 32.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.293 -0.88 . . . . 0.0 109.294 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -133.09 168.46 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 121.175 -0.953 . . . . 0.0 109.357 -179.647 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -96.29 121.76 38.42 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.681 -0.637 . . . . 0.0 109.324 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 50' ' ' ARG . 11.1 mt -82.59 168.79 16.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.949 . . . . 0.0 109.523 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 49' ' ' LEU . 1.1 tpt180 -43.21 -67.14 0.3 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.251 -0.906 . . . . 0.0 109.261 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -60.18 -26.07 66.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 109.125 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.98 40.2 3.37 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 54' ' ' LEU . 37.9 m-20 -87.66 14.79 7.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.11 -1.229 . . . . 0.0 109.316 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.624 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 11.7 mt 43.79 96.83 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.511 0.672 . . . . 0.0 109.444 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -69.18 153.62 43.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.528 -0.732 . . . . 0.0 109.245 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.412 ' CD2' ' O ' ' A' ' 54' ' ' LEU . 70.7 m-85 -138.0 114.86 10.7 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.171 -0.956 . . . . 0.0 109.623 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -124.78 116.7 22.72 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.027 HD12 ' H ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -102.84 145.72 29.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.134 -0.979 . . . . 0.0 110.076 -179.021 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.532 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 3.1 m-70 -131.34 150.52 52.12 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.469 -0.769 . . . . 0.0 109.4 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.882 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -129.37 121.33 27.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.352 -0.843 . . . . 0.0 109.34 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.467 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 44.8 t90 -101.84 123.77 46.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.92 . . . . 0.0 109.59 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.467 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 18.4 mt -104.55 162.04 13.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.279 -0.888 . . . . 0.0 109.382 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.515 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -112.86 162.0 12.5 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -82.14 -11.62 58.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -1.168 . . . . 0.0 109.599 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.68 33.89 4.12 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.657 ' SG ' ' O ' ' A' ' 66' ' ' CYS . 18.0 p -130.58 97.91 4.51 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 122.478 1.133 . . . . 0.0 108.951 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.49 ' O ' ' O ' ' A' ' 66' ' ' CYS . 0.5 OUTLIER -46.57 177.18 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.731 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.555 ' O ' ' N ' ' A' ' 72' ' ' GLY . 4.6 pt20 -66.52 -17.78 65.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.476 -0.765 . . . . 0.0 109.553 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.1 p30 -62.85 -58.43 7.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.263 -0.898 . . . . 0.0 109.626 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.401 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 2.6 mp0 -62.04 -51.93 65.99 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.301 -0.874 . . . . 0.0 109.129 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.43 -22.87 66.22 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.405 -0.809 . . . . 0.0 108.879 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -75.16 -46.26 16.74 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.79 -39.09 87.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.186 -1.185 . . . . 0.0 109.151 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.882 ' HB1' ' CE2' ' A' ' 60' ' ' TYR . . . -59.4 -59.49 5.36 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.394 -0.816 . . . . 0.0 108.968 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.775 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -48.25 -43.21 32.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.31 -0.869 . . . . 0.0 109.48 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.8 mt -56.67 -39.14 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.143 -0.973 . . . . 0.0 109.564 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -64.7 -50.48 66.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 109.704 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.483 ' OG1' ' CE1' ' A' ' 60' ' ' TYR . 2.7 m -63.72 -35.03 79.24 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.065 -1.022 . . . . 0.0 108.794 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 75' ' ' ALA . 74.5 t -59.59 -41.9 86.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.343 -0.848 . . . . 0.0 108.729 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -62.55 -43.75 98.03 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.666 ' CD1' ' CE1' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -50.83 -45.47 59.62 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.403 -0.811 . . . . 0.0 108.921 179.5 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 85' ' ' LEU . 1.6 m-20 -60.33 -60.42 3.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.294 -0.879 . . . . 0.0 108.967 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 82' ' ' ASP . 39.6 t0 -46.94 -32.99 4.23 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.116 -0.99 . . . . 0.0 108.412 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.468 ' CD2' ' O ' ' A' ' 84' ' ' TYR . 2.8 t80 -74.49 -27.1 60.41 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.568 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.6 tp -110.24 26.47 10.64 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.475 -0.765 . . . . 0.0 109.306 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER 44.71 37.47 2.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.487 -0.758 . . . . 0.0 109.579 179.795 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 53.7 34.13 49.92 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -90.64 31.38 1.05 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -1.138 . . . . 0.0 109.138 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.24 179.22 7.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.434 -0.791 . . . . 0.0 109.31 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.686 ' O ' HD12 ' A' ' 58' ' ' LEU . 21.9 t -119.13 140.83 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -0.964 . . . . 0.0 109.672 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.41 ' CD ' ' N ' ' A' ' 91' ' ' GLN . 0.2 OUTLIER -102.74 149.28 24.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.328 -0.857 . . . . 0.0 109.319 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -124.49 121.78 35.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 109.553 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.43 ' H ' ' HD2' ' A' ' 93' ' ' ARG . 1.5 mpt_? -91.5 105.42 17.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.943 . . . . 0.0 109.063 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.417 ' OE2' ' CD1' ' A' ' 103' ' ' PHE . 35.8 mt-10 -113.12 148.06 36.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.764 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.713 HG12 ' N ' ' A' ' 96' ' ' GLN . 61.5 t -151.9 174.04 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -0.869 . . . . 0.0 109.091 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.713 ' N ' HG12 ' A' ' 95' ' ' VAL . 10.2 tt0 -62.58 115.84 4.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.051 -1.031 . . . . 0.0 109.542 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.95 11.66 82.29 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.47 ' O ' ' C ' ' A' ' 99' ' ' GLU . 3.2 t80 -132.66 19.39 4.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.252 -1.146 . . . . 0.0 109.551 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.631 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 8.8 mp0 -39.63 137.6 0.84 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.549 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.85 166.91 16.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 109.654 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.27 -64.45 0.85 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 0.0 109.448 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.8 m -47.03 -54.86 9.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.207 -0.933 . . . . 0.0 109.198 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.417 ' CD1' ' OE2' ' A' ' 94' ' ' GLU . 3.3 t80 -50.81 -45.27 59.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.471 -0.768 . . . . 0.0 109.295 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.506 ' O ' ' CD1' ' A' ' 107' ' ' PHE . 5.8 mt -59.01 -30.81 68.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.913 . . . . 0.0 109.388 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.79 -19.27 48.5 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.423 ' O ' ' C ' ' A' ' 107' ' ' PHE . 35.4 t80 -76.35 -27.36 56.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.346 -1.091 . . . . 0.0 109.458 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.54 ' CD1' ' O ' ' A' ' 107' ' ' PHE . 1.3 p90 -42.42 125.83 3.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.183 -0.948 . . . . 0.0 109.494 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -110.87 -47.85 3.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.913 . . . . 0.0 109.433 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.6 m -96.67 -28.55 14.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 109.493 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 124.24 112.5 1.98 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.2 mt -57.76 176.69 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.334 -1.098 . . . . 0.0 109.47 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -159.97 122.25 3.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.352 -0.842 . . . . 0.0 109.279 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -106.75 141.66 37.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 109.414 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -146.19 126.29 13.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.887 . . . . 0.0 109.387 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.2 pttp . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.346 -0.846 . . . . 0.0 109.47 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.517 ' HB3' HD12 ' A' ' 6' ' ' LEU . 36.2 Cg_endo . . . . . 0 N--CA 1.492 1.396 0 CA-C-O 121.343 0.476 . . . . 0.0 112.077 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.542 ' OE1' ' NE1' ' A' ' 17' ' ' TRP . 74.7 mt-10 -83.15 -46.24 12.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 109.756 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.519 ' CE2' ' CG1' ' A' ' 42' ' ' VAL . 22.8 t80 -66.95 -18.76 65.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.281 -0.887 . . . . 0.0 109.406 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.517 HD12 ' HB3' ' A' ' 3' ' ' PRO . 10.1 mt -76.61 -37.2 56.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.258 -0.901 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.453 ' O ' ' C ' ' A' ' 8' ' ' ALA . 7.4 mtpm? -86.12 -15.6 40.63 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.334 -0.854 . . . . 0.0 109.335 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -40.94 142.36 0.49 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 109.567 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.26 42.32 0.2 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -140.65 26.38 2.11 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.339 -1.095 . . . . 0.0 109.692 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -148.84 128.1 6.29 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.192 -0.943 . . . . 0.0 109.433 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.81 80.1 2.69 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.494 2.129 . . . . 0.0 112.272 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 173.32 -99.37 0.14 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.9 tt -162.25 152.26 16.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -1.131 . . . . 0.0 109.834 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.42 ' HB3' ' CZ3' ' A' ' 17' ' ' TRP . 42.1 mt-30 -135.74 141.31 44.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 109.367 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 28.5 mt -113.99 139.11 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.36 -0.838 . . . . 0.0 110.1 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.542 ' NE1' ' OE1' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -142.75 156.77 45.05 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.535 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.811 ' O ' HD23 ' A' ' 24' ' ' LEU . 18.8 ttt180 -116.29 140.13 49.65 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.172 -0.955 . . . . 0.0 109.62 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 19' ' ' VAL . 8.4 p -85.33 131.72 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.917 . . . . 0.0 109.409 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.606 ' O ' ' N ' ' A' ' 22' ' ' PHE . 20.4 tt0 -84.06 151.36 25.01 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.165 -0.96 . . . . 0.0 109.225 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.486 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 10.8 ttmm -45.25 -11.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.271 -0.893 . . . . 0.0 109.92 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.606 ' N ' ' O ' ' A' ' 20' ' ' GLU . 20.7 m-85 -162.96 20.97 0.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.961 -1.087 . . . . 0.0 110.065 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.474 ' CG ' ' O ' ' A' ' 22' ' ' PHE . 24.5 m-20 -166.38 -116.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.193 -0.942 . . . . 0.0 109.499 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.811 HD23 ' O ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -158.19 138.6 12.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -0.892 . . . . 0.0 109.296 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 t -119.98 132.62 24.01 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 0.0 109.282 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.1 136.87 23.07 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.428 2.085 . . . . 0.0 112.343 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.7 t -97.49 112.03 60.12 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.224 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -45.54 127.88 9.98 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.33 2.02 . . . . 0.0 112.104 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.64 -10.11 59.27 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.146 -0.971 . . . . 0.0 109.485 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -90.91 -3.06 57.62 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.237 -0.914 . . . . 0.0 109.113 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 38.4 mt -136.81 -1.93 2.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.288 -0.882 . . . . 0.0 109.801 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.426 ' O ' ' CG ' ' A' ' 32' ' ' TYR . 3.6 p90 -50.42 135.17 22.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.952 . . . . 0.0 109.507 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.94 -25.44 3.21 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.8 105.29 16.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -1.154 . . . . 0.0 109.43 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -96.5 146.26 24.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.511 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -94.46 128.36 40.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.568 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.472 ' OG1' ' OE1' ' A' ' 65' ' ' GLU . 35.7 p -72.24 -4.78 31.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.307 -0.87 . . . . 0.0 109.426 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.44 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -109.67 38.25 3.4 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 22.6 m-20 -163.52 -169.38 1.92 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -1.122 . . . . 0.0 109.465 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -136.72 138.28 40.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.401 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -126.01 139.0 53.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.332 -0.855 . . . . 0.0 109.519 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.006 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -105.95 136.97 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 121.178 -0.951 . . . . 0.0 108.767 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.006 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -127.84 137.17 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.269 -0.895 . . . . 0.0 110.369 -179.496 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.682 HD23 ' C ' ' A' ' 44' ' ' LEU . 6.9 tt -117.83 116.98 28.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.7 -0.625 . . . . 0.0 109.335 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.481 ' N ' HD23 ' A' ' 44' ' ' LEU . 4.8 ttpm? -98.9 118.24 35.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.544 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.41 ' CG2' HD22 ' A' ' 54' ' ' LEU . 8.4 m -118.62 131.33 56.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.34 -0.85 . . . . 0.0 109.201 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -132.01 168.46 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.193 -0.942 . . . . 0.0 109.569 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.576 ' NE2' ' O ' ' A' ' 49' ' ' LEU . 8.4 tm0? -95.97 112.33 24.09 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.576 ' O ' ' NE2' ' A' ' 48' ' ' GLN . 63.8 mt -72.28 155.61 40.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.924 . . . . 0.0 109.748 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 49' ' ' LEU . 20.9 mtm105 -42.89 -77.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.895 . . . . 0.0 109.388 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 50' ' ' ARG . 4.1 t-20 -43.33 -31.1 0.59 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.166 -0.959 . . . . 0.0 109.259 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.64 75.47 1.16 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.481 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.1 t-20 -132.76 14.09 4.39 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.251 -1.147 . . . . 0.0 109.199 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 11.9 mt 43.22 95.98 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.386 0.612 . . . . 0.0 109.616 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 47' ' ' VAL . 17.2 tt0 -68.85 154.48 41.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.549 -0.719 . . . . 0.0 109.144 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.614 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 97.6 m-85 -134.53 121.69 21.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 0.0 109.674 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 58' ' ' LEU . 1.5 t0 -133.0 155.44 49.17 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.581 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -143.58 145.79 32.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.825 -1.172 . . . . 0.0 110.388 -179.629 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.472 ' HE1' ' HB2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -141.06 131.93 25.94 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.401 -0.812 . . . . 0.0 108.957 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.751 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -96.64 120.74 37.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.094 -1.004 . . . . 0.0 109.463 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.517 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 31.2 t90 -89.13 123.71 33.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.876 . . . . 0.0 109.357 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.517 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 6.6 mt -106.36 162.18 13.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.321 -0.862 . . . . 0.0 109.423 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.93 156.59 15.46 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -75.79 -12.24 60.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -1.135 . . . . 0.0 109.357 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.472 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 2.7 mt-10 -106.47 26.25 10.13 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.5 m -130.85 97.51 4.35 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.136 0.969 . . . . 0.0 108.397 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 66' ' ' CYS . 39.7 p -49.82 -177.18 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.589 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.49 ' O ' ' N ' ' A' ' 72' ' ' GLY . 29.2 mt-30 -66.04 -17.82 64.94 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.304 -0.873 . . . . 0.0 109.5 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.503 ' OD2' ' N ' ' A' ' 69' ' ' ASP . 2.5 m-20 -63.75 -58.57 6.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 109.369 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -61.03 -51.02 70.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.288 -0.882 . . . . 0.0 109.131 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.0 m -64.23 -27.37 69.01 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.442 -0.786 . . . . 0.0 109.065 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -69.24 -43.05 72.96 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.04 -41.56 97.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.317 -1.108 . . . . 0.0 109.245 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.52 -47.03 87.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.398 -0.814 . . . . 0.0 109.25 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.89 -46.44 81.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.173 -0.955 . . . . 0.0 109.345 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.2 mt -51.96 -49.82 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.214 -0.929 . . . . 0.0 109.207 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -57.91 -33.92 69.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.866 . . . . 0.0 109.277 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.405 HG21 ' CE1' ' A' ' 60' ' ' TYR . 2.1 m -68.34 -46.79 69.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.231 -0.918 . . . . 0.0 109.263 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.6 t -57.26 -31.93 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.168 -0.957 . . . . 0.0 109.318 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -68.06 -54.44 18.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.913 . . . . 0.0 109.246 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.831 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -53.47 -29.46 35.98 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.285 -0.884 . . . . 0.0 108.981 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 85' ' ' LEU . 3.4 m-20 -66.53 -59.32 3.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.272 -0.892 . . . . 0.0 108.913 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 82' ' ' ASP . 1.0 OUTLIER -45.62 -34.51 3.48 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.294 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.595 ' CD1' ' O ' ' A' ' 84' ' ' TYR . 0.6 OUTLIER -69.55 -32.56 71.44 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.886 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.591 ' N ' ' O ' ' A' ' 82' ' ' ASP . 5.6 mp -104.51 27.39 7.95 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.417 -0.802 . . . . 0.0 109.026 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 85' ' ' LEU . 13.1 m-80 42.7 35.03 0.64 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.449 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 86' ' ' ASN . . . 43.44 85.31 0.01 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -145.61 47.73 1.27 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.202 -1.175 . . . . 0.0 109.384 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.614 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -155.1 179.15 9.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.894 . . . . 0.0 109.505 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.505 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 8.7 t -94.58 116.13 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.625 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -109.7 125.36 52.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.268 -0.895 . . . . 0.0 109.193 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.574 ' N ' ' CD2' ' A' ' 92' ' ' HIS . 1.3 p80 -151.0 136.05 17.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.028 -1.045 . . . . 0.0 110.197 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -85.85 131.43 34.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.176 -0.953 . . . . 0.0 109.713 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -100.34 121.37 41.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.95 . . . . 0.0 109.359 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.596 HG12 ' N ' ' A' ' 96' ' ' GLN . 44.4 t -89.64 167.71 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 109.615 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.686 ' NE2' ' N ' ' A' ' 97' ' ' GLY . 17.5 tp60 -88.03 136.12 33.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 109.394 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.686 ' N ' ' NE2' ' A' ' 96' ' ' GLN . . . 110.41 -26.91 12.26 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.487 ' O ' ' O ' ' A' ' 99' ' ' GLU . 2.9 t80 -133.21 -30.14 1.36 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.414 -1.051 . . . . 0.0 109.413 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 98' ' ' PHE . 18.1 mp0 47.02 -176.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 109.477 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.6 t -100.92 143.88 30.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 109.53 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -47.65 -40.42 19.73 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.194 -0.941 . . . . 0.0 109.527 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.1 m -54.02 -44.5 71.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.899 . . . . 0.0 109.442 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.81 -55.35 8.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 109.268 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.443 ' O ' ' CD1' ' A' ' 107' ' ' PHE . 92.7 mt -48.15 -21.52 0.5 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.36 -0.838 . . . . 0.0 109.497 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.23 -24.29 9.74 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -84.61 -5.98 59.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -1.183 . . . . 0.0 109.549 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 5.0 p90 -54.03 118.0 3.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.492 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -114.88 -55.79 2.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 109.483 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.1 p -92.63 -14.08 28.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.541 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.15 75.62 1.23 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.087 HD23 ' H ' ' A' ' 111' ' ' LEU . 1.1 pt? -56.58 163.31 1.85 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -1.124 . . . . 0.0 109.608 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -141.38 179.75 6.6 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.374 -0.829 . . . . 0.0 109.432 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.99 111.43 7.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 0.0 109.333 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -75.5 110.04 9.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.43 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.9 mttp . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 109.452 179.955 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo . . . . . 0 N--CA 1.492 1.402 0 CA-C-O 121.355 0.481 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -83.24 -28.84 28.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.878 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.55 ' CE2' HG12 ' A' ' 42' ' ' VAL . 5.7 t80 -70.46 -16.05 62.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.785 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.0 mt -83.74 -38.28 21.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 109.446 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 8' ' ' ALA . 48.2 mmtt -95.25 -2.59 49.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.343 -0.848 . . . . 0.0 109.388 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.484 ' HB3' HD13 ' A' ' 44' ' ' LEU . . . -42.12 139.27 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.885 . . . . 0.0 109.529 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.23 56.83 0.06 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 pttm -137.45 18.7 2.92 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.2 -1.177 . . . . 0.0 109.514 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.469 ' O ' ' OE1' ' A' ' 11' ' ' GLU . 1.7 pp20? -165.93 127.38 1.37 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.419 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.12 85.16 1.7 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.421 2.081 . . . . 0.0 112.148 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -174.62 -103.28 0.16 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.0 tp -153.2 146.73 25.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.356 -1.085 . . . . 0.0 109.608 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.401 ' HB3' ' CZ3' ' A' ' 17' ' ' TRP . 37.4 mt-30 -135.89 128.72 31.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.866 . . . . 0.0 109.367 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.5 mt -105.91 150.08 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 0.0 109.557 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.401 ' CZ3' ' HB3' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -156.68 135.59 11.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.134 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -104.82 148.61 26.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.27 -0.894 . . . . 0.0 109.568 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.481 ' O ' ' OD1' ' A' ' 39' ' ' ASP . 9.5 p -83.44 146.0 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.42 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.595 ' O ' ' N ' ' A' ' 22' ' ' PHE . 22.8 tt0 -99.3 154.52 18.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 109.382 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 20' ' ' GLU . 39.3 tttm -42.31 -18.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.892 . . . . 0.0 109.599 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.595 ' N ' ' O ' ' A' ' 20' ' ' GLU . 53.5 t80 -163.42 32.67 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.186 -0.946 . . . . 0.0 109.647 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.544 ' OD2' ' N ' ' A' ' 24' ' ' LEU . 9.3 t0 -173.23 -122.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.431 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.544 ' N ' ' OD2' ' A' ' 23' ' ' ASP . 4.6 tp -152.44 146.04 24.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.57 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.62 134.03 25.83 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.398 -0.813 . . . . 0.0 109.17 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.77 146.8 49.1 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.378 2.052 . . . . 0.0 112.16 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.5 t -105.24 105.89 53.73 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.411 -0.806 . . . . 0.0 109.191 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -47.85 127.9 15.22 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.463 2.109 . . . . 0.0 112.358 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.6 m -76.37 -3.6 37.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.32 -0.862 . . . . 0.0 109.285 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -77.75 -15.2 59.29 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.167 -0.958 . . . . 0.0 109.358 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.63 ' C ' HD12 ' A' ' 31' ' ' LEU . 0.9 OUTLIER -156.3 12.5 0.29 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 110.129 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.487 ' N ' HD12 ' A' ' 31' ' ' LEU . 20.6 p90 -43.35 163.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.127 -0.983 . . . . 0.0 109.377 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.25 -4.71 26.81 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -96.17 102.04 13.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.184 -1.186 . . . . 0.0 109.497 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -96.21 124.43 40.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.243 -0.911 . . . . 0.0 109.511 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -92.16 146.79 23.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.443 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.425 ' OG1' ' CD ' ' A' ' 65' ' ' GLU . 13.3 p -84.46 -15.79 44.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 109.436 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.21 22.91 32.17 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.481 ' OD1' ' O ' ' A' ' 19' ' ' VAL . 3.5 t70 -164.34 150.78 11.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.205 -1.174 . . . . 0.0 109.463 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.481 ' O ' ' OD2' ' A' ' 39' ' ' ASP . . . -92.55 153.08 19.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.391 -0.818 . . . . 0.0 109.528 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -125.01 134.79 52.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.366 -0.834 . . . . 0.0 109.32 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.55 HG12 ' CE2' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -109.93 144.39 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.269 -0.894 . . . . 0.0 109.018 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.072 ' N ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -143.32 121.83 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.932 -1.105 . . . . 0.0 109.852 -179.438 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.484 HD13 ' HB3' ' A' ' 8' ' ' ALA . 7.5 tt -111.35 124.58 52.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.593 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.543 ' CE ' ' OH ' ' A' ' 106' ' ' TYR . 23.2 tttm -101.33 140.47 35.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -0.883 . . . . 0.0 109.225 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.526 HG22 HD22 ' A' ' 54' ' ' LEU . 98.9 m -139.32 123.22 17.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.88 . . . . 0.0 109.574 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -128.55 168.32 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.171 -0.955 . . . . 0.0 108.894 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -103.64 108.88 20.35 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.58 -0.7 . . . . 0.0 109.411 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 50' ' ' ARG . 14.5 mt -72.8 169.06 17.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 109.564 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' A' ' 49' ' ' LEU . 8.9 tpp85 -43.25 -70.36 0.11 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.217 -0.927 . . . . 0.0 109.252 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -52.74 -31.22 36.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 109.207 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.35 36.74 4.53 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.495 ' O ' ' O ' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -84.52 13.21 5.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.118 -1.225 . . . . 0.0 109.175 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.647 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.4 mt 44.37 97.63 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.573 0.701 . . . . 0.0 109.418 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -71.39 113.18 8.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.475 -0.766 . . . . 0.0 109.325 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.536 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 92.6 m-85 -98.89 114.38 26.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.239 -0.913 . . . . 0.0 109.849 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -118.28 154.98 31.39 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.421 HD13 HD11 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -142.68 144.59 32.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.964 -1.085 . . . . 0.0 110.674 -179.274 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.781 ' HB2' HD13 ' A' ' 43' ' ' ILE . 2.0 m80 -129.62 150.21 51.05 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.614 ' CD1' ' O ' ' A' ' 60' ' ' TYR . 19.8 p90 -128.98 124.95 36.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.205 -0.934 . . . . 0.0 109.434 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.554 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 56.1 t90 -107.78 127.75 53.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.369 -0.832 . . . . 0.0 109.647 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.554 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 24.2 mt -106.65 161.98 14.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.314 -0.866 . . . . 0.0 109.405 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -109.12 157.49 15.1 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -82.29 -11.81 58.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -1.14 . . . . 0.0 109.545 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.425 ' CD ' ' OG1' ' A' ' 37' ' ' THR . 2.2 mt-10 -110.26 33.11 4.66 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.655 ' SG ' ' O ' ' A' ' 66' ' ' CYS . 18.8 p -130.44 97.66 4.46 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 122.432 1.11 . . . . 0.0 108.965 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.485 ' O ' ' OG ' ' A' ' 71' ' ' SER . 3.1 m -43.77 170.86 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.763 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 72' ' ' GLY . 80.8 mt-30 -65.44 -17.78 64.81 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.422 -0.799 . . . . 0.0 109.584 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -65.07 -58.59 5.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.52 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -63.7 -47.07 82.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.378 -0.826 . . . . 0.0 109.196 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 67' ' ' SER . 0.2 OUTLIER -68.65 -24.21 64.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.386 -0.821 . . . . 0.0 109.074 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -71.46 -36.02 62.96 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.16 -42.7 62.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -1.152 . . . . 0.0 109.344 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.37 -46.59 88.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.363 -0.836 . . . . 0.0 109.234 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.513 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -59.48 -49.33 78.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.323 -0.861 . . . . 0.0 109.29 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.9 mt -49.26 -42.22 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.252 -0.905 . . . . 0.0 109.239 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -61.75 -45.75 92.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.24 -0.913 . . . . 0.0 109.307 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.9 m -63.08 -40.12 96.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.296 -0.878 . . . . 0.0 109.413 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 75' ' ' ALA . 24.9 t -67.32 -31.9 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.269 -0.894 . . . . 0.0 109.667 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -61.46 1.88 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.261 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.479 ' C ' HD12 ' A' ' 81' ' ' LEU . 1.5 pp -54.13 -28.15 38.02 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.107 -0.996 . . . . 0.0 108.821 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.638 ' O ' ' N ' ' A' ' 86' ' ' ASN . 8.3 t70 -62.83 -54.09 44.24 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.142 -0.974 . . . . 0.0 109.022 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.56 -34.53 62.01 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -77.92 -26.17 48.84 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.616 ' C ' ' H ' ' A' ' 87' ' ' GLY . 7.3 mt -121.49 33.28 5.58 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.535 -0.728 . . . . 0.0 109.484 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.638 ' N ' ' O ' ' A' ' 82' ' ' ASP . 4.6 t-20 -70.42 25.56 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 108.956 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.616 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -68.79 25.63 0.29 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.578 ' H ' ' C ' ' A' ' 86' ' ' ASN . 0.4 OUTLIER 80.87 35.94 0.1 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.427 -1.043 . . . . 0.0 109.704 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -73.25 179.46 3.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.0 109.123 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.8 t -116.2 121.65 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.217 -0.927 . . . . 0.0 109.874 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -97.65 143.26 28.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.107 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.759 ' CG ' ' CD2' ' A' ' 59' ' ' HIS . 49.9 m80 -120.6 146.61 46.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 109.519 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.454 ' H ' ' HG2' ' A' ' 93' ' ' ARG . 5.5 ptm180 -116.6 103.01 9.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 0.0 109.617 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.548 ' OE2' ' CG ' ' A' ' 103' ' ' PHE . 42.1 mt-10 -113.78 144.64 42.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.459 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.721 HG12 ' N ' ' A' ' 96' ' ' GLN . 47.4 t -149.1 176.56 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.879 . . . . 0.0 109.368 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.721 ' N ' HG12 ' A' ' 95' ' ' VAL . 62.5 tp60 -67.96 118.08 10.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.934 . . . . 0.0 109.453 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.13 11.6 84.93 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.441 ' O ' ' C ' ' A' ' 99' ' ' GLU . 0.3 OUTLIER -140.98 19.32 2.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.163 -1.198 . . . . 0.0 109.485 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 98' ' ' PHE . 22.0 mt-10 -43.27 163.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 109.532 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.0 m -100.12 167.79 10.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.302 -0.873 . . . . 0.0 109.418 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.73 -50.88 31.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.449 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.6 m -46.97 -59.69 2.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.147 -0.971 . . . . 0.0 109.381 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.548 ' CG ' ' OE2' ' A' ' 94' ' ' GLU . 5.4 t80 -53.69 -51.18 64.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.392 -0.818 . . . . 0.0 109.328 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.612 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 6.6 mt -53.35 -18.71 2.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 0.0 109.094 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.81 -21.98 24.62 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.543 ' OH ' ' CE ' ' A' ' 45' ' ' LYS . 3.0 m-85 -73.68 -33.74 64.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.273 -1.134 . . . . 0.0 109.247 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.691 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 1.0 OUTLIER -41.09 108.14 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.356 -0.84 . . . . 0.0 109.599 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -115.37 -47.43 2.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.146 -0.972 . . . . 0.0 109.378 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.7 m -86.11 -29.14 23.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.896 . . . . 0.0 109.522 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 120.48 111.47 2.28 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.445 ' H ' ' HG ' ' A' ' 111' ' ' LEU . 2.4 pp -120.99 166.87 13.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.326 -1.103 . . . . 0.0 109.524 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -172.81 -178.17 1.81 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.638 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -93.52 139.7 30.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.286 -0.884 . . . . 0.0 109.44 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -146.46 105.05 3.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.4 pttt . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 109.402 179.971 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 N--CA 1.491 1.354 0 CA-C-O 121.219 0.425 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -83.18 -38.0 22.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.905 . . . . 0.0 110.022 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.593 ' CE1' HG12 ' A' ' 42' ' ' VAL . 22.4 t80 -55.17 -19.85 8.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.101 -1.0 . . . . 0.0 109.519 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.626 HD23 HD11 ' A' ' 81' ' ' LEU . 9.0 mt -83.77 -35.38 24.39 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.183 -0.948 . . . . 0.0 109.466 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 8' ' ' ALA . 2.2 mmmp? -89.68 -0.96 57.87 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.197 -0.939 . . . . 0.0 109.511 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.479 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -42.88 166.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.882 . . . . 0.0 109.546 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.34 75.37 1.13 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -142.99 5.49 1.52 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.19 -1.182 . . . . 0.0 109.622 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -172.34 143.27 1.26 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 0.0 109.342 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.38 88.45 1.15 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.585 2.19 . . . . 0.0 112.295 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -172.37 -104.71 0.18 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 tp -156.2 143.39 19.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.263 -1.14 . . . . 0.0 109.697 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -129.06 130.65 46.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.363 -0.835 . . . . 0.0 109.237 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 53.2 mt -113.37 137.66 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.263 -0.898 . . . . 0.0 109.958 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -141.61 136.51 31.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.368 -0.832 . . . . 0.0 108.82 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -98.03 150.71 21.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.148 -0.97 . . . . 0.0 109.671 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.626 ' O ' HG13 ' A' ' 19' ' ' VAL . 8.1 p -92.12 122.77 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.387 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.611 ' O ' ' N ' ' A' ' 22' ' ' PHE . 4.2 tm-20 -75.12 149.5 39.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.126 -0.984 . . . . 0.0 109.012 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 20' ' ' GLU . 57.9 mttt -40.3 -20.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.447 -0.783 . . . . 0.0 109.841 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.611 ' N ' ' O ' ' A' ' 20' ' ' GLU . 40.4 t80 -151.46 13.24 0.65 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.081 -1.012 . . . . 0.0 109.819 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 20' ' ' GLU . 35.0 m-20 -160.81 -143.06 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.938 . . . . 0.0 109.385 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.446 ' CD2' ' H ' ' A' ' 5' ' ' PHE . 0.8 OUTLIER -129.35 139.83 51.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.31 -0.869 . . . . 0.0 109.571 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 t -119.76 133.06 23.85 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.361 -0.837 . . . . 0.0 108.947 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.62 150.75 45.9 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.431 2.088 . . . . 0.0 112.495 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.8 t -148.79 101.53 3.44 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.306 -0.871 . . . . 0.0 109.214 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -50.1 139.46 34.57 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.591 2.194 . . . . 0.0 112.262 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.475 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 12.4 t -67.53 -21.08 65.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.325 -0.86 . . . . 0.0 109.347 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -77.04 -2.74 35.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.365 -0.835 . . . . 0.0 109.415 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.486 ' O ' ' O ' ' A' ' 32' ' ' TYR . 50.1 mt -124.91 -18.87 5.4 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.339 -0.851 . . . . 0.0 109.5 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.486 ' O ' ' O ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -49.24 -178.61 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.123 -0.986 . . . . 0.0 109.51 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.15 -41.01 2.09 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -98.47 102.37 14.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -1.154 . . . . 0.0 109.495 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -90.33 136.43 33.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.187 -0.946 . . . . 0.0 109.461 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.439 ' CD2' ' OH ' ' A' ' 41' ' ' TYR . 25.1 m-85 -92.9 138.72 31.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 109.435 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.423 ' OG1' ' CD ' ' A' ' 65' ' ' GLU . 55.8 p -80.45 -4.83 55.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.31 -0.869 . . . . 0.0 109.48 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.7 -74.9 1.21 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -78.7 155.05 29.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -1.126 . . . . 0.0 109.601 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.528 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -90.69 165.44 13.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.335 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.439 ' OH ' ' CD2' ' A' ' 36' ' ' PHE . 11.1 m-85 -126.84 136.02 51.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.296 -0.878 . . . . 0.0 109.542 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.07 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -111.68 128.6 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.07 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -124.79 141.96 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.949 . . . . 0.0 110.494 -178.667 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.5 tt -128.21 120.6 27.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.55 -0.719 . . . . 0.0 109.081 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.559 ' HZ2' HG22 ' A' ' 47' ' ' VAL . 38.2 tttp -93.11 146.54 23.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.364 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 13' ' ' GLY . 85.1 m -143.16 129.2 19.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.094 -1.004 . . . . 0.0 109.549 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -133.33 168.49 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 121.178 -0.951 . . . . 0.0 109.262 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -101.72 111.0 23.1 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.616 -0.677 . . . . 0.0 109.376 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 52' ' ' GLY . 81.2 mt -74.92 158.28 33.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.227 -0.92 . . . . 0.0 109.572 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.713 ' CD ' ' H ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -44.85 -47.04 11.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.363 -0.836 . . . . 0.0 109.203 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -65.69 -28.82 69.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.279 -0.888 . . . . 0.0 109.203 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . 94.17 30.75 8.51 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.498 ' O ' ' O ' ' A' ' 54' ' ' LEU . 32.7 t30 -89.89 12.78 16.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.085 -1.244 . . . . 0.0 109.373 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.576 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.1 mt 45.12 99.12 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.665 0.745 . . . . 0.0 109.554 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.58 ' NE2' ' H ' ' A' ' 56' ' ' TYR . 5.1 tm0? -68.56 152.83 44.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.476 -0.765 . . . . 0.0 109.118 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.58 ' H ' ' NE2' ' A' ' 55' ' ' GLN . 68.4 m-85 -133.05 114.25 13.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.223 -0.923 . . . . 0.0 109.806 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.63 155.72 26.03 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.458 ' C ' ' CD2' ' A' ' 59' ' ' HIS . 1.1 mp -130.41 146.44 51.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.884 -1.135 . . . . 0.0 110.664 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.461 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 6.9 m-70 -136.22 144.19 44.75 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.437 ' CE1' ' HG ' ' A' ' 62' ' ' LEU . 13.5 t80 -129.27 128.97 44.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.245 -0.909 . . . . 0.0 109.857 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -109.2 126.0 52.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.403 -0.811 . . . . 0.0 109.587 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.437 ' HG ' ' CE1' ' A' ' 60' ' ' TYR . 7.9 mt -104.06 162.18 13.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.423 -0.798 . . . . 0.0 109.906 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.536 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -120.54 158.6 15.53 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -82.34 -11.95 58.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.158 -1.201 . . . . 0.0 109.957 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.423 ' CD ' ' OG1' ' A' ' 37' ' ' THR . 0.4 OUTLIER -109.73 35.17 3.45 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.447 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.649 ' SG ' ' O ' ' A' ' 66' ' ' CYS . 18.5 p -130.45 97.76 4.49 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 122.44 1.114 . . . . 0.0 108.916 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 66' ' ' CYS . 1.2 m -52.46 -170.91 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.645 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -76.54 -17.82 59.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 109.561 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -64.18 -58.71 5.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.236 -0.915 . . . . 0.0 109.547 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -66.54 -40.1 88.91 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.375 -0.828 . . . . 0.0 109.123 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.7 t -73.81 -22.75 59.69 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.398 -0.813 . . . . 0.0 109.251 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -75.1 -35.36 49.57 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.75 -46.78 34.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.284 -1.127 . . . . 0.0 109.297 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.15 -39.81 87.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.349 -0.844 . . . . 0.0 109.324 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.46 -49.58 58.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.31 -0.869 . . . . 0.0 109.425 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.413 HG22 ' OE1' ' A' ' 80' ' ' GLN . 39.3 mt -48.31 -42.18 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -0.912 . . . . 0.0 109.411 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -70.06 -36.48 75.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 109.377 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.467 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 5.7 m -68.68 -34.94 76.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.265 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 87.5 t -70.37 -46.65 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.362 -0.836 . . . . 0.0 109.424 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.413 ' OE1' HG22 ' A' ' 76' ' ' ILE . 43.6 mt-30 -64.03 -46.27 85.18 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.295 -0.878 . . . . 0.0 109.192 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.626 HD11 HD23 ' A' ' 6' ' ' LEU . 2.5 mt -56.63 -36.61 69.69 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.261 -0.899 . . . . 0.0 108.88 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 86' ' ' ASN . 0.7 OUTLIER -61.53 -58.12 9.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.298 -0.876 . . . . 0.0 109.154 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.49 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 10.8 m-20 -50.7 -33.11 21.47 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.993 -1.067 . . . . 0.0 108.355 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -78.14 -25.87 47.57 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.569 ' C ' ' H ' ' A' ' 87' ' ' GLY . 8.5 mt -121.38 32.09 6.05 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.497 -0.752 . . . . 0.0 109.371 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 82' ' ' ASP . 26.8 p30 -72.77 26.38 0.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.271 -0.893 . . . . 0.0 108.849 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.569 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -78.25 56.59 4.04 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 62.03 55.23 2.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.477 -1.014 . . . . 0.0 109.69 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.22 179.09 4.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.373 -0.83 . . . . 0.0 109.186 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.1 t -134.68 151.52 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.607 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -115.75 136.63 52.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.383 -0.823 . . . . 0.0 109.416 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.485 ' O ' ' OE2' ' A' ' 94' ' ' GLU . 23.8 m80 -107.22 110.4 22.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.159 -0.963 . . . . 0.0 109.55 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.1 mtp85 -86.39 92.93 8.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.248 -0.908 . . . . 0.0 109.142 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.485 ' OE2' ' O ' ' A' ' 92' ' ' HIS . 20.2 mp0 -99.87 140.46 34.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.871 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.6 t -132.61 157.35 43.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.417 -0.802 . . . . 0.0 109.123 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.456 ' O ' ' CD ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -56.99 115.98 2.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.917 . . . . 0.0 109.499 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.89 9.92 65.39 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.456 ' O ' ' C ' ' A' ' 99' ' ' GLU . 11.5 t80 -144.98 30.07 1.18 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -1.156 . . . . 0.0 109.588 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.654 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 6.7 mp0 -41.82 157.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 0.0 109.497 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.7 p -87.29 177.76 7.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -0.889 . . . . 0.0 109.564 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.35 -57.01 4.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.458 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.8 m -46.77 -51.18 16.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.189 -0.945 . . . . 0.0 109.269 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.76 -52.5 63.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.387 -0.821 . . . . 0.0 109.203 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.6 mt -49.09 -28.68 4.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.89 . . . . 0.0 109.424 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.56 -14.11 51.44 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.444 ' O ' ' C ' ' A' ' 107' ' ' PHE . 7.2 t80 -83.08 -20.29 35.19 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.269 -1.136 . . . . 0.0 109.564 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.545 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 3.3 p90 -42.31 122.97 2.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.163 -0.961 . . . . 0.0 109.549 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -103.1 -57.12 2.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 109.427 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 72.8 m -106.15 -29.2 10.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -0.874 . . . . 0.0 109.413 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 132.49 107.9 1.09 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.697 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -76.42 160.27 29.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.211 -1.17 . . . . 0.0 109.449 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.1 mtpp -153.54 152.05 30.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -0.885 . . . . 0.0 109.511 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -98.28 138.68 35.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 109.421 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -142.5 154.36 44.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.894 . . . . 0.0 109.604 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 71.1 tttt . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.429 179.975 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo . . . . . 0 N--CA 1.488 1.176 0 CA-C-O 121.252 0.438 . . . . 0.0 112.086 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.688 ' H ' HD22 ' A' ' 24' ' ' LEU . 67.5 tt0 -83.21 -18.02 40.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.355 -0.841 . . . . 0.0 109.999 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.465 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 2.3 m-85 -74.09 -5.91 44.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.092 -1.005 . . . . 0.0 109.541 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.5 mt -85.49 -39.62 17.26 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.205 -0.934 . . . . 0.0 109.417 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 8' ' ' ALA . 41.9 mtpt -97.67 -9.97 25.84 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.352 -0.843 . . . . 0.0 109.515 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -43.84 166.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 0.0 109.577 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 134.87 -29.9 2.91 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -78.94 23.7 0.34 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.245 -1.15 . . . . 0.0 109.377 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 13' ' ' GLY . 55.3 mt-10 -137.01 76.77 44.84 Favored Pre-proline 0 C--N 1.305 -1.367 0 O-C-N 121.288 -0.882 . . . . 0.0 109.547 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -52.25 81.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 122.867 2.378 . . . . 0.0 112.207 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 46' ' ' THR . . . 179.65 -102.98 0.17 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.639 HD21 ' CG2' ' A' ' 43' ' ' ILE . 7.1 tt -162.53 127.53 3.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -1.179 . . . . 0.0 109.81 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.59 ' N ' HD23 ' A' ' 14' ' ' LEU . 35.1 mt-30 -114.42 146.82 40.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.346 -0.846 . . . . 0.0 109.316 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.625 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 11.8 mt -130.68 123.86 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.502 -0.749 . . . . 0.0 110.284 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.625 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 11.3 m0 -143.88 158.94 43.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.043 -1.036 . . . . 0.0 108.528 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.504 ' NE ' ' CZ ' ' A' ' 41' ' ' TYR . 20.8 ttm180 -105.76 152.48 23.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.019 -1.051 . . . . 0.0 110.001 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.6 p -88.38 139.61 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.277 -0.889 . . . . 0.0 109.422 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.595 ' O ' ' N ' ' A' ' 22' ' ' PHE . 18.8 tt0 -88.69 152.61 21.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.23 -0.919 . . . . 0.0 109.203 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 20' ' ' GLU . 24.3 tttt -40.72 -20.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.307 -0.87 . . . . 0.0 109.555 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.595 ' N ' ' O ' ' A' ' 20' ' ' GLU . 7.2 t80 -160.14 32.1 0.17 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.175 -0.953 . . . . 0.0 109.492 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -170.71 -130.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.516 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.688 HD22 ' H ' ' A' ' 4' ' ' GLU . 5.9 tp -144.2 146.2 32.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 109.558 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 t -129.3 126.99 23.14 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.017 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -75.21 141.6 26.24 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.368 2.045 . . . . 0.0 112.383 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.5 t -104.35 122.84 42.56 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.379 -0.826 . . . . 0.0 109.242 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.32 162.08 34.14 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.514 2.143 . . . . 0.0 112.28 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.94 -24.64 67.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.216 -0.928 . . . . 0.0 109.428 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -64.02 -10.71 23.43 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 109.429 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 32' ' ' TYR . 94.9 mt -127.26 -13.16 5.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.289 -0.882 . . . . 0.0 109.531 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.531 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 4.4 t80 -41.11 131.05 2.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.372 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 112' ' ' LYS . . . 85.8 15.03 66.3 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -141.24 99.28 3.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -1.145 . . . . 0.0 109.48 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -97.04 164.94 12.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.276 -0.89 . . . . 0.0 109.494 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -105.2 136.08 45.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.449 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.449 ' OG1' ' CD ' ' A' ' 65' ' ' GLU . 4.1 p -73.35 -4.99 36.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.184 -0.948 . . . . 0.0 109.486 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.97 38.75 3.18 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 40' ' ' ALA . 5.9 t0 -171.23 171.01 5.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -1.189 . . . . 0.0 109.489 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.463 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -113.59 136.01 53.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.89 . . . . 0.0 109.546 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.504 ' CZ ' ' NE ' ' A' ' 18' ' ' ARG . 27.7 m-85 -114.91 142.64 46.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.333 -0.854 . . . . 0.0 109.345 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.011 ' O ' HD13 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -113.14 143.96 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.273 -0.892 . . . . 0.0 108.871 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.011 HD13 ' O ' ' A' ' 42' ' ' VAL . 1.2 mm -136.7 151.41 27.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.359 -0.937 . . . . 0.0 110.091 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.706 HD23 ' N ' ' A' ' 45' ' ' LYS . 4.5 tt -135.27 121.14 19.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.554 -0.716 . . . . 0.0 109.207 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.706 ' N ' HD23 ' A' ' 44' ' ' LEU . 31.5 tttt -104.96 112.48 25.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.251 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 55' ' ' GLN . 39.1 m -119.78 135.54 54.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.418 -0.801 . . . . 0.0 109.484 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.535 ' O ' HD23 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -126.95 168.29 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 121.304 -0.872 . . . . 0.0 108.907 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 40.9 tp60 -106.9 98.49 8.14 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.611 -0.68 . . . . 0.0 109.422 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.61 ' O ' ' N ' ' A' ' 51' ' ' ASN . 9.3 mt -65.03 157.75 27.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 109.239 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -51.72 84.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.12 -0.988 . . . . 0.0 109.099 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.61 ' N ' ' O ' ' A' ' 49' ' ' LEU . 6.6 m-20 51.43 43.36 29.59 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.229 -0.92 . . . . 0.0 109.192 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.82 -79.9 1.49 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -174.53 26.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.079 -1.248 . . . . 0.0 109.908 -179.674 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.616 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 3.9 mt 58.51 106.7 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.666 0.746 . . . . 0.0 109.118 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.593 ' O ' HG23 ' A' ' 46' ' ' THR . 32.1 tt0 -68.82 147.53 51.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.523 -0.735 . . . . 0.0 109.503 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.616 ' CE1' ' O ' ' A' ' 54' ' ' LEU . 97.7 m-85 -129.95 114.67 16.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.48 -0.762 . . . . 0.0 109.507 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.593 ' OD1' ' CE1' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -123.1 154.94 37.92 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.176 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.5 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 1.8 mp -132.93 150.2 52.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.958 -1.089 . . . . 0.0 110.753 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.704 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -141.96 116.93 9.93 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.36 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.667 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -103.8 121.89 43.98 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.023 -1.048 . . . . 0.0 109.52 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.553 ' NE1' ' OE1' ' A' ' 99' ' ' GLU . 71.4 t90 -98.99 136.25 39.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.866 . . . . 0.0 109.725 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.565 ' H ' HD12 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -116.63 159.04 22.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.397 -0.814 . . . . 0.0 109.4 179.791 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -101.07 148.34 18.1 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -70.37 -12.25 61.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -1.16 . . . . 0.0 109.49 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.449 ' CD ' ' OG1' ' A' ' 37' ' ' THR . 1.7 mt-10 -106.6 31.37 5.29 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.3 m -130.48 97.57 4.43 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.091 0.948 . . . . 0.0 108.513 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 66' ' ' CYS . 94.3 p -52.57 -170.88 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.783 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 72' ' ' GLY . 44.2 tt0 -64.63 -17.95 64.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.367 -0.833 . . . . 0.0 109.537 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -63.29 -58.69 6.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 109.473 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -68.16 -39.46 82.57 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.396 -0.815 . . . . 0.0 108.898 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 t -73.48 -20.98 60.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.515 -0.741 . . . . 0.0 109.064 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -75.66 -41.06 30.19 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.53 -42.16 71.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -1.121 . . . . 0.0 109.22 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.436 ' HB2' ' CB ' ' A' ' 40' ' ' ALA . . . -62.05 -42.04 98.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.328 -0.858 . . . . 0.0 109.285 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.513 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -64.91 -47.82 76.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.308 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.2 mt -52.76 -37.14 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.348 -0.845 . . . . 0.0 109.235 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.56 -41.34 79.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.342 -0.849 . . . . 0.0 109.293 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.9 m -68.28 -34.45 76.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 109.557 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 75' ' ' ALA . 61.8 t -68.06 -37.99 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.223 -0.923 . . . . 0.0 109.426 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.411 ' HG2' ' N ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -68.39 -47.03 68.42 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.723 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.463 HD13 HD23 ' A' ' 58' ' ' LEU . 0.6 OUTLIER -55.43 -38.13 68.59 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.189 -0.945 . . . . 0.0 108.974 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.628 ' O ' ' N ' ' A' ' 86' ' ' ASN . 16.1 t70 -61.74 -58.33 8.45 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.318 -0.864 . . . . 0.0 109.109 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 82' ' ' ASP . 59.1 m-20 -45.43 -35.09 3.48 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.119 -0.988 . . . . 0.0 108.744 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -74.25 -32.66 63.04 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.361 -0.837 . . . . 0.0 108.834 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.577 ' C ' ' H ' ' A' ' 87' ' ' GLY . 7.7 mt -121.69 36.17 4.69 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.409 -0.807 . . . . 0.0 109.283 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.628 ' N ' ' O ' ' A' ' 82' ' ' ASP . 9.6 p30 -72.03 25.4 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.95 . . . . 0.0 109.143 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.577 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -80.41 -75.65 1.06 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.409 ' HG3' HH21 ' A' ' 88' ' ' ARG . 12.7 mtt85 -152.32 50.65 0.77 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.262 -1.14 . . . . 0.0 109.458 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -96.87 179.14 5.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.404 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.0 t -135.99 96.36 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.282 -0.886 . . . . 0.0 109.532 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 7.2 pt20 -95.87 143.92 26.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.905 . . . . 0.0 109.308 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.672 ' CE1' ' HD1' ' A' ' 59' ' ' HIS . 2.0 p80 -147.09 158.6 43.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.841 -1.162 . . . . 0.0 110.144 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.537 ' CG ' HD11 ' A' ' 62' ' ' LEU . 4.4 ttt180 -91.68 126.29 36.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.456 -0.778 . . . . 0.0 109.902 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.441 ' O ' HD12 ' A' ' 62' ' ' LEU . 21.4 mt-10 -107.49 129.91 54.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 109.229 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.491 ' O ' ' OE1' ' A' ' 99' ' ' GLU . 3.4 t -127.57 161.41 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 109.66 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -62.44 145.21 54.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.328 -0.858 . . . . 0.0 109.551 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.69 4.18 6.71 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.447 ' O ' ' C ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -134.08 6.13 3.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -1.101 . . . . 0.0 109.293 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.553 ' OE1' ' NE1' ' A' ' 61' ' ' TRP . 3.5 mp0 -42.64 158.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.417 -0.802 . . . . 0.0 109.351 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.1 m -80.32 147.44 31.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.313 -0.867 . . . . 0.0 109.369 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.71 -33.26 66.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -0.964 . . . . 0.0 109.432 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 99.4 m -68.68 -33.86 74.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -0.916 . . . . 0.0 109.481 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -68.74 -46.6 68.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.361 -0.837 . . . . 0.0 109.422 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.6 mt -69.36 -23.49 63.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.466 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.14 -26.24 22.04 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -77.33 -30.9 54.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.363 -1.081 . . . . 0.0 109.559 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -80.65 129.17 34.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.446 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.47 ' HB2' ' HZ3' ' A' ' 108' ' ' LYS . 1.9 mtmp? -103.21 -12.86 17.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.895 . . . . 0.0 109.457 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.9 t -97.05 -9.21 28.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.927 . . . . 0.0 109.511 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.59 104.48 0.3 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.766 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -63.27 179.82 0.39 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -1.123 . . . . 0.0 109.32 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -164.54 167.13 19.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.204 -0.935 . . . . 0.0 109.459 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.5 103.24 5.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 0.0 109.316 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -79.51 124.06 28.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.897 . . . . 0.0 109.536 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.125 -0.985 . . . . 0.0 109.479 -179.945 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo . . . . . 0 N--CA 1.494 1.511 0 CA-C-O 121.192 0.413 . . . . 0.0 111.994 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.425 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 6.0 mm-40 -83.42 -46.45 12.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -0.877 . . . . 0.0 109.993 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.804 ' CZ ' HG12 ' A' ' 42' ' ' VAL . 23.1 t80 -65.29 -32.66 74.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.207 -0.933 . . . . 0.0 109.058 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.509 HD23 HD11 ' A' ' 81' ' ' LEU . 12.2 mt -74.01 -35.85 64.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.31 -0.869 . . . . 0.0 109.314 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.497 ' O ' ' O ' ' A' ' 8' ' ' ALA . 12.4 mmmt -82.76 -9.88 59.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.435 -0.79 . . . . 0.0 109.307 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.497 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -45.58 173.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.595 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.4 32.57 1.77 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -150.25 35.61 0.66 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.324 -1.103 . . . . 0.0 109.412 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -155.09 115.5 2.36 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.296 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.15 81.85 2.6 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.442 2.094 . . . . 0.0 112.354 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 46' ' ' THR . . . 175.44 -100.62 0.15 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 tt -161.44 145.06 12.76 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.217 -1.167 . . . . 0.0 109.652 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.42 ' HB3' ' CZ3' ' A' ' 17' ' ' TRP . 1.2 mt-30 -133.75 135.96 44.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 109.239 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.409 HG23 HD12 ' A' ' 43' ' ' ILE . 13.3 mt -106.83 135.65 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.349 -0.844 . . . . 0.0 110.067 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.425 ' CE2' ' HB3' ' A' ' 4' ' ' GLU . 0.6 OUTLIER -144.34 111.38 5.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.379 -0.825 . . . . 0.0 108.948 179.466 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.569 ' NH2' ' CD1' ' A' ' 36' ' ' PHE . 28.2 ttt180 -74.79 153.03 38.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.192 -0.942 . . . . 0.0 109.473 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.9 p -77.14 145.14 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 109.792 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 22' ' ' PHE . 21.6 tt0 -108.08 154.58 21.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.405 -0.809 . . . . 0.0 109.187 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.591 ' O ' ' CD2' ' A' ' 22' ' ' PHE . 7.2 mtmp? -46.93 -10.86 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.287 -0.883 . . . . 0.0 109.513 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 21' ' ' LYS . 9.5 m-85 -169.53 28.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 109.529 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.675 ' C ' HD22 ' A' ' 24' ' ' LEU . 3.7 t70 -176.03 -154.17 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.918 . . . . 0.0 109.592 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.675 HD22 ' C ' ' A' ' 23' ' ' ASP . 4.5 mm? -117.83 146.01 44.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.312 -0.868 . . . . 0.0 109.425 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 18' ' ' ARG . 2.1 t -125.08 130.65 24.12 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.323 -0.861 . . . . 0.0 109.048 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.56 137.61 20.71 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.344 2.029 . . . . 0.0 112.631 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -122.25 101.68 40.88 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.428 -0.795 . . . . 0.0 108.973 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.66 166.93 23.21 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.466 2.111 . . . . 0.0 112.478 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.35 -17.8 22.73 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.22 -0.925 . . . . 0.0 109.31 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.476 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 1.5 m-20 -44.45 -31.18 1.01 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.939 . . . . 0.0 109.361 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.487 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 2.3 pp -160.45 16.64 0.13 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.247 -0.908 . . . . 0.0 109.837 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -56.33 161.4 2.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.992 -1.067 . . . . 0.0 109.423 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.57 -7.77 63.69 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.487 ' OD2' ' O ' ' A' ' 31' ' ' LEU . 11.3 p-10 -93.01 98.14 11.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -1.145 . . . . 0.0 109.373 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.485 ' CE1' HD23 ' A' ' 111' ' ' LEU . 51.1 m-85 -89.61 133.71 34.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.279 -0.888 . . . . 0.0 109.508 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.569 ' CD1' ' NH2' ' A' ' 18' ' ' ARG . 28.2 m-85 -96.52 127.4 42.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 109.525 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 28.5 p -68.83 -4.87 17.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.879 . . . . 0.0 109.576 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.22 43.82 1.54 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -167.99 -168.25 0.95 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.244 -1.15 . . . . 0.0 109.49 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.83 145.25 44.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.959 . . . . 0.0 109.497 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.574 ' HB3' HD11 ' A' ' 43' ' ' ILE . 1.7 m-85 -118.73 135.77 54.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.399 -0.813 . . . . 0.0 109.455 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.064 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -115.62 120.11 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.428 -0.795 . . . . 0.0 109.048 179.785 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.064 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -125.1 130.0 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.16 -0.962 . . . . 0.0 110.299 -179.211 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 57' ' ' ASP . 6.0 tp -104.79 121.0 42.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.565 -0.709 . . . . 0.0 109.166 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.554 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.1 tptm -104.83 103.81 13.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.37 -0.831 . . . . 0.0 109.178 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 55' ' ' GLN . 16.9 m -117.22 139.1 51.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.331 -0.856 . . . . 0.0 109.521 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.561 ' O ' HD23 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -131.65 168.39 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.246 -0.909 . . . . 0.0 109.491 -179.685 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.565 HE22 ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -111.69 133.49 53.89 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.651 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.626 ' O ' ' C ' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -116.06 100.33 7.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.202 -0.936 . . . . 0.0 109.554 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.626 ' C ' ' O ' ' A' ' 49' ' ' LEU . 31.0 ttt85 21.23 72.54 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.68 -0.638 . . . . 0.0 110.235 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.412 ' OD1' ' N ' ' A' ' 51' ' ' ASN . 1.8 m120 45.87 52.04 10.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.381 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . -97.11 -81.74 1.6 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -165.15 20.73 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.347 -1.09 . . . . 0.0 109.754 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.592 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 5.9 mt 53.77 104.65 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.489 -0.757 . . . . 0.0 109.306 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.501 ' O ' HG23 ' A' ' 46' ' ' THR . 32.1 tt0 -68.04 149.69 49.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.538 -0.726 . . . . 0.0 109.043 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.592 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 97.1 m-85 -131.47 114.89 15.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.941 . . . . 0.0 109.94 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.613 ' O ' HD12 ' A' ' 44' ' ' LEU . 2.0 m-20 -120.29 155.03 34.11 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.465 HD13 ' HG3' ' A' ' 91' ' ' GLN . 4.8 mp -136.25 129.78 32.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.947 -1.095 . . . . 0.0 110.162 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.586 ' ND1' ' NE2' ' A' ' 92' ' ' HIS . 3.1 m-70 -115.62 109.65 18.05 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.658 ' CZ ' HD22 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -99.55 115.81 30.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 109.317 -179.61 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -108.16 142.31 38.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.29 -0.881 . . . . 0.0 109.752 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.658 HD22 ' CZ ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -133.52 162.21 32.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 109.526 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -87.24 154.41 26.3 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -82.07 -12.42 58.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -1.122 . . . . 0.0 109.564 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -106.81 32.79 4.3 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.498 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.3 m -130.23 97.67 4.5 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.261 1.029 . . . . 0.0 108.438 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 66' ' ' CYS . 1.2 t -44.32 173.87 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.855 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.596 ' O ' ' N ' ' A' ' 72' ' ' GLY . 3.3 pt20 -57.25 -17.45 11.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.483 -0.761 . . . . 0.0 109.732 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -61.22 -59.1 5.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.054 -1.029 . . . . 0.0 109.384 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.28 -50.75 66.69 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 108.691 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.2 m -64.98 -20.87 66.71 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.15 -43.83 62.55 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.69 -49.07 67.31 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -1.157 . . . . 0.0 109.103 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.69 -43.9 90.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.393 -0.817 . . . . 0.0 109.211 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.553 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -66.73 -47.2 73.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.353 -0.842 . . . . 0.0 109.478 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.9 mt -47.08 -44.12 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.888 . . . . 0.0 109.091 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.458 ' O ' HD12 ' A' ' 81' ' ' LEU . 37.5 m-85 -65.77 -45.92 80.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.298 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.4 m -66.14 -22.58 66.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.245 -0.909 . . . . 0.0 109.009 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 75' ' ' ALA . 66.3 t -73.57 -50.28 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.288 -0.883 . . . . 0.0 109.459 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -61.66 -49.86 74.84 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.321 -0.862 . . . . 0.0 108.92 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.509 HD11 HD23 ' A' ' 6' ' ' LEU . 0.9 OUTLIER -55.15 -37.68 67.29 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.28 -0.888 . . . . 0.0 109.037 179.552 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 86' ' ' ASN . 64.5 t0 -58.07 -55.87 29.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.226 -0.921 . . . . 0.0 108.883 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -50.32 -33.98 22.08 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.08 -1.012 . . . . 0.0 108.362 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -77.1 -24.27 51.8 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 82' ' ' ASP . 12.6 mt -121.4 30.45 6.76 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.326 -0.859 . . . . 0.0 109.419 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.1 OUTLIER -80.13 27.99 0.31 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.309 -0.869 . . . . 0.0 108.974 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -83.17 -54.35 3.2 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.6 ptt-85 -175.81 42.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -1.112 . . . . 0.0 109.62 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.581 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -95.53 178.88 5.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.497 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 87.4 t -123.27 91.97 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.437 -0.789 . . . . 0.0 109.337 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.535 ' H ' ' CD ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -96.57 125.18 40.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.342 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.586 ' NE2' ' ND1' ' A' ' 59' ' ' HIS . 2.7 p80 -133.52 143.78 48.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.143 -0.973 . . . . 0.0 109.618 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -99.32 105.29 17.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.227 -0.92 . . . . 0.0 109.69 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.423 ' OE1' ' OG ' ' A' ' 100' ' ' SER . 41.0 mt-10 -87.11 148.16 25.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.321 -0.862 . . . . 0.0 109.391 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 t -135.28 163.46 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.196 -0.94 . . . . 0.0 109.487 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 97' ' ' GLY . 6.2 tp-100 -75.4 126.35 30.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.242 -0.911 . . . . 0.0 109.557 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.548 ' N ' ' OE1' ' A' ' 96' ' ' GLN . . . 121.19 4.58 10.03 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.459 ' O ' ' C ' ' A' ' 99' ' ' GLU . 35.9 t80 -174.0 -34.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.226 -1.161 . . . . 0.0 109.448 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 98' ' ' PHE . 14.1 mt-10 41.64 -155.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.356 -0.84 . . . . 0.0 109.569 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.423 ' OG ' ' OE1' ' A' ' 94' ' ' GLU . 78.7 p -129.78 134.3 47.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 109.5 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 100' ' ' SER . . . -44.81 -37.66 3.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.292 -0.88 . . . . 0.0 109.38 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 m -55.54 -48.34 74.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.231 -0.918 . . . . 0.0 109.346 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -62.69 -55.64 25.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 0.0 109.194 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.3 mt -47.39 -26.67 1.38 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.877 . . . . 0.0 109.242 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.71 -40.16 7.83 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.5 ' OH ' ' NZ ' ' A' ' 45' ' ' LYS . 2.7 m-85 -51.87 -46.71 64.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -1.114 . . . . 0.0 109.314 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -139.27 149.71 44.61 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.387 -0.821 . . . . 0.0 109.6 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.89 -56.82 2.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 0.0 109.286 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 110' ' ' GLY . 5.0 m -103.02 -26.81 12.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.496 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 109' ' ' SER . . . -42.44 -59.93 2.94 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.485 HD23 ' CE1' ' A' ' 35' ' ' PHE . 13.9 mt -44.87 134.28 5.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.257 -1.143 . . . . 0.0 109.445 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.3 mttp -151.23 121.56 7.31 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.224 -0.923 . . . . 0.0 109.406 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.448 ' CD2' ' N ' ' A' ' 113' ' ' TYR . 0.6 OUTLIER -98.0 127.8 44.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.302 -0.874 . . . . 0.0 109.443 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -135.42 134.13 39.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 109.457 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 31.9 mtmt . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.146 -0.971 . . . . 0.0 109.506 179.991 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo . . . . . 0 N--CA 1.493 1.476 0 CA-C-O 121.272 0.447 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.585 ' H ' HD13 ' A' ' 24' ' ' LEU . 4.4 mm-40 -83.41 -37.4 23.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 109.973 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.592 ' CE1' ' CG1' ' A' ' 42' ' ' VAL . 23.5 t80 -70.07 -24.29 63.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.175 -0.953 . . . . 0.0 110.031 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.492 HD23 ' N ' ' A' ' 6' ' ' LEU . 4.1 mt -80.76 -40.34 25.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.081 -1.012 . . . . 0.0 109.677 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.493 ' O ' ' O ' ' A' ' 8' ' ' ALA . 4.2 pttm -96.51 3.45 52.7 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.294 -0.879 . . . . 0.0 109.587 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -54.03 -165.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.77 64.9 1.35 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.18 17.96 1.91 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.336 -1.097 . . . . 0.0 109.588 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.476 ' O ' ' OE1' ' A' ' 11' ' ' GLU . 1.9 pp20? -156.18 134.15 7.05 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.18 -0.95 . . . . 0.0 109.421 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.34 84.65 1.67 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.526 2.151 . . . . 0.0 112.286 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 46' ' ' THR . . . 178.35 -100.55 0.14 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 tt -162.21 152.63 17.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.24 -1.153 . . . . 0.0 109.487 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -135.36 142.24 45.7 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.272 -0.892 . . . . 0.0 109.553 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.535 HG23 HD12 ' A' ' 43' ' ' ILE . 22.3 mt -117.22 133.16 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.32 -0.863 . . . . 0.0 109.801 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -139.26 119.37 13.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.313 -0.867 . . . . 0.0 109.085 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.479 HH11 ' CB ' ' A' ' 39' ' ' ASP . 15.3 ttt85 -85.47 153.62 22.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.235 -0.916 . . . . 0.0 109.647 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 22' ' ' PHE . 38.8 t -91.99 123.49 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.218 -0.926 . . . . 0.0 110.043 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.763 ' O ' ' N ' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -71.02 85.82 0.72 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.982 -1.074 . . . . 0.0 108.482 179.405 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.652 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 48.8 tttt 43.63 6.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.361 -0.837 . . . . 0.0 109.415 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.763 ' N ' ' O ' ' A' ' 20' ' ' GLU . 0.7 OUTLIER 160.92 -30.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.849 . . . . 0.0 109.292 -179.802 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -95.08 -129.52 0.14 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.179 -0.951 . . . . 0.0 110.076 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.585 HD13 ' H ' ' A' ' 4' ' ' GLU . 3.8 mt -139.99 142.65 36.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.127 -0.983 . . . . 0.0 110.265 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 18' ' ' ARG . 3.4 t -142.11 110.29 5.97 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.831 . . . . 0.0 108.96 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -46.27 151.59 1.63 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.067 1.845 . . . . 0.0 111.808 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.11 101.47 45.04 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.944 . . . . 0.0 109.61 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.02 162.58 1.83 Allowed 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.506 2.138 . . . . 0.0 112.257 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.6 m -78.22 -34.79 49.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 109.348 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -56.63 -16.95 7.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.405 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.458 ' O ' ' C ' ' A' ' 32' ' ' TYR . 15.6 mt -112.35 -25.96 8.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.263 -0.898 . . . . 0.0 109.551 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.566 ' OH ' ' CE2' ' A' ' 107' ' ' PHE . 19.0 t80 -41.63 137.08 1.7 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.891 . . . . 0.0 109.453 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.44 -16.71 48.27 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -100.18 121.96 42.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -1.189 . . . . 0.0 109.438 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -102.53 121.58 42.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.189 -0.945 . . . . 0.0 109.536 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -95.96 144.23 26.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.465 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.4 p -97.05 -10.22 26.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -100.22 34.23 5.69 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.479 ' CB ' HH11 ' A' ' 18' ' ' ARG . 4.8 m-20 -163.78 -177.1 4.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -1.149 . . . . 0.0 109.496 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.406 ' C ' ' CD2' ' A' ' 41' ' ' TYR . . . -140.46 146.9 38.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.256 -0.903 . . . . 0.0 109.405 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.585 ' OH ' ' CZ3' ' A' ' 61' ' ' TRP . 0.1 OUTLIER -142.56 137.88 30.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.121 -0.987 . . . . 0.0 109.793 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.945 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -101.29 144.23 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.945 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.6 OUTLIER -128.02 134.37 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.512 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.668 HD23 ' C ' ' A' ' 44' ' ' LEU . 4.7 tt -109.66 116.2 31.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.627 -0.671 . . . . 0.0 109.397 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.649 ' N ' HD23 ' A' ' 44' ' ' LEU . 8.5 ttpt -92.43 139.48 30.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.219 -0.926 . . . . 0.0 109.44 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.525 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.6 OUTLIER -143.07 118.62 10.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.119 -0.988 . . . . 0.0 109.413 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.694 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -128.24 167.97 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.109 -0.995 . . . . 0.0 109.224 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -95.37 120.25 35.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.571 -0.705 . . . . 0.0 109.433 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 52' ' ' GLY . 82.2 mt -74.86 168.8 19.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -0.956 . . . . 0.0 109.487 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 49' ' ' LEU . 13.5 ttt-85 -43.31 -48.92 6.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.273 -0.892 . . . . 0.0 109.177 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.426 HD21 ' C ' ' A' ' 51' ' ' ASN . 0.1 OUTLIER -81.49 -12.07 58.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.308 -0.87 . . . . 0.0 109.132 179.693 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . 88.77 31.85 12.09 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.499 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.8 m120 -78.65 13.92 1.48 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.13 -1.217 . . . . 0.0 109.206 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.694 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.0 mt 43.82 96.8 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 121.438 0.637 . . . . 0.0 109.566 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.51 ' HB2' HD21 ' A' ' 49' ' ' LEU . 28.1 tp60 -77.67 118.09 19.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.386 -0.821 . . . . 0.0 109.465 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -96.16 114.14 25.81 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.137 -0.977 . . . . 0.0 109.585 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -113.43 150.2 33.09 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.189 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.587 HD22 ' O ' ' A' ' 57' ' ' ASP . 4.1 mm? -117.1 136.56 52.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.089 -1.007 . . . . 0.0 110.068 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.544 ' CD2' ' HB2' ' A' ' 92' ' ' HIS . 32.1 m80 -135.43 125.48 26.0 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.653 ' CE2' HD22 ' A' ' 62' ' ' LEU . 9.4 t80 -117.36 135.18 54.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 109.819 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.585 ' CZ3' ' OH ' ' A' ' 41' ' ' TYR . 27.9 t90 -120.2 124.24 45.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.413 -0.804 . . . . 0.0 109.289 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.653 HD22 ' CE2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -112.86 162.31 15.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.359 -0.838 . . . . 0.0 109.523 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.02 156.1 19.62 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -78.12 -11.71 59.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.391 -1.064 . . . . 0.0 109.482 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -102.25 32.41 3.54 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.498 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.0 OUTLIER -130.79 97.56 4.38 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.181 0.991 . . . . 0.0 108.359 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 66' ' ' CYS . 20.6 t -42.02 167.97 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.785 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.564 ' O ' ' N ' ' A' ' 72' ' ' GLY . 27.0 tt0 -56.59 -17.76 9.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.901 . . . . 0.0 109.592 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -62.6 -58.65 6.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 109.376 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.557 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -63.07 -48.63 77.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 0.0 109.079 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.8 -21.62 64.31 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.311 -0.868 . . . . 0.0 109.055 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -75.65 -40.5 31.76 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.59 -39.2 77.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.194 -1.18 . . . . 0.0 109.162 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.515 ' CB ' ' CZ ' ' A' ' 60' ' ' TYR . . . -65.81 -46.53 78.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.489 -0.757 . . . . 0.0 109.226 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -60.3 -37.52 80.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.311 -0.868 . . . . 0.0 109.337 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.8 mt -60.88 -49.25 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.41 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -65.56 -31.43 72.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.279 -0.888 . . . . 0.0 109.405 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.1 m -72.8 -41.95 64.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.225 -0.922 . . . . 0.0 109.278 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 75' ' ' ALA . 89.8 t -63.34 -35.83 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.243 -0.91 . . . . 0.0 109.297 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -65.67 -51.37 59.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.331 -0.856 . . . . 0.0 109.071 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 mt -51.72 -39.49 58.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.034 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 85' ' ' LEU . 13.4 t0 -60.16 -58.75 7.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.307 -0.87 . . . . 0.0 109.144 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 82' ' ' ASP . 24.0 t0 -45.14 -34.16 2.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.207 -0.933 . . . . 0.0 108.881 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -76.57 -28.25 56.17 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.309 -0.869 . . . . 0.0 108.868 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.555 ' N ' ' O ' ' A' ' 82' ' ' ASP . 11.5 mt -121.69 32.14 5.99 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.354 -0.841 . . . . 0.0 109.736 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.1 OUTLIER -79.34 27.51 0.26 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.165 -0.959 . . . . 0.0 109.13 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -89.9 -49.22 3.4 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.434 ' CG ' ' O ' ' A' ' 87' ' ' GLY . 57.8 mtm-85 -158.41 41.61 0.26 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.248 -1.148 . . . . 0.0 109.462 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -127.63 165.25 20.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.399 -0.813 . . . . 0.0 109.226 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.623 HG12 ' N ' ' A' ' 91' ' ' GLN . 98.6 t -135.92 167.34 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.914 . . . . 0.0 109.589 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.623 ' N ' HG12 ' A' ' 90' ' ' VAL . 10.3 mp0 -119.31 134.51 55.17 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.39 -0.819 . . . . 0.0 109.465 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.544 ' HB2' ' CD2' ' A' ' 59' ' ' HIS . 20.8 m80 -105.72 105.14 15.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 109.582 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.2 mtm180 -77.95 102.4 7.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.946 . . . . 0.0 109.309 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.558 ' OE2' ' CD2' ' A' ' 103' ' ' PHE . 50.2 mt-10 -102.33 134.09 46.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.189 -0.944 . . . . 0.0 109.747 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 96' ' ' GLN . 3.1 t -132.88 168.62 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.401 -0.812 . . . . 0.0 109.269 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.453 ' H ' HG12 ' A' ' 95' ' ' VAL . 4.5 tt0 -69.94 118.34 12.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 109.57 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.514 ' O ' ' CD1' ' A' ' 98' ' ' PHE . . . 91.0 11.29 61.67 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 24.8 m-85 -152.55 24.66 0.6 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -1.161 . . . . 0.0 109.665 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 98' ' ' PHE . 27.6 mt-10 -42.82 150.96 0.14 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.173 -0.955 . . . . 0.0 109.409 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.8 p -78.24 168.14 20.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.226 -0.921 . . . . 0.0 109.553 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.45 -61.68 1.78 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -0.906 . . . . 0.0 109.485 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.4 m -47.25 -45.04 23.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.377 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.558 ' CD2' ' OE2' ' A' ' 94' ' ' GLU . 29.1 t80 -58.67 -53.49 57.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.38 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.7 mt -56.1 -28.83 59.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.89 . . . . 0.0 109.386 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -78.0 -25.54 61.9 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -77.83 -30.08 50.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -1.158 . . . . 0.0 109.338 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.566 ' CE2' ' OH ' ' A' ' 32' ' ' TYR . 54.3 m-85 -139.06 127.35 22.74 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.256 -0.902 . . . . 0.0 109.35 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.455 ' HB2' ' HZ3' ' A' ' 108' ' ' LYS . 12.6 ttmm -105.51 -57.01 2.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 109.51 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.0 t -106.03 15.2 26.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.497 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -106.33 28.42 13.68 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.406 HD23 ' N ' ' A' ' 111' ' ' LEU . 0.3 OUTLIER -140.69 54.78 1.59 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.281 -1.129 . . . . 0.0 109.558 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -73.87 135.67 43.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.317 -0.865 . . . . 0.0 109.486 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.496 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 0.9 OUTLIER -92.37 111.32 22.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.472 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -107.99 121.14 44.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.313 -0.867 . . . . 0.0 109.582 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 58.6 mttt . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.504 179.937 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo . . . . . 0 N--CA 1.493 1.475 0 CA-C-O 121.295 0.456 . . . . 0.0 112.091 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 8' ' ' ALA . 41.9 mt-10 -83.13 -45.74 13.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.126 -0.984 . . . . 0.0 109.703 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.537 ' CE1' ' CD1' ' A' ' 81' ' ' LEU . 68.2 t80 -48.67 -22.57 0.8 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -0.908 . . . . 0.0 109.287 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.569 HD23 HD11 ' A' ' 81' ' ' LEU . 85.1 mt -83.61 -40.52 18.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 109.484 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' ALA . 42.8 mmtm -101.24 7.15 43.1 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.39 -0.819 . . . . 0.0 109.549 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 4' ' ' GLU . . . -56.01 -164.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.421 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.464 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 104.86 -27.67 17.94 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -75.76 21.51 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -1.152 . . . . 0.0 109.4 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.464 ' H ' ' C ' ' A' ' 9' ' ' GLY . 26.9 mm-40 -135.12 115.43 11.95 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.259 -0.9 . . . . 0.0 109.356 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.86 73.85 5.5 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.376 2.051 . . . . 0.0 112.277 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -177.28 -103.34 0.17 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.767 HD23 ' C ' ' A' ' 14' ' ' LEU . 3.3 tt -162.26 146.98 12.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.239 -1.153 . . . . 0.0 109.581 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.566 ' N ' HD23 ' A' ' 14' ' ' LEU . 24.0 mt-30 -139.3 145.53 39.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.28 -0.887 . . . . 0.0 109.347 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.55 HD12 ' CE1' ' A' ' 32' ' ' TYR . 10.7 mt -114.18 146.52 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.396 -0.815 . . . . 0.0 110.198 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.451 ' CZ2' ' CB ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER -149.55 138.73 21.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.435 -0.791 . . . . 0.0 109.063 179.665 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -96.67 144.64 26.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 109.473 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.562 HG12 ' O ' ' A' ' 40' ' ' ALA . 12.4 p -81.02 143.82 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 109.494 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.58 ' O ' ' N ' ' A' ' 22' ' ' PHE . 39.9 tt0 -103.3 153.41 20.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.368 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 20' ' ' GLU . 7.6 mtmp? -41.48 -20.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.648 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.58 ' N ' ' O ' ' A' ' 20' ' ' GLU . 3.0 p90 -160.99 30.52 0.14 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.17 -0.956 . . . . 0.0 109.524 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.625 ' C ' HD12 ' A' ' 24' ' ' LEU . 9.8 t70 -174.07 -130.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -0.912 . . . . 0.0 109.53 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.625 HD12 ' C ' ' A' ' 23' ' ' ASP . 5.5 mp -144.34 146.07 32.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.322 -0.861 . . . . 0.0 109.562 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 t -126.31 112.93 23.55 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.393 -0.817 . . . . 0.0 109.427 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.49 152.64 5.89 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.436 2.091 . . . . 0.0 112.313 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.9 t -110.39 101.89 49.81 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.898 . . . . 0.0 109.317 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -48.43 143.47 15.45 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.476 2.117 . . . . 0.0 112.319 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.528 ' C ' ' H ' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -55.96 -44.11 78.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.876 . . . . 0.0 109.376 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -56.72 -2.6 0.08 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 0.0 109.481 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.528 ' H ' ' C ' ' A' ' 29' ' ' THR . 86.4 mt -129.23 -10.73 4.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.202 -0.936 . . . . 0.0 109.551 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.55 ' CE1' HD12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -41.84 124.37 2.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -0.89 . . . . 0.0 109.453 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.39 -9.37 57.46 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -97.98 107.13 19.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.184 -1.186 . . . . 0.0 109.462 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -96.15 150.52 20.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.89 . . . . 0.0 109.536 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -105.03 112.14 25.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 109.402 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.1 p -58.36 -17.07 17.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 109.586 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.447 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -88.15 10.71 69.88 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.447 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 46.6 m-20 -159.49 170.56 21.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.225 -1.162 . . . . 0.0 109.511 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.562 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -109.76 152.38 25.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.387 -0.821 . . . . 0.0 109.504 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -122.12 134.9 54.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.337 -0.852 . . . . 0.0 109.239 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.93 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -103.19 138.38 27.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.143 -0.973 . . . . 0.0 108.91 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.93 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.9 OUTLIER -131.25 145.62 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.615 -179.357 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.63 HD23 ' N ' ' A' ' 45' ' ' LYS . 3.9 tt -123.64 118.45 27.3 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.63 ' N ' HD23 ' A' ' 44' ' ' LEU . 35.0 tttp -103.94 103.77 13.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.358 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.788 HG23 ' O ' ' A' ' 55' ' ' GLN . 33.8 m -112.63 137.15 51.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 109.423 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -133.03 168.58 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 121.158 -0.964 . . . . 0.0 109.586 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -102.58 100.74 10.84 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.8 mt -69.19 168.34 14.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.739 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.594 ' CD ' ' H ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -48.23 -73.18 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.331 -0.855 . . . . 0.0 109.265 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 50' ' ' ARG . 28.3 m-20 -43.63 -25.9 0.2 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.303 -0.873 . . . . 0.0 109.16 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 50' ' ' ARG . . . 89.03 36.68 7.55 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.515 ' O ' ' O ' ' A' ' 54' ' ' LEU . 51.2 m-20 -87.61 12.81 11.63 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.15 -1.206 . . . . 0.0 109.361 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.598 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 11.1 mt 42.56 97.3 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 121.455 0.645 . . . . 0.0 109.443 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.788 ' O ' HG23 ' A' ' 46' ' ' THR . 58.3 tt0 -68.07 154.09 42.38 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.239 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.598 ' CE1' ' O ' ' A' ' 54' ' ' LEU . 95.6 m-85 -133.74 114.82 13.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.295 -0.878 . . . . 0.0 109.66 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -121.0 155.12 35.02 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 58' ' ' LEU . 3.2 mp -138.78 129.06 25.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.943 -1.098 . . . . 0.0 109.972 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -121.3 127.39 51.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.415 -0.803 . . . . 0.0 109.024 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.704 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -106.15 124.9 50.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.187 -0.946 . . . . 0.0 109.537 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.498 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 39.2 t90 -102.88 123.89 47.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.216 -0.927 . . . . 0.0 109.354 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.498 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 20.1 mt -102.73 162.01 13.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.49 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.0 155.99 15.81 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.438 ' ND2' ' HG2' ' A' ' 65' ' ' GLU . 7.2 p-10 -78.98 -11.97 60.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.188 -1.183 . . . . 0.0 109.448 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.438 ' HG2' ' ND2' ' A' ' 64' ' ' ASN . 4.6 mt-10 -106.44 24.37 12.67 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.496 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.7 m -130.95 97.56 4.35 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.163 0.982 . . . . 0.0 108.473 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 66' ' ' CYS . 9.9 m -51.48 -171.25 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.673 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.594 ' OE1' ' N ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -70.74 -17.6 62.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.349 -0.845 . . . . 0.0 109.516 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -62.29 -58.64 6.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.13 -0.981 . . . . 0.0 109.435 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.508 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 3.3 mp0 -65.87 -45.06 83.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.32 -0.863 . . . . 0.0 108.894 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.2 t -69.67 -20.97 63.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.331 -0.856 . . . . 0.0 109.041 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -73.25 -41.01 47.96 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.92 -46.09 66.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.298 -1.119 . . . . 0.0 109.247 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.46 -44.58 92.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.349 -0.844 . . . . 0.0 109.23 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -61.12 -47.58 85.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.275 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.5 mt -49.62 -46.34 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 109.241 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -61.01 -40.53 93.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 109.345 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.4 m -67.02 -31.52 72.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.159 -0.963 . . . . 0.0 109.33 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 75' ' ' ALA . 91.2 t -66.0 -44.19 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.335 -0.853 . . . . 0.0 109.334 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -61.63 -50.92 70.6 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.281 -0.887 . . . . 0.0 109.192 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.569 HD11 HD23 ' A' ' 6' ' ' LEU . 4.1 mt -54.55 -41.4 69.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.341 -0.849 . . . . 0.0 109.069 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.627 ' O ' ' N ' ' A' ' 86' ' ' ASN . 27.1 t70 -61.69 -54.97 35.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.238 -0.914 . . . . 0.0 109.133 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -47.76 -32.21 5.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.081 -1.012 . . . . 0.0 108.858 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.676 ' CE2' HD21 ' A' ' 85' ' ' LEU . 10.1 t80 -77.64 -31.77 52.91 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.676 HD21 ' CE2' ' A' ' 84' ' ' TYR . 53.2 mt -121.59 33.49 5.5 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.369 -0.832 . . . . 0.0 109.427 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.627 ' N ' ' O ' ' A' ' 82' ' ' ASP . 38.4 t30 -79.71 27.7 0.28 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.211 -0.931 . . . . 0.0 109.16 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -78.12 -45.57 10.09 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -173.34 33.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -1.121 . . . . 0.0 109.299 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.53 179.1 7.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.182 -0.949 . . . . 0.0 109.433 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.5 t -127.11 128.03 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.843 . . . . 0.0 109.546 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -96.06 137.2 35.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.384 -0.823 . . . . 0.0 109.357 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -126.59 126.85 44.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.156 -0.965 . . . . 0.0 109.662 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 -100.74 95.99 7.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -0.874 . . . . 0.0 109.3 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.455 ' OE1' ' CD1' ' A' ' 103' ' ' PHE . 81.9 mt-10 -97.36 138.84 34.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.919 . . . . 0.0 109.712 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 96' ' ' GLN . 15.4 t -145.01 163.75 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.344 -0.848 . . . . 0.0 109.305 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.455 ' N ' HG12 ' A' ' 95' ' ' VAL . 50.0 tt0 -53.28 117.9 3.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.43 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.09 13.88 81.38 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.439 ' O ' ' C ' ' A' ' 99' ' ' GLU . 6.4 t80 -135.54 17.49 3.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.243 -1.151 . . . . 0.0 109.443 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.651 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 11.1 mp0 -41.46 148.22 0.15 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 109.564 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.2 t -87.2 166.81 14.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -0.889 . . . . 0.0 109.488 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.53 -65.1 0.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.533 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 51.4 m -47.55 -51.56 20.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.261 -0.899 . . . . 0.0 109.422 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.455 ' CD1' ' OE1' ' A' ' 94' ' ' GLU . 14.5 t80 -54.46 -44.79 72.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.417 -0.802 . . . . 0.0 109.437 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.9 mt -60.82 -34.16 74.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.955 . . . . 0.0 109.415 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.07 -22.57 70.98 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -79.5 -29.21 41.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -1.12 . . . . 0.0 109.365 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -139.12 120.84 15.31 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.303 -0.873 . . . . 0.0 109.457 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -101.67 -56.65 2.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.512 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.5 t -103.3 -13.25 16.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 109.51 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.3 -12.82 64.02 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.4 mt -71.94 121.2 18.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.175 -1.191 . . . . 0.0 109.499 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -148.55 154.7 40.13 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.188 -0.945 . . . . 0.0 109.417 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -135.97 134.59 38.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.365 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.89 105.87 16.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 109.338 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.202 -0.936 . . . . 0.0 109.488 179.915 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.422 ' HB2' HD12 ' A' ' 6' ' ' LEU . 55.4 Cg_endo . . . . . 0 N--CA 1.492 1.416 0 CA-C-O 121.233 0.43 . . . . 0.0 112.043 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -83.08 -28.7 29.33 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.618 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.64 ' CE1' HG12 ' A' ' 42' ' ' VAL . 69.0 t80 -58.46 -16.55 15.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.142 -0.974 . . . . 0.0 109.354 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.422 HD12 ' HB2' ' A' ' 3' ' ' PRO . 3.3 mt -90.24 -34.88 15.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.218 -0.926 . . . . 0.0 109.553 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 8' ' ' ALA . 30.8 mttm -87.59 -15.22 37.98 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.272 -0.892 . . . . 0.0 109.672 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -42.45 128.95 3.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 0.0 109.406 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.38 30.55 0.03 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.434 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -129.64 38.36 3.86 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.308 -1.113 . . . . 0.0 109.379 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 13' ' ' GLY . 31.1 mt-10 -157.78 79.75 3.31 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.298 -0.876 . . . . 0.0 109.31 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.1 80.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.792 2.328 . . . . 0.0 112.148 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 11' ' ' GLU . . . 177.58 -99.87 0.13 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.751 HD23 ' C ' ' A' ' 14' ' ' LEU . 7.1 tt -156.94 125.7 5.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -1.138 . . . . 0.0 109.727 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.586 ' N ' HD23 ' A' ' 14' ' ' LEU . 11.8 mt-30 -112.66 133.45 54.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.384 -0.822 . . . . 0.0 109.239 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.611 HG23 HD12 ' A' ' 43' ' ' ILE . 5.7 mt -101.25 146.68 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.365 -0.834 . . . . 0.0 110.16 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.78 139.25 27.7 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -108.45 140.32 41.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.2 -0.938 . . . . 0.0 109.404 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 40' ' ' ALA . 8.9 p -84.01 138.33 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.914 . . . . 0.0 109.495 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.609 ' O ' ' N ' ' A' ' 22' ' ' PHE . 18.5 tt0 -88.19 154.32 20.53 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.327 -0.858 . . . . 0.0 109.043 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.542 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 39.9 mttp -40.39 -20.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 109.664 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.609 ' N ' ' O ' ' A' ' 20' ' ' GLU . 63.6 m-85 -160.09 21.82 0.16 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 0.0 109.679 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.432 ' N ' ' HB3' ' A' ' 20' ' ' GLU . 2.9 m-20 -160.23 -128.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 0.0 109.429 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 mt -145.53 146.09 31.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.208 -0.932 . . . . 0.0 109.584 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 t -131.31 133.81 24.97 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.316 -0.865 . . . . 0.0 108.963 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -72.63 146.9 44.53 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.367 2.045 . . . . 0.0 112.431 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -119.23 105.15 44.94 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.359 -0.838 . . . . 0.0 109.272 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.473 ' C ' ' H ' ' A' ' 30' ' ' ASN . 61.3 Cg_endo -79.93 148.81 19.91 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.417 2.078 . . . . 0.0 112.469 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.632 ' O ' HG22 ' A' ' 29' ' ' THR . 14.7 m -63.32 1.32 0.52 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.2 -0.938 . . . . 0.0 109.368 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 28' ' ' PRO . 14.8 m120 -76.09 -19.1 58.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.334 -0.854 . . . . 0.0 109.37 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.728 ' C ' HD12 ' A' ' 31' ' ' LEU . 2.6 pp -148.26 2.64 0.66 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 110.289 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.595 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.6 p90 -55.58 173.5 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.87 -1.143 . . . . 0.0 109.366 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.76 -32.14 6.59 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -99.45 100.59 11.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.348 -1.089 . . . . 0.0 109.527 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.605 ' CZ ' ' CZ3' ' A' ' 61' ' ' TRP . 45.5 m-85 -86.93 137.51 32.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.482 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -88.34 131.21 34.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 109.441 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.4 p -73.99 -6.42 47.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.369 -0.832 . . . . 0.0 109.409 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.437 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -97.31 20.59 50.13 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 9.7 m-20 -167.35 146.15 4.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -1.112 . . . . 0.0 109.449 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.647 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -90.92 149.33 21.94 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.216 -0.928 . . . . 0.0 109.399 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -117.15 139.02 51.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 109.351 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.01 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -105.58 129.36 58.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 121.177 -0.952 . . . . 0.0 108.623 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.01 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -126.21 134.25 66.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.231 -0.918 . . . . 0.0 110.421 -179.315 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.514 ' CD2' ' OG1' ' A' ' 46' ' ' THR . 7.7 tt -114.94 115.84 27.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.58 -0.7 . . . . 0.0 109.114 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -92.42 114.3 26.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.939 . . . . 0.0 109.534 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.514 ' OG1' ' CD2' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -113.89 129.23 56.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.181 -0.949 . . . . 0.0 109.524 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -132.18 168.48 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 121.071 -1.018 . . . . 0.0 109.252 -179.852 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -98.54 117.36 32.79 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.58 -0.7 . . . . 0.0 109.401 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.6 mt -81.05 160.83 24.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -0.911 . . . . 0.0 109.609 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 25.0 mtt180 -51.44 -65.49 0.55 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.336 -0.852 . . . . 0.0 109.305 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.437 ' ND2' ' HB2' ' A' ' 53' ' ' ASN . 2.3 p-10 -48.27 -29.58 3.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.263 -0.898 . . . . 0.0 109.252 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.76 71.29 1.12 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 54' ' ' LEU . 4.3 t-20 -134.85 13.46 3.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.287 -1.125 . . . . 0.0 109.32 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.592 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 11.7 mt 45.71 99.69 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.579 0.704 . . . . 0.0 109.535 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -68.6 152.1 45.83 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.498 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 61.3 m-85 -129.49 116.56 19.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 109.866 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.626 ' O ' HD23 ' A' ' 58' ' ' LEU . 0.7 OUTLIER -122.36 155.17 36.58 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.427 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.626 HD23 ' O ' ' A' ' 57' ' ' ASP . 2.6 mt -132.83 150.18 52.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.913 -1.117 . . . . 0.0 110.172 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.545 ' CD2' ' C ' ' A' ' 58' ' ' LEU . 4.6 m-70 -143.26 123.09 13.43 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.71 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -100.62 129.57 46.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.082 -1.011 . . . . 0.0 109.641 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.605 ' CZ3' ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -102.85 123.83 47.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.345 -0.847 . . . . 0.0 109.314 179.835 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.7 mt -102.15 162.07 13.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.402 -0.811 . . . . 0.0 109.461 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.25 157.69 14.88 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -75.68 -12.29 60.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.324 -1.104 . . . . 0.0 109.566 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -106.84 23.21 14.71 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.9 m -131.09 97.5 4.32 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.06 0.933 . . . . 0.0 108.514 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 m -59.6 -170.98 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.593 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 72' ' ' GLY . 37.2 tt0 -61.6 -17.95 57.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 109.559 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -63.87 -58.81 5.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.955 . . . . 0.0 109.46 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.69 -42.5 91.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.446 -0.784 . . . . 0.0 108.987 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 m -71.08 -23.28 62.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.389 -0.82 . . . . 0.0 109.016 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -71.53 -40.11 60.0 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.38 -49.09 52.72 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.261 -1.141 . . . . 0.0 109.25 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.15 -45.66 83.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.374 -0.829 . . . . 0.0 109.058 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.443 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -58.54 -51.29 70.53 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.406 -0.809 . . . . 0.0 109.189 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.6 mt -48.9 -41.08 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -0.942 . . . . 0.0 109.209 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.45 -43.24 99.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.222 -0.924 . . . . 0.0 109.101 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 86.3 m -61.05 -49.45 77.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.145 -0.972 . . . . 0.0 109.093 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 75' ' ' ALA . 10.6 t -51.06 -40.06 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.238 -0.913 . . . . 0.0 109.211 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -61.25 -48.21 82.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.36 -0.838 . . . . 0.0 109.082 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.521 ' CD1' ' CE1' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -50.71 -40.17 53.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.32 -0.862 . . . . 0.0 108.929 179.63 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 85' ' ' LEU . 10.3 m-20 -61.89 -61.8 2.24 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.16 -0.962 . . . . 0.0 109.069 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -47.31 -30.62 3.25 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.049 -1.032 . . . . 0.0 108.445 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -76.81 -27.06 55.04 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.562 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.9 mt -113.87 27.23 9.69 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.37 -0.831 . . . . 0.0 109.169 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 44.47 38.36 2.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.377 -0.827 . . . . 0.0 109.479 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 56.35 31.19 59.4 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 85' ' ' LEU . 21.4 ttt-85 -92.69 31.92 1.3 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.204 -1.174 . . . . 0.0 109.38 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 56' ' ' TYR . . . -141.14 161.17 38.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.526 -0.734 . . . . 0.0 109.395 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 38.8 t -96.0 146.26 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.263 -0.898 . . . . 0.0 109.426 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.676 ' H ' ' CD ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -111.4 131.59 55.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.382 -0.824 . . . . 0.0 109.314 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.472 ' CG ' ' ND1' ' A' ' 59' ' ' HIS . 22.6 m80 -115.68 136.35 53.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.866 . . . . 0.0 109.414 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.431 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 3.9 ptp180 -102.71 92.92 4.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.22 -0.925 . . . . 0.0 109.309 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.499 ' OE1' ' CD2' ' A' ' 103' ' ' PHE . 13.6 mt-10 -92.88 128.94 38.92 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.148 -0.97 . . . . 0.0 109.538 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 96' ' ' GLN . 10.5 t -132.94 163.52 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.336 -0.852 . . . . 0.0 109.241 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.621 ' OE1' ' N ' ' A' ' 97' ' ' GLY . 0.8 OUTLIER -62.22 115.59 4.27 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.238 -0.914 . . . . 0.0 109.429 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.621 ' N ' ' OE1' ' A' ' 96' ' ' GLN . . . 90.38 5.74 69.31 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.475 ' O ' ' O ' ' A' ' 99' ' ' GLU . 5.1 t80 -143.26 32.6 1.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.366 -1.079 . . . . 0.0 109.526 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.66 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 2.4 mp0 -41.51 164.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.537 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.62 161.69 19.16 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.09 -60.39 2.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.477 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 76.9 m -46.95 -41.35 15.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.145 -0.972 . . . . 0.0 109.355 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.499 ' CD2' ' OE1' ' A' ' 94' ' ' GLU . 1.6 m-85 -69.9 -41.1 75.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.352 -0.843 . . . . 0.0 109.383 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.5 mt -58.79 -23.67 60.59 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.175 -0.953 . . . . 0.0 109.451 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -105.43 -12.94 25.68 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -86.42 -37.67 18.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -1.188 . . . . 0.0 109.602 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -84.37 117.78 23.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.309 -0.869 . . . . 0.0 109.638 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -115.0 3.0 14.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.395 -0.815 . . . . 0.0 109.387 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.0 m -89.31 -4.65 58.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 109.54 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.53 97.32 0.43 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.705 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -77.78 165.74 23.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.158 -1.201 . . . . 0.0 109.509 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.442 ' CG ' ' O ' ' A' ' 111' ' ' LEU . 38.3 mtmt -158.41 152.2 23.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.246 -0.908 . . . . 0.0 109.475 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.445 ' OH ' ' CD ' ' A' ' 99' ' ' GLU . 53.8 m-85 -101.51 125.2 48.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.373 -0.83 . . . . 0.0 109.438 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.0 120.04 25.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.489 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.42 -179.987 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.501 ' HB2' HD13 ' A' ' 6' ' ' LEU . 17.8 Cg_endo . . . . . 0 N--CA 1.493 1.46 0 CA-C-O 121.266 0.444 . . . . 0.0 111.857 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -83.33 -43.43 15.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.296 -0.877 . . . . 0.0 110.071 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.593 ' CE2' ' CG1' ' A' ' 42' ' ' VAL . 21.6 t80 -50.94 -41.45 59.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.134 -0.979 . . . . 0.0 109.606 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.501 HD13 ' HB2' ' A' ' 3' ' ' PRO . 4.1 mp -69.4 -27.83 65.63 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.121 -0.987 . . . . 0.0 109.51 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -96.4 3.84 52.59 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.237 -0.914 . . . . 0.0 109.38 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.472 ' HB3' HD13 ' A' ' 44' ' ' LEU . . . -59.52 151.9 23.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.216 -0.928 . . . . 0.0 109.517 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.9 45.19 0.07 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -149.08 24.23 0.93 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.276 -1.132 . . . . 0.0 109.564 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -146.55 117.65 4.76 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.278 -0.889 . . . . 0.0 109.338 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.7 91.25 1.2 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.387 2.058 . . . . 0.0 112.221 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.07 -95.38 0.12 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 tp -160.23 130.35 5.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.318 -1.107 . . . . 0.0 109.627 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -113.88 135.71 53.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 109.355 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.2 mt -115.56 136.01 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.345 -0.847 . . . . 0.0 109.99 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.44 134.67 31.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.425 -0.797 . . . . 0.0 108.969 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 25' ' ' VAL . 33.5 ttt180 -98.38 153.54 18.49 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.201 -0.937 . . . . 0.0 109.444 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.1 t -106.13 123.49 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.18 -0.95 . . . . 0.0 109.593 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.635 ' O ' ' N ' ' A' ' 22' ' ' PHE . 5.2 tt0 -72.06 87.04 1.05 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.107 -0.996 . . . . 0.0 108.915 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.579 ' O ' ' CB ' ' A' ' 22' ' ' PHE . 16.5 tttm 49.04 2.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.359 -0.838 . . . . 0.0 109.85 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.635 ' N ' ' O ' ' A' ' 20' ' ' GLU . 2.1 t80 158.01 -29.34 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.289 -0.882 . . . . 0.0 109.422 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.76 -157.83 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.932 . . . . 0.0 109.584 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.26 132.75 56.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.287 -0.883 . . . . 0.0 109.344 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.545 ' CG2' ' N ' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -129.9 120.81 19.58 Favored Pre-proline 0 N--CA 1.487 1.387 0 O-C-N 121.311 -0.868 . . . . 0.0 109.227 -179.686 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.88 132.0 11.52 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.303 2.002 . . . . 0.0 112.238 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.7 t -110.34 101.57 48.65 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.335 -0.853 . . . . 0.0 109.394 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -51.22 156.56 5.25 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.434 2.089 . . . . 0.0 112.208 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.3 m -66.89 -12.2 58.57 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.328 -0.857 . . . . 0.0 109.488 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.481 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 23.9 t-20 -75.98 -10.03 59.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.357 -0.839 . . . . 0.0 109.522 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 32' ' ' TYR . 96.3 mt -122.83 -23.35 5.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -0.847 . . . . 0.0 109.417 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 33' ' ' GLY . 1.7 t80 -42.88 138.33 2.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.617 ' N ' ' CD1' ' A' ' 32' ' ' TYR . . . 125.95 -28.68 4.83 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -107.19 148.19 29.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -1.152 . . . . 0.0 109.531 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -142.06 114.16 8.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 109.424 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -79.39 159.05 27.25 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.529 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.1 p -97.74 -4.77 36.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 109.447 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.445 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -88.28 16.4 52.72 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 7.6 m-20 -159.23 164.07 35.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -1.163 . . . . 0.0 109.544 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -108.29 151.98 25.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 0.0 109.406 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.575 ' N ' ' CD1' ' A' ' 41' ' ' TYR . 4.0 m-85 -130.21 134.61 47.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.884 . . . . 0.0 109.667 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.991 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -105.4 139.44 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 121.182 -0.949 . . . . 0.0 108.596 179.202 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.991 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.4 OUTLIER -128.01 134.72 64.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.27 -0.894 . . . . 0.0 110.213 -179.421 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.472 HD13 ' HB3' ' A' ' 8' ' ' ALA . 7.2 tt -115.86 109.57 17.81 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -82.42 144.31 30.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.363 -0.835 . . . . 0.0 109.098 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.2 m -143.24 129.01 19.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.09 -1.006 . . . . 0.0 109.725 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -134.18 168.56 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 O-C-N 121.143 -0.973 . . . . 0.0 109.208 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -99.31 118.04 35.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.68 -0.638 . . . . 0.0 109.422 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 93.4 mt -81.9 165.08 21.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 109.605 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -45.35 -58.39 3.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.94 . . . . 0.0 109.145 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -61.52 -27.03 68.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.915 . . . . 0.0 109.151 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.01 33.29 6.68 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.5 ' O ' ' O ' ' A' ' 54' ' ' LEU . 5.8 t30 -85.58 12.67 8.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -1.187 . . . . 0.0 109.304 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.578 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 12.3 mt 44.91 98.38 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 121.563 0.697 . . . . 0.0 109.468 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.407 ' HG3' ' N ' ' A' ' 56' ' ' TYR . 3.3 tp-100 -68.56 155.84 39.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.505 -0.747 . . . . 0.0 109.072 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 79.6 m-85 -138.16 114.35 10.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.163 -0.96 . . . . 0.0 109.803 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.424 ' O ' HD23 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -114.38 155.25 26.65 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.136 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.85 HD13 HD21 ' A' ' 81' ' ' LEU . 11.2 mt -125.16 150.29 47.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.023 -1.048 . . . . 0.0 110.372 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -145.18 130.43 18.57 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.741 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -111.69 138.87 47.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.951 -1.093 . . . . 0.0 110.063 -179.297 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -111.41 123.55 50.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.392 -0.817 . . . . 0.0 108.987 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 49.6 mt -104.18 145.92 29.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.386 -0.821 . . . . 0.0 109.413 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.9 152.2 19.84 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -80.21 -12.02 59.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -1.121 . . . . 0.0 109.478 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -107.93 31.87 5.18 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.533 ' SG ' ' OE2' ' A' ' 70' ' ' GLU . 2.1 m -130.56 97.5 4.4 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 122.043 0.925 . . . . 0.0 108.533 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 66' ' ' CYS . 30.0 m -45.63 175.89 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.78 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.48 ' O ' ' N ' ' A' ' 72' ' ' GLY . 39.0 tt0 -64.63 -17.7 64.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 0.0 109.621 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -63.14 -58.59 6.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 109.344 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.533 ' OE2' ' SG ' ' A' ' 66' ' ' CYS . 11.5 mt-10 -64.84 -44.31 90.19 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.356 -0.84 . . . . 0.0 109.034 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.55 -26.85 67.33 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.429 -0.795 . . . . 0.0 109.02 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.15 -48.17 40.8 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.18 -35.36 76.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.342 -1.093 . . . . 0.0 109.098 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.741 ' HB1' ' CZ ' ' A' ' 60' ' ' TYR . . . -61.28 -51.95 66.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.418 -0.801 . . . . 0.0 109.211 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.424 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -52.94 -46.93 68.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 109.232 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.3 mt -51.9 -47.92 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.271 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -54.61 -44.06 72.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.31 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.426 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 0.9 OUTLIER -54.08 -50.97 65.59 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.3 -0.875 . . . . 0.0 109.507 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.481 HG23 ' H ' ' A' ' 79' ' ' VAL . 1.5 t -61.18 -35.39 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.361 -0.837 . . . . 0.0 109.63 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -64.57 -58.83 5.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.898 . . . . 0.0 109.302 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.954 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -53.81 -33.51 56.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 108.911 179.828 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 85' ' ' LEU . 0.9 OUTLIER -65.73 -55.13 18.93 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.22 -0.925 . . . . 0.0 108.891 179.531 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 82' ' ' ASP . 8.7 t70 -45.87 -37.47 6.3 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -68.53 -33.39 74.02 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 82' ' ' ASP . 4.8 tp -105.81 28.15 7.82 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.496 -0.752 . . . . 0.0 109.268 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 85' ' ' LEU . 26.6 m-20 42.49 36.25 0.76 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.459 -0.776 . . . . 0.0 109.436 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 46.29 35.12 6.65 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.7 mmm-85 -86.46 29.97 0.74 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.137 -1.213 . . . . 0.0 109.106 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.426 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -144.13 166.9 23.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.565 -0.71 . . . . 0.0 109.376 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 t -100.62 153.9 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.44 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -117.57 130.29 56.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.392 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -105.5 104.93 14.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 109.521 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.84 97.99 6.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.253 -0.904 . . . . 0.0 109.229 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.476 ' OE1' ' CG ' ' A' ' 103' ' ' PHE . 39.3 mt-10 -100.47 148.76 24.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.348 -0.845 . . . . 0.0 109.722 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 96' ' ' GLN . 6.2 t -137.68 166.12 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.327 -0.858 . . . . 0.0 109.27 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.5 ' OE1' ' O ' ' A' ' 96' ' ' GLN . 1.4 tm0? -59.86 116.81 4.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 109.481 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.2 12.24 81.09 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.445 ' O ' ' C ' ' A' ' 99' ' ' GLU . 2.4 t80 -137.51 20.79 2.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -1.167 . . . . 0.0 109.569 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 98' ' ' PHE . 7.5 mm-40 -42.16 156.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.918 . . . . 0.0 109.469 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.2 p -88.01 174.29 8.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -0.961 . . . . 0.0 109.491 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.09 -53.69 7.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.492 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.1 m -47.07 -46.78 22.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 0.0 109.459 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' A' ' 106' ' ' TYR . 0.2 OUTLIER -67.46 -54.07 23.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.391 -0.818 . . . . 0.0 109.397 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 103' ' ' PHE . 29.5 mt -44.57 -26.36 0.36 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.228 -0.92 . . . . 0.0 109.462 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -99.95 -17.09 26.37 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.492 ' N ' ' O ' ' A' ' 103' ' ' PHE . 14.4 t80 -81.73 -13.43 57.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.292 -1.122 . . . . 0.0 109.559 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.534 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 8.7 p90 -45.95 122.48 3.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.137 -0.977 . . . . 0.0 109.589 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -111.19 -56.41 2.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 109.349 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.4 t -90.88 0.38 57.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.891 . . . . 0.0 109.501 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 111' ' ' LEU . . . 87.3 68.96 1.31 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 110' ' ' GLY . 2.3 pp -42.96 155.24 0.06 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.305 -1.115 . . . . 0.0 109.453 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -154.23 135.99 14.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.455 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 0.0 OUTLIER -104.21 140.02 38.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.318 -0.864 . . . . 0.0 109.47 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -108.26 120.93 43.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.853 . . . . 0.0 109.333 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.2 mttm . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 109.396 180.0 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.528 ' HB3' HD13 ' A' ' 6' ' ' LEU . 32.5 Cg_exo . . . . . 0 N--CA 1.493 1.46 0 CA-C-O 121.039 0.35 . . . . 0.0 112.007 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 8' ' ' ALA . 61.5 mm-40 -83.45 -46.71 12.19 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.104 -0.998 . . . . 0.0 110.259 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.508 ' CZ ' ' O ' ' A' ' 42' ' ' VAL . 21.7 m-85 -66.94 -43.35 83.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.078 -1.014 . . . . 0.0 109.151 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 1.035 ' H ' HD12 ' A' ' 6' ' ' LEU . 3.0 mp -62.36 -33.9 75.62 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.343 -0.848 . . . . 0.0 109.628 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -106.35 9.1 31.97 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.248 -0.907 . . . . 0.0 109.605 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.576 ' HB1' ' NE2' ' A' ' 15' ' ' GLN . . . -62.73 -162.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.194 -0.941 . . . . 0.0 109.395 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.45 58.02 1.31 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -146.63 10.88 1.09 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.267 -1.137 . . . . 0.0 109.452 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -161.92 124.32 1.73 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.258 -0.901 . . . . 0.0 109.282 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.87 82.28 2.19 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.396 2.064 . . . . 0.0 112.348 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -164.61 -108.05 0.21 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.6 tt -162.71 143.5 9.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.326 -1.102 . . . . 0.0 109.439 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.576 ' NE2' ' HB1' ' A' ' 8' ' ' ALA . 1.3 mt-30 -129.48 144.0 51.07 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.235 -0.916 . . . . 0.0 109.523 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.604 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 9.2 mt -126.58 125.85 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.418 -0.801 . . . . 0.0 109.992 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.604 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 8.1 m0 -145.22 155.85 43.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.205 -0.934 . . . . 0.0 109.061 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.439 ' N ' HG23 ' A' ' 27' ' ' VAL . 7.8 ttp180 -95.94 153.17 17.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.063 -1.023 . . . . 0.0 109.386 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 40' ' ' ALA . 7.0 p -94.48 133.35 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.212 -0.93 . . . . 0.0 109.739 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.636 ' O ' ' N ' ' A' ' 22' ' ' PHE . 17.9 tt0 -82.0 154.71 25.55 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.338 -0.851 . . . . 0.0 108.768 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 20' ' ' GLU . 39.7 mttt -38.35 -22.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.394 -0.816 . . . . 0.0 109.683 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.636 ' N ' ' O ' ' A' ' 20' ' ' GLU . 3.4 t80 -158.75 21.05 0.21 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.258 -0.901 . . . . 0.0 109.394 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.657 ' O ' HD22 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -155.58 -147.37 0.2 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.135 -0.978 . . . . 0.0 109.749 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.657 HD22 ' O ' ' A' ' 23' ' ' ASP . 2.9 mm? -123.29 146.4 47.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.352 -0.843 . . . . 0.0 109.447 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -131.42 99.26 17.51 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.341 -0.849 . . . . 0.0 109.173 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -47.64 132.96 21.3 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.557 2.172 . . . . 0.0 112.42 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.439 HG23 ' N ' ' A' ' 18' ' ' ARG . 61.0 t -104.51 106.2 53.3 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.317 -0.864 . . . . 0.0 109.482 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -46.64 145.89 5.98 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.484 2.123 . . . . 0.0 112.32 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.4 t -61.7 -25.63 67.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -0.882 . . . . 0.0 109.554 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -69.04 -10.98 60.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 0.0 109.509 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.467 ' O ' ' C ' ' A' ' 32' ' ' TYR . 57.7 mt -110.14 -28.25 8.75 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -0.847 . . . . 0.0 109.572 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.467 ' C ' ' O ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -40.33 143.85 0.27 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.288 -0.883 . . . . 0.0 109.458 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.05 -32.02 7.58 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -101.89 104.53 15.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -1.144 . . . . 0.0 109.398 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -102.67 140.91 36.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 109.53 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.595 ' CD2' ' OH ' ' A' ' 41' ' ' TYR . 0.7 OUTLIER -101.67 161.12 13.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.393 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.9 p -94.89 -4.88 46.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.238 -0.914 . . . . 0.0 109.614 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -101.56 34.75 5.41 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -171.52 151.53 3.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.196 -1.179 . . . . 0.0 109.51 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.469 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -100.23 139.25 36.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.598 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.595 ' OH ' ' CD2' ' A' ' 36' ' ' PHE . 44.2 m-85 -121.38 144.36 48.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.365 -0.834 . . . . 0.0 109.359 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.923 ' O ' HD13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -118.76 144.82 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.286 -0.884 . . . . 0.0 109.216 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.923 HD13 ' O ' ' A' ' 42' ' ' VAL . 1.0 OUTLIER -134.18 146.49 31.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.98 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 45' ' ' LYS . 15.7 tp -129.5 118.07 21.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.46 -0.775 . . . . 0.0 109.467 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.539 ' CE ' ' CE2' ' A' ' 106' ' ' TYR . 36.3 tttt -97.39 133.96 41.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.41 -0.806 . . . . 0.0 109.046 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.608 HG22 HD22 ' A' ' 54' ' ' LEU . 88.8 m -142.74 118.4 10.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.099 -1.001 . . . . 0.0 109.401 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.676 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -125.98 168.2 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.226 -0.921 . . . . 0.0 109.122 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -102.88 112.41 25.2 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.512 -0.742 . . . . 0.0 109.331 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.9 mt -77.3 169.22 18.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.438 -0.789 . . . . 0.0 109.59 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.517 ' CG ' ' N ' ' A' ' 51' ' ' ASN . 5.7 ptp85 -47.69 -49.33 28.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.884 . . . . 0.0 109.299 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.517 ' N ' ' CG ' ' A' ' 50' ' ' ARG . 5.0 m120 -70.75 -27.24 63.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.271 -0.893 . . . . 0.0 109.157 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.65 28.52 11.17 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.0 t-20 -80.66 12.59 3.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.072 -1.252 . . . . 0.0 109.21 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.676 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 13.8 mt 43.88 97.72 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.535 0.683 . . . . 0.0 109.562 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -74.3 111.45 9.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.491 -0.756 . . . . 0.0 109.538 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.779 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 96.2 m-85 -96.55 114.75 26.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.933 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.578 ' OD1' ' NE2' ' A' ' 92' ' ' HIS . 0.4 OUTLIER -115.99 120.8 40.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.022 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.424 ' N ' HD23 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -97.77 150.61 21.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.921 -1.112 . . . . 0.0 110.778 -178.467 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.454 ' HE2' ' HB2' ' A' ' 45' ' ' LYS . 6.1 m-70 -149.19 122.19 8.82 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.408 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 10.5 p90 -113.39 131.43 55.99 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.117 -0.989 . . . . 0.0 109.846 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.565 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 55.6 t90 -103.44 124.01 47.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.488 -0.758 . . . . 0.0 109.356 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.565 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 62.8 mt -102.76 162.12 13.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.329 -0.857 . . . . 0.0 109.591 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.92 162.96 12.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -82.07 -12.37 58.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -1.168 . . . . 0.0 109.576 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.51 28.95 7.32 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.3 m -130.84 97.57 4.37 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.115 0.959 . . . . 0.0 108.54 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 64.6 m -56.19 -170.87 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.674 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -64.87 -17.81 64.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.562 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -63.13 -58.7 6.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.118 -0.989 . . . . 0.0 109.405 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -66.81 -41.59 87.29 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.15 -23.06 62.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.401 -0.812 . . . . 0.0 108.995 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -71.64 -44.24 49.73 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.97 -43.94 86.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.343 -1.092 . . . . 0.0 109.172 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.9 -49.28 77.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.415 -0.803 . . . . 0.0 109.304 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.67 -48.62 77.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.328 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.7 mt -50.09 -42.39 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.386 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -63.77 -37.15 86.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.198 -0.939 . . . . 0.0 109.328 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.6 m -65.52 -46.96 77.58 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.366 -0.834 . . . . 0.0 109.362 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.5 t -56.09 -39.85 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 0.0 109.163 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -61.52 -47.39 85.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.304 -0.873 . . . . 0.0 109.041 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 81' ' ' LEU . 34.1 mt -50.59 -46.05 57.66 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.309 -0.869 . . . . 0.0 109.001 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 85' ' ' LEU . 0.8 OUTLIER -56.59 -59.01 5.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.232 -0.918 . . . . 0.0 109.177 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 82' ' ' ASP . 9.1 t0 -45.26 -30.05 1.14 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.108 -0.995 . . . . 0.0 108.611 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -75.44 -29.7 59.76 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.588 ' N ' ' O ' ' A' ' 82' ' ' ASP . 11.6 mt -116.0 30.91 7.05 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.389 -0.819 . . . . 0.0 109.412 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 61.3 t30 46.32 34.5 2.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.293 -0.879 . . . . 0.0 109.507 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 51.29 22.2 6.89 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -90.34 30.93 1.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.102 -1.234 . . . . 0.0 109.228 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.779 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -123.49 177.1 5.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.542 -0.724 . . . . 0.0 109.306 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 95.1 t -113.32 115.45 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 109.477 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.93 157.87 18.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.264 -0.898 . . . . 0.0 109.374 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.578 ' NE2' ' OD1' ' A' ' 57' ' ' ASP . 27.6 m-70 -132.4 131.56 41.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.338 -0.851 . . . . 0.0 109.201 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.715 ' CD ' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -98.66 103.19 15.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.112 -0.992 . . . . 0.0 109.54 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.521 ' N ' ' CD ' ' A' ' 94' ' ' GLU . 3.9 mp0 -101.91 143.44 31.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.244 -0.91 . . . . 0.0 109.403 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.525 HG12 ' N ' ' A' ' 96' ' ' GLN . 13.8 t -141.81 169.91 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.298 -0.876 . . . . 0.0 109.62 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.665 ' CD ' ' H ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -82.11 118.95 23.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 109.384 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.83 13.07 48.09 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.446 ' O ' ' O ' ' A' ' 99' ' ' GLU . 37.5 m-85 -150.93 -37.57 0.13 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.221 -1.164 . . . . 0.0 109.37 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 98' ' ' PHE . 40.7 mt-10 40.61 -160.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.0 109.561 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.4 ' O ' HD12 ' A' ' 104' ' ' LEU . 1.8 m -139.09 159.79 41.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.176 -0.953 . . . . 0.0 109.422 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.95 -65.12 0.71 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.648 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.1 m -48.56 -54.51 14.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.159 -0.963 . . . . 0.0 109.464 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -53.78 -41.87 67.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.445 -0.784 . . . . 0.0 109.534 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 100' ' ' SER . 7.3 mt -69.54 -31.82 70.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.17 -0.956 . . . . 0.0 109.484 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.68 -21.14 67.01 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.539 ' CE2' ' CE ' ' A' ' 45' ' ' LYS . 8.2 t80 -76.79 -54.49 6.54 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.262 -1.14 . . . . 0.0 109.477 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -96.77 79.65 2.98 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.39 -0.819 . . . . 0.0 109.607 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -78.38 1.43 22.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.383 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.7 p -67.5 -22.04 65.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 109.493 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . 92.59 64.19 1.11 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.744 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -49.23 178.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -1.095 . . . . 0.0 109.546 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.48 155.32 43.03 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.226 -0.921 . . . . 0.0 109.329 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -126.47 143.68 51.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.212 -0.93 . . . . 0.0 109.451 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 44.3 mttt -140.18 134.75 31.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.875 . . . . 0.0 109.392 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.275 -0.891 . . . . 0.0 109.523 179.869 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.535 ' HB2' HD11 ' A' ' 6' ' ' LEU . 46.7 Cg_endo . . . . . 0 N--CA 1.491 1.33 0 CA-C-O 121.273 0.447 . . . . 0.0 111.893 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.43 ' C ' ' N ' ' A' ' 6' ' ' LEU . 20.3 mm-40 -83.6 -25.71 30.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.222 -0.923 . . . . 0.0 110.035 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.529 ' CE1' HG12 ' A' ' 42' ' ' VAL . 43.6 t80 -51.65 -11.96 0.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.036 -1.04 . . . . 0.0 109.747 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.535 HD11 ' HB2' ' A' ' 3' ' ' PRO . 0.3 OUTLIER -93.94 -29.97 14.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.146 -0.971 . . . . 0.0 109.032 179.582 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.506 ' O ' ' O ' ' A' ' 8' ' ' ALA . 17.0 mtpp -87.94 -6.63 57.93 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.391 -0.818 . . . . 0.0 109.264 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -43.71 170.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.351 -0.843 . . . . 0.0 109.568 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.04 76.68 1.09 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -136.04 -1.26 2.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.226 -1.161 . . . . 0.0 109.694 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -171.46 149.58 2.54 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.152 -0.968 . . . . 0.0 109.419 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.4 89.34 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.727 2.285 . . . . 0.0 112.193 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -170.29 -106.15 0.19 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.7 tt -162.33 149.17 13.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.222 -1.163 . . . . 0.0 109.665 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -135.77 132.97 37.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.368 -0.832 . . . . 0.0 109.309 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.428 HG22 ' N ' ' A' ' 17' ' ' TRP . 42.7 mt -102.96 159.7 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 109.767 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.428 ' N ' HG22 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -157.87 162.17 38.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -0.867 . . . . 0.0 109.047 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -129.03 147.29 50.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.355 -0.84 . . . . 0.0 109.555 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.536 ' CG1' ' OD1' ' A' ' 39' ' ' ASP . 8.1 p -81.03 145.98 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.862 . . . . 0.0 109.548 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.58 ' O ' ' N ' ' A' ' 22' ' ' PHE . 22.3 tt0 -100.52 153.93 18.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.343 -0.848 . . . . 0.0 109.344 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 20' ' ' GLU . 18.7 tptm -40.32 -22.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 109.509 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.58 ' N ' ' O ' ' A' ' 20' ' ' GLU . 58.6 t80 -160.86 33.97 0.15 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 109.416 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -173.89 -127.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.305 -0.872 . . . . 0.0 109.526 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.459 HD22 ' H ' ' A' ' 5' ' ' PHE . 4.7 tp -148.43 146.06 28.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -0.951 . . . . 0.0 109.572 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.5 133.36 25.02 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.888 . . . . 0.0 109.225 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.26 140.91 28.27 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.453 2.102 . . . . 0.0 112.138 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.9 t -99.76 133.74 21.54 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.218 -0.926 . . . . 0.0 109.241 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -72.7 133.14 19.78 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.525 2.15 . . . . 0.0 112.308 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.508 ' C ' ' H ' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -68.25 176.01 2.98 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.239 -0.913 . . . . 0.0 109.431 179.865 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 29' ' ' THR . 3.1 t-20 69.91 -39.1 0.43 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.406 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.508 ' H ' ' C ' ' A' ' 29' ' ' THR . 31.6 mt -96.94 -32.75 11.87 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.287 -0.883 . . . . 0.0 109.414 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.456 ' C ' ' O ' ' A' ' 31' ' ' LEU . 14.6 p90 -41.58 160.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 109.58 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 128.82 -19.15 5.57 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -98.26 124.33 42.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -1.136 . . . . 0.0 109.604 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -105.31 131.44 52.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -0.876 . . . . 0.0 109.335 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -96.5 135.67 38.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.211 -0.931 . . . . 0.0 109.582 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.7 p -83.71 -16.58 44.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.383 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.02 30.14 8.44 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.536 ' OD1' ' CG1' ' A' ' 19' ' ' VAL . 32.8 t0 -165.03 171.66 13.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.273 -1.133 . . . . 0.0 109.518 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.4 145.56 38.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.308 -0.87 . . . . 0.0 109.396 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -122.62 134.96 54.49 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.28 -0.888 . . . . 0.0 109.421 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.529 HG12 ' CE1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -108.71 144.16 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.324 -0.86 . . . . 0.0 109.018 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.082 ' N ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -144.34 125.12 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.049 -1.032 . . . . 0.0 109.738 -179.644 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 tt -113.22 124.12 51.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.282 -0.886 . . . . 0.0 109.53 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 29.6 tttm -97.69 145.81 25.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.316 -0.865 . . . . 0.0 109.515 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 13' ' ' GLY . 85.0 m -142.96 128.33 18.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.292 -0.88 . . . . 0.0 109.276 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -131.98 168.45 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 O-C-N 120.986 -1.071 . . . . 0.0 109.535 -179.626 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -99.66 98.46 9.3 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.556 HD13 HH11 ' A' ' 88' ' ' ARG . 10.1 mt -60.84 168.65 2.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.328 -0.858 . . . . 0.0 109.594 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 51' ' ' ASN . 34.0 ttm180 -48.95 -77.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 0.0 109.394 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 50' ' ' ARG . 13.4 m-20 -42.84 -27.89 0.21 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.912 . . . . 0.0 109.214 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 50' ' ' ARG . . . 96.03 44.17 3.13 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.3 t-20 -95.35 14.05 23.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.983 -1.304 . . . . 0.0 109.288 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.574 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 11.5 mt 43.68 97.22 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.649 0.738 . . . . 0.0 109.377 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.412 ' HB2' HD11 ' A' ' 49' ' ' LEU . 9.3 tt0 -68.86 151.89 46.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.497 -0.752 . . . . 0.0 109.156 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.574 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 90.7 m-85 -136.08 114.31 11.54 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.318 -0.864 . . . . 0.0 109.419 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.73 153.94 34.89 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.3 137.62 40.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.934 -1.104 . . . . 0.0 110.324 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.716 ' HB2' HD13 ' A' ' 43' ' ' ILE . 1.0 OUTLIER -122.5 150.11 42.98 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.447 -0.783 . . . . 0.0 109.138 179.545 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.707 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -124.78 116.42 22.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -0.851 . . . . 0.0 109.122 179.663 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.404 ' CE3' ' O ' ' A' ' 62' ' ' LEU . 16.7 t90 -97.77 123.93 41.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.294 -0.879 . . . . 0.0 109.61 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.404 ' O ' ' CE3' ' A' ' 61' ' ' TRP . 0.7 OUTLIER -104.54 161.49 14.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.316 -0.865 . . . . 0.0 109.394 179.861 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -106.26 157.83 15.75 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -77.52 -12.25 59.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -1.126 . . . . 0.0 109.389 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -107.16 24.36 12.96 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.8 m -130.97 97.5 4.33 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 122.105 0.955 . . . . 0.0 108.496 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 66' ' ' CYS . 1.4 m -50.85 -173.52 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.315 0 CA-C-O 121.378 0.609 . . . . 0.0 109.569 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.439 ' O ' ' N ' ' A' ' 72' ' ' GLY . 54.9 mt-30 -71.49 -17.8 62.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -0.944 . . . . 0.0 109.598 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -63.82 -58.5 6.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.463 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.32 -46.99 84.1 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.369 -0.832 . . . . 0.0 109.053 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.6 m -63.79 -29.18 70.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.493 -0.755 . . . . 0.0 108.968 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -65.1 -45.92 90.21 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.22 -49.97 74.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -1.146 . . . . 0.0 109.326 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.83 -45.43 93.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 0.0 109.252 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.641 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -62.21 -38.54 89.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.159 -0.963 . . . . 0.0 109.425 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.1 mt -58.84 -44.56 90.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.189 -0.945 . . . . 0.0 109.468 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -61.75 -42.0 98.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.37 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 82.2 m -68.0 -39.96 83.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.333 -0.854 . . . . 0.0 109.232 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 75' ' ' ALA . 68.2 t -67.87 -27.41 37.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.402 -0.811 . . . . 0.0 109.372 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.486 ' O ' ' OD2' ' A' ' 83' ' ' ASP . 40.8 mm-40 -70.4 -61.47 1.76 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.254 -0.904 . . . . 0.0 109.285 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.8 pp -58.03 -24.06 56.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 0.0 108.645 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' A' ' 86' ' ' ASN . 13.9 t70 -72.25 -54.96 8.04 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.39 -0.819 . . . . 0.0 108.912 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.486 ' OD2' ' O ' ' A' ' 80' ' ' GLN . 1.1 p30 -48.33 -35.42 12.37 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.113 -0.992 . . . . 0.0 108.368 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.457 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -72.93 -32.07 65.03 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.297 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 82' ' ' ASP . 4.6 tp -121.56 35.29 4.93 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.327 -0.858 . . . . 0.0 109.415 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.615 ' N ' ' O ' ' A' ' 82' ' ' ASP . 42.6 t30 -87.71 30.16 0.84 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.193 -0.942 . . . . 0.0 109.205 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -107.41 -21.3 8.05 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.556 HH11 HD13 ' A' ' 49' ' ' LEU . 25.3 ttt85 -159.53 64.81 0.38 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.282 -1.128 . . . . 0.0 109.41 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.13 174.43 14.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.924 . . . . 0.0 109.379 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.9 t -136.11 142.51 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 109.641 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -103.24 147.71 26.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.328 -0.858 . . . . 0.0 109.077 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.401 ' HB2' ' ND1' ' A' ' 59' ' ' HIS . 38.4 m-70 -132.1 119.16 20.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 109.655 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.524 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 11.0 ptp180 -91.97 109.32 20.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.367 -0.833 . . . . 0.0 109.299 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 100' ' ' SER . 86.6 mt-10 -113.32 144.19 43.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 109.43 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 96' ' ' GLN . 37.5 t -148.55 166.59 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.299 -0.876 . . . . 0.0 109.37 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.541 ' N ' HG12 ' A' ' 95' ' ' VAL . 32.3 tt0 -59.16 115.99 3.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.245 -0.91 . . . . 0.0 109.388 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.06 9.79 85.75 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.48 ' O ' ' O ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -143.17 24.71 1.78 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -1.147 . . . . 0.0 109.305 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.538 ' OE1' HD21 ' A' ' 104' ' ' LEU . 9.7 pt-20 -44.53 170.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.276 -0.89 . . . . 0.0 109.556 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.407 ' H ' ' HG2' ' A' ' 94' ' ' GLU . 4.3 t -91.51 167.8 11.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.279 -0.888 . . . . 0.0 109.573 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.66 -59.89 2.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.295 -0.878 . . . . 0.0 109.527 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.0 m -46.85 -35.59 6.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.355 -0.841 . . . . 0.0 109.373 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -68.87 -46.49 68.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.347 -0.846 . . . . 0.0 109.292 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.58 ' O ' ' CD1' ' A' ' 107' ' ' PHE . 12.0 mt -61.15 -20.57 62.85 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.252 -0.905 . . . . 0.0 109.436 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -93.74 -24.85 19.5 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.414 ' O ' ' C ' ' A' ' 107' ' ' PHE . 7.8 t80 -80.0 -21.42 43.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -1.133 . . . . 0.0 109.461 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.583 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 1.6 p90 -44.97 121.67 2.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.456 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -108.98 -50.67 2.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.979 . . . . 0.0 109.536 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 94.9 p -101.42 -9.79 20.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 109.539 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 96.29 108.48 2.44 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.735 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -67.6 177.06 2.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -1.153 . . . . 0.0 109.512 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -146.88 143.7 28.74 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.288 -0.883 . . . . 0.0 109.436 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.61 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -112.41 124.67 53.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.312 -0.868 . . . . 0.0 109.485 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 17.0 mtpt -97.42 160.62 14.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 109.531 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.364 -0.835 . . . . 0.0 109.364 179.979 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo . . . . . 0 N--CA 1.494 1.521 0 CA-C-O 121.286 0.453 . . . . 0.0 111.974 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.52 ' H ' HD13 ' A' ' 24' ' ' LEU . 57.2 mm-40 -83.06 -46.02 13.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.972 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.553 ' CE2' ' CG1' ' A' ' 42' ' ' VAL . 34.8 t80 -69.74 -12.54 61.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.111 -0.993 . . . . 0.0 109.558 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.415 ' N ' HD23 ' A' ' 6' ' ' LEU . 9.4 mt -90.34 -33.71 15.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.216 -0.927 . . . . 0.0 109.381 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 8' ' ' ALA . 25.1 mttp -91.17 -11.34 38.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.229 -0.919 . . . . 0.0 109.494 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -42.73 166.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.177 -0.952 . . . . 0.0 109.47 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.542 ' H ' ' NE2' ' A' ' 15' ' ' GLN . . . 106.24 68.27 0.69 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.8 pttt -135.97 -0.87 2.49 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.211 -1.17 . . . . 0.0 109.576 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -159.02 142.48 10.81 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 109.326 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.35 89.88 1.04 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.594 2.196 . . . . 0.0 112.256 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -169.14 -105.92 0.19 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.5 tt -162.38 144.82 11.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -1.15 . . . . 0.0 109.472 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.542 ' NE2' ' H ' ' A' ' 9' ' ' GLY . 9.0 mt-30 -134.6 144.39 47.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 109.629 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.505 HG23 HD12 ' A' ' 43' ' ' ILE . 7.8 mt -122.89 143.96 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.455 -0.778 . . . . 0.0 109.812 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.423 ' CE2' ' HB3' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -146.68 136.07 22.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.307 -0.87 . . . . 0.0 109.019 179.738 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.552 ' O ' ' N ' ' A' ' 25' ' ' VAL . 51.5 ttt180 -94.11 153.17 18.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.124 -0.985 . . . . 0.0 109.645 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 23' ' ' ASP . 28.3 t -96.45 133.31 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.92 . . . . 0.0 109.722 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.774 ' O ' ' N ' ' A' ' 22' ' ' PHE . 6.0 tt0 -80.09 85.58 5.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.132 -0.98 . . . . 0.0 108.774 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.648 ' O ' ' CD2' ' A' ' 22' ' ' PHE . 7.5 mtpm? 40.43 9.86 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.548 -0.72 . . . . 0.0 109.792 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.774 ' N ' ' O ' ' A' ' 20' ' ' GLU . 0.7 OUTLIER 160.22 -32.35 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.225 -0.922 . . . . 0.0 109.167 -179.723 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.737 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -94.49 -142.38 0.24 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.273 -0.892 . . . . 0.0 110.257 -179.214 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.52 HD13 ' H ' ' A' ' 4' ' ' GLU . 8.9 mt -125.95 146.12 49.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.341 -0.849 . . . . 0.0 109.942 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' A' ' 18' ' ' ARG . 7.8 t -142.05 132.29 12.66 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 0.0 109.15 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -76.3 144.67 26.37 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.39 2.06 . . . . 0.0 112.26 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.2 t -110.96 101.51 50.09 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.346 -0.846 . . . . 0.0 109.437 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -51.19 161.6 1.58 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.508 2.139 . . . . 0.0 112.153 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.7 m -68.64 -22.15 64.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.389 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -67.0 -11.83 58.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 109.433 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 32' ' ' TYR . 15.3 mt -122.93 -17.11 6.87 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.268 -0.895 . . . . 0.0 109.52 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.55 ' C ' ' CD2' ' A' ' 32' ' ' TYR . 4.4 t80 -42.46 133.12 3.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.907 . . . . 0.0 109.348 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.83 22.26 16.36 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -143.02 151.37 40.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -1.192 . . . . 0.0 109.444 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -141.83 137.48 31.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.231 -0.918 . . . . 0.0 109.549 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -102.04 137.63 40.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 109.325 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.4 p -78.2 -4.79 49.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.882 . . . . 0.0 109.48 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.35 30.94 8.92 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 40' ' ' ALA . 8.8 t70 -173.66 156.13 2.86 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.188 -1.184 . . . . 0.0 109.521 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.447 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -97.77 147.68 24.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.246 -0.909 . . . . 0.0 109.279 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.44 ' N ' ' CD2' ' A' ' 41' ' ' TYR . 17.1 m-85 -128.72 134.82 48.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.324 -0.86 . . . . 0.0 109.46 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.918 ' O ' HD13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -105.44 140.94 21.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.213 -0.929 . . . . 0.0 109.06 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.918 HD13 ' O ' ' A' ' 42' ' ' VAL . 1.1 mm -131.22 134.89 60.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.37 -0.831 . . . . 0.0 110.028 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 tt -120.22 120.13 35.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.536 -0.727 . . . . 0.0 109.531 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.403 ' HE3' ' CE1' ' A' ' 106' ' ' TYR . 43.6 tttt -93.79 147.91 22.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.116 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.6 OUTLIER -142.68 122.14 13.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 109.526 -179.768 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -129.97 168.18 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 O-C-N 121.249 -0.907 . . . . 0.0 108.908 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -94.51 131.29 40.39 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.533 -0.729 . . . . 0.0 109.487 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 15.8 mt -96.32 167.52 11.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 109.534 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.53 ' CG ' ' N ' ' A' ' 51' ' ' ASN . 4.6 ptm180 -47.93 -46.86 32.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.261 -0.899 . . . . 0.0 109.296 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.53 ' N ' ' CG ' ' A' ' 50' ' ' ARG . 98.6 m-20 -75.75 -27.48 58.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.316 -0.865 . . . . 0.0 109.199 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.85 28.96 7.95 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.497 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.4 t-20 -84.67 13.64 5.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.099 -1.236 . . . . 0.0 109.359 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.8 mt 47.31 100.26 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.527 0.68 . . . . 0.0 109.509 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -68.85 117.77 10.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.534 -0.729 . . . . 0.0 109.214 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.515 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 96.7 m-85 -98.07 114.71 26.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.174 -0.954 . . . . 0.0 109.865 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.21 155.76 22.46 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.553 ' C ' ' CD2' ' A' ' 59' ' ' HIS . 5.2 mp -134.36 144.7 48.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.838 -1.164 . . . . 0.0 110.517 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.603 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.5 OUTLIER -141.97 126.55 17.89 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.566 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.701 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -105.94 131.13 53.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.1 -1.0 . . . . 0.0 109.593 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -104.94 123.94 48.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.422 -0.799 . . . . 0.0 109.331 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.9 mt -104.7 162.12 13.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.863 . . . . 0.0 109.595 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -117.37 162.69 12.81 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.412 ' HB2' ' NE2' ' A' ' 96' ' ' GLN . 3.7 t-20 -81.08 -12.57 59.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.302 -1.117 . . . . 0.0 109.614 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -106.24 26.98 9.13 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.3 m -130.75 97.61 4.4 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 122.2 1.0 . . . . 0.0 108.42 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 66' ' ' CYS . 31.4 m -49.71 -176.49 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.733 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 72' ' ' GLY . 13.7 pt20 -68.17 -17.5 64.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.4 -0.812 . . . . 0.0 109.561 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -63.48 -58.57 6.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.919 . . . . 0.0 109.652 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.449 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 3.8 mm-40 -62.32 -48.13 81.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.229 -0.919 . . . . 0.0 109.177 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.7 p -66.01 -27.53 68.19 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.338 -0.851 . . . . 0.0 109.231 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.89 -31.82 66.86 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.22 -51.22 18.53 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.278 -1.131 . . . . 0.0 109.342 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.92 -48.18 73.44 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.414 -0.804 . . . . 0.0 109.279 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.406 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -57.11 -48.38 78.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 109.303 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.4 mt -50.77 -47.28 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.204 -0.935 . . . . 0.0 109.319 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -58.06 -37.75 75.02 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.306 -0.871 . . . . 0.0 109.264 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 m -65.32 -46.22 81.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.33 -0.856 . . . . 0.0 109.266 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 75' ' ' ALA . 17.1 t -56.02 -36.41 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 0.0 109.451 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -64.89 -50.09 67.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.277 -0.889 . . . . 0.0 109.255 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.2 mt -53.13 -36.1 60.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.204 -0.935 . . . . 0.0 109.247 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 85' ' ' LEU . 40.6 m-20 -63.36 -58.34 7.42 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.247 -0.908 . . . . 0.0 109.109 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 82' ' ' ASP . 1.8 t70 -45.4 -34.0 2.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.212 -0.93 . . . . 0.0 108.54 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -73.7 -28.87 61.96 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 82' ' ' ASP . 6.4 mt -112.93 28.36 8.86 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.394 -0.816 . . . . 0.0 109.272 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 85' ' ' LEU . 9.6 t-20 43.56 37.22 1.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.397 -0.815 . . . . 0.0 109.429 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 48.72 32.95 11.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -89.09 30.96 0.9 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.192 -1.181 . . . . 0.0 109.22 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -129.76 179.14 6.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.423 -0.798 . . . . 0.0 109.347 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.7 128.23 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.15 -0.969 . . . . 0.0 109.5 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.435 ' N ' ' OE1' ' A' ' 91' ' ' GLN . 15.7 mp0 -88.98 144.33 26.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.932 . . . . 0.0 109.366 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.42 ' HB2' ' CG ' ' A' ' 59' ' ' HIS . 28.4 m-70 -131.31 107.27 8.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.94 . . . . 0.0 109.576 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -86.25 105.04 16.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 109.377 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.596 ' OE1' ' CD1' ' A' ' 103' ' ' PHE . 22.3 mt-10 -110.3 141.77 42.84 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.36 -0.837 . . . . 0.0 109.732 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 96' ' ' GLN . 12.0 t -144.38 163.3 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.342 -0.848 . . . . 0.0 109.147 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.426 ' N ' HG12 ' A' ' 95' ' ' VAL . 2.3 pt20 -56.89 120.52 8.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.939 . . . . 0.0 109.442 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.42 15.76 77.54 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.438 ' O ' ' C ' ' A' ' 99' ' ' GLU . 7.0 t80 -141.7 12.13 2.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -1.145 . . . . 0.0 109.443 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.6 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 30.2 mp0 -41.52 138.4 1.33 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.506 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.446 ' H ' ' HG2' ' A' ' 94' ' ' GLU . 4.1 m -72.29 -177.36 2.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 0.0 109.402 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.2 -65.21 0.98 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.187 -0.945 . . . . 0.0 109.505 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.6 m -47.64 -36.21 10.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 109.444 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.685 ' CZ ' ' CZ ' ' A' ' 107' ' ' PHE . 2.1 t80 -67.8 -47.16 69.87 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.259 -0.901 . . . . 0.0 109.442 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 104' ' ' LEU . 63.5 mt -66.83 -23.1 65.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.934 . . . . 0.0 109.508 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -93.32 -24.17 22.49 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.403 ' CE1' ' HE3' ' A' ' 45' ' ' LYS . 32.6 t80 -86.94 -33.62 19.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.225 -1.162 . . . . 0.0 109.51 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.685 ' CZ ' ' CZ ' ' A' ' 103' ' ' PHE . 24.2 m-85 -90.31 99.31 12.36 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.29 -0.881 . . . . 0.0 109.528 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.419 ' C ' ' H ' ' A' ' 110' ' ' GLY . 19.9 mtpp -99.74 -6.16 27.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.913 . . . . 0.0 109.365 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 26.0 m -77.75 22.29 0.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 109.426 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 111' ' ' LEU . . . 47.62 80.85 0.05 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.75 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.5 OUTLIER -43.01 118.33 1.25 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -1.145 . . . . 0.0 109.441 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -82.04 123.57 29.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.28 -0.887 . . . . 0.0 109.497 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -94.93 108.73 20.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.511 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -111.43 140.12 46.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.348 -0.845 . . . . 0.0 109.556 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 30.3 pttt . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.911 . . . . 0.0 109.397 179.983 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo . . . . . 0 N--CA 1.492 1.388 0 CA-C-O 121.296 0.457 . . . . 0.0 112.099 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.409 ' C ' ' N ' ' A' ' 6' ' ' LEU . 0.4 OUTLIER -82.25 -34.83 28.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 109.698 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.628 ' CE2' HG12 ' A' ' 42' ' ' VAL . 15.9 t80 -56.78 -8.87 0.66 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.184 -0.948 . . . . 0.0 109.291 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.409 ' N ' ' C ' ' A' ' 4' ' ' GLU . 51.1 mt -90.24 -45.73 8.88 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.227 -0.921 . . . . 0.0 109.385 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.455 ' O ' ' C ' ' A' ' 8' ' ' ALA . 43.6 mtpt -87.27 -2.08 58.37 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.292 -0.88 . . . . 0.0 109.439 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -41.48 150.46 0.1 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.42 -0.8 . . . . 0.0 109.581 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.54 68.83 0.29 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -134.64 9.69 3.66 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.373 -1.075 . . . . 0.0 109.539 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -172.67 139.37 0.93 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.148 -0.97 . . . . 0.0 109.451 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.38 86.3 1.17 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.547 2.165 . . . . 0.0 112.265 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -166.31 -107.58 0.2 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.6 tt -162.6 151.0 14.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.291 -1.123 . . . . 0.0 109.635 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.424 ' HB3' ' CZ3' ' A' ' 17' ' ' TRP . 32.7 mt-30 -146.66 140.25 25.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 109.403 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.582 ' HB ' HG11 ' A' ' 27' ' ' VAL . 3.4 mt -114.38 149.39 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.312 -0.867 . . . . 0.0 109.923 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.424 ' CZ3' ' HB3' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -145.27 135.23 23.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.302 -0.874 . . . . 0.0 109.122 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -92.27 142.83 27.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.164 -0.96 . . . . 0.0 109.381 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.634 ' O ' HG13 ' A' ' 19' ' ' VAL . 9.9 p -80.45 119.62 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.198 -0.939 . . . . 0.0 109.501 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.614 ' O ' ' N ' ' A' ' 22' ' ' PHE . 8.6 tm-20 -74.79 147.83 40.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.234 -0.916 . . . . 0.0 109.157 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.425 ' N ' ' CD ' ' A' ' 20' ' ' GLU . 23.8 mttp -45.19 -11.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.901 . . . . 0.0 109.833 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.614 ' N ' ' O ' ' A' ' 20' ' ' GLU . 7.6 t80 -165.71 29.75 0.05 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.126 -0.984 . . . . 0.0 109.797 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.463 ' N ' ' HB3' ' A' ' 20' ' ' GLU . 27.5 t70 -175.29 -116.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 109.597 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.6 tp -157.99 146.2 18.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.346 -0.846 . . . . 0.0 109.499 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -134.38 107.9 11.17 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.244 -0.91 . . . . 0.0 109.604 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.74 132.79 37.62 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.192 1.928 . . . . 0.0 111.843 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.582 HG11 ' HB ' ' A' ' 16' ' ' ILE . 2.2 p -75.7 121.57 85.35 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 109.572 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -78.17 166.84 24.14 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.4 2.067 . . . . 0.0 112.139 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.86 -6.25 43.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.332 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -87.19 -6.39 58.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 109.346 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 32' ' ' TYR . 56.6 mt -132.87 -11.4 3.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 109.778 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.528 ' CZ ' ' CD1' ' A' ' 16' ' ' ILE . 9.6 t80 -43.25 118.98 1.44 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 109.487 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.66 -11.91 56.45 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.514 ' C ' ' CG ' ' A' ' 35' ' ' PHE . 1.9 m-20 -110.52 150.52 28.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -1.154 . . . . 0.0 109.503 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.514 ' CG ' ' C ' ' A' ' 34' ' ' ASP . 5.2 m-85 -155.1 148.17 24.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 109.421 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.478 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 2.0 m-85 -102.34 135.96 43.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 109.536 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 44.7 p -67.13 -9.57 41.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.354 -0.841 . . . . 0.0 109.289 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.52 30.36 8.9 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 40' ' ' ALA . 3.1 t70 -161.36 159.44 28.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -1.154 . . . . 0.0 109.399 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.6 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -107.46 150.71 26.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 109.392 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -130.03 138.89 51.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.312 -0.867 . . . . 0.0 109.511 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.08 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -112.81 126.52 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.25 -0.906 . . . . 0.0 108.591 179.698 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.08 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -123.73 137.77 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 119.319 -0.952 . . . . 0.0 110.373 -178.862 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.6 tt -121.09 146.96 46.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.542 -0.724 . . . . 0.0 109.396 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 57' ' ' ASP . 1.8 ttmp? -123.67 139.34 54.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.417 -0.802 . . . . 0.0 109.259 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 13' ' ' GLY . 20.4 m -136.31 117.93 14.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.342 -0.849 . . . . 0.0 109.328 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -126.52 167.86 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.317 -0.864 . . . . 0.0 109.01 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -98.48 125.44 43.68 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.498 -0.752 . . . . 0.0 109.442 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.435 HD11 ' HB2' ' A' ' 55' ' ' GLN . 11.1 mt -87.9 154.43 20.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.27 -0.894 . . . . 0.0 109.673 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.432 ' CZ ' ' CB ' ' A' ' 50' ' ' ARG . 10.3 mtp-105 -48.24 -43.39 32.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -0.916 . . . . 0.0 109.255 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -68.41 -32.85 73.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.312 -0.868 . . . . 0.0 109.3 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.09 74.67 1.18 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.508 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.1 t-20 -143.69 13.77 1.73 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.203 -1.175 . . . . 0.0 109.336 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.708 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 31.4 mt 44.52 98.26 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.536 0.684 . . . . 0.0 109.496 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.435 ' HB2' HD11 ' A' ' 49' ' ' LEU . 66.0 tt0 -73.97 121.31 20.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.559 -0.713 . . . . 0.0 109.682 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -99.54 114.54 27.59 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.248 -0.908 . . . . 0.0 109.751 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 45' ' ' LYS . 0.9 OUTLIER -127.51 122.56 33.7 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.362 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.431 HD13 HD21 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -126.16 150.37 48.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.114 -0.991 . . . . 0.0 110.71 -178.984 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.611 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -129.53 141.71 50.92 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.34 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.572 ' HE1' ' HB1' ' A' ' 40' ' ' ALA . 2.4 t80 -103.24 126.22 50.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.897 . . . . 0.0 109.56 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.457 ' N ' ' CD1' ' A' ' 60' ' ' TYR . 44.2 t90 -100.74 127.8 47.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.09 -1.006 . . . . 0.0 109.824 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.499 HD21 ' CE2' ' A' ' 60' ' ' TYR . 2.9 mp -112.53 157.0 21.68 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.491 -0.756 . . . . 0.0 109.412 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -104.78 161.68 14.99 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 64' ' ' ASN . 0.5 OUTLIER -81.72 -12.05 58.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.333 -1.098 . . . . 0.0 109.474 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -106.66 29.59 6.82 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.552 ' SG ' ' OE2' ' A' ' 70' ' ' GLU . 1.6 m -130.78 97.51 4.36 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.591 ' OG ' ' N ' ' A' ' 68' ' ' GLN . 1.0 OUTLIER -58.67 -173.76 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.573 -179.829 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.591 ' N ' ' OG ' ' A' ' 67' ' ' SER . 8.6 pt20 -62.45 -17.97 60.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 109.66 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -65.35 -58.77 5.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.557 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.552 ' OE2' ' SG ' ' A' ' 66' ' ' CYS . 13.4 mt-10 -64.63 -43.1 94.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.336 -0.852 . . . . 0.0 109.139 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.7 t -69.33 -26.7 64.83 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.491 -0.756 . . . . 0.0 109.191 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.31 -38.89 71.18 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.02 -47.98 64.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.331 -1.1 . . . . 0.0 109.366 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.483 ' O ' ' OG1' ' A' ' 78' ' ' THR . . . -60.36 -42.22 95.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.366 -0.834 . . . . 0.0 109.311 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.487 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -62.95 -44.8 95.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.883 . . . . 0.0 109.598 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.2 mt -53.45 -51.53 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 0.0 109.341 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -61.36 -33.23 73.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 109.307 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -68.81 -44.77 72.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.382 -0.824 . . . . 0.0 109.374 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 75' ' ' ALA . 42.9 t -63.34 -31.2 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.293 -0.879 . . . . 0.0 109.409 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -66.9 -60.97 2.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.334 -0.854 . . . . 0.0 109.165 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.805 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -50.78 -31.09 15.84 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.046 -1.034 . . . . 0.0 108.708 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' A' ' 86' ' ' ASN . 29.2 t70 -63.64 -59.57 4.44 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.418 -0.802 . . . . 0.0 108.928 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 1.3 m-20 -46.03 -34.09 3.84 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.158 -0.964 . . . . 0.0 108.46 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -74.7 -32.79 62.28 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 82' ' ' ASP . 1.1 tt -121.48 35.67 4.82 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.369 -0.832 . . . . 0.0 109.532 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.609 ' N ' ' O ' ' A' ' 82' ' ' ASP . 11.4 p-10 -76.89 27.03 0.14 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.125 -0.985 . . . . 0.0 109.092 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -69.9 -57.86 6.74 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -176.67 46.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.346 -1.091 . . . . 0.0 109.564 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.63 179.13 6.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 0.0 109.406 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.7 t -126.25 111.95 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 109.45 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -102.38 136.43 42.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.364 -0.835 . . . . 0.0 109.397 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.611 ' CD2' ' HB2' ' A' ' 59' ' ' HIS . 1.2 p-80 -143.82 118.65 9.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.077 -1.014 . . . . 0.0 109.515 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.1 mtm180 -83.01 138.28 33.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 109.774 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' A' ' 100' ' ' SER . 5.4 mt-10 -131.37 155.98 46.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.304 -0.873 . . . . 0.0 109.283 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.698 HG12 ' N ' ' A' ' 96' ' ' GLN . 48.1 t -131.66 173.8 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.219 -0.925 . . . . 0.0 109.575 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.698 ' N ' HG12 ' A' ' 95' ' ' VAL . 26.8 tt0 -60.55 139.75 57.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.374 -0.829 . . . . 0.0 109.54 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 70.53 -18.55 0.75 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.517 ' H ' ' C ' ' A' ' 96' ' ' GLN . 7.9 t80 -106.59 4.7 28.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.301 -1.117 . . . . 0.0 109.452 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.54 ' OE2' HD22 ' A' ' 111' ' ' LEU . 27.7 mt-10 -42.69 148.26 0.24 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.903 . . . . 0.0 109.559 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.467 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 38.4 m -81.06 168.7 18.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.9 . . . . 0.0 109.529 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.93 -35.02 78.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.153 -0.967 . . . . 0.0 109.607 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.8 m -58.03 -61.03 2.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.568 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -57.78 -41.79 82.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.35 -0.844 . . . . 0.0 109.732 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.2 mt -66.28 -28.52 68.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.189 -0.944 . . . . 0.0 109.552 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -81.7 -19.22 66.29 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.43 ' CD1' ' CZ ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -81.37 -45.55 15.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -1.121 . . . . 0.0 109.431 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.43 ' CZ ' ' CD1' ' A' ' 106' ' ' TYR . 20.4 m-85 -139.41 87.21 2.17 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.352 -0.842 . . . . 0.0 109.496 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.35 -20.76 20.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.386 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.7 t -96.94 -12.39 23.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -0.939 . . . . 0.0 109.484 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.456 ' O ' ' C ' ' A' ' 111' ' ' LEU . . . -97.65 -107.15 2.53 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.54 HD22 ' OE2' ' A' ' 99' ' ' GLU . 14.5 mt 41.52 61.64 1.77 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.329 -1.1 . . . . 0.0 109.507 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tppt? -75.59 117.04 16.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.172 -0.955 . . . . 0.0 109.479 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -84.5 114.38 21.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.297 -0.877 . . . . 0.0 109.478 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -103.05 166.28 10.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 0.0 109.355 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.854 . . . . 0.0 109.465 179.881 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo . . . . . 0 N--CA 1.488 1.152 0 CA-C-O 121.22 0.425 . . . . 0.0 112.238 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.644 ' H ' HD22 ' A' ' 24' ' ' LEU . 1.2 tp10 -83.07 -29.35 28.86 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.26 -0.9 . . . . 0.0 109.563 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.616 ' CZ ' ' O ' ' A' ' 42' ' ' VAL . 2.9 m-85 -56.32 -4.59 0.14 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.951 . . . . 0.0 109.13 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.511 ' H ' ' C ' ' A' ' 4' ' ' GLU . 14.4 mt -84.54 -38.4 20.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.88 . . . . 0.0 109.279 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 8' ' ' ALA . 23.2 mttt -101.43 -3.37 28.79 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.393 -0.817 . . . . 0.0 109.358 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.503 ' HB3' HD13 ' A' ' 44' ' ' LEU . . . -42.01 137.52 1.81 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.31 -0.869 . . . . 0.0 109.637 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . 0.555 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 154.86 -37.45 0.66 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.623 ' CD ' ' H ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -70.78 19.83 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -1.152 . . . . 0.0 109.309 179.85 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.555 ' H ' ' C ' ' A' ' 9' ' ' GLY . 79.9 mt-10 -139.23 103.02 7.31 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.374 -0.829 . . . . 0.0 109.293 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -78.33 83.97 2.11 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.426 2.084 . . . . 0.0 112.157 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -174.22 -102.01 0.15 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -159.97 132.47 6.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.134 . . . . 0.0 109.427 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -115.23 135.93 53.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.276 -0.89 . . . . 0.0 109.478 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.58 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 6.3 mt -130.96 110.11 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.44 -0.787 . . . . 0.0 109.91 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.58 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 6.1 m0 -139.32 149.76 44.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.176 -0.953 . . . . 0.0 108.769 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.641 ' HE ' HG22 ' A' ' 27' ' ' VAL . 6.7 ptp180 -114.83 153.27 30.73 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.122 -0.986 . . . . 0.0 110.139 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.552 ' O ' HG13 ' A' ' 19' ' ' VAL . 7.3 p -89.26 125.68 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -0.843 . . . . 0.0 109.13 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.657 ' CB ' HG21 ' A' ' 25' ' ' VAL . 5.6 mt-10 -157.45 138.02 13.02 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.214 -0.929 . . . . 0.0 109.319 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 22' ' ' PHE . 12.8 mttt 72.97 48.21 0.18 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.501 -0.75 . . . . 0.0 109.458 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.428 ' C ' ' O ' ' A' ' 21' ' ' LYS . 20.5 m-85 43.74 36.93 1.41 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.541 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -169.01 166.75 10.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.28 -0.888 . . . . 0.0 109.405 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.644 HD22 ' H ' ' A' ' 4' ' ' GLU . 4.4 tp -68.15 146.16 53.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.246 -0.909 . . . . 0.0 109.431 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.657 HG21 ' CB ' ' A' ' 20' ' ' GLU . 44.1 t -138.5 97.67 9.25 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.371 -0.831 . . . . 0.0 109.071 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -50.31 168.99 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.771 2.314 . . . . 0.0 112.632 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.641 HG22 ' HE ' ' A' ' 18' ' ' ARG . 58.0 t -126.92 107.43 22.27 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.462 -0.774 . . . . 0.0 109.173 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -45.69 144.04 5.75 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.434 2.089 . . . . 0.0 112.492 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 31' ' ' LEU . 6.5 m -51.89 -50.19 61.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.266 -0.896 . . . . 0.0 109.39 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -48.11 -11.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.418 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' THR . 94.5 mt -114.96 -17.45 11.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 109.552 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.525 ' CE1' HD12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -38.74 122.4 1.15 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.325 -0.859 . . . . 0.0 109.352 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.2 -10.9 36.89 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.477 ' C ' ' CD2' ' A' ' 35' ' ' PHE . 4.3 m-20 -93.5 156.71 16.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.151 -1.205 . . . . 0.0 109.381 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.477 ' CD2' ' C ' ' A' ' 34' ' ' ASP . 77.2 m-85 -146.83 134.38 20.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.201 -0.937 . . . . 0.0 109.6 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.598 ' CD2' ' NZ ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -103.63 120.02 40.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 109.329 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.471 ' OG1' ' OE1' ' A' ' 65' ' ' GLU . 59.1 p -61.9 -23.05 66.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 109.44 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.451 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -88.33 24.97 9.85 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.511 ' OD1' ' CG ' ' A' ' 20' ' ' GLU . 7.1 m-20 -159.52 135.34 8.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.283 -1.128 . . . . 0.0 109.334 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.534 ' HB1' ' HE1' ' A' ' 60' ' ' TYR . . . -77.83 140.6 39.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -0.901 . . . . 0.0 109.318 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -116.33 135.04 54.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -0.859 . . . . 0.0 109.383 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.95 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -118.92 136.37 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.414 -0.804 . . . . 0.0 109.265 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.95 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -130.64 141.58 45.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.776 179.81 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.682 HD23 ' N ' ' A' ' 45' ' ' LYS . 4.6 tt -129.32 117.31 20.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.311 -0.868 . . . . 0.0 109.688 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.682 ' N ' HD23 ' A' ' 44' ' ' LEU . 4.6 ttmm -89.07 134.65 33.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.842 . . . . 0.0 109.38 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.6 OUTLIER -140.81 116.33 10.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.159 -0.963 . . . . 0.0 109.432 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.803 ' O ' HD23 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -125.58 168.44 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.18 -0.95 . . . . 0.0 109.183 -179.816 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.832 HE22 ' H ' ' A' ' 51' ' ' ASN . 1.0 OUTLIER -115.56 123.33 48.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.564 -0.71 . . . . 0.0 109.163 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.594 ' N ' ' OE1' ' A' ' 48' ' ' GLN . 0.5 OUTLIER -103.46 100.41 10.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.285 -0.885 . . . . 0.0 109.532 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.584 ' C ' ' O ' ' A' ' 49' ' ' LEU . 19.7 mtp180 25.89 58.99 0.06 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.654 -0.654 . . . . 0.0 110.032 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.832 ' H ' HE22 ' A' ' 48' ' ' GLN . 1.8 m-20 55.23 50.54 14.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.351 -0.843 . . . . 0.0 109.382 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . -93.53 -79.71 1.45 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.419 ' O ' ' O ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -164.61 22.06 0.06 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -1.171 . . . . 0.0 109.515 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.803 HD23 ' O ' ' A' ' 47' ' ' VAL . 11.4 mt 56.35 104.81 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.641 0.734 . . . . 0.0 109.359 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 46' ' ' THR . 4.5 tt0 -68.71 116.29 9.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.55 -0.719 . . . . 0.0 109.236 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.627 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 96.3 m-85 -104.39 115.24 30.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.364 -0.835 . . . . 0.0 109.964 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.89 155.05 36.25 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.439 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 4.3 tp -142.63 137.91 30.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.936 -1.102 . . . . 0.0 110.521 -179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.653 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -130.02 119.55 23.32 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.524 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.534 ' HE1' ' HB1' ' A' ' 40' ' ' ALA . 3.6 t80 -101.57 124.44 47.23 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.01 -1.056 . . . . 0.0 109.387 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -103.81 126.64 51.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.11 -0.994 . . . . 0.0 109.799 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.425 ' CD2' ' OH ' ' A' ' 60' ' ' TYR . 6.4 mt -97.28 162.07 13.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.449 -0.782 . . . . 0.0 109.657 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.97 154.59 16.87 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.62 -12.34 60.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.056 -1.261 . . . . 0.0 109.52 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.471 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 1.2 mt-10 -109.23 30.35 6.68 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 2.1 m -130.49 97.42 4.39 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 122.075 0.94 . . . . 0.0 108.586 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.2 p -73.27 -170.88 0.85 Allowed 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.665 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -55.49 -28.18 52.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.792 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.31 -58.87 4.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 0.0 109.571 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.451 ' OE2' ' O ' ' A' ' 65' ' ' GLU . 24.3 mt-10 -62.95 -43.02 99.93 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.264 -0.898 . . . . 0.0 108.998 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.0 t -64.69 -34.68 78.88 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.454 -0.779 . . . . 0.0 108.953 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.03 -43.15 99.81 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.23 -50.33 73.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -1.125 . . . . 0.0 109.116 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.479 ' O ' ' OG1' ' A' ' 78' ' ' THR . . . -61.63 -40.02 93.38 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.469 -0.769 . . . . 0.0 109.267 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.488 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -64.37 -42.7 96.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.866 . . . . 0.0 109.428 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.2 mt -55.4 -53.88 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.183 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -57.87 -32.19 67.44 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.187 -0.946 . . . . 0.0 109.228 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -69.44 -52.42 27.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.008 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 75' ' ' ALA . 37.7 t -56.92 -26.55 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.289 -0.882 . . . . 0.0 109.097 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -70.11 -55.9 8.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.383 -0.823 . . . . 0.0 109.295 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.695 ' C ' HD12 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -54.17 -29.82 47.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.035 -1.041 . . . . 0.0 109.04 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 85' ' ' LEU . 72.7 m-20 -68.94 -58.77 3.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.244 -0.91 . . . . 0.0 108.806 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 82' ' ' ASP . 52.9 t0 -46.86 -29.6 2.07 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.124 -0.985 . . . . 0.0 108.465 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -75.15 -33.79 61.55 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.9 tp -107.63 25.72 11.15 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.424 -0.797 . . . . 0.0 109.375 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 85' ' ' LEU . 2.9 m120 39.09 33.9 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.582 -0.699 . . . . 0.0 109.476 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . 53.98 84.6 0.03 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 45.0 mtp85 -140.22 43.08 1.91 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.318 -1.107 . . . . 0.0 109.391 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.627 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -150.67 170.68 18.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.858 . . . . 0.0 109.404 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.1 t -91.26 91.87 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 109.266 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.525 ' H ' ' CD ' ' A' ' 91' ' ' GLN . 2.3 mp0 -94.34 120.07 34.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -0.885 . . . . 0.0 109.49 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.602 ' NE2' ' ND1' ' A' ' 59' ' ' HIS . 3.9 p80 -127.94 134.09 49.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.359 -0.838 . . . . 0.0 109.381 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.496 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 0.8 OUTLIER -90.52 117.82 29.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.718 -179.753 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.477 ' OE2' ' OG ' ' A' ' 100' ' ' SER . 11.3 mt-10 -108.28 161.13 15.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 109.354 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.7 t -132.53 158.03 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.184 -0.947 . . . . 0.0 109.538 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -61.98 143.79 56.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 109.443 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 73.95 7.71 76.51 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -151.39 22.01 0.73 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.316 -1.108 . . . . 0.0 109.322 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -51.62 171.21 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.569 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.477 ' OG ' ' OE2' ' A' ' 94' ' ' GLU . 67.5 p -101.11 165.77 11.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.328 -0.858 . . . . 0.0 109.488 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.47 -33.21 73.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 0.0 109.487 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.2 m -59.92 -42.81 94.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.479 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -66.21 -53.46 36.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.242 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.3 mt -62.58 -27.94 69.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.352 -0.843 . . . . 0.0 109.169 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -69.35 -35.65 76.73 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.522 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 1.9 m-85 -70.13 -54.92 10.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -1.101 . . . . 0.0 109.251 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.522 ' CD2' ' O ' ' A' ' 106' ' ' TYR . 10.0 m-85 -139.36 115.57 10.4 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.425 -0.797 . . . . 0.0 109.562 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.8 tttp -98.72 -52.02 3.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.313 -0.867 . . . . 0.0 109.52 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 m -92.61 23.11 4.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 109.467 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -119.16 -30.27 1.62 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.0 mt -63.8 123.39 18.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.221 -1.164 . . . . 0.0 109.509 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -137.12 102.65 4.9 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.305 -0.872 . . . . 0.0 109.448 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.69 136.42 35.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.905 . . . . 0.0 109.373 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.598 ' NZ ' ' CD2' ' A' ' 36' ' ' PHE . 9.5 pttp -131.54 147.38 52.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 109.464 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.417 ' HD3' ' H ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.353 -0.842 . . . . 0.0 109.433 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo . . . . . 0 N--CA 1.488 1.183 0 CA-C-O 121.248 0.437 . . . . 0.0 112.085 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 6' ' ' LEU . 75.8 mt-10 -83.11 -30.77 27.66 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.275 -0.89 . . . . 0.0 109.708 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.61 ' CE1' HG12 ' A' ' 42' ' ' VAL . 46.8 t80 -43.88 -18.31 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.134 -0.979 . . . . 0.0 109.233 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.565 ' N ' ' O ' ' A' ' 4' ' ' GLU . 4.6 mt -81.4 -39.96 24.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.337 -0.852 . . . . 0.0 109.53 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 8' ' ' ALA . 28.3 mtpt -86.93 -12.83 46.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 109.615 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.471 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -42.23 164.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.193 -0.942 . . . . 0.0 109.509 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.12 26.95 5.28 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -102.04 12.53 36.71 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.205 -1.173 . . . . 0.0 109.653 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -158.3 133.69 5.79 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.915 . . . . 0.0 109.466 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -74.58 86.02 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.499 2.133 . . . . 0.0 112.34 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -170.18 -105.59 0.18 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.3 tt -162.2 144.69 11.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.311 -1.111 . . . . 0.0 109.517 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -138.02 134.73 35.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 109.375 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.735 HG23 HD12 ' A' ' 43' ' ' ILE . 27.1 mt -106.92 147.38 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.338 -0.851 . . . . 0.0 110.167 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.08 141.94 36.15 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 25' ' ' VAL . 18.7 ttt180 -110.39 144.85 38.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.177 -0.952 . . . . 0.0 109.635 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.553 HG21 ' HB3' ' A' ' 40' ' ' ALA . 52.0 t -72.48 133.51 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.436 -0.79 . . . . 0.0 109.502 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.633 ' O ' ' N ' ' A' ' 22' ' ' PHE . 28.0 tt0 -81.08 86.85 6.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -0.966 . . . . 0.0 109.366 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.463 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 26.2 mmtp 61.05 -33.09 0.08 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.487 -0.758 . . . . 0.0 109.994 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.633 ' N ' ' O ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER 179.34 27.31 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -0.932 . . . . 0.0 109.394 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -145.15 -113.52 0.09 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.083 -1.01 . . . . 0.0 109.626 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.7 mt -143.66 136.37 27.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.066 -1.021 . . . . 0.0 109.799 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 18' ' ' ARG . 0.9 OUTLIER -149.16 140.37 14.18 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.302 -0.874 . . . . 0.0 108.759 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.49 149.42 68.59 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.551 2.167 . . . . 0.0 112.516 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.421 HG23 ' N ' ' A' ' 18' ' ' ARG . 71.6 t -117.94 101.82 51.56 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.492 -0.755 . . . . 0.0 109.207 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -80.84 167.91 18.0 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.655 2.237 . . . . 0.0 112.461 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.564 ' C ' ' H ' ' A' ' 31' ' ' LEU . 1.9 t -61.03 -173.91 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.546 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.464 ' N ' ' OG1' ' A' ' 29' ' ' THR . 8.1 t30 70.31 -27.71 0.17 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.861 . . . . 0.0 109.343 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.564 ' H ' ' C ' ' A' ' 29' ' ' THR . 43.5 mt -122.73 -33.41 3.39 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.392 -0.818 . . . . 0.0 109.369 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -48.59 165.13 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 0.0 109.319 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.468 ' N ' ' CD1' ' A' ' 32' ' ' TYR . . . 89.04 -24.08 14.85 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -96.71 150.76 20.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -1.182 . . . . 0.0 109.469 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -141.03 134.17 29.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.898 . . . . 0.0 109.418 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.484 ' C ' ' H ' ' A' ' 38' ' ' GLY . 25.6 m-85 -104.53 111.78 24.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.872 . . . . 0.0 109.482 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.469 ' OG1' ' OE1' ' A' ' 65' ' ' GLU . 19.6 p -51.55 -9.51 0.08 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.237 -0.915 . . . . 0.0 109.356 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.484 ' H ' ' C ' ' A' ' 36' ' ' PHE . . . -99.51 27.12 21.64 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.443 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 50.2 m-20 -161.01 146.76 14.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -1.086 . . . . 0.0 109.368 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.553 ' HB3' HG21 ' A' ' 19' ' ' VAL . . . -92.23 158.88 15.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.192 -0.942 . . . . 0.0 109.483 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.437 ' CD2' ' C ' ' A' ' 40' ' ' ALA . 36.4 m-85 -138.26 138.12 38.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 109.369 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.005 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -108.83 128.44 64.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.129 -0.982 . . . . 0.0 108.902 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 1.005 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.4 OUTLIER -125.76 136.97 59.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.242 -0.911 . . . . 0.0 110.023 -179.523 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 tt -124.55 128.85 49.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.545 -0.722 . . . . 0.0 109.582 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.447 ' NZ ' HG21 ' A' ' 102' ' ' THR . 30.3 ttpt -103.79 145.96 29.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.311 -0.868 . . . . 0.0 109.06 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 13' ' ' GLY . 1.0 OUTLIER -143.01 126.78 17.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 109.764 -179.681 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -131.94 168.09 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.29 -0.881 . . . . 0.0 109.16 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -96.82 131.86 43.13 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.597 -0.689 . . . . 0.0 109.497 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 50' ' ' ARG . 14.5 mt -96.92 166.93 11.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.301 -0.874 . . . . 0.0 109.538 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.48 ' H ' ' HD2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -45.18 -78.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.272 -0.892 . . . . 0.0 109.17 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -45.53 -28.97 1.04 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.291 -0.881 . . . . 0.0 109.252 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.55 69.07 1.03 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.499 ' O ' ' O ' ' A' ' 54' ' ' LEU . 63.5 m-20 -120.73 14.44 11.72 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.242 -1.152 . . . . 0.0 109.384 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.661 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 17.7 mt 44.1 97.05 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.509 0.671 . . . . 0.0 109.364 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -71.08 112.08 6.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.428 -0.795 . . . . 0.0 109.527 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.59 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 73.7 m-85 -95.74 114.54 26.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.136 -0.978 . . . . 0.0 109.701 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -115.78 155.38 27.92 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 58' ' ' LEU . 3.8 mp -132.3 141.1 48.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.815 -1.178 . . . . 0.0 110.884 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.484 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -136.7 112.43 9.46 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.233 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.735 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -94.38 126.93 39.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.086 -1.008 . . . . 0.0 109.458 -179.6 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.456 ' HE1' ' HG2' ' A' ' 99' ' ' GLU . 2.3 t90 -98.08 124.73 42.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.475 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 mt -107.64 145.86 32.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.532 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -95.01 158.87 22.59 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -76.23 -12.53 60.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.322 -1.105 . . . . 0.0 109.662 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.469 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 1.1 mt-10 -109.45 29.16 7.82 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 2.0 m -130.7 97.48 4.37 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.211 1.005 . . . . 0.0 108.579 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.8 t -57.35 -170.92 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.735 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.562 ' O ' ' N ' ' A' ' 72' ' ' GLY . 3.2 mm100 -68.99 -17.39 63.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -0.86 . . . . 0.0 109.647 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -61.02 -58.75 7.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 109.394 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -64.38 -49.08 73.0 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.237 -0.914 . . . . 0.0 108.884 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.3 m -64.43 -23.22 67.21 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.399 -0.813 . . . . 0.0 108.844 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -68.44 -47.09 59.62 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.433 ' O ' ' CE2' ' A' ' 77' ' ' PHE . . . -62.63 -49.25 75.92 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.293 -1.122 . . . . 0.0 109.138 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.62 -32.51 74.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.507 -0.746 . . . . 0.0 109.214 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.556 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -71.59 -43.96 65.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.264 -0.898 . . . . 0.0 109.376 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.496 ' O ' ' OE1' ' A' ' 80' ' ' GLN . 59.4 mt -55.09 -53.17 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.188 -0.945 . . . . 0.0 109.24 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.559 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -60.0 -36.57 77.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.134 179.784 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.1 m -69.2 -31.42 70.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.283 -0.886 . . . . 0.0 108.999 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 75' ' ' ALA . 55.1 t -64.83 -46.09 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.271 -0.893 . . . . 0.0 109.242 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLN . . . . . 0.552 ' OE1' ' N ' ' A' ' 80' ' ' GLN . 5.1 mp0 -60.97 -45.42 94.82 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.6 mt -53.27 -43.93 67.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.315 -0.866 . . . . 0.0 109.037 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.64 ' O ' ' N ' ' A' ' 86' ' ' ASN . 68.4 t0 -58.14 -58.23 9.37 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.396 -0.815 . . . . 0.0 109.145 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 82' ' ' ASP . 1.9 m-20 -44.73 -34.41 2.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.155 -0.966 . . . . 0.0 108.948 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -77.08 -30.94 55.69 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.299 -0.876 . . . . 0.0 108.98 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 82' ' ' ASP . 18.7 mt -121.56 32.39 5.91 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.315 -0.866 . . . . 0.0 109.486 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.64 ' N ' ' O ' ' A' ' 82' ' ' ASP . 60.8 t30 -81.08 28.28 0.37 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.207 -0.933 . . . . 0.0 109.097 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -110.45 -37.26 1.79 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -163.23 67.78 0.2 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.154 -1.204 . . . . 0.0 109.45 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.07 166.17 24.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.0 109.321 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.9 t -123.12 96.34 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.342 -0.849 . . . . 0.0 109.545 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.58 131.38 44.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.315 -0.865 . . . . 0.0 109.036 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.569 ' N ' ' CD2' ' A' ' 92' ' ' HIS . 1.6 p80 -150.55 157.36 42.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.006 -1.059 . . . . 0.0 110.037 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.71 121.34 40.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.407 -0.808 . . . . 0.0 109.666 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.447 ' N ' ' CD ' ' A' ' 94' ' ' GLU . 1.5 mp0 -104.69 120.93 42.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.296 -0.878 . . . . 0.0 109.407 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.556 HG12 ' N ' ' A' ' 96' ' ' GLN . 38.9 t -101.18 166.72 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.317 -0.865 . . . . 0.0 109.581 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLN . . . . . 0.556 ' N ' HG12 ' A' ' 95' ' ' VAL . 41.4 tt0 -76.17 140.87 41.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.493 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.424 ' O ' ' CG ' ' A' ' 98' ' ' PHE . . . 80.51 5.02 90.1 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.472 ' O ' ' O ' ' A' ' 99' ' ' GLU . 46.1 m-85 -157.64 22.42 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -1.126 . . . . 0.0 109.457 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' A' ' 98' ' ' PHE . 97.3 mt-10 -49.05 178.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.405 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.3 t -89.63 163.09 15.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.424 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.08 -26.73 67.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.404 -0.81 . . . . 0.0 109.433 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.447 HG21 ' NZ ' ' A' ' 45' ' ' LYS . 7.5 m -65.62 -41.72 92.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.485 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -75.26 -41.95 56.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.372 -0.83 . . . . 0.0 109.336 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.5 mt -62.46 -24.68 67.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.271 -0.893 . . . . 0.0 109.519 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -92.94 -24.02 23.87 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.11 -35.77 69.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.274 -1.133 . . . . 0.0 109.417 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -139.16 133.82 31.97 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.328 -0.858 . . . . 0.0 109.529 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -108.59 -55.45 2.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.436 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.4 t -105.56 15.36 27.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 109.532 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.45 -20.01 18.84 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.5 mt -72.61 70.66 0.94 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -1.18 . . . . 0.0 109.438 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -85.4 124.04 31.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.291 -0.881 . . . . 0.0 109.581 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -105.29 152.76 22.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.485 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.4 mttt -138.83 163.65 31.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.329 -0.857 . . . . 0.0 109.416 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.8 mttt . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.313 -0.867 . . . . 0.0 109.461 -179.949 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PRO . . . . . 0.586 ' HA ' HD23 ' A' ' 24' ' ' LEU . 54.0 Cg_exo . . . . . 0 N--CA 1.492 1.42 0 CA-C-O 121.262 0.443 . . . . 0.0 112.116 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.497 ' OE2' ' CH2' ' A' ' 17' ' ' TRP . 19.6 tt0 -83.23 -44.03 15.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 109.982 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.464 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 5.4 m-85 -49.35 -28.73 5.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.185 -0.947 . . . . 0.0 109.435 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.5 mt -74.78 -29.22 61.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 109.597 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.6 mmtm -123.76 26.38 7.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -0.911 . . . . 0.0 109.523 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 4' ' ' GLU . . . -81.35 173.3 12.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.354 -0.841 . . . . 0.0 109.568 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.32 44.8 0.17 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.92 30.54 3.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.381 -1.07 . . . . 0.0 109.497 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -164.14 117.17 1.01 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.173 -0.955 . . . . 0.0 109.367 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -77.67 89.47 1.33 Allowed 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.432 2.088 . . . . 0.0 112.088 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -177.98 -98.34 0.11 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -162.06 138.51 7.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -1.142 . . . . 0.0 109.638 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -114.99 135.89 53.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.435 -0.791 . . . . 0.0 108.974 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.62 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 13.1 mt -130.19 116.53 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.345 -0.847 . . . . 0.0 110.114 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TRP . . . . . 0.62 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 7.6 m0 -144.2 152.16 40.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.054 -1.029 . . . . 0.0 109.116 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.58 ' O ' ' N ' ' A' ' 25' ' ' VAL . 0.9 OUTLIER -101.84 153.29 19.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.93 . . . . 0.0 109.801 -179.283 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 23' ' ' ASP . 12.5 t -97.47 131.2 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.42 -0.8 . . . . 0.0 109.538 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.65 ' O ' ' N ' ' A' ' 22' ' ' PHE . 1.9 tm-20 -76.83 86.65 3.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.132 -0.98 . . . . 0.0 108.732 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.6 ' O ' ' CB ' ' A' ' 22' ' ' PHE . 25.2 mtmm 48.31 3.86 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.375 -0.828 . . . . 0.0 109.539 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.65 ' N ' ' O ' ' A' ' 20' ' ' GLU . 1.4 t80 155.59 -30.22 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.424 -0.797 . . . . 0.0 109.472 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.728 ' O ' HG13 ' A' ' 19' ' ' VAL . 1.7 t70 -81.62 -133.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.171 -0.956 . . . . 0.0 109.844 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.741 HD13 ' H ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -137.03 140.13 41.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -0.916 . . . . 0.0 109.607 -179.767 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.741 ' H ' HD13 ' A' ' 24' ' ' LEU . 9.4 t -137.79 91.6 13.47 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 108.999 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -52.42 159.35 4.56 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.654 2.236 . . . . 0.0 112.574 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.1 t -145.25 112.83 4.77 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.354 -0.841 . . . . 0.0 109.077 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 29' ' ' THR . 60.0 Cg_endo -77.88 168.14 22.66 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.44 2.093 . . . . 0.0 112.468 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -51.73 -174.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.389 -0.819 . . . . 0.0 109.361 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.573 ' N ' ' OG1' ' A' ' 29' ' ' THR . 14.9 t-20 69.17 -36.76 0.35 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.17 -0.956 . . . . 0.0 109.222 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.555 ' H ' ' C ' ' A' ' 29' ' ' THR . 14.4 mt -109.21 -36.36 6.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.442 -0.786 . . . . 0.0 109.198 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 31' ' ' LEU . 1.9 p90 -43.22 166.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.348 -0.845 . . . . 0.0 109.376 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.89 -12.88 15.38 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.3 158.81 18.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.212 -1.17 . . . . 0.0 109.481 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -144.99 108.42 4.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 109.56 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.474 ' C ' ' H ' ' A' ' 38' ' ' GLY . 2.8 m-85 -80.32 111.91 17.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 109.136 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.44 ' OG1' ' OE1' ' A' ' 65' ' ' GLU . 8.7 p -56.65 -4.97 0.18 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.185 -0.947 . . . . 0.0 109.618 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 36' ' ' PHE . . . -109.7 39.09 3.03 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.529 ' N ' ' SG ' ' A' ' 66' ' ' CYS . 8.2 m-20 -169.34 -176.38 2.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -1.173 . . . . 0.0 109.622 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.51 129.37 50.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.372 -0.83 . . . . 0.0 109.343 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -114.07 137.31 51.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 109.688 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.966 ' O ' HD13 ' A' ' 43' ' ' ILE . 0.4 OUTLIER -115.24 142.82 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.297 -0.877 . . . . 0.0 109.18 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.966 HD13 ' O ' ' A' ' 42' ' ' VAL . 0.7 OUTLIER -136.34 143.2 36.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.108 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.8 tt -128.05 118.97 24.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.484 -0.76 . . . . 0.0 109.238 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 50.2 tttt -88.85 138.74 31.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 109.426 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -141.64 114.37 8.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.93 . . . . 0.0 109.477 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.674 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -126.03 168.04 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 121.13 -0.981 . . . . 0.0 109.069 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -100.92 101.37 12.17 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.675 -0.641 . . . . 0.0 109.395 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.6 mt -57.04 163.86 1.87 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.933 . . . . 0.0 109.434 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.2 ptt85 -48.82 -47.65 42.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 0.0 109.308 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -70.65 -30.1 66.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.176 -0.952 . . . . 0.0 109.158 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.47 34.93 3.99 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.501 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.6 t-20 -89.97 13.39 14.85 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.183 -1.187 . . . . 0.0 109.325 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.674 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.4 mt 43.38 96.97 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.578 0.704 . . . . 0.0 109.456 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -71.17 116.16 11.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.551 -0.718 . . . . 0.0 109.581 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.54 ' CD1' ' O ' ' A' ' 54' ' ' LEU . 90.4 m-85 -100.7 114.7 28.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 0.0 109.858 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.428 ' HB3' ' HE2' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -120.7 155.16 34.48 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.064 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.449 ' C ' ' CG ' ' A' ' 59' ' ' HIS . 5.2 mp -132.62 147.79 52.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.967 -1.083 . . . . 0.0 110.466 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' HIS . . . . . 0.462 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 1.4 m-70 -150.34 127.17 11.03 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.628 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 1.1 p90 -115.18 132.69 56.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.045 -1.035 . . . . 0.0 109.941 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.458 ' CE3' ' O ' ' A' ' 62' ' ' LEU . 10.3 t90 -102.97 123.88 47.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.375 -0.828 . . . . 0.0 109.238 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.458 ' O ' ' CE3' ' A' ' 61' ' ' TRP . 22.7 mt -101.85 162.12 13.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 109.657 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.03 154.61 16.49 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -82.15 -12.09 58.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -1.128 . . . . 0.0 109.572 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.44 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 2.8 mt-10 -106.58 29.09 7.23 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 39' ' ' ASP . 1.6 m -130.64 97.55 4.4 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 122.15 0.976 . . . . 0.0 108.381 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 66' ' ' CYS . 9.9 m -39.03 161.57 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.707 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 72' ' ' GLY . 15.9 mm-40 -56.2 -17.41 7.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.389 -0.819 . . . . 0.0 109.661 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -63.98 -58.56 6.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 109.371 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.455 ' OE1' ' SG ' ' A' ' 66' ' ' CYS . 24.2 mt-10 -61.06 -54.26 46.95 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.345 -0.847 . . . . 0.0 108.987 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 p -64.13 -26.22 68.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.318 -0.864 . . . . 0.0 109.043 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.38 -41.77 66.75 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.14 -46.74 82.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -1.18 . . . . 0.0 109.28 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.12 -46.31 89.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.427 -0.795 . . . . 0.0 109.07 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.39 -41.53 80.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.345 -0.847 . . . . 0.0 109.26 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 51.0 mt -57.68 -46.24 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.278 -0.889 . . . . 0.0 109.279 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -59.03 -35.34 73.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 109.143 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.7 m -72.34 -25.55 61.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.183 -0.948 . . . . 0.0 109.038 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.4 t -72.77 -48.77 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.306 -0.871 . . . . 0.0 109.541 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -65.86 -35.94 82.07 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.141 -0.975 . . . . 0.0 108.85 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.85 -42.56 98.04 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.628 ' O ' ' N ' ' A' ' 86' ' ' ASN . 51.9 t0 -61.16 -57.35 12.85 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.315 -0.865 . . . . 0.0 109.214 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -48.43 -31.38 6.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.142 -0.974 . . . . 0.0 108.707 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -78.59 -31.12 47.06 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.423 -0.798 . . . . 0.0 108.882 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.484 ' C ' ' H ' ' A' ' 87' ' ' GLY . 9.9 mt -121.71 32.7 5.77 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.435 -0.79 . . . . 0.0 109.518 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASN . . . . . 0.628 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.8 OUTLIER -77.35 27.03 0.16 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.243 -0.91 . . . . 0.0 109.024 179.913 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.484 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -94.34 -48.41 2.6 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -152.21 45.61 0.74 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.168 -1.196 . . . . 0.0 109.638 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 56' ' ' TYR . . . -136.95 157.46 46.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.431 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 19.2 t -136.05 141.37 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 109.466 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.423 ' N ' ' CD ' ' A' ' 91' ' ' GLN . 6.8 mm-40 -88.95 142.47 27.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.212 -0.93 . . . . 0.0 109.37 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.492 ' O ' ' OE1' ' A' ' 94' ' ' GLU . 15.3 m-70 -118.29 115.24 24.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.268 -0.895 . . . . 0.0 109.461 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.84 104.92 15.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.233 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.589 ' OE2' ' CE2' ' A' ' 103' ' ' PHE . 1.5 mp0 -104.62 124.09 48.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.877 . . . . 0.0 109.65 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.1 t -125.76 155.56 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.312 -0.867 . . . . 0.0 109.17 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -55.54 115.98 2.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.19 -0.943 . . . . 0.0 109.624 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.519 ' O ' ' CD1' ' A' ' 98' ' ' PHE . . . 93.34 10.18 59.68 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 78.8 m-85 -152.94 25.37 0.56 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.179 -1.189 . . . . 0.0 109.669 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 2.1 mp0 -48.19 135.52 13.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.119 -0.988 . . . . 0.0 109.428 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.5 t -61.46 171.42 1.46 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.104 -0.998 . . . . 0.0 109.552 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.11 -65.06 0.82 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 109.593 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.0 m -50.55 -27.39 6.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 109.308 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PHE . . . . . 0.589 ' CE2' ' OE2' ' A' ' 94' ' ' GLU . 32.0 t80 -74.82 -55.59 5.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 0.0 109.799 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.439 ' C ' HD12 ' A' ' 104' ' ' LEU . 1.6 pp -67.18 -22.08 65.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.057 -1.027 . . . . 0.0 109.372 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.76 -33.12 34.86 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -78.4 -43.82 26.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -1.127 . . . . 0.0 109.422 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.465 ' HB2' HD21 ' A' ' 111' ' ' LEU . 51.8 m-85 -102.21 105.83 16.57 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.397 -0.814 . . . . 0.0 109.579 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -111.65 -49.85 2.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.358 -0.839 . . . . 0.0 109.513 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.0 t -106.04 23.16 14.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.094 -1.003 . . . . 0.0 109.514 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.575 ' O ' ' N ' ' A' ' 112' ' ' LYS . . . -125.18 -15.41 3.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.465 HD21 ' HB2' ' A' ' 107' ' ' PHE . 95.2 mt -62.13 70.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -1.176 . . . . 0.0 109.508 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.575 ' N ' ' O ' ' A' ' 110' ' ' GLY . 29.4 tttt -93.25 108.49 20.11 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.202 -0.936 . . . . 0.0 109.565 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.66 143.79 27.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.369 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -133.54 115.99 15.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 0.0 109.426 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.87 . . . . 0.0 109.47 179.969 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.481 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 1.6 p-80 -146.2 78.35 11.34 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.212 -0.93 . . . . 0.0 109.526 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -76.84 97.06 1.12 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.747 2.298 . . . . 0.0 111.946 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.574 ' O ' ' N ' ' A' ' 8' ' ' ALA . 16.7 mt-10 -83.34 -39.68 20.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 110.138 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.715 ' CE2' HG12 ' A' ' 42' ' ' VAL . 23.5 t80 -61.78 -46.81 87.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.133 -0.979 . . . . 0.0 109.866 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.579 ' H ' HD12 ' A' ' 6' ' ' LEU . 3.4 mp -71.84 -32.99 68.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.068 -1.02 . . . . 0.0 109.439 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.9 mmtm -94.78 0.88 55.3 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.257 -0.902 . . . . 0.0 109.459 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 4' ' ' GLU . . . -52.1 153.74 2.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 109.424 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 137.52 68.42 0.05 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -144.66 8.14 1.3 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.24 -1.153 . . . . 0.0 109.567 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -166.61 126.76 1.19 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 109.243 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.85 94.56 1.0 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.405 2.07 . . . . 0.0 112.213 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -174.18 -104.18 0.17 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.6 tp -156.01 134.42 11.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.366 -1.079 . . . . 0.0 109.764 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -126.55 131.93 51.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.866 . . . . 0.0 109.357 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.6 mt -108.0 137.1 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -0.799 . . . . 0.0 109.758 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -139.5 166.19 25.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.261 -0.899 . . . . 0.0 109.063 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -144.96 142.16 29.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.126 -0.984 . . . . 0.0 109.725 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 19' ' ' VAL . 7.6 p -79.76 127.95 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.292 -0.88 . . . . 0.0 109.566 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.529 ' CB ' HG21 ' A' ' 25' ' ' VAL . 2.6 mm-40 -164.18 134.47 4.16 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.298 -0.876 . . . . 0.0 109.267 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 29.4 tttm 75.99 41.62 0.23 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.369 -0.832 . . . . 0.0 109.56 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 48.33 43.62 19.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.173 -0.954 . . . . 0.0 109.444 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.481 ' OD2' ' CE1' ' A' ' 2' ' ' HIS . 26.3 t0 -173.33 -172.05 0.76 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.896 . . . . 0.0 109.459 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.549 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.9 mm? -88.49 138.15 31.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.529 HG21 ' CB ' ' A' ' 20' ' ' GLU . 5.0 t -138.83 128.36 14.45 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.219 -0.926 . . . . 0.0 109.253 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -74.95 166.36 29.39 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.36 2.04 . . . . 0.0 112.355 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.6 t -111.12 101.3 49.86 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.367 -0.833 . . . . 0.0 109.404 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -53.27 168.08 0.67 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.533 2.155 . . . . 0.0 112.363 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.559 HG22 ' N ' ' A' ' 30' ' ' ASN . 24.5 m -60.16 170.56 1.23 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.342 -0.849 . . . . 0.0 109.032 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.559 ' N ' HG22 ' A' ' 29' ' ' THR . 0.9 OUTLIER 69.69 -40.91 0.47 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.205 -0.934 . . . . 0.0 109.195 -179.726 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.502 ' H ' ' C ' ' A' ' 29' ' ' THR . 96.0 mt -81.79 -44.22 17.27 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.376 -0.828 . . . . 0.0 109.209 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 33' ' ' GLY . 0.3 OUTLIER -53.42 138.33 33.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.359 -0.838 . . . . 0.0 109.138 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.498 ' N ' ' CD1' ' A' ' 32' ' ' TYR . . . 109.43 -8.99 32.86 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -121.81 115.5 22.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.351 -1.088 . . . . 0.0 109.375 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -87.86 140.07 29.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 109.589 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -102.17 146.19 28.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.334 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 p -92.42 -8.93 43.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 109.468 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.434 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -107.94 35.79 4.78 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 9.7 m-20 -167.57 171.98 9.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.333 -1.098 . . . . 0.0 109.497 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.94 141.2 48.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 109.546 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -116.24 134.75 54.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.392 -0.817 . . . . 0.0 109.472 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.034 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -114.13 124.47 70.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.21 -0.931 . . . . 0.0 108.603 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.034 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -121.33 133.8 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.174 -0.954 . . . . 0.0 110.03 -178.417 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.0 tt -122.68 121.65 36.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.504 -0.747 . . . . 0.0 109.906 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -96.56 141.87 29.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.371 -0.831 . . . . 0.0 108.954 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.529 ' O ' ' N ' ' A' ' 13' ' ' GLY . 29.1 m -137.17 128.05 27.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.037 -1.039 . . . . 0.0 109.72 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -132.68 168.72 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 O-C-N 121.223 -0.923 . . . . 0.0 109.231 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -102.82 103.57 13.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.574 -0.704 . . . . 0.0 109.464 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.8 mt -72.7 169.01 17.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.282 -0.886 . . . . 0.0 109.711 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.42 ' C ' ' N ' ' A' ' 52' ' ' GLY . 14.7 mtt180 -45.52 -72.83 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.265 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 50' ' ' ARG . 19.4 t-20 -44.97 -24.18 0.2 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 109.255 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' A' ' 50' ' ' ARG . . . 84.62 32.96 20.57 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.488 ' O ' ' O ' ' A' ' 54' ' ' LEU . 3.5 m-20 -86.58 14.26 7.19 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.165 -1.197 . . . . 0.0 109.205 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.59 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 12.6 mt 47.15 100.27 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.544 0.688 . . . . 0.0 109.608 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.597 ' NE2' ' H ' ' A' ' 56' ' ' TYR . 3.2 tm0? -68.57 145.35 54.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.573 -0.704 . . . . 0.0 109.129 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.597 ' H ' ' NE2' ' A' ' 55' ' ' GLN . 91.3 m-85 -129.77 114.67 16.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.923 . . . . 0.0 109.925 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.413 ' OD1' ' OE1' ' A' ' 55' ' ' GLN . 70.7 m-20 -123.93 155.48 38.06 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -150.35 142.76 24.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.683 -1.261 . . . . 0.0 110.983 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.418 ' ND1' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -120.71 133.91 55.32 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.277 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.649 ' CZ ' HD22 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -105.14 115.38 30.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.361 -0.837 . . . . 0.0 109.366 -179.653 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.539 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 36.0 t90 -106.9 135.38 48.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.212 -0.93 . . . . 0.0 109.939 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.649 HD22 ' CZ ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -124.27 162.18 24.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.379 -0.826 . . . . 0.0 109.501 179.627 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -96.31 161.77 22.45 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -82.11 -11.88 58.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.277 -1.131 . . . . 0.0 109.614 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -104.26 30.83 4.99 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.516 ' SG ' ' CD ' ' A' ' 70' ' ' GLU . 1.2 m -130.73 97.53 4.38 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.162 0.982 . . . . 0.0 108.433 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 66' ' ' CYS . 1.5 m -47.09 178.05 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.694 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.497 ' O ' ' N ' ' A' ' 72' ' ' GLY . 10.0 mp0 -61.22 -18.07 56.45 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.235 -0.915 . . . . 0.0 109.534 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -64.42 -58.78 5.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 0.0 109.359 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.516 ' CD ' ' SG ' ' A' ' 66' ' ' CYS . 25.5 mt-10 -66.02 -44.5 84.54 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 108.824 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.85 -25.69 66.54 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.523 -0.736 . . . . 0.0 109.03 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.07 -47.01 48.26 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.74 91.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.271 -1.135 . . . . 0.0 109.193 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.404 ' HB1' ' CE1' ' A' ' 60' ' ' TYR . . . -61.32 -49.47 76.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.401 -0.812 . . . . 0.0 109.195 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.577 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -62.75 -34.73 77.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.273 -0.892 . . . . 0.0 109.537 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.2 mt -57.26 -54.63 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.934 . . . . 0.0 109.418 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -60.51 -33.47 72.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.108 -0.995 . . . . 0.0 109.47 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 m -69.72 -40.18 76.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.244 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 75' ' ' ALA . 81.0 t -61.81 -42.12 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.417 -0.802 . . . . 0.0 109.319 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 12.1 mm100 -60.31 -51.32 70.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.009 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.6 mt -49.29 -43.1 43.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 108.951 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' A' ' 86' ' ' ASN . 19.6 t0 -57.02 -60.32 3.77 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.222 -0.924 . . . . 0.0 109.389 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.467 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 30.7 t0 -45.0 -35.86 3.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.145 -0.972 . . . . 0.0 108.88 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.505 ' CE1' HD21 ' A' ' 85' ' ' LEU . 18.1 t80 -75.89 -28.87 58.27 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.563 ' C ' ' H ' ' A' ' 87' ' ' GLY . 47.8 mt -121.49 33.46 5.52 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.432 -0.792 . . . . 0.0 109.424 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.605 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.4 OUTLIER -73.13 25.62 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 109.052 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -84.4 -58.24 2.21 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.98 35.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -1.122 . . . . 0.0 109.545 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.589 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -78.55 179.28 7.18 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.26 -0.9 . . . . 0.0 109.269 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.9 t -114.4 91.48 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.17 -0.956 . . . . 0.0 109.37 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.454 ' O ' ' CD ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -96.93 125.45 41.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.336 -0.852 . . . . 0.0 109.206 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.482 ' N ' ' CD2' ' A' ' 92' ' ' HIS . 1.8 p80 -151.48 118.68 5.93 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.036 -1.04 . . . . 0.0 109.513 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 8.5 ptt-85 -91.71 134.63 34.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.382 -0.824 . . . . 0.0 109.792 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -112.89 155.98 23.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.424 -0.797 . . . . 0.0 109.566 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.498 HG12 ' H ' ' A' ' 96' ' ' GLN . 3.7 t -121.41 169.51 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.335 -0.853 . . . . 0.0 109.486 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.498 ' H ' HG12 ' A' ' 95' ' ' VAL . 14.1 tt0 -78.31 129.35 34.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 109.425 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.4 5.21 79.61 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.48 ' O ' ' O ' ' A' ' 99' ' ' GLU . 20.2 m-85 -146.06 19.51 1.42 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -1.152 . . . . 0.0 109.463 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.48 ' O ' ' O ' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -51.68 -173.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 109.403 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.0 t -137.89 175.77 9.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 109.524 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.53 -34.53 72.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.924 . . . . 0.0 109.424 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.5 m -53.57 -47.01 70.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.53 -56.81 7.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.319 -0.863 . . . . 0.0 109.328 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.6 mt -56.36 -24.23 42.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.25 -0.906 . . . . 0.0 109.509 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.1 -30.03 26.69 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -71.01 -30.26 66.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.184 -1.186 . . . . 0.0 109.273 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -139.14 103.57 4.8 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.28 -0.888 . . . . 0.0 109.451 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -102.86 -2.72 27.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.173 -0.954 . . . . 0.0 109.52 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.5 p -66.47 -16.12 63.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.187 -0.946 . . . . 0.0 109.486 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.89 88.78 2.07 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.685 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -70.1 135.44 49.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.236 -1.155 . . . . 0.0 109.379 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -90.18 142.23 27.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.331 -0.856 . . . . 0.0 109.582 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.443 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 20.4 m-85 -106.23 111.78 24.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 109.442 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -94.12 145.23 24.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 109.43 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm -138.28 137.67 37.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.356 -0.84 . . . . 0.0 109.52 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.4 115.01 0.07 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -100.25 74.65 0.44 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.5 t -60.82 89.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -1.139 . . . . 0.0 109.507 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -176.47 117.18 0.12 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 0.0 109.439 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.6 m -90.13 21.16 3.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.454 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.83 90.25 0.4 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -174.8 124.75 0.27 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.191 -1.182 . . . . 0.0 109.491 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.0 pttm -131.93 154.96 48.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.351 -0.843 . . . . 0.0 109.425 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -97.61 125.38 42.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.299 -0.875 . . . . 0.0 109.492 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 64.2 t -64.59 125.56 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.894 . . . . 0.0 109.412 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 126' ' ' VAL . 0.3 OUTLIER -95.61 153.89 39.34 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.948 . . . . 0.0 109.465 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 128' ' ' ASN . 41.5 Cg_endo -70.89 97.36 0.73 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.673 2.249 . . . . 0.0 112.142 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 127' ' ' PRO . 29.2 m-20 43.04 -164.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.257 -0.902 . . . . 0.0 109.512 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.433 ' H ' ' CD ' ' A' ' 129' ' ' GLU . 35.1 mp0 -77.22 163.76 26.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.376 -0.828 . . . . 0.0 109.48 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.603 ' O ' HG12 ' A' ' 130' ' ' VAL . 39.1 t -74.59 13.31 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.145 -0.972 . . . . 0.0 109.434 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.422 ' C ' ' O ' ' A' ' 130' ' ' VAL . 2.2 p -43.66 -42.08 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.203 -0.935 . . . . 0.0 109.439 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 37.1 t -73.52 142.93 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -0.948 . . . . 0.0 109.341 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 38.4 tp60 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.448 179.964 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.492 ' O ' ' CG ' ' A' ' 2' ' ' HIS . 16.5 tm-20 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.492 ' CG ' ' O ' ' A' ' 1' ' ' GLU . 9.1 m80 -163.74 58.92 0.73 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.251 -0.906 . . . . 0.0 109.495 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -71.33 71.84 2.32 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.845 2.363 . . . . 0.0 112.174 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 8' ' ' ALA . 13.5 mm-40 -83.34 -46.04 13.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 109.872 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.616 ' CE1' ' O ' ' A' ' 42' ' ' VAL . 2.8 m-85 -67.17 -35.32 79.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.312 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.51 ' H ' HD12 ' A' ' 6' ' ' LEU . 4.2 mp -64.97 -35.23 80.52 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.293 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 8' ' ' ALA . 10.5 mttp -103.86 2.4 32.6 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.354 -0.842 . . . . 0.0 109.472 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.621 ' HB1' ' OE1' ' A' ' 15' ' ' GLN . . . -46.81 175.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.91 . . . . 0.0 109.533 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.67 10.47 21.31 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.75 6.06 9.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.27 -1.135 . . . . 0.0 109.496 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -173.28 132.89 0.62 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.926 . . . . 0.0 109.468 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.65 90.8 1.02 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.482 2.122 . . . . 0.0 112.2 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -164.33 -107.73 0.21 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 51.6 tp -157.83 142.24 16.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.295 -1.121 . . . . 0.0 109.67 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.621 ' OE1' ' HB1' ' A' ' 8' ' ' ALA . 4.0 mt-30 -126.58 136.45 52.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.422 -0.799 . . . . 0.0 109.296 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.557 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 7.1 mt -133.01 113.77 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.387 -0.821 . . . . 0.0 109.875 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.557 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 8.3 m0 -139.77 151.41 45.77 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.073 -1.017 . . . . 0.0 109.378 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.434 ' HB2' HH21 ' A' ' 18' ' ' ARG . 18.1 ttp-105 -99.17 153.11 19.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.851 . . . . 0.0 109.564 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.8 p -89.29 135.68 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.263 -0.898 . . . . 0.0 109.577 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.6 ' O ' ' N ' ' A' ' 22' ' ' PHE . 17.3 tt0 -86.93 151.03 23.66 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.169 -0.957 . . . . 0.0 109.131 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.475 ' O ' ' CD2' ' A' ' 22' ' ' PHE . 3.5 pttm -41.35 -19.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.354 -0.842 . . . . 0.0 109.515 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.6 ' N ' ' O ' ' A' ' 20' ' ' GLU . 26.2 m-85 -161.22 35.38 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.953 . . . . 0.0 109.471 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -174.65 -131.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.178 -0.951 . . . . 0.0 109.572 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.7 tp -143.33 146.23 33.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 109.526 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 t -131.09 95.07 26.04 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.463 -0.773 . . . . 0.0 109.402 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -48.18 147.78 7.91 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.58 2.187 . . . . 0.0 112.176 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.7 t -110.72 101.59 49.72 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.32 -0.862 . . . . 0.0 109.579 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -52.89 163.14 2.17 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.536 2.158 . . . . 0.0 112.402 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.601 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -64.55 175.99 1.24 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.267 -0.896 . . . . 0.0 109.042 179.641 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.452 ' N ' ' OG1' ' A' ' 29' ' ' THR . 0.8 OUTLIER 64.54 -39.26 0.24 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.411 -0.806 . . . . 0.0 109.386 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.601 ' N ' ' O ' ' A' ' 29' ' ' THR . 21.0 mt -83.77 -42.63 16.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.21 -0.931 . . . . 0.0 109.277 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.411 ' C ' ' O ' ' A' ' 31' ' ' LEU . 4.1 p90 -42.66 140.35 1.32 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.36 -0.838 . . . . 0.0 109.448 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.33 -26.35 8.22 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -94.84 154.62 17.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.337 -1.096 . . . . 0.0 109.374 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -141.34 125.64 17.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 109.56 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.549 ' C ' ' H ' ' A' ' 38' ' ' GLY . 36.2 m-85 -84.54 115.97 22.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.932 . . . . 0.0 109.372 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.408 ' H ' HG23 ' A' ' 37' ' ' THR . 1.5 p -52.95 -4.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.516 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 36' ' ' PHE . . . -111.06 32.27 6.64 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.442 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 30.6 m-20 -160.16 -173.46 4.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -1.159 . . . . 0.0 109.544 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.88 142.25 46.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.337 -0.852 . . . . 0.0 109.511 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.507 ' OH ' ' CD2' ' A' ' 36' ' ' PHE . 35.1 m-85 -121.45 138.53 54.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.331 -0.856 . . . . 0.0 109.699 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.988 ' C ' HD13 ' A' ' 43' ' ' ILE . 1.1 t -118.1 134.44 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.394 -0.816 . . . . 0.0 109.084 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.988 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -129.99 148.08 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.846 . . . . 0.0 110.206 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.484 ' CD2' ' OG1' ' A' ' 46' ' ' THR . 7.8 tt -139.33 115.87 10.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.471 -0.768 . . . . 0.0 109.597 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -93.87 120.86 34.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.435 -0.791 . . . . 0.0 109.371 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.602 ' O ' ' N ' ' A' ' 13' ' ' GLY . 2.0 m -120.6 127.56 52.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.276 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 1.4 t -134.29 168.82 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.163 -0.96 . . . . 0.0 109.394 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -105.5 115.63 30.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.709 -0.619 . . . . 0.0 109.44 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.579 HD21 ' OE1' ' A' ' 55' ' ' GLN . 86.5 mt -97.71 169.43 9.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 109.436 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.589 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -38.37 151.04 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.326 -0.859 . . . . 0.0 109.368 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 34.0 t30 68.04 -32.22 0.2 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.16 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.589 ' H ' ' C ' ' A' ' 50' ' ' ARG . . . 95.55 54.34 1.45 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 54' ' ' LEU . 16.3 t30 -88.05 6.25 37.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.21 -1.171 . . . . 0.0 109.197 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.665 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 14.5 mt 38.39 95.04 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.608 0.718 . . . . 0.0 109.658 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.579 ' OE1' HD21 ' A' ' 49' ' ' LEU . 12.2 pt20 -70.0 149.17 48.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 109.065 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.497 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 38.1 m-85 -129.78 114.97 16.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.44 -0.788 . . . . 0.0 110.01 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -124.28 155.26 38.95 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.062 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 pp -151.22 150.07 30.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.822 -1.174 . . . . 0.0 110.713 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -127.46 133.88 49.88 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.62 ' CE2' HD22 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -108.69 115.92 31.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.402 -0.811 . . . . 0.0 109.208 -179.651 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.59 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 17.4 t90 -109.31 133.49 52.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 109.988 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.62 HD22 ' CE2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -127.48 162.15 27.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.397 -0.814 . . . . 0.0 109.292 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.68 153.73 21.38 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -82.23 -11.78 58.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.24 -1.153 . . . . 0.0 109.529 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.11 35.15 3.25 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.683 ' SG ' ' O ' ' A' ' 66' ' ' CYS . 15.9 p -130.09 98.12 4.66 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 122.471 1.129 . . . . 0.0 108.891 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 66' ' ' CYS . 18.4 m -37.0 159.28 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.045 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.553 ' O ' ' N ' ' A' ' 72' ' ' GLY . 39.4 mt-30 -52.11 -17.8 1.21 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.41 -0.806 . . . . 0.0 109.662 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -62.37 -58.56 7.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 0.0 109.386 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.68 -49.4 73.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.361 -0.837 . . . . 0.0 108.854 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.29 -22.55 66.3 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.303 -0.873 . . . . 0.0 108.947 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -73.11 -43.9 37.95 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.94 -44.84 91.64 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.216 -1.167 . . . . 0.0 109.231 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.14 -43.69 98.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.367 -0.833 . . . . 0.0 109.053 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.478 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -58.28 -44.91 88.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.254 -0.904 . . . . 0.0 109.046 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.9 mt -54.14 -50.84 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.391 -0.818 . . . . 0.0 109.074 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -53.79 -38.26 64.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.853 . . . . 0.0 109.122 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.2 m -68.97 -48.92 61.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.407 -0.808 . . . . 0.0 108.978 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 75' ' ' ALA . 42.2 t -57.63 -33.35 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.311 -0.868 . . . . 0.0 109.018 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -42.2 81.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.358 -0.838 . . . . 0.0 108.929 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.77 -42.89 80.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 0.0 108.96 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 85' ' ' LEU . 5.9 t0 -62.54 -56.94 13.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.105 -0.997 . . . . 0.0 108.904 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -47.3 -31.14 3.59 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.171 -0.956 . . . . 0.0 108.607 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -74.0 -30.92 62.72 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.315 -0.866 . . . . 0.0 108.7 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 82' ' ' ASP . 78.3 mt -105.73 24.38 12.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.24 -0.913 . . . . 0.0 109.302 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.458 ' C ' ' O ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER 39.75 33.44 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.437 -0.789 . . . . 0.0 109.463 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.82 73.68 0.59 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 81.9 mtm-85 -143.01 35.05 1.37 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.149 -1.207 . . . . 0.0 109.346 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.497 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -144.02 178.66 7.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -0.88 . . . . 0.0 109.381 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.33 112.82 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.693 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -93.94 121.69 35.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.306 -0.871 . . . . 0.0 109.209 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -107.16 104.95 14.72 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -0.946 . . . . 0.0 109.695 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.4 mtm105 -75.53 97.36 3.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 0.0 109.073 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.616 ' CD ' ' H ' ' A' ' 100' ' ' SER . 18.0 mm-40 -96.6 137.28 35.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.272 -0.893 . . . . 0.0 109.943 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.6 t -132.85 157.56 43.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.334 -0.854 . . . . 0.0 109.17 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.466 ' C ' ' OE1' ' A' ' 96' ' ' GLN . 1.0 OUTLIER -62.21 117.3 5.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.071 -1.018 . . . . 0.0 109.398 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.74 13.52 69.64 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.83 24.0 0.76 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.146 -1.208 . . . . 0.0 109.625 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.634 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 0.9 OUTLIER -52.64 137.85 29.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 0.0 109.423 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.616 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 28.7 t -64.79 165.49 10.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.294 -0.879 . . . . 0.0 109.634 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.3 -58.13 4.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.915 . . . . 0.0 109.517 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.2 m -46.89 -32.11 3.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 109.429 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.689 ' CE1' ' CE1' ' A' ' 107' ' ' PHE . 23.9 t80 -73.16 -43.3 61.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.366 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.2 mt -69.27 -19.68 63.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.166 -0.959 . . . . 0.0 109.504 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -102.71 -24.98 7.86 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -82.14 -36.18 27.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.177 -1.19 . . . . 0.0 109.525 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.689 ' CE1' ' CE1' ' A' ' 103' ' ' PHE . 49.1 m-85 -89.71 81.43 6.42 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.251 -0.906 . . . . 0.0 109.524 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.9 mttt -77.57 -5.43 50.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.4 t -63.96 -7.34 8.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.117 -0.99 . . . . 0.0 109.48 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.43 82.97 0.74 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.74 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -67.84 158.06 33.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -1.116 . . . . 0.0 109.379 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -158.38 135.06 9.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.242 -0.911 . . . . 0.0 109.437 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -95.2 153.19 17.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.899 . . . . 0.0 109.261 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.9 tttm -133.62 112.75 11.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.247 -0.908 . . . . 0.0 109.423 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -76.87 147.34 37.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.187 -0.946 . . . . 0.0 109.367 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -56.08 115.03 5.59 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.09 56.6 4.35 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.7 m -55.68 -17.22 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.348 -1.09 . . . . 0.0 109.515 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -44.94 -67.24 0.3 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 109.478 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.2 p 63.13 -172.47 0.16 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.193 -0.942 . . . . 0.0 109.53 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 143.92 -37.02 1.46 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.509 ' O ' ' CG ' ' A' ' 122' ' ' PHE . 37.6 p90 -153.64 121.97 6.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -1.123 . . . . 0.0 109.462 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -169.16 8.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.456 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.422 ' O ' ' CG ' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -157.31 41.92 0.32 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 109.54 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -79.7 68.19 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.298 -0.876 . . . . 0.0 109.464 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.8 t -143.59 65.02 14.18 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.168 -0.958 . . . . 0.0 109.585 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -73.81 179.5 5.6 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.757 2.304 . . . . 0.0 112.094 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -76.74 138.93 40.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.442 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -76.83 -171.91 2.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.858 . . . . 0.0 109.404 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.7 t -63.09 146.58 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.301 -0.874 . . . . 0.0 109.408 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.649 HG13 ' O ' ' A' ' 131' ' ' VAL . 7.1 p -59.44 99.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.0 109.572 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 67.1 t -82.49 116.51 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.226 -0.921 . . . . 0.0 109.5 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.469 -179.997 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.56 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 10.7 tt0 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.493 ' CB ' ' O ' ' A' ' 1' ' ' GLU . 5.4 t60 75.15 60.66 0.27 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.881 . . . . 0.0 109.554 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.18 74.37 2.5 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.773 2.316 . . . . 0.0 111.988 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.555 ' O ' ' N ' ' A' ' 6' ' ' LEU . 6.4 mt-10 -83.15 -31.67 27.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 109.72 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.686 ' CE1' HG12 ' A' ' 42' ' ' VAL . 13.7 t80 -50.08 -7.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.114 -0.991 . . . . 0.0 109.435 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.555 ' N ' ' O ' ' A' ' 4' ' ' GLU . 13.1 mt -85.79 -26.83 25.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.88 . . . . 0.0 109.506 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.2 pttm -130.94 13.03 5.25 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.39 -0.819 . . . . 0.0 109.566 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.507 ' HB3' HD13 ' A' ' 44' ' ' LEU . . . -50.93 153.04 1.93 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.175 -0.953 . . . . 0.0 109.477 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.86 50.66 0.02 OUTLIER Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -150.15 31.36 0.68 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.127 -1.219 . . . . 0.0 109.649 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 13' ' ' GLY . 26.7 mt-10 -147.62 83.26 7.65 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.911 . . . . 0.0 109.394 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.83 80.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.693 2.262 . . . . 0.0 112.398 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 11' ' ' GLU . . . 177.36 -100.18 0.14 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.1 tp -159.37 119.94 3.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.33 -1.1 . . . . 0.0 109.537 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.479 ' OE1' ' OE2' ' A' ' 11' ' ' GLU . 19.0 mt-30 -108.22 127.67 54.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.866 . . . . 0.0 109.366 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.549 HG23 HD12 ' A' ' 43' ' ' ILE . 53.0 mt -101.1 144.88 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.312 -0.868 . . . . 0.0 110.042 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -142.85 159.49 42.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.357 -0.84 . . . . 0.0 108.835 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -127.15 143.68 51.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.139 -0.975 . . . . 0.0 109.729 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.54 146.09 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.53 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.6 ' O ' ' N ' ' A' ' 22' ' ' PHE . 44.4 tt0 -92.76 154.32 18.37 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.197 -0.939 . . . . 0.0 109.222 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -44.9 -13.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.314 -0.866 . . . . 0.0 109.496 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.6 ' N ' ' O ' ' A' ' 20' ' ' GLU . 74.3 t80 -162.94 28.16 0.1 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.673 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.666 ' O ' HD22 ' A' ' 24' ' ' LEU . 8.4 t70 -175.29 -136.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.172 -0.955 . . . . 0.0 109.616 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.666 HD22 ' O ' ' A' ' 23' ' ' ASP . 1.7 mm? -126.76 146.11 50.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.38 -0.825 . . . . 0.0 109.259 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.495 HG23 ' HB2' ' A' ' 20' ' ' GLU . 2.1 t -141.63 130.23 12.19 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 109.017 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.44 174.64 11.82 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.348 2.032 . . . . 0.0 112.313 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.8 t -139.85 121.45 9.71 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.887 . . . . 0.0 109.246 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.76 157.79 35.36 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.296 1.997 . . . . 0.0 112.301 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.64 -11.77 55.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.16 -0.962 . . . . 0.0 109.358 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -74.28 -10.91 60.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 109.387 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 32' ' ' TYR . 91.8 mt -126.56 -20.48 4.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.356 -0.84 . . . . 0.0 109.471 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.51 ' CE2' ' CD1' ' A' ' 16' ' ' ILE . 11.1 t80 -43.16 131.02 4.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.353 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.67 -14.16 8.12 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -101.61 148.18 25.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.193 -1.181 . . . . 0.0 109.627 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -142.09 116.63 9.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.376 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -94.24 125.19 38.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.923 . . . . 0.0 109.501 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.5 p -68.33 -4.84 15.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.171 -0.956 . . . . 0.0 109.301 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.454 ' O ' ' OD2' ' A' ' 39' ' ' ASP . . . -107.51 36.18 4.55 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.454 ' OD2' ' O ' ' A' ' 38' ' ' GLY . 2.1 m-20 -159.93 156.63 27.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.265 -1.138 . . . . 0.0 109.424 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.63 134.03 48.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.365 -0.834 . . . . 0.0 109.514 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.51 ' HB3' HD11 ' A' ' 43' ' ' ILE . 3.0 m-85 -113.43 134.95 54.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.42 -0.8 . . . . 0.0 109.188 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.015 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -111.24 126.12 68.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 O-C-N 121.217 -0.927 . . . . 0.0 108.892 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.015 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -126.2 134.55 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.197 -0.94 . . . . 0.0 110.417 -179.308 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.727 HD23 ' C ' ' A' ' 44' ' ' LEU . 6.9 tt -117.42 115.4 25.13 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -89.95 144.48 25.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 109.786 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.576 HG22 HD22 ' A' ' 54' ' ' LEU . 38.4 m -143.4 117.68 9.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 109.083 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -128.54 168.37 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.142 -0.974 . . . . 0.0 109.234 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -96.32 126.91 41.85 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.545 -0.722 . . . . 0.0 109.451 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.469 HD21 ' OE1' ' A' ' 55' ' ' GLN . 79.2 mt -91.06 166.77 12.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 0.0 109.495 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 49' ' ' LEU . 2.3 mtt-85 -44.67 -57.99 3.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.089 -1.007 . . . . 0.0 109.231 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -66.38 -20.51 66.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.295 -0.878 . . . . 0.0 109.188 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . 89.62 37.34 6.99 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.508 ' O ' ' O ' ' A' ' 54' ' ' LEU . 10.7 m-80 -88.62 14.37 10.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.118 -1.225 . . . . 0.0 109.403 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.642 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.7 mt 44.79 98.44 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.621 0.724 . . . . 0.0 109.418 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.469 ' OE1' HD21 ' A' ' 49' ' ' LEU . 40.3 tt0 -73.9 110.23 8.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.39 -0.819 . . . . 0.0 109.697 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.512 ' CD2' ' O ' ' A' ' 54' ' ' LEU . 85.3 m-85 -95.91 114.3 26.0 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.186 -0.946 . . . . 0.0 109.546 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.28 155.35 24.2 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.694 HD11 HD11 ' A' ' 81' ' ' LEU . 10.6 mt -129.84 133.38 46.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.171 -0.956 . . . . 0.0 109.776 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.693 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.1 OUTLIER -133.43 115.11 14.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.396 -0.815 . . . . 0.0 109.075 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.725 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -99.95 120.58 40.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.258 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 4.4 t90 -93.26 127.03 38.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.892 . . . . 0.0 109.539 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 mt -106.12 161.65 14.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.261 -0.899 . . . . 0.0 109.396 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -109.55 150.9 17.33 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.23 -12.26 61.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -1.182 . . . . 0.0 109.461 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -108.86 26.63 10.35 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.538 ' SG ' ' OE2' ' A' ' 70' ' ' GLU . 5.4 m -130.59 97.44 4.37 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.021 0.915 . . . . 0.0 108.545 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 m -60.46 -170.91 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.782 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.49 ' O ' ' N ' ' A' ' 72' ' ' GLY . 7.8 mp0 -65.38 -17.8 64.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 0.0 109.696 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.03 -58.84 5.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.112 -0.992 . . . . 0.0 109.481 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.538 ' OE2' ' SG ' ' A' ' 66' ' ' CYS . 22.8 mt-10 -64.07 -46.25 85.18 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.261 -0.899 . . . . 0.0 109.092 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 m -65.54 -26.81 68.05 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.347 -0.846 . . . . 0.0 108.826 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -65.87 -45.86 85.71 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.86 -48.98 74.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -1.157 . . . . 0.0 109.261 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.67 -39.82 92.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.179 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.454 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -65.84 -46.27 79.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.364 -0.835 . . . . 0.0 109.316 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.6 mt -51.47 -49.22 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.134 -0.979 . . . . 0.0 109.294 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -62.29 -35.25 78.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 109.325 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.3 m -69.53 -36.42 76.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.372 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 75' ' ' ALA . 63.8 t -68.14 -42.33 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.517 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -62.49 -60.59 3.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 0.0 109.26 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.728 ' C ' HD12 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -52.57 -29.18 24.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.215 -0.928 . . . . 0.0 108.835 179.688 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.626 ' O ' ' N ' ' A' ' 86' ' ' ASN . 55.2 t0 -67.47 -57.68 6.09 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.239 -0.913 . . . . 0.0 108.815 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.469 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 88.1 m-20 -45.25 -36.14 3.79 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.201 -0.937 . . . . 0.0 108.579 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.517 ' CD1' ' O ' ' A' ' 84' ' ' TYR . 1.8 t80 -73.66 -31.57 63.55 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 82' ' ' ASP . 96.2 mt -121.65 34.44 5.18 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.461 -0.774 . . . . 0.0 109.419 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.626 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.4 OUTLIER -82.82 27.81 0.52 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.207 -0.933 . . . . 0.0 109.371 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.77 -51.15 54.22 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -175.94 34.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.181 -1.188 . . . . 0.0 109.377 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.11 179.02 7.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -0.947 . . . . 0.0 109.529 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 78.9 t -130.39 102.98 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.313 -0.867 . . . . 0.0 109.505 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.66 ' H ' ' CD ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -97.04 134.83 39.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 109.145 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.601 ' NE2' ' ND1' ' A' ' 59' ' ' HIS . 3.7 p80 -144.35 161.14 39.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.121 -0.987 . . . . 0.0 109.756 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -103.38 121.7 43.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.464 -0.772 . . . . 0.0 109.585 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.561 ' OE2' ' CD2' ' A' ' 103' ' ' PHE . 42.5 mt-10 -102.32 150.58 23.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.357 -0.84 . . . . 0.0 109.164 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.6 t -140.75 161.93 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.113 -0.992 . . . . 0.0 109.567 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -60.84 134.42 57.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 109.597 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.11 -26.23 5.04 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.547 ' CD1' ' O ' ' A' ' 98' ' ' PHE . 71.5 t80 -108.02 10.4 28.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -1.115 . . . . 0.0 109.442 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 98' ' ' PHE . 80.5 mt-10 -43.05 123.61 2.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.875 . . . . 0.0 109.508 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.1 p -55.57 179.69 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.334 -0.854 . . . . 0.0 109.501 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.1 -41.31 82.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.344 -0.847 . . . . 0.0 109.501 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.7 m -48.68 -57.58 6.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.307 -0.87 . . . . 0.0 109.529 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.561 ' CD2' ' OE2' ' A' ' 94' ' ' GLU . 5.9 m-85 -59.18 -53.57 56.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.412 -0.805 . . . . 0.0 109.56 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.58 ' O ' ' CD1' ' A' ' 107' ' ' PHE . 25.7 mt -54.36 -14.66 1.27 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.227 -0.921 . . . . 0.0 109.56 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -104.98 -27.29 5.99 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -79.49 -15.29 58.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.261 -1.14 . . . . 0.0 109.636 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.58 ' CD1' ' O ' ' A' ' 104' ' ' LEU . 3.2 p90 -55.8 128.66 36.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.92 . . . . 0.0 109.589 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -114.92 -55.6 2.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.298 -0.876 . . . . 0.0 109.417 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.5 p -103.74 -8.61 19.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.923 . . . . 0.0 109.466 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.63 109.07 3.33 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.737 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -53.37 120.03 5.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -1.132 . . . . 0.0 109.469 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -81.42 125.06 29.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.292 -0.88 . . . . 0.0 109.47 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -95.28 144.09 26.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.938 . . . . 0.0 109.425 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -141.7 132.03 25.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 109.407 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -74.1 156.32 37.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 109.513 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -84.56 -64.92 1.53 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -159.26 -130.52 1.15 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.1 t -103.14 -77.6 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -1.16 . . . . 0.0 109.56 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.19 -152.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.464 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 18.9 t -144.2 64.09 1.32 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 109.427 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -177.73 -35.1 0.05 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 124' ' ' HIS . 8.6 m-85 -70.29 -83.86 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -1.161 . . . . 0.0 109.504 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.2 ttpt 68.9 -62.72 0.39 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.342 -0.849 . . . . 0.0 109.51 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.425 ' N ' ' O ' ' A' ' 122' ' ' PHE . 3.0 t-160 -158.71 128.06 5.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.145 -0.972 . . . . 0.0 109.523 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.2 p -93.87 148.87 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 109.432 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.4 m -142.26 83.81 11.97 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 0.0 109.482 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.16 -70.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.73 2.287 . . . . 0.0 112.321 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.54 168.51 19.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.182 -0.949 . . . . 0.0 109.515 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -90.11 104.21 16.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -0.956 . . . . 0.0 109.422 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.666 HG13 ' O ' ' A' ' 130' ' ' VAL . 14.0 p -105.06 112.48 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.333 -0.855 . . . . 0.0 109.572 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 t -75.45 127.69 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.303 -0.873 . . . . 0.0 109.479 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.6 p -45.15 148.44 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.943 . . . . 0.0 109.44 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.494 -179.953 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.594 ' O ' ' N ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER 176.0 -48.11 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 109.76 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 2' ' ' HIS . 50.8 Cg_exo -52.26 70.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.575 2.183 . . . . 0.0 112.167 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.594 ' N ' ' O ' ' A' ' 2' ' ' HIS . 34.1 mt-10 -83.27 -46.21 12.92 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.836 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.666 ' CE1' ' CD1' ' A' ' 81' ' ' LEU . 50.2 t80 -47.64 -16.12 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.235 -0.915 . . . . 0.0 109.391 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 4' ' ' GLU . 71.7 mt -84.05 -52.03 6.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 0.0 109.439 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.468 ' O ' ' O ' ' A' ' 8' ' ' ALA . 46.3 mtpt -91.08 5.97 46.82 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.553 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -44.43 169.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.231 -0.918 . . . . 0.0 109.632 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.75 70.75 0.51 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.46 6.63 2.54 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.17 -1.194 . . . . 0.0 109.647 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -172.13 141.97 1.2 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.899 . . . . 0.0 109.409 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.02 84.13 1.53 Allowed 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.675 2.25 . . . . 0.0 112.291 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -164.96 -108.02 0.21 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.3 tt -162.54 148.03 12.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -1.114 . . . . 0.0 109.553 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.415 ' HB3' ' CZ3' ' A' ' 17' ' ' TRP . 3.5 mt-30 -136.51 131.75 34.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.242 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.492 ' HA ' HG23 ' A' ' 43' ' ' ILE . 12.2 mt -102.28 157.63 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.215 -0.928 . . . . 0.0 110.22 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.428 ' N ' HG22 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -159.17 130.46 6.2 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.495 -0.753 . . . . 0.0 109.17 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -100.92 152.5 20.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.174 -0.954 . . . . 0.0 109.403 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 23' ' ' ASP . 41.4 t -77.03 129.02 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.255 -0.903 . . . . 0.0 109.532 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.711 ' O ' ' N ' ' A' ' 22' ' ' PHE . 27.6 tt0 -80.49 86.82 5.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.126 -0.984 . . . . 0.0 109.479 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.599 ' O ' ' CB ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER 39.35 15.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.574 -0.704 . . . . 0.0 110.081 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.711 ' N ' ' O ' ' A' ' 20' ' ' GLU . 1.4 t80 154.82 -39.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.391 -0.818 . . . . 0.0 109.134 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 20' ' ' GLU . 1.3 t0 -98.99 -146.56 0.33 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.251 -0.906 . . . . 0.0 109.341 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.43 ' CD2' ' H ' ' A' ' 5' ' ' PHE . 3.3 tp -116.1 138.83 50.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.196 -0.94 . . . . 0.0 109.714 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.533 HG23 ' CD ' ' A' ' 20' ' ' GLU . 1.2 t -137.98 144.6 44.48 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -69.69 152.04 69.6 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.527 2.151 . . . . 0.0 112.392 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.0 t -120.54 101.61 45.97 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.874 . . . . 0.0 109.376 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -49.64 158.06 2.08 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.561 2.174 . . . . 0.0 112.128 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 31' ' ' LEU . 5.9 m -59.54 -46.26 89.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.915 . . . . 0.0 109.526 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 29' ' ' THR . 3.0 m120 -43.05 -22.14 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.119 -0.988 . . . . 0.0 109.475 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 29' ' ' THR . 79.7 mt -105.63 -25.49 12.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -0.861 . . . . 0.0 109.451 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.454 ' C ' ' O ' ' A' ' 31' ' ' LEU . 2.0 t80 -42.18 129.49 3.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.328 -0.858 . . . . 0.0 109.371 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.443 ' N ' ' CD2' ' A' ' 32' ' ' TYR . . . 100.28 -20.88 46.79 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.43 ' C ' ' CD1' ' A' ' 35' ' ' PHE . 4.3 m-20 -97.83 155.62 16.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.222 -1.163 . . . . 0.0 109.501 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.43 ' CD1' ' C ' ' A' ' 34' ' ' ASP . 57.1 m-85 -146.65 136.05 22.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 109.457 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -97.42 162.83 13.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 109.406 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.7 p -97.97 -4.87 35.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 109.383 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.91 -76.93 1.28 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.97 157.81 32.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -1.085 . . . . 0.0 109.415 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.74 167.2 11.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.444 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -128.47 134.8 48.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 109.52 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.562 HG11 ' CD1' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -108.7 144.52 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.254 -0.903 . . . . 0.0 109.052 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.985 ' N ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -143.88 139.54 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.996 -1.065 . . . . 0.0 110.097 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.661 HD23 ' N ' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -123.52 126.09 46.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.408 -0.808 . . . . 0.0 109.149 179.256 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.661 ' N ' HD23 ' A' ' 44' ' ' LEU . 30.3 ttpt -104.46 130.37 52.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.326 -0.859 . . . . 0.0 109.6 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 13' ' ' GLY . 99.8 m -131.83 125.66 32.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.293 -0.88 . . . . 0.0 109.294 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -133.09 168.46 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 121.175 -0.953 . . . . 0.0 109.357 -179.647 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -96.29 121.76 38.42 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.681 -0.637 . . . . 0.0 109.324 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 50' ' ' ARG . 11.1 mt -82.59 168.79 16.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.949 . . . . 0.0 109.523 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 49' ' ' LEU . 1.1 tpt180 -43.21 -67.14 0.3 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.251 -0.906 . . . . 0.0 109.261 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -60.18 -26.07 66.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 109.125 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.98 40.2 3.37 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 54' ' ' LEU . 37.9 m-20 -87.66 14.79 7.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.11 -1.229 . . . . 0.0 109.316 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.624 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 11.7 mt 43.79 96.83 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.511 0.672 . . . . 0.0 109.444 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -69.18 153.62 43.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.528 -0.732 . . . . 0.0 109.245 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.412 ' CD2' ' O ' ' A' ' 54' ' ' LEU . 70.7 m-85 -138.0 114.86 10.7 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.171 -0.956 . . . . 0.0 109.623 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -124.78 116.7 22.72 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.027 HD12 ' H ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -102.84 145.72 29.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.134 -0.979 . . . . 0.0 110.076 -179.021 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.532 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 3.1 m-70 -131.34 150.52 52.12 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.469 -0.769 . . . . 0.0 109.4 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.882 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -129.37 121.33 27.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.352 -0.843 . . . . 0.0 109.34 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.467 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 44.8 t90 -101.84 123.77 46.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.92 . . . . 0.0 109.59 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.467 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 18.4 mt -104.55 162.04 13.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.279 -0.888 . . . . 0.0 109.382 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.515 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -112.86 162.0 12.5 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -82.14 -11.62 58.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -1.168 . . . . 0.0 109.599 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.68 33.89 4.12 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.657 ' SG ' ' O ' ' A' ' 66' ' ' CYS . 18.0 p -130.58 97.91 4.51 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 122.478 1.133 . . . . 0.0 108.951 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.49 ' O ' ' O ' ' A' ' 66' ' ' CYS . 0.5 OUTLIER -46.57 177.18 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.731 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.555 ' O ' ' N ' ' A' ' 72' ' ' GLY . 4.6 pt20 -66.52 -17.78 65.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.476 -0.765 . . . . 0.0 109.553 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.1 p30 -62.85 -58.43 7.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.263 -0.898 . . . . 0.0 109.626 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.401 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 2.6 mp0 -62.04 -51.93 65.99 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.301 -0.874 . . . . 0.0 109.129 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.43 -22.87 66.22 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.405 -0.809 . . . . 0.0 108.879 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -75.16 -46.26 16.74 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.79 -39.09 87.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.186 -1.185 . . . . 0.0 109.151 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.882 ' HB1' ' CE2' ' A' ' 60' ' ' TYR . . . -59.4 -59.49 5.36 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.394 -0.816 . . . . 0.0 108.968 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.775 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -48.25 -43.21 32.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.31 -0.869 . . . . 0.0 109.48 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.8 mt -56.67 -39.14 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.143 -0.973 . . . . 0.0 109.564 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -64.7 -50.48 66.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 109.704 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.483 ' OG1' ' CE1' ' A' ' 60' ' ' TYR . 2.7 m -63.72 -35.03 79.24 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.065 -1.022 . . . . 0.0 108.794 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 75' ' ' ALA . 74.5 t -59.59 -41.9 86.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.343 -0.848 . . . . 0.0 108.729 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -62.55 -43.75 98.03 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.666 ' CD1' ' CE1' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -50.83 -45.47 59.62 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.403 -0.811 . . . . 0.0 108.921 179.5 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 85' ' ' LEU . 1.6 m-20 -60.33 -60.42 3.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.294 -0.879 . . . . 0.0 108.967 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 82' ' ' ASP . 39.6 t0 -46.94 -32.99 4.23 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.116 -0.99 . . . . 0.0 108.412 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.468 ' CD2' ' O ' ' A' ' 84' ' ' TYR . 2.8 t80 -74.49 -27.1 60.41 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.568 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.6 tp -110.24 26.47 10.64 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.475 -0.765 . . . . 0.0 109.306 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER 44.71 37.47 2.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.487 -0.758 . . . . 0.0 109.579 179.795 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 53.7 34.13 49.92 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -90.64 31.38 1.05 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -1.138 . . . . 0.0 109.138 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.24 179.22 7.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.434 -0.791 . . . . 0.0 109.31 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.686 ' O ' HD12 ' A' ' 58' ' ' LEU . 21.9 t -119.13 140.83 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -0.964 . . . . 0.0 109.672 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.41 ' CD ' ' N ' ' A' ' 91' ' ' GLN . 0.2 OUTLIER -102.74 149.28 24.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.328 -0.857 . . . . 0.0 109.319 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -124.49 121.78 35.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 109.553 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.43 ' H ' ' HD2' ' A' ' 93' ' ' ARG . 1.5 mpt_? -91.5 105.42 17.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.943 . . . . 0.0 109.063 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.417 ' OE2' ' CD1' ' A' ' 103' ' ' PHE . 35.8 mt-10 -113.12 148.06 36.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.764 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.713 HG12 ' N ' ' A' ' 96' ' ' GLN . 61.5 t -151.9 174.04 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -0.869 . . . . 0.0 109.091 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.713 ' N ' HG12 ' A' ' 95' ' ' VAL . 10.2 tt0 -62.58 115.84 4.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.051 -1.031 . . . . 0.0 109.542 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.95 11.66 82.29 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.47 ' O ' ' C ' ' A' ' 99' ' ' GLU . 3.2 t80 -132.66 19.39 4.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.252 -1.146 . . . . 0.0 109.551 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.631 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 8.8 mp0 -39.63 137.6 0.84 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.549 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.85 166.91 16.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 109.654 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.27 -64.45 0.85 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 0.0 109.448 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.8 m -47.03 -54.86 9.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.207 -0.933 . . . . 0.0 109.198 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.417 ' CD1' ' OE2' ' A' ' 94' ' ' GLU . 3.3 t80 -50.81 -45.27 59.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.471 -0.768 . . . . 0.0 109.295 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.506 ' O ' ' CD1' ' A' ' 107' ' ' PHE . 5.8 mt -59.01 -30.81 68.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.913 . . . . 0.0 109.388 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.79 -19.27 48.5 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.423 ' O ' ' C ' ' A' ' 107' ' ' PHE . 35.4 t80 -76.35 -27.36 56.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.346 -1.091 . . . . 0.0 109.458 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.54 ' CD1' ' O ' ' A' ' 107' ' ' PHE . 1.3 p90 -42.42 125.83 3.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.183 -0.948 . . . . 0.0 109.494 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -110.87 -47.85 3.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.913 . . . . 0.0 109.433 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.6 m -96.67 -28.55 14.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 109.493 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 124.24 112.5 1.98 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.2 mt -57.76 176.69 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.334 -1.098 . . . . 0.0 109.47 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -159.97 122.25 3.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.352 -0.842 . . . . 0.0 109.279 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -106.75 141.66 37.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 109.414 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -146.19 126.29 13.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.887 . . . . 0.0 109.387 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -114.02 131.39 56.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.346 -0.846 . . . . 0.0 109.47 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 166.79 -52.6 0.25 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.06 23.71 12.74 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.2 m -145.55 153.1 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.343 -1.093 . . . . 0.0 109.474 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.43 -80.55 0.15 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.321 -0.862 . . . . 0.0 109.471 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.5 m -147.05 -152.94 0.46 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.952 . . . . 0.0 109.423 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -175.53 169.61 42.42 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -94.11 151.8 19.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.337 -1.096 . . . . 0.0 109.446 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 ttmm -157.39 -48.57 0.07 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.366 -0.834 . . . . 0.0 109.318 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.54 119.1 11.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.302 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.1 t -87.46 -56.79 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.307 -0.87 . . . . 0.0 109.435 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 26.1 m -50.75 147.87 7.92 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.401 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.32 178.44 5.52 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.579 2.186 . . . . 0.0 112.136 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -70.95 -73.89 0.16 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.254 -0.904 . . . . 0.0 109.405 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -131.52 151.15 51.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.436 -0.79 . . . . 0.0 109.42 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 131' ' ' VAL . 55.1 t -69.35 149.22 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.187 -0.945 . . . . 0.0 109.441 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.415 ' C ' ' O ' ' A' ' 130' ' ' VAL . 58.0 t -42.82 121.99 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.529 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 132' ' ' VAL . 12.6 p -49.22 130.54 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 109.448 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.536 ' H ' ' CD ' ' A' ' 133' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.097 -0.954 . . . . 0.0 109.39 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.54 ' C ' ' ND1' ' A' ' 2' ' ' HIS . 10.5 mm-40 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.282 0.563 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.54 ' ND1' ' C ' ' A' ' 1' ' ' GLU . 8.7 m80 -146.48 57.29 3.66 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.91 . . . . 0.0 109.398 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.517 ' HB3' HD12 ' A' ' 6' ' ' LEU . 36.2 Cg_endo -68.13 66.74 0.99 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.78 2.32 . . . . 0.0 112.077 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.542 ' OE1' ' NE1' ' A' ' 17' ' ' TRP . 74.7 mt-10 -83.15 -46.24 12.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 109.756 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.519 ' CE2' ' CG1' ' A' ' 42' ' ' VAL . 22.8 t80 -66.95 -18.76 65.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.281 -0.887 . . . . 0.0 109.406 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.517 HD12 ' HB3' ' A' ' 3' ' ' PRO . 10.1 mt -76.61 -37.2 56.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.258 -0.901 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.453 ' O ' ' C ' ' A' ' 8' ' ' ALA . 7.4 mtpm? -86.12 -15.6 40.63 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.334 -0.854 . . . . 0.0 109.335 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -40.94 142.36 0.49 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 109.567 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.26 42.32 0.2 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -140.65 26.38 2.11 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.339 -1.095 . . . . 0.0 109.692 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -148.84 128.1 6.29 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.192 -0.943 . . . . 0.0 109.433 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.81 80.1 2.69 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.494 2.129 . . . . 0.0 112.272 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 173.32 -99.37 0.14 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.9 tt -162.25 152.26 16.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -1.131 . . . . 0.0 109.834 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.42 ' HB3' ' CZ3' ' A' ' 17' ' ' TRP . 42.1 mt-30 -135.74 141.31 44.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 109.367 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 28.5 mt -113.99 139.11 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.36 -0.838 . . . . 0.0 110.1 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.542 ' NE1' ' OE1' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -142.75 156.77 45.05 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.535 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.811 ' O ' HD23 ' A' ' 24' ' ' LEU . 18.8 ttt180 -116.29 140.13 49.65 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.172 -0.955 . . . . 0.0 109.62 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 19' ' ' VAL . 8.4 p -85.33 131.72 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.917 . . . . 0.0 109.409 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.606 ' O ' ' N ' ' A' ' 22' ' ' PHE . 20.4 tt0 -84.06 151.36 25.01 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.165 -0.96 . . . . 0.0 109.225 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.486 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 10.8 ttmm -45.25 -11.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.271 -0.893 . . . . 0.0 109.92 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.606 ' N ' ' O ' ' A' ' 20' ' ' GLU . 20.7 m-85 -162.96 20.97 0.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.961 -1.087 . . . . 0.0 110.065 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.474 ' CG ' ' O ' ' A' ' 22' ' ' PHE . 24.5 m-20 -166.38 -116.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.193 -0.942 . . . . 0.0 109.499 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.811 HD23 ' O ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -158.19 138.6 12.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -0.892 . . . . 0.0 109.296 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 t -119.98 132.62 24.01 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 0.0 109.282 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.1 136.87 23.07 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.428 2.085 . . . . 0.0 112.343 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.7 t -97.49 112.03 60.12 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.224 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -45.54 127.88 9.98 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.33 2.02 . . . . 0.0 112.104 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.64 -10.11 59.27 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.146 -0.971 . . . . 0.0 109.485 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -90.91 -3.06 57.62 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.237 -0.914 . . . . 0.0 109.113 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 38.4 mt -136.81 -1.93 2.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.288 -0.882 . . . . 0.0 109.801 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.426 ' O ' ' CG ' ' A' ' 32' ' ' TYR . 3.6 p90 -50.42 135.17 22.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.952 . . . . 0.0 109.507 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.94 -25.44 3.21 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.8 105.29 16.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -1.154 . . . . 0.0 109.43 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -96.5 146.26 24.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.511 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -94.46 128.36 40.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.568 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.472 ' OG1' ' OE1' ' A' ' 65' ' ' GLU . 35.7 p -72.24 -4.78 31.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.307 -0.87 . . . . 0.0 109.426 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.44 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -109.67 38.25 3.4 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 22.6 m-20 -163.52 -169.38 1.92 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -1.122 . . . . 0.0 109.465 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -136.72 138.28 40.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.401 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -126.01 139.0 53.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.332 -0.855 . . . . 0.0 109.519 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.006 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -105.95 136.97 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 121.178 -0.951 . . . . 0.0 108.767 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.006 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -127.84 137.17 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.269 -0.895 . . . . 0.0 110.369 -179.496 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.682 HD23 ' C ' ' A' ' 44' ' ' LEU . 6.9 tt -117.83 116.98 28.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.7 -0.625 . . . . 0.0 109.335 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.481 ' N ' HD23 ' A' ' 44' ' ' LEU . 4.8 ttpm? -98.9 118.24 35.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.544 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.41 ' CG2' HD22 ' A' ' 54' ' ' LEU . 8.4 m -118.62 131.33 56.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.34 -0.85 . . . . 0.0 109.201 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -132.01 168.46 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.193 -0.942 . . . . 0.0 109.569 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.576 ' NE2' ' O ' ' A' ' 49' ' ' LEU . 8.4 tm0? -95.97 112.33 24.09 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.576 ' O ' ' NE2' ' A' ' 48' ' ' GLN . 63.8 mt -72.28 155.61 40.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.924 . . . . 0.0 109.748 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 49' ' ' LEU . 20.9 mtm105 -42.89 -77.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.895 . . . . 0.0 109.388 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 50' ' ' ARG . 4.1 t-20 -43.33 -31.1 0.59 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.166 -0.959 . . . . 0.0 109.259 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.64 75.47 1.16 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.481 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.1 t-20 -132.76 14.09 4.39 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.251 -1.147 . . . . 0.0 109.199 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 11.9 mt 43.22 95.98 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.386 0.612 . . . . 0.0 109.616 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 47' ' ' VAL . 17.2 tt0 -68.85 154.48 41.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.549 -0.719 . . . . 0.0 109.144 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.614 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 97.6 m-85 -134.53 121.69 21.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 0.0 109.674 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 58' ' ' LEU . 1.5 t0 -133.0 155.44 49.17 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.581 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -143.58 145.79 32.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.825 -1.172 . . . . 0.0 110.388 -179.629 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.472 ' HE1' ' HB2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -141.06 131.93 25.94 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.401 -0.812 . . . . 0.0 108.957 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.751 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -96.64 120.74 37.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.094 -1.004 . . . . 0.0 109.463 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.517 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 31.2 t90 -89.13 123.71 33.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.876 . . . . 0.0 109.357 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.517 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 6.6 mt -106.36 162.18 13.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.321 -0.862 . . . . 0.0 109.423 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.93 156.59 15.46 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -75.79 -12.24 60.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -1.135 . . . . 0.0 109.357 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 116' ' ' GLY . 2.7 mt-10 -106.47 26.25 10.13 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.5 m -130.85 97.51 4.35 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.136 0.969 . . . . 0.0 108.397 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 66' ' ' CYS . 39.7 p -49.82 -177.18 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.589 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.49 ' O ' ' N ' ' A' ' 72' ' ' GLY . 29.2 mt-30 -66.04 -17.82 64.94 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.304 -0.873 . . . . 0.0 109.5 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.503 ' OD2' ' N ' ' A' ' 69' ' ' ASP . 2.5 m-20 -63.75 -58.57 6.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 109.369 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -61.03 -51.02 70.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.288 -0.882 . . . . 0.0 109.131 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.0 m -64.23 -27.37 69.01 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.442 -0.786 . . . . 0.0 109.065 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -69.24 -43.05 72.96 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.04 -41.56 97.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.317 -1.108 . . . . 0.0 109.245 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.52 -47.03 87.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.398 -0.814 . . . . 0.0 109.25 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.89 -46.44 81.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.173 -0.955 . . . . 0.0 109.345 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.2 mt -51.96 -49.82 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.214 -0.929 . . . . 0.0 109.207 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -57.91 -33.92 69.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.866 . . . . 0.0 109.277 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.405 HG21 ' CE1' ' A' ' 60' ' ' TYR . 2.1 m -68.34 -46.79 69.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.231 -0.918 . . . . 0.0 109.263 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.6 t -57.26 -31.93 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.168 -0.957 . . . . 0.0 109.318 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -68.06 -54.44 18.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.913 . . . . 0.0 109.246 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.831 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -53.47 -29.46 35.98 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.285 -0.884 . . . . 0.0 108.981 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 85' ' ' LEU . 3.4 m-20 -66.53 -59.32 3.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.272 -0.892 . . . . 0.0 108.913 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 82' ' ' ASP . 1.0 OUTLIER -45.62 -34.51 3.48 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.294 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.595 ' CD1' ' O ' ' A' ' 84' ' ' TYR . 0.6 OUTLIER -69.55 -32.56 71.44 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.886 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.591 ' N ' ' O ' ' A' ' 82' ' ' ASP . 5.6 mp -104.51 27.39 7.95 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.417 -0.802 . . . . 0.0 109.026 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 85' ' ' LEU . 13.1 m-80 42.7 35.03 0.64 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.449 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 86' ' ' ASN . . . 43.44 85.31 0.01 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -145.61 47.73 1.27 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.202 -1.175 . . . . 0.0 109.384 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.614 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -155.1 179.15 9.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.894 . . . . 0.0 109.505 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.505 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 8.7 t -94.58 116.13 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.625 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -109.7 125.36 52.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.268 -0.895 . . . . 0.0 109.193 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.574 ' N ' ' CD2' ' A' ' 92' ' ' HIS . 1.3 p80 -151.0 136.05 17.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.028 -1.045 . . . . 0.0 110.197 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -85.85 131.43 34.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.176 -0.953 . . . . 0.0 109.713 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -100.34 121.37 41.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.95 . . . . 0.0 109.359 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.596 HG12 ' N ' ' A' ' 96' ' ' GLN . 44.4 t -89.64 167.71 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 109.615 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.686 ' NE2' ' N ' ' A' ' 97' ' ' GLY . 17.5 tp60 -88.03 136.12 33.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 109.394 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.686 ' N ' ' NE2' ' A' ' 96' ' ' GLN . . . 110.41 -26.91 12.26 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.487 ' O ' ' O ' ' A' ' 99' ' ' GLU . 2.9 t80 -133.21 -30.14 1.36 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.414 -1.051 . . . . 0.0 109.413 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 98' ' ' PHE . 18.1 mp0 47.02 -176.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 109.477 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.6 t -100.92 143.88 30.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 109.53 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -47.65 -40.42 19.73 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.194 -0.941 . . . . 0.0 109.527 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.1 m -54.02 -44.5 71.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.899 . . . . 0.0 109.442 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.81 -55.35 8.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 109.268 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.443 ' O ' ' CD1' ' A' ' 107' ' ' PHE . 92.7 mt -48.15 -21.52 0.5 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.36 -0.838 . . . . 0.0 109.497 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.23 -24.29 9.74 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -84.61 -5.98 59.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -1.183 . . . . 0.0 109.549 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 5.0 p90 -54.03 118.0 3.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.492 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -114.88 -55.79 2.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 109.483 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.1 p -92.63 -14.08 28.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.541 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.15 75.62 1.23 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.087 HD23 ' H ' ' A' ' 111' ' ' LEU . 1.1 pt? -56.58 163.31 1.85 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -1.124 . . . . 0.0 109.608 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -141.38 179.75 6.6 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.374 -0.829 . . . . 0.0 109.432 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.99 111.43 7.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 0.0 109.333 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -75.5 110.04 9.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.43 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -77.44 114.86 16.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 109.452 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.549 ' N ' ' OE1' ' A' ' 65' ' ' GLU . . . -72.27 -125.12 0.07 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -176.24 120.17 0.74 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.46 ' C ' ' H ' ' A' ' 120' ' ' SER . 16.5 m -88.05 -159.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -1.126 . . . . 0.0 109.442 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.22 33.36 0.1 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.91 . . . . 0.0 109.392 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.46 ' H ' ' C ' ' A' ' 118' ' ' VAL . 3.5 t 56.15 178.57 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.423 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.597 ' O ' ' CG ' ' A' ' 122' ' ' PHE . . . -179.33 120.01 0.67 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.597 ' CG ' ' O ' ' A' ' 121' ' ' GLY . 4.9 m-85 -177.07 -165.87 0.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.265 -1.138 . . . . 0.0 109.374 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.499 ' O ' ' O ' ' A' ' 122' ' ' PHE . 3.3 mptp? 57.47 122.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.382 -0.824 . . . . 0.0 109.701 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.533 ' O ' ' C ' ' A' ' 125' ' ' VAL . 16.4 m170 -66.51 -151.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.3 -0.875 . . . . 0.0 109.45 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.533 ' C ' ' O ' ' A' ' 124' ' ' HIS . 1.3 p -34.48 105.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.574 -0.703 . . . . 0.0 109.73 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.624 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -83.66 -41.42 0.79 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.849 . . . . 0.0 109.924 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 126' ' ' VAL . 73.1 Cg_endo -83.52 -102.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.513 2.142 . . . . 0.0 112.359 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.459 ' CG ' ' O ' ' A' ' 127' ' ' PRO . 20.8 m-80 -160.12 -159.05 0.68 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.133 -0.98 . . . . 0.0 109.528 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.531 ' O ' HG23 ' A' ' 130' ' ' VAL . 2.8 tm-20 -173.87 100.51 0.11 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.357 -0.84 . . . . 0.0 109.312 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 129' ' ' GLU . 56.1 t -157.49 -61.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.168 -0.958 . . . . 0.0 109.596 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.434 ' C ' ' O ' ' A' ' 130' ' ' VAL . 11.6 t -42.61 113.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.208 -0.933 . . . . 0.0 109.506 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.02 51.01 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.885 . . . . 0.0 109.573 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.066 -0.969 . . . . 0.0 109.433 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.662 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -100.38 -40.93 0.22 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.863 . . . . 0.0 109.572 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.662 ' CD ' ' N ' ' A' ' 2' ' ' HIS . 25.8 Cg_exo -59.82 86.03 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.711 2.274 . . . . 0.0 111.965 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -83.24 -28.84 28.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.878 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.55 ' CE2' HG12 ' A' ' 42' ' ' VAL . 5.7 t80 -70.46 -16.05 62.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.785 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.0 mt -83.74 -38.28 21.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 109.446 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 8' ' ' ALA . 48.2 mmtt -95.25 -2.59 49.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.343 -0.848 . . . . 0.0 109.388 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.484 ' HB3' HD13 ' A' ' 44' ' ' LEU . . . -42.12 139.27 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.885 . . . . 0.0 109.529 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.23 56.83 0.06 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 pttm -137.45 18.7 2.92 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.2 -1.177 . . . . 0.0 109.514 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.469 ' O ' ' OE1' ' A' ' 11' ' ' GLU . 1.7 pp20? -165.93 127.38 1.37 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.419 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.12 85.16 1.7 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.421 2.081 . . . . 0.0 112.148 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -174.62 -103.28 0.16 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.0 tp -153.2 146.73 25.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.356 -1.085 . . . . 0.0 109.608 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.401 ' HB3' ' CZ3' ' A' ' 17' ' ' TRP . 37.4 mt-30 -135.89 128.72 31.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.866 . . . . 0.0 109.367 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.5 mt -105.91 150.08 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 0.0 109.557 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.401 ' CZ3' ' HB3' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -156.68 135.59 11.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.134 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -104.82 148.61 26.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.27 -0.894 . . . . 0.0 109.568 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.481 ' O ' ' OD1' ' A' ' 39' ' ' ASP . 9.5 p -83.44 146.0 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.42 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.595 ' O ' ' N ' ' A' ' 22' ' ' PHE . 22.8 tt0 -99.3 154.52 18.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 109.382 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 20' ' ' GLU . 39.3 tttm -42.31 -18.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.892 . . . . 0.0 109.599 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.595 ' N ' ' O ' ' A' ' 20' ' ' GLU . 53.5 t80 -163.42 32.67 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.186 -0.946 . . . . 0.0 109.647 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.544 ' OD2' ' N ' ' A' ' 24' ' ' LEU . 9.3 t0 -173.23 -122.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.431 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.544 ' N ' ' OD2' ' A' ' 23' ' ' ASP . 4.6 tp -152.44 146.04 24.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.57 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.62 134.03 25.83 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.398 -0.813 . . . . 0.0 109.17 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.77 146.8 49.1 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.378 2.052 . . . . 0.0 112.16 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.5 t -105.24 105.89 53.73 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.411 -0.806 . . . . 0.0 109.191 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -47.85 127.9 15.22 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.463 2.109 . . . . 0.0 112.358 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.6 m -76.37 -3.6 37.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.32 -0.862 . . . . 0.0 109.285 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -77.75 -15.2 59.29 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.167 -0.958 . . . . 0.0 109.358 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.63 ' C ' HD12 ' A' ' 31' ' ' LEU . 0.9 OUTLIER -156.3 12.5 0.29 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 110.129 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.487 ' N ' HD12 ' A' ' 31' ' ' LEU . 20.6 p90 -43.35 163.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.127 -0.983 . . . . 0.0 109.377 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.25 -4.71 26.81 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -96.17 102.04 13.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.184 -1.186 . . . . 0.0 109.497 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -96.21 124.43 40.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.243 -0.911 . . . . 0.0 109.511 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -92.16 146.79 23.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.443 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.425 ' OG1' ' CD ' ' A' ' 65' ' ' GLU . 13.3 p -84.46 -15.79 44.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 109.436 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.21 22.91 32.17 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.481 ' OD1' ' O ' ' A' ' 19' ' ' VAL . 3.5 t70 -164.34 150.78 11.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.205 -1.174 . . . . 0.0 109.463 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.481 ' O ' ' OD2' ' A' ' 39' ' ' ASP . . . -92.55 153.08 19.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.391 -0.818 . . . . 0.0 109.528 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -125.01 134.79 52.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.366 -0.834 . . . . 0.0 109.32 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.55 HG12 ' CE2' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -109.93 144.39 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.269 -0.894 . . . . 0.0 109.018 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.072 ' N ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -143.32 121.83 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.932 -1.105 . . . . 0.0 109.852 -179.438 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.484 HD13 ' HB3' ' A' ' 8' ' ' ALA . 7.5 tt -111.35 124.58 52.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.593 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.543 ' CE ' ' OH ' ' A' ' 106' ' ' TYR . 23.2 tttm -101.33 140.47 35.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -0.883 . . . . 0.0 109.225 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.526 HG22 HD22 ' A' ' 54' ' ' LEU . 98.9 m -139.32 123.22 17.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.88 . . . . 0.0 109.574 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -128.55 168.32 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.171 -0.955 . . . . 0.0 108.894 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -103.64 108.88 20.35 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.58 -0.7 . . . . 0.0 109.411 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 50' ' ' ARG . 14.5 mt -72.8 169.06 17.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 109.564 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' A' ' 49' ' ' LEU . 8.9 tpp85 -43.25 -70.36 0.11 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.217 -0.927 . . . . 0.0 109.252 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.5 m-20 -52.74 -31.22 36.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 109.207 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.35 36.74 4.53 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.495 ' O ' ' O ' ' A' ' 54' ' ' LEU . 0.1 OUTLIER -84.52 13.21 5.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.118 -1.225 . . . . 0.0 109.175 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.647 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.4 mt 44.37 97.63 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.573 0.701 . . . . 0.0 109.418 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 41.0 tt0 -71.39 113.18 8.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.475 -0.766 . . . . 0.0 109.325 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.536 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 92.6 m-85 -98.89 114.38 26.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.239 -0.913 . . . . 0.0 109.849 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -118.28 154.98 31.39 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.421 HD13 HD11 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -142.68 144.59 32.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.964 -1.085 . . . . 0.0 110.674 -179.274 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.781 ' HB2' HD13 ' A' ' 43' ' ' ILE . 2.0 m80 -129.62 150.21 51.05 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.614 ' CD1' ' O ' ' A' ' 60' ' ' TYR . 19.8 p90 -128.98 124.95 36.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.205 -0.934 . . . . 0.0 109.434 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.554 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 56.1 t90 -107.78 127.75 53.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.369 -0.832 . . . . 0.0 109.647 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.554 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 24.2 mt -106.65 161.98 14.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.314 -0.866 . . . . 0.0 109.405 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -109.12 157.49 15.1 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -82.29 -11.81 58.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -1.14 . . . . 0.0 109.545 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.425 ' CD ' ' OG1' ' A' ' 37' ' ' THR . 2.2 mt-10 -110.26 33.11 4.66 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.655 ' SG ' ' O ' ' A' ' 66' ' ' CYS . 18.8 p -130.44 97.66 4.46 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 122.432 1.11 . . . . 0.0 108.965 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.485 ' O ' ' OG ' ' A' ' 71' ' ' SER . 3.1 m -43.77 170.86 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.763 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 72' ' ' GLY . 80.8 mt-30 -65.44 -17.78 64.81 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.422 -0.799 . . . . 0.0 109.584 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -65.07 -58.59 5.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.52 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -63.7 -47.07 82.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.378 -0.826 . . . . 0.0 109.196 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 67' ' ' SER . 0.2 OUTLIER -68.65 -24.21 64.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.386 -0.821 . . . . 0.0 109.074 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -71.46 -36.02 62.96 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.16 -42.7 62.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -1.152 . . . . 0.0 109.344 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.37 -46.59 88.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.363 -0.836 . . . . 0.0 109.234 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.513 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -59.48 -49.33 78.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.323 -0.861 . . . . 0.0 109.29 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.9 mt -49.26 -42.22 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.252 -0.905 . . . . 0.0 109.239 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -61.75 -45.75 92.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.24 -0.913 . . . . 0.0 109.307 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.9 m -63.08 -40.12 96.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.296 -0.878 . . . . 0.0 109.413 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 75' ' ' ALA . 24.9 t -67.32 -31.9 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.269 -0.894 . . . . 0.0 109.667 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.65 -61.46 1.88 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.261 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.479 ' C ' HD12 ' A' ' 81' ' ' LEU . 1.5 pp -54.13 -28.15 38.02 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.107 -0.996 . . . . 0.0 108.821 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.638 ' O ' ' N ' ' A' ' 86' ' ' ASN . 8.3 t70 -62.83 -54.09 44.24 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.142 -0.974 . . . . 0.0 109.022 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.56 -34.53 62.01 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -77.92 -26.17 48.84 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.616 ' C ' ' H ' ' A' ' 87' ' ' GLY . 7.3 mt -121.49 33.28 5.58 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.535 -0.728 . . . . 0.0 109.484 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.638 ' N ' ' O ' ' A' ' 82' ' ' ASP . 4.6 t-20 -70.42 25.56 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 108.956 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.616 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -68.79 25.63 0.29 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.578 ' H ' ' C ' ' A' ' 86' ' ' ASN . 0.4 OUTLIER 80.87 35.94 0.1 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.427 -1.043 . . . . 0.0 109.704 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -73.25 179.46 3.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.0 109.123 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.8 t -116.2 121.65 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.217 -0.927 . . . . 0.0 109.874 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -97.65 143.26 28.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.107 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.759 ' CG ' ' CD2' ' A' ' 59' ' ' HIS . 49.9 m80 -120.6 146.61 46.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 109.519 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.454 ' H ' ' HG2' ' A' ' 93' ' ' ARG . 5.5 ptm180 -116.6 103.01 9.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 0.0 109.617 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.548 ' OE2' ' CG ' ' A' ' 103' ' ' PHE . 42.1 mt-10 -113.78 144.64 42.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.459 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.721 HG12 ' N ' ' A' ' 96' ' ' GLN . 47.4 t -149.1 176.56 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.879 . . . . 0.0 109.368 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.721 ' N ' HG12 ' A' ' 95' ' ' VAL . 62.5 tp60 -67.96 118.08 10.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.934 . . . . 0.0 109.453 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.13 11.6 84.93 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.441 ' O ' ' C ' ' A' ' 99' ' ' GLU . 0.3 OUTLIER -140.98 19.32 2.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.163 -1.198 . . . . 0.0 109.485 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 98' ' ' PHE . 22.0 mt-10 -43.27 163.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 109.532 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.0 m -100.12 167.79 10.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.302 -0.873 . . . . 0.0 109.418 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.73 -50.88 31.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.449 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.6 m -46.97 -59.69 2.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.147 -0.971 . . . . 0.0 109.381 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.548 ' CG ' ' OE2' ' A' ' 94' ' ' GLU . 5.4 t80 -53.69 -51.18 64.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.392 -0.818 . . . . 0.0 109.328 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.612 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 6.6 mt -53.35 -18.71 2.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 0.0 109.094 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.81 -21.98 24.62 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.543 ' OH ' ' CE ' ' A' ' 45' ' ' LYS . 3.0 m-85 -73.68 -33.74 64.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.273 -1.134 . . . . 0.0 109.247 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.691 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 1.0 OUTLIER -41.09 108.14 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.356 -0.84 . . . . 0.0 109.599 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -115.37 -47.43 2.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.146 -0.972 . . . . 0.0 109.378 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.7 m -86.11 -29.14 23.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.896 . . . . 0.0 109.522 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 120.48 111.47 2.28 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.445 ' H ' ' HG ' ' A' ' 111' ' ' LEU . 2.4 pp -120.99 166.87 13.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.326 -1.103 . . . . 0.0 109.524 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -172.81 -178.17 1.81 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.638 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -93.52 139.7 30.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.286 -0.884 . . . . 0.0 109.44 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -146.46 105.05 3.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -88.95 150.97 22.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 109.402 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.06 150.1 37.11 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.52 87.81 0.23 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 119' ' ' ALA . 2.7 p -101.29 154.66 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.161 -1.199 . . . . 0.0 109.418 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 118' ' ' VAL . . . 174.87 -76.36 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.0 109.426 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -93.09 -61.55 1.55 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -0.872 . . . . 0.0 109.494 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 48.45 -155.86 1.34 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -85.13 -34.56 22.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -1.159 . . . . 0.0 109.504 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.481 ' CG ' ' H ' ' A' ' 124' ' ' HIS . 23.0 tptt 54.22 -138.78 1.07 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.218 -0.926 . . . . 0.0 109.41 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.481 ' H ' ' CG ' ' A' ' 123' ' ' LYS . 33.4 m170 52.87 59.35 4.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.343 -0.848 . . . . 0.0 109.489 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.43 ' C ' ' O ' ' A' ' 124' ' ' HIS . 12.7 p -42.79 150.29 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.183 -0.948 . . . . 0.0 109.461 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.418 HG22 ' H ' ' A' ' 126' ' ' VAL . 0.7 OUTLIER -79.12 153.04 77.11 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.922 . . . . 0.0 109.433 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.52 -159.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.7 2.267 . . . . 0.0 112.096 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -134.96 84.58 2.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.9 . . . . 0.0 109.462 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -140.54 152.45 45.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.458 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.445 ' H ' HG23 ' A' ' 130' ' ' VAL . 2.1 t -72.69 -133.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.441 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.32 154.6 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.47 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.7 t -73.5 134.55 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.501 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 118.058 -0.972 . . . . 0.0 109.477 -179.991 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.477 ' C ' ' CG ' ' A' ' 2' ' ' HIS . 18.3 tt0 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.287 0.565 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.477 ' CG ' ' C ' ' A' ' 1' ' ' GLU . 0.2 OUTLIER 171.71 81.24 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.24 -0.913 . . . . 0.0 109.52 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.21 89.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.702 2.268 . . . . 0.0 111.966 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -83.18 -38.0 22.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.905 . . . . 0.0 110.022 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.593 ' CE1' HG12 ' A' ' 42' ' ' VAL . 22.4 t80 -55.17 -19.85 8.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.101 -1.0 . . . . 0.0 109.519 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.626 HD23 HD11 ' A' ' 81' ' ' LEU . 9.0 mt -83.77 -35.38 24.39 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.183 -0.948 . . . . 0.0 109.466 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 8' ' ' ALA . 2.2 mmmp? -89.68 -0.96 57.87 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.197 -0.939 . . . . 0.0 109.511 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.479 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -42.88 166.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.882 . . . . 0.0 109.546 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.34 75.37 1.13 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -142.99 5.49 1.52 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.19 -1.182 . . . . 0.0 109.622 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -172.34 143.27 1.26 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 0.0 109.342 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.38 88.45 1.15 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.585 2.19 . . . . 0.0 112.295 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -172.37 -104.71 0.18 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 tp -156.2 143.39 19.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.263 -1.14 . . . . 0.0 109.697 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -129.06 130.65 46.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.363 -0.835 . . . . 0.0 109.237 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 53.2 mt -113.37 137.66 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.263 -0.898 . . . . 0.0 109.958 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -141.61 136.51 31.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.368 -0.832 . . . . 0.0 108.82 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -98.03 150.71 21.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.148 -0.97 . . . . 0.0 109.671 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.626 ' O ' HG13 ' A' ' 19' ' ' VAL . 8.1 p -92.12 122.77 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.387 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.611 ' O ' ' N ' ' A' ' 22' ' ' PHE . 4.2 tm-20 -75.12 149.5 39.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.126 -0.984 . . . . 0.0 109.012 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 20' ' ' GLU . 57.9 mttt -40.3 -20.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.447 -0.783 . . . . 0.0 109.841 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.611 ' N ' ' O ' ' A' ' 20' ' ' GLU . 40.4 t80 -151.46 13.24 0.65 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.081 -1.012 . . . . 0.0 109.819 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 20' ' ' GLU . 35.0 m-20 -160.81 -143.06 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.938 . . . . 0.0 109.385 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.446 ' CD2' ' H ' ' A' ' 5' ' ' PHE . 0.8 OUTLIER -129.35 139.83 51.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.31 -0.869 . . . . 0.0 109.571 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 t -119.76 133.06 23.85 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.361 -0.837 . . . . 0.0 108.947 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.62 150.75 45.9 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.431 2.088 . . . . 0.0 112.495 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.8 t -148.79 101.53 3.44 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.306 -0.871 . . . . 0.0 109.214 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -50.1 139.46 34.57 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.591 2.194 . . . . 0.0 112.262 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.475 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 12.4 t -67.53 -21.08 65.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.325 -0.86 . . . . 0.0 109.347 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -77.04 -2.74 35.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.365 -0.835 . . . . 0.0 109.415 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.486 ' O ' ' O ' ' A' ' 32' ' ' TYR . 50.1 mt -124.91 -18.87 5.4 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.339 -0.851 . . . . 0.0 109.5 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.486 ' O ' ' O ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -49.24 -178.61 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.123 -0.986 . . . . 0.0 109.51 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.15 -41.01 2.09 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -98.47 102.37 14.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -1.154 . . . . 0.0 109.495 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -90.33 136.43 33.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.187 -0.946 . . . . 0.0 109.461 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.439 ' CD2' ' OH ' ' A' ' 41' ' ' TYR . 25.1 m-85 -92.9 138.72 31.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 109.435 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.423 ' OG1' ' CD ' ' A' ' 65' ' ' GLU . 55.8 p -80.45 -4.83 55.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.31 -0.869 . . . . 0.0 109.48 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.7 -74.9 1.21 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -78.7 155.05 29.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -1.126 . . . . 0.0 109.601 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.528 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -90.69 165.44 13.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.335 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.439 ' OH ' ' CD2' ' A' ' 36' ' ' PHE . 11.1 m-85 -126.84 136.02 51.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.296 -0.878 . . . . 0.0 109.542 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.07 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -111.68 128.6 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.07 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -124.79 141.96 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.949 . . . . 0.0 110.494 -178.667 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.5 tt -128.21 120.6 27.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.55 -0.719 . . . . 0.0 109.081 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.559 ' HZ2' HG22 ' A' ' 47' ' ' VAL . 38.2 tttp -93.11 146.54 23.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.364 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 13' ' ' GLY . 85.1 m -143.16 129.2 19.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.094 -1.004 . . . . 0.0 109.549 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -133.33 168.49 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 121.178 -0.951 . . . . 0.0 109.262 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -101.72 111.0 23.1 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.616 -0.677 . . . . 0.0 109.376 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 52' ' ' GLY . 81.2 mt -74.92 158.28 33.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.227 -0.92 . . . . 0.0 109.572 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.713 ' CD ' ' H ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -44.85 -47.04 11.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.363 -0.836 . . . . 0.0 109.203 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -65.69 -28.82 69.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.279 -0.888 . . . . 0.0 109.203 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . 94.17 30.75 8.51 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.498 ' O ' ' O ' ' A' ' 54' ' ' LEU . 32.7 t30 -89.89 12.78 16.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.085 -1.244 . . . . 0.0 109.373 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.576 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.1 mt 45.12 99.12 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.665 0.745 . . . . 0.0 109.554 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.58 ' NE2' ' H ' ' A' ' 56' ' ' TYR . 5.1 tm0? -68.56 152.83 44.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.476 -0.765 . . . . 0.0 109.118 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.58 ' H ' ' NE2' ' A' ' 55' ' ' GLN . 68.4 m-85 -133.05 114.25 13.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.223 -0.923 . . . . 0.0 109.806 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.63 155.72 26.03 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.458 ' C ' ' CD2' ' A' ' 59' ' ' HIS . 1.1 mp -130.41 146.44 51.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.884 -1.135 . . . . 0.0 110.664 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.461 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 6.9 m-70 -136.22 144.19 44.75 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.437 ' CE1' ' HG ' ' A' ' 62' ' ' LEU . 13.5 t80 -129.27 128.97 44.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.245 -0.909 . . . . 0.0 109.857 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -109.2 126.0 52.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.403 -0.811 . . . . 0.0 109.587 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.437 ' HG ' ' CE1' ' A' ' 60' ' ' TYR . 7.9 mt -104.06 162.18 13.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.423 -0.798 . . . . 0.0 109.906 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.536 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -120.54 158.6 15.53 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -82.34 -11.95 58.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.158 -1.201 . . . . 0.0 109.957 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.423 ' CD ' ' OG1' ' A' ' 37' ' ' THR . 0.4 OUTLIER -109.73 35.17 3.45 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.447 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.649 ' SG ' ' O ' ' A' ' 66' ' ' CYS . 18.5 p -130.45 97.76 4.49 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 122.44 1.114 . . . . 0.0 108.916 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 66' ' ' CYS . 1.2 m -52.46 -170.91 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.645 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -76.54 -17.82 59.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 109.561 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -64.18 -58.71 5.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.236 -0.915 . . . . 0.0 109.547 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -66.54 -40.1 88.91 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.375 -0.828 . . . . 0.0 109.123 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.7 t -73.81 -22.75 59.69 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.398 -0.813 . . . . 0.0 109.251 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -75.1 -35.36 49.57 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.75 -46.78 34.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.284 -1.127 . . . . 0.0 109.297 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.15 -39.81 87.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.349 -0.844 . . . . 0.0 109.324 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.46 -49.58 58.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.31 -0.869 . . . . 0.0 109.425 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.413 HG22 ' OE1' ' A' ' 80' ' ' GLN . 39.3 mt -48.31 -42.18 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -0.912 . . . . 0.0 109.411 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -70.06 -36.48 75.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 109.377 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.467 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 5.7 m -68.68 -34.94 76.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.265 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 87.5 t -70.37 -46.65 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.362 -0.836 . . . . 0.0 109.424 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.413 ' OE1' HG22 ' A' ' 76' ' ' ILE . 43.6 mt-30 -64.03 -46.27 85.18 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.295 -0.878 . . . . 0.0 109.192 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.626 HD11 HD23 ' A' ' 6' ' ' LEU . 2.5 mt -56.63 -36.61 69.69 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.261 -0.899 . . . . 0.0 108.88 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 86' ' ' ASN . 0.7 OUTLIER -61.53 -58.12 9.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.298 -0.876 . . . . 0.0 109.154 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.49 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 10.8 m-20 -50.7 -33.11 21.47 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.993 -1.067 . . . . 0.0 108.355 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -78.14 -25.87 47.57 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.569 ' C ' ' H ' ' A' ' 87' ' ' GLY . 8.5 mt -121.38 32.09 6.05 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.497 -0.752 . . . . 0.0 109.371 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 82' ' ' ASP . 26.8 p30 -72.77 26.38 0.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.271 -0.893 . . . . 0.0 108.849 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.569 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -78.25 56.59 4.04 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 62.03 55.23 2.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.477 -1.014 . . . . 0.0 109.69 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.22 179.09 4.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.373 -0.83 . . . . 0.0 109.186 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.1 t -134.68 151.52 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.607 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -115.75 136.63 52.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.383 -0.823 . . . . 0.0 109.416 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.485 ' O ' ' OE2' ' A' ' 94' ' ' GLU . 23.8 m80 -107.22 110.4 22.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.159 -0.963 . . . . 0.0 109.55 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.1 mtp85 -86.39 92.93 8.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.248 -0.908 . . . . 0.0 109.142 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.485 ' OE2' ' O ' ' A' ' 92' ' ' HIS . 20.2 mp0 -99.87 140.46 34.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.871 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.6 t -132.61 157.35 43.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.417 -0.802 . . . . 0.0 109.123 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.456 ' O ' ' CD ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -56.99 115.98 2.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.917 . . . . 0.0 109.499 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.89 9.92 65.39 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.456 ' O ' ' C ' ' A' ' 99' ' ' GLU . 11.5 t80 -144.98 30.07 1.18 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -1.156 . . . . 0.0 109.588 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.654 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 6.7 mp0 -41.82 157.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 0.0 109.497 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.7 p -87.29 177.76 7.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -0.889 . . . . 0.0 109.564 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.35 -57.01 4.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.458 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.8 m -46.77 -51.18 16.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.189 -0.945 . . . . 0.0 109.269 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.76 -52.5 63.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.387 -0.821 . . . . 0.0 109.203 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.6 mt -49.09 -28.68 4.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.89 . . . . 0.0 109.424 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.56 -14.11 51.44 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.444 ' O ' ' C ' ' A' ' 107' ' ' PHE . 7.2 t80 -83.08 -20.29 35.19 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.269 -1.136 . . . . 0.0 109.564 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.545 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 3.3 p90 -42.31 122.97 2.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.163 -0.961 . . . . 0.0 109.549 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -103.1 -57.12 2.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 109.427 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 72.8 m -106.15 -29.2 10.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -0.874 . . . . 0.0 109.413 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 132.49 107.9 1.09 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.697 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -76.42 160.27 29.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.211 -1.17 . . . . 0.0 109.449 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.1 mtpp -153.54 152.05 30.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -0.885 . . . . 0.0 109.511 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -98.28 138.68 35.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 109.421 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -142.5 154.36 44.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.894 . . . . 0.0 109.604 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -94.91 139.29 31.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.429 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -95.47 87.61 1.03 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -155.24 -62.19 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.6 m -95.82 142.81 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -1.14 . . . . 0.0 109.547 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.65 100.92 12.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 109.442 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.1 t -89.83 79.89 6.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.396 -0.815 . . . . 0.0 109.508 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 148.58 105.15 0.36 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 48.44 -140.63 0.64 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.261 -1.14 . . . . 0.0 109.435 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.0 tttp -158.47 123.98 4.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.898 . . . . 0.0 109.389 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.401 ' O ' HG23 ' A' ' 126' ' ' VAL . 1.1 t-80 -59.37 153.0 19.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.164 -0.96 . . . . 0.0 109.488 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.2 t -53.49 153.23 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.185 -0.947 . . . . 0.0 109.504 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 124' ' ' HIS . 91.7 t -145.07 83.21 9.43 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.88 . . . . 0.0 109.459 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 128' ' ' ASN . 51.7 Cg_exo -50.59 -38.91 55.95 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.726 2.284 . . . . 0.0 112.28 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 127' ' ' PRO . 5.3 t-20 61.04 133.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.383 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -92.6 95.43 9.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.489 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' A' ' 131' ' ' VAL . 96.8 t -151.91 107.91 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.174 -0.953 . . . . 0.0 109.426 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.478 HG13 ' N ' ' A' ' 132' ' ' VAL . 6.5 p -43.11 -40.84 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.323 -0.861 . . . . 0.0 109.482 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.478 ' N ' HG13 ' A' ' 131' ' ' VAL . 2.2 t -66.32 123.87 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.179 -0.951 . . . . 0.0 109.51 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.3 tp60 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.432 -179.953 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.491 ' O ' ' N ' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -142.0 154.75 65.44 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.271 -0.893 . . . . 0.0 109.3 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -40.94 87.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.648 2.232 . . . . 0.0 112.086 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.688 ' H ' HD22 ' A' ' 24' ' ' LEU . 67.5 tt0 -83.21 -18.02 40.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.355 -0.841 . . . . 0.0 109.999 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.465 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 2.3 m-85 -74.09 -5.91 44.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.092 -1.005 . . . . 0.0 109.541 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.5 mt -85.49 -39.62 17.26 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.205 -0.934 . . . . 0.0 109.417 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 8' ' ' ALA . 41.9 mtpt -97.67 -9.97 25.84 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.352 -0.843 . . . . 0.0 109.515 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -43.84 166.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 0.0 109.577 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 134.87 -29.9 2.91 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -78.94 23.7 0.34 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.245 -1.15 . . . . 0.0 109.377 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 13' ' ' GLY . 55.3 mt-10 -137.01 76.77 44.84 Favored Pre-proline 0 C--N 1.305 -1.367 0 O-C-N 121.288 -0.882 . . . . 0.0 109.547 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -52.25 81.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 122.867 2.378 . . . . 0.0 112.207 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 46' ' ' THR . . . 179.65 -102.98 0.17 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.639 HD21 ' CG2' ' A' ' 43' ' ' ILE . 7.1 tt -162.53 127.53 3.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -1.179 . . . . 0.0 109.81 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.59 ' N ' HD23 ' A' ' 14' ' ' LEU . 35.1 mt-30 -114.42 146.82 40.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.346 -0.846 . . . . 0.0 109.316 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.625 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 11.8 mt -130.68 123.86 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.502 -0.749 . . . . 0.0 110.284 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.625 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 11.3 m0 -143.88 158.94 43.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.043 -1.036 . . . . 0.0 108.528 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.504 ' NE ' ' CZ ' ' A' ' 41' ' ' TYR . 20.8 ttm180 -105.76 152.48 23.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.019 -1.051 . . . . 0.0 110.001 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.6 p -88.38 139.61 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.277 -0.889 . . . . 0.0 109.422 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.595 ' O ' ' N ' ' A' ' 22' ' ' PHE . 18.8 tt0 -88.69 152.61 21.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.23 -0.919 . . . . 0.0 109.203 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 20' ' ' GLU . 24.3 tttt -40.72 -20.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.307 -0.87 . . . . 0.0 109.555 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.595 ' N ' ' O ' ' A' ' 20' ' ' GLU . 7.2 t80 -160.14 32.1 0.17 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.175 -0.953 . . . . 0.0 109.492 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -170.71 -130.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.516 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.688 HD22 ' H ' ' A' ' 4' ' ' GLU . 5.9 tp -144.2 146.2 32.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 109.558 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 t -129.3 126.99 23.14 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.017 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -75.21 141.6 26.24 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.368 2.045 . . . . 0.0 112.383 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.5 t -104.35 122.84 42.56 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.379 -0.826 . . . . 0.0 109.242 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.32 162.08 34.14 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.514 2.143 . . . . 0.0 112.28 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.94 -24.64 67.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.216 -0.928 . . . . 0.0 109.428 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -64.02 -10.71 23.43 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 109.429 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 32' ' ' TYR . 94.9 mt -127.26 -13.16 5.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.289 -0.882 . . . . 0.0 109.531 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.531 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 4.4 t80 -41.11 131.05 2.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.372 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 112' ' ' LYS . . . 85.8 15.03 66.3 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -141.24 99.28 3.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -1.145 . . . . 0.0 109.48 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -97.04 164.94 12.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.276 -0.89 . . . . 0.0 109.494 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -105.2 136.08 45.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.449 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.449 ' OG1' ' CD ' ' A' ' 65' ' ' GLU . 4.1 p -73.35 -4.99 36.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.184 -0.948 . . . . 0.0 109.486 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.97 38.75 3.18 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 40' ' ' ALA . 5.9 t0 -171.23 171.01 5.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -1.189 . . . . 0.0 109.489 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.463 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -113.59 136.01 53.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.89 . . . . 0.0 109.546 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.504 ' CZ ' ' NE ' ' A' ' 18' ' ' ARG . 27.7 m-85 -114.91 142.64 46.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.333 -0.854 . . . . 0.0 109.345 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.011 ' O ' HD13 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -113.14 143.96 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.273 -0.892 . . . . 0.0 108.871 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.011 HD13 ' O ' ' A' ' 42' ' ' VAL . 1.2 mm -136.7 151.41 27.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.359 -0.937 . . . . 0.0 110.091 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.706 HD23 ' N ' ' A' ' 45' ' ' LYS . 4.5 tt -135.27 121.14 19.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.554 -0.716 . . . . 0.0 109.207 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.706 ' N ' HD23 ' A' ' 44' ' ' LEU . 31.5 tttt -104.96 112.48 25.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.251 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 55' ' ' GLN . 39.1 m -119.78 135.54 54.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.418 -0.801 . . . . 0.0 109.484 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.535 ' O ' HD23 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -126.95 168.29 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 121.304 -0.872 . . . . 0.0 108.907 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 40.9 tp60 -106.9 98.49 8.14 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.611 -0.68 . . . . 0.0 109.422 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.61 ' O ' ' N ' ' A' ' 51' ' ' ASN . 9.3 mt -65.03 157.75 27.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 109.239 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -51.72 84.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.12 -0.988 . . . . 0.0 109.099 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.61 ' N ' ' O ' ' A' ' 49' ' ' LEU . 6.6 m-20 51.43 43.36 29.59 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.229 -0.92 . . . . 0.0 109.192 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.82 -79.9 1.49 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -174.53 26.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.079 -1.248 . . . . 0.0 109.908 -179.674 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.616 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 3.9 mt 58.51 106.7 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.666 0.746 . . . . 0.0 109.118 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.593 ' O ' HG23 ' A' ' 46' ' ' THR . 32.1 tt0 -68.82 147.53 51.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.523 -0.735 . . . . 0.0 109.503 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.616 ' CE1' ' O ' ' A' ' 54' ' ' LEU . 97.7 m-85 -129.95 114.67 16.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.48 -0.762 . . . . 0.0 109.507 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.593 ' OD1' ' CE1' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -123.1 154.94 37.92 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.176 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.5 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 1.8 mp -132.93 150.2 52.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.958 -1.089 . . . . 0.0 110.753 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.704 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -141.96 116.93 9.93 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.36 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.667 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -103.8 121.89 43.98 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.023 -1.048 . . . . 0.0 109.52 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.553 ' NE1' ' OE1' ' A' ' 99' ' ' GLU . 71.4 t90 -98.99 136.25 39.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.866 . . . . 0.0 109.725 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.565 ' H ' HD12 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -116.63 159.04 22.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.397 -0.814 . . . . 0.0 109.4 179.791 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -101.07 148.34 18.1 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -70.37 -12.25 61.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -1.16 . . . . 0.0 109.49 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.449 ' CD ' ' OG1' ' A' ' 37' ' ' THR . 1.7 mt-10 -106.6 31.37 5.29 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.3 m -130.48 97.57 4.43 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.091 0.948 . . . . 0.0 108.513 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 66' ' ' CYS . 94.3 p -52.57 -170.88 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.783 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 72' ' ' GLY . 44.2 tt0 -64.63 -17.95 64.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.367 -0.833 . . . . 0.0 109.537 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -63.29 -58.69 6.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 109.473 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -68.16 -39.46 82.57 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.396 -0.815 . . . . 0.0 108.898 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 t -73.48 -20.98 60.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.515 -0.741 . . . . 0.0 109.064 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -75.66 -41.06 30.19 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.53 -42.16 71.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -1.121 . . . . 0.0 109.22 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.436 ' HB2' ' CB ' ' A' ' 40' ' ' ALA . . . -62.05 -42.04 98.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.328 -0.858 . . . . 0.0 109.285 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.513 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -64.91 -47.82 76.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.308 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.2 mt -52.76 -37.14 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.348 -0.845 . . . . 0.0 109.235 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.56 -41.34 79.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.342 -0.849 . . . . 0.0 109.293 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.9 m -68.28 -34.45 76.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 109.557 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 75' ' ' ALA . 61.8 t -68.06 -37.99 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.223 -0.923 . . . . 0.0 109.426 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.411 ' HG2' ' N ' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -68.39 -47.03 68.42 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.723 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.463 HD13 HD23 ' A' ' 58' ' ' LEU . 0.6 OUTLIER -55.43 -38.13 68.59 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.189 -0.945 . . . . 0.0 108.974 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.628 ' O ' ' N ' ' A' ' 86' ' ' ASN . 16.1 t70 -61.74 -58.33 8.45 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.318 -0.864 . . . . 0.0 109.109 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 82' ' ' ASP . 59.1 m-20 -45.43 -35.09 3.48 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.119 -0.988 . . . . 0.0 108.744 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -74.25 -32.66 63.04 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.361 -0.837 . . . . 0.0 108.834 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.577 ' C ' ' H ' ' A' ' 87' ' ' GLY . 7.7 mt -121.69 36.17 4.69 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.409 -0.807 . . . . 0.0 109.283 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.628 ' N ' ' O ' ' A' ' 82' ' ' ASP . 9.6 p30 -72.03 25.4 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.95 . . . . 0.0 109.143 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.577 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -80.41 -75.65 1.06 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.409 ' HG3' HH21 ' A' ' 88' ' ' ARG . 12.7 mtt85 -152.32 50.65 0.77 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.262 -1.14 . . . . 0.0 109.458 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -96.87 179.14 5.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.404 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.0 t -135.99 96.36 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.282 -0.886 . . . . 0.0 109.532 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 7.2 pt20 -95.87 143.92 26.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.905 . . . . 0.0 109.308 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.672 ' CE1' ' HD1' ' A' ' 59' ' ' HIS . 2.0 p80 -147.09 158.6 43.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.841 -1.162 . . . . 0.0 110.144 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.537 ' CG ' HD11 ' A' ' 62' ' ' LEU . 4.4 ttt180 -91.68 126.29 36.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.456 -0.778 . . . . 0.0 109.902 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.441 ' O ' HD12 ' A' ' 62' ' ' LEU . 21.4 mt-10 -107.49 129.91 54.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 109.229 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.491 ' O ' ' OE1' ' A' ' 99' ' ' GLU . 3.4 t -127.57 161.41 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 109.66 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -62.44 145.21 54.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.328 -0.858 . . . . 0.0 109.551 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.69 4.18 6.71 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.447 ' O ' ' C ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -134.08 6.13 3.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -1.101 . . . . 0.0 109.293 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.553 ' OE1' ' NE1' ' A' ' 61' ' ' TRP . 3.5 mp0 -42.64 158.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.417 -0.802 . . . . 0.0 109.351 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.1 m -80.32 147.44 31.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.313 -0.867 . . . . 0.0 109.369 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.71 -33.26 66.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -0.964 . . . . 0.0 109.432 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 99.4 m -68.68 -33.86 74.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -0.916 . . . . 0.0 109.481 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -68.74 -46.6 68.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.361 -0.837 . . . . 0.0 109.422 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.6 mt -69.36 -23.49 63.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.466 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.14 -26.24 22.04 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -77.33 -30.9 54.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.363 -1.081 . . . . 0.0 109.559 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -80.65 129.17 34.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.446 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.47 ' HB2' ' HZ3' ' A' ' 108' ' ' LYS . 1.9 mtmp? -103.21 -12.86 17.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.895 . . . . 0.0 109.457 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.9 t -97.05 -9.21 28.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.927 . . . . 0.0 109.511 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.59 104.48 0.3 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.766 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -63.27 179.82 0.39 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -1.123 . . . . 0.0 109.32 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -164.54 167.13 19.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.204 -0.935 . . . . 0.0 109.459 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.5 103.24 5.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 0.0 109.316 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -79.51 124.06 28.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.897 . . . . 0.0 109.536 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -92.73 144.49 25.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.125 -0.985 . . . . 0.0 109.479 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -102.01 48.81 1.05 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -161.1 95.86 0.14 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.0 p -147.64 -13.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.276 -1.132 . . . . 0.0 109.416 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.419 ' C ' ' H ' ' A' ' 121' ' ' GLY . . . -159.42 -174.44 4.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.495 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 47.0 t -75.42 37.23 0.13 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 109.46 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 122' ' ' PHE . . . 77.74 123.04 0.25 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 123' ' ' LYS . 55.6 t80 -47.66 -95.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -1.141 . . . . 0.0 109.376 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.452 ' N ' ' CD1' ' A' ' 122' ' ' PHE . 14.8 ptpt -57.01 -169.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 0.0 109.492 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.7 m80 -94.97 94.67 8.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 109.437 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.0 p -120.48 1.06 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.909 . . . . 0.0 109.409 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 126' ' ' VAL . 8.3 p -51.95 114.26 5.13 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.175 -0.953 . . . . 0.0 109.416 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -45.59 169.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.432 2.088 . . . . 0.0 112.237 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -99.19 55.22 0.99 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.566 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -56.68 158.25 4.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 109.477 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 49.0 t -69.46 72.81 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.247 -0.908 . . . . 0.0 109.533 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.2 t -151.12 113.05 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.245 -0.91 . . . . 0.0 109.429 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 61.4 t -150.85 79.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.29 -0.881 . . . . 0.0 109.445 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.441 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.555 ' OE2' ' N ' ' A' ' 1' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.546 ' H ' ' CG ' ' A' ' 23' ' ' ASP . 22.0 m80 -157.35 52.55 0.6 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.201 -0.937 . . . . 0.0 109.551 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 2' ' ' HIS . 34.8 Cg_endo -68.08 75.05 0.7 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.786 2.324 . . . . 0.0 111.994 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.425 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 6.0 mm-40 -83.42 -46.45 12.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -0.877 . . . . 0.0 109.993 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.804 ' CZ ' HG12 ' A' ' 42' ' ' VAL . 23.1 t80 -65.29 -32.66 74.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.207 -0.933 . . . . 0.0 109.058 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.509 HD23 HD11 ' A' ' 81' ' ' LEU . 12.2 mt -74.01 -35.85 64.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.31 -0.869 . . . . 0.0 109.314 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.497 ' O ' ' O ' ' A' ' 8' ' ' ALA . 12.4 mmmt -82.76 -9.88 59.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.435 -0.79 . . . . 0.0 109.307 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.497 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -45.58 173.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.595 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.4 32.57 1.77 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -150.25 35.61 0.66 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.324 -1.103 . . . . 0.0 109.412 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -155.09 115.5 2.36 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.296 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.15 81.85 2.6 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.442 2.094 . . . . 0.0 112.354 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 46' ' ' THR . . . 175.44 -100.62 0.15 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 tt -161.44 145.06 12.76 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.217 -1.167 . . . . 0.0 109.652 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.42 ' HB3' ' CZ3' ' A' ' 17' ' ' TRP . 1.2 mt-30 -133.75 135.96 44.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 109.239 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.409 HG23 HD12 ' A' ' 43' ' ' ILE . 13.3 mt -106.83 135.65 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.349 -0.844 . . . . 0.0 110.067 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.425 ' CE2' ' HB3' ' A' ' 4' ' ' GLU . 0.6 OUTLIER -144.34 111.38 5.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.379 -0.825 . . . . 0.0 108.948 179.466 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.569 ' NH2' ' CD1' ' A' ' 36' ' ' PHE . 28.2 ttt180 -74.79 153.03 38.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.192 -0.942 . . . . 0.0 109.473 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.9 p -77.14 145.14 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 109.792 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 22' ' ' PHE . 21.6 tt0 -108.08 154.58 21.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.405 -0.809 . . . . 0.0 109.187 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.591 ' O ' ' CD2' ' A' ' 22' ' ' PHE . 7.2 mtmp? -46.93 -10.86 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.287 -0.883 . . . . 0.0 109.513 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 21' ' ' LYS . 9.5 m-85 -169.53 28.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 109.529 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.675 ' C ' HD22 ' A' ' 24' ' ' LEU . 3.7 t70 -176.03 -154.17 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.918 . . . . 0.0 109.592 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.675 HD22 ' C ' ' A' ' 23' ' ' ASP . 4.5 mm? -117.83 146.01 44.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.312 -0.868 . . . . 0.0 109.425 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 18' ' ' ARG . 2.1 t -125.08 130.65 24.12 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.323 -0.861 . . . . 0.0 109.048 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.56 137.61 20.71 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.344 2.029 . . . . 0.0 112.631 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -122.25 101.68 40.88 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.428 -0.795 . . . . 0.0 108.973 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.66 166.93 23.21 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.466 2.111 . . . . 0.0 112.478 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.35 -17.8 22.73 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.22 -0.925 . . . . 0.0 109.31 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.476 ' N ' ' OD1' ' A' ' 30' ' ' ASN . 1.5 m-20 -44.45 -31.18 1.01 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.939 . . . . 0.0 109.361 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.487 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 2.3 pp -160.45 16.64 0.13 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.247 -0.908 . . . . 0.0 109.837 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -56.33 161.4 2.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.992 -1.067 . . . . 0.0 109.423 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.57 -7.77 63.69 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.487 ' OD2' ' O ' ' A' ' 31' ' ' LEU . 11.3 p-10 -93.01 98.14 11.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -1.145 . . . . 0.0 109.373 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.485 ' CE1' HD23 ' A' ' 111' ' ' LEU . 51.1 m-85 -89.61 133.71 34.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.279 -0.888 . . . . 0.0 109.508 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.569 ' CD1' ' NH2' ' A' ' 18' ' ' ARG . 28.2 m-85 -96.52 127.4 42.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 109.525 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 28.5 p -68.83 -4.87 17.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.879 . . . . 0.0 109.576 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.22 43.82 1.54 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -167.99 -168.25 0.95 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.244 -1.15 . . . . 0.0 109.49 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.83 145.25 44.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.959 . . . . 0.0 109.497 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.574 ' HB3' HD11 ' A' ' 43' ' ' ILE . 1.7 m-85 -118.73 135.77 54.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.399 -0.813 . . . . 0.0 109.455 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.064 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -115.62 120.11 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.428 -0.795 . . . . 0.0 109.048 179.785 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.064 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -125.1 130.0 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.16 -0.962 . . . . 0.0 110.299 -179.211 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 57' ' ' ASP . 6.0 tp -104.79 121.0 42.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.565 -0.709 . . . . 0.0 109.166 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.554 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.1 tptm -104.83 103.81 13.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.37 -0.831 . . . . 0.0 109.178 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 55' ' ' GLN . 16.9 m -117.22 139.1 51.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.331 -0.856 . . . . 0.0 109.521 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.561 ' O ' HD23 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -131.65 168.39 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.246 -0.909 . . . . 0.0 109.491 -179.685 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.565 HE22 ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -111.69 133.49 53.89 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.651 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.626 ' O ' ' C ' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -116.06 100.33 7.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.202 -0.936 . . . . 0.0 109.554 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.626 ' C ' ' O ' ' A' ' 49' ' ' LEU . 31.0 ttt85 21.23 72.54 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.68 -0.638 . . . . 0.0 110.235 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.412 ' OD1' ' N ' ' A' ' 51' ' ' ASN . 1.8 m120 45.87 52.04 10.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.381 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . -97.11 -81.74 1.6 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -165.15 20.73 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.347 -1.09 . . . . 0.0 109.754 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.592 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 5.9 mt 53.77 104.65 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.489 -0.757 . . . . 0.0 109.306 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.501 ' O ' HG23 ' A' ' 46' ' ' THR . 32.1 tt0 -68.04 149.69 49.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.538 -0.726 . . . . 0.0 109.043 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.592 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 97.1 m-85 -131.47 114.89 15.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.941 . . . . 0.0 109.94 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.613 ' O ' HD12 ' A' ' 44' ' ' LEU . 2.0 m-20 -120.29 155.03 34.11 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.465 HD13 ' HG3' ' A' ' 91' ' ' GLN . 4.8 mp -136.25 129.78 32.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.947 -1.095 . . . . 0.0 110.162 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.586 ' ND1' ' NE2' ' A' ' 92' ' ' HIS . 3.1 m-70 -115.62 109.65 18.05 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.658 ' CZ ' HD22 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -99.55 115.81 30.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 109.317 -179.61 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -108.16 142.31 38.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.29 -0.881 . . . . 0.0 109.752 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.658 HD22 ' CZ ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -133.52 162.21 32.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 109.526 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -87.24 154.41 26.3 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -82.07 -12.42 58.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -1.122 . . . . 0.0 109.564 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -106.81 32.79 4.3 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.498 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.3 m -130.23 97.67 4.5 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.261 1.029 . . . . 0.0 108.438 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 66' ' ' CYS . 1.2 t -44.32 173.87 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.855 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.596 ' O ' ' N ' ' A' ' 72' ' ' GLY . 3.3 pt20 -57.25 -17.45 11.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.483 -0.761 . . . . 0.0 109.732 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -61.22 -59.1 5.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.054 -1.029 . . . . 0.0 109.384 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.28 -50.75 66.69 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 108.691 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.2 m -64.98 -20.87 66.71 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.15 -43.83 62.55 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.69 -49.07 67.31 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -1.157 . . . . 0.0 109.103 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.69 -43.9 90.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.393 -0.817 . . . . 0.0 109.211 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.553 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -66.73 -47.2 73.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.353 -0.842 . . . . 0.0 109.478 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.9 mt -47.08 -44.12 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.888 . . . . 0.0 109.091 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.458 ' O ' HD12 ' A' ' 81' ' ' LEU . 37.5 m-85 -65.77 -45.92 80.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.298 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.4 m -66.14 -22.58 66.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.245 -0.909 . . . . 0.0 109.009 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 75' ' ' ALA . 66.3 t -73.57 -50.28 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.288 -0.883 . . . . 0.0 109.459 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -61.66 -49.86 74.84 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.321 -0.862 . . . . 0.0 108.92 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.509 HD11 HD23 ' A' ' 6' ' ' LEU . 0.9 OUTLIER -55.15 -37.68 67.29 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.28 -0.888 . . . . 0.0 109.037 179.552 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 86' ' ' ASN . 64.5 t0 -58.07 -55.87 29.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.226 -0.921 . . . . 0.0 108.883 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 -50.32 -33.98 22.08 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.08 -1.012 . . . . 0.0 108.362 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -77.1 -24.27 51.8 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 82' ' ' ASP . 12.6 mt -121.4 30.45 6.76 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.326 -0.859 . . . . 0.0 109.419 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.1 OUTLIER -80.13 27.99 0.31 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.309 -0.869 . . . . 0.0 108.974 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -83.17 -54.35 3.2 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.6 ptt-85 -175.81 42.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -1.112 . . . . 0.0 109.62 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.581 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -95.53 178.88 5.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.497 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 87.4 t -123.27 91.97 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.437 -0.789 . . . . 0.0 109.337 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.535 ' H ' ' CD ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -96.57 125.18 40.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.342 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.586 ' NE2' ' ND1' ' A' ' 59' ' ' HIS . 2.7 p80 -133.52 143.78 48.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.143 -0.973 . . . . 0.0 109.618 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -99.32 105.29 17.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.227 -0.92 . . . . 0.0 109.69 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.423 ' OE1' ' OG ' ' A' ' 100' ' ' SER . 41.0 mt-10 -87.11 148.16 25.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.321 -0.862 . . . . 0.0 109.391 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 t -135.28 163.46 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.196 -0.94 . . . . 0.0 109.487 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 97' ' ' GLY . 6.2 tp-100 -75.4 126.35 30.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.242 -0.911 . . . . 0.0 109.557 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.548 ' N ' ' OE1' ' A' ' 96' ' ' GLN . . . 121.19 4.58 10.03 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.459 ' O ' ' C ' ' A' ' 99' ' ' GLU . 35.9 t80 -174.0 -34.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.226 -1.161 . . . . 0.0 109.448 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 98' ' ' PHE . 14.1 mt-10 41.64 -155.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.356 -0.84 . . . . 0.0 109.569 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.423 ' OG ' ' OE1' ' A' ' 94' ' ' GLU . 78.7 p -129.78 134.3 47.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 109.5 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 100' ' ' SER . . . -44.81 -37.66 3.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.292 -0.88 . . . . 0.0 109.38 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 m -55.54 -48.34 74.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.231 -0.918 . . . . 0.0 109.346 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -62.69 -55.64 25.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 0.0 109.194 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.3 mt -47.39 -26.67 1.38 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.877 . . . . 0.0 109.242 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.71 -40.16 7.83 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.5 ' OH ' ' NZ ' ' A' ' 45' ' ' LYS . 2.7 m-85 -51.87 -46.71 64.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -1.114 . . . . 0.0 109.314 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -139.27 149.71 44.61 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.387 -0.821 . . . . 0.0 109.6 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.89 -56.82 2.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 0.0 109.286 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 110' ' ' GLY . 5.0 m -103.02 -26.81 12.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.496 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 109' ' ' SER . . . -42.44 -59.93 2.94 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.485 HD23 ' CE1' ' A' ' 35' ' ' PHE . 13.9 mt -44.87 134.28 5.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.257 -1.143 . . . . 0.0 109.445 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.3 mttp -151.23 121.56 7.31 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.224 -0.923 . . . . 0.0 109.406 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.448 ' CD2' ' N ' ' A' ' 113' ' ' TYR . 0.6 OUTLIER -98.0 127.8 44.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.302 -0.874 . . . . 0.0 109.443 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -135.42 134.13 39.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 109.457 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 31.9 mtmt -66.2 143.84 57.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.146 -0.971 . . . . 0.0 109.506 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' A' ' 118' ' ' VAL . . . -66.98 -9.09 52.68 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.18 -39.4 0.44 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.494 ' H ' ' C ' ' A' ' 116' ' ' GLY . 60.2 t -96.41 69.31 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -1.152 . . . . 0.0 109.416 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . -60.38 -153.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.294 -0.879 . . . . 0.0 109.422 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.99 -73.8 0.33 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 47.73 -152.6 1.88 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -75.17 -168.43 0.77 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -1.136 . . . . 0.0 109.418 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -166.5 128.12 1.77 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 109.519 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.29 124.78 37.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 109.443 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.427 ' C ' HG23 ' A' ' 126' ' ' VAL . 2.0 t -98.49 5.72 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.884 . . . . 0.0 109.497 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 127' ' ' PRO . 2.2 t 61.01 80.82 0.25 Allowed Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.329 -0.857 . . . . 0.0 109.515 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 126' ' ' VAL . 50.9 Cg_exo -51.44 -155.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.809 2.339 . . . . 0.0 112.239 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.525 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.5 OUTLIER -89.29 179.18 6.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.466 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -157.02 68.19 0.55 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.207 -0.933 . . . . 0.0 109.47 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.5 t -65.19 82.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 109.583 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 131' ' ' VAL . 6.5 p -75.31 93.72 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 109.536 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.6 t -56.0 125.57 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.193 -0.942 . . . . 0.0 109.506 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.418 ' OXT' ' CD ' ' A' ' 133' ' ' GLN . 10.4 tm0? . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.507 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.449 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 2.3 pm0 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.35 155.66 37.1 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.428 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -66.71 87.77 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.764 2.309 . . . . 0.0 112.007 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.585 ' H ' HD13 ' A' ' 24' ' ' LEU . 4.4 mm-40 -83.41 -37.4 23.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 109.973 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.592 ' CE1' ' CG1' ' A' ' 42' ' ' VAL . 23.5 t80 -70.07 -24.29 63.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.175 -0.953 . . . . 0.0 110.031 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.492 HD23 ' N ' ' A' ' 6' ' ' LEU . 4.1 mt -80.76 -40.34 25.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.081 -1.012 . . . . 0.0 109.677 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.493 ' O ' ' O ' ' A' ' 8' ' ' ALA . 4.2 pttm -96.51 3.45 52.7 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.294 -0.879 . . . . 0.0 109.587 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -54.03 -165.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.77 64.9 1.35 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.18 17.96 1.91 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.336 -1.097 . . . . 0.0 109.588 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.476 ' O ' ' OE1' ' A' ' 11' ' ' GLU . 1.9 pp20? -156.18 134.15 7.05 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.18 -0.95 . . . . 0.0 109.421 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.34 84.65 1.67 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.526 2.151 . . . . 0.0 112.286 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 46' ' ' THR . . . 178.35 -100.55 0.14 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 tt -162.21 152.63 17.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.24 -1.153 . . . . 0.0 109.487 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -135.36 142.24 45.7 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.272 -0.892 . . . . 0.0 109.553 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.535 HG23 HD12 ' A' ' 43' ' ' ILE . 22.3 mt -117.22 133.16 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.32 -0.863 . . . . 0.0 109.801 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -139.26 119.37 13.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.313 -0.867 . . . . 0.0 109.085 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.479 HH11 ' CB ' ' A' ' 39' ' ' ASP . 15.3 ttt85 -85.47 153.62 22.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.235 -0.916 . . . . 0.0 109.647 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 22' ' ' PHE . 38.8 t -91.99 123.49 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.218 -0.926 . . . . 0.0 110.043 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.763 ' O ' ' N ' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -71.02 85.82 0.72 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.982 -1.074 . . . . 0.0 108.482 179.405 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.652 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 48.8 tttt 43.63 6.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.361 -0.837 . . . . 0.0 109.415 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.763 ' N ' ' O ' ' A' ' 20' ' ' GLU . 0.7 OUTLIER 160.92 -30.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.849 . . . . 0.0 109.292 -179.802 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -95.08 -129.52 0.14 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.179 -0.951 . . . . 0.0 110.076 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.585 HD13 ' H ' ' A' ' 4' ' ' GLU . 3.8 mt -139.99 142.65 36.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.127 -0.983 . . . . 0.0 110.265 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 18' ' ' ARG . 3.4 t -142.11 110.29 5.97 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.831 . . . . 0.0 108.96 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -46.27 151.59 1.63 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.067 1.845 . . . . 0.0 111.808 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.11 101.47 45.04 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.944 . . . . 0.0 109.61 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.02 162.58 1.83 Allowed 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.506 2.138 . . . . 0.0 112.257 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.6 m -78.22 -34.79 49.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 109.348 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -56.63 -16.95 7.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.405 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.458 ' O ' ' C ' ' A' ' 32' ' ' TYR . 15.6 mt -112.35 -25.96 8.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.263 -0.898 . . . . 0.0 109.551 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.566 ' OH ' ' CE2' ' A' ' 107' ' ' PHE . 19.0 t80 -41.63 137.08 1.7 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.891 . . . . 0.0 109.453 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.44 -16.71 48.27 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -100.18 121.96 42.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -1.189 . . . . 0.0 109.438 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -102.53 121.58 42.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.189 -0.945 . . . . 0.0 109.536 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -95.96 144.23 26.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.465 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.4 p -97.05 -10.22 26.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -100.22 34.23 5.69 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.479 ' CB ' HH11 ' A' ' 18' ' ' ARG . 4.8 m-20 -163.78 -177.1 4.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -1.149 . . . . 0.0 109.496 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.406 ' C ' ' CD2' ' A' ' 41' ' ' TYR . . . -140.46 146.9 38.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.256 -0.903 . . . . 0.0 109.405 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.585 ' OH ' ' CZ3' ' A' ' 61' ' ' TRP . 0.1 OUTLIER -142.56 137.88 30.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.121 -0.987 . . . . 0.0 109.793 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.945 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -101.29 144.23 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.945 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.6 OUTLIER -128.02 134.37 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.512 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.668 HD23 ' C ' ' A' ' 44' ' ' LEU . 4.7 tt -109.66 116.2 31.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.627 -0.671 . . . . 0.0 109.397 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.649 ' N ' HD23 ' A' ' 44' ' ' LEU . 8.5 ttpt -92.43 139.48 30.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.219 -0.926 . . . . 0.0 109.44 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.525 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.6 OUTLIER -143.07 118.62 10.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.119 -0.988 . . . . 0.0 109.413 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.694 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -128.24 167.97 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.109 -0.995 . . . . 0.0 109.224 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -95.37 120.25 35.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.571 -0.705 . . . . 0.0 109.433 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 52' ' ' GLY . 82.2 mt -74.86 168.8 19.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -0.956 . . . . 0.0 109.487 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 49' ' ' LEU . 13.5 ttt-85 -43.31 -48.92 6.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.273 -0.892 . . . . 0.0 109.177 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.426 HD21 ' C ' ' A' ' 51' ' ' ASN . 0.1 OUTLIER -81.49 -12.07 58.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.308 -0.87 . . . . 0.0 109.132 179.693 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . 88.77 31.85 12.09 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.499 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.8 m120 -78.65 13.92 1.48 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.13 -1.217 . . . . 0.0 109.206 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.694 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.0 mt 43.82 96.8 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 121.438 0.637 . . . . 0.0 109.566 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.51 ' HB2' HD21 ' A' ' 49' ' ' LEU . 28.1 tp60 -77.67 118.09 19.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.386 -0.821 . . . . 0.0 109.465 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -96.16 114.14 25.81 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.137 -0.977 . . . . 0.0 109.585 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -113.43 150.2 33.09 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.189 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.587 HD22 ' O ' ' A' ' 57' ' ' ASP . 4.1 mm? -117.1 136.56 52.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.089 -1.007 . . . . 0.0 110.068 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.544 ' CD2' ' HB2' ' A' ' 92' ' ' HIS . 32.1 m80 -135.43 125.48 26.0 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.653 ' CE2' HD22 ' A' ' 62' ' ' LEU . 9.4 t80 -117.36 135.18 54.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 109.819 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.585 ' CZ3' ' OH ' ' A' ' 41' ' ' TYR . 27.9 t90 -120.2 124.24 45.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.413 -0.804 . . . . 0.0 109.289 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.653 HD22 ' CE2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -112.86 162.31 15.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.359 -0.838 . . . . 0.0 109.523 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.02 156.1 19.62 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -78.12 -11.71 59.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.391 -1.064 . . . . 0.0 109.482 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -102.25 32.41 3.54 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.498 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.0 OUTLIER -130.79 97.56 4.38 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.181 0.991 . . . . 0.0 108.359 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 66' ' ' CYS . 20.6 t -42.02 167.97 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.785 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.564 ' O ' ' N ' ' A' ' 72' ' ' GLY . 27.0 tt0 -56.59 -17.76 9.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.901 . . . . 0.0 109.592 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -62.6 -58.65 6.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 109.376 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.557 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -63.07 -48.63 77.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 0.0 109.079 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.8 -21.62 64.31 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.311 -0.868 . . . . 0.0 109.055 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -75.65 -40.5 31.76 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.59 -39.2 77.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.194 -1.18 . . . . 0.0 109.162 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.515 ' CB ' ' CZ ' ' A' ' 60' ' ' TYR . . . -65.81 -46.53 78.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.489 -0.757 . . . . 0.0 109.226 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -60.3 -37.52 80.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.311 -0.868 . . . . 0.0 109.337 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.8 mt -60.88 -49.25 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.41 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -65.56 -31.43 72.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.279 -0.888 . . . . 0.0 109.405 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.1 m -72.8 -41.95 64.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.225 -0.922 . . . . 0.0 109.278 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 75' ' ' ALA . 89.8 t -63.34 -35.83 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.243 -0.91 . . . . 0.0 109.297 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 19.0 mt-30 -65.67 -51.37 59.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.331 -0.856 . . . . 0.0 109.071 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 mt -51.72 -39.49 58.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.034 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 85' ' ' LEU . 13.4 t0 -60.16 -58.75 7.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.307 -0.87 . . . . 0.0 109.144 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 82' ' ' ASP . 24.0 t0 -45.14 -34.16 2.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.207 -0.933 . . . . 0.0 108.881 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -76.57 -28.25 56.17 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.309 -0.869 . . . . 0.0 108.868 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.555 ' N ' ' O ' ' A' ' 82' ' ' ASP . 11.5 mt -121.69 32.14 5.99 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.354 -0.841 . . . . 0.0 109.736 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.1 OUTLIER -79.34 27.51 0.26 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.165 -0.959 . . . . 0.0 109.13 179.796 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -89.9 -49.22 3.4 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.434 ' CG ' ' O ' ' A' ' 87' ' ' GLY . 57.8 mtm-85 -158.41 41.61 0.26 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.248 -1.148 . . . . 0.0 109.462 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -127.63 165.25 20.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.399 -0.813 . . . . 0.0 109.226 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.623 HG12 ' N ' ' A' ' 91' ' ' GLN . 98.6 t -135.92 167.34 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.914 . . . . 0.0 109.589 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.623 ' N ' HG12 ' A' ' 90' ' ' VAL . 10.3 mp0 -119.31 134.51 55.17 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.39 -0.819 . . . . 0.0 109.465 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.544 ' HB2' ' CD2' ' A' ' 59' ' ' HIS . 20.8 m80 -105.72 105.14 15.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 109.582 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.2 mtm180 -77.95 102.4 7.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.946 . . . . 0.0 109.309 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.558 ' OE2' ' CD2' ' A' ' 103' ' ' PHE . 50.2 mt-10 -102.33 134.09 46.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.189 -0.944 . . . . 0.0 109.747 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 96' ' ' GLN . 3.1 t -132.88 168.62 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.401 -0.812 . . . . 0.0 109.269 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.453 ' H ' HG12 ' A' ' 95' ' ' VAL . 4.5 tt0 -69.94 118.34 12.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 109.57 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.514 ' O ' ' CD1' ' A' ' 98' ' ' PHE . . . 91.0 11.29 61.67 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 24.8 m-85 -152.55 24.66 0.6 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -1.161 . . . . 0.0 109.665 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 98' ' ' PHE . 27.6 mt-10 -42.82 150.96 0.14 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.173 -0.955 . . . . 0.0 109.409 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.8 p -78.24 168.14 20.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.226 -0.921 . . . . 0.0 109.553 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.45 -61.68 1.78 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -0.906 . . . . 0.0 109.485 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.4 m -47.25 -45.04 23.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.377 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.558 ' CD2' ' OE2' ' A' ' 94' ' ' GLU . 29.1 t80 -58.67 -53.49 57.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.38 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.7 mt -56.1 -28.83 59.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.89 . . . . 0.0 109.386 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -78.0 -25.54 61.9 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -77.83 -30.08 50.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -1.158 . . . . 0.0 109.338 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.566 ' CE2' ' OH ' ' A' ' 32' ' ' TYR . 54.3 m-85 -139.06 127.35 22.74 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.256 -0.902 . . . . 0.0 109.35 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.455 ' HB2' ' HZ3' ' A' ' 108' ' ' LYS . 12.6 ttmm -105.51 -57.01 2.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 109.51 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.0 t -106.03 15.2 26.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.497 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -106.33 28.42 13.68 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.406 HD23 ' N ' ' A' ' 111' ' ' LEU . 0.3 OUTLIER -140.69 54.78 1.59 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.281 -1.129 . . . . 0.0 109.558 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -73.87 135.67 43.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.317 -0.865 . . . . 0.0 109.486 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.496 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 0.9 OUTLIER -92.37 111.32 22.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.472 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -107.99 121.14 44.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.313 -0.867 . . . . 0.0 109.582 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -56.97 122.08 11.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.504 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -87.51 138.76 15.51 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -151.95 -61.73 0.01 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.415 HG12 ' H ' ' A' ' 120' ' ' SER . 18.6 t -83.86 118.29 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.275 -1.132 . . . . 0.0 109.522 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.51 30.45 0.71 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 109.513 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' SER . . . . . 0.415 ' H ' HG12 ' A' ' 118' ' ' VAL . 94.4 p -172.77 107.1 0.17 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 109.396 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -169.66 14.66 0.06 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -151.69 91.12 1.61 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.282 -1.128 . . . . 0.0 109.513 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.451 ' O ' ' C ' ' A' ' 124' ' ' HIS . 42.2 mttm -68.07 -156.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.947 . . . . 0.0 109.422 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.451 ' C ' ' O ' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -42.1 162.01 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -0.865 . . . . 0.0 109.485 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.597 HG22 ' N ' ' A' ' 126' ' ' VAL . 7.6 p -66.99 165.4 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.122 -0.986 . . . . 0.0 109.423 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.597 ' N ' HG22 ' A' ' 125' ' ' VAL . 2.3 m -117.89 87.4 27.55 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.331 -0.856 . . . . 0.0 109.424 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -50.66 -69.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.704 2.27 . . . . 0.0 112.255 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -162.48 131.4 4.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 109.494 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -103.59 162.29 13.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 109.376 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.475 ' O ' ' N ' ' A' ' 132' ' ' VAL . 55.6 t -83.07 -33.95 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.254 -0.904 . . . . 0.0 109.543 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.775 HG13 ' O ' ' A' ' 131' ' ' VAL . 12.0 p -67.44 68.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 109.474 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.475 ' N ' ' O ' ' A' ' 130' ' ' VAL . 72.3 t -86.01 129.98 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.92 . . . . 0.0 109.514 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.549 -179.976 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.684 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -92.09 -38.53 0.36 Allowed Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.216 -0.927 . . . . 0.0 109.694 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' A' ' 2' ' ' HIS . 16.7 Cg_exo -64.63 49.72 0.17 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.756 2.304 . . . . 0.0 112.091 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 8' ' ' ALA . 41.9 mt-10 -83.13 -45.74 13.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.126 -0.984 . . . . 0.0 109.703 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.537 ' CE1' ' CD1' ' A' ' 81' ' ' LEU . 68.2 t80 -48.67 -22.57 0.8 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -0.908 . . . . 0.0 109.287 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.569 HD23 HD11 ' A' ' 81' ' ' LEU . 85.1 mt -83.61 -40.52 18.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 109.484 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' ALA . 42.8 mmtm -101.24 7.15 43.1 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.39 -0.819 . . . . 0.0 109.549 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 4' ' ' GLU . . . -56.01 -164.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.421 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.464 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 104.86 -27.67 17.94 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -75.76 21.51 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -1.152 . . . . 0.0 109.4 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.464 ' H ' ' C ' ' A' ' 9' ' ' GLY . 26.9 mm-40 -135.12 115.43 11.95 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.259 -0.9 . . . . 0.0 109.356 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.86 73.85 5.5 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.376 2.051 . . . . 0.0 112.277 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -177.28 -103.34 0.17 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.767 HD23 ' C ' ' A' ' 14' ' ' LEU . 3.3 tt -162.26 146.98 12.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.239 -1.153 . . . . 0.0 109.581 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.566 ' N ' HD23 ' A' ' 14' ' ' LEU . 24.0 mt-30 -139.3 145.53 39.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.28 -0.887 . . . . 0.0 109.347 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.55 HD12 ' CE1' ' A' ' 32' ' ' TYR . 10.7 mt -114.18 146.52 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.396 -0.815 . . . . 0.0 110.198 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.451 ' CZ2' ' CB ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER -149.55 138.73 21.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.435 -0.791 . . . . 0.0 109.063 179.665 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -96.67 144.64 26.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 109.473 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.562 HG12 ' O ' ' A' ' 40' ' ' ALA . 12.4 p -81.02 143.82 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 109.494 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.58 ' O ' ' N ' ' A' ' 22' ' ' PHE . 39.9 tt0 -103.3 153.41 20.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.368 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 20' ' ' GLU . 7.6 mtmp? -41.48 -20.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.648 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.58 ' N ' ' O ' ' A' ' 20' ' ' GLU . 3.0 p90 -160.99 30.52 0.14 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.17 -0.956 . . . . 0.0 109.524 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.625 ' C ' HD12 ' A' ' 24' ' ' LEU . 9.8 t70 -174.07 -130.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -0.912 . . . . 0.0 109.53 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.625 HD12 ' C ' ' A' ' 23' ' ' ASP . 5.5 mp -144.34 146.07 32.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.322 -0.861 . . . . 0.0 109.562 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 t -126.31 112.93 23.55 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.393 -0.817 . . . . 0.0 109.427 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.49 152.64 5.89 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.436 2.091 . . . . 0.0 112.313 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.9 t -110.39 101.89 49.81 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.898 . . . . 0.0 109.317 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -48.43 143.47 15.45 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.476 2.117 . . . . 0.0 112.319 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.528 ' C ' ' H ' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -55.96 -44.11 78.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.876 . . . . 0.0 109.376 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -56.72 -2.6 0.08 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 0.0 109.481 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.528 ' H ' ' C ' ' A' ' 29' ' ' THR . 86.4 mt -129.23 -10.73 4.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.202 -0.936 . . . . 0.0 109.551 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.55 ' CE1' HD12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -41.84 124.37 2.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -0.89 . . . . 0.0 109.453 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.39 -9.37 57.46 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -97.98 107.13 19.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.184 -1.186 . . . . 0.0 109.462 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -96.15 150.52 20.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.89 . . . . 0.0 109.536 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -105.03 112.14 25.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 109.402 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.1 p -58.36 -17.07 17.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 109.586 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.447 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -88.15 10.71 69.88 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.447 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 46.6 m-20 -159.49 170.56 21.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.225 -1.162 . . . . 0.0 109.511 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.562 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -109.76 152.38 25.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.387 -0.821 . . . . 0.0 109.504 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -122.12 134.9 54.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.337 -0.852 . . . . 0.0 109.239 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.93 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -103.19 138.38 27.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.143 -0.973 . . . . 0.0 108.91 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.93 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.9 OUTLIER -131.25 145.62 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.615 -179.357 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.63 HD23 ' N ' ' A' ' 45' ' ' LYS . 3.9 tt -123.64 118.45 27.3 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.63 ' N ' HD23 ' A' ' 44' ' ' LEU . 35.0 tttp -103.94 103.77 13.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.358 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.788 HG23 ' O ' ' A' ' 55' ' ' GLN . 33.8 m -112.63 137.15 51.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 109.423 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -133.03 168.58 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 121.158 -0.964 . . . . 0.0 109.586 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -102.58 100.74 10.84 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.8 mt -69.19 168.34 14.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.739 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.594 ' CD ' ' H ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -48.23 -73.18 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.331 -0.855 . . . . 0.0 109.265 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 50' ' ' ARG . 28.3 m-20 -43.63 -25.9 0.2 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.303 -0.873 . . . . 0.0 109.16 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 50' ' ' ARG . . . 89.03 36.68 7.55 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.515 ' O ' ' O ' ' A' ' 54' ' ' LEU . 51.2 m-20 -87.61 12.81 11.63 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.15 -1.206 . . . . 0.0 109.361 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.598 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 11.1 mt 42.56 97.3 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 121.455 0.645 . . . . 0.0 109.443 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.788 ' O ' HG23 ' A' ' 46' ' ' THR . 58.3 tt0 -68.07 154.09 42.38 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.239 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.598 ' CE1' ' O ' ' A' ' 54' ' ' LEU . 95.6 m-85 -133.74 114.82 13.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.295 -0.878 . . . . 0.0 109.66 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -121.0 155.12 35.02 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 58' ' ' LEU . 3.2 mp -138.78 129.06 25.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.943 -1.098 . . . . 0.0 109.972 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 3.3 m-70 -121.3 127.39 51.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.415 -0.803 . . . . 0.0 109.024 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.704 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -106.15 124.9 50.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.187 -0.946 . . . . 0.0 109.537 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.498 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 39.2 t90 -102.88 123.89 47.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.216 -0.927 . . . . 0.0 109.354 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.498 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 20.1 mt -102.73 162.01 13.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.49 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.0 155.99 15.81 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.438 ' ND2' ' HG2' ' A' ' 65' ' ' GLU . 7.2 p-10 -78.98 -11.97 60.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.188 -1.183 . . . . 0.0 109.448 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.438 ' HG2' ' ND2' ' A' ' 64' ' ' ASN . 4.6 mt-10 -106.44 24.37 12.67 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.496 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.7 m -130.95 97.56 4.35 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.163 0.982 . . . . 0.0 108.473 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 66' ' ' CYS . 9.9 m -51.48 -171.25 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.673 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.594 ' OE1' ' N ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -70.74 -17.6 62.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.349 -0.845 . . . . 0.0 109.516 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -62.29 -58.64 6.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.13 -0.981 . . . . 0.0 109.435 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.508 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 3.3 mp0 -65.87 -45.06 83.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.32 -0.863 . . . . 0.0 108.894 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.2 t -69.67 -20.97 63.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.331 -0.856 . . . . 0.0 109.041 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -73.25 -41.01 47.96 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.92 -46.09 66.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.298 -1.119 . . . . 0.0 109.247 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.46 -44.58 92.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.349 -0.844 . . . . 0.0 109.23 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -61.12 -47.58 85.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.275 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.5 mt -49.62 -46.34 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 109.241 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -61.01 -40.53 93.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 109.345 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.4 m -67.02 -31.52 72.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.159 -0.963 . . . . 0.0 109.33 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 75' ' ' ALA . 91.2 t -66.0 -44.19 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.335 -0.853 . . . . 0.0 109.334 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -61.63 -50.92 70.6 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.281 -0.887 . . . . 0.0 109.192 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.569 HD11 HD23 ' A' ' 6' ' ' LEU . 4.1 mt -54.55 -41.4 69.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.341 -0.849 . . . . 0.0 109.069 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.627 ' O ' ' N ' ' A' ' 86' ' ' ASN . 27.1 t70 -61.69 -54.97 35.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.238 -0.914 . . . . 0.0 109.133 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -47.76 -32.21 5.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.081 -1.012 . . . . 0.0 108.858 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.676 ' CE2' HD21 ' A' ' 85' ' ' LEU . 10.1 t80 -77.64 -31.77 52.91 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.676 HD21 ' CE2' ' A' ' 84' ' ' TYR . 53.2 mt -121.59 33.49 5.5 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.369 -0.832 . . . . 0.0 109.427 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.627 ' N ' ' O ' ' A' ' 82' ' ' ASP . 38.4 t30 -79.71 27.7 0.28 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.211 -0.931 . . . . 0.0 109.16 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -78.12 -45.57 10.09 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -173.34 33.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -1.121 . . . . 0.0 109.299 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.53 179.1 7.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.182 -0.949 . . . . 0.0 109.433 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.5 t -127.11 128.03 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.843 . . . . 0.0 109.546 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -96.06 137.2 35.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.384 -0.823 . . . . 0.0 109.357 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -126.59 126.85 44.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.156 -0.965 . . . . 0.0 109.662 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 -100.74 95.99 7.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -0.874 . . . . 0.0 109.3 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.455 ' OE1' ' CD1' ' A' ' 103' ' ' PHE . 81.9 mt-10 -97.36 138.84 34.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.919 . . . . 0.0 109.712 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 96' ' ' GLN . 15.4 t -145.01 163.75 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.344 -0.848 . . . . 0.0 109.305 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.455 ' N ' HG12 ' A' ' 95' ' ' VAL . 50.0 tt0 -53.28 117.9 3.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.43 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.09 13.88 81.38 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.439 ' O ' ' C ' ' A' ' 99' ' ' GLU . 6.4 t80 -135.54 17.49 3.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.243 -1.151 . . . . 0.0 109.443 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.651 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 11.1 mp0 -41.46 148.22 0.15 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 109.564 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.2 t -87.2 166.81 14.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -0.889 . . . . 0.0 109.488 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.53 -65.1 0.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.533 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 51.4 m -47.55 -51.56 20.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.261 -0.899 . . . . 0.0 109.422 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.455 ' CD1' ' OE1' ' A' ' 94' ' ' GLU . 14.5 t80 -54.46 -44.79 72.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.417 -0.802 . . . . 0.0 109.437 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.9 mt -60.82 -34.16 74.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.955 . . . . 0.0 109.415 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.07 -22.57 70.98 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -79.5 -29.21 41.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -1.12 . . . . 0.0 109.365 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -139.12 120.84 15.31 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.303 -0.873 . . . . 0.0 109.457 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -101.67 -56.65 2.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.512 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.5 t -103.3 -13.25 16.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 109.51 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.3 -12.82 64.02 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.4 mt -71.94 121.2 18.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.175 -1.191 . . . . 0.0 109.499 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -148.55 154.7 40.13 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.188 -0.945 . . . . 0.0 109.417 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -135.97 134.59 38.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.365 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.89 105.87 16.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 109.338 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 116' ' ' GLY . 9.3 mtpm? -83.78 108.28 16.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.202 -0.936 . . . . 0.0 109.488 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . 44.06 -161.02 0.08 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 146.26 3.79 0.52 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.6 m -139.22 142.28 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.303 -1.116 . . . . 0.0 109.435 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -101.49 -76.05 0.58 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.306 -0.871 . . . . 0.0 109.537 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.5 m -90.25 169.48 11.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.18 -0.95 . . . . 0.0 109.556 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -160.91 81.13 0.14 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -92.05 -161.72 0.85 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -1.143 . . . . 0.0 109.422 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -132.88 89.77 2.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 109.407 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -77.67 82.11 4.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.315 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.9 t -52.14 -25.19 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.541 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.7 m -145.06 145.83 28.62 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.97 . . . . 0.0 109.439 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -41.88 -65.88 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.543 2.162 . . . . 0.0 112.266 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -136.37 -122.91 0.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.936 . . . . 0.0 109.471 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -105.06 130.24 53.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.344 -0.847 . . . . 0.0 109.503 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.08 4.36 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.237 -0.915 . . . . 0.0 109.539 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 64.6 t -46.93 126.72 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.943 . . . . 0.0 109.459 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.466 ' O ' ' OXT' ' A' ' 133' ' ' GLN . 11.1 t -74.65 104.79 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.342 -0.849 . . . . 0.0 109.536 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.466 ' OXT' ' O ' ' A' ' 132' ' ' VAL . 48.0 mm-40 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.572 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.417 ' C ' ' ND1' ' A' ' 2' ' ' HIS . 20.5 mt-10 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.417 ' ND1' ' C ' ' A' ' 1' ' ' GLU . 8.8 m80 -142.01 57.33 6.64 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.584 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.422 ' HB2' HD12 ' A' ' 6' ' ' LEU . 55.4 Cg_endo -73.97 65.34 5.07 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.692 2.261 . . . . 0.0 112.043 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -83.08 -28.7 29.33 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.618 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.64 ' CE1' HG12 ' A' ' 42' ' ' VAL . 69.0 t80 -58.46 -16.55 15.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.142 -0.974 . . . . 0.0 109.354 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.422 HD12 ' HB2' ' A' ' 3' ' ' PRO . 3.3 mt -90.24 -34.88 15.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.218 -0.926 . . . . 0.0 109.553 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 8' ' ' ALA . 30.8 mttm -87.59 -15.22 37.98 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.272 -0.892 . . . . 0.0 109.672 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -42.45 128.95 3.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 0.0 109.406 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.38 30.55 0.03 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.434 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -129.64 38.36 3.86 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.308 -1.113 . . . . 0.0 109.379 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 13' ' ' GLY . 31.1 mt-10 -157.78 79.75 3.31 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.298 -0.876 . . . . 0.0 109.31 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.1 80.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.792 2.328 . . . . 0.0 112.148 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 11' ' ' GLU . . . 177.58 -99.87 0.13 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.751 HD23 ' C ' ' A' ' 14' ' ' LEU . 7.1 tt -156.94 125.7 5.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -1.138 . . . . 0.0 109.727 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.586 ' N ' HD23 ' A' ' 14' ' ' LEU . 11.8 mt-30 -112.66 133.45 54.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.384 -0.822 . . . . 0.0 109.239 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.611 HG23 HD12 ' A' ' 43' ' ' ILE . 5.7 mt -101.25 146.68 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.365 -0.834 . . . . 0.0 110.16 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.78 139.25 27.7 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -108.45 140.32 41.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.2 -0.938 . . . . 0.0 109.404 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 40' ' ' ALA . 8.9 p -84.01 138.33 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.914 . . . . 0.0 109.495 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.609 ' O ' ' N ' ' A' ' 22' ' ' PHE . 18.5 tt0 -88.19 154.32 20.53 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.327 -0.858 . . . . 0.0 109.043 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.542 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 39.9 mttp -40.39 -20.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 109.664 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.609 ' N ' ' O ' ' A' ' 20' ' ' GLU . 63.6 m-85 -160.09 21.82 0.16 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 0.0 109.679 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.432 ' N ' ' HB3' ' A' ' 20' ' ' GLU . 2.9 m-20 -160.23 -128.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 0.0 109.429 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 mt -145.53 146.09 31.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.208 -0.932 . . . . 0.0 109.584 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 t -131.31 133.81 24.97 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.316 -0.865 . . . . 0.0 108.963 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -72.63 146.9 44.53 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.367 2.045 . . . . 0.0 112.431 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -119.23 105.15 44.94 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.359 -0.838 . . . . 0.0 109.272 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.473 ' C ' ' H ' ' A' ' 30' ' ' ASN . 61.3 Cg_endo -79.93 148.81 19.91 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.417 2.078 . . . . 0.0 112.469 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.632 ' O ' HG22 ' A' ' 29' ' ' THR . 14.7 m -63.32 1.32 0.52 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.2 -0.938 . . . . 0.0 109.368 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 28' ' ' PRO . 14.8 m120 -76.09 -19.1 58.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.334 -0.854 . . . . 0.0 109.37 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.728 ' C ' HD12 ' A' ' 31' ' ' LEU . 2.6 pp -148.26 2.64 0.66 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 110.289 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.595 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.6 p90 -55.58 173.5 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.87 -1.143 . . . . 0.0 109.366 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.76 -32.14 6.59 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -99.45 100.59 11.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.348 -1.089 . . . . 0.0 109.527 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.605 ' CZ ' ' CZ3' ' A' ' 61' ' ' TRP . 45.5 m-85 -86.93 137.51 32.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.482 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -88.34 131.21 34.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 109.441 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.4 p -73.99 -6.42 47.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.369 -0.832 . . . . 0.0 109.409 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.437 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -97.31 20.59 50.13 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 9.7 m-20 -167.35 146.15 4.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -1.112 . . . . 0.0 109.449 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.647 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -90.92 149.33 21.94 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.216 -0.928 . . . . 0.0 109.399 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -117.15 139.02 51.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 109.351 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.01 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -105.58 129.36 58.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 121.177 -0.952 . . . . 0.0 108.623 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.01 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -126.21 134.25 66.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.231 -0.918 . . . . 0.0 110.421 -179.315 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.514 ' CD2' ' OG1' ' A' ' 46' ' ' THR . 7.7 tt -114.94 115.84 27.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.58 -0.7 . . . . 0.0 109.114 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -92.42 114.3 26.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.939 . . . . 0.0 109.534 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.514 ' OG1' ' CD2' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -113.89 129.23 56.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.181 -0.949 . . . . 0.0 109.524 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -132.18 168.48 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 121.071 -1.018 . . . . 0.0 109.252 -179.852 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -98.54 117.36 32.79 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.58 -0.7 . . . . 0.0 109.401 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.6 mt -81.05 160.83 24.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -0.911 . . . . 0.0 109.609 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 25.0 mtt180 -51.44 -65.49 0.55 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.336 -0.852 . . . . 0.0 109.305 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.437 ' ND2' ' HB2' ' A' ' 53' ' ' ASN . 2.3 p-10 -48.27 -29.58 3.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.263 -0.898 . . . . 0.0 109.252 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.76 71.29 1.12 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 54' ' ' LEU . 4.3 t-20 -134.85 13.46 3.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.287 -1.125 . . . . 0.0 109.32 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.592 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 11.7 mt 45.71 99.69 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.579 0.704 . . . . 0.0 109.535 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -68.6 152.1 45.83 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.498 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 61.3 m-85 -129.49 116.56 19.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 109.866 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.626 ' O ' HD23 ' A' ' 58' ' ' LEU . 0.7 OUTLIER -122.36 155.17 36.58 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.427 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.626 HD23 ' O ' ' A' ' 57' ' ' ASP . 2.6 mt -132.83 150.18 52.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.913 -1.117 . . . . 0.0 110.172 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.545 ' CD2' ' C ' ' A' ' 58' ' ' LEU . 4.6 m-70 -143.26 123.09 13.43 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.71 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -100.62 129.57 46.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.082 -1.011 . . . . 0.0 109.641 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.605 ' CZ3' ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -102.85 123.83 47.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.345 -0.847 . . . . 0.0 109.314 179.835 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.7 mt -102.15 162.07 13.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.402 -0.811 . . . . 0.0 109.461 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.25 157.69 14.88 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.7 t30 -75.68 -12.29 60.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.324 -1.104 . . . . 0.0 109.566 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -106.84 23.21 14.71 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.9 m -131.09 97.5 4.32 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.06 0.933 . . . . 0.0 108.514 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 m -59.6 -170.98 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.593 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 72' ' ' GLY . 37.2 tt0 -61.6 -17.95 57.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 109.559 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -63.87 -58.81 5.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.955 . . . . 0.0 109.46 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.69 -42.5 91.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.446 -0.784 . . . . 0.0 108.987 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 m -71.08 -23.28 62.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.389 -0.82 . . . . 0.0 109.016 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -71.53 -40.11 60.0 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.38 -49.09 52.72 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.261 -1.141 . . . . 0.0 109.25 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.15 -45.66 83.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.374 -0.829 . . . . 0.0 109.058 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.443 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -58.54 -51.29 70.53 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.406 -0.809 . . . . 0.0 109.189 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.6 mt -48.9 -41.08 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -0.942 . . . . 0.0 109.209 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.45 -43.24 99.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.222 -0.924 . . . . 0.0 109.101 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 86.3 m -61.05 -49.45 77.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.145 -0.972 . . . . 0.0 109.093 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 75' ' ' ALA . 10.6 t -51.06 -40.06 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.238 -0.913 . . . . 0.0 109.211 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -61.25 -48.21 82.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.36 -0.838 . . . . 0.0 109.082 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.521 ' CD1' ' CE1' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -50.71 -40.17 53.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.32 -0.862 . . . . 0.0 108.929 179.63 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 85' ' ' LEU . 10.3 m-20 -61.89 -61.8 2.24 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.16 -0.962 . . . . 0.0 109.069 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -47.31 -30.62 3.25 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.049 -1.032 . . . . 0.0 108.445 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -76.81 -27.06 55.04 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.562 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.9 mt -113.87 27.23 9.69 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.37 -0.831 . . . . 0.0 109.169 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 44.47 38.36 2.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.377 -0.827 . . . . 0.0 109.479 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 56.35 31.19 59.4 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 85' ' ' LEU . 21.4 ttt-85 -92.69 31.92 1.3 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.204 -1.174 . . . . 0.0 109.38 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 56' ' ' TYR . . . -141.14 161.17 38.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.526 -0.734 . . . . 0.0 109.395 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 38.8 t -96.0 146.26 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.263 -0.898 . . . . 0.0 109.426 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.676 ' H ' ' CD ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -111.4 131.59 55.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.382 -0.824 . . . . 0.0 109.314 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.472 ' CG ' ' ND1' ' A' ' 59' ' ' HIS . 22.6 m80 -115.68 136.35 53.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.866 . . . . 0.0 109.414 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.431 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 3.9 ptp180 -102.71 92.92 4.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.22 -0.925 . . . . 0.0 109.309 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.499 ' OE1' ' CD2' ' A' ' 103' ' ' PHE . 13.6 mt-10 -92.88 128.94 38.92 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.148 -0.97 . . . . 0.0 109.538 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 96' ' ' GLN . 10.5 t -132.94 163.52 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.336 -0.852 . . . . 0.0 109.241 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.621 ' OE1' ' N ' ' A' ' 97' ' ' GLY . 0.8 OUTLIER -62.22 115.59 4.27 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.238 -0.914 . . . . 0.0 109.429 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.621 ' N ' ' OE1' ' A' ' 96' ' ' GLN . . . 90.38 5.74 69.31 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.475 ' O ' ' O ' ' A' ' 99' ' ' GLU . 5.1 t80 -143.26 32.6 1.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.366 -1.079 . . . . 0.0 109.526 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.66 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 2.4 mp0 -41.51 164.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.537 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.62 161.69 19.16 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.09 -60.39 2.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.477 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 76.9 m -46.95 -41.35 15.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.145 -0.972 . . . . 0.0 109.355 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.499 ' CD2' ' OE1' ' A' ' 94' ' ' GLU . 1.6 m-85 -69.9 -41.1 75.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.352 -0.843 . . . . 0.0 109.383 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.5 mt -58.79 -23.67 60.59 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.175 -0.953 . . . . 0.0 109.451 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -105.43 -12.94 25.68 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -86.42 -37.67 18.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -1.188 . . . . 0.0 109.602 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -84.37 117.78 23.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.309 -0.869 . . . . 0.0 109.638 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -115.0 3.0 14.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.395 -0.815 . . . . 0.0 109.387 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.0 m -89.31 -4.65 58.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 109.54 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.53 97.32 0.43 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.705 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -77.78 165.74 23.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.158 -1.201 . . . . 0.0 109.509 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.442 ' CG ' ' O ' ' A' ' 111' ' ' LEU . 38.3 mtmt -158.41 152.2 23.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.246 -0.908 . . . . 0.0 109.475 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.445 ' OH ' ' CD ' ' A' ' 99' ' ' GLU . 53.8 m-85 -101.51 125.2 48.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.373 -0.83 . . . . 0.0 109.438 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.0 120.04 25.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.489 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt -82.02 140.07 34.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.42 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -96.07 22.89 37.13 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -94.82 -127.04 4.93 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.462 HG23 ' N ' ' A' ' 119' ' ' ALA . 9.1 m -93.53 -155.08 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -1.151 . . . . 0.0 109.515 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.462 ' N ' HG23 ' A' ' 118' ' ' VAL . . . -146.88 -51.97 0.21 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 0.0 109.46 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.1 m -164.32 -65.72 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 93.95 24.31 20.39 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -48.93 -34.38 12.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.132 -1.217 . . . . 0.0 109.377 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.4 tptt -89.62 144.09 26.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.931 . . . . 0.0 109.376 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -136.65 -155.59 0.63 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.899 . . . . 0.0 109.488 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 126' ' ' VAL . 59.7 t -91.05 161.91 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.478 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.515 ' N ' HG12 ' A' ' 125' ' ' VAL . 10.0 t -148.34 99.17 3.66 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.456 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -79.62 0.76 9.76 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.586 2.19 . . . . 0.0 112.227 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -101.92 94.03 5.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 109.368 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 130' ' ' VAL . 6.7 mt-10 -129.31 -159.07 0.93 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.883 . . . . 0.0 109.441 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 130' ' ' VAL . 7.6 p -42.73 119.56 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.201 -0.937 . . . . 0.0 109.447 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.3 p -47.22 142.68 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.338 -0.851 . . . . 0.0 109.555 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.414 HG23 ' H ' ' A' ' 132' ' ' VAL . 12.3 t -48.32 99.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.594 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.442 -179.952 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.498 ' O ' ' O ' ' A' ' 2' ' ' HIS . 7.1 mm-40 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.498 ' O ' ' O ' ' A' ' 1' ' ' GLU . 2.8 m80 56.92 156.41 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.353 -0.842 . . . . 0.0 109.374 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.501 ' HB2' HD13 ' A' ' 6' ' ' LEU . 17.8 Cg_endo -62.21 90.34 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.726 2.284 . . . . 0.0 111.857 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -83.33 -43.43 15.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.296 -0.877 . . . . 0.0 110.071 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.593 ' CE2' ' CG1' ' A' ' 42' ' ' VAL . 21.6 t80 -50.94 -41.45 59.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.134 -0.979 . . . . 0.0 109.606 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.501 HD13 ' HB2' ' A' ' 3' ' ' PRO . 4.1 mp -69.4 -27.83 65.63 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.121 -0.987 . . . . 0.0 109.51 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -96.4 3.84 52.59 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.237 -0.914 . . . . 0.0 109.38 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.472 ' HB3' HD13 ' A' ' 44' ' ' LEU . . . -59.52 151.9 23.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.216 -0.928 . . . . 0.0 109.517 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.9 45.19 0.07 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -149.08 24.23 0.93 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.276 -1.132 . . . . 0.0 109.564 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -146.55 117.65 4.76 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.278 -0.889 . . . . 0.0 109.338 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.7 91.25 1.2 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.387 2.058 . . . . 0.0 112.221 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.07 -95.38 0.12 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 tp -160.23 130.35 5.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.318 -1.107 . . . . 0.0 109.627 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -113.88 135.71 53.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 109.355 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.2 mt -115.56 136.01 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.345 -0.847 . . . . 0.0 109.99 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.44 134.67 31.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.425 -0.797 . . . . 0.0 108.969 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 25' ' ' VAL . 33.5 ttt180 -98.38 153.54 18.49 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.201 -0.937 . . . . 0.0 109.444 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.1 t -106.13 123.49 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.18 -0.95 . . . . 0.0 109.593 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.635 ' O ' ' N ' ' A' ' 22' ' ' PHE . 5.2 tt0 -72.06 87.04 1.05 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.107 -0.996 . . . . 0.0 108.915 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.579 ' O ' ' CB ' ' A' ' 22' ' ' PHE . 16.5 tttm 49.04 2.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.359 -0.838 . . . . 0.0 109.85 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.635 ' N ' ' O ' ' A' ' 20' ' ' GLU . 2.1 t80 158.01 -29.34 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.289 -0.882 . . . . 0.0 109.422 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.76 -157.83 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.932 . . . . 0.0 109.584 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.26 132.75 56.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.287 -0.883 . . . . 0.0 109.344 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.545 ' CG2' ' N ' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -129.9 120.81 19.58 Favored Pre-proline 0 N--CA 1.487 1.387 0 O-C-N 121.311 -0.868 . . . . 0.0 109.227 -179.686 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.88 132.0 11.52 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.303 2.002 . . . . 0.0 112.238 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.7 t -110.34 101.57 48.65 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.335 -0.853 . . . . 0.0 109.394 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -51.22 156.56 5.25 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.434 2.089 . . . . 0.0 112.208 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.3 m -66.89 -12.2 58.57 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.328 -0.857 . . . . 0.0 109.488 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.481 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 23.9 t-20 -75.98 -10.03 59.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.357 -0.839 . . . . 0.0 109.522 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 32' ' ' TYR . 96.3 mt -122.83 -23.35 5.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -0.847 . . . . 0.0 109.417 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 33' ' ' GLY . 1.7 t80 -42.88 138.33 2.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.617 ' N ' ' CD1' ' A' ' 32' ' ' TYR . . . 125.95 -28.68 4.83 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -107.19 148.19 29.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -1.152 . . . . 0.0 109.531 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -142.06 114.16 8.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 109.424 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -79.39 159.05 27.25 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.529 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.1 p -97.74 -4.77 36.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 109.447 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.445 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -88.28 16.4 52.72 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 7.6 m-20 -159.23 164.07 35.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -1.163 . . . . 0.0 109.544 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -108.29 151.98 25.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 0.0 109.406 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.575 ' N ' ' CD1' ' A' ' 41' ' ' TYR . 4.0 m-85 -130.21 134.61 47.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.884 . . . . 0.0 109.667 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.991 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -105.4 139.44 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 121.182 -0.949 . . . . 0.0 108.596 179.202 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.991 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.4 OUTLIER -128.01 134.72 64.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.27 -0.894 . . . . 0.0 110.213 -179.421 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.472 HD13 ' HB3' ' A' ' 8' ' ' ALA . 7.2 tt -115.86 109.57 17.81 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -82.42 144.31 30.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.363 -0.835 . . . . 0.0 109.098 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.2 m -143.24 129.01 19.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.09 -1.006 . . . . 0.0 109.725 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -134.18 168.56 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 O-C-N 121.143 -0.973 . . . . 0.0 109.208 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -99.31 118.04 35.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.68 -0.638 . . . . 0.0 109.422 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 93.4 mt -81.9 165.08 21.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 109.605 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -45.35 -58.39 3.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.94 . . . . 0.0 109.145 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -61.52 -27.03 68.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.915 . . . . 0.0 109.151 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.01 33.29 6.68 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.5 ' O ' ' O ' ' A' ' 54' ' ' LEU . 5.8 t30 -85.58 12.67 8.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -1.187 . . . . 0.0 109.304 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.578 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 12.3 mt 44.91 98.38 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 121.563 0.697 . . . . 0.0 109.468 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.407 ' HG3' ' N ' ' A' ' 56' ' ' TYR . 3.3 tp-100 -68.56 155.84 39.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.505 -0.747 . . . . 0.0 109.072 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 79.6 m-85 -138.16 114.35 10.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.163 -0.96 . . . . 0.0 109.803 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.424 ' O ' HD23 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -114.38 155.25 26.65 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.136 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.85 HD13 HD21 ' A' ' 81' ' ' LEU . 11.2 mt -125.16 150.29 47.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.023 -1.048 . . . . 0.0 110.372 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -145.18 130.43 18.57 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.741 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -111.69 138.87 47.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.951 -1.093 . . . . 0.0 110.063 -179.297 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -111.41 123.55 50.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.392 -0.817 . . . . 0.0 108.987 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 49.6 mt -104.18 145.92 29.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.386 -0.821 . . . . 0.0 109.413 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.9 152.2 19.84 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -80.21 -12.02 59.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -1.121 . . . . 0.0 109.478 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -107.93 31.87 5.18 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.533 ' SG ' ' OE2' ' A' ' 70' ' ' GLU . 2.1 m -130.56 97.5 4.4 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 122.043 0.925 . . . . 0.0 108.533 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 66' ' ' CYS . 30.0 m -45.63 175.89 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.78 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.48 ' O ' ' N ' ' A' ' 72' ' ' GLY . 39.0 tt0 -64.63 -17.7 64.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 0.0 109.621 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -63.14 -58.59 6.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 109.344 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.533 ' OE2' ' SG ' ' A' ' 66' ' ' CYS . 11.5 mt-10 -64.84 -44.31 90.19 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.356 -0.84 . . . . 0.0 109.034 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.55 -26.85 67.33 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.429 -0.795 . . . . 0.0 109.02 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.15 -48.17 40.8 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.18 -35.36 76.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.342 -1.093 . . . . 0.0 109.098 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.741 ' HB1' ' CZ ' ' A' ' 60' ' ' TYR . . . -61.28 -51.95 66.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.418 -0.801 . . . . 0.0 109.211 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.424 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -52.94 -46.93 68.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 109.232 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.3 mt -51.9 -47.92 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.271 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -54.61 -44.06 72.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.31 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.426 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 0.9 OUTLIER -54.08 -50.97 65.59 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.3 -0.875 . . . . 0.0 109.507 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.481 HG23 ' H ' ' A' ' 79' ' ' VAL . 1.5 t -61.18 -35.39 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.361 -0.837 . . . . 0.0 109.63 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -64.57 -58.83 5.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.898 . . . . 0.0 109.302 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.954 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -53.81 -33.51 56.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 108.911 179.828 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 85' ' ' LEU . 0.9 OUTLIER -65.73 -55.13 18.93 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.22 -0.925 . . . . 0.0 108.891 179.531 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 82' ' ' ASP . 8.7 t70 -45.87 -37.47 6.3 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -68.53 -33.39 74.02 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 82' ' ' ASP . 4.8 tp -105.81 28.15 7.82 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.496 -0.752 . . . . 0.0 109.268 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 85' ' ' LEU . 26.6 m-20 42.49 36.25 0.76 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.459 -0.776 . . . . 0.0 109.436 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 46.29 35.12 6.65 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.7 mmm-85 -86.46 29.97 0.74 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.137 -1.213 . . . . 0.0 109.106 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.426 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -144.13 166.9 23.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.565 -0.71 . . . . 0.0 109.376 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 t -100.62 153.9 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.44 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -117.57 130.29 56.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.392 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.6 m80 -105.5 104.93 14.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 109.521 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.84 97.99 6.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.253 -0.904 . . . . 0.0 109.229 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.476 ' OE1' ' CG ' ' A' ' 103' ' ' PHE . 39.3 mt-10 -100.47 148.76 24.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.348 -0.845 . . . . 0.0 109.722 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 96' ' ' GLN . 6.2 t -137.68 166.12 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.327 -0.858 . . . . 0.0 109.27 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.5 ' OE1' ' O ' ' A' ' 96' ' ' GLN . 1.4 tm0? -59.86 116.81 4.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 109.481 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.2 12.24 81.09 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.445 ' O ' ' C ' ' A' ' 99' ' ' GLU . 2.4 t80 -137.51 20.79 2.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -1.167 . . . . 0.0 109.569 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 98' ' ' PHE . 7.5 mm-40 -42.16 156.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.918 . . . . 0.0 109.469 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.2 p -88.01 174.29 8.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -0.961 . . . . 0.0 109.491 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.09 -53.69 7.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.492 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.1 m -47.07 -46.78 22.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 0.0 109.459 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' A' ' 106' ' ' TYR . 0.2 OUTLIER -67.46 -54.07 23.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.391 -0.818 . . . . 0.0 109.397 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 103' ' ' PHE . 29.5 mt -44.57 -26.36 0.36 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.228 -0.92 . . . . 0.0 109.462 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -99.95 -17.09 26.37 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.492 ' N ' ' O ' ' A' ' 103' ' ' PHE . 14.4 t80 -81.73 -13.43 57.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.292 -1.122 . . . . 0.0 109.559 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.534 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 8.7 p90 -45.95 122.48 3.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.137 -0.977 . . . . 0.0 109.589 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -111.19 -56.41 2.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 109.349 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.4 t -90.88 0.38 57.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.891 . . . . 0.0 109.501 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 111' ' ' LEU . . . 87.3 68.96 1.31 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 110' ' ' GLY . 2.3 pp -42.96 155.24 0.06 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.305 -1.115 . . . . 0.0 109.453 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -154.23 135.99 14.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.455 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 0.0 OUTLIER -104.21 140.02 38.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.318 -0.864 . . . . 0.0 109.47 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -108.26 120.93 43.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.853 . . . . 0.0 109.333 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -76.81 138.34 39.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 109.396 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -142.99 -97.69 0.26 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 48.86 65.4 2.68 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.406 ' O ' ' C ' ' A' ' 119' ' ' ALA . 24.5 m -95.8 152.7 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -1.116 . . . . 0.0 109.49 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 118' ' ' VAL . . . 45.34 75.93 0.1 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.479 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.9 t -62.87 -159.89 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.149 -0.97 . . . . 0.0 109.453 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 123' ' ' LYS . . . 174.24 -160.83 30.66 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -50.16 90.09 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.301 -1.117 . . . . 0.0 109.467 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 121' ' ' GLY . 4.7 mmtp -141.25 -59.15 0.49 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 109.492 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -83.17 99.26 9.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.7 t -114.14 100.25 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.4 -0.813 . . . . 0.0 109.435 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 47.5 t -139.96 74.13 32.0 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.447 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.95 170.21 19.26 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.82 2.347 . . . . 0.0 112.24 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.445 ' O ' ' O ' ' A' ' 129' ' ' GLU . 1.0 OUTLIER -85.63 131.19 34.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.0 109.494 -179.922 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.447 ' OE1' ' C ' ' A' ' 130' ' ' VAL . 0.2 OUTLIER 53.0 101.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.429 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 130' ' ' VAL . 8.3 p -66.28 120.19 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.225 -0.922 . . . . 0.0 109.533 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.553 HG12 ' N ' ' A' ' 132' ' ' VAL . 82.8 t -73.32 164.46 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.175 -0.953 . . . . 0.0 109.497 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.553 ' N ' HG12 ' A' ' 131' ' ' VAL . 27.4 t -146.89 59.52 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.224 -0.923 . . . . 0.0 109.483 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.957 -1.02 . . . . 0.0 109.422 -179.911 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.542 ' NE2' ' O ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -159.22 76.32 3.16 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.528 ' HB3' HD13 ' A' ' 6' ' ' LEU . 32.5 Cg_exo -58.0 93.21 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.953 2.435 . . . . 0.0 112.007 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 8' ' ' ALA . 61.5 mm-40 -83.45 -46.71 12.19 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.104 -0.998 . . . . 0.0 110.259 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.508 ' CZ ' ' O ' ' A' ' 42' ' ' VAL . 21.7 m-85 -66.94 -43.35 83.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.078 -1.014 . . . . 0.0 109.151 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 1.035 ' H ' HD12 ' A' ' 6' ' ' LEU . 3.0 mp -62.36 -33.9 75.62 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.343 -0.848 . . . . 0.0 109.628 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -106.35 9.1 31.97 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.248 -0.907 . . . . 0.0 109.605 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.576 ' HB1' ' NE2' ' A' ' 15' ' ' GLN . . . -62.73 -162.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.194 -0.941 . . . . 0.0 109.395 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.45 58.02 1.31 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -146.63 10.88 1.09 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.267 -1.137 . . . . 0.0 109.452 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -161.92 124.32 1.73 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.258 -0.901 . . . . 0.0 109.282 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.87 82.28 2.19 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.396 2.064 . . . . 0.0 112.348 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -164.61 -108.05 0.21 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.6 tt -162.71 143.5 9.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.326 -1.102 . . . . 0.0 109.439 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.576 ' NE2' ' HB1' ' A' ' 8' ' ' ALA . 1.3 mt-30 -129.48 144.0 51.07 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.235 -0.916 . . . . 0.0 109.523 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.604 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 9.2 mt -126.58 125.85 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.418 -0.801 . . . . 0.0 109.992 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.604 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 8.1 m0 -145.22 155.85 43.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.205 -0.934 . . . . 0.0 109.061 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.439 ' N ' HG23 ' A' ' 27' ' ' VAL . 7.8 ttp180 -95.94 153.17 17.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.063 -1.023 . . . . 0.0 109.386 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 40' ' ' ALA . 7.0 p -94.48 133.35 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.212 -0.93 . . . . 0.0 109.739 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.636 ' O ' ' N ' ' A' ' 22' ' ' PHE . 17.9 tt0 -82.0 154.71 25.55 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.338 -0.851 . . . . 0.0 108.768 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 20' ' ' GLU . 39.7 mttt -38.35 -22.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.394 -0.816 . . . . 0.0 109.683 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.636 ' N ' ' O ' ' A' ' 20' ' ' GLU . 3.4 t80 -158.75 21.05 0.21 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.258 -0.901 . . . . 0.0 109.394 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.657 ' O ' HD22 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -155.58 -147.37 0.2 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.135 -0.978 . . . . 0.0 109.749 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.657 HD22 ' O ' ' A' ' 23' ' ' ASP . 2.9 mm? -123.29 146.4 47.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.352 -0.843 . . . . 0.0 109.447 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -131.42 99.26 17.51 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.341 -0.849 . . . . 0.0 109.173 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -47.64 132.96 21.3 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.557 2.172 . . . . 0.0 112.42 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.439 HG23 ' N ' ' A' ' 18' ' ' ARG . 61.0 t -104.51 106.2 53.3 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.317 -0.864 . . . . 0.0 109.482 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -46.64 145.89 5.98 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.484 2.123 . . . . 0.0 112.32 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.4 t -61.7 -25.63 67.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -0.882 . . . . 0.0 109.554 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -69.04 -10.98 60.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 0.0 109.509 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.467 ' O ' ' C ' ' A' ' 32' ' ' TYR . 57.7 mt -110.14 -28.25 8.75 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -0.847 . . . . 0.0 109.572 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.467 ' C ' ' O ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -40.33 143.85 0.27 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.288 -0.883 . . . . 0.0 109.458 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.05 -32.02 7.58 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -101.89 104.53 15.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -1.144 . . . . 0.0 109.398 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -102.67 140.91 36.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 109.53 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.595 ' CD2' ' OH ' ' A' ' 41' ' ' TYR . 0.7 OUTLIER -101.67 161.12 13.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.393 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.9 p -94.89 -4.88 46.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.238 -0.914 . . . . 0.0 109.614 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -101.56 34.75 5.41 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -171.52 151.53 3.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.196 -1.179 . . . . 0.0 109.51 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.469 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -100.23 139.25 36.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.598 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.595 ' OH ' ' CD2' ' A' ' 36' ' ' PHE . 44.2 m-85 -121.38 144.36 48.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.365 -0.834 . . . . 0.0 109.359 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.923 ' O ' HD13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -118.76 144.82 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.286 -0.884 . . . . 0.0 109.216 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.923 HD13 ' O ' ' A' ' 42' ' ' VAL . 1.0 OUTLIER -134.18 146.49 31.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.98 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 45' ' ' LYS . 15.7 tp -129.5 118.07 21.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.46 -0.775 . . . . 0.0 109.467 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.539 ' CE ' ' CE2' ' A' ' 106' ' ' TYR . 36.3 tttt -97.39 133.96 41.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.41 -0.806 . . . . 0.0 109.046 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.608 HG22 HD22 ' A' ' 54' ' ' LEU . 88.8 m -142.74 118.4 10.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.099 -1.001 . . . . 0.0 109.401 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.676 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -125.98 168.2 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.226 -0.921 . . . . 0.0 109.122 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -102.88 112.41 25.2 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.512 -0.742 . . . . 0.0 109.331 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.9 mt -77.3 169.22 18.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.438 -0.789 . . . . 0.0 109.59 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.517 ' CG ' ' N ' ' A' ' 51' ' ' ASN . 5.7 ptp85 -47.69 -49.33 28.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.884 . . . . 0.0 109.299 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.517 ' N ' ' CG ' ' A' ' 50' ' ' ARG . 5.0 m120 -70.75 -27.24 63.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.271 -0.893 . . . . 0.0 109.157 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.65 28.52 11.17 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.0 t-20 -80.66 12.59 3.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.072 -1.252 . . . . 0.0 109.21 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.676 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 13.8 mt 43.88 97.72 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.535 0.683 . . . . 0.0 109.562 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -74.3 111.45 9.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.491 -0.756 . . . . 0.0 109.538 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.779 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 96.2 m-85 -96.55 114.75 26.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.933 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.578 ' OD1' ' NE2' ' A' ' 92' ' ' HIS . 0.4 OUTLIER -115.99 120.8 40.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.022 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.424 ' N ' HD23 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -97.77 150.61 21.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.921 -1.112 . . . . 0.0 110.778 -178.467 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.454 ' HE2' ' HB2' ' A' ' 45' ' ' LYS . 6.1 m-70 -149.19 122.19 8.82 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.408 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 10.5 p90 -113.39 131.43 55.99 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.117 -0.989 . . . . 0.0 109.846 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.565 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 55.6 t90 -103.44 124.01 47.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.488 -0.758 . . . . 0.0 109.356 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.565 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 62.8 mt -102.76 162.12 13.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.329 -0.857 . . . . 0.0 109.591 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.92 162.96 12.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -82.07 -12.37 58.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -1.168 . . . . 0.0 109.576 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.51 28.95 7.32 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.3 m -130.84 97.57 4.37 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.115 0.959 . . . . 0.0 108.54 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 64.6 m -56.19 -170.87 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.674 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -64.87 -17.81 64.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.562 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -63.13 -58.7 6.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.118 -0.989 . . . . 0.0 109.405 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -66.81 -41.59 87.29 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.15 -23.06 62.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.401 -0.812 . . . . 0.0 108.995 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -71.64 -44.24 49.73 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.97 -43.94 86.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.343 -1.092 . . . . 0.0 109.172 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.9 -49.28 77.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.415 -0.803 . . . . 0.0 109.304 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.67 -48.62 77.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.328 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.7 mt -50.09 -42.39 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.386 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -63.77 -37.15 86.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.198 -0.939 . . . . 0.0 109.328 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.6 m -65.52 -46.96 77.58 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.366 -0.834 . . . . 0.0 109.362 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.5 t -56.09 -39.85 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 0.0 109.163 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -61.52 -47.39 85.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.304 -0.873 . . . . 0.0 109.041 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 81' ' ' LEU . 34.1 mt -50.59 -46.05 57.66 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.309 -0.869 . . . . 0.0 109.001 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 85' ' ' LEU . 0.8 OUTLIER -56.59 -59.01 5.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.232 -0.918 . . . . 0.0 109.177 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 82' ' ' ASP . 9.1 t0 -45.26 -30.05 1.14 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.108 -0.995 . . . . 0.0 108.611 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -75.44 -29.7 59.76 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.588 ' N ' ' O ' ' A' ' 82' ' ' ASP . 11.6 mt -116.0 30.91 7.05 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.389 -0.819 . . . . 0.0 109.412 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 61.3 t30 46.32 34.5 2.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.293 -0.879 . . . . 0.0 109.507 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 51.29 22.2 6.89 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -90.34 30.93 1.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.102 -1.234 . . . . 0.0 109.228 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.779 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -123.49 177.1 5.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.542 -0.724 . . . . 0.0 109.306 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 95.1 t -113.32 115.45 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 109.477 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.93 157.87 18.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.264 -0.898 . . . . 0.0 109.374 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.578 ' NE2' ' OD1' ' A' ' 57' ' ' ASP . 27.6 m-70 -132.4 131.56 41.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.338 -0.851 . . . . 0.0 109.201 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.715 ' CD ' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -98.66 103.19 15.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.112 -0.992 . . . . 0.0 109.54 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.521 ' N ' ' CD ' ' A' ' 94' ' ' GLU . 3.9 mp0 -101.91 143.44 31.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.244 -0.91 . . . . 0.0 109.403 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.525 HG12 ' N ' ' A' ' 96' ' ' GLN . 13.8 t -141.81 169.91 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.298 -0.876 . . . . 0.0 109.62 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.665 ' CD ' ' H ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -82.11 118.95 23.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 109.384 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.83 13.07 48.09 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.446 ' O ' ' O ' ' A' ' 99' ' ' GLU . 37.5 m-85 -150.93 -37.57 0.13 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.221 -1.164 . . . . 0.0 109.37 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 98' ' ' PHE . 40.7 mt-10 40.61 -160.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.0 109.561 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.4 ' O ' HD12 ' A' ' 104' ' ' LEU . 1.8 m -139.09 159.79 41.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.176 -0.953 . . . . 0.0 109.422 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.95 -65.12 0.71 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.648 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.1 m -48.56 -54.51 14.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.159 -0.963 . . . . 0.0 109.464 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -53.78 -41.87 67.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.445 -0.784 . . . . 0.0 109.534 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 100' ' ' SER . 7.3 mt -69.54 -31.82 70.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.17 -0.956 . . . . 0.0 109.484 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.68 -21.14 67.01 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.539 ' CE2' ' CE ' ' A' ' 45' ' ' LYS . 8.2 t80 -76.79 -54.49 6.54 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.262 -1.14 . . . . 0.0 109.477 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -96.77 79.65 2.98 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.39 -0.819 . . . . 0.0 109.607 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -78.38 1.43 22.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.383 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.7 p -67.5 -22.04 65.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 109.493 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . 92.59 64.19 1.11 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.744 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -49.23 178.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -1.095 . . . . 0.0 109.546 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.48 155.32 43.03 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.226 -0.921 . . . . 0.0 109.329 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -126.47 143.68 51.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.212 -0.93 . . . . 0.0 109.451 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 44.3 mttt -140.18 134.75 31.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.875 . . . . 0.0 109.392 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm -68.28 151.75 46.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.275 -0.891 . . . . 0.0 109.523 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -143.33 63.15 0.5 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -73.67 127.11 10.26 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.5 p -155.81 151.4 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -1.127 . . . . 0.0 109.488 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.38 -90.77 0.11 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.878 . . . . 0.0 109.472 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.4 m -174.57 137.81 0.49 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.297 -0.877 . . . . 0.0 109.576 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -142.85 135.42 6.5 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -72.13 49.42 0.19 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -1.16 . . . . 0.0 109.424 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -96.12 -84.03 0.36 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 109.371 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -62.04 98.84 0.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.217 -0.927 . . . . 0.0 109.441 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.2 t -75.44 -72.61 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.658 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 126' ' ' VAL . 5.7 p -157.58 80.0 3.34 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.17 -0.956 . . . . 0.0 109.421 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.98 -9.91 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.846 2.364 . . . . 0.0 112.281 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -96.62 110.74 23.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.237 -0.914 . . . . 0.0 109.54 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.477 ' O ' HG23 ' A' ' 131' ' ' VAL . 36.6 mt-10 -72.29 -162.97 0.1 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 51.9 t -68.52 76.43 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.27 -0.894 . . . . 0.0 109.472 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 129' ' ' GLU . 2.0 t -72.57 -137.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.292 -0.88 . . . . 0.0 109.503 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 132' ' ' VAL . 7.3 p -73.15 117.49 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 109.474 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.414 179.986 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.55 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 67.2 tt0 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.303 0.573 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.601 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 33.0 m80 -159.52 53.35 0.54 Allowed Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.22 -0.925 . . . . 0.0 109.644 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.535 ' HB2' HD11 ' A' ' 6' ' ' LEU . 46.7 Cg_endo -71.33 91.74 0.66 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.758 2.305 . . . . 0.0 111.893 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.43 ' C ' ' N ' ' A' ' 6' ' ' LEU . 20.3 mm-40 -83.6 -25.71 30.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.222 -0.923 . . . . 0.0 110.035 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.529 ' CE1' HG12 ' A' ' 42' ' ' VAL . 43.6 t80 -51.65 -11.96 0.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.036 -1.04 . . . . 0.0 109.747 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.535 HD11 ' HB2' ' A' ' 3' ' ' PRO . 0.3 OUTLIER -93.94 -29.97 14.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.146 -0.971 . . . . 0.0 109.032 179.582 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.506 ' O ' ' O ' ' A' ' 8' ' ' ALA . 17.0 mtpp -87.94 -6.63 57.93 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.391 -0.818 . . . . 0.0 109.264 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -43.71 170.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.351 -0.843 . . . . 0.0 109.568 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.04 76.68 1.09 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -136.04 -1.26 2.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.226 -1.161 . . . . 0.0 109.694 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -171.46 149.58 2.54 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.152 -0.968 . . . . 0.0 109.419 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.4 89.34 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.727 2.285 . . . . 0.0 112.193 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -170.29 -106.15 0.19 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.7 tt -162.33 149.17 13.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.222 -1.163 . . . . 0.0 109.665 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -135.77 132.97 37.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.368 -0.832 . . . . 0.0 109.309 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.428 HG22 ' N ' ' A' ' 17' ' ' TRP . 42.7 mt -102.96 159.7 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 109.767 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.428 ' N ' HG22 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -157.87 162.17 38.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -0.867 . . . . 0.0 109.047 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -129.03 147.29 50.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.355 -0.84 . . . . 0.0 109.555 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.536 ' CG1' ' OD1' ' A' ' 39' ' ' ASP . 8.1 p -81.03 145.98 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.862 . . . . 0.0 109.548 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.58 ' O ' ' N ' ' A' ' 22' ' ' PHE . 22.3 tt0 -100.52 153.93 18.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.343 -0.848 . . . . 0.0 109.344 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 20' ' ' GLU . 18.7 tptm -40.32 -22.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 109.509 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.58 ' N ' ' O ' ' A' ' 20' ' ' GLU . 58.6 t80 -160.86 33.97 0.15 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 109.416 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.601 ' OD1' ' N ' ' A' ' 2' ' ' HIS . 25.9 t0 -173.89 -127.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.305 -0.872 . . . . 0.0 109.526 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.459 HD22 ' H ' ' A' ' 5' ' ' PHE . 4.7 tp -148.43 146.06 28.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -0.951 . . . . 0.0 109.572 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.5 133.36 25.02 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.888 . . . . 0.0 109.225 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.26 140.91 28.27 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.453 2.102 . . . . 0.0 112.138 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.9 t -99.76 133.74 21.54 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.218 -0.926 . . . . 0.0 109.241 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -72.7 133.14 19.78 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.525 2.15 . . . . 0.0 112.308 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.508 ' C ' ' H ' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -68.25 176.01 2.98 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.239 -0.913 . . . . 0.0 109.431 179.865 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 29' ' ' THR . 3.1 t-20 69.91 -39.1 0.43 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.406 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.508 ' H ' ' C ' ' A' ' 29' ' ' THR . 31.6 mt -96.94 -32.75 11.87 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.287 -0.883 . . . . 0.0 109.414 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.456 ' C ' ' O ' ' A' ' 31' ' ' LEU . 14.6 p90 -41.58 160.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 109.58 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 128.82 -19.15 5.57 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -98.26 124.33 42.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -1.136 . . . . 0.0 109.604 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -105.31 131.44 52.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -0.876 . . . . 0.0 109.335 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -96.5 135.67 38.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.211 -0.931 . . . . 0.0 109.582 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.7 p -83.71 -16.58 44.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.383 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.02 30.14 8.44 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.536 ' OD1' ' CG1' ' A' ' 19' ' ' VAL . 32.8 t0 -165.03 171.66 13.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.273 -1.133 . . . . 0.0 109.518 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.4 145.56 38.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.308 -0.87 . . . . 0.0 109.396 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -122.62 134.96 54.49 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.28 -0.888 . . . . 0.0 109.421 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.529 HG12 ' CE1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -108.71 144.16 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.324 -0.86 . . . . 0.0 109.018 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.082 ' N ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -144.34 125.12 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.049 -1.032 . . . . 0.0 109.738 -179.644 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 tt -113.22 124.12 51.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.282 -0.886 . . . . 0.0 109.53 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 29.6 tttm -97.69 145.81 25.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.316 -0.865 . . . . 0.0 109.515 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 13' ' ' GLY . 85.0 m -142.96 128.33 18.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.292 -0.88 . . . . 0.0 109.276 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -131.98 168.45 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 O-C-N 120.986 -1.071 . . . . 0.0 109.535 -179.626 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -99.66 98.46 9.3 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.556 HD13 HH11 ' A' ' 88' ' ' ARG . 10.1 mt -60.84 168.65 2.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.328 -0.858 . . . . 0.0 109.594 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 51' ' ' ASN . 34.0 ttm180 -48.95 -77.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 0.0 109.394 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 50' ' ' ARG . 13.4 m-20 -42.84 -27.89 0.21 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.912 . . . . 0.0 109.214 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 50' ' ' ARG . . . 96.03 44.17 3.13 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.3 t-20 -95.35 14.05 23.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.983 -1.304 . . . . 0.0 109.288 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.574 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 11.5 mt 43.68 97.22 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.649 0.738 . . . . 0.0 109.377 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.412 ' HB2' HD11 ' A' ' 49' ' ' LEU . 9.3 tt0 -68.86 151.89 46.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.497 -0.752 . . . . 0.0 109.156 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.574 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 90.7 m-85 -136.08 114.31 11.54 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.318 -0.864 . . . . 0.0 109.419 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.73 153.94 34.89 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.3 137.62 40.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.934 -1.104 . . . . 0.0 110.324 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.716 ' HB2' HD13 ' A' ' 43' ' ' ILE . 1.0 OUTLIER -122.5 150.11 42.98 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.447 -0.783 . . . . 0.0 109.138 179.545 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.707 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -124.78 116.42 22.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -0.851 . . . . 0.0 109.122 179.663 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.404 ' CE3' ' O ' ' A' ' 62' ' ' LEU . 16.7 t90 -97.77 123.93 41.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.294 -0.879 . . . . 0.0 109.61 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.404 ' O ' ' CE3' ' A' ' 61' ' ' TRP . 0.7 OUTLIER -104.54 161.49 14.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.316 -0.865 . . . . 0.0 109.394 179.861 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -106.26 157.83 15.75 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.0 t30 -77.52 -12.25 59.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -1.126 . . . . 0.0 109.389 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -107.16 24.36 12.96 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.8 m -130.97 97.5 4.33 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 122.105 0.955 . . . . 0.0 108.496 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 66' ' ' CYS . 1.4 m -50.85 -173.52 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.315 0 CA-C-O 121.378 0.609 . . . . 0.0 109.569 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.439 ' O ' ' N ' ' A' ' 72' ' ' GLY . 54.9 mt-30 -71.49 -17.8 62.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -0.944 . . . . 0.0 109.598 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -63.82 -58.5 6.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.463 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.32 -46.99 84.1 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.369 -0.832 . . . . 0.0 109.053 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.6 m -63.79 -29.18 70.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.493 -0.755 . . . . 0.0 108.968 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -65.1 -45.92 90.21 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.22 -49.97 74.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -1.146 . . . . 0.0 109.326 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.83 -45.43 93.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 0.0 109.252 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.641 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -62.21 -38.54 89.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.159 -0.963 . . . . 0.0 109.425 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.1 mt -58.84 -44.56 90.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.189 -0.945 . . . . 0.0 109.468 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -61.75 -42.0 98.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.37 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 82.2 m -68.0 -39.96 83.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.333 -0.854 . . . . 0.0 109.232 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 75' ' ' ALA . 68.2 t -67.87 -27.41 37.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.402 -0.811 . . . . 0.0 109.372 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.486 ' O ' ' OD2' ' A' ' 83' ' ' ASP . 40.8 mm-40 -70.4 -61.47 1.76 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.254 -0.904 . . . . 0.0 109.285 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.8 pp -58.03 -24.06 56.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 0.0 108.645 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' A' ' 86' ' ' ASN . 13.9 t70 -72.25 -54.96 8.04 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.39 -0.819 . . . . 0.0 108.912 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.486 ' OD2' ' O ' ' A' ' 80' ' ' GLN . 1.1 p30 -48.33 -35.42 12.37 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.113 -0.992 . . . . 0.0 108.368 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.457 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -72.93 -32.07 65.03 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.297 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 82' ' ' ASP . 4.6 tp -121.56 35.29 4.93 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.327 -0.858 . . . . 0.0 109.415 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.615 ' N ' ' O ' ' A' ' 82' ' ' ASP . 42.6 t30 -87.71 30.16 0.84 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.193 -0.942 . . . . 0.0 109.205 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -107.41 -21.3 8.05 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.556 HH11 HD13 ' A' ' 49' ' ' LEU . 25.3 ttt85 -159.53 64.81 0.38 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.282 -1.128 . . . . 0.0 109.41 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.13 174.43 14.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.924 . . . . 0.0 109.379 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.9 t -136.11 142.51 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 109.641 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -103.24 147.71 26.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.328 -0.858 . . . . 0.0 109.077 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.401 ' HB2' ' ND1' ' A' ' 59' ' ' HIS . 38.4 m-70 -132.1 119.16 20.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 109.655 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.524 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 11.0 ptp180 -91.97 109.32 20.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.367 -0.833 . . . . 0.0 109.299 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 100' ' ' SER . 86.6 mt-10 -113.32 144.19 43.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 109.43 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 96' ' ' GLN . 37.5 t -148.55 166.59 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.299 -0.876 . . . . 0.0 109.37 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.541 ' N ' HG12 ' A' ' 95' ' ' VAL . 32.3 tt0 -59.16 115.99 3.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.245 -0.91 . . . . 0.0 109.388 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.06 9.79 85.75 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.48 ' O ' ' O ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -143.17 24.71 1.78 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -1.147 . . . . 0.0 109.305 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.538 ' OE1' HD21 ' A' ' 104' ' ' LEU . 9.7 pt-20 -44.53 170.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.276 -0.89 . . . . 0.0 109.556 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.407 ' H ' ' HG2' ' A' ' 94' ' ' GLU . 4.3 t -91.51 167.8 11.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.279 -0.888 . . . . 0.0 109.573 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.66 -59.89 2.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.295 -0.878 . . . . 0.0 109.527 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.0 m -46.85 -35.59 6.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.355 -0.841 . . . . 0.0 109.373 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -68.87 -46.49 68.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.347 -0.846 . . . . 0.0 109.292 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.58 ' O ' ' CD1' ' A' ' 107' ' ' PHE . 12.0 mt -61.15 -20.57 62.85 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.252 -0.905 . . . . 0.0 109.436 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -93.74 -24.85 19.5 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.414 ' O ' ' C ' ' A' ' 107' ' ' PHE . 7.8 t80 -80.0 -21.42 43.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -1.133 . . . . 0.0 109.461 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.583 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 1.6 p90 -44.97 121.67 2.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.456 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -108.98 -50.67 2.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.979 . . . . 0.0 109.536 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 94.9 p -101.42 -9.79 20.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 109.539 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 96.29 108.48 2.44 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.735 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -67.6 177.06 2.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -1.153 . . . . 0.0 109.512 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -146.88 143.7 28.74 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.288 -0.883 . . . . 0.0 109.436 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.61 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -112.41 124.67 53.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.312 -0.868 . . . . 0.0 109.485 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 17.0 mtpt -97.42 160.62 14.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 109.531 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -125.35 123.98 40.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.364 -0.835 . . . . 0.0 109.364 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.69 -109.53 0.21 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.85 145.46 12.88 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.82 -156.43 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -1.179 . . . . 0.0 109.433 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.437 ' C ' ' N ' ' A' ' 121' ' ' GLY . . . -139.65 -0.31 1.75 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 0.0 109.466 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.1 m 53.33 10.29 0.19 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.437 ' N ' ' C ' ' A' ' 119' ' ' ALA . . . 59.79 -128.84 47.41 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.579 ' CD2' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -85.57 -78.67 0.26 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -1.151 . . . . 0.0 109.419 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.459 ' HE3' ' H ' ' A' ' 124' ' ' HIS . 6.0 ttpp -78.95 -152.95 0.07 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.18 -0.95 . . . . 0.0 109.324 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.459 ' H ' ' HE3' ' A' ' 123' ' ' LYS . 4.9 t-80 59.11 35.96 23.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.549 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.1 t -116.92 24.8 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.321 -0.862 . . . . 0.0 109.35 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.5 t -144.11 69.33 16.14 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.894 . . . . 0.0 109.39 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.482 ' C ' ' H ' ' A' ' 129' ' ' GLU . 55.4 Cg_endo -74.71 6.47 3.25 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.708 2.272 . . . . 0.0 112.226 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -74.3 20.43 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.946 . . . . 0.0 109.36 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.482 ' H ' ' C ' ' A' ' 127' ' ' PRO . 6.2 pt-20 -141.01 64.2 1.43 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.453 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.451 ' C ' ' O ' ' A' ' 129' ' ' GLU . 42.7 t -40.72 125.25 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.312 -0.868 . . . . 0.0 109.64 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.498 HG13 ' O ' ' A' ' 131' ' ' VAL . 15.0 p -72.24 127.73 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.438 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.92 -27.84 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.873 . . . . 0.0 109.433 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.453 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.581 ' O ' ' ND1' ' A' ' 2' ' ' HIS . 60.1 mm-40 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.601 ' O ' ' N ' ' A' ' 4' ' ' GLU . 13.8 m-70 -156.53 81.61 3.51 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.168 -0.957 . . . . 0.0 109.627 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -54.13 67.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.774 2.316 . . . . 0.0 111.974 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 2' ' ' HIS . 57.2 mm-40 -83.06 -46.02 13.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.972 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.553 ' CE2' ' CG1' ' A' ' 42' ' ' VAL . 34.8 t80 -69.74 -12.54 61.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.111 -0.993 . . . . 0.0 109.558 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.415 ' N ' HD23 ' A' ' 6' ' ' LEU . 9.4 mt -90.34 -33.71 15.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.216 -0.927 . . . . 0.0 109.381 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 8' ' ' ALA . 25.1 mttp -91.17 -11.34 38.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.229 -0.919 . . . . 0.0 109.494 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -42.73 166.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.177 -0.952 . . . . 0.0 109.47 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.542 ' H ' ' NE2' ' A' ' 15' ' ' GLN . . . 106.24 68.27 0.69 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.8 pttt -135.97 -0.87 2.49 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.211 -1.17 . . . . 0.0 109.576 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -159.02 142.48 10.81 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 109.326 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.35 89.88 1.04 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.594 2.196 . . . . 0.0 112.256 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -169.14 -105.92 0.19 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.5 tt -162.38 144.82 11.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -1.15 . . . . 0.0 109.472 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.542 ' NE2' ' H ' ' A' ' 9' ' ' GLY . 9.0 mt-30 -134.6 144.39 47.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 109.629 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.505 HG23 HD12 ' A' ' 43' ' ' ILE . 7.8 mt -122.89 143.96 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.455 -0.778 . . . . 0.0 109.812 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.423 ' CE2' ' HB3' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -146.68 136.07 22.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.307 -0.87 . . . . 0.0 109.019 179.738 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.552 ' O ' ' N ' ' A' ' 25' ' ' VAL . 51.5 ttt180 -94.11 153.17 18.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.124 -0.985 . . . . 0.0 109.645 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 23' ' ' ASP . 28.3 t -96.45 133.31 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.92 . . . . 0.0 109.722 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.774 ' O ' ' N ' ' A' ' 22' ' ' PHE . 6.0 tt0 -80.09 85.58 5.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.132 -0.98 . . . . 0.0 108.774 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.648 ' O ' ' CD2' ' A' ' 22' ' ' PHE . 7.5 mtpm? 40.43 9.86 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.548 -0.72 . . . . 0.0 109.792 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.774 ' N ' ' O ' ' A' ' 20' ' ' GLU . 0.7 OUTLIER 160.22 -32.35 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.225 -0.922 . . . . 0.0 109.167 -179.723 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.737 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -94.49 -142.38 0.24 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.273 -0.892 . . . . 0.0 110.257 -179.214 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.52 HD13 ' H ' ' A' ' 4' ' ' GLU . 8.9 mt -125.95 146.12 49.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.341 -0.849 . . . . 0.0 109.942 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' A' ' 18' ' ' ARG . 7.8 t -142.05 132.29 12.66 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 0.0 109.15 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -76.3 144.67 26.37 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.39 2.06 . . . . 0.0 112.26 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.2 t -110.96 101.51 50.09 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.346 -0.846 . . . . 0.0 109.437 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -51.19 161.6 1.58 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.508 2.139 . . . . 0.0 112.153 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.7 m -68.64 -22.15 64.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.389 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -67.0 -11.83 58.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 109.433 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 32' ' ' TYR . 15.3 mt -122.93 -17.11 6.87 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.268 -0.895 . . . . 0.0 109.52 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.55 ' C ' ' CD2' ' A' ' 32' ' ' TYR . 4.4 t80 -42.46 133.12 3.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.907 . . . . 0.0 109.348 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.83 22.26 16.36 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -143.02 151.37 40.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -1.192 . . . . 0.0 109.444 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -141.83 137.48 31.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.231 -0.918 . . . . 0.0 109.549 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -102.04 137.63 40.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 109.325 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.4 p -78.2 -4.79 49.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.882 . . . . 0.0 109.48 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.35 30.94 8.92 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 40' ' ' ALA . 8.8 t70 -173.66 156.13 2.86 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.188 -1.184 . . . . 0.0 109.521 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.447 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -97.77 147.68 24.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.246 -0.909 . . . . 0.0 109.279 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.44 ' N ' ' CD2' ' A' ' 41' ' ' TYR . 17.1 m-85 -128.72 134.82 48.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.324 -0.86 . . . . 0.0 109.46 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.918 ' O ' HD13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -105.44 140.94 21.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.213 -0.929 . . . . 0.0 109.06 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.918 HD13 ' O ' ' A' ' 42' ' ' VAL . 1.1 mm -131.22 134.89 60.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.37 -0.831 . . . . 0.0 110.028 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 tt -120.22 120.13 35.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.536 -0.727 . . . . 0.0 109.531 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.403 ' HE3' ' CE1' ' A' ' 106' ' ' TYR . 43.6 tttt -93.79 147.91 22.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.116 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.6 OUTLIER -142.68 122.14 13.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 109.526 -179.768 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -129.97 168.18 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 O-C-N 121.249 -0.907 . . . . 0.0 108.908 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -94.51 131.29 40.39 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.533 -0.729 . . . . 0.0 109.487 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 15.8 mt -96.32 167.52 11.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 109.534 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.53 ' CG ' ' N ' ' A' ' 51' ' ' ASN . 4.6 ptm180 -47.93 -46.86 32.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.261 -0.899 . . . . 0.0 109.296 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.53 ' N ' ' CG ' ' A' ' 50' ' ' ARG . 98.6 m-20 -75.75 -27.48 58.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.316 -0.865 . . . . 0.0 109.199 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.85 28.96 7.95 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.497 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.4 t-20 -84.67 13.64 5.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.099 -1.236 . . . . 0.0 109.359 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.8 mt 47.31 100.26 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.527 0.68 . . . . 0.0 109.509 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -68.85 117.77 10.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.534 -0.729 . . . . 0.0 109.214 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.515 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 96.7 m-85 -98.07 114.71 26.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.174 -0.954 . . . . 0.0 109.865 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.21 155.76 22.46 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.553 ' C ' ' CD2' ' A' ' 59' ' ' HIS . 5.2 mp -134.36 144.7 48.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.838 -1.164 . . . . 0.0 110.517 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.603 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.5 OUTLIER -141.97 126.55 17.89 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.566 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.701 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -105.94 131.13 53.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.1 -1.0 . . . . 0.0 109.593 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -104.94 123.94 48.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.422 -0.799 . . . . 0.0 109.331 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.9 mt -104.7 162.12 13.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.863 . . . . 0.0 109.595 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -117.37 162.69 12.81 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.412 ' HB2' ' NE2' ' A' ' 96' ' ' GLN . 3.7 t-20 -81.08 -12.57 59.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.302 -1.117 . . . . 0.0 109.614 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -106.24 26.98 9.13 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.3 m -130.75 97.61 4.4 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 122.2 1.0 . . . . 0.0 108.42 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 66' ' ' CYS . 31.4 m -49.71 -176.49 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.733 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 72' ' ' GLY . 13.7 pt20 -68.17 -17.5 64.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.4 -0.812 . . . . 0.0 109.561 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -63.48 -58.57 6.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.919 . . . . 0.0 109.652 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.449 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 3.8 mm-40 -62.32 -48.13 81.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.229 -0.919 . . . . 0.0 109.177 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.7 p -66.01 -27.53 68.19 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.338 -0.851 . . . . 0.0 109.231 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.89 -31.82 66.86 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.22 -51.22 18.53 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.278 -1.131 . . . . 0.0 109.342 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.92 -48.18 73.44 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.414 -0.804 . . . . 0.0 109.279 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.406 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -57.11 -48.38 78.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 109.303 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.4 mt -50.77 -47.28 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.204 -0.935 . . . . 0.0 109.319 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -58.06 -37.75 75.02 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.306 -0.871 . . . . 0.0 109.264 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 m -65.32 -46.22 81.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.33 -0.856 . . . . 0.0 109.266 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 75' ' ' ALA . 17.1 t -56.02 -36.41 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 0.0 109.451 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -64.89 -50.09 67.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.277 -0.889 . . . . 0.0 109.255 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.2 mt -53.13 -36.1 60.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.204 -0.935 . . . . 0.0 109.247 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 85' ' ' LEU . 40.6 m-20 -63.36 -58.34 7.42 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.247 -0.908 . . . . 0.0 109.109 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 82' ' ' ASP . 1.8 t70 -45.4 -34.0 2.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.212 -0.93 . . . . 0.0 108.54 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -73.7 -28.87 61.96 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 82' ' ' ASP . 6.4 mt -112.93 28.36 8.86 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.394 -0.816 . . . . 0.0 109.272 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 85' ' ' LEU . 9.6 t-20 43.56 37.22 1.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.397 -0.815 . . . . 0.0 109.429 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 48.72 32.95 11.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -89.09 30.96 0.9 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.192 -1.181 . . . . 0.0 109.22 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -129.76 179.14 6.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.423 -0.798 . . . . 0.0 109.347 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.7 128.23 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.15 -0.969 . . . . 0.0 109.5 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.435 ' N ' ' OE1' ' A' ' 91' ' ' GLN . 15.7 mp0 -88.98 144.33 26.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.932 . . . . 0.0 109.366 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.42 ' HB2' ' CG ' ' A' ' 59' ' ' HIS . 28.4 m-70 -131.31 107.27 8.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.94 . . . . 0.0 109.576 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -86.25 105.04 16.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 109.377 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.596 ' OE1' ' CD1' ' A' ' 103' ' ' PHE . 22.3 mt-10 -110.3 141.77 42.84 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.36 -0.837 . . . . 0.0 109.732 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 96' ' ' GLN . 12.0 t -144.38 163.3 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.342 -0.848 . . . . 0.0 109.147 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.426 ' N ' HG12 ' A' ' 95' ' ' VAL . 2.3 pt20 -56.89 120.52 8.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.939 . . . . 0.0 109.442 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.42 15.76 77.54 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.438 ' O ' ' C ' ' A' ' 99' ' ' GLU . 7.0 t80 -141.7 12.13 2.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -1.145 . . . . 0.0 109.443 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.6 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 30.2 mp0 -41.52 138.4 1.33 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.506 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.446 ' H ' ' HG2' ' A' ' 94' ' ' GLU . 4.1 m -72.29 -177.36 2.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 0.0 109.402 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.2 -65.21 0.98 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.187 -0.945 . . . . 0.0 109.505 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.6 m -47.64 -36.21 10.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 109.444 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.685 ' CZ ' ' CZ ' ' A' ' 107' ' ' PHE . 2.1 t80 -67.8 -47.16 69.87 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.259 -0.901 . . . . 0.0 109.442 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 104' ' ' LEU . 63.5 mt -66.83 -23.1 65.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.934 . . . . 0.0 109.508 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -93.32 -24.17 22.49 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.403 ' CE1' ' HE3' ' A' ' 45' ' ' LYS . 32.6 t80 -86.94 -33.62 19.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.225 -1.162 . . . . 0.0 109.51 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.685 ' CZ ' ' CZ ' ' A' ' 103' ' ' PHE . 24.2 m-85 -90.31 99.31 12.36 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.29 -0.881 . . . . 0.0 109.528 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.419 ' C ' ' H ' ' A' ' 110' ' ' GLY . 19.9 mtpp -99.74 -6.16 27.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.913 . . . . 0.0 109.365 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 26.0 m -77.75 22.29 0.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 109.426 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 111' ' ' LEU . . . 47.62 80.85 0.05 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.75 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.5 OUTLIER -43.01 118.33 1.25 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -1.145 . . . . 0.0 109.441 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -82.04 123.57 29.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.28 -0.887 . . . . 0.0 109.497 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -94.93 108.73 20.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.511 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -111.43 140.12 46.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.348 -0.845 . . . . 0.0 109.556 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 30.3 pttt -137.57 139.91 40.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.911 . . . . 0.0 109.397 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.87 112.55 3.5 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 177.1 0.04 0.03 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.5 t -96.04 -48.56 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -1.122 . . . . 0.0 109.433 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 53.31 -117.88 1.25 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.162 -0.961 . . . . 0.0 109.384 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 t -93.67 111.96 23.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.182 -0.948 . . . . 0.0 109.422 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -155.22 19.29 0.54 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -151.66 -31.6 0.16 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.33 -1.1 . . . . 0.0 109.487 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.416 ' O ' ' CG ' ' A' ' 124' ' ' HIS . 28.6 mtmt -67.67 -29.32 68.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.903 . . . . 0.0 109.413 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' HIS . . . . . 0.416 ' CG ' ' O ' ' A' ' 123' ' ' LYS . 80.1 m80 -153.87 100.63 2.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.29 -0.881 . . . . 0.0 109.401 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.482 ' O ' ' C ' ' A' ' 126' ' ' VAL . 2.1 t -69.64 66.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 109.532 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.482 ' C ' ' O ' ' A' ' 125' ' ' VAL . 1.2 m -38.92 103.35 0.28 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.435 -0.791 . . . . 0.0 109.574 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.99 119.58 5.03 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.461 2.107 . . . . 0.0 112.187 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -102.55 -12.7 17.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 109.499 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -163.2 84.61 0.5 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.317 -0.864 . . . . 0.0 109.508 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.435 ' H ' HG23 ' A' ' 130' ' ' VAL . 2.4 t -71.25 139.53 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.164 -0.96 . . . . 0.0 109.43 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 131' ' ' VAL . 13.3 p -72.25 124.86 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.895 . . . . 0.0 109.474 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.4 t -69.15 77.5 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 109.428 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.427 -179.951 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.618 ' N ' ' ND1' ' A' ' 2' ' ' HIS . 0.0 OUTLIER -144.07 173.28 4.56 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.372 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -49.39 73.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.73 2.287 . . . . 0.0 112.099 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.592 ' N ' ' O ' ' A' ' 2' ' ' HIS . 0.4 OUTLIER -82.25 -34.83 28.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 109.698 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.628 ' CE2' HG12 ' A' ' 42' ' ' VAL . 15.9 t80 -56.78 -8.87 0.66 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.184 -0.948 . . . . 0.0 109.291 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.409 ' N ' ' C ' ' A' ' 4' ' ' GLU . 51.1 mt -90.24 -45.73 8.88 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.227 -0.921 . . . . 0.0 109.385 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.455 ' O ' ' C ' ' A' ' 8' ' ' ALA . 43.6 mtpt -87.27 -2.08 58.37 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.292 -0.88 . . . . 0.0 109.439 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -41.48 150.46 0.1 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.42 -0.8 . . . . 0.0 109.581 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.54 68.83 0.29 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -134.64 9.69 3.66 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.373 -1.075 . . . . 0.0 109.539 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -172.67 139.37 0.93 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.148 -0.97 . . . . 0.0 109.451 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.38 86.3 1.17 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.547 2.165 . . . . 0.0 112.265 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -166.31 -107.58 0.2 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.6 tt -162.6 151.0 14.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.291 -1.123 . . . . 0.0 109.635 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.424 ' HB3' ' CZ3' ' A' ' 17' ' ' TRP . 32.7 mt-30 -146.66 140.25 25.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 109.403 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.582 ' HB ' HG11 ' A' ' 27' ' ' VAL . 3.4 mt -114.38 149.39 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.312 -0.867 . . . . 0.0 109.923 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.424 ' CZ3' ' HB3' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -145.27 135.23 23.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.302 -0.874 . . . . 0.0 109.122 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -92.27 142.83 27.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.164 -0.96 . . . . 0.0 109.381 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.634 ' O ' HG13 ' A' ' 19' ' ' VAL . 9.9 p -80.45 119.62 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.198 -0.939 . . . . 0.0 109.501 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.614 ' O ' ' N ' ' A' ' 22' ' ' PHE . 8.6 tm-20 -74.79 147.83 40.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.234 -0.916 . . . . 0.0 109.157 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.425 ' N ' ' CD ' ' A' ' 20' ' ' GLU . 23.8 mttp -45.19 -11.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.901 . . . . 0.0 109.833 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.614 ' N ' ' O ' ' A' ' 20' ' ' GLU . 7.6 t80 -165.71 29.75 0.05 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.126 -0.984 . . . . 0.0 109.797 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.463 ' N ' ' HB3' ' A' ' 20' ' ' GLU . 27.5 t70 -175.29 -116.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 109.597 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.6 tp -157.99 146.2 18.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.346 -0.846 . . . . 0.0 109.499 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -134.38 107.9 11.17 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.244 -0.91 . . . . 0.0 109.604 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.74 132.79 37.62 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.192 1.928 . . . . 0.0 111.843 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.582 HG11 ' HB ' ' A' ' 16' ' ' ILE . 2.2 p -75.7 121.57 85.35 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 109.572 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -78.17 166.84 24.14 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.4 2.067 . . . . 0.0 112.139 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.86 -6.25 43.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.332 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -87.19 -6.39 58.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 109.346 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 32' ' ' TYR . 56.6 mt -132.87 -11.4 3.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 109.778 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.528 ' CZ ' ' CD1' ' A' ' 16' ' ' ILE . 9.6 t80 -43.25 118.98 1.44 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 109.487 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.66 -11.91 56.45 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.514 ' C ' ' CG ' ' A' ' 35' ' ' PHE . 1.9 m-20 -110.52 150.52 28.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -1.154 . . . . 0.0 109.503 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.514 ' CG ' ' C ' ' A' ' 34' ' ' ASP . 5.2 m-85 -155.1 148.17 24.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 109.421 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.478 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 2.0 m-85 -102.34 135.96 43.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 109.536 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 44.7 p -67.13 -9.57 41.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.354 -0.841 . . . . 0.0 109.289 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.52 30.36 8.9 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 40' ' ' ALA . 3.1 t70 -161.36 159.44 28.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -1.154 . . . . 0.0 109.399 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.6 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -107.46 150.71 26.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 109.392 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -130.03 138.89 51.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.312 -0.867 . . . . 0.0 109.511 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.08 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -112.81 126.52 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.25 -0.906 . . . . 0.0 108.591 179.698 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.08 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -123.73 137.77 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 119.319 -0.952 . . . . 0.0 110.373 -178.862 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.6 tt -121.09 146.96 46.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.542 -0.724 . . . . 0.0 109.396 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 57' ' ' ASP . 1.8 ttmp? -123.67 139.34 54.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.417 -0.802 . . . . 0.0 109.259 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 13' ' ' GLY . 20.4 m -136.31 117.93 14.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.342 -0.849 . . . . 0.0 109.328 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -126.52 167.86 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.317 -0.864 . . . . 0.0 109.01 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -98.48 125.44 43.68 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.498 -0.752 . . . . 0.0 109.442 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.435 HD11 ' HB2' ' A' ' 55' ' ' GLN . 11.1 mt -87.9 154.43 20.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.27 -0.894 . . . . 0.0 109.673 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.432 ' CZ ' ' CB ' ' A' ' 50' ' ' ARG . 10.3 mtp-105 -48.24 -43.39 32.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -0.916 . . . . 0.0 109.255 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -68.41 -32.85 73.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.312 -0.868 . . . . 0.0 109.3 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.09 74.67 1.18 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.508 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.1 t-20 -143.69 13.77 1.73 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.203 -1.175 . . . . 0.0 109.336 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.708 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 31.4 mt 44.52 98.26 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.536 0.684 . . . . 0.0 109.496 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.435 ' HB2' HD11 ' A' ' 49' ' ' LEU . 66.0 tt0 -73.97 121.31 20.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.559 -0.713 . . . . 0.0 109.682 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -99.54 114.54 27.59 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.248 -0.908 . . . . 0.0 109.751 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 45' ' ' LYS . 0.9 OUTLIER -127.51 122.56 33.7 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.362 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.431 HD13 HD21 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -126.16 150.37 48.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.114 -0.991 . . . . 0.0 110.71 -178.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.611 ' HB2' ' CD2' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -129.53 141.71 50.92 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.34 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.572 ' HE1' ' HB1' ' A' ' 40' ' ' ALA . 2.4 t80 -103.24 126.22 50.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.897 . . . . 0.0 109.56 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.457 ' N ' ' CD1' ' A' ' 60' ' ' TYR . 44.2 t90 -100.74 127.8 47.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.09 -1.006 . . . . 0.0 109.824 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.499 HD21 ' CE2' ' A' ' 60' ' ' TYR . 2.9 mp -112.53 157.0 21.68 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.491 -0.756 . . . . 0.0 109.412 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -104.78 161.68 14.99 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' A' ' 64' ' ' ASN . 0.5 OUTLIER -81.72 -12.05 58.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.333 -1.098 . . . . 0.0 109.474 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -106.66 29.59 6.82 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.552 ' SG ' ' OE2' ' A' ' 70' ' ' GLU . 1.6 m -130.78 97.51 4.36 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.591 ' OG ' ' N ' ' A' ' 68' ' ' GLN . 1.0 OUTLIER -58.67 -173.76 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.573 -179.829 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.591 ' N ' ' OG ' ' A' ' 67' ' ' SER . 8.6 pt20 -62.45 -17.97 60.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 109.66 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -65.35 -58.77 5.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.557 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.552 ' OE2' ' SG ' ' A' ' 66' ' ' CYS . 13.4 mt-10 -64.63 -43.1 94.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.336 -0.852 . . . . 0.0 109.139 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.7 t -69.33 -26.7 64.83 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.491 -0.756 . . . . 0.0 109.191 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.31 -38.89 71.18 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.02 -47.98 64.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.331 -1.1 . . . . 0.0 109.366 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.483 ' O ' ' OG1' ' A' ' 78' ' ' THR . . . -60.36 -42.22 95.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.366 -0.834 . . . . 0.0 109.311 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.487 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -62.95 -44.8 95.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.883 . . . . 0.0 109.598 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.2 mt -53.45 -51.53 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 0.0 109.341 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -61.36 -33.23 73.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 109.307 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -68.81 -44.77 72.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.382 -0.824 . . . . 0.0 109.374 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 75' ' ' ALA . 42.9 t -63.34 -31.2 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.293 -0.879 . . . . 0.0 109.409 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -66.9 -60.97 2.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.334 -0.854 . . . . 0.0 109.165 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.805 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -50.78 -31.09 15.84 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.046 -1.034 . . . . 0.0 108.708 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' A' ' 86' ' ' ASN . 29.2 t70 -63.64 -59.57 4.44 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.418 -0.802 . . . . 0.0 108.928 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.432 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 1.3 m-20 -46.03 -34.09 3.84 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.158 -0.964 . . . . 0.0 108.46 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -74.7 -32.79 62.28 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 82' ' ' ASP . 1.1 tt -121.48 35.67 4.82 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.369 -0.832 . . . . 0.0 109.532 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.609 ' N ' ' O ' ' A' ' 82' ' ' ASP . 11.4 p-10 -76.89 27.03 0.14 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.125 -0.985 . . . . 0.0 109.092 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -69.9 -57.86 6.74 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -176.67 46.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.346 -1.091 . . . . 0.0 109.564 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.63 179.13 6.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 0.0 109.406 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.7 t -126.25 111.95 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 109.45 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -102.38 136.43 42.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.364 -0.835 . . . . 0.0 109.397 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.611 ' CD2' ' HB2' ' A' ' 59' ' ' HIS . 1.2 p-80 -143.82 118.65 9.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.077 -1.014 . . . . 0.0 109.515 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.1 mtm180 -83.01 138.28 33.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 109.774 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' A' ' 100' ' ' SER . 5.4 mt-10 -131.37 155.98 46.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.304 -0.873 . . . . 0.0 109.283 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.698 HG12 ' N ' ' A' ' 96' ' ' GLN . 48.1 t -131.66 173.8 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.219 -0.925 . . . . 0.0 109.575 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.698 ' N ' HG12 ' A' ' 95' ' ' VAL . 26.8 tt0 -60.55 139.75 57.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.374 -0.829 . . . . 0.0 109.54 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 70.53 -18.55 0.75 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.517 ' H ' ' C ' ' A' ' 96' ' ' GLN . 7.9 t80 -106.59 4.7 28.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.301 -1.117 . . . . 0.0 109.452 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.54 ' OE2' HD22 ' A' ' 111' ' ' LEU . 27.7 mt-10 -42.69 148.26 0.24 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.903 . . . . 0.0 109.559 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.467 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 38.4 m -81.06 168.7 18.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.9 . . . . 0.0 109.529 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.93 -35.02 78.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.153 -0.967 . . . . 0.0 109.607 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.8 m -58.03 -61.03 2.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.568 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -57.78 -41.79 82.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.35 -0.844 . . . . 0.0 109.732 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.2 mt -66.28 -28.52 68.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.189 -0.944 . . . . 0.0 109.552 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -81.7 -19.22 66.29 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.43 ' CD1' ' CZ ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -81.37 -45.55 15.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -1.121 . . . . 0.0 109.431 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.43 ' CZ ' ' CD1' ' A' ' 106' ' ' TYR . 20.4 m-85 -139.41 87.21 2.17 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.352 -0.842 . . . . 0.0 109.496 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.35 -20.76 20.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.386 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.7 t -96.94 -12.39 23.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -0.939 . . . . 0.0 109.484 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.456 ' O ' ' C ' ' A' ' 111' ' ' LEU . . . -97.65 -107.15 2.53 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.54 HD22 ' OE2' ' A' ' 99' ' ' GLU . 14.5 mt 41.52 61.64 1.77 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.329 -1.1 . . . . 0.0 109.507 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tppt? -75.59 117.04 16.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.172 -0.955 . . . . 0.0 109.479 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -84.5 114.38 21.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.297 -0.877 . . . . 0.0 109.478 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -103.05 166.28 10.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 0.0 109.355 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -127.8 156.59 42.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.854 . . . . 0.0 109.465 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.04 -162.46 12.69 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -176.04 -176.32 44.15 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 p -156.76 139.21 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.097 -1.237 . . . . 0.0 109.541 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -98.39 84.34 3.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.293 -0.879 . . . . 0.0 109.507 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.1 t -70.92 -59.96 2.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.911 . . . . 0.0 109.395 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -160.08 26.38 0.32 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -65.75 -73.08 0.14 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -1.161 . . . . 0.0 109.488 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -95.97 -64.72 1.03 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 109.607 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -140.3 -174.41 3.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.297 -0.877 . . . . 0.0 109.502 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 125' ' ' VAL . 14.5 p -103.4 3.45 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.56 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.7 t 57.21 66.91 2.76 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 0.0 109.458 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -73.32 -172.58 1.06 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.73 2.287 . . . . 0.0 112.185 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.421 ' O ' ' O ' ' A' ' 129' ' ' GLU . 56.9 m-80 -85.47 -64.67 1.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.499 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' A' ' 128' ' ' ASN . 28.5 tt0 61.65 145.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.405 -0.809 . . . . 0.0 109.442 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.5 t -146.65 -78.04 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.22 -0.925 . . . . 0.0 109.458 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.42 ' C ' ' N ' ' A' ' 133' ' ' GLN . 2.0 t -71.76 146.97 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.292 -0.88 . . . . 0.0 109.481 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.436 ' O ' ' OXT' ' A' ' 133' ' ' GLN . 75.3 t -51.55 -14.38 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.927 . . . . 0.0 109.515 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.436 ' OXT' ' O ' ' A' ' 132' ' ' VAL . 14.7 mm100 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.066 -0.969 . . . . 0.0 109.534 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.281 0.562 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.579 ' O ' ' N ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER -176.46 145.44 0.7 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.246 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.404 ' HD2' ' CG ' ' A' ' 2' ' ' HIS . 84.3 Cg_exo -39.4 81.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.65 2.234 . . . . 0.0 112.238 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.644 ' H ' HD22 ' A' ' 24' ' ' LEU . 1.2 tp10 -83.07 -29.35 28.86 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.26 -0.9 . . . . 0.0 109.563 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.616 ' CZ ' ' O ' ' A' ' 42' ' ' VAL . 2.9 m-85 -56.32 -4.59 0.14 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.951 . . . . 0.0 109.13 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.511 ' H ' ' C ' ' A' ' 4' ' ' GLU . 14.4 mt -84.54 -38.4 20.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.88 . . . . 0.0 109.279 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 8' ' ' ALA . 23.2 mttt -101.43 -3.37 28.79 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.393 -0.817 . . . . 0.0 109.358 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.503 ' HB3' HD13 ' A' ' 44' ' ' LEU . . . -42.01 137.52 1.81 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.31 -0.869 . . . . 0.0 109.637 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . 0.555 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 154.86 -37.45 0.66 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.623 ' CD ' ' H ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -70.78 19.83 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -1.152 . . . . 0.0 109.309 179.85 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.555 ' H ' ' C ' ' A' ' 9' ' ' GLY . 79.9 mt-10 -139.23 103.02 7.31 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.374 -0.829 . . . . 0.0 109.293 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -78.33 83.97 2.11 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.426 2.084 . . . . 0.0 112.157 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -174.22 -102.01 0.15 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -159.97 132.47 6.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.134 . . . . 0.0 109.427 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -115.23 135.93 53.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.276 -0.89 . . . . 0.0 109.478 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.58 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 6.3 mt -130.96 110.11 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.44 -0.787 . . . . 0.0 109.91 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.58 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 6.1 m0 -139.32 149.76 44.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.176 -0.953 . . . . 0.0 108.769 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.641 ' HE ' HG22 ' A' ' 27' ' ' VAL . 6.7 ptp180 -114.83 153.27 30.73 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.122 -0.986 . . . . 0.0 110.139 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.552 ' O ' HG13 ' A' ' 19' ' ' VAL . 7.3 p -89.26 125.68 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -0.843 . . . . 0.0 109.13 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.657 ' CB ' HG21 ' A' ' 25' ' ' VAL . 5.6 mt-10 -157.45 138.02 13.02 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.214 -0.929 . . . . 0.0 109.319 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 22' ' ' PHE . 12.8 mttt 72.97 48.21 0.18 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.501 -0.75 . . . . 0.0 109.458 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.428 ' C ' ' O ' ' A' ' 21' ' ' LYS . 20.5 m-85 43.74 36.93 1.41 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.541 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -169.01 166.75 10.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.28 -0.888 . . . . 0.0 109.405 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.644 HD22 ' H ' ' A' ' 4' ' ' GLU . 4.4 tp -68.15 146.16 53.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.246 -0.909 . . . . 0.0 109.431 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.657 HG21 ' CB ' ' A' ' 20' ' ' GLU . 44.1 t -138.5 97.67 9.25 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.371 -0.831 . . . . 0.0 109.071 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -50.31 168.99 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.771 2.314 . . . . 0.0 112.632 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.641 HG22 ' HE ' ' A' ' 18' ' ' ARG . 58.0 t -126.92 107.43 22.27 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.462 -0.774 . . . . 0.0 109.173 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -45.69 144.04 5.75 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.434 2.089 . . . . 0.0 112.492 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 31' ' ' LEU . 6.5 m -51.89 -50.19 61.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.266 -0.896 . . . . 0.0 109.39 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -48.11 -11.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.418 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' THR . 94.5 mt -114.96 -17.45 11.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 109.552 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.525 ' CE1' HD12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -38.74 122.4 1.15 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.325 -0.859 . . . . 0.0 109.352 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.2 -10.9 36.89 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.477 ' C ' ' CD2' ' A' ' 35' ' ' PHE . 4.3 m-20 -93.5 156.71 16.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.151 -1.205 . . . . 0.0 109.381 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.477 ' CD2' ' C ' ' A' ' 34' ' ' ASP . 77.2 m-85 -146.83 134.38 20.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.201 -0.937 . . . . 0.0 109.6 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.598 ' CD2' ' NZ ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -103.63 120.02 40.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 109.329 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.471 ' OG1' ' OE1' ' A' ' 65' ' ' GLU . 59.1 p -61.9 -23.05 66.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 109.44 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.451 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -88.33 24.97 9.85 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.511 ' OD1' ' CG ' ' A' ' 20' ' ' GLU . 7.1 m-20 -159.52 135.34 8.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.283 -1.128 . . . . 0.0 109.334 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.534 ' HB1' ' HE1' ' A' ' 60' ' ' TYR . . . -77.83 140.6 39.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -0.901 . . . . 0.0 109.318 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -116.33 135.04 54.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -0.859 . . . . 0.0 109.383 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.95 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -118.92 136.37 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.414 -0.804 . . . . 0.0 109.265 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.95 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -130.64 141.58 45.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.776 179.81 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.682 HD23 ' N ' ' A' ' 45' ' ' LYS . 4.6 tt -129.32 117.31 20.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.311 -0.868 . . . . 0.0 109.688 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.682 ' N ' HD23 ' A' ' 44' ' ' LEU . 4.6 ttmm -89.07 134.65 33.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.842 . . . . 0.0 109.38 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.6 OUTLIER -140.81 116.33 10.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.159 -0.963 . . . . 0.0 109.432 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.803 ' O ' HD23 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -125.58 168.44 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.18 -0.95 . . . . 0.0 109.183 -179.816 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.832 HE22 ' H ' ' A' ' 51' ' ' ASN . 1.0 OUTLIER -115.56 123.33 48.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.564 -0.71 . . . . 0.0 109.163 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.594 ' N ' ' OE1' ' A' ' 48' ' ' GLN . 0.5 OUTLIER -103.46 100.41 10.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.285 -0.885 . . . . 0.0 109.532 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.584 ' C ' ' O ' ' A' ' 49' ' ' LEU . 19.7 mtp180 25.89 58.99 0.06 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.654 -0.654 . . . . 0.0 110.032 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.832 ' H ' HE22 ' A' ' 48' ' ' GLN . 1.8 m-20 55.23 50.54 14.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.351 -0.843 . . . . 0.0 109.382 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . -93.53 -79.71 1.45 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.419 ' O ' ' O ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -164.61 22.06 0.06 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -1.171 . . . . 0.0 109.515 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.803 HD23 ' O ' ' A' ' 47' ' ' VAL . 11.4 mt 56.35 104.81 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.641 0.734 . . . . 0.0 109.359 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 46' ' ' THR . 4.5 tt0 -68.71 116.29 9.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.55 -0.719 . . . . 0.0 109.236 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.627 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 96.3 m-85 -104.39 115.24 30.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.364 -0.835 . . . . 0.0 109.964 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.89 155.05 36.25 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.439 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 4.3 tp -142.63 137.91 30.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.936 -1.102 . . . . 0.0 110.521 -179.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.653 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -130.02 119.55 23.32 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.524 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.534 ' HE1' ' HB1' ' A' ' 40' ' ' ALA . 3.6 t80 -101.57 124.44 47.23 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.01 -1.056 . . . . 0.0 109.387 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -103.81 126.64 51.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.11 -0.994 . . . . 0.0 109.799 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.425 ' CD2' ' OH ' ' A' ' 60' ' ' TYR . 6.4 mt -97.28 162.07 13.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.449 -0.782 . . . . 0.0 109.657 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.97 154.59 16.87 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -74.62 -12.34 60.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.056 -1.261 . . . . 0.0 109.52 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.471 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 1.2 mt-10 -109.23 30.35 6.68 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 2.1 m -130.49 97.42 4.39 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 122.075 0.94 . . . . 0.0 108.586 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.2 p -73.27 -170.88 0.85 Allowed 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.665 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -55.49 -28.18 52.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.792 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.31 -58.87 4.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 0.0 109.571 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.451 ' OE2' ' O ' ' A' ' 65' ' ' GLU . 24.3 mt-10 -62.95 -43.02 99.93 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.264 -0.898 . . . . 0.0 108.998 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.0 t -64.69 -34.68 78.88 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.454 -0.779 . . . . 0.0 108.953 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.03 -43.15 99.81 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.23 -50.33 73.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -1.125 . . . . 0.0 109.116 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.479 ' O ' ' OG1' ' A' ' 78' ' ' THR . . . -61.63 -40.02 93.38 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.469 -0.769 . . . . 0.0 109.267 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.488 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -64.37 -42.7 96.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.866 . . . . 0.0 109.428 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.2 mt -55.4 -53.88 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.183 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -57.87 -32.19 67.44 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.187 -0.946 . . . . 0.0 109.228 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -69.44 -52.42 27.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.008 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 75' ' ' ALA . 37.7 t -56.92 -26.55 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.289 -0.882 . . . . 0.0 109.097 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -70.11 -55.9 8.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.383 -0.823 . . . . 0.0 109.295 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.695 ' C ' HD12 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -54.17 -29.82 47.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.035 -1.041 . . . . 0.0 109.04 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 85' ' ' LEU . 72.7 m-20 -68.94 -58.77 3.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.244 -0.91 . . . . 0.0 108.806 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 82' ' ' ASP . 52.9 t0 -46.86 -29.6 2.07 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.124 -0.985 . . . . 0.0 108.465 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -75.15 -33.79 61.55 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.9 tp -107.63 25.72 11.15 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.424 -0.797 . . . . 0.0 109.375 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 85' ' ' LEU . 2.9 m120 39.09 33.9 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.582 -0.699 . . . . 0.0 109.476 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . 53.98 84.6 0.03 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 45.0 mtp85 -140.22 43.08 1.91 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.318 -1.107 . . . . 0.0 109.391 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.627 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -150.67 170.68 18.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.858 . . . . 0.0 109.404 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.1 t -91.26 91.87 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 109.266 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.525 ' H ' ' CD ' ' A' ' 91' ' ' GLN . 2.3 mp0 -94.34 120.07 34.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -0.885 . . . . 0.0 109.49 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.602 ' NE2' ' ND1' ' A' ' 59' ' ' HIS . 3.9 p80 -127.94 134.09 49.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.359 -0.838 . . . . 0.0 109.381 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.496 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 0.8 OUTLIER -90.52 117.82 29.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.718 -179.753 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.477 ' OE2' ' OG ' ' A' ' 100' ' ' SER . 11.3 mt-10 -108.28 161.13 15.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 109.354 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.7 t -132.53 158.03 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.184 -0.947 . . . . 0.0 109.538 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 pp0? -61.98 143.79 56.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 109.443 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 73.95 7.71 76.51 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -151.39 22.01 0.73 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.316 -1.108 . . . . 0.0 109.322 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -51.62 171.21 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.569 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.477 ' OG ' ' OE2' ' A' ' 94' ' ' GLU . 67.5 p -101.11 165.77 11.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.328 -0.858 . . . . 0.0 109.488 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.47 -33.21 73.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 0.0 109.487 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.2 m -59.92 -42.81 94.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.479 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -66.21 -53.46 36.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.242 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.3 mt -62.58 -27.94 69.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.352 -0.843 . . . . 0.0 109.169 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -69.35 -35.65 76.73 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.522 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 1.9 m-85 -70.13 -54.92 10.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -1.101 . . . . 0.0 109.251 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.522 ' CD2' ' O ' ' A' ' 106' ' ' TYR . 10.0 m-85 -139.36 115.57 10.4 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.425 -0.797 . . . . 0.0 109.562 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.8 tttp -98.72 -52.02 3.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.313 -0.867 . . . . 0.0 109.52 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 m -92.61 23.11 4.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 109.467 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -119.16 -30.27 1.62 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.0 mt -63.8 123.39 18.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.221 -1.164 . . . . 0.0 109.509 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -137.12 102.65 4.9 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.305 -0.872 . . . . 0.0 109.448 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.69 136.42 35.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.905 . . . . 0.0 109.373 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.598 ' NZ ' ' CD2' ' A' ' 36' ' ' PHE . 9.5 pttp -131.54 147.38 52.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 109.464 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.417 ' HD3' ' H ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -107.74 153.25 23.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.353 -0.842 . . . . 0.0 109.433 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 117' ' ' GLY . . . -163.67 143.54 8.71 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 118' ' ' VAL . . . -42.96 -55.24 4.91 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 117' ' ' GLY . 32.4 t 44.21 -105.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -1.123 . . . . 0.0 109.417 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ALA . . . . . 0.408 ' N ' HG12 ' A' ' 118' ' ' VAL . . . -81.44 54.52 2.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.172 -0.955 . . . . 0.0 109.508 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.9 p -58.42 -78.0 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.88 . . . . 0.0 109.533 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 158.59 100.48 0.17 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -46.16 -63.88 0.88 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -1.127 . . . . 0.0 109.539 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -93.09 -133.68 0.15 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.371 -0.831 . . . . 0.0 109.492 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -148.17 35.15 0.81 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 109.392 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.661 HG22 ' H ' ' A' ' 126' ' ' VAL . 0.9 OUTLIER -110.37 -171.82 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.237 -0.914 . . . . 0.0 109.342 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.661 ' H ' HG22 ' A' ' 125' ' ' VAL . 7.4 p -174.32 118.17 0.35 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 109.307 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -76.94 83.5 2.11 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.274 1.983 . . . . 0.0 112.268 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.579 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 4.9 p-10 -90.27 149.87 22.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 109.473 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -172.42 62.08 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.867 . . . . 0.0 109.337 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 130' ' ' VAL . 6.3 p -79.11 87.35 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.276 -0.89 . . . . 0.0 109.638 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 131' ' ' VAL . 9.5 p -83.49 118.0 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.318 -0.864 . . . . 0.0 109.477 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.1 t -77.33 -96.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.192 -0.943 . . . . 0.0 109.582 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.056 -0.974 . . . . 0.0 109.466 179.981 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.495 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 0.1 OUTLIER -85.87 -51.3 0.49 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.941 . . . . 0.0 109.58 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 2' ' ' HIS . 65.3 Cg_endo -79.44 72.85 6.3 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.607 2.205 . . . . 0.0 112.085 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 6' ' ' LEU . 75.8 mt-10 -83.11 -30.77 27.66 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.275 -0.89 . . . . 0.0 109.708 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.61 ' CE1' HG12 ' A' ' 42' ' ' VAL . 46.8 t80 -43.88 -18.31 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.134 -0.979 . . . . 0.0 109.233 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.565 ' N ' ' O ' ' A' ' 4' ' ' GLU . 4.6 mt -81.4 -39.96 24.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.337 -0.852 . . . . 0.0 109.53 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 8' ' ' ALA . 28.3 mtpt -86.93 -12.83 46.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 109.615 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.471 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -42.23 164.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.193 -0.942 . . . . 0.0 109.509 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.12 26.95 5.28 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -102.04 12.53 36.71 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.205 -1.173 . . . . 0.0 109.653 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -158.3 133.69 5.79 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.915 . . . . 0.0 109.466 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -74.58 86.02 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.499 2.133 . . . . 0.0 112.34 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -170.18 -105.59 0.18 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.3 tt -162.2 144.69 11.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.311 -1.111 . . . . 0.0 109.517 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -138.02 134.73 35.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 109.375 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.735 HG23 HD12 ' A' ' 43' ' ' ILE . 27.1 mt -106.92 147.38 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.338 -0.851 . . . . 0.0 110.167 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.08 141.94 36.15 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 25' ' ' VAL . 18.7 ttt180 -110.39 144.85 38.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.177 -0.952 . . . . 0.0 109.635 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.553 HG21 ' HB3' ' A' ' 40' ' ' ALA . 52.0 t -72.48 133.51 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.436 -0.79 . . . . 0.0 109.502 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.633 ' O ' ' N ' ' A' ' 22' ' ' PHE . 28.0 tt0 -81.08 86.85 6.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -0.966 . . . . 0.0 109.366 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.463 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 26.2 mmtp 61.05 -33.09 0.08 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.487 -0.758 . . . . 0.0 109.994 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.633 ' N ' ' O ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER 179.34 27.31 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -0.932 . . . . 0.0 109.394 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -145.15 -113.52 0.09 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.083 -1.01 . . . . 0.0 109.626 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.7 mt -143.66 136.37 27.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.066 -1.021 . . . . 0.0 109.799 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 18' ' ' ARG . 0.9 OUTLIER -149.16 140.37 14.18 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.302 -0.874 . . . . 0.0 108.759 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.49 149.42 68.59 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.551 2.167 . . . . 0.0 112.516 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.421 HG23 ' N ' ' A' ' 18' ' ' ARG . 71.6 t -117.94 101.82 51.56 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.492 -0.755 . . . . 0.0 109.207 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -80.84 167.91 18.0 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.655 2.237 . . . . 0.0 112.461 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.564 ' C ' ' H ' ' A' ' 31' ' ' LEU . 1.9 t -61.03 -173.91 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.546 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.464 ' N ' ' OG1' ' A' ' 29' ' ' THR . 8.1 t30 70.31 -27.71 0.17 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.861 . . . . 0.0 109.343 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.564 ' H ' ' C ' ' A' ' 29' ' ' THR . 43.5 mt -122.73 -33.41 3.39 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.392 -0.818 . . . . 0.0 109.369 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -48.59 165.13 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 0.0 109.319 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.468 ' N ' ' CD1' ' A' ' 32' ' ' TYR . . . 89.04 -24.08 14.85 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -96.71 150.76 20.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -1.182 . . . . 0.0 109.469 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -141.03 134.17 29.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.898 . . . . 0.0 109.418 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.484 ' C ' ' H ' ' A' ' 38' ' ' GLY . 25.6 m-85 -104.53 111.78 24.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.872 . . . . 0.0 109.482 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.469 ' OG1' ' OE1' ' A' ' 65' ' ' GLU . 19.6 p -51.55 -9.51 0.08 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.237 -0.915 . . . . 0.0 109.356 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.484 ' H ' ' C ' ' A' ' 36' ' ' PHE . . . -99.51 27.12 21.64 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.443 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 50.2 m-20 -161.01 146.76 14.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -1.086 . . . . 0.0 109.368 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.553 ' HB3' HG21 ' A' ' 19' ' ' VAL . . . -92.23 158.88 15.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.192 -0.942 . . . . 0.0 109.483 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.437 ' CD2' ' C ' ' A' ' 40' ' ' ALA . 36.4 m-85 -138.26 138.12 38.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 109.369 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.005 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -108.83 128.44 64.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.129 -0.982 . . . . 0.0 108.902 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 1.005 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.4 OUTLIER -125.76 136.97 59.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.242 -0.911 . . . . 0.0 110.023 -179.523 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 tt -124.55 128.85 49.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.545 -0.722 . . . . 0.0 109.582 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.447 ' NZ ' HG21 ' A' ' 102' ' ' THR . 30.3 ttpt -103.79 145.96 29.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.311 -0.868 . . . . 0.0 109.06 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 13' ' ' GLY . 1.0 OUTLIER -143.01 126.78 17.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 109.764 -179.681 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -131.94 168.09 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.29 -0.881 . . . . 0.0 109.16 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -96.82 131.86 43.13 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.597 -0.689 . . . . 0.0 109.497 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 50' ' ' ARG . 14.5 mt -96.92 166.93 11.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.301 -0.874 . . . . 0.0 109.538 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.48 ' H ' ' HD2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -45.18 -78.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.272 -0.892 . . . . 0.0 109.17 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -45.53 -28.97 1.04 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.291 -0.881 . . . . 0.0 109.252 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.55 69.07 1.03 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.499 ' O ' ' O ' ' A' ' 54' ' ' LEU . 63.5 m-20 -120.73 14.44 11.72 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.242 -1.152 . . . . 0.0 109.384 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.661 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 17.7 mt 44.1 97.05 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.509 0.671 . . . . 0.0 109.364 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -71.08 112.08 6.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.428 -0.795 . . . . 0.0 109.527 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.59 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 73.7 m-85 -95.74 114.54 26.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.136 -0.978 . . . . 0.0 109.701 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -115.78 155.38 27.92 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 58' ' ' LEU . 3.8 mp -132.3 141.1 48.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.815 -1.178 . . . . 0.0 110.884 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.484 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -136.7 112.43 9.46 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.233 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.735 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -94.38 126.93 39.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.086 -1.008 . . . . 0.0 109.458 -179.6 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.456 ' HE1' ' HG2' ' A' ' 99' ' ' GLU . 2.3 t90 -98.08 124.73 42.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.475 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 mt -107.64 145.86 32.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.532 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -95.01 158.87 22.59 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -76.23 -12.53 60.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.322 -1.105 . . . . 0.0 109.662 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.469 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 1.1 mt-10 -109.45 29.16 7.82 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 2.0 m -130.7 97.48 4.37 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.211 1.005 . . . . 0.0 108.579 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.8 t -57.35 -170.92 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.735 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.562 ' O ' ' N ' ' A' ' 72' ' ' GLY . 3.2 mm100 -68.99 -17.39 63.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -0.86 . . . . 0.0 109.647 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -61.02 -58.75 7.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 109.394 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -64.38 -49.08 73.0 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.237 -0.914 . . . . 0.0 108.884 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.3 m -64.43 -23.22 67.21 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.399 -0.813 . . . . 0.0 108.844 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -68.44 -47.09 59.62 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.433 ' O ' ' CE2' ' A' ' 77' ' ' PHE . . . -62.63 -49.25 75.92 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.293 -1.122 . . . . 0.0 109.138 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.62 -32.51 74.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.507 -0.746 . . . . 0.0 109.214 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.556 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -71.59 -43.96 65.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.264 -0.898 . . . . 0.0 109.376 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.496 ' O ' ' OE1' ' A' ' 80' ' ' GLN . 59.4 mt -55.09 -53.17 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.188 -0.945 . . . . 0.0 109.24 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.559 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -60.0 -36.57 77.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.134 179.784 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.1 m -69.2 -31.42 70.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.283 -0.886 . . . . 0.0 108.999 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 75' ' ' ALA . 55.1 t -64.83 -46.09 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.271 -0.893 . . . . 0.0 109.242 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLN . . . . . 0.552 ' OE1' ' N ' ' A' ' 80' ' ' GLN . 5.1 mp0 -60.97 -45.42 94.82 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.6 mt -53.27 -43.93 67.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.315 -0.866 . . . . 0.0 109.037 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.64 ' O ' ' N ' ' A' ' 86' ' ' ASN . 68.4 t0 -58.14 -58.23 9.37 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.396 -0.815 . . . . 0.0 109.145 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 82' ' ' ASP . 1.9 m-20 -44.73 -34.41 2.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.155 -0.966 . . . . 0.0 108.948 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -77.08 -30.94 55.69 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.299 -0.876 . . . . 0.0 108.98 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 82' ' ' ASP . 18.7 mt -121.56 32.39 5.91 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.315 -0.866 . . . . 0.0 109.486 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.64 ' N ' ' O ' ' A' ' 82' ' ' ASP . 60.8 t30 -81.08 28.28 0.37 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.207 -0.933 . . . . 0.0 109.097 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -110.45 -37.26 1.79 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -163.23 67.78 0.2 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.154 -1.204 . . . . 0.0 109.45 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.07 166.17 24.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.0 109.321 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.9 t -123.12 96.34 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.342 -0.849 . . . . 0.0 109.545 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.58 131.38 44.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.315 -0.865 . . . . 0.0 109.036 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.569 ' N ' ' CD2' ' A' ' 92' ' ' HIS . 1.6 p80 -150.55 157.36 42.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.006 -1.059 . . . . 0.0 110.037 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.71 121.34 40.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.407 -0.808 . . . . 0.0 109.666 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.447 ' N ' ' CD ' ' A' ' 94' ' ' GLU . 1.5 mp0 -104.69 120.93 42.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.296 -0.878 . . . . 0.0 109.407 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.556 HG12 ' N ' ' A' ' 96' ' ' GLN . 38.9 t -101.18 166.72 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.317 -0.865 . . . . 0.0 109.581 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.556 ' N ' HG12 ' A' ' 95' ' ' VAL . 41.4 tt0 -76.17 140.87 41.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.493 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.424 ' O ' ' CG ' ' A' ' 98' ' ' PHE . . . 80.51 5.02 90.1 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.472 ' O ' ' O ' ' A' ' 99' ' ' GLU . 46.1 m-85 -157.64 22.42 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -1.126 . . . . 0.0 109.457 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' A' ' 98' ' ' PHE . 97.3 mt-10 -49.05 178.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.405 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.3 t -89.63 163.09 15.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.424 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.08 -26.73 67.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.404 -0.81 . . . . 0.0 109.433 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.447 HG21 ' NZ ' ' A' ' 45' ' ' LYS . 7.5 m -65.62 -41.72 92.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.485 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -75.26 -41.95 56.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.372 -0.83 . . . . 0.0 109.336 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.5 mt -62.46 -24.68 67.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.271 -0.893 . . . . 0.0 109.519 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -92.94 -24.02 23.87 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.11 -35.77 69.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.274 -1.133 . . . . 0.0 109.417 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -139.16 133.82 31.97 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.328 -0.858 . . . . 0.0 109.529 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -108.59 -55.45 2.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.436 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.4 t -105.56 15.36 27.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 109.532 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.45 -20.01 18.84 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.5 mt -72.61 70.66 0.94 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -1.18 . . . . 0.0 109.438 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -85.4 124.04 31.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.291 -0.881 . . . . 0.0 109.581 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -105.29 152.76 22.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.485 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.4 mttt -138.83 163.65 31.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.329 -0.857 . . . . 0.0 109.416 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.8 mttt -116.38 126.75 53.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.313 -0.867 . . . . 0.0 109.461 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 60.51 -100.36 0.22 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 145.2 173.25 16.29 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.3 m -144.54 140.9 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -1.127 . . . . 0.0 109.426 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -157.54 134.77 10.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 109.481 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.4 m -174.69 -27.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.194 -0.942 . . . . 0.0 109.519 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.34 66.24 0.98 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -53.01 -44.51 67.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -1.131 . . . . 0.0 109.496 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp -101.69 -84.39 0.44 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -0.859 . . . . 0.0 109.454 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -142.14 104.32 4.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.889 . . . . 0.0 109.544 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 125' ' ' VAL . 7.3 p -72.98 -13.06 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.268 -0.895 . . . . 0.0 109.467 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.59 HG13 ' O ' ' A' ' 126' ' ' VAL . 6.2 p -149.7 76.67 8.91 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.875 . . . . 0.0 109.407 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.484 ' O ' ' O ' ' A' ' 128' ' ' ASN . 50.5 Cg_exo -49.19 -69.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.792 2.328 . . . . 0.0 112.192 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 127' ' ' PRO . 15.6 t30 53.43 105.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 0.0 109.38 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -138.47 -166.56 2.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -0.942 . . . . 0.0 109.397 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.9 t -65.53 -56.63 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.286 -0.884 . . . . 0.0 109.506 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.62 HG13 ' O ' ' A' ' 131' ' ' VAL . 6.5 p -46.23 104.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.471 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' A' ' 133' ' ' GLN . 7.6 p -76.47 -15.71 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -0.932 . . . . 0.0 109.461 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 132' ' ' VAL . 25.0 tp60 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.891 -1.052 . . . . 0.0 109.534 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 24' ' ' LEU . 29.3 mt-10 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.4 ' H ' ' HB3' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -176.53 96.15 0.25 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.374 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.586 ' HA ' HD23 ' A' ' 24' ' ' LEU . 54.0 Cg_exo -48.61 90.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.563 2.176 . . . . 0.0 112.116 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.497 ' OE2' ' CH2' ' A' ' 17' ' ' TRP . 19.6 tt0 -83.23 -44.03 15.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 109.982 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.464 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 5.4 m-85 -49.35 -28.73 5.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.185 -0.947 . . . . 0.0 109.435 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.5 mt -74.78 -29.22 61.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 109.597 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.6 mmtm -123.76 26.38 7.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -0.911 . . . . 0.0 109.523 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 4' ' ' GLU . . . -81.35 173.3 12.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.354 -0.841 . . . . 0.0 109.568 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.32 44.8 0.17 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.92 30.54 3.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.381 -1.07 . . . . 0.0 109.497 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -164.14 117.17 1.01 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.173 -0.955 . . . . 0.0 109.367 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -77.67 89.47 1.33 Allowed 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.432 2.088 . . . . 0.0 112.088 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -177.98 -98.34 0.11 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -162.06 138.51 7.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -1.142 . . . . 0.0 109.638 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -114.99 135.89 53.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.435 -0.791 . . . . 0.0 108.974 179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.62 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 13.1 mt -130.19 116.53 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.345 -0.847 . . . . 0.0 110.114 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TRP . . . . . 0.62 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 7.6 m0 -144.2 152.16 40.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.054 -1.029 . . . . 0.0 109.116 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.58 ' O ' ' N ' ' A' ' 25' ' ' VAL . 0.9 OUTLIER -101.84 153.29 19.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.93 . . . . 0.0 109.801 -179.283 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 23' ' ' ASP . 12.5 t -97.47 131.2 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.42 -0.8 . . . . 0.0 109.538 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.65 ' O ' ' N ' ' A' ' 22' ' ' PHE . 1.9 tm-20 -76.83 86.65 3.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.132 -0.98 . . . . 0.0 108.732 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.6 ' O ' ' CB ' ' A' ' 22' ' ' PHE . 25.2 mtmm 48.31 3.86 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.375 -0.828 . . . . 0.0 109.539 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.65 ' N ' ' O ' ' A' ' 20' ' ' GLU . 1.4 t80 155.59 -30.22 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.424 -0.797 . . . . 0.0 109.472 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.728 ' O ' HG13 ' A' ' 19' ' ' VAL . 1.7 t70 -81.62 -133.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.171 -0.956 . . . . 0.0 109.844 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.741 HD13 ' H ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -137.03 140.13 41.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -0.916 . . . . 0.0 109.607 -179.767 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.741 ' H ' HD13 ' A' ' 24' ' ' LEU . 9.4 t -137.79 91.6 13.47 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 108.999 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -52.42 159.35 4.56 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.654 2.236 . . . . 0.0 112.574 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.1 t -145.25 112.83 4.77 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.354 -0.841 . . . . 0.0 109.077 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 29' ' ' THR . 60.0 Cg_endo -77.88 168.14 22.66 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.44 2.093 . . . . 0.0 112.468 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -51.73 -174.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.389 -0.819 . . . . 0.0 109.361 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.573 ' N ' ' OG1' ' A' ' 29' ' ' THR . 14.9 t-20 69.17 -36.76 0.35 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.17 -0.956 . . . . 0.0 109.222 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.555 ' H ' ' C ' ' A' ' 29' ' ' THR . 14.4 mt -109.21 -36.36 6.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.442 -0.786 . . . . 0.0 109.198 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 31' ' ' LEU . 1.9 p90 -43.22 166.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.348 -0.845 . . . . 0.0 109.376 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.89 -12.88 15.38 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.3 158.81 18.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.212 -1.17 . . . . 0.0 109.481 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -144.99 108.42 4.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 109.56 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.474 ' C ' ' H ' ' A' ' 38' ' ' GLY . 2.8 m-85 -80.32 111.91 17.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 109.136 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.44 ' OG1' ' OE1' ' A' ' 65' ' ' GLU . 8.7 p -56.65 -4.97 0.18 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.185 -0.947 . . . . 0.0 109.618 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 36' ' ' PHE . . . -109.7 39.09 3.03 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.529 ' N ' ' SG ' ' A' ' 66' ' ' CYS . 8.2 m-20 -169.34 -176.38 2.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -1.173 . . . . 0.0 109.622 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.51 129.37 50.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.372 -0.83 . . . . 0.0 109.343 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -114.07 137.31 51.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 109.688 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.966 ' O ' HD13 ' A' ' 43' ' ' ILE . 0.4 OUTLIER -115.24 142.82 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.297 -0.877 . . . . 0.0 109.18 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.966 HD13 ' O ' ' A' ' 42' ' ' VAL . 0.7 OUTLIER -136.34 143.2 36.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.108 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.8 tt -128.05 118.97 24.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.484 -0.76 . . . . 0.0 109.238 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 50.2 tttt -88.85 138.74 31.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 109.426 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -141.64 114.37 8.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.93 . . . . 0.0 109.477 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.674 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -126.03 168.04 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 121.13 -0.981 . . . . 0.0 109.069 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -100.92 101.37 12.17 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.675 -0.641 . . . . 0.0 109.395 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.6 mt -57.04 163.86 1.87 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.933 . . . . 0.0 109.434 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.2 ptt85 -48.82 -47.65 42.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 0.0 109.308 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -70.65 -30.1 66.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.176 -0.952 . . . . 0.0 109.158 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.47 34.93 3.99 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.501 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.6 t-20 -89.97 13.39 14.85 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.183 -1.187 . . . . 0.0 109.325 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.674 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.4 mt 43.38 96.97 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.578 0.704 . . . . 0.0 109.456 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -71.17 116.16 11.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.551 -0.718 . . . . 0.0 109.581 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.54 ' CD1' ' O ' ' A' ' 54' ' ' LEU . 90.4 m-85 -100.7 114.7 28.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 0.0 109.858 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.428 ' HB3' ' HE2' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -120.7 155.16 34.48 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.064 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.449 ' C ' ' CG ' ' A' ' 59' ' ' HIS . 5.2 mp -132.62 147.79 52.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.967 -1.083 . . . . 0.0 110.466 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' HIS . . . . . 0.462 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 1.4 m-70 -150.34 127.17 11.03 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.628 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 1.1 p90 -115.18 132.69 56.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.045 -1.035 . . . . 0.0 109.941 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.458 ' CE3' ' O ' ' A' ' 62' ' ' LEU . 10.3 t90 -102.97 123.88 47.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.375 -0.828 . . . . 0.0 109.238 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.458 ' O ' ' CE3' ' A' ' 61' ' ' TRP . 22.7 mt -101.85 162.12 13.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 109.657 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.03 154.61 16.49 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -82.15 -12.09 58.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -1.128 . . . . 0.0 109.572 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.44 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 2.8 mt-10 -106.58 29.09 7.23 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 39' ' ' ASP . 1.6 m -130.64 97.55 4.4 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 122.15 0.976 . . . . 0.0 108.381 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 66' ' ' CYS . 9.9 m -39.03 161.57 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.707 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 72' ' ' GLY . 15.9 mm-40 -56.2 -17.41 7.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.389 -0.819 . . . . 0.0 109.661 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -63.98 -58.56 6.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 109.371 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.455 ' OE1' ' SG ' ' A' ' 66' ' ' CYS . 24.2 mt-10 -61.06 -54.26 46.95 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.345 -0.847 . . . . 0.0 108.987 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 p -64.13 -26.22 68.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.318 -0.864 . . . . 0.0 109.043 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.38 -41.77 66.75 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.14 -46.74 82.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -1.18 . . . . 0.0 109.28 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.12 -46.31 89.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.427 -0.795 . . . . 0.0 109.07 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.39 -41.53 80.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.345 -0.847 . . . . 0.0 109.26 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 51.0 mt -57.68 -46.24 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.278 -0.889 . . . . 0.0 109.279 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -59.03 -35.34 73.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 109.143 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.7 m -72.34 -25.55 61.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.183 -0.948 . . . . 0.0 109.038 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.4 t -72.77 -48.77 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.306 -0.871 . . . . 0.0 109.541 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -65.86 -35.94 82.07 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.141 -0.975 . . . . 0.0 108.85 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.85 -42.56 98.04 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.628 ' O ' ' N ' ' A' ' 86' ' ' ASN . 51.9 t0 -61.16 -57.35 12.85 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.315 -0.865 . . . . 0.0 109.214 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -48.43 -31.38 6.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.142 -0.974 . . . . 0.0 108.707 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -78.59 -31.12 47.06 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.423 -0.798 . . . . 0.0 108.882 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.484 ' C ' ' H ' ' A' ' 87' ' ' GLY . 9.9 mt -121.71 32.7 5.77 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.435 -0.79 . . . . 0.0 109.518 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.628 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.8 OUTLIER -77.35 27.03 0.16 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.243 -0.91 . . . . 0.0 109.024 179.913 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.484 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -94.34 -48.41 2.6 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -152.21 45.61 0.74 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.168 -1.196 . . . . 0.0 109.638 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 56' ' ' TYR . . . -136.95 157.46 46.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.431 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 19.2 t -136.05 141.37 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 109.466 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.423 ' N ' ' CD ' ' A' ' 91' ' ' GLN . 6.8 mm-40 -88.95 142.47 27.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.212 -0.93 . . . . 0.0 109.37 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.492 ' O ' ' OE1' ' A' ' 94' ' ' GLU . 15.3 m-70 -118.29 115.24 24.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.268 -0.895 . . . . 0.0 109.461 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.84 104.92 15.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.233 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.589 ' OE2' ' CE2' ' A' ' 103' ' ' PHE . 1.5 mp0 -104.62 124.09 48.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.877 . . . . 0.0 109.65 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.1 t -125.76 155.56 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.312 -0.867 . . . . 0.0 109.17 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -55.54 115.98 2.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.19 -0.943 . . . . 0.0 109.624 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.519 ' O ' ' CD1' ' A' ' 98' ' ' PHE . . . 93.34 10.18 59.68 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 78.8 m-85 -152.94 25.37 0.56 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.179 -1.189 . . . . 0.0 109.669 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 2.1 mp0 -48.19 135.52 13.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.119 -0.988 . . . . 0.0 109.428 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.5 t -61.46 171.42 1.46 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.104 -0.998 . . . . 0.0 109.552 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.11 -65.06 0.82 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 109.593 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.0 m -50.55 -27.39 6.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 109.308 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.589 ' CE2' ' OE2' ' A' ' 94' ' ' GLU . 32.0 t80 -74.82 -55.59 5.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 0.0 109.799 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.439 ' C ' HD12 ' A' ' 104' ' ' LEU . 1.6 pp -67.18 -22.08 65.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.057 -1.027 . . . . 0.0 109.372 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.76 -33.12 34.86 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -78.4 -43.82 26.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -1.127 . . . . 0.0 109.422 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.465 ' HB2' HD21 ' A' ' 111' ' ' LEU . 51.8 m-85 -102.21 105.83 16.57 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.397 -0.814 . . . . 0.0 109.579 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -111.65 -49.85 2.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.358 -0.839 . . . . 0.0 109.513 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.0 t -106.04 23.16 14.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.094 -1.003 . . . . 0.0 109.514 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.575 ' O ' ' N ' ' A' ' 112' ' ' LYS . . . -125.18 -15.41 3.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.465 HD21 ' HB2' ' A' ' 107' ' ' PHE . 95.2 mt -62.13 70.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -1.176 . . . . 0.0 109.508 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.575 ' N ' ' O ' ' A' ' 110' ' ' GLY . 29.4 tttt -93.25 108.49 20.11 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.202 -0.936 . . . . 0.0 109.565 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.66 143.79 27.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.369 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -133.54 115.99 15.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 0.0 109.426 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -75.04 163.13 27.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.87 . . . . 0.0 109.47 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.08 -162.04 35.02 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -175.41 -74.45 0.05 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.655 ' O ' HG13 ' A' ' 118' ' ' VAL . 7.6 p -79.1 116.83 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.27 -1.136 . . . . 0.0 109.427 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.75 -75.24 0.07 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.308 -0.87 . . . . 0.0 109.484 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 70.2 m -65.69 -107.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.218 -0.926 . . . . 0.0 109.409 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 140.26 -109.65 0.63 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -166.39 3.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.386 -1.067 . . . . 0.0 109.388 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -66.81 -62.28 1.53 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 0.0 109.507 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -97.21 97.74 9.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 109.489 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -104.23 79.92 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.341 -0.849 . . . . 0.0 109.449 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.611 ' O ' HG23 ' A' ' 126' ' ' VAL . 30.6 m -143.67 81.17 12.27 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 109.433 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.512 ' O ' ' O ' ' A' ' 126' ' ' VAL . 48.5 Cg_exo -52.16 -145.72 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.747 2.298 . . . . 0.0 112.318 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 62.76 24.85 14.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.186 -0.946 . . . . 0.0 109.256 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -51.1 161.24 0.42 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.325 -0.859 . . . . 0.0 109.515 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.437 HG22 ' N ' ' A' ' 131' ' ' VAL . 9.1 p -75.46 165.25 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.342 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 131' ' ' VAL . 9.2 p -64.19 116.13 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.166 -0.959 . . . . 0.0 109.466 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 69.8 t -83.17 -25.2 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.196 -0.94 . . . . 0.0 109.505 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.382 179.997 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 N--CA 1.49 1.278 0 CA-C-O 121.216 0.423 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.574 ' O ' ' N ' ' A' ' 8' ' ' ALA . 16.7 mt-10 -83.34 -39.68 20.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 110.138 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.715 ' CE2' HG12 ' A' ' 42' ' ' VAL . 23.5 t80 -61.78 -46.81 87.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.133 -0.979 . . . . 0.0 109.866 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.579 ' H ' HD12 ' A' ' 6' ' ' LEU . 3.4 mp -71.84 -32.99 68.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.068 -1.02 . . . . 0.0 109.439 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.9 mmtm -94.78 0.88 55.3 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.257 -0.902 . . . . 0.0 109.459 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 4' ' ' GLU . . . -52.1 153.74 2.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 109.424 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 137.52 68.42 0.05 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -144.66 8.14 1.3 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.24 -1.153 . . . . 0.0 109.567 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -166.61 126.76 1.19 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 109.243 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.85 94.56 1.0 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.405 2.07 . . . . 0.0 112.213 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -174.18 -104.18 0.17 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.6 tp -156.01 134.42 11.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.366 -1.079 . . . . 0.0 109.764 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -126.55 131.93 51.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.866 . . . . 0.0 109.357 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.6 mt -108.0 137.1 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -0.799 . . . . 0.0 109.758 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -139.5 166.19 25.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.261 -0.899 . . . . 0.0 109.063 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -144.96 142.16 29.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.126 -0.984 . . . . 0.0 109.725 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 19' ' ' VAL . 7.6 p -79.76 127.95 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.292 -0.88 . . . . 0.0 109.566 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.529 ' CB ' HG21 ' A' ' 25' ' ' VAL . 2.6 mm-40 -164.18 134.47 4.16 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.298 -0.876 . . . . 0.0 109.267 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 29.4 tttm 75.99 41.62 0.23 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.369 -0.832 . . . . 0.0 109.56 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 48.33 43.62 19.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.173 -0.954 . . . . 0.0 109.444 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -173.33 -172.05 0.76 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.896 . . . . 0.0 109.459 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.549 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.9 mm? -88.49 138.15 31.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.529 HG21 ' CB ' ' A' ' 20' ' ' GLU . 5.0 t -138.83 128.36 14.45 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.219 -0.926 . . . . 0.0 109.253 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -74.95 166.36 29.39 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.36 2.04 . . . . 0.0 112.355 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.6 t -111.12 101.3 49.86 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.367 -0.833 . . . . 0.0 109.404 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -53.27 168.08 0.67 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.533 2.155 . . . . 0.0 112.363 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.559 HG22 ' N ' ' A' ' 30' ' ' ASN . 24.5 m -60.16 170.56 1.23 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.342 -0.849 . . . . 0.0 109.032 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.559 ' N ' HG22 ' A' ' 29' ' ' THR . 0.9 OUTLIER 69.69 -40.91 0.47 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.205 -0.934 . . . . 0.0 109.195 -179.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.502 ' H ' ' C ' ' A' ' 29' ' ' THR . 96.0 mt -81.79 -44.22 17.27 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.376 -0.828 . . . . 0.0 109.209 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 33' ' ' GLY . 0.3 OUTLIER -53.42 138.33 33.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.359 -0.838 . . . . 0.0 109.138 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.498 ' N ' ' CD1' ' A' ' 32' ' ' TYR . . . 109.43 -8.99 32.86 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -121.81 115.5 22.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.351 -1.088 . . . . 0.0 109.375 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -87.86 140.07 29.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 109.589 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -102.17 146.19 28.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.334 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 p -92.42 -8.93 43.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 109.468 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.434 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -107.94 35.79 4.78 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 9.7 m-20 -167.57 171.98 9.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.333 -1.098 . . . . 0.0 109.497 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.94 141.2 48.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 109.546 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -116.24 134.75 54.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.392 -0.817 . . . . 0.0 109.472 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.034 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -114.13 124.47 70.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.21 -0.931 . . . . 0.0 108.603 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.034 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -121.33 133.8 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.174 -0.954 . . . . 0.0 110.03 -178.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.0 tt -122.68 121.65 36.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.504 -0.747 . . . . 0.0 109.906 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -96.56 141.87 29.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.371 -0.831 . . . . 0.0 108.954 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.529 ' O ' ' N ' ' A' ' 13' ' ' GLY . 29.1 m -137.17 128.05 27.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.037 -1.039 . . . . 0.0 109.72 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -132.68 168.72 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 O-C-N 121.223 -0.923 . . . . 0.0 109.231 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -102.82 103.57 13.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.574 -0.704 . . . . 0.0 109.464 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.8 mt -72.7 169.01 17.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.282 -0.886 . . . . 0.0 109.711 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.42 ' C ' ' N ' ' A' ' 52' ' ' GLY . 14.7 mtt180 -45.52 -72.83 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.265 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -44.97 -24.18 0.2 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 109.255 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' A' ' 50' ' ' ARG . . . 84.62 32.96 20.57 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.488 ' O ' ' O ' ' A' ' 54' ' ' LEU . 1.0 OUTLIER -86.58 14.26 7.19 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.165 -1.197 . . . . 0.0 109.205 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.59 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 12.6 mt 47.15 100.27 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.544 0.688 . . . . 0.0 109.608 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.597 ' NE2' ' H ' ' A' ' 56' ' ' TYR . 3.2 tm0? -68.57 145.35 54.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.573 -0.704 . . . . 0.0 109.129 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.597 ' H ' ' NE2' ' A' ' 55' ' ' GLN . 91.3 m-85 -129.77 114.67 16.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.923 . . . . 0.0 109.925 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.413 ' OD1' ' OE1' ' A' ' 55' ' ' GLN . 70.7 m-20 -123.93 155.48 38.06 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -150.35 142.76 24.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.683 -1.261 . . . . 0.0 110.983 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.615 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -120.71 133.91 55.32 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.277 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.649 ' CZ ' HD22 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -105.14 115.38 30.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.361 -0.837 . . . . 0.0 109.366 -179.653 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.539 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 36.0 t90 -106.9 135.38 48.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.212 -0.93 . . . . 0.0 109.939 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.649 HD22 ' CZ ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -124.27 162.18 24.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.379 -0.826 . . . . 0.0 109.501 179.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -96.31 161.77 22.45 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -82.11 -11.88 58.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.277 -1.131 . . . . 0.0 109.614 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -104.26 30.83 4.99 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.516 ' SG ' ' CD ' ' A' ' 70' ' ' GLU . 1.2 m -130.73 97.53 4.38 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.162 0.982 . . . . 0.0 108.433 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 66' ' ' CYS . 1.5 m -47.09 178.05 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.694 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.759 ' H ' ' NE2' ' A' ' 68' ' ' GLN . 1.4 mp0 -61.22 -18.07 56.45 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.235 -0.915 . . . . 0.0 109.534 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -64.42 -58.78 5.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 0.0 109.359 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.516 ' CD ' ' SG ' ' A' ' 66' ' ' CYS . 25.5 mt-10 -66.02 -44.5 84.54 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 108.824 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.85 -25.69 66.54 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.523 -0.736 . . . . 0.0 109.03 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.07 -47.01 48.26 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.74 91.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.271 -1.135 . . . . 0.0 109.193 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.404 ' HB1' ' CE1' ' A' ' 60' ' ' TYR . . . -61.32 -49.47 76.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.401 -0.812 . . . . 0.0 109.195 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.577 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -62.75 -34.73 77.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.273 -0.892 . . . . 0.0 109.537 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.2 mt -57.26 -54.63 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.934 . . . . 0.0 109.418 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -60.51 -33.47 72.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.108 -0.995 . . . . 0.0 109.47 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 m -69.72 -40.18 76.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.244 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 75' ' ' ALA . 81.0 t -61.81 -42.12 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.417 -0.802 . . . . 0.0 109.319 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.4 HE21 ' HA ' ' A' ' 80' ' ' GLN . 6.1 mm-40 -60.31 -51.32 70.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.009 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.6 mt -49.29 -43.1 43.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 108.951 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' A' ' 86' ' ' ASN . 19.6 t0 -57.02 -60.32 3.77 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.222 -0.924 . . . . 0.0 109.389 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.467 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 30.7 t0 -45.0 -35.86 3.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.145 -0.972 . . . . 0.0 108.88 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.505 ' CE1' HD21 ' A' ' 85' ' ' LEU . 18.1 t80 -75.89 -28.87 58.27 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.563 ' C ' ' H ' ' A' ' 87' ' ' GLY . 47.8 mt -121.49 33.46 5.52 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.432 -0.792 . . . . 0.0 109.424 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.605 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.4 OUTLIER -73.13 25.62 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 109.052 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -84.4 -58.24 2.21 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.98 35.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -1.122 . . . . 0.0 109.545 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.589 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -78.55 179.28 7.18 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.26 -0.9 . . . . 0.0 109.269 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.9 t -114.4 91.48 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.17 -0.956 . . . . 0.0 109.37 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.454 ' O ' ' CD ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -96.93 125.45 41.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.336 -0.852 . . . . 0.0 109.206 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.482 ' N ' ' CD2' ' A' ' 92' ' ' HIS . 1.8 p80 -151.48 118.68 5.93 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.036 -1.04 . . . . 0.0 109.513 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 8.5 ptt-85 -91.71 134.63 34.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.382 -0.824 . . . . 0.0 109.792 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -112.89 155.98 23.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.424 -0.797 . . . . 0.0 109.566 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.498 HG12 ' H ' ' A' ' 96' ' ' GLN . 3.7 t -121.41 169.51 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.335 -0.853 . . . . 0.0 109.486 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.498 ' H ' HG12 ' A' ' 95' ' ' VAL . 14.1 tt0 -78.31 129.35 34.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 109.425 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.4 5.21 79.61 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.48 ' O ' ' O ' ' A' ' 99' ' ' GLU . 20.2 m-85 -146.06 19.51 1.42 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -1.152 . . . . 0.0 109.463 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.48 ' O ' ' O ' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -51.68 -173.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 109.403 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.0 t -137.89 175.77 9.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 109.524 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.53 -34.53 72.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.924 . . . . 0.0 109.424 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.5 m -53.57 -47.01 70.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.53 -56.81 7.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.319 -0.863 . . . . 0.0 109.328 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.6 mt -56.36 -24.23 42.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.25 -0.906 . . . . 0.0 109.509 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.1 -30.03 26.69 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -71.01 -30.26 66.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.184 -1.186 . . . . 0.0 109.273 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -139.14 103.57 4.8 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.28 -0.888 . . . . 0.0 109.451 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -102.86 -2.72 27.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.173 -0.954 . . . . 0.0 109.52 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.5 p -66.47 -16.12 63.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.187 -0.946 . . . . 0.0 109.486 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.89 88.78 2.07 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.685 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -70.1 135.44 49.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.236 -1.155 . . . . 0.0 109.379 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -90.18 142.23 27.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.331 -0.856 . . . . 0.0 109.582 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.443 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 20.4 m-85 -106.23 111.78 24.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 109.442 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -94.12 145.23 24.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 109.43 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.356 -0.84 . . . . 0.0 109.52 -179.95 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo . . . . . 0 N--CA 1.491 1.361 0 CA-C-O 121.331 0.471 . . . . 0.0 112.174 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 8' ' ' ALA . 13.5 mm-40 -83.34 -46.04 13.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 109.872 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.616 ' CE1' ' O ' ' A' ' 42' ' ' VAL . 2.8 m-85 -67.17 -35.32 79.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.312 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.51 ' H ' HD12 ' A' ' 6' ' ' LEU . 4.2 mp -64.97 -35.23 80.52 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.293 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 8' ' ' ALA . 10.5 mttp -103.86 2.4 32.6 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.354 -0.842 . . . . 0.0 109.472 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.852 ' HB1' HE22 ' A' ' 15' ' ' GLN . . . -46.81 175.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.91 . . . . 0.0 109.533 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.67 10.47 21.31 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.75 6.06 9.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.27 -1.135 . . . . 0.0 109.496 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -173.28 132.89 0.62 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.926 . . . . 0.0 109.468 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.65 90.8 1.02 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.482 2.122 . . . . 0.0 112.2 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -164.33 -107.73 0.21 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 51.6 tp -157.83 142.24 16.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.295 -1.121 . . . . 0.0 109.67 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.852 HE22 ' HB1' ' A' ' 8' ' ' ALA . 2.7 mt-30 -126.58 136.45 52.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.422 -0.799 . . . . 0.0 109.296 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.557 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 7.1 mt -133.01 113.77 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.387 -0.821 . . . . 0.0 109.875 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.557 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 8.3 m0 -139.77 151.41 45.77 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.073 -1.017 . . . . 0.0 109.378 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.434 ' HB2' HH21 ' A' ' 18' ' ' ARG . 18.1 ttp-105 -99.17 153.11 19.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.851 . . . . 0.0 109.564 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.8 p -89.29 135.68 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.263 -0.898 . . . . 0.0 109.577 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.6 ' O ' ' N ' ' A' ' 22' ' ' PHE . 17.3 tt0 -86.93 151.03 23.66 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.169 -0.957 . . . . 0.0 109.131 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.475 ' O ' ' CD2' ' A' ' 22' ' ' PHE . 3.5 pttm -41.35 -19.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.354 -0.842 . . . . 0.0 109.515 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.6 ' N ' ' O ' ' A' ' 20' ' ' GLU . 26.2 m-85 -161.22 35.38 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.953 . . . . 0.0 109.471 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -174.65 -131.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.178 -0.951 . . . . 0.0 109.572 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.7 tp -143.33 146.23 33.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 109.526 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 t -131.09 95.07 26.04 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.463 -0.773 . . . . 0.0 109.402 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -48.18 147.78 7.91 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.58 2.187 . . . . 0.0 112.176 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.7 t -110.72 101.59 49.72 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.32 -0.862 . . . . 0.0 109.579 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -52.89 163.14 2.17 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.536 2.158 . . . . 0.0 112.402 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.601 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -64.55 175.99 1.24 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.267 -0.896 . . . . 0.0 109.042 179.641 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.452 ' N ' ' OG1' ' A' ' 29' ' ' THR . 0.8 OUTLIER 64.54 -39.26 0.24 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.411 -0.806 . . . . 0.0 109.386 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.601 ' N ' ' O ' ' A' ' 29' ' ' THR . 21.0 mt -83.77 -42.63 16.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.21 -0.931 . . . . 0.0 109.277 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.411 ' C ' ' O ' ' A' ' 31' ' ' LEU . 4.1 p90 -42.66 140.35 1.32 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.36 -0.838 . . . . 0.0 109.448 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.33 -26.35 8.22 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -94.84 154.62 17.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.337 -1.096 . . . . 0.0 109.374 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -141.34 125.64 17.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 109.56 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.549 ' C ' ' H ' ' A' ' 38' ' ' GLY . 36.2 m-85 -84.54 115.97 22.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.932 . . . . 0.0 109.372 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.408 ' H ' HG23 ' A' ' 37' ' ' THR . 1.5 p -52.95 -4.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.516 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 36' ' ' PHE . . . -111.06 32.27 6.64 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.442 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 30.6 m-20 -160.16 -173.46 4.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -1.159 . . . . 0.0 109.544 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.88 142.25 46.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.337 -0.852 . . . . 0.0 109.511 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.507 ' OH ' ' CD2' ' A' ' 36' ' ' PHE . 35.1 m-85 -121.45 138.53 54.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.331 -0.856 . . . . 0.0 109.699 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.988 ' C ' HD13 ' A' ' 43' ' ' ILE . 1.1 t -118.1 134.44 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.394 -0.816 . . . . 0.0 109.084 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.988 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -129.99 148.08 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.846 . . . . 0.0 110.206 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.484 ' CD2' ' OG1' ' A' ' 46' ' ' THR . 7.8 tt -139.33 115.87 10.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.471 -0.768 . . . . 0.0 109.597 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -93.87 120.86 34.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.435 -0.791 . . . . 0.0 109.371 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.602 ' O ' ' N ' ' A' ' 13' ' ' GLY . 2.0 m -120.6 127.56 52.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.276 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 1.4 t -134.29 168.82 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.163 -0.96 . . . . 0.0 109.394 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -105.5 115.63 30.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.709 -0.619 . . . . 0.0 109.44 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.579 HD21 ' OE1' ' A' ' 55' ' ' GLN . 86.5 mt -97.71 169.43 9.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 109.436 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.589 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -38.37 151.04 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.326 -0.859 . . . . 0.0 109.368 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 34.0 t30 68.04 -32.22 0.2 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.16 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.589 ' H ' ' C ' ' A' ' 50' ' ' ARG . . . 95.55 54.34 1.45 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 54' ' ' LEU . 16.3 t30 -88.05 6.25 37.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.21 -1.171 . . . . 0.0 109.197 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.665 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 14.5 mt 38.39 95.04 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.608 0.718 . . . . 0.0 109.658 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.579 ' OE1' HD21 ' A' ' 49' ' ' LEU . 12.2 pt20 -70.0 149.17 48.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 109.065 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.497 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 38.1 m-85 -129.78 114.97 16.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.44 -0.788 . . . . 0.0 110.01 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -124.28 155.26 38.95 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.062 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 pp -151.22 150.07 30.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.822 -1.174 . . . . 0.0 110.713 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -127.46 133.88 49.88 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.62 ' CE2' HD22 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -108.69 115.92 31.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.402 -0.811 . . . . 0.0 109.208 -179.651 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.59 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 17.4 t90 -109.31 133.49 52.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 109.988 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.62 HD22 ' CE2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -127.48 162.15 27.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.397 -0.814 . . . . 0.0 109.292 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.68 153.73 21.38 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -82.23 -11.78 58.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.24 -1.153 . . . . 0.0 109.529 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.11 35.15 3.25 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.683 ' SG ' ' O ' ' A' ' 66' ' ' CYS . 15.9 p -130.09 98.12 4.66 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 122.471 1.129 . . . . 0.0 108.891 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 66' ' ' CYS . 18.4 m -37.0 159.28 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.045 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.553 ' O ' ' N ' ' A' ' 72' ' ' GLY . 39.4 mt-30 -52.11 -17.8 1.21 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.41 -0.806 . . . . 0.0 109.662 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -62.37 -58.56 7.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 0.0 109.386 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.68 -49.4 73.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.361 -0.837 . . . . 0.0 108.854 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.29 -22.55 66.3 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.303 -0.873 . . . . 0.0 108.947 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -73.11 -43.9 37.95 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.94 -44.84 91.64 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.216 -1.167 . . . . 0.0 109.231 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.14 -43.69 98.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.367 -0.833 . . . . 0.0 109.053 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.478 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -58.28 -44.91 88.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.254 -0.904 . . . . 0.0 109.046 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.9 mt -54.14 -50.84 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.391 -0.818 . . . . 0.0 109.074 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -53.79 -38.26 64.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.853 . . . . 0.0 109.122 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.2 m -68.97 -48.92 61.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.407 -0.808 . . . . 0.0 108.978 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 75' ' ' ALA . 42.2 t -57.63 -33.35 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.311 -0.868 . . . . 0.0 109.018 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -42.2 81.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.358 -0.838 . . . . 0.0 108.929 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.77 -42.89 80.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 0.0 108.96 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 85' ' ' LEU . 5.9 t0 -62.54 -56.94 13.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.105 -0.997 . . . . 0.0 108.904 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -47.3 -31.14 3.59 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.171 -0.956 . . . . 0.0 108.607 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -74.0 -30.92 62.72 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.315 -0.866 . . . . 0.0 108.7 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 82' ' ' ASP . 78.3 mt -105.73 24.38 12.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.24 -0.913 . . . . 0.0 109.302 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.458 ' C ' ' O ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER 39.75 33.44 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.437 -0.789 . . . . 0.0 109.463 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.82 73.68 0.59 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 81.9 mtm-85 -143.01 35.05 1.37 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.149 -1.207 . . . . 0.0 109.346 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.497 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -144.02 178.66 7.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -0.88 . . . . 0.0 109.381 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.33 112.82 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.693 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -93.94 121.69 35.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.306 -0.871 . . . . 0.0 109.209 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -107.16 104.95 14.72 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -0.946 . . . . 0.0 109.695 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.4 mtm105 -75.53 97.36 3.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 0.0 109.073 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.616 ' CD ' ' H ' ' A' ' 100' ' ' SER . 18.0 mm-40 -96.6 137.28 35.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.272 -0.893 . . . . 0.0 109.943 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.6 t -132.85 157.56 43.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.334 -0.854 . . . . 0.0 109.17 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.466 ' C ' ' OE1' ' A' ' 96' ' ' GLN . 1.0 OUTLIER -62.21 117.3 5.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.071 -1.018 . . . . 0.0 109.398 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.74 13.52 69.64 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.83 24.0 0.76 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.146 -1.208 . . . . 0.0 109.625 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.634 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 0.9 OUTLIER -52.64 137.85 29.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 0.0 109.423 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.616 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 28.7 t -64.79 165.49 10.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.294 -0.879 . . . . 0.0 109.634 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.3 -58.13 4.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.915 . . . . 0.0 109.517 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.2 m -46.89 -32.11 3.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 109.429 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.689 ' CE1' ' CE1' ' A' ' 107' ' ' PHE . 23.9 t80 -73.16 -43.3 61.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.366 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.2 mt -69.27 -19.68 63.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.166 -0.959 . . . . 0.0 109.504 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -102.71 -24.98 7.86 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -82.14 -36.18 27.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.177 -1.19 . . . . 0.0 109.525 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.689 ' CE1' ' CE1' ' A' ' 103' ' ' PHE . 49.1 m-85 -89.71 81.43 6.42 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.251 -0.906 . . . . 0.0 109.524 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.9 mttt -77.57 -5.43 50.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.4 t -63.96 -7.34 8.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.117 -0.99 . . . . 0.0 109.48 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.43 82.97 0.74 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.74 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -67.84 158.06 33.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -1.116 . . . . 0.0 109.379 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -158.38 135.06 9.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.242 -0.911 . . . . 0.0 109.437 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -95.2 153.19 17.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.899 . . . . 0.0 109.261 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.9 tttm -133.62 112.75 11.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.247 -0.908 . . . . 0.0 109.423 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.2 mptt . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.187 -0.946 . . . . 0.0 109.367 179.954 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo . . . . . 0 N--CA 1.492 1.389 0 CA-C-O 121.256 0.44 . . . . 0.0 111.988 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.555 ' O ' ' N ' ' A' ' 6' ' ' LEU . 6.4 mt-10 -83.15 -31.67 27.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 109.72 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.686 ' CE1' HG12 ' A' ' 42' ' ' VAL . 13.7 t80 -50.08 -7.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.114 -0.991 . . . . 0.0 109.435 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.555 ' N ' ' O ' ' A' ' 4' ' ' GLU . 13.1 mt -85.79 -26.83 25.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.88 . . . . 0.0 109.506 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.2 pttm -130.94 13.03 5.25 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.39 -0.819 . . . . 0.0 109.566 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.507 ' HB3' HD13 ' A' ' 44' ' ' LEU . . . -50.93 153.04 1.93 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.175 -0.953 . . . . 0.0 109.477 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.86 50.66 0.02 OUTLIER Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -150.15 31.36 0.68 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.127 -1.219 . . . . 0.0 109.649 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 13' ' ' GLY . 26.7 mt-10 -147.62 83.26 7.65 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.911 . . . . 0.0 109.394 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.83 80.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.693 2.262 . . . . 0.0 112.398 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 11' ' ' GLU . . . 177.36 -100.18 0.14 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.1 tp -159.37 119.94 3.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.33 -1.1 . . . . 0.0 109.537 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.479 ' OE1' ' OE2' ' A' ' 11' ' ' GLU . 19.0 mt-30 -108.22 127.67 54.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.866 . . . . 0.0 109.366 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.549 HG23 HD12 ' A' ' 43' ' ' ILE . 53.0 mt -101.1 144.88 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.312 -0.868 . . . . 0.0 110.042 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -142.85 159.49 42.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.357 -0.84 . . . . 0.0 108.835 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -127.15 143.68 51.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.139 -0.975 . . . . 0.0 109.729 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.54 146.09 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.53 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.6 ' O ' ' N ' ' A' ' 22' ' ' PHE . 44.4 tt0 -92.76 154.32 18.37 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.197 -0.939 . . . . 0.0 109.222 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -44.9 -13.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.314 -0.866 . . . . 0.0 109.496 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.6 ' N ' ' O ' ' A' ' 20' ' ' GLU . 74.3 t80 -162.94 28.16 0.1 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.673 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.666 ' O ' HD22 ' A' ' 24' ' ' LEU . 8.4 t70 -175.29 -136.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.172 -0.955 . . . . 0.0 109.616 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.666 HD22 ' O ' ' A' ' 23' ' ' ASP . 1.7 mm? -126.76 146.11 50.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.38 -0.825 . . . . 0.0 109.259 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.495 HG23 ' HB2' ' A' ' 20' ' ' GLU . 2.1 t -141.63 130.23 12.19 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 109.017 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.44 174.64 11.82 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.348 2.032 . . . . 0.0 112.313 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.8 t -139.85 121.45 9.71 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.887 . . . . 0.0 109.246 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.76 157.79 35.36 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.296 1.997 . . . . 0.0 112.301 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.64 -11.77 55.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.16 -0.962 . . . . 0.0 109.358 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -74.28 -10.91 60.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 109.387 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 32' ' ' TYR . 91.8 mt -126.56 -20.48 4.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.356 -0.84 . . . . 0.0 109.471 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.51 ' CE2' ' CD1' ' A' ' 16' ' ' ILE . 11.1 t80 -43.16 131.02 4.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.353 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.67 -14.16 8.12 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -101.61 148.18 25.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.193 -1.181 . . . . 0.0 109.627 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -142.09 116.63 9.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.376 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -94.24 125.19 38.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.923 . . . . 0.0 109.501 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.5 p -68.33 -4.84 15.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.171 -0.956 . . . . 0.0 109.301 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.454 ' O ' ' OD2' ' A' ' 39' ' ' ASP . . . -107.51 36.18 4.55 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.454 ' OD2' ' O ' ' A' ' 38' ' ' GLY . 2.1 m-20 -159.93 156.63 27.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.265 -1.138 . . . . 0.0 109.424 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.63 134.03 48.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.365 -0.834 . . . . 0.0 109.514 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.51 ' HB3' HD11 ' A' ' 43' ' ' ILE . 3.0 m-85 -113.43 134.95 54.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.42 -0.8 . . . . 0.0 109.188 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.015 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -111.24 126.12 68.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 O-C-N 121.217 -0.927 . . . . 0.0 108.892 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.015 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -126.2 134.55 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.197 -0.94 . . . . 0.0 110.417 -179.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.727 HD23 ' C ' ' A' ' 44' ' ' LEU . 6.9 tt -117.42 115.4 25.13 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -89.95 144.48 25.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 109.786 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.576 HG22 HD22 ' A' ' 54' ' ' LEU . 38.4 m -143.4 117.68 9.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 109.083 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -128.54 168.37 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.142 -0.974 . . . . 0.0 109.234 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -96.32 126.91 41.85 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.545 -0.722 . . . . 0.0 109.451 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.469 HD21 ' OE1' ' A' ' 55' ' ' GLN . 79.2 mt -91.06 166.77 12.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 0.0 109.495 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 49' ' ' LEU . 2.3 mtt-85 -44.67 -57.99 3.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.089 -1.007 . . . . 0.0 109.231 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -66.38 -20.51 66.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.295 -0.878 . . . . 0.0 109.188 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . 89.62 37.34 6.99 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.508 ' O ' ' O ' ' A' ' 54' ' ' LEU . 10.7 m-80 -88.62 14.37 10.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.118 -1.225 . . . . 0.0 109.403 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.642 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.7 mt 44.79 98.44 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.621 0.724 . . . . 0.0 109.418 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.469 ' OE1' HD21 ' A' ' 49' ' ' LEU . 40.3 tt0 -73.9 110.23 8.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.39 -0.819 . . . . 0.0 109.697 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.512 ' CD2' ' O ' ' A' ' 54' ' ' LEU . 85.3 m-85 -95.91 114.3 26.0 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.186 -0.946 . . . . 0.0 109.546 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.28 155.35 24.2 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.694 HD11 HD11 ' A' ' 81' ' ' LEU . 10.6 mt -129.84 133.38 46.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.171 -0.956 . . . . 0.0 109.776 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.693 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.1 OUTLIER -133.43 115.11 14.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.396 -0.815 . . . . 0.0 109.075 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.725 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -99.95 120.58 40.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.258 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 4.4 t90 -93.26 127.03 38.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.892 . . . . 0.0 109.539 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 mt -106.12 161.65 14.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.261 -0.899 . . . . 0.0 109.396 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -109.55 150.9 17.33 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.23 -12.26 61.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -1.182 . . . . 0.0 109.461 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -108.86 26.63 10.35 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.538 ' SG ' ' OE2' ' A' ' 70' ' ' GLU . 5.4 m -130.59 97.44 4.37 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.021 0.915 . . . . 0.0 108.545 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 m -60.46 -170.91 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.782 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.636 ' H ' ' NE2' ' A' ' 68' ' ' GLN . 2.0 mp0 -65.38 -17.8 64.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 0.0 109.696 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.03 -58.84 5.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.112 -0.992 . . . . 0.0 109.481 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.538 ' OE2' ' SG ' ' A' ' 66' ' ' CYS . 22.8 mt-10 -64.07 -46.25 85.18 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.261 -0.899 . . . . 0.0 109.092 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 m -65.54 -26.81 68.05 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.347 -0.846 . . . . 0.0 108.826 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -65.87 -45.86 85.71 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.86 -48.98 74.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -1.157 . . . . 0.0 109.261 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.67 -39.82 92.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.179 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.454 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -65.84 -46.27 79.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.364 -0.835 . . . . 0.0 109.316 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.6 mt -51.47 -49.22 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.134 -0.979 . . . . 0.0 109.294 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -62.29 -35.25 78.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 109.325 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.3 m -69.53 -36.42 76.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.372 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 75' ' ' ALA . 63.8 t -68.14 -42.33 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.517 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -62.49 -60.59 3.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 0.0 109.26 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.728 ' C ' HD12 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -52.57 -29.18 24.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.215 -0.928 . . . . 0.0 108.835 179.688 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.626 ' O ' ' N ' ' A' ' 86' ' ' ASN . 55.2 t0 -67.47 -57.68 6.09 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.239 -0.913 . . . . 0.0 108.815 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.469 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 88.1 m-20 -45.25 -36.14 3.79 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.201 -0.937 . . . . 0.0 108.579 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.517 ' CD1' ' O ' ' A' ' 84' ' ' TYR . 1.8 t80 -73.66 -31.57 63.55 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 82' ' ' ASP . 96.2 mt -121.65 34.44 5.18 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.461 -0.774 . . . . 0.0 109.419 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.626 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.4 OUTLIER -82.82 27.81 0.52 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.207 -0.933 . . . . 0.0 109.371 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.77 -51.15 54.22 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -175.94 34.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.181 -1.188 . . . . 0.0 109.377 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.11 179.02 7.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -0.947 . . . . 0.0 109.529 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 78.9 t -130.39 102.98 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.313 -0.867 . . . . 0.0 109.505 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.66 ' H ' ' CD ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -97.04 134.83 39.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 109.145 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.601 ' NE2' ' ND1' ' A' ' 59' ' ' HIS . 3.7 p80 -144.35 161.14 39.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.121 -0.987 . . . . 0.0 109.756 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -103.38 121.7 43.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.464 -0.772 . . . . 0.0 109.585 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.561 ' OE2' ' CD2' ' A' ' 103' ' ' PHE . 42.5 mt-10 -102.32 150.58 23.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.357 -0.84 . . . . 0.0 109.164 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.6 t -140.75 161.93 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.113 -0.992 . . . . 0.0 109.567 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -60.84 134.42 57.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 109.597 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.11 -26.23 5.04 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.547 ' CD1' ' O ' ' A' ' 98' ' ' PHE . 71.5 t80 -108.02 10.4 28.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -1.115 . . . . 0.0 109.442 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 98' ' ' PHE . 80.5 mt-10 -43.05 123.61 2.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.875 . . . . 0.0 109.508 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.1 p -55.57 179.69 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.334 -0.854 . . . . 0.0 109.501 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.1 -41.31 82.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.344 -0.847 . . . . 0.0 109.501 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.7 m -48.68 -57.58 6.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.307 -0.87 . . . . 0.0 109.529 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.561 ' CD2' ' OE2' ' A' ' 94' ' ' GLU . 5.9 m-85 -59.18 -53.57 56.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.412 -0.805 . . . . 0.0 109.56 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.58 ' O ' ' CD1' ' A' ' 107' ' ' PHE . 25.7 mt -54.36 -14.66 1.27 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.227 -0.921 . . . . 0.0 109.56 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -104.98 -27.29 5.99 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -79.49 -15.29 58.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.261 -1.14 . . . . 0.0 109.636 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.58 ' CD1' ' O ' ' A' ' 104' ' ' LEU . 3.2 p90 -55.8 128.66 36.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.92 . . . . 0.0 109.589 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -114.92 -55.6 2.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.298 -0.876 . . . . 0.0 109.417 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.5 p -103.74 -8.61 19.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.923 . . . . 0.0 109.466 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.63 109.07 3.33 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.737 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -53.37 120.03 5.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -1.132 . . . . 0.0 109.469 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -81.42 125.06 29.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.292 -0.88 . . . . 0.0 109.47 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -95.28 144.09 26.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.938 . . . . 0.0 109.425 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -141.7 132.03 25.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 109.407 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 69.6 mttt . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 109.513 -179.908 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.432 ' HB3' HD12 ' A' ' 6' ' ' LEU . 50.8 Cg_exo . . . . . 0 N--CA 1.493 1.483 0 CA-C-O 121.255 0.439 . . . . 0.0 112.167 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.485 ' O ' ' N ' ' A' ' 6' ' ' LEU . 34.1 mt-10 -83.27 -46.21 12.92 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.836 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.666 ' CE1' ' CD1' ' A' ' 81' ' ' LEU . 50.2 t80 -47.64 -16.12 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.235 -0.915 . . . . 0.0 109.391 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 4' ' ' GLU . 71.7 mt -84.05 -52.03 6.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 0.0 109.439 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.468 ' O ' ' O ' ' A' ' 8' ' ' ALA . 46.3 mtpt -91.08 5.97 46.82 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.553 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -44.43 169.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.231 -0.918 . . . . 0.0 109.632 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.75 70.75 0.51 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.46 6.63 2.54 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.17 -1.194 . . . . 0.0 109.647 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -172.13 141.97 1.2 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.899 . . . . 0.0 109.409 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.02 84.13 1.53 Allowed 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.675 2.25 . . . . 0.0 112.291 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -164.96 -108.02 0.21 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.3 tt -162.54 148.03 12.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -1.114 . . . . 0.0 109.553 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.421 ' NE2' ' HB1' ' A' ' 8' ' ' ALA . 1.0 OUTLIER -136.51 131.75 34.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.242 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.492 ' HA ' HG23 ' A' ' 43' ' ' ILE . 12.2 mt -102.28 157.63 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.215 -0.928 . . . . 0.0 110.22 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.428 ' N ' HG22 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -159.17 130.46 6.2 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.495 -0.753 . . . . 0.0 109.17 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -100.92 152.5 20.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.174 -0.954 . . . . 0.0 109.403 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 23' ' ' ASP . 41.4 t -77.03 129.02 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.255 -0.903 . . . . 0.0 109.532 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.711 ' O ' ' N ' ' A' ' 22' ' ' PHE . 27.6 tt0 -80.49 86.82 5.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.126 -0.984 . . . . 0.0 109.479 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.599 ' O ' ' CB ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER 39.35 15.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.574 -0.704 . . . . 0.0 110.081 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.711 ' N ' ' O ' ' A' ' 20' ' ' GLU . 1.4 t80 154.82 -39.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.391 -0.818 . . . . 0.0 109.134 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 20' ' ' GLU . 1.3 t0 -98.99 -146.56 0.33 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.251 -0.906 . . . . 0.0 109.341 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.43 ' CD2' ' H ' ' A' ' 5' ' ' PHE . 3.3 tp -116.1 138.83 50.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.196 -0.94 . . . . 0.0 109.714 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.533 HG23 ' CD ' ' A' ' 20' ' ' GLU . 1.2 t -137.98 144.6 44.48 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -69.69 152.04 69.6 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.527 2.151 . . . . 0.0 112.392 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.0 t -120.54 101.61 45.97 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.874 . . . . 0.0 109.376 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -49.64 158.06 2.08 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.561 2.174 . . . . 0.0 112.128 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 31' ' ' LEU . 5.9 m -59.54 -46.26 89.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.915 . . . . 0.0 109.526 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 29' ' ' THR . 3.0 m120 -43.05 -22.14 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.119 -0.988 . . . . 0.0 109.475 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 29' ' ' THR . 79.7 mt -105.63 -25.49 12.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -0.861 . . . . 0.0 109.451 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.454 ' C ' ' O ' ' A' ' 31' ' ' LEU . 2.0 t80 -42.18 129.49 3.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.328 -0.858 . . . . 0.0 109.371 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.443 ' N ' ' CD2' ' A' ' 32' ' ' TYR . . . 100.28 -20.88 46.79 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.43 ' C ' ' CD1' ' A' ' 35' ' ' PHE . 4.3 m-20 -97.83 155.62 16.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.222 -1.163 . . . . 0.0 109.501 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.43 ' CD1' ' C ' ' A' ' 34' ' ' ASP . 57.1 m-85 -146.65 136.05 22.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 109.457 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -97.42 162.83 13.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 109.406 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.7 p -97.97 -4.87 35.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 109.383 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.91 -76.93 1.28 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.97 157.81 32.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -1.085 . . . . 0.0 109.415 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.74 167.2 11.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.444 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -128.47 134.8 48.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 109.52 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.562 HG11 ' CD1' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -108.7 144.52 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.254 -0.903 . . . . 0.0 109.052 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.985 ' N ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -143.88 139.54 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.996 -1.065 . . . . 0.0 110.097 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.661 HD23 ' N ' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -123.52 126.09 46.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.408 -0.808 . . . . 0.0 109.149 179.256 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.661 ' N ' HD23 ' A' ' 44' ' ' LEU . 30.3 ttpt -104.46 130.37 52.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.326 -0.859 . . . . 0.0 109.6 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 13' ' ' GLY . 99.8 m -131.83 125.66 32.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.293 -0.88 . . . . 0.0 109.294 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -133.09 168.46 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 121.175 -0.953 . . . . 0.0 109.357 -179.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -96.29 121.76 38.42 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.681 -0.637 . . . . 0.0 109.324 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 50' ' ' ARG . 11.1 mt -82.59 168.79 16.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.949 . . . . 0.0 109.523 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 49' ' ' LEU . 1.1 tpt180 -43.21 -67.14 0.3 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.251 -0.906 . . . . 0.0 109.261 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -60.18 -26.07 66.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 109.125 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.98 40.2 3.37 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.7 m120 -87.66 14.79 7.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.11 -1.229 . . . . 0.0 109.316 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.624 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 11.7 mt 43.79 96.83 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.511 0.672 . . . . 0.0 109.444 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -69.18 153.62 43.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.528 -0.732 . . . . 0.0 109.245 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.412 ' CD2' ' O ' ' A' ' 54' ' ' LEU . 70.7 m-85 -138.0 114.86 10.7 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.171 -0.956 . . . . 0.0 109.623 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -124.78 116.7 22.72 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.027 HD12 ' H ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -102.84 145.72 29.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.134 -0.979 . . . . 0.0 110.076 -179.021 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.532 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 3.1 m-70 -131.34 150.52 52.12 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.469 -0.769 . . . . 0.0 109.4 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.882 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -129.37 121.33 27.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.352 -0.843 . . . . 0.0 109.34 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.467 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 44.8 t90 -101.84 123.77 46.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.92 . . . . 0.0 109.59 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.467 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 18.4 mt -104.55 162.04 13.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.279 -0.888 . . . . 0.0 109.382 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.515 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -112.86 162.0 12.5 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -82.14 -11.62 58.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -1.168 . . . . 0.0 109.599 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.68 33.89 4.12 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.657 ' SG ' ' O ' ' A' ' 66' ' ' CYS . 18.0 p -130.58 97.91 4.51 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 122.478 1.133 . . . . 0.0 108.951 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.49 ' O ' ' O ' ' A' ' 66' ' ' CYS . 0.5 OUTLIER -46.57 177.18 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.731 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.555 ' O ' ' N ' ' A' ' 72' ' ' GLY . 4.6 pt20 -66.52 -17.78 65.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.476 -0.765 . . . . 0.0 109.553 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.1 p30 -62.85 -58.43 7.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.263 -0.898 . . . . 0.0 109.626 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.401 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 2.6 mp0 -62.04 -51.93 65.99 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.301 -0.874 . . . . 0.0 109.129 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.43 -22.87 66.22 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.405 -0.809 . . . . 0.0 108.879 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -75.16 -46.26 16.74 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.79 -39.09 87.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.186 -1.185 . . . . 0.0 109.151 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.882 ' HB1' ' CE2' ' A' ' 60' ' ' TYR . . . -59.4 -59.49 5.36 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.394 -0.816 . . . . 0.0 108.968 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.775 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -48.25 -43.21 32.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.31 -0.869 . . . . 0.0 109.48 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.8 mt -56.67 -39.14 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.143 -0.973 . . . . 0.0 109.564 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -64.7 -50.48 66.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 109.704 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.483 ' OG1' ' CE1' ' A' ' 60' ' ' TYR . 2.7 m -63.72 -35.03 79.24 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.065 -1.022 . . . . 0.0 108.794 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 75' ' ' ALA . 74.5 t -59.59 -41.9 86.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.343 -0.848 . . . . 0.0 108.729 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -62.55 -43.75 98.03 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.666 ' CD1' ' CE1' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -50.83 -45.47 59.62 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.403 -0.811 . . . . 0.0 108.921 179.5 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 85' ' ' LEU . 1.6 m-20 -60.33 -60.42 3.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.294 -0.879 . . . . 0.0 108.967 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 82' ' ' ASP . 39.6 t0 -46.94 -32.99 4.23 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.116 -0.99 . . . . 0.0 108.412 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.468 ' CD2' ' O ' ' A' ' 84' ' ' TYR . 2.8 t80 -74.49 -27.1 60.41 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.568 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.6 tp -110.24 26.47 10.64 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.475 -0.765 . . . . 0.0 109.306 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER 44.71 37.47 2.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.487 -0.758 . . . . 0.0 109.579 179.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 53.7 34.13 49.92 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -90.64 31.38 1.05 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -1.138 . . . . 0.0 109.138 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.24 179.22 7.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.434 -0.791 . . . . 0.0 109.31 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.686 ' O ' HD12 ' A' ' 58' ' ' LEU . 21.9 t -119.13 140.83 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -0.964 . . . . 0.0 109.672 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.41 ' CD ' ' N ' ' A' ' 91' ' ' GLN . 0.2 OUTLIER -102.74 149.28 24.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.328 -0.857 . . . . 0.0 109.319 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -124.49 121.78 35.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 109.553 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.43 ' H ' ' HD2' ' A' ' 93' ' ' ARG . 1.5 mpt_? -91.5 105.42 17.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.943 . . . . 0.0 109.063 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.417 ' OE2' ' CD1' ' A' ' 103' ' ' PHE . 35.8 mt-10 -113.12 148.06 36.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.764 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.713 HG12 ' N ' ' A' ' 96' ' ' GLN . 61.5 t -151.9 174.04 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -0.869 . . . . 0.0 109.091 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.713 ' N ' HG12 ' A' ' 95' ' ' VAL . 10.2 tt0 -62.58 115.84 4.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.051 -1.031 . . . . 0.0 109.542 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.95 11.66 82.29 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.47 ' O ' ' C ' ' A' ' 99' ' ' GLU . 3.2 t80 -132.66 19.39 4.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.252 -1.146 . . . . 0.0 109.551 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.631 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 8.8 mp0 -39.63 137.6 0.84 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.549 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.85 166.91 16.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 109.654 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.27 -64.45 0.85 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 0.0 109.448 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.8 m -47.03 -54.86 9.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.207 -0.933 . . . . 0.0 109.198 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.417 ' CD1' ' OE2' ' A' ' 94' ' ' GLU . 3.3 t80 -50.81 -45.27 59.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.471 -0.768 . . . . 0.0 109.295 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.506 ' O ' ' CD1' ' A' ' 107' ' ' PHE . 5.8 mt -59.01 -30.81 68.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.913 . . . . 0.0 109.388 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.79 -19.27 48.5 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.423 ' O ' ' C ' ' A' ' 107' ' ' PHE . 35.4 t80 -76.35 -27.36 56.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.346 -1.091 . . . . 0.0 109.458 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.54 ' CD1' ' O ' ' A' ' 107' ' ' PHE . 1.3 p90 -42.42 125.83 3.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.183 -0.948 . . . . 0.0 109.494 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -110.87 -47.85 3.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.913 . . . . 0.0 109.433 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.6 m -96.67 -28.55 14.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 109.493 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 124.24 112.5 1.98 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.2 mt -57.76 176.69 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.334 -1.098 . . . . 0.0 109.47 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -159.97 122.25 3.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.352 -0.842 . . . . 0.0 109.279 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -106.75 141.66 37.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 109.414 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -146.19 126.29 13.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.887 . . . . 0.0 109.387 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.2 pttp . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.346 -0.846 . . . . 0.0 109.47 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.517 ' HB3' HD12 ' A' ' 6' ' ' LEU . 36.2 Cg_endo . . . . . 0 N--CA 1.492 1.396 0 CA-C-O 121.343 0.476 . . . . 0.0 112.077 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.542 ' OE1' ' NE1' ' A' ' 17' ' ' TRP . 74.7 mt-10 -83.15 -46.24 12.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 109.756 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.519 ' CE2' ' CG1' ' A' ' 42' ' ' VAL . 22.8 t80 -66.95 -18.76 65.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.281 -0.887 . . . . 0.0 109.406 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.517 HD12 ' HB3' ' A' ' 3' ' ' PRO . 10.1 mt -76.61 -37.2 56.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.258 -0.901 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.453 ' O ' ' C ' ' A' ' 8' ' ' ALA . 7.4 mtpm? -86.12 -15.6 40.63 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.334 -0.854 . . . . 0.0 109.335 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -40.94 142.36 0.49 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 109.567 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.26 42.32 0.2 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -140.65 26.38 2.11 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.339 -1.095 . . . . 0.0 109.692 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -148.84 128.1 6.29 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.192 -0.943 . . . . 0.0 109.433 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.81 80.1 2.69 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.494 2.129 . . . . 0.0 112.272 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 173.32 -99.37 0.14 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.9 tt -162.25 152.26 16.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -1.131 . . . . 0.0 109.834 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.42 ' HB3' ' CZ3' ' A' ' 17' ' ' TRP . 42.1 mt-30 -135.74 141.31 44.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 109.367 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 28.5 mt -113.99 139.11 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.36 -0.838 . . . . 0.0 110.1 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.542 ' NE1' ' OE1' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -142.75 156.77 45.05 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.535 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.811 ' O ' HD23 ' A' ' 24' ' ' LEU . 18.8 ttt180 -116.29 140.13 49.65 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.172 -0.955 . . . . 0.0 109.62 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 19' ' ' VAL . 8.4 p -85.33 131.72 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.917 . . . . 0.0 109.409 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.606 ' O ' ' N ' ' A' ' 22' ' ' PHE . 20.4 tt0 -84.06 151.36 25.01 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.165 -0.96 . . . . 0.0 109.225 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.486 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 10.8 ttmm -45.25 -11.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.271 -0.893 . . . . 0.0 109.92 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.606 ' N ' ' O ' ' A' ' 20' ' ' GLU . 20.7 m-85 -162.96 20.97 0.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.961 -1.087 . . . . 0.0 110.065 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.474 ' CG ' ' O ' ' A' ' 22' ' ' PHE . 24.5 m-20 -166.38 -116.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.193 -0.942 . . . . 0.0 109.499 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.811 HD23 ' O ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -158.19 138.6 12.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -0.892 . . . . 0.0 109.296 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 t -119.98 132.62 24.01 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 0.0 109.282 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.1 136.87 23.07 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.428 2.085 . . . . 0.0 112.343 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.7 t -97.49 112.03 60.12 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.224 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -45.54 127.88 9.98 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.33 2.02 . . . . 0.0 112.104 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.64 -10.11 59.27 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.146 -0.971 . . . . 0.0 109.485 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -90.91 -3.06 57.62 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.237 -0.914 . . . . 0.0 109.113 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 38.4 mt -136.81 -1.93 2.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.288 -0.882 . . . . 0.0 109.801 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.426 ' O ' ' CG ' ' A' ' 32' ' ' TYR . 3.6 p90 -50.42 135.17 22.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.952 . . . . 0.0 109.507 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.94 -25.44 3.21 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.8 105.29 16.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -1.154 . . . . 0.0 109.43 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -96.5 146.26 24.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.511 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -94.46 128.36 40.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.568 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.472 ' OG1' ' OE1' ' A' ' 65' ' ' GLU . 35.7 p -72.24 -4.78 31.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.307 -0.87 . . . . 0.0 109.426 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.44 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -109.67 38.25 3.4 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 22.6 m-20 -163.52 -169.38 1.92 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -1.122 . . . . 0.0 109.465 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -136.72 138.28 40.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.401 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -126.01 139.0 53.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.332 -0.855 . . . . 0.0 109.519 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.006 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -105.95 136.97 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 121.178 -0.951 . . . . 0.0 108.767 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.006 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -127.84 137.17 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.269 -0.895 . . . . 0.0 110.369 -179.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.682 HD23 ' C ' ' A' ' 44' ' ' LEU . 6.9 tt -117.83 116.98 28.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.7 -0.625 . . . . 0.0 109.335 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.481 ' N ' HD23 ' A' ' 44' ' ' LEU . 4.8 ttpm? -98.9 118.24 35.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.544 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.41 ' CG2' HD22 ' A' ' 54' ' ' LEU . 8.4 m -118.62 131.33 56.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.34 -0.85 . . . . 0.0 109.201 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -132.01 168.46 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.193 -0.942 . . . . 0.0 109.569 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.576 ' NE2' ' O ' ' A' ' 49' ' ' LEU . 8.4 tm0? -95.97 112.33 24.09 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.576 ' O ' ' NE2' ' A' ' 48' ' ' GLN . 63.8 mt -72.28 155.61 40.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.924 . . . . 0.0 109.748 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 49' ' ' LEU . 20.9 mtm105 -42.89 -77.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.895 . . . . 0.0 109.388 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 50' ' ' ARG . 4.1 t-20 -43.33 -31.1 0.59 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.166 -0.959 . . . . 0.0 109.259 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.64 75.47 1.16 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.481 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.1 t-20 -132.76 14.09 4.39 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.251 -1.147 . . . . 0.0 109.199 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 11.9 mt 43.22 95.98 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.386 0.612 . . . . 0.0 109.616 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 47' ' ' VAL . 17.2 tt0 -68.85 154.48 41.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.549 -0.719 . . . . 0.0 109.144 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.614 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 97.6 m-85 -134.53 121.69 21.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 0.0 109.674 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 58' ' ' LEU . 1.5 t0 -133.0 155.44 49.17 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.581 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -143.58 145.79 32.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.825 -1.172 . . . . 0.0 110.388 -179.629 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.477 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -141.06 131.93 25.94 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.401 -0.812 . . . . 0.0 108.957 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.751 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -96.64 120.74 37.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.094 -1.004 . . . . 0.0 109.463 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.517 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 31.2 t90 -89.13 123.71 33.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.876 . . . . 0.0 109.357 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.517 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 6.6 mt -106.36 162.18 13.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.321 -0.862 . . . . 0.0 109.423 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.93 156.59 15.46 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -75.79 -12.24 60.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -1.135 . . . . 0.0 109.357 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.472 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 2.7 mt-10 -106.47 26.25 10.13 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.5 m -130.85 97.51 4.35 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.136 0.969 . . . . 0.0 108.397 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 66' ' ' CYS . 39.7 p -49.82 -177.18 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.589 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.49 ' O ' ' N ' ' A' ' 72' ' ' GLY . 29.2 mt-30 -66.04 -17.82 64.94 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.304 -0.873 . . . . 0.0 109.5 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.503 ' OD2' ' N ' ' A' ' 69' ' ' ASP . 2.5 m-20 -63.75 -58.57 6.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 109.369 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -61.03 -51.02 70.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.288 -0.882 . . . . 0.0 109.131 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.0 m -64.23 -27.37 69.01 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.442 -0.786 . . . . 0.0 109.065 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -69.24 -43.05 72.96 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.04 -41.56 97.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.317 -1.108 . . . . 0.0 109.245 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.52 -47.03 87.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.398 -0.814 . . . . 0.0 109.25 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.89 -46.44 81.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.173 -0.955 . . . . 0.0 109.345 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.2 mt -51.96 -49.82 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.214 -0.929 . . . . 0.0 109.207 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -57.91 -33.92 69.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.866 . . . . 0.0 109.277 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.405 HG21 ' CE1' ' A' ' 60' ' ' TYR . 2.1 m -68.34 -46.79 69.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.231 -0.918 . . . . 0.0 109.263 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.6 t -57.26 -31.93 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.168 -0.957 . . . . 0.0 109.318 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -68.06 -54.44 18.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.913 . . . . 0.0 109.246 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.831 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -53.47 -29.46 35.98 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.285 -0.884 . . . . 0.0 108.981 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 85' ' ' LEU . 3.4 m-20 -66.53 -59.32 3.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.272 -0.892 . . . . 0.0 108.913 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 82' ' ' ASP . 1.0 OUTLIER -45.62 -34.51 3.48 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.294 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.595 ' CD1' ' O ' ' A' ' 84' ' ' TYR . 0.6 OUTLIER -69.55 -32.56 71.44 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.591 ' N ' ' O ' ' A' ' 82' ' ' ASP . 5.6 mp -104.51 27.39 7.95 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.417 -0.802 . . . . 0.0 109.026 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 85' ' ' LEU . 13.1 m-80 42.7 35.03 0.64 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.449 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 86' ' ' ASN . . . 43.44 85.31 0.01 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -145.61 47.73 1.27 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.202 -1.175 . . . . 0.0 109.384 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.614 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -155.1 179.15 9.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.894 . . . . 0.0 109.505 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.505 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 8.7 t -94.58 116.13 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.625 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -109.7 125.36 52.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.268 -0.895 . . . . 0.0 109.193 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.574 ' N ' ' CD2' ' A' ' 92' ' ' HIS . 1.3 p80 -151.0 136.05 17.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.028 -1.045 . . . . 0.0 110.197 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -85.85 131.43 34.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.176 -0.953 . . . . 0.0 109.713 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -100.34 121.37 41.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.95 . . . . 0.0 109.359 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.596 HG12 ' N ' ' A' ' 96' ' ' GLN . 44.4 t -89.64 167.71 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 109.615 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.686 ' NE2' ' N ' ' A' ' 97' ' ' GLY . 17.5 tp60 -88.03 136.12 33.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 109.394 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.686 ' N ' ' NE2' ' A' ' 96' ' ' GLN . . . 110.41 -26.91 12.26 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.487 ' O ' ' O ' ' A' ' 99' ' ' GLU . 2.9 t80 -133.21 -30.14 1.36 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.414 -1.051 . . . . 0.0 109.413 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 98' ' ' PHE . 18.1 mp0 47.02 -176.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 109.477 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.6 t -100.92 143.88 30.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 109.53 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -47.65 -40.42 19.73 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.194 -0.941 . . . . 0.0 109.527 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.1 m -54.02 -44.5 71.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.899 . . . . 0.0 109.442 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.81 -55.35 8.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 109.268 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.443 ' O ' ' CD1' ' A' ' 107' ' ' PHE . 92.7 mt -48.15 -21.52 0.5 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.36 -0.838 . . . . 0.0 109.497 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.23 -24.29 9.74 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -84.61 -5.98 59.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -1.183 . . . . 0.0 109.549 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 5.0 p90 -54.03 118.0 3.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.492 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -114.88 -55.79 2.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 109.483 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.1 p -92.63 -14.08 28.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.541 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.15 75.62 1.23 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.087 HD23 ' H ' ' A' ' 111' ' ' LEU . 1.1 pt? -56.58 163.31 1.85 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -1.124 . . . . 0.0 109.608 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -141.38 179.75 6.6 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.374 -0.829 . . . . 0.0 109.432 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.99 111.43 7.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 0.0 109.333 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -75.5 110.04 9.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.43 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.9 mttp . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 109.452 179.955 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo . . . . . 0 N--CA 1.492 1.402 0 CA-C-O 121.355 0.481 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -83.24 -28.84 28.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.878 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.55 ' CE2' HG12 ' A' ' 42' ' ' VAL . 5.7 t80 -70.46 -16.05 62.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.785 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.0 mt -83.74 -38.28 21.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 109.446 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 8' ' ' ALA . 48.2 mmtt -95.25 -2.59 49.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.343 -0.848 . . . . 0.0 109.388 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.484 ' HB3' HD13 ' A' ' 44' ' ' LEU . . . -42.12 139.27 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.885 . . . . 0.0 109.529 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.23 56.83 0.06 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 pttm -137.45 18.7 2.92 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.2 -1.177 . . . . 0.0 109.514 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.469 ' O ' ' OE1' ' A' ' 11' ' ' GLU . 1.7 pp20? -165.93 127.38 1.37 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.419 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.12 85.16 1.7 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.421 2.081 . . . . 0.0 112.148 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -174.62 -103.28 0.16 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.0 tp -153.2 146.73 25.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.356 -1.085 . . . . 0.0 109.608 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.401 ' HB3' ' CZ3' ' A' ' 17' ' ' TRP . 25.1 mt-30 -135.89 128.72 31.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.866 . . . . 0.0 109.367 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.5 mt -105.91 150.08 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 0.0 109.557 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.401 ' CZ3' ' HB3' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -156.68 135.59 11.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.134 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -104.82 148.61 26.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.27 -0.894 . . . . 0.0 109.568 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.481 ' O ' ' OD1' ' A' ' 39' ' ' ASP . 9.5 p -83.44 146.0 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.42 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.595 ' O ' ' N ' ' A' ' 22' ' ' PHE . 22.8 tt0 -99.3 154.52 18.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 109.382 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 20' ' ' GLU . 39.3 tttm -42.31 -18.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.892 . . . . 0.0 109.599 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.595 ' N ' ' O ' ' A' ' 20' ' ' GLU . 53.5 t80 -163.42 32.67 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.186 -0.946 . . . . 0.0 109.647 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.544 ' OD2' ' N ' ' A' ' 24' ' ' LEU . 9.3 t0 -173.23 -122.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.431 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.544 ' N ' ' OD2' ' A' ' 23' ' ' ASP . 4.6 tp -152.44 146.04 24.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.57 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.62 134.03 25.83 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.398 -0.813 . . . . 0.0 109.17 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.77 146.8 49.1 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.378 2.052 . . . . 0.0 112.16 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.5 t -105.24 105.89 53.73 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.411 -0.806 . . . . 0.0 109.191 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -47.85 127.9 15.22 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.463 2.109 . . . . 0.0 112.358 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.6 m -76.37 -3.6 37.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.32 -0.862 . . . . 0.0 109.285 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.75 -15.2 59.29 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.167 -0.958 . . . . 0.0 109.358 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.63 ' C ' HD12 ' A' ' 31' ' ' LEU . 0.9 OUTLIER -156.3 12.5 0.29 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 110.129 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.487 ' N ' HD12 ' A' ' 31' ' ' LEU . 20.6 p90 -43.35 163.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.127 -0.983 . . . . 0.0 109.377 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.25 -4.71 26.81 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -96.17 102.04 13.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.184 -1.186 . . . . 0.0 109.497 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -96.21 124.43 40.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.243 -0.911 . . . . 0.0 109.511 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -92.16 146.79 23.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.443 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.425 ' OG1' ' CD ' ' A' ' 65' ' ' GLU . 13.3 p -84.46 -15.79 44.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 109.436 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.21 22.91 32.17 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.481 ' OD1' ' O ' ' A' ' 19' ' ' VAL . 3.5 t70 -164.34 150.78 11.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.205 -1.174 . . . . 0.0 109.463 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.481 ' O ' ' OD2' ' A' ' 39' ' ' ASP . . . -92.55 153.08 19.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.391 -0.818 . . . . 0.0 109.528 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -125.01 134.79 52.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.366 -0.834 . . . . 0.0 109.32 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.55 HG12 ' CE2' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -109.93 144.39 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.269 -0.894 . . . . 0.0 109.018 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.072 ' N ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -143.32 121.83 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.932 -1.105 . . . . 0.0 109.852 -179.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.484 HD13 ' HB3' ' A' ' 8' ' ' ALA . 7.5 tt -111.35 124.58 52.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.593 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.543 ' CE ' ' OH ' ' A' ' 106' ' ' TYR . 23.2 tttm -101.33 140.47 35.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -0.883 . . . . 0.0 109.225 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.526 HG22 HD22 ' A' ' 54' ' ' LEU . 98.9 m -139.32 123.22 17.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.88 . . . . 0.0 109.574 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -128.55 168.32 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.171 -0.955 . . . . 0.0 108.894 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -103.64 108.88 20.35 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.58 -0.7 . . . . 0.0 109.411 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 50' ' ' ARG . 14.5 mt -72.8 169.06 17.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 109.564 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' A' ' 49' ' ' LEU . 8.9 tpp85 -43.25 -70.36 0.11 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.217 -0.927 . . . . 0.0 109.252 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -52.74 -31.22 36.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 109.207 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.35 36.74 4.53 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.495 ' O ' ' O ' ' A' ' 54' ' ' LEU . 5.8 t-20 -84.52 13.21 5.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.118 -1.225 . . . . 0.0 109.175 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.647 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.4 mt 44.37 97.63 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.573 0.701 . . . . 0.0 109.418 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -71.39 113.18 8.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.475 -0.766 . . . . 0.0 109.325 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.536 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 92.6 m-85 -98.89 114.38 26.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.239 -0.913 . . . . 0.0 109.849 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -118.28 154.98 31.39 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.421 HD13 HD11 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -142.68 144.59 32.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.964 -1.085 . . . . 0.0 110.674 -179.274 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.781 ' HB2' HD13 ' A' ' 43' ' ' ILE . 4.2 m-70 -129.62 150.21 51.05 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.614 ' CD1' ' O ' ' A' ' 60' ' ' TYR . 19.8 p90 -128.98 124.95 36.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.205 -0.934 . . . . 0.0 109.434 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.554 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 56.1 t90 -107.78 127.75 53.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.369 -0.832 . . . . 0.0 109.647 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.554 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 24.2 mt -106.65 161.98 14.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.314 -0.866 . . . . 0.0 109.405 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -109.12 157.49 15.1 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -82.29 -11.81 58.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -1.14 . . . . 0.0 109.545 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.425 ' CD ' ' OG1' ' A' ' 37' ' ' THR . 2.2 mt-10 -110.26 33.11 4.66 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.655 ' SG ' ' O ' ' A' ' 66' ' ' CYS . 18.8 p -130.44 97.66 4.46 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 122.432 1.11 . . . . 0.0 108.965 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.485 ' O ' ' OG ' ' A' ' 71' ' ' SER . 3.1 m -43.77 170.86 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.763 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 72' ' ' GLY . 19.5 mt-30 -65.44 -17.78 64.81 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.422 -0.799 . . . . 0.0 109.584 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -65.07 -58.59 5.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.52 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -63.7 -47.07 82.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.378 -0.826 . . . . 0.0 109.196 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 67' ' ' SER . 0.2 OUTLIER -68.65 -24.21 64.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.386 -0.821 . . . . 0.0 109.074 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -71.46 -36.02 62.96 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.16 -42.7 62.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -1.152 . . . . 0.0 109.344 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.37 -46.59 88.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.363 -0.836 . . . . 0.0 109.234 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.513 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -59.48 -49.33 78.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.323 -0.861 . . . . 0.0 109.29 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.9 mt -49.26 -42.22 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.252 -0.905 . . . . 0.0 109.239 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -61.75 -45.75 92.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.24 -0.913 . . . . 0.0 109.307 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.9 m -63.08 -40.12 96.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.296 -0.878 . . . . 0.0 109.413 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 75' ' ' ALA . 24.9 t -67.32 -31.9 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.269 -0.894 . . . . 0.0 109.667 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.65 -61.46 1.88 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.261 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.479 ' C ' HD12 ' A' ' 81' ' ' LEU . 1.5 pp -54.13 -28.15 38.02 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.107 -0.996 . . . . 0.0 108.821 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.638 ' O ' ' N ' ' A' ' 86' ' ' ASN . 8.3 t70 -62.83 -54.09 44.24 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.142 -0.974 . . . . 0.0 109.022 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.56 -34.53 62.01 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -77.92 -26.17 48.84 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.616 ' C ' ' H ' ' A' ' 87' ' ' GLY . 7.3 mt -121.49 33.28 5.58 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.535 -0.728 . . . . 0.0 109.484 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.638 ' N ' ' O ' ' A' ' 82' ' ' ASP . 4.6 t-20 -70.42 25.56 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 108.956 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.616 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -68.79 25.63 0.29 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.578 ' H ' ' C ' ' A' ' 86' ' ' ASN . 0.4 OUTLIER 80.87 35.94 0.1 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.427 -1.043 . . . . 0.0 109.704 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -73.25 179.46 3.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.0 109.123 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.8 t -116.2 121.65 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.217 -0.927 . . . . 0.0 109.874 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -97.65 143.26 28.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.107 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.659 ' CD2' ' CE1' ' A' ' 59' ' ' HIS . 33.8 m-70 -120.6 146.61 46.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 109.519 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.454 ' H ' ' HG2' ' A' ' 93' ' ' ARG . 5.5 ptm180 -116.6 103.01 9.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 0.0 109.617 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.548 ' OE2' ' CG ' ' A' ' 103' ' ' PHE . 42.1 mt-10 -113.78 144.64 42.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.459 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.721 HG12 ' N ' ' A' ' 96' ' ' GLN . 47.4 t -149.1 176.56 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.879 . . . . 0.0 109.368 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.721 ' N ' HG12 ' A' ' 95' ' ' VAL . 10.4 tp-100 -67.96 118.08 10.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.934 . . . . 0.0 109.453 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.13 11.6 84.93 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.441 ' O ' ' C ' ' A' ' 99' ' ' GLU . 0.3 OUTLIER -140.98 19.32 2.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.163 -1.198 . . . . 0.0 109.485 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 98' ' ' PHE . 22.0 mt-10 -43.27 163.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 109.532 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.0 m -100.12 167.79 10.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.302 -0.873 . . . . 0.0 109.418 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.73 -50.88 31.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.449 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.6 m -46.97 -59.69 2.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.147 -0.971 . . . . 0.0 109.381 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.548 ' CG ' ' OE2' ' A' ' 94' ' ' GLU . 5.4 t80 -53.69 -51.18 64.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.392 -0.818 . . . . 0.0 109.328 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.612 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 6.6 mt -53.35 -18.71 2.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 0.0 109.094 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.81 -21.98 24.62 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.543 ' OH ' ' CE ' ' A' ' 45' ' ' LYS . 3.0 m-85 -73.68 -33.74 64.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.273 -1.134 . . . . 0.0 109.247 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.691 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 1.0 OUTLIER -41.09 108.14 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.356 -0.84 . . . . 0.0 109.599 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -115.37 -47.43 2.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.146 -0.972 . . . . 0.0 109.378 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.7 m -86.11 -29.14 23.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.896 . . . . 0.0 109.522 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 120.48 111.47 2.28 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.445 ' H ' ' HG ' ' A' ' 111' ' ' LEU . 2.4 pp -120.99 166.87 13.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.326 -1.103 . . . . 0.0 109.524 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -172.81 -178.17 1.81 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.638 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -93.52 139.7 30.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.286 -0.884 . . . . 0.0 109.44 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -146.46 105.05 3.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.4 pttt . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 109.402 179.971 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo . . . . . 0 N--CA 1.491 1.354 0 CA-C-O 121.219 0.425 . . . . 0.0 111.966 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -83.18 -38.0 22.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.905 . . . . 0.0 110.022 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.593 ' CE1' HG12 ' A' ' 42' ' ' VAL . 22.4 t80 -55.17 -19.85 8.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.101 -1.0 . . . . 0.0 109.519 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.626 HD23 HD11 ' A' ' 81' ' ' LEU . 9.0 mt -83.77 -35.38 24.39 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.183 -0.948 . . . . 0.0 109.466 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 8' ' ' ALA . 2.2 mmmp? -89.68 -0.96 57.87 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.197 -0.939 . . . . 0.0 109.511 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.479 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -42.88 166.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.882 . . . . 0.0 109.546 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.34 75.37 1.13 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -142.99 5.49 1.52 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.19 -1.182 . . . . 0.0 109.622 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -172.34 143.27 1.26 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 0.0 109.342 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.38 88.45 1.15 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.585 2.19 . . . . 0.0 112.295 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -172.37 -104.71 0.18 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 tp -156.2 143.39 19.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.263 -1.14 . . . . 0.0 109.697 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -129.06 130.65 46.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.363 -0.835 . . . . 0.0 109.237 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 53.2 mt -113.37 137.66 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.263 -0.898 . . . . 0.0 109.958 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -141.61 136.51 31.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.368 -0.832 . . . . 0.0 108.82 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -98.03 150.71 21.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.148 -0.97 . . . . 0.0 109.671 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.626 ' O ' HG13 ' A' ' 19' ' ' VAL . 8.1 p -92.12 122.77 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.387 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.611 ' O ' ' N ' ' A' ' 22' ' ' PHE . 4.2 tm-20 -75.12 149.5 39.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.126 -0.984 . . . . 0.0 109.012 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 20' ' ' GLU . 57.9 mttt -40.3 -20.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.447 -0.783 . . . . 0.0 109.841 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.611 ' N ' ' O ' ' A' ' 20' ' ' GLU . 40.4 t80 -151.46 13.24 0.65 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.081 -1.012 . . . . 0.0 109.819 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 20' ' ' GLU . 35.0 m-20 -160.81 -143.06 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.938 . . . . 0.0 109.385 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.446 ' CD2' ' H ' ' A' ' 5' ' ' PHE . 0.8 OUTLIER -129.35 139.83 51.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.31 -0.869 . . . . 0.0 109.571 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 t -119.76 133.06 23.85 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.361 -0.837 . . . . 0.0 108.947 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.62 150.75 45.9 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.431 2.088 . . . . 0.0 112.495 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.8 t -148.79 101.53 3.44 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.306 -0.871 . . . . 0.0 109.214 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -50.1 139.46 34.57 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.591 2.194 . . . . 0.0 112.262 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.475 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 12.4 t -67.53 -21.08 65.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.325 -0.86 . . . . 0.0 109.347 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -77.04 -2.74 35.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.365 -0.835 . . . . 0.0 109.415 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.486 ' O ' ' O ' ' A' ' 32' ' ' TYR . 50.1 mt -124.91 -18.87 5.4 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.339 -0.851 . . . . 0.0 109.5 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.486 ' O ' ' O ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -49.24 -178.61 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.123 -0.986 . . . . 0.0 109.51 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.15 -41.01 2.09 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -98.47 102.37 14.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -1.154 . . . . 0.0 109.495 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -90.33 136.43 33.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.187 -0.946 . . . . 0.0 109.461 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.439 ' CD2' ' OH ' ' A' ' 41' ' ' TYR . 25.1 m-85 -92.9 138.72 31.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 109.435 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.423 ' OG1' ' CD ' ' A' ' 65' ' ' GLU . 55.8 p -80.45 -4.83 55.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.31 -0.869 . . . . 0.0 109.48 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.7 -74.9 1.21 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -78.7 155.05 29.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -1.126 . . . . 0.0 109.601 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.528 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -90.69 165.44 13.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.335 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.439 ' OH ' ' CD2' ' A' ' 36' ' ' PHE . 11.1 m-85 -126.84 136.02 51.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.296 -0.878 . . . . 0.0 109.542 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.07 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -111.68 128.6 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.07 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -124.79 141.96 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.949 . . . . 0.0 110.494 -178.667 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.5 tt -128.21 120.6 27.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.55 -0.719 . . . . 0.0 109.081 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.559 ' HZ2' HG22 ' A' ' 47' ' ' VAL . 38.2 tttp -93.11 146.54 23.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.364 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 13' ' ' GLY . 85.1 m -143.16 129.2 19.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.094 -1.004 . . . . 0.0 109.549 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -133.33 168.49 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 121.178 -0.951 . . . . 0.0 109.262 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -101.72 111.0 23.1 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.616 -0.677 . . . . 0.0 109.376 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 52' ' ' GLY . 81.2 mt -74.92 158.28 33.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.227 -0.92 . . . . 0.0 109.572 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.713 ' CD ' ' H ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -44.85 -47.04 11.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.363 -0.836 . . . . 0.0 109.203 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.465 ' ND2' ' N ' ' A' ' 51' ' ' ASN . 0.9 OUTLIER -65.69 -28.82 69.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.279 -0.888 . . . . 0.0 109.203 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . 94.17 30.75 8.51 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.498 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.1 t-20 -89.89 12.78 16.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.085 -1.244 . . . . 0.0 109.373 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.576 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.1 mt 45.12 99.12 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.665 0.745 . . . . 0.0 109.554 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.547 ' CD ' ' N ' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -68.56 152.83 44.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.476 -0.765 . . . . 0.0 109.118 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.547 ' N ' ' CD ' ' A' ' 55' ' ' GLN . 68.4 m-85 -133.05 114.25 13.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.223 -0.923 . . . . 0.0 109.806 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.63 155.72 26.03 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.458 ' C ' ' CD2' ' A' ' 59' ' ' HIS . 1.1 mp -130.41 146.44 51.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.884 -1.135 . . . . 0.0 110.664 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.461 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 6.9 m-70 -136.22 144.19 44.75 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.437 ' CE1' ' HG ' ' A' ' 62' ' ' LEU . 13.5 t80 -129.27 128.97 44.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.245 -0.909 . . . . 0.0 109.857 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -109.2 126.0 52.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.403 -0.811 . . . . 0.0 109.587 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.437 ' HG ' ' CE1' ' A' ' 60' ' ' TYR . 7.9 mt -104.06 162.18 13.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.423 -0.798 . . . . 0.0 109.906 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.536 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -120.54 158.6 15.53 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -82.34 -11.95 58.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.158 -1.201 . . . . 0.0 109.957 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.423 ' CD ' ' OG1' ' A' ' 37' ' ' THR . 0.4 OUTLIER -109.73 35.17 3.45 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.447 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.649 ' SG ' ' O ' ' A' ' 66' ' ' CYS . 18.5 p -130.45 97.76 4.49 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 122.44 1.114 . . . . 0.0 108.916 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 66' ' ' CYS . 1.2 m -52.46 -170.91 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.645 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -76.54 -17.82 59.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 109.561 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -64.18 -58.71 5.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.236 -0.915 . . . . 0.0 109.547 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -66.54 -40.1 88.91 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.375 -0.828 . . . . 0.0 109.123 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.7 t -73.81 -22.75 59.69 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.398 -0.813 . . . . 0.0 109.251 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -75.1 -35.36 49.57 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.75 -46.78 34.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.284 -1.127 . . . . 0.0 109.297 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.15 -39.81 87.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.349 -0.844 . . . . 0.0 109.324 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.46 -49.58 58.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.31 -0.869 . . . . 0.0 109.425 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.413 HG22 ' OE1' ' A' ' 80' ' ' GLN . 39.3 mt -48.31 -42.18 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -0.912 . . . . 0.0 109.411 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -70.06 -36.48 75.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 109.377 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.467 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 5.7 m -68.68 -34.94 76.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.265 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 87.5 t -70.37 -46.65 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.362 -0.836 . . . . 0.0 109.424 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.413 ' OE1' HG22 ' A' ' 76' ' ' ILE . 43.6 mt-30 -64.03 -46.27 85.18 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.295 -0.878 . . . . 0.0 109.192 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.626 HD11 HD23 ' A' ' 6' ' ' LEU . 2.5 mt -56.63 -36.61 69.69 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.261 -0.899 . . . . 0.0 108.88 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 86' ' ' ASN . 0.7 OUTLIER -61.53 -58.12 9.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.298 -0.876 . . . . 0.0 109.154 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.49 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 10.8 m-20 -50.7 -33.11 21.47 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.993 -1.067 . . . . 0.0 108.355 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -78.14 -25.87 47.57 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.569 ' C ' ' H ' ' A' ' 87' ' ' GLY . 8.5 mt -121.38 32.09 6.05 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.497 -0.752 . . . . 0.0 109.371 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 82' ' ' ASP . 26.8 p30 -72.77 26.38 0.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.271 -0.893 . . . . 0.0 108.849 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.569 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -78.25 56.59 4.04 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 62.03 55.23 2.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.477 -1.014 . . . . 0.0 109.69 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.22 179.09 4.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.373 -0.83 . . . . 0.0 109.186 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.1 t -134.68 151.52 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.607 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -115.75 136.63 52.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.383 -0.823 . . . . 0.0 109.416 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.485 ' O ' ' OE2' ' A' ' 94' ' ' GLU . 21.2 m-70 -107.22 110.4 22.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.159 -0.963 . . . . 0.0 109.55 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.1 mtp85 -86.39 92.93 8.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.248 -0.908 . . . . 0.0 109.142 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.485 ' OE2' ' O ' ' A' ' 92' ' ' HIS . 20.2 mp0 -99.87 140.46 34.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.871 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.6 t -132.61 157.35 43.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.417 -0.802 . . . . 0.0 109.123 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.456 ' O ' ' CD ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -56.99 115.98 2.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.917 . . . . 0.0 109.499 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.89 9.92 65.39 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.456 ' O ' ' C ' ' A' ' 99' ' ' GLU . 11.5 t80 -144.98 30.07 1.18 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -1.156 . . . . 0.0 109.588 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.654 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 6.7 mp0 -41.82 157.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 0.0 109.497 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.7 p -87.29 177.76 7.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -0.889 . . . . 0.0 109.564 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.35 -57.01 4.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.458 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.8 m -46.77 -51.18 16.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.189 -0.945 . . . . 0.0 109.269 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.76 -52.5 63.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.387 -0.821 . . . . 0.0 109.203 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.6 mt -49.09 -28.68 4.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.89 . . . . 0.0 109.424 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.56 -14.11 51.44 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.444 ' O ' ' C ' ' A' ' 107' ' ' PHE . 7.2 t80 -83.08 -20.29 35.19 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.269 -1.136 . . . . 0.0 109.564 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.545 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 3.3 p90 -42.31 122.97 2.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.163 -0.961 . . . . 0.0 109.549 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -103.1 -57.12 2.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 109.427 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 72.8 m -106.15 -29.2 10.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -0.874 . . . . 0.0 109.413 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 132.49 107.9 1.09 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.697 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -76.42 160.27 29.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.211 -1.17 . . . . 0.0 109.449 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.1 mtpp -153.54 152.05 30.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -0.885 . . . . 0.0 109.511 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -98.28 138.68 35.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 109.421 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -142.5 154.36 44.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.894 . . . . 0.0 109.604 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 71.1 tttt . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.429 179.975 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo . . . . . 0 N--CA 1.488 1.176 0 CA-C-O 121.252 0.438 . . . . 0.0 112.086 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.688 ' H ' HD22 ' A' ' 24' ' ' LEU . 67.5 tt0 -83.21 -18.02 40.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.355 -0.841 . . . . 0.0 109.999 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.465 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 2.3 m-85 -74.09 -5.91 44.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.092 -1.005 . . . . 0.0 109.541 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.421 ' CD2' HE21 ' A' ' 80' ' ' GLN . 11.5 mt -85.49 -39.62 17.26 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.205 -0.934 . . . . 0.0 109.417 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 8' ' ' ALA . 41.9 mtpt -97.67 -9.97 25.84 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.352 -0.843 . . . . 0.0 109.515 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -43.84 166.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 0.0 109.577 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 134.87 -29.9 2.91 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -78.94 23.7 0.34 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.245 -1.15 . . . . 0.0 109.377 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 13' ' ' GLY . 55.3 mt-10 -137.01 76.77 44.84 Favored Pre-proline 0 C--N 1.305 -1.367 0 O-C-N 121.288 -0.882 . . . . 0.0 109.547 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -52.25 81.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 122.867 2.378 . . . . 0.0 112.207 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 46' ' ' THR . . . 179.65 -102.98 0.17 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.639 HD21 ' CG2' ' A' ' 43' ' ' ILE . 7.1 tt -162.53 127.53 3.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -1.179 . . . . 0.0 109.81 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.59 ' N ' HD23 ' A' ' 14' ' ' LEU . 35.1 mt-30 -114.42 146.82 40.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.346 -0.846 . . . . 0.0 109.316 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.625 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 11.8 mt -130.68 123.86 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.502 -0.749 . . . . 0.0 110.284 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.625 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 11.3 m0 -143.88 158.94 43.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.043 -1.036 . . . . 0.0 108.528 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.504 ' NE ' ' CZ ' ' A' ' 41' ' ' TYR . 20.8 ttm180 -105.76 152.48 23.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.019 -1.051 . . . . 0.0 110.001 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.6 p -88.38 139.61 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.277 -0.889 . . . . 0.0 109.422 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.595 ' O ' ' N ' ' A' ' 22' ' ' PHE . 18.8 tt0 -88.69 152.61 21.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.23 -0.919 . . . . 0.0 109.203 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 20' ' ' GLU . 24.3 tttt -40.72 -20.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.307 -0.87 . . . . 0.0 109.555 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.595 ' N ' ' O ' ' A' ' 20' ' ' GLU . 7.2 t80 -160.14 32.1 0.17 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.175 -0.953 . . . . 0.0 109.492 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -170.71 -130.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.516 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.688 HD22 ' H ' ' A' ' 4' ' ' GLU . 5.9 tp -144.2 146.2 32.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 109.558 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 t -129.3 126.99 23.14 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.017 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -75.21 141.6 26.24 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.368 2.045 . . . . 0.0 112.383 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.5 t -104.35 122.84 42.56 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.379 -0.826 . . . . 0.0 109.242 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.32 162.08 34.14 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.514 2.143 . . . . 0.0 112.28 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.94 -24.64 67.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.216 -0.928 . . . . 0.0 109.428 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -64.02 -10.71 23.43 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 109.429 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 32' ' ' TYR . 94.9 mt -127.26 -13.16 5.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.289 -0.882 . . . . 0.0 109.531 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.531 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 4.4 t80 -41.11 131.05 2.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.372 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 112' ' ' LYS . . . 85.8 15.03 66.3 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -141.24 99.28 3.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -1.145 . . . . 0.0 109.48 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -97.04 164.94 12.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.276 -0.89 . . . . 0.0 109.494 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -105.2 136.08 45.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.449 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.449 ' OG1' ' CD ' ' A' ' 65' ' ' GLU . 4.1 p -73.35 -4.99 36.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.184 -0.948 . . . . 0.0 109.486 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.97 38.75 3.18 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 40' ' ' ALA . 5.9 t0 -171.23 171.01 5.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -1.189 . . . . 0.0 109.489 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.463 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -113.59 136.01 53.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.89 . . . . 0.0 109.546 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.504 ' CZ ' ' NE ' ' A' ' 18' ' ' ARG . 27.7 m-85 -114.91 142.64 46.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.333 -0.854 . . . . 0.0 109.345 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.011 ' O ' HD13 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -113.14 143.96 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.273 -0.892 . . . . 0.0 108.871 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.011 HD13 ' O ' ' A' ' 42' ' ' VAL . 1.2 mm -136.7 151.41 27.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.359 -0.937 . . . . 0.0 110.091 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.706 HD23 ' N ' ' A' ' 45' ' ' LYS . 4.5 tt -135.27 121.14 19.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.554 -0.716 . . . . 0.0 109.207 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.706 ' N ' HD23 ' A' ' 44' ' ' LEU . 31.5 tttt -104.96 112.48 25.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.251 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 55' ' ' GLN . 39.1 m -119.78 135.54 54.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.418 -0.801 . . . . 0.0 109.484 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.535 ' O ' HD23 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -126.95 168.29 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 121.304 -0.872 . . . . 0.0 108.907 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 40.9 tp60 -106.9 98.49 8.14 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.611 -0.68 . . . . 0.0 109.422 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.61 ' O ' ' N ' ' A' ' 51' ' ' ASN . 9.3 mt -65.03 157.75 27.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 109.239 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -51.72 84.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.12 -0.988 . . . . 0.0 109.099 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.61 ' N ' ' O ' ' A' ' 49' ' ' LEU . 6.6 m-20 51.43 43.36 29.59 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.229 -0.92 . . . . 0.0 109.192 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.82 -79.9 1.49 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 54' ' ' LEU . 1.2 t30 -174.53 26.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.079 -1.248 . . . . 0.0 109.908 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.616 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 3.9 mt 58.51 106.7 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.666 0.746 . . . . 0.0 109.118 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.593 ' O ' HG23 ' A' ' 46' ' ' THR . 32.1 tt0 -68.82 147.53 51.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.523 -0.735 . . . . 0.0 109.503 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.616 ' CE1' ' O ' ' A' ' 54' ' ' LEU . 97.7 m-85 -129.95 114.67 16.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.48 -0.762 . . . . 0.0 109.507 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.593 ' OD1' ' CE1' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -123.1 154.94 37.92 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.176 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.5 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 1.8 mp -132.93 150.2 52.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.958 -1.089 . . . . 0.0 110.753 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.704 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -141.96 116.93 9.93 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.36 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.667 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -103.8 121.89 43.98 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.023 -1.048 . . . . 0.0 109.52 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.553 ' NE1' ' OE1' ' A' ' 99' ' ' GLU . 71.4 t90 -98.99 136.25 39.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.866 . . . . 0.0 109.725 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.565 ' H ' HD12 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -116.63 159.04 22.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.397 -0.814 . . . . 0.0 109.4 179.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -101.07 148.34 18.1 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -70.37 -12.25 61.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -1.16 . . . . 0.0 109.49 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.449 ' CD ' ' OG1' ' A' ' 37' ' ' THR . 1.7 mt-10 -106.6 31.37 5.29 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.3 m -130.48 97.57 4.43 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.091 0.948 . . . . 0.0 108.513 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 66' ' ' CYS . 94.3 p -52.57 -170.88 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.783 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 72' ' ' GLY . 44.2 tt0 -64.63 -17.95 64.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.367 -0.833 . . . . 0.0 109.537 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -63.29 -58.69 6.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 109.473 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -68.16 -39.46 82.57 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.396 -0.815 . . . . 0.0 108.898 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 t -73.48 -20.98 60.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.515 -0.741 . . . . 0.0 109.064 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -75.66 -41.06 30.19 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.53 -42.16 71.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -1.121 . . . . 0.0 109.22 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.436 ' HB2' ' CB ' ' A' ' 40' ' ' ALA . . . -62.05 -42.04 98.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.328 -0.858 . . . . 0.0 109.285 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.513 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -64.91 -47.82 76.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.308 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.2 mt -52.76 -37.14 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.348 -0.845 . . . . 0.0 109.235 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.56 -41.34 79.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.342 -0.849 . . . . 0.0 109.293 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.9 m -68.28 -34.45 76.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 109.557 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 75' ' ' ALA . 61.8 t -68.06 -37.99 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.223 -0.923 . . . . 0.0 109.426 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.421 HE21 ' CD2' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -68.39 -47.03 68.42 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.463 HD13 HD23 ' A' ' 58' ' ' LEU . 0.6 OUTLIER -55.43 -38.13 68.59 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.189 -0.945 . . . . 0.0 108.974 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.628 ' O ' ' N ' ' A' ' 86' ' ' ASN . 16.1 t70 -61.74 -58.33 8.45 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.318 -0.864 . . . . 0.0 109.109 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 82' ' ' ASP . 59.1 m-20 -45.43 -35.09 3.48 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.119 -0.988 . . . . 0.0 108.744 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -74.25 -32.66 63.04 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.361 -0.837 . . . . 0.0 108.834 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.577 ' C ' ' H ' ' A' ' 87' ' ' GLY . 7.7 mt -121.69 36.17 4.69 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.409 -0.807 . . . . 0.0 109.283 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.628 ' N ' ' O ' ' A' ' 82' ' ' ASP . 9.6 p30 -72.03 25.4 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.95 . . . . 0.0 109.143 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.577 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -80.41 -75.65 1.06 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.409 ' HG3' HH21 ' A' ' 88' ' ' ARG . 12.7 mtt85 -152.32 50.65 0.77 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.262 -1.14 . . . . 0.0 109.458 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -96.87 179.14 5.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.404 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.0 t -135.99 96.36 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.282 -0.886 . . . . 0.0 109.532 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 7.2 pt20 -95.87 143.92 26.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.905 . . . . 0.0 109.308 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.672 ' CE1' ' HD1' ' A' ' 59' ' ' HIS . 2.0 p80 -147.09 158.6 43.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.841 -1.162 . . . . 0.0 110.144 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.537 ' CG ' HD11 ' A' ' 62' ' ' LEU . 4.4 ttt180 -91.68 126.29 36.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.456 -0.778 . . . . 0.0 109.902 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.441 ' O ' HD12 ' A' ' 62' ' ' LEU . 21.4 mt-10 -107.49 129.91 54.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 109.229 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.491 ' O ' ' OE1' ' A' ' 99' ' ' GLU . 3.4 t -127.57 161.41 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 109.66 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -62.44 145.21 54.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.328 -0.858 . . . . 0.0 109.551 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.69 4.18 6.71 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.447 ' O ' ' C ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -134.08 6.13 3.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -1.101 . . . . 0.0 109.293 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.553 ' OE1' ' NE1' ' A' ' 61' ' ' TRP . 3.5 mp0 -42.64 158.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.417 -0.802 . . . . 0.0 109.351 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.1 m -80.32 147.44 31.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.313 -0.867 . . . . 0.0 109.369 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.71 -33.26 66.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -0.964 . . . . 0.0 109.432 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 99.4 m -68.68 -33.86 74.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -0.916 . . . . 0.0 109.481 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -68.74 -46.6 68.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.361 -0.837 . . . . 0.0 109.422 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.6 mt -69.36 -23.49 63.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.466 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.14 -26.24 22.04 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -77.33 -30.9 54.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.363 -1.081 . . . . 0.0 109.559 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -80.65 129.17 34.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.446 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.47 ' HB2' ' HZ3' ' A' ' 108' ' ' LYS . 1.9 mtmp? -103.21 -12.86 17.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.895 . . . . 0.0 109.457 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.9 t -97.05 -9.21 28.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.927 . . . . 0.0 109.511 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.59 104.48 0.3 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.766 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -63.27 179.82 0.39 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -1.123 . . . . 0.0 109.32 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -164.54 167.13 19.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.204 -0.935 . . . . 0.0 109.459 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.5 103.24 5.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 0.0 109.316 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -79.51 124.06 28.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.897 . . . . 0.0 109.536 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.125 -0.985 . . . . 0.0 109.479 -179.945 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo . . . . . 0 N--CA 1.494 1.511 0 CA-C-O 121.192 0.413 . . . . 0.0 111.994 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.425 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 6.0 mm-40 -83.42 -46.45 12.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -0.877 . . . . 0.0 109.993 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.804 ' CZ ' HG12 ' A' ' 42' ' ' VAL . 23.1 t80 -65.29 -32.66 74.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.207 -0.933 . . . . 0.0 109.058 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.509 HD23 HD11 ' A' ' 81' ' ' LEU . 12.2 mt -74.01 -35.85 64.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.31 -0.869 . . . . 0.0 109.314 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.497 ' O ' ' O ' ' A' ' 8' ' ' ALA . 12.4 mmmt -82.76 -9.88 59.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.435 -0.79 . . . . 0.0 109.307 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.497 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -45.58 173.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.595 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.4 32.57 1.77 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -150.25 35.61 0.66 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.324 -1.103 . . . . 0.0 109.412 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -155.09 115.5 2.36 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.296 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.15 81.85 2.6 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.442 2.094 . . . . 0.0 112.354 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 46' ' ' THR . . . 175.44 -100.62 0.15 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 tt -161.44 145.06 12.76 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.217 -1.167 . . . . 0.0 109.652 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.42 ' HB3' ' CZ3' ' A' ' 17' ' ' TRP . 1.2 mt-30 -133.75 135.96 44.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 109.239 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.409 HG23 HD12 ' A' ' 43' ' ' ILE . 13.3 mt -106.83 135.65 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.349 -0.844 . . . . 0.0 110.067 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.425 ' CE2' ' HB3' ' A' ' 4' ' ' GLU . 0.6 OUTLIER -144.34 111.38 5.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.379 -0.825 . . . . 0.0 108.948 179.466 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.569 ' NH2' ' CD1' ' A' ' 36' ' ' PHE . 28.2 ttt180 -74.79 153.03 38.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.192 -0.942 . . . . 0.0 109.473 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.9 p -77.14 145.14 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 109.792 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 22' ' ' PHE . 21.6 tt0 -108.08 154.58 21.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.405 -0.809 . . . . 0.0 109.187 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.591 ' O ' ' CD2' ' A' ' 22' ' ' PHE . 7.2 mtmp? -46.93 -10.86 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.287 -0.883 . . . . 0.0 109.513 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 21' ' ' LYS . 9.5 m-85 -169.53 28.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 109.529 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.675 ' C ' HD22 ' A' ' 24' ' ' LEU . 3.7 t70 -176.03 -154.17 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.918 . . . . 0.0 109.592 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.675 HD22 ' C ' ' A' ' 23' ' ' ASP . 4.5 mm? -117.83 146.01 44.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.312 -0.868 . . . . 0.0 109.425 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 18' ' ' ARG . 2.1 t -125.08 130.65 24.12 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.323 -0.861 . . . . 0.0 109.048 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.56 137.61 20.71 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.344 2.029 . . . . 0.0 112.631 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -122.25 101.68 40.88 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.428 -0.795 . . . . 0.0 108.973 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.66 166.93 23.21 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.466 2.111 . . . . 0.0 112.478 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.35 -17.8 22.73 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.22 -0.925 . . . . 0.0 109.31 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.723 HD22 ' N ' ' A' ' 30' ' ' ASN . 0.6 OUTLIER -44.45 -31.18 1.01 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.939 . . . . 0.0 109.361 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.487 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 2.3 pp -160.45 16.64 0.13 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.247 -0.908 . . . . 0.0 109.837 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -56.33 161.4 2.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.992 -1.067 . . . . 0.0 109.423 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.57 -7.77 63.69 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.487 ' OD2' ' O ' ' A' ' 31' ' ' LEU . 11.3 p-10 -93.01 98.14 11.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -1.145 . . . . 0.0 109.373 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.485 ' CE1' HD23 ' A' ' 111' ' ' LEU . 51.1 m-85 -89.61 133.71 34.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.279 -0.888 . . . . 0.0 109.508 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.569 ' CD1' ' NH2' ' A' ' 18' ' ' ARG . 28.2 m-85 -96.52 127.4 42.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 109.525 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 28.5 p -68.83 -4.87 17.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.879 . . . . 0.0 109.576 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.22 43.82 1.54 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -167.99 -168.25 0.95 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.244 -1.15 . . . . 0.0 109.49 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.83 145.25 44.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.959 . . . . 0.0 109.497 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.574 ' HB3' HD11 ' A' ' 43' ' ' ILE . 1.7 m-85 -118.73 135.77 54.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.399 -0.813 . . . . 0.0 109.455 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.064 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -115.62 120.11 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.428 -0.795 . . . . 0.0 109.048 179.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.064 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -125.1 130.0 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.16 -0.962 . . . . 0.0 110.299 -179.211 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 57' ' ' ASP . 6.0 tp -104.79 121.0 42.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.565 -0.709 . . . . 0.0 109.166 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.554 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.1 tptm -104.83 103.81 13.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.37 -0.831 . . . . 0.0 109.178 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 55' ' ' GLN . 16.9 m -117.22 139.1 51.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.331 -0.856 . . . . 0.0 109.521 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.561 ' O ' HD23 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -131.65 168.39 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.246 -0.909 . . . . 0.0 109.491 -179.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.762 HE22 ' H ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -111.69 133.49 53.89 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.651 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.626 ' O ' ' C ' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -116.06 100.33 7.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.202 -0.936 . . . . 0.0 109.554 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.626 ' C ' ' O ' ' A' ' 49' ' ' LEU . 31.0 ttt85 21.23 72.54 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.68 -0.638 . . . . 0.0 110.235 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.762 ' H ' HE22 ' A' ' 48' ' ' GLN . 1.8 m120 45.87 52.04 10.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.381 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . -97.11 -81.74 1.6 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -165.15 20.73 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.347 -1.09 . . . . 0.0 109.754 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.592 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 5.9 mt 53.77 104.65 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.489 -0.757 . . . . 0.0 109.306 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.501 ' O ' HG23 ' A' ' 46' ' ' THR . 32.1 tt0 -68.04 149.69 49.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.538 -0.726 . . . . 0.0 109.043 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.592 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 97.1 m-85 -131.47 114.89 15.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.941 . . . . 0.0 109.94 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.613 ' O ' HD12 ' A' ' 44' ' ' LEU . 2.0 m-20 -120.29 155.03 34.11 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.465 HD13 ' HG3' ' A' ' 91' ' ' GLN . 4.8 mp -136.25 129.78 32.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.947 -1.095 . . . . 0.0 110.162 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.586 ' ND1' ' NE2' ' A' ' 92' ' ' HIS . 3.1 m-70 -115.62 109.65 18.05 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.658 ' CZ ' HD22 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -99.55 115.81 30.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 109.317 -179.61 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -108.16 142.31 38.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.29 -0.881 . . . . 0.0 109.752 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.658 HD22 ' CZ ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -133.52 162.21 32.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 109.526 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -87.24 154.41 26.3 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -82.07 -12.42 58.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -1.122 . . . . 0.0 109.564 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -106.81 32.79 4.3 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.498 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.3 m -130.23 97.67 4.5 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.261 1.029 . . . . 0.0 108.438 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 66' ' ' CYS . 1.2 t -44.32 173.87 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.855 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.596 ' O ' ' N ' ' A' ' 72' ' ' GLY . 3.3 pt20 -57.25 -17.45 11.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.483 -0.761 . . . . 0.0 109.732 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -61.22 -59.1 5.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.054 -1.029 . . . . 0.0 109.384 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.28 -50.75 66.69 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 108.691 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.2 m -64.98 -20.87 66.71 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.15 -43.83 62.55 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.69 -49.07 67.31 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -1.157 . . . . 0.0 109.103 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.69 -43.9 90.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.393 -0.817 . . . . 0.0 109.211 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.553 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -66.73 -47.2 73.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.353 -0.842 . . . . 0.0 109.478 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.9 mt -47.08 -44.12 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.888 . . . . 0.0 109.091 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.458 ' O ' HD12 ' A' ' 81' ' ' LEU . 37.5 m-85 -65.77 -45.92 80.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.298 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.4 m -66.14 -22.58 66.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.245 -0.909 . . . . 0.0 109.009 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 75' ' ' ALA . 66.3 t -73.57 -50.28 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.288 -0.883 . . . . 0.0 109.459 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -61.66 -49.86 74.84 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.321 -0.862 . . . . 0.0 108.92 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.509 HD11 HD23 ' A' ' 6' ' ' LEU . 0.9 OUTLIER -55.15 -37.68 67.29 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.28 -0.888 . . . . 0.0 109.037 179.552 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 86' ' ' ASN . 64.5 t0 -58.07 -55.87 29.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.226 -0.921 . . . . 0.0 108.883 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.435 ' HA ' HD22 ' A' ' 86' ' ' ASN . 39.4 m-20 -50.32 -33.98 22.08 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.08 -1.012 . . . . 0.0 108.362 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -77.1 -24.27 51.8 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 82' ' ' ASP . 12.6 mt -121.4 30.45 6.76 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.326 -0.859 . . . . 0.0 109.419 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.5 OUTLIER -80.13 27.99 0.31 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.309 -0.869 . . . . 0.0 108.974 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -83.17 -54.35 3.2 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.6 ptt-85 -175.81 42.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -1.112 . . . . 0.0 109.62 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.581 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -95.53 178.88 5.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.497 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 87.4 t -123.27 91.97 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.437 -0.789 . . . . 0.0 109.337 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.535 ' H ' ' CD ' ' A' ' 91' ' ' GLN . 3.9 mp0 -96.57 125.18 40.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.342 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.586 ' NE2' ' ND1' ' A' ' 59' ' ' HIS . 2.7 p80 -133.52 143.78 48.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.143 -0.973 . . . . 0.0 109.618 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -99.32 105.29 17.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.227 -0.92 . . . . 0.0 109.69 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.423 ' OE1' ' OG ' ' A' ' 100' ' ' SER . 41.0 mt-10 -87.11 148.16 25.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.321 -0.862 . . . . 0.0 109.391 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 t -135.28 163.46 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.196 -0.94 . . . . 0.0 109.487 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 97' ' ' GLY . 6.2 tp-100 -75.4 126.35 30.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.242 -0.911 . . . . 0.0 109.557 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.548 ' N ' ' OE1' ' A' ' 96' ' ' GLN . . . 121.19 4.58 10.03 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.459 ' O ' ' C ' ' A' ' 99' ' ' GLU . 35.9 t80 -174.0 -34.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.226 -1.161 . . . . 0.0 109.448 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 98' ' ' PHE . 14.1 mt-10 41.64 -155.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.356 -0.84 . . . . 0.0 109.569 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.423 ' OG ' ' OE1' ' A' ' 94' ' ' GLU . 78.7 p -129.78 134.3 47.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 109.5 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 100' ' ' SER . . . -44.81 -37.66 3.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.292 -0.88 . . . . 0.0 109.38 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 m -55.54 -48.34 74.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.231 -0.918 . . . . 0.0 109.346 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -62.69 -55.64 25.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 0.0 109.194 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.3 mt -47.39 -26.67 1.38 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.877 . . . . 0.0 109.242 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.71 -40.16 7.83 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.5 ' OH ' ' NZ ' ' A' ' 45' ' ' LYS . 2.7 m-85 -51.87 -46.71 64.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -1.114 . . . . 0.0 109.314 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -139.27 149.71 44.61 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.387 -0.821 . . . . 0.0 109.6 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.89 -56.82 2.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 0.0 109.286 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 110' ' ' GLY . 5.0 m -103.02 -26.81 12.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.496 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 109' ' ' SER . . . -42.44 -59.93 2.94 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.485 HD23 ' CE1' ' A' ' 35' ' ' PHE . 13.9 mt -44.87 134.28 5.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.257 -1.143 . . . . 0.0 109.445 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.3 mttp -151.23 121.56 7.31 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.224 -0.923 . . . . 0.0 109.406 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.448 ' CD2' ' N ' ' A' ' 113' ' ' TYR . 0.6 OUTLIER -98.0 127.8 44.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.302 -0.874 . . . . 0.0 109.443 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -135.42 134.13 39.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 109.457 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 31.9 mtmt . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.146 -0.971 . . . . 0.0 109.506 179.991 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo . . . . . 0 N--CA 1.493 1.476 0 CA-C-O 121.272 0.447 . . . . 0.0 112.007 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.585 ' H ' HD13 ' A' ' 24' ' ' LEU . 4.4 mm-40 -83.41 -37.4 23.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 109.973 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.592 ' CE1' ' CG1' ' A' ' 42' ' ' VAL . 23.5 t80 -70.07 -24.29 63.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.175 -0.953 . . . . 0.0 110.031 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.492 HD23 ' N ' ' A' ' 6' ' ' LEU . 4.1 mt -80.76 -40.34 25.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.081 -1.012 . . . . 0.0 109.677 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.493 ' O ' ' O ' ' A' ' 8' ' ' ALA . 4.2 pttm -96.51 3.45 52.7 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.294 -0.879 . . . . 0.0 109.587 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -54.03 -165.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.77 64.9 1.35 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.18 17.96 1.91 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.336 -1.097 . . . . 0.0 109.588 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.476 ' O ' ' OE1' ' A' ' 11' ' ' GLU . 1.9 pp20? -156.18 134.15 7.05 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.18 -0.95 . . . . 0.0 109.421 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.34 84.65 1.67 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.526 2.151 . . . . 0.0 112.286 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 46' ' ' THR . . . 178.35 -100.55 0.14 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 tt -162.21 152.63 17.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.24 -1.153 . . . . 0.0 109.487 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -135.36 142.24 45.7 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.272 -0.892 . . . . 0.0 109.553 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.535 HG23 HD12 ' A' ' 43' ' ' ILE . 22.3 mt -117.22 133.16 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.32 -0.863 . . . . 0.0 109.801 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -139.26 119.37 13.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.313 -0.867 . . . . 0.0 109.085 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.479 HH11 ' CB ' ' A' ' 39' ' ' ASP . 15.3 ttt85 -85.47 153.62 22.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.235 -0.916 . . . . 0.0 109.647 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 22' ' ' PHE . 38.8 t -91.99 123.49 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.218 -0.926 . . . . 0.0 110.043 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.763 ' O ' ' N ' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -71.02 85.82 0.72 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.982 -1.074 . . . . 0.0 108.482 179.405 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.652 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 48.8 tttt 43.63 6.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.361 -0.837 . . . . 0.0 109.415 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.763 ' N ' ' O ' ' A' ' 20' ' ' GLU . 0.7 OUTLIER 160.92 -30.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.849 . . . . 0.0 109.292 -179.802 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -95.08 -129.52 0.14 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.179 -0.951 . . . . 0.0 110.076 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.585 HD13 ' H ' ' A' ' 4' ' ' GLU . 3.8 mt -139.99 142.65 36.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.127 -0.983 . . . . 0.0 110.265 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 18' ' ' ARG . 3.4 t -142.11 110.29 5.97 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.831 . . . . 0.0 108.96 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -46.27 151.59 1.63 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.067 1.845 . . . . 0.0 111.808 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.11 101.47 45.04 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.944 . . . . 0.0 109.61 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.02 162.58 1.83 Allowed 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.506 2.138 . . . . 0.0 112.257 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.6 m -78.22 -34.79 49.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 109.348 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -56.63 -16.95 7.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.405 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.458 ' O ' ' C ' ' A' ' 32' ' ' TYR . 15.6 mt -112.35 -25.96 8.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.263 -0.898 . . . . 0.0 109.551 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.566 ' OH ' ' CE2' ' A' ' 107' ' ' PHE . 19.0 t80 -41.63 137.08 1.7 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.891 . . . . 0.0 109.453 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.44 -16.71 48.27 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -100.18 121.96 42.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -1.189 . . . . 0.0 109.438 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -102.53 121.58 42.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.189 -0.945 . . . . 0.0 109.536 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -95.96 144.23 26.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.465 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.4 p -97.05 -10.22 26.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -100.22 34.23 5.69 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.479 ' CB ' HH11 ' A' ' 18' ' ' ARG . 4.8 m-20 -163.78 -177.1 4.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -1.149 . . . . 0.0 109.496 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.406 ' C ' ' CD2' ' A' ' 41' ' ' TYR . . . -140.46 146.9 38.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.256 -0.903 . . . . 0.0 109.405 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.585 ' OH ' ' CZ3' ' A' ' 61' ' ' TRP . 0.1 OUTLIER -142.56 137.88 30.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.121 -0.987 . . . . 0.0 109.793 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.945 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -101.29 144.23 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.945 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.6 OUTLIER -128.02 134.37 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.512 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.668 HD23 ' C ' ' A' ' 44' ' ' LEU . 4.7 tt -109.66 116.2 31.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.627 -0.671 . . . . 0.0 109.397 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.649 ' N ' HD23 ' A' ' 44' ' ' LEU . 8.5 ttpt -92.43 139.48 30.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.219 -0.926 . . . . 0.0 109.44 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.525 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.6 OUTLIER -143.07 118.62 10.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.119 -0.988 . . . . 0.0 109.413 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.694 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -128.24 167.97 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.109 -0.995 . . . . 0.0 109.224 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -95.37 120.25 35.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.571 -0.705 . . . . 0.0 109.433 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 52' ' ' GLY . 82.2 mt -74.86 168.8 19.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -0.956 . . . . 0.0 109.487 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 49' ' ' LEU . 13.5 ttt-85 -43.31 -48.92 6.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.273 -0.892 . . . . 0.0 109.177 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.434 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 33.0 t-20 -81.49 -12.07 58.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.308 -0.87 . . . . 0.0 109.132 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . 88.77 31.85 12.09 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.499 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.8 m120 -78.65 13.92 1.48 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.13 -1.217 . . . . 0.0 109.206 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.694 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.0 mt 43.82 96.8 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 121.438 0.637 . . . . 0.0 109.566 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.51 ' HB2' HD21 ' A' ' 49' ' ' LEU . 28.1 tp60 -77.67 118.09 19.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.386 -0.821 . . . . 0.0 109.465 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -96.16 114.14 25.81 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.137 -0.977 . . . . 0.0 109.585 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -113.43 150.2 33.09 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.189 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.587 HD22 ' O ' ' A' ' 57' ' ' ASP . 4.1 mm? -117.1 136.56 52.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.089 -1.007 . . . . 0.0 110.068 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.578 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 27.2 m-70 -135.43 125.48 26.0 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.653 ' CE2' HD22 ' A' ' 62' ' ' LEU . 9.4 t80 -117.36 135.18 54.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 109.819 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.585 ' CZ3' ' OH ' ' A' ' 41' ' ' TYR . 27.9 t90 -120.2 124.24 45.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.413 -0.804 . . . . 0.0 109.289 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.653 HD22 ' CE2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -112.86 162.31 15.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.359 -0.838 . . . . 0.0 109.523 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.02 156.1 19.62 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -78.12 -11.71 59.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.391 -1.064 . . . . 0.0 109.482 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -102.25 32.41 3.54 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.498 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.0 OUTLIER -130.79 97.56 4.38 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.181 0.991 . . . . 0.0 108.359 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 66' ' ' CYS . 20.6 t -42.02 167.97 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.785 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.564 ' O ' ' N ' ' A' ' 72' ' ' GLY . 27.0 tt0 -56.59 -17.76 9.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.901 . . . . 0.0 109.592 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -62.6 -58.65 6.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 109.376 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.557 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -63.07 -48.63 77.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 0.0 109.079 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.8 -21.62 64.31 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.311 -0.868 . . . . 0.0 109.055 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -75.65 -40.5 31.76 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.59 -39.2 77.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.194 -1.18 . . . . 0.0 109.162 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.515 ' CB ' ' CZ ' ' A' ' 60' ' ' TYR . . . -65.81 -46.53 78.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.489 -0.757 . . . . 0.0 109.226 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -60.3 -37.52 80.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.311 -0.868 . . . . 0.0 109.337 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.8 mt -60.88 -49.25 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.41 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -65.56 -31.43 72.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.279 -0.888 . . . . 0.0 109.405 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.1 m -72.8 -41.95 64.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.225 -0.922 . . . . 0.0 109.278 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 75' ' ' ALA . 89.8 t -63.34 -35.83 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.243 -0.91 . . . . 0.0 109.297 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -65.67 -51.37 59.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.331 -0.856 . . . . 0.0 109.071 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 mt -51.72 -39.49 58.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.034 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 85' ' ' LEU . 13.4 t0 -60.16 -58.75 7.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.307 -0.87 . . . . 0.0 109.144 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 82' ' ' ASP . 24.0 t0 -45.14 -34.16 2.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.207 -0.933 . . . . 0.0 108.881 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -76.57 -28.25 56.17 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.309 -0.869 . . . . 0.0 108.868 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.555 ' N ' ' O ' ' A' ' 82' ' ' ASP . 11.5 mt -121.69 32.14 5.99 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.354 -0.841 . . . . 0.0 109.736 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 82' ' ' ASP . 24.2 t-20 -79.34 27.51 0.26 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.165 -0.959 . . . . 0.0 109.13 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -89.9 -49.22 3.4 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.434 ' CG ' ' O ' ' A' ' 87' ' ' GLY . 57.8 mtm-85 -158.41 41.61 0.26 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.248 -1.148 . . . . 0.0 109.462 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -127.63 165.25 20.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.399 -0.813 . . . . 0.0 109.226 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.623 HG12 ' N ' ' A' ' 91' ' ' GLN . 98.6 t -135.92 167.34 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.914 . . . . 0.0 109.589 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.717 ' NE2' ' H ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -119.31 134.51 55.17 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.39 -0.819 . . . . 0.0 109.465 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.578 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 20.2 m-70 -105.72 105.14 15.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 109.582 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.2 mtm180 -77.95 102.4 7.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.946 . . . . 0.0 109.309 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.558 ' OE2' ' CD2' ' A' ' 103' ' ' PHE . 50.2 mt-10 -102.33 134.09 46.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.189 -0.944 . . . . 0.0 109.747 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 96' ' ' GLN . 3.1 t -132.88 168.62 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.401 -0.812 . . . . 0.0 109.269 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.453 ' H ' HG12 ' A' ' 95' ' ' VAL . 4.5 tt0 -69.94 118.34 12.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 109.57 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.514 ' O ' ' CD1' ' A' ' 98' ' ' PHE . . . 91.0 11.29 61.67 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 24.8 m-85 -152.55 24.66 0.6 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -1.161 . . . . 0.0 109.665 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 98' ' ' PHE . 27.6 mt-10 -42.82 150.96 0.14 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.173 -0.955 . . . . 0.0 109.409 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.8 p -78.24 168.14 20.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.226 -0.921 . . . . 0.0 109.553 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.45 -61.68 1.78 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -0.906 . . . . 0.0 109.485 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.4 m -47.25 -45.04 23.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.377 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.558 ' CD2' ' OE2' ' A' ' 94' ' ' GLU . 29.1 t80 -58.67 -53.49 57.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.38 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.7 mt -56.1 -28.83 59.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.89 . . . . 0.0 109.386 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -78.0 -25.54 61.9 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -77.83 -30.08 50.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -1.158 . . . . 0.0 109.338 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.566 ' CE2' ' OH ' ' A' ' 32' ' ' TYR . 54.3 m-85 -139.06 127.35 22.74 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.256 -0.902 . . . . 0.0 109.35 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.455 ' HB2' ' HZ3' ' A' ' 108' ' ' LYS . 12.6 ttmm -105.51 -57.01 2.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 109.51 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.0 t -106.03 15.2 26.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.497 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -106.33 28.42 13.68 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.406 HD23 ' N ' ' A' ' 111' ' ' LEU . 0.3 OUTLIER -140.69 54.78 1.59 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.281 -1.129 . . . . 0.0 109.558 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -73.87 135.67 43.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.317 -0.865 . . . . 0.0 109.486 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.496 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 0.9 OUTLIER -92.37 111.32 22.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.472 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -107.99 121.14 44.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.313 -0.867 . . . . 0.0 109.582 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 58.6 mttt . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.504 179.937 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo . . . . . 0 N--CA 1.493 1.475 0 CA-C-O 121.295 0.456 . . . . 0.0 112.091 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 8' ' ' ALA . 41.9 mt-10 -83.13 -45.74 13.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.126 -0.984 . . . . 0.0 109.703 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.537 ' CE1' ' CD1' ' A' ' 81' ' ' LEU . 68.2 t80 -48.67 -22.57 0.8 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -0.908 . . . . 0.0 109.287 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.569 HD23 HD11 ' A' ' 81' ' ' LEU . 85.1 mt -83.61 -40.52 18.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 109.484 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' ALA . 42.8 mmtm -101.24 7.15 43.1 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.39 -0.819 . . . . 0.0 109.549 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 4' ' ' GLU . . . -56.01 -164.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.421 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.464 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 104.86 -27.67 17.94 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -75.76 21.51 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -1.152 . . . . 0.0 109.4 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.464 ' H ' ' C ' ' A' ' 9' ' ' GLY . 26.9 mm-40 -135.12 115.43 11.95 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.259 -0.9 . . . . 0.0 109.356 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.86 73.85 5.5 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.376 2.051 . . . . 0.0 112.277 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -177.28 -103.34 0.17 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.767 HD23 ' C ' ' A' ' 14' ' ' LEU . 3.3 tt -162.26 146.98 12.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.239 -1.153 . . . . 0.0 109.581 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.566 ' N ' HD23 ' A' ' 14' ' ' LEU . 24.0 mt-30 -139.3 145.53 39.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.28 -0.887 . . . . 0.0 109.347 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.55 HD12 ' CE1' ' A' ' 32' ' ' TYR . 10.7 mt -114.18 146.52 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.396 -0.815 . . . . 0.0 110.198 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.451 ' CZ2' ' CB ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER -149.55 138.73 21.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.435 -0.791 . . . . 0.0 109.063 179.665 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -96.67 144.64 26.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 109.473 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.562 HG12 ' O ' ' A' ' 40' ' ' ALA . 12.4 p -81.02 143.82 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 109.494 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.58 ' O ' ' N ' ' A' ' 22' ' ' PHE . 39.9 tt0 -103.3 153.41 20.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.368 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 20' ' ' GLU . 7.6 mtmp? -41.48 -20.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.648 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.58 ' N ' ' O ' ' A' ' 20' ' ' GLU . 3.0 p90 -160.99 30.52 0.14 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.17 -0.956 . . . . 0.0 109.524 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.625 ' C ' HD12 ' A' ' 24' ' ' LEU . 9.8 t70 -174.07 -130.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -0.912 . . . . 0.0 109.53 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.625 HD12 ' C ' ' A' ' 23' ' ' ASP . 5.5 mp -144.34 146.07 32.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.322 -0.861 . . . . 0.0 109.562 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 t -126.31 112.93 23.55 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.393 -0.817 . . . . 0.0 109.427 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.49 152.64 5.89 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.436 2.091 . . . . 0.0 112.313 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.9 t -110.39 101.89 49.81 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.898 . . . . 0.0 109.317 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -48.43 143.47 15.45 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.476 2.117 . . . . 0.0 112.319 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.528 ' C ' ' H ' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -55.96 -44.11 78.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.876 . . . . 0.0 109.376 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 30' ' ' ASN . 1.4 t-20 -56.72 -2.6 0.08 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 0.0 109.481 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.528 ' H ' ' C ' ' A' ' 29' ' ' THR . 86.4 mt -129.23 -10.73 4.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.202 -0.936 . . . . 0.0 109.551 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.55 ' CE1' HD12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -41.84 124.37 2.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -0.89 . . . . 0.0 109.453 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.39 -9.37 57.46 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -97.98 107.13 19.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.184 -1.186 . . . . 0.0 109.462 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -96.15 150.52 20.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.89 . . . . 0.0 109.536 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -105.03 112.14 25.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 109.402 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.1 p -58.36 -17.07 17.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 109.586 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.447 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -88.15 10.71 69.88 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.447 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 46.6 m-20 -159.49 170.56 21.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.225 -1.162 . . . . 0.0 109.511 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.562 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -109.76 152.38 25.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.387 -0.821 . . . . 0.0 109.504 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -122.12 134.9 54.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.337 -0.852 . . . . 0.0 109.239 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.93 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -103.19 138.38 27.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.143 -0.973 . . . . 0.0 108.91 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.93 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.9 OUTLIER -131.25 145.62 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.615 -179.357 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.63 HD23 ' N ' ' A' ' 45' ' ' LYS . 3.9 tt -123.64 118.45 27.3 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.63 ' N ' HD23 ' A' ' 44' ' ' LEU . 35.0 tttp -103.94 103.77 13.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.358 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.788 HG23 ' O ' ' A' ' 55' ' ' GLN . 33.8 m -112.63 137.15 51.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 109.423 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -133.03 168.58 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 121.158 -0.964 . . . . 0.0 109.586 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -102.58 100.74 10.84 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.8 mt -69.19 168.34 14.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.739 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.594 ' CD ' ' H ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -48.23 -73.18 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.331 -0.855 . . . . 0.0 109.265 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 50' ' ' ARG . 1.9 m120 -43.63 -25.9 0.2 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.303 -0.873 . . . . 0.0 109.16 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 50' ' ' ARG . . . 89.03 36.68 7.55 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.515 ' O ' ' O ' ' A' ' 54' ' ' LEU . 51.2 m-20 -87.61 12.81 11.63 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.15 -1.206 . . . . 0.0 109.361 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.598 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 11.1 mt 42.56 97.3 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 121.455 0.645 . . . . 0.0 109.443 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.788 ' O ' HG23 ' A' ' 46' ' ' THR . 7.4 tt0 -68.07 154.09 42.38 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.239 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.598 ' CE1' ' O ' ' A' ' 54' ' ' LEU . 95.6 m-85 -133.74 114.82 13.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.295 -0.878 . . . . 0.0 109.66 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -121.0 155.12 35.02 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 58' ' ' LEU . 3.2 mp -138.78 129.06 25.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.943 -1.098 . . . . 0.0 109.972 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -121.3 127.39 51.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.415 -0.803 . . . . 0.0 109.024 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.704 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -106.15 124.9 50.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.187 -0.946 . . . . 0.0 109.537 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.498 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 39.2 t90 -102.88 123.89 47.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.216 -0.927 . . . . 0.0 109.354 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.498 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 20.1 mt -102.73 162.01 13.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.49 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.0 155.99 15.81 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -78.98 -11.97 60.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.188 -1.183 . . . . 0.0 109.448 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -106.44 24.37 12.67 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.496 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.7 m -130.95 97.56 4.35 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.163 0.982 . . . . 0.0 108.473 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 66' ' ' CYS . 9.9 m -51.48 -171.25 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.673 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.594 ' OE1' ' N ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -70.74 -17.6 62.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.349 -0.845 . . . . 0.0 109.516 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -62.29 -58.64 6.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.13 -0.981 . . . . 0.0 109.435 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.508 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 3.3 mp0 -65.87 -45.06 83.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.32 -0.863 . . . . 0.0 108.894 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.2 t -69.67 -20.97 63.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.331 -0.856 . . . . 0.0 109.041 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -73.25 -41.01 47.96 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.92 -46.09 66.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.298 -1.119 . . . . 0.0 109.247 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.46 -44.58 92.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.349 -0.844 . . . . 0.0 109.23 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -61.12 -47.58 85.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.275 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.5 mt -49.62 -46.34 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 109.241 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -61.01 -40.53 93.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 109.345 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.4 m -67.02 -31.52 72.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.159 -0.963 . . . . 0.0 109.33 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 75' ' ' ALA . 91.2 t -66.0 -44.19 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.335 -0.853 . . . . 0.0 109.334 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -61.63 -50.92 70.6 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.281 -0.887 . . . . 0.0 109.192 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.569 HD11 HD23 ' A' ' 6' ' ' LEU . 4.1 mt -54.55 -41.4 69.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.341 -0.849 . . . . 0.0 109.069 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.627 ' O ' ' N ' ' A' ' 86' ' ' ASN . 27.1 t70 -61.69 -54.97 35.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.238 -0.914 . . . . 0.0 109.133 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -47.76 -32.21 5.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.081 -1.012 . . . . 0.0 108.858 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.676 ' CE2' HD21 ' A' ' 85' ' ' LEU . 10.1 t80 -77.64 -31.77 52.91 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.676 HD21 ' CE2' ' A' ' 84' ' ' TYR . 53.2 mt -121.59 33.49 5.5 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.369 -0.832 . . . . 0.0 109.427 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.627 ' N ' ' O ' ' A' ' 82' ' ' ASP . 38.4 t30 -79.71 27.7 0.28 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.211 -0.931 . . . . 0.0 109.16 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -78.12 -45.57 10.09 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -173.34 33.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -1.121 . . . . 0.0 109.299 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.53 179.1 7.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.182 -0.949 . . . . 0.0 109.433 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.5 t -127.11 128.03 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.843 . . . . 0.0 109.546 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -96.06 137.2 35.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.384 -0.823 . . . . 0.0 109.357 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -126.59 126.85 44.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.156 -0.965 . . . . 0.0 109.662 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 -100.74 95.99 7.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -0.874 . . . . 0.0 109.3 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.455 ' OE1' ' CD1' ' A' ' 103' ' ' PHE . 81.9 mt-10 -97.36 138.84 34.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.919 . . . . 0.0 109.712 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 96' ' ' GLN . 15.4 t -145.01 163.75 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.344 -0.848 . . . . 0.0 109.305 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.455 ' N ' HG12 ' A' ' 95' ' ' VAL . 50.0 tt0 -53.28 117.9 3.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.43 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.09 13.88 81.38 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.439 ' O ' ' C ' ' A' ' 99' ' ' GLU . 6.4 t80 -135.54 17.49 3.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.243 -1.151 . . . . 0.0 109.443 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.651 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 11.1 mp0 -41.46 148.22 0.15 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 109.564 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.2 t -87.2 166.81 14.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -0.889 . . . . 0.0 109.488 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.53 -65.1 0.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.533 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 51.4 m -47.55 -51.56 20.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.261 -0.899 . . . . 0.0 109.422 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.455 ' CD1' ' OE1' ' A' ' 94' ' ' GLU . 14.5 t80 -54.46 -44.79 72.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.417 -0.802 . . . . 0.0 109.437 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.9 mt -60.82 -34.16 74.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.955 . . . . 0.0 109.415 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.07 -22.57 70.98 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -79.5 -29.21 41.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -1.12 . . . . 0.0 109.365 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -139.12 120.84 15.31 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.303 -0.873 . . . . 0.0 109.457 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -101.67 -56.65 2.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.512 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.5 t -103.3 -13.25 16.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 109.51 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.3 -12.82 64.02 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.4 mt -71.94 121.2 18.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.175 -1.191 . . . . 0.0 109.499 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -148.55 154.7 40.13 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.188 -0.945 . . . . 0.0 109.417 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -135.97 134.59 38.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.365 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.89 105.87 16.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 109.338 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.202 -0.936 . . . . 0.0 109.488 179.915 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.422 ' HB2' HD12 ' A' ' 6' ' ' LEU . 55.4 Cg_endo . . . . . 0 N--CA 1.492 1.416 0 CA-C-O 121.233 0.43 . . . . 0.0 112.043 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -83.08 -28.7 29.33 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.618 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.64 ' CE1' HG12 ' A' ' 42' ' ' VAL . 69.0 t80 -58.46 -16.55 15.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.142 -0.974 . . . . 0.0 109.354 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.422 HD12 ' HB2' ' A' ' 3' ' ' PRO . 3.3 mt -90.24 -34.88 15.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.218 -0.926 . . . . 0.0 109.553 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 8' ' ' ALA . 30.8 mttm -87.59 -15.22 37.98 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.272 -0.892 . . . . 0.0 109.672 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -42.45 128.95 3.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 0.0 109.406 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.38 30.55 0.03 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.434 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -129.64 38.36 3.86 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.308 -1.113 . . . . 0.0 109.379 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 13' ' ' GLY . 31.1 mt-10 -157.78 79.75 3.31 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.298 -0.876 . . . . 0.0 109.31 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.1 80.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.792 2.328 . . . . 0.0 112.148 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 11' ' ' GLU . . . 177.58 -99.87 0.13 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.751 HD23 ' C ' ' A' ' 14' ' ' LEU . 7.1 tt -156.94 125.7 5.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -1.138 . . . . 0.0 109.727 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.586 ' N ' HD23 ' A' ' 14' ' ' LEU . 11.8 mt-30 -112.66 133.45 54.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.384 -0.822 . . . . 0.0 109.239 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.611 HG23 HD12 ' A' ' 43' ' ' ILE . 5.7 mt -101.25 146.68 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.365 -0.834 . . . . 0.0 110.16 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.78 139.25 27.7 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -108.45 140.32 41.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.2 -0.938 . . . . 0.0 109.404 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 40' ' ' ALA . 8.9 p -84.01 138.33 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.914 . . . . 0.0 109.495 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.609 ' O ' ' N ' ' A' ' 22' ' ' PHE . 18.5 tt0 -88.19 154.32 20.53 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.327 -0.858 . . . . 0.0 109.043 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.542 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 39.9 mttp -40.39 -20.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 109.664 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.609 ' N ' ' O ' ' A' ' 20' ' ' GLU . 63.6 m-85 -160.09 21.82 0.16 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 0.0 109.679 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.432 ' N ' ' HB3' ' A' ' 20' ' ' GLU . 2.9 m-20 -160.23 -128.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 0.0 109.429 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 mt -145.53 146.09 31.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.208 -0.932 . . . . 0.0 109.584 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 t -131.31 133.81 24.97 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.316 -0.865 . . . . 0.0 108.963 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -72.63 146.9 44.53 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.367 2.045 . . . . 0.0 112.431 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -119.23 105.15 44.94 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.359 -0.838 . . . . 0.0 109.272 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.473 ' C ' ' H ' ' A' ' 30' ' ' ASN . 61.3 Cg_endo -79.93 148.81 19.91 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.417 2.078 . . . . 0.0 112.469 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.632 ' O ' HG22 ' A' ' 29' ' ' THR . 14.7 m -63.32 1.32 0.52 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.2 -0.938 . . . . 0.0 109.368 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 28' ' ' PRO . 14.8 m120 -76.09 -19.1 58.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.334 -0.854 . . . . 0.0 109.37 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.728 ' C ' HD12 ' A' ' 31' ' ' LEU . 2.6 pp -148.26 2.64 0.66 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 110.289 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.595 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.6 p90 -55.58 173.5 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.87 -1.143 . . . . 0.0 109.366 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.76 -32.14 6.59 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -99.45 100.59 11.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.348 -1.089 . . . . 0.0 109.527 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.605 ' CZ ' ' CZ3' ' A' ' 61' ' ' TRP . 45.5 m-85 -86.93 137.51 32.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.482 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -88.34 131.21 34.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 109.441 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.4 p -73.99 -6.42 47.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.369 -0.832 . . . . 0.0 109.409 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.437 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -97.31 20.59 50.13 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 9.7 m-20 -167.35 146.15 4.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -1.112 . . . . 0.0 109.449 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.647 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -90.92 149.33 21.94 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.216 -0.928 . . . . 0.0 109.399 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -117.15 139.02 51.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 109.351 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.01 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -105.58 129.36 58.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 121.177 -0.952 . . . . 0.0 108.623 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.01 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -126.21 134.25 66.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.231 -0.918 . . . . 0.0 110.421 -179.315 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.514 ' CD2' ' OG1' ' A' ' 46' ' ' THR . 7.7 tt -114.94 115.84 27.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.58 -0.7 . . . . 0.0 109.114 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -92.42 114.3 26.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.939 . . . . 0.0 109.534 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.514 ' OG1' ' CD2' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -113.89 129.23 56.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.181 -0.949 . . . . 0.0 109.524 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -132.18 168.48 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 121.071 -1.018 . . . . 0.0 109.252 -179.852 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -98.54 117.36 32.79 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.58 -0.7 . . . . 0.0 109.401 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.6 mt -81.05 160.83 24.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -0.911 . . . . 0.0 109.609 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 25.0 mtt180 -51.44 -65.49 0.55 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.336 -0.852 . . . . 0.0 109.305 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.444 ' ND2' ' H ' ' A' ' 51' ' ' ASN . 1.4 p30 -48.27 -29.58 3.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.263 -0.898 . . . . 0.0 109.252 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.76 71.29 1.12 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 54' ' ' LEU . 4.3 t-20 -134.85 13.46 3.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.287 -1.125 . . . . 0.0 109.32 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.592 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 11.7 mt 45.71 99.69 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.579 0.704 . . . . 0.0 109.535 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -68.6 152.1 45.83 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.498 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 61.3 m-85 -129.49 116.56 19.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 109.866 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.626 ' O ' HD23 ' A' ' 58' ' ' LEU . 0.7 OUTLIER -122.36 155.17 36.58 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.427 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.626 HD23 ' O ' ' A' ' 57' ' ' ASP . 2.6 mt -132.83 150.18 52.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.913 -1.117 . . . . 0.0 110.172 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.545 ' CD2' ' C ' ' A' ' 58' ' ' LEU . 4.6 m-70 -143.26 123.09 13.43 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.71 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -100.62 129.57 46.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.082 -1.011 . . . . 0.0 109.641 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.605 ' CZ3' ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -102.85 123.83 47.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.345 -0.847 . . . . 0.0 109.314 179.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.7 mt -102.15 162.07 13.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.402 -0.811 . . . . 0.0 109.461 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.25 157.69 14.88 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -75.68 -12.29 60.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.324 -1.104 . . . . 0.0 109.566 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -106.84 23.21 14.71 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.9 m -131.09 97.5 4.32 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.06 0.933 . . . . 0.0 108.514 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 m -59.6 -170.98 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.593 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 72' ' ' GLY . 37.2 tt0 -61.6 -17.95 57.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 109.559 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -63.87 -58.81 5.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.955 . . . . 0.0 109.46 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.69 -42.5 91.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.446 -0.784 . . . . 0.0 108.987 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 m -71.08 -23.28 62.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.389 -0.82 . . . . 0.0 109.016 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -71.53 -40.11 60.0 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.38 -49.09 52.72 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.261 -1.141 . . . . 0.0 109.25 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.15 -45.66 83.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.374 -0.829 . . . . 0.0 109.058 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.443 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -58.54 -51.29 70.53 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.406 -0.809 . . . . 0.0 109.189 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.6 mt -48.9 -41.08 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -0.942 . . . . 0.0 109.209 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.45 -43.24 99.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.222 -0.924 . . . . 0.0 109.101 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 86.3 m -61.05 -49.45 77.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.145 -0.972 . . . . 0.0 109.093 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 75' ' ' ALA . 10.6 t -51.06 -40.06 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.238 -0.913 . . . . 0.0 109.211 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.437 HE21 ' HA ' ' A' ' 80' ' ' GLN . 5.3 mm-40 -61.25 -48.21 82.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.36 -0.838 . . . . 0.0 109.082 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.521 ' CD1' ' CE1' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -50.71 -40.17 53.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.32 -0.862 . . . . 0.0 108.929 179.63 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 85' ' ' LEU . 10.3 m-20 -61.89 -61.8 2.24 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.16 -0.962 . . . . 0.0 109.069 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -47.31 -30.62 3.25 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.049 -1.032 . . . . 0.0 108.445 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -76.81 -27.06 55.04 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.562 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.9 mt -113.87 27.23 9.69 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.37 -0.831 . . . . 0.0 109.169 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 44.47 38.36 2.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.377 -0.827 . . . . 0.0 109.479 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 56.35 31.19 59.4 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 85' ' ' LEU . 21.4 ttt-85 -92.69 31.92 1.3 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.204 -1.174 . . . . 0.0 109.38 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 56' ' ' TYR . . . -141.14 161.17 38.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.526 -0.734 . . . . 0.0 109.395 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 38.8 t -96.0 146.26 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.263 -0.898 . . . . 0.0 109.426 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.676 ' H ' ' CD ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -111.4 131.59 55.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.382 -0.824 . . . . 0.0 109.314 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.472 ' CG ' ' ND1' ' A' ' 59' ' ' HIS . 20.3 m-70 -115.68 136.35 53.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.866 . . . . 0.0 109.414 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.431 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 3.9 ptp180 -102.71 92.92 4.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.22 -0.925 . . . . 0.0 109.309 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.499 ' OE1' ' CD2' ' A' ' 103' ' ' PHE . 13.6 mt-10 -92.88 128.94 38.92 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.148 -0.97 . . . . 0.0 109.538 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 96' ' ' GLN . 10.5 t -132.94 163.52 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.336 -0.852 . . . . 0.0 109.241 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.621 ' OE1' ' N ' ' A' ' 97' ' ' GLY . 0.8 OUTLIER -62.22 115.59 4.27 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.238 -0.914 . . . . 0.0 109.429 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.621 ' N ' ' OE1' ' A' ' 96' ' ' GLN . . . 90.38 5.74 69.31 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.475 ' O ' ' O ' ' A' ' 99' ' ' GLU . 5.1 t80 -143.26 32.6 1.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.366 -1.079 . . . . 0.0 109.526 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.66 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 2.4 mp0 -41.51 164.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.537 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.62 161.69 19.16 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.09 -60.39 2.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.477 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 76.9 m -46.95 -41.35 15.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.145 -0.972 . . . . 0.0 109.355 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.499 ' CD2' ' OE1' ' A' ' 94' ' ' GLU . 1.6 m-85 -69.9 -41.1 75.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.352 -0.843 . . . . 0.0 109.383 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.5 mt -58.79 -23.67 60.59 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.175 -0.953 . . . . 0.0 109.451 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -105.43 -12.94 25.68 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -86.42 -37.67 18.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -1.188 . . . . 0.0 109.602 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -84.37 117.78 23.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.309 -0.869 . . . . 0.0 109.638 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -115.0 3.0 14.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.395 -0.815 . . . . 0.0 109.387 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.0 m -89.31 -4.65 58.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 109.54 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.53 97.32 0.43 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.705 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -77.78 165.74 23.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.158 -1.201 . . . . 0.0 109.509 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.442 ' CG ' ' O ' ' A' ' 111' ' ' LEU . 38.3 mtmt -158.41 152.2 23.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.246 -0.908 . . . . 0.0 109.475 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.445 ' OH ' ' CD ' ' A' ' 99' ' ' GLU . 53.8 m-85 -101.51 125.2 48.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.373 -0.83 . . . . 0.0 109.438 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.0 120.04 25.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.489 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.42 -179.987 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.501 ' HB2' HD13 ' A' ' 6' ' ' LEU . 17.8 Cg_endo . . . . . 0 N--CA 1.493 1.46 0 CA-C-O 121.266 0.444 . . . . 0.0 111.857 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -83.33 -43.43 15.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.296 -0.877 . . . . 0.0 110.071 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.593 ' CE2' ' CG1' ' A' ' 42' ' ' VAL . 21.6 t80 -50.94 -41.45 59.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.134 -0.979 . . . . 0.0 109.606 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.501 HD13 ' HB2' ' A' ' 3' ' ' PRO . 4.1 mp -69.4 -27.83 65.63 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.121 -0.987 . . . . 0.0 109.51 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -96.4 3.84 52.59 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.237 -0.914 . . . . 0.0 109.38 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.472 ' HB3' HD13 ' A' ' 44' ' ' LEU . . . -59.52 151.9 23.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.216 -0.928 . . . . 0.0 109.517 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.9 45.19 0.07 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -149.08 24.23 0.93 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.276 -1.132 . . . . 0.0 109.564 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -146.55 117.65 4.76 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.278 -0.889 . . . . 0.0 109.338 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.7 91.25 1.2 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.387 2.058 . . . . 0.0 112.221 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.07 -95.38 0.12 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 tp -160.23 130.35 5.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.318 -1.107 . . . . 0.0 109.627 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -113.88 135.71 53.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 109.355 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.2 mt -115.56 136.01 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.345 -0.847 . . . . 0.0 109.99 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.44 134.67 31.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.425 -0.797 . . . . 0.0 108.969 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 25' ' ' VAL . 33.5 ttt180 -98.38 153.54 18.49 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.201 -0.937 . . . . 0.0 109.444 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.1 t -106.13 123.49 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.18 -0.95 . . . . 0.0 109.593 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.635 ' O ' ' N ' ' A' ' 22' ' ' PHE . 5.2 tt0 -72.06 87.04 1.05 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.107 -0.996 . . . . 0.0 108.915 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.579 ' O ' ' CB ' ' A' ' 22' ' ' PHE . 16.5 tttm 49.04 2.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.359 -0.838 . . . . 0.0 109.85 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.635 ' N ' ' O ' ' A' ' 20' ' ' GLU . 2.1 t80 158.01 -29.34 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.289 -0.882 . . . . 0.0 109.422 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.76 -157.83 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.932 . . . . 0.0 109.584 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.26 132.75 56.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.287 -0.883 . . . . 0.0 109.344 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.545 ' CG2' ' N ' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -129.9 120.81 19.58 Favored Pre-proline 0 N--CA 1.487 1.387 0 O-C-N 121.311 -0.868 . . . . 0.0 109.227 -179.686 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.88 132.0 11.52 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.303 2.002 . . . . 0.0 112.238 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.7 t -110.34 101.57 48.65 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.335 -0.853 . . . . 0.0 109.394 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -51.22 156.56 5.25 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.434 2.089 . . . . 0.0 112.208 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.3 m -66.89 -12.2 58.57 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.328 -0.857 . . . . 0.0 109.488 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.481 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 23.9 t-20 -75.98 -10.03 59.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.357 -0.839 . . . . 0.0 109.522 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 32' ' ' TYR . 96.3 mt -122.83 -23.35 5.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -0.847 . . . . 0.0 109.417 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 33' ' ' GLY . 1.7 t80 -42.88 138.33 2.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.617 ' N ' ' CD1' ' A' ' 32' ' ' TYR . . . 125.95 -28.68 4.83 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -107.19 148.19 29.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -1.152 . . . . 0.0 109.531 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -142.06 114.16 8.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 109.424 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -79.39 159.05 27.25 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.529 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.1 p -97.74 -4.77 36.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 109.447 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.445 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -88.28 16.4 52.72 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 7.6 m-20 -159.23 164.07 35.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -1.163 . . . . 0.0 109.544 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -108.29 151.98 25.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 0.0 109.406 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.575 ' N ' ' CD1' ' A' ' 41' ' ' TYR . 4.0 m-85 -130.21 134.61 47.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.884 . . . . 0.0 109.667 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.991 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -105.4 139.44 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 121.182 -0.949 . . . . 0.0 108.596 179.202 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.991 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.4 OUTLIER -128.01 134.72 64.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.27 -0.894 . . . . 0.0 110.213 -179.421 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.472 HD13 ' HB3' ' A' ' 8' ' ' ALA . 7.2 tt -115.86 109.57 17.81 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -82.42 144.31 30.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.363 -0.835 . . . . 0.0 109.098 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.2 m -143.24 129.01 19.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.09 -1.006 . . . . 0.0 109.725 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -134.18 168.56 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 O-C-N 121.143 -0.973 . . . . 0.0 109.208 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -99.31 118.04 35.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.68 -0.638 . . . . 0.0 109.422 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 93.4 mt -81.9 165.08 21.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 109.605 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -45.35 -58.39 3.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.94 . . . . 0.0 109.145 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -61.52 -27.03 68.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.915 . . . . 0.0 109.151 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.01 33.29 6.68 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.5 ' O ' ' O ' ' A' ' 54' ' ' LEU . 5.8 t30 -85.58 12.67 8.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -1.187 . . . . 0.0 109.304 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.578 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 12.3 mt 44.91 98.38 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 121.563 0.697 . . . . 0.0 109.468 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.407 ' HG3' ' N ' ' A' ' 56' ' ' TYR . 3.3 tp-100 -68.56 155.84 39.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.505 -0.747 . . . . 0.0 109.072 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 79.6 m-85 -138.16 114.35 10.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.163 -0.96 . . . . 0.0 109.803 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.424 ' O ' HD23 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -114.38 155.25 26.65 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.136 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.85 HD13 HD21 ' A' ' 81' ' ' LEU . 11.2 mt -125.16 150.29 47.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.023 -1.048 . . . . 0.0 110.372 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -145.18 130.43 18.57 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.741 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -111.69 138.87 47.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.951 -1.093 . . . . 0.0 110.063 -179.297 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -111.41 123.55 50.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.392 -0.817 . . . . 0.0 108.987 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 49.6 mt -104.18 145.92 29.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.386 -0.821 . . . . 0.0 109.413 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.9 152.2 19.84 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -80.21 -12.02 59.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -1.121 . . . . 0.0 109.478 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -107.93 31.87 5.18 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.533 ' SG ' ' OE2' ' A' ' 70' ' ' GLU . 2.1 m -130.56 97.5 4.4 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 122.043 0.925 . . . . 0.0 108.533 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 66' ' ' CYS . 30.0 m -45.63 175.89 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.78 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.48 ' O ' ' N ' ' A' ' 72' ' ' GLY . 39.0 tt0 -64.63 -17.7 64.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 0.0 109.621 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -63.14 -58.59 6.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 109.344 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.533 ' OE2' ' SG ' ' A' ' 66' ' ' CYS . 11.5 mt-10 -64.84 -44.31 90.19 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.356 -0.84 . . . . 0.0 109.034 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.55 -26.85 67.33 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.429 -0.795 . . . . 0.0 109.02 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.15 -48.17 40.8 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.18 -35.36 76.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.342 -1.093 . . . . 0.0 109.098 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.741 ' HB1' ' CZ ' ' A' ' 60' ' ' TYR . . . -61.28 -51.95 66.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.418 -0.801 . . . . 0.0 109.211 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.424 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -52.94 -46.93 68.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 109.232 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.3 mt -51.9 -47.92 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.271 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -54.61 -44.06 72.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.31 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.426 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 0.9 OUTLIER -54.08 -50.97 65.59 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.3 -0.875 . . . . 0.0 109.507 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.481 HG23 ' H ' ' A' ' 79' ' ' VAL . 1.5 t -61.18 -35.39 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.361 -0.837 . . . . 0.0 109.63 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -64.57 -58.83 5.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.898 . . . . 0.0 109.302 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.954 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -53.81 -33.51 56.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 108.911 179.828 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 85' ' ' LEU . 0.9 OUTLIER -65.73 -55.13 18.93 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.22 -0.925 . . . . 0.0 108.891 179.531 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 82' ' ' ASP . 8.7 t70 -45.87 -37.47 6.3 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -68.53 -33.39 74.02 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 82' ' ' ASP . 4.8 tp -105.81 28.15 7.82 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.496 -0.752 . . . . 0.0 109.268 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 85' ' ' LEU . 26.6 m-20 42.49 36.25 0.76 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.459 -0.776 . . . . 0.0 109.436 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 46.29 35.12 6.65 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.7 mmm-85 -86.46 29.97 0.74 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.137 -1.213 . . . . 0.0 109.106 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.426 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -144.13 166.9 23.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.565 -0.71 . . . . 0.0 109.376 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 t -100.62 153.9 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.44 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -117.57 130.29 56.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.392 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -105.5 104.93 14.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 109.521 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.84 97.99 6.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.253 -0.904 . . . . 0.0 109.229 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.476 ' OE1' ' CG ' ' A' ' 103' ' ' PHE . 39.3 mt-10 -100.47 148.76 24.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.348 -0.845 . . . . 0.0 109.722 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 96' ' ' GLN . 6.2 t -137.68 166.12 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.327 -0.858 . . . . 0.0 109.27 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.5 ' OE1' ' O ' ' A' ' 96' ' ' GLN . 1.4 tm0? -59.86 116.81 4.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 109.481 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.2 12.24 81.09 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.445 ' O ' ' C ' ' A' ' 99' ' ' GLU . 2.4 t80 -137.51 20.79 2.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -1.167 . . . . 0.0 109.569 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 98' ' ' PHE . 7.5 mm-40 -42.16 156.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.918 . . . . 0.0 109.469 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.2 p -88.01 174.29 8.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -0.961 . . . . 0.0 109.491 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.09 -53.69 7.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.492 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.1 m -47.07 -46.78 22.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 0.0 109.459 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' A' ' 106' ' ' TYR . 0.2 OUTLIER -67.46 -54.07 23.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.391 -0.818 . . . . 0.0 109.397 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 103' ' ' PHE . 29.5 mt -44.57 -26.36 0.36 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.228 -0.92 . . . . 0.0 109.462 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -99.95 -17.09 26.37 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.492 ' N ' ' O ' ' A' ' 103' ' ' PHE . 14.4 t80 -81.73 -13.43 57.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.292 -1.122 . . . . 0.0 109.559 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.534 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 8.7 p90 -45.95 122.48 3.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.137 -0.977 . . . . 0.0 109.589 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -111.19 -56.41 2.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 109.349 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.4 t -90.88 0.38 57.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.891 . . . . 0.0 109.501 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 111' ' ' LEU . . . 87.3 68.96 1.31 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 110' ' ' GLY . 2.3 pp -42.96 155.24 0.06 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.305 -1.115 . . . . 0.0 109.453 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -154.23 135.99 14.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.455 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 0.0 OUTLIER -104.21 140.02 38.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.318 -0.864 . . . . 0.0 109.47 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -108.26 120.93 43.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.853 . . . . 0.0 109.333 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.2 mttm . . . . . 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 109.396 180.0 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.528 ' HB3' HD13 ' A' ' 6' ' ' LEU . 32.5 Cg_exo . . . . . 0 N--CA 1.493 1.46 0 CA-C-O 121.039 0.35 . . . . 0.0 112.007 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 8' ' ' ALA . 61.5 mm-40 -83.45 -46.71 12.19 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.104 -0.998 . . . . 0.0 110.259 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.508 ' CZ ' ' O ' ' A' ' 42' ' ' VAL . 21.7 m-85 -66.94 -43.35 83.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.078 -1.014 . . . . 0.0 109.151 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 1.035 ' H ' HD12 ' A' ' 6' ' ' LEU . 3.0 mp -62.36 -33.9 75.62 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.343 -0.848 . . . . 0.0 109.628 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -106.35 9.1 31.97 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.248 -0.907 . . . . 0.0 109.605 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.576 ' HB1' ' NE2' ' A' ' 15' ' ' GLN . . . -62.73 -162.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.194 -0.941 . . . . 0.0 109.395 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.45 58.02 1.31 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -146.63 10.88 1.09 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.267 -1.137 . . . . 0.0 109.452 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -161.92 124.32 1.73 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.258 -0.901 . . . . 0.0 109.282 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.87 82.28 2.19 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.396 2.064 . . . . 0.0 112.348 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -164.61 -108.05 0.21 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.6 tt -162.71 143.5 9.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.326 -1.102 . . . . 0.0 109.439 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.576 ' NE2' ' HB1' ' A' ' 8' ' ' ALA . 1.3 mt-30 -129.48 144.0 51.07 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.235 -0.916 . . . . 0.0 109.523 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.604 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 9.2 mt -126.58 125.85 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.418 -0.801 . . . . 0.0 109.992 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.604 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 8.1 m0 -145.22 155.85 43.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.205 -0.934 . . . . 0.0 109.061 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.439 ' N ' HG23 ' A' ' 27' ' ' VAL . 7.8 ttp180 -95.94 153.17 17.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.063 -1.023 . . . . 0.0 109.386 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 40' ' ' ALA . 7.0 p -94.48 133.35 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.212 -0.93 . . . . 0.0 109.739 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.636 ' O ' ' N ' ' A' ' 22' ' ' PHE . 17.9 tt0 -82.0 154.71 25.55 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.338 -0.851 . . . . 0.0 108.768 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 20' ' ' GLU . 39.7 mttt -38.35 -22.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.394 -0.816 . . . . 0.0 109.683 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.636 ' N ' ' O ' ' A' ' 20' ' ' GLU . 3.4 t80 -158.75 21.05 0.21 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.258 -0.901 . . . . 0.0 109.394 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.657 ' O ' HD22 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -155.58 -147.37 0.2 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.135 -0.978 . . . . 0.0 109.749 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.657 HD22 ' O ' ' A' ' 23' ' ' ASP . 2.9 mm? -123.29 146.4 47.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.352 -0.843 . . . . 0.0 109.447 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -131.42 99.26 17.51 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.341 -0.849 . . . . 0.0 109.173 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -47.64 132.96 21.3 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.557 2.172 . . . . 0.0 112.42 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.439 HG23 ' N ' ' A' ' 18' ' ' ARG . 61.0 t -104.51 106.2 53.3 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.317 -0.864 . . . . 0.0 109.482 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -46.64 145.89 5.98 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.484 2.123 . . . . 0.0 112.32 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.4 t -61.7 -25.63 67.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -0.882 . . . . 0.0 109.554 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -69.04 -10.98 60.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 0.0 109.509 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.467 ' O ' ' C ' ' A' ' 32' ' ' TYR . 57.7 mt -110.14 -28.25 8.75 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -0.847 . . . . 0.0 109.572 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.467 ' C ' ' O ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -40.33 143.85 0.27 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.288 -0.883 . . . . 0.0 109.458 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.05 -32.02 7.58 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -101.89 104.53 15.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -1.144 . . . . 0.0 109.398 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -102.67 140.91 36.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 109.53 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.595 ' CD2' ' OH ' ' A' ' 41' ' ' TYR . 0.7 OUTLIER -101.67 161.12 13.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.393 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.9 p -94.89 -4.88 46.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.238 -0.914 . . . . 0.0 109.614 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -101.56 34.75 5.41 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -171.52 151.53 3.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.196 -1.179 . . . . 0.0 109.51 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.469 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -100.23 139.25 36.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.598 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.595 ' OH ' ' CD2' ' A' ' 36' ' ' PHE . 44.2 m-85 -121.38 144.36 48.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.365 -0.834 . . . . 0.0 109.359 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.923 ' O ' HD13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -118.76 144.82 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.286 -0.884 . . . . 0.0 109.216 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.923 HD13 ' O ' ' A' ' 42' ' ' VAL . 1.0 OUTLIER -134.18 146.49 31.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.98 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 45' ' ' LYS . 15.7 tp -129.5 118.07 21.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.46 -0.775 . . . . 0.0 109.467 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.539 ' CE ' ' CE2' ' A' ' 106' ' ' TYR . 36.3 tttt -97.39 133.96 41.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.41 -0.806 . . . . 0.0 109.046 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.608 HG22 HD22 ' A' ' 54' ' ' LEU . 88.8 m -142.74 118.4 10.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.099 -1.001 . . . . 0.0 109.401 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.676 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -125.98 168.2 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.226 -0.921 . . . . 0.0 109.122 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -102.88 112.41 25.2 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.512 -0.742 . . . . 0.0 109.331 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.9 mt -77.3 169.22 18.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.438 -0.789 . . . . 0.0 109.59 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.517 ' CG ' ' N ' ' A' ' 51' ' ' ASN . 5.7 ptp85 -47.69 -49.33 28.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.884 . . . . 0.0 109.299 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.517 ' N ' ' CG ' ' A' ' 50' ' ' ARG . 5.0 m120 -70.75 -27.24 63.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.271 -0.893 . . . . 0.0 109.157 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.65 28.52 11.17 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.0 t-20 -80.66 12.59 3.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.072 -1.252 . . . . 0.0 109.21 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.676 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 13.8 mt 43.88 97.72 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.535 0.683 . . . . 0.0 109.562 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -74.3 111.45 9.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.491 -0.756 . . . . 0.0 109.538 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.779 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 96.2 m-85 -96.55 114.75 26.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.933 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.578 ' OD1' ' NE2' ' A' ' 92' ' ' HIS . 0.4 OUTLIER -115.99 120.8 40.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.022 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.424 ' N ' HD23 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -97.77 150.61 21.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.921 -1.112 . . . . 0.0 110.778 -178.467 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.454 ' HE2' ' HB2' ' A' ' 45' ' ' LYS . 6.1 m-70 -149.19 122.19 8.82 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.408 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 10.5 p90 -113.39 131.43 55.99 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.117 -0.989 . . . . 0.0 109.846 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.565 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 55.6 t90 -103.44 124.01 47.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.488 -0.758 . . . . 0.0 109.356 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.565 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 62.8 mt -102.76 162.12 13.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.329 -0.857 . . . . 0.0 109.591 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.92 162.96 12.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -82.07 -12.37 58.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -1.168 . . . . 0.0 109.576 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.51 28.95 7.32 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.3 m -130.84 97.57 4.37 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.115 0.959 . . . . 0.0 108.54 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 64.6 m -56.19 -170.87 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.674 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -64.87 -17.81 64.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.562 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -63.13 -58.7 6.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.118 -0.989 . . . . 0.0 109.405 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -66.81 -41.59 87.29 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.15 -23.06 62.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.401 -0.812 . . . . 0.0 108.995 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -71.64 -44.24 49.73 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.97 -43.94 86.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.343 -1.092 . . . . 0.0 109.172 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.9 -49.28 77.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.415 -0.803 . . . . 0.0 109.304 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.67 -48.62 77.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.328 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.7 mt -50.09 -42.39 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.386 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -63.77 -37.15 86.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.198 -0.939 . . . . 0.0 109.328 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.6 m -65.52 -46.96 77.58 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.366 -0.834 . . . . 0.0 109.362 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.5 t -56.09 -39.85 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 0.0 109.163 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -61.52 -47.39 85.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.304 -0.873 . . . . 0.0 109.041 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 81' ' ' LEU . 34.1 mt -50.59 -46.05 57.66 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.309 -0.869 . . . . 0.0 109.001 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 85' ' ' LEU . 0.8 OUTLIER -56.59 -59.01 5.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.232 -0.918 . . . . 0.0 109.177 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 82' ' ' ASP . 9.1 t0 -45.26 -30.05 1.14 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.108 -0.995 . . . . 0.0 108.611 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -75.44 -29.7 59.76 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.588 ' N ' ' O ' ' A' ' 82' ' ' ASP . 11.6 mt -116.0 30.91 7.05 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.389 -0.819 . . . . 0.0 109.412 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 46.32 34.5 2.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.293 -0.879 . . . . 0.0 109.507 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 51.29 22.2 6.89 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -90.34 30.93 1.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.102 -1.234 . . . . 0.0 109.228 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.779 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -123.49 177.1 5.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.542 -0.724 . . . . 0.0 109.306 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 95.1 t -113.32 115.45 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 109.477 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.93 157.87 18.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.264 -0.898 . . . . 0.0 109.374 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.578 ' NE2' ' OD1' ' A' ' 57' ' ' ASP . 27.6 m-70 -132.4 131.56 41.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.338 -0.851 . . . . 0.0 109.201 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.715 ' CD ' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -98.66 103.19 15.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.112 -0.992 . . . . 0.0 109.54 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.521 ' N ' ' CD ' ' A' ' 94' ' ' GLU . 3.9 mp0 -101.91 143.44 31.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.244 -0.91 . . . . 0.0 109.403 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.525 HG12 ' N ' ' A' ' 96' ' ' GLN . 13.8 t -141.81 169.91 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.298 -0.876 . . . . 0.0 109.62 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.665 ' CD ' ' H ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -82.11 118.95 23.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 109.384 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.83 13.07 48.09 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.446 ' O ' ' O ' ' A' ' 99' ' ' GLU . 37.5 m-85 -150.93 -37.57 0.13 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.221 -1.164 . . . . 0.0 109.37 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 98' ' ' PHE . 40.7 mt-10 40.61 -160.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.0 109.561 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.4 ' O ' HD12 ' A' ' 104' ' ' LEU . 1.8 m -139.09 159.79 41.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.176 -0.953 . . . . 0.0 109.422 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.95 -65.12 0.71 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.648 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.1 m -48.56 -54.51 14.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.159 -0.963 . . . . 0.0 109.464 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -53.78 -41.87 67.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.445 -0.784 . . . . 0.0 109.534 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 100' ' ' SER . 7.3 mt -69.54 -31.82 70.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.17 -0.956 . . . . 0.0 109.484 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.68 -21.14 67.01 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.539 ' CE2' ' CE ' ' A' ' 45' ' ' LYS . 8.2 t80 -76.79 -54.49 6.54 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.262 -1.14 . . . . 0.0 109.477 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -96.77 79.65 2.98 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.39 -0.819 . . . . 0.0 109.607 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -78.38 1.43 22.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.383 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.7 p -67.5 -22.04 65.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 109.493 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . 92.59 64.19 1.11 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.744 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -49.23 178.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -1.095 . . . . 0.0 109.546 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.48 155.32 43.03 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.226 -0.921 . . . . 0.0 109.329 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -126.47 143.68 51.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.212 -0.93 . . . . 0.0 109.451 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 44.3 mttt -140.18 134.75 31.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.875 . . . . 0.0 109.392 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.275 -0.891 . . . . 0.0 109.523 179.869 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.535 ' HB2' HD11 ' A' ' 6' ' ' LEU . 46.7 Cg_endo . . . . . 0 N--CA 1.491 1.33 0 CA-C-O 121.273 0.447 . . . . 0.0 111.893 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.43 ' C ' ' N ' ' A' ' 6' ' ' LEU . 20.3 mm-40 -83.6 -25.71 30.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.222 -0.923 . . . . 0.0 110.035 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.529 ' CE1' HG12 ' A' ' 42' ' ' VAL . 43.6 t80 -51.65 -11.96 0.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.036 -1.04 . . . . 0.0 109.747 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.535 HD11 ' HB2' ' A' ' 3' ' ' PRO . 0.3 OUTLIER -93.94 -29.97 14.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.146 -0.971 . . . . 0.0 109.032 179.582 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.506 ' O ' ' O ' ' A' ' 8' ' ' ALA . 17.0 mtpp -87.94 -6.63 57.93 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.391 -0.818 . . . . 0.0 109.264 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -43.71 170.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.351 -0.843 . . . . 0.0 109.568 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.04 76.68 1.09 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -136.04 -1.26 2.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.226 -1.161 . . . . 0.0 109.694 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -171.46 149.58 2.54 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.152 -0.968 . . . . 0.0 109.419 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.4 89.34 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.727 2.285 . . . . 0.0 112.193 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -170.29 -106.15 0.19 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.7 tt -162.33 149.17 13.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.222 -1.163 . . . . 0.0 109.665 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -135.77 132.97 37.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.368 -0.832 . . . . 0.0 109.309 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.428 HG22 ' N ' ' A' ' 17' ' ' TRP . 42.7 mt -102.96 159.7 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 109.767 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.428 ' N ' HG22 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -157.87 162.17 38.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -0.867 . . . . 0.0 109.047 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -129.03 147.29 50.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.355 -0.84 . . . . 0.0 109.555 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.536 ' CG1' ' OD1' ' A' ' 39' ' ' ASP . 8.1 p -81.03 145.98 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.862 . . . . 0.0 109.548 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.58 ' O ' ' N ' ' A' ' 22' ' ' PHE . 22.3 tt0 -100.52 153.93 18.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.343 -0.848 . . . . 0.0 109.344 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 20' ' ' GLU . 18.7 tptm -40.32 -22.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 109.509 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.58 ' N ' ' O ' ' A' ' 20' ' ' GLU . 58.6 t80 -160.86 33.97 0.15 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 109.416 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -173.89 -127.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.305 -0.872 . . . . 0.0 109.526 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.459 HD22 ' H ' ' A' ' 5' ' ' PHE . 4.7 tp -148.43 146.06 28.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -0.951 . . . . 0.0 109.572 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.5 133.36 25.02 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.888 . . . . 0.0 109.225 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.26 140.91 28.27 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.453 2.102 . . . . 0.0 112.138 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.9 t -99.76 133.74 21.54 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.218 -0.926 . . . . 0.0 109.241 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -72.7 133.14 19.78 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.525 2.15 . . . . 0.0 112.308 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.508 ' C ' ' H ' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -68.25 176.01 2.98 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.239 -0.913 . . . . 0.0 109.431 179.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 29' ' ' THR . 3.1 t-20 69.91 -39.1 0.43 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.406 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.508 ' H ' ' C ' ' A' ' 29' ' ' THR . 31.6 mt -96.94 -32.75 11.87 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.287 -0.883 . . . . 0.0 109.414 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.456 ' C ' ' O ' ' A' ' 31' ' ' LEU . 14.6 p90 -41.58 160.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 109.58 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 128.82 -19.15 5.57 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -98.26 124.33 42.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -1.136 . . . . 0.0 109.604 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -105.31 131.44 52.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -0.876 . . . . 0.0 109.335 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -96.5 135.67 38.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.211 -0.931 . . . . 0.0 109.582 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.7 p -83.71 -16.58 44.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.383 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.02 30.14 8.44 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.536 ' OD1' ' CG1' ' A' ' 19' ' ' VAL . 32.8 t0 -165.03 171.66 13.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.273 -1.133 . . . . 0.0 109.518 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.4 145.56 38.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.308 -0.87 . . . . 0.0 109.396 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -122.62 134.96 54.49 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.28 -0.888 . . . . 0.0 109.421 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.529 HG12 ' CE1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -108.71 144.16 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.324 -0.86 . . . . 0.0 109.018 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.082 ' N ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -144.34 125.12 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.049 -1.032 . . . . 0.0 109.738 -179.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 tt -113.22 124.12 51.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.282 -0.886 . . . . 0.0 109.53 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 29.6 tttm -97.69 145.81 25.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.316 -0.865 . . . . 0.0 109.515 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 13' ' ' GLY . 85.0 m -142.96 128.33 18.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.292 -0.88 . . . . 0.0 109.276 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -131.98 168.45 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 O-C-N 120.986 -1.071 . . . . 0.0 109.535 -179.626 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -99.66 98.46 9.3 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.556 HD13 HH11 ' A' ' 88' ' ' ARG . 10.1 mt -60.84 168.65 2.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.328 -0.858 . . . . 0.0 109.594 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 51' ' ' ASN . 34.0 ttm180 -48.95 -77.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 0.0 109.394 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 50' ' ' ARG . 1.2 m120 -42.84 -27.89 0.21 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.912 . . . . 0.0 109.214 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 50' ' ' ARG . . . 96.03 44.17 3.13 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.3 t-20 -95.35 14.05 23.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.983 -1.304 . . . . 0.0 109.288 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.574 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 11.5 mt 43.68 97.22 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.649 0.738 . . . . 0.0 109.377 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.412 ' HB2' HD11 ' A' ' 49' ' ' LEU . 9.3 tt0 -68.86 151.89 46.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.497 -0.752 . . . . 0.0 109.156 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.574 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 90.7 m-85 -136.08 114.31 11.54 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.318 -0.864 . . . . 0.0 109.419 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.73 153.94 34.89 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.3 137.62 40.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.934 -1.104 . . . . 0.0 110.324 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.716 ' HB2' HD13 ' A' ' 43' ' ' ILE . 1.0 OUTLIER -122.5 150.11 42.98 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.447 -0.783 . . . . 0.0 109.138 179.545 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.707 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -124.78 116.42 22.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -0.851 . . . . 0.0 109.122 179.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.404 ' CE3' ' O ' ' A' ' 62' ' ' LEU . 16.7 t90 -97.77 123.93 41.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.294 -0.879 . . . . 0.0 109.61 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.404 ' O ' ' CE3' ' A' ' 61' ' ' TRP . 0.7 OUTLIER -104.54 161.49 14.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.316 -0.865 . . . . 0.0 109.394 179.861 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -106.26 157.83 15.75 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.408 ' HB2' HE21 ' A' ' 96' ' ' GLN . 6.6 t-20 -77.52 -12.25 59.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -1.126 . . . . 0.0 109.389 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -107.16 24.36 12.96 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.8 m -130.97 97.5 4.33 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 122.105 0.955 . . . . 0.0 108.496 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 66' ' ' CYS . 1.4 m -50.85 -173.52 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.315 0 CA-C-O 121.378 0.609 . . . . 0.0 109.569 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.439 ' O ' ' N ' ' A' ' 72' ' ' GLY . 54.9 mt-30 -71.49 -17.8 62.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -0.944 . . . . 0.0 109.598 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -63.82 -58.5 6.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.463 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.32 -46.99 84.1 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.369 -0.832 . . . . 0.0 109.053 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.6 m -63.79 -29.18 70.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.493 -0.755 . . . . 0.0 108.968 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -65.1 -45.92 90.21 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.22 -49.97 74.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -1.146 . . . . 0.0 109.326 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.83 -45.43 93.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 0.0 109.252 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.641 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -62.21 -38.54 89.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.159 -0.963 . . . . 0.0 109.425 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.1 mt -58.84 -44.56 90.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.189 -0.945 . . . . 0.0 109.468 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -61.75 -42.0 98.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.37 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 82.2 m -68.0 -39.96 83.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.333 -0.854 . . . . 0.0 109.232 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 75' ' ' ALA . 68.2 t -67.87 -27.41 37.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.402 -0.811 . . . . 0.0 109.372 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.486 ' O ' ' OD2' ' A' ' 83' ' ' ASP . 40.8 mm-40 -70.4 -61.47 1.76 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.254 -0.904 . . . . 0.0 109.285 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.8 pp -58.03 -24.06 56.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 0.0 108.645 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' A' ' 86' ' ' ASN . 13.9 t70 -72.25 -54.96 8.04 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.39 -0.819 . . . . 0.0 108.912 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.486 ' OD2' ' O ' ' A' ' 80' ' ' GLN . 1.1 p30 -48.33 -35.42 12.37 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.113 -0.992 . . . . 0.0 108.368 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.457 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -72.93 -32.07 65.03 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.297 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 82' ' ' ASP . 4.6 tp -121.56 35.29 4.93 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.327 -0.858 . . . . 0.0 109.415 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.615 ' N ' ' O ' ' A' ' 82' ' ' ASP . 42.6 t30 -87.71 30.16 0.84 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.193 -0.942 . . . . 0.0 109.205 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -107.41 -21.3 8.05 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.556 HH11 HD13 ' A' ' 49' ' ' LEU . 25.3 ttt85 -159.53 64.81 0.38 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.282 -1.128 . . . . 0.0 109.41 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.13 174.43 14.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.924 . . . . 0.0 109.379 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.9 t -136.11 142.51 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 109.641 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -103.24 147.71 26.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.328 -0.858 . . . . 0.0 109.077 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.401 ' HB2' ' ND1' ' A' ' 59' ' ' HIS . 38.4 m-70 -132.1 119.16 20.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 109.655 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.524 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 11.0 ptp180 -91.97 109.32 20.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.367 -0.833 . . . . 0.0 109.299 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 100' ' ' SER . 86.6 mt-10 -113.32 144.19 43.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 109.43 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 96' ' ' GLN . 37.5 t -148.55 166.59 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.299 -0.876 . . . . 0.0 109.37 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.541 ' N ' HG12 ' A' ' 95' ' ' VAL . 12.7 tt0 -59.16 115.99 3.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.245 -0.91 . . . . 0.0 109.388 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.06 9.79 85.75 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.48 ' O ' ' O ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -143.17 24.71 1.78 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -1.147 . . . . 0.0 109.305 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.538 ' OE1' HD21 ' A' ' 104' ' ' LEU . 9.7 pt-20 -44.53 170.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.276 -0.89 . . . . 0.0 109.556 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.407 ' H ' ' HG2' ' A' ' 94' ' ' GLU . 4.3 t -91.51 167.8 11.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.279 -0.888 . . . . 0.0 109.573 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.66 -59.89 2.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.295 -0.878 . . . . 0.0 109.527 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.0 m -46.85 -35.59 6.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.355 -0.841 . . . . 0.0 109.373 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -68.87 -46.49 68.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.347 -0.846 . . . . 0.0 109.292 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.58 ' O ' ' CD1' ' A' ' 107' ' ' PHE . 12.0 mt -61.15 -20.57 62.85 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.252 -0.905 . . . . 0.0 109.436 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -93.74 -24.85 19.5 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.414 ' O ' ' C ' ' A' ' 107' ' ' PHE . 7.8 t80 -80.0 -21.42 43.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -1.133 . . . . 0.0 109.461 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.583 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 1.6 p90 -44.97 121.67 2.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.456 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -108.98 -50.67 2.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.979 . . . . 0.0 109.536 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 94.9 p -101.42 -9.79 20.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 109.539 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 96.29 108.48 2.44 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.735 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -67.6 177.06 2.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -1.153 . . . . 0.0 109.512 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -146.88 143.7 28.74 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.288 -0.883 . . . . 0.0 109.436 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.61 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -112.41 124.67 53.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.312 -0.868 . . . . 0.0 109.485 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 17.0 mtpt -97.42 160.62 14.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 109.531 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.364 -0.835 . . . . 0.0 109.364 179.979 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo . . . . . 0 N--CA 1.494 1.521 0 CA-C-O 121.286 0.453 . . . . 0.0 111.974 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.52 ' H ' HD13 ' A' ' 24' ' ' LEU . 57.2 mm-40 -83.06 -46.02 13.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.972 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.553 ' CE2' ' CG1' ' A' ' 42' ' ' VAL . 34.8 t80 -69.74 -12.54 61.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.111 -0.993 . . . . 0.0 109.558 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.415 ' N ' HD23 ' A' ' 6' ' ' LEU . 9.4 mt -90.34 -33.71 15.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.216 -0.927 . . . . 0.0 109.381 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 8' ' ' ALA . 25.1 mttp -91.17 -11.34 38.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.229 -0.919 . . . . 0.0 109.494 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -42.73 166.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.177 -0.952 . . . . 0.0 109.47 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.542 ' H ' ' NE2' ' A' ' 15' ' ' GLN . . . 106.24 68.27 0.69 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.8 pttt -135.97 -0.87 2.49 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.211 -1.17 . . . . 0.0 109.576 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -159.02 142.48 10.81 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 109.326 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.35 89.88 1.04 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.594 2.196 . . . . 0.0 112.256 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -169.14 -105.92 0.19 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.5 tt -162.38 144.82 11.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -1.15 . . . . 0.0 109.472 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.542 ' NE2' ' H ' ' A' ' 9' ' ' GLY . 9.0 mt-30 -134.6 144.39 47.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 109.629 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.505 HG23 HD12 ' A' ' 43' ' ' ILE . 7.8 mt -122.89 143.96 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.455 -0.778 . . . . 0.0 109.812 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.423 ' CE2' ' HB3' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -146.68 136.07 22.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.307 -0.87 . . . . 0.0 109.019 179.738 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.552 ' O ' ' N ' ' A' ' 25' ' ' VAL . 51.5 ttt180 -94.11 153.17 18.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.124 -0.985 . . . . 0.0 109.645 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 23' ' ' ASP . 28.3 t -96.45 133.31 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.92 . . . . 0.0 109.722 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.774 ' O ' ' N ' ' A' ' 22' ' ' PHE . 6.0 tt0 -80.09 85.58 5.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.132 -0.98 . . . . 0.0 108.774 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.648 ' O ' ' CD2' ' A' ' 22' ' ' PHE . 7.5 mtpm? 40.43 9.86 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.548 -0.72 . . . . 0.0 109.792 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.774 ' N ' ' O ' ' A' ' 20' ' ' GLU . 0.7 OUTLIER 160.22 -32.35 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.225 -0.922 . . . . 0.0 109.167 -179.723 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.737 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -94.49 -142.38 0.24 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.273 -0.892 . . . . 0.0 110.257 -179.214 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.52 HD13 ' H ' ' A' ' 4' ' ' GLU . 8.9 mt -125.95 146.12 49.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.341 -0.849 . . . . 0.0 109.942 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' A' ' 18' ' ' ARG . 7.8 t -142.05 132.29 12.66 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 0.0 109.15 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -76.3 144.67 26.37 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.39 2.06 . . . . 0.0 112.26 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.2 t -110.96 101.51 50.09 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.346 -0.846 . . . . 0.0 109.437 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -51.19 161.6 1.58 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.508 2.139 . . . . 0.0 112.153 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.7 m -68.64 -22.15 64.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.389 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -67.0 -11.83 58.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 109.433 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 32' ' ' TYR . 15.3 mt -122.93 -17.11 6.87 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.268 -0.895 . . . . 0.0 109.52 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.55 ' C ' ' CD2' ' A' ' 32' ' ' TYR . 4.4 t80 -42.46 133.12 3.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.907 . . . . 0.0 109.348 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.83 22.26 16.36 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -143.02 151.37 40.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -1.192 . . . . 0.0 109.444 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -141.83 137.48 31.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.231 -0.918 . . . . 0.0 109.549 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -102.04 137.63 40.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 109.325 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.4 p -78.2 -4.79 49.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.882 . . . . 0.0 109.48 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.35 30.94 8.92 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 40' ' ' ALA . 8.8 t70 -173.66 156.13 2.86 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.188 -1.184 . . . . 0.0 109.521 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.447 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -97.77 147.68 24.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.246 -0.909 . . . . 0.0 109.279 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.44 ' N ' ' CD2' ' A' ' 41' ' ' TYR . 17.1 m-85 -128.72 134.82 48.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.324 -0.86 . . . . 0.0 109.46 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.918 ' O ' HD13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -105.44 140.94 21.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.213 -0.929 . . . . 0.0 109.06 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.918 HD13 ' O ' ' A' ' 42' ' ' VAL . 1.1 mm -131.22 134.89 60.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.37 -0.831 . . . . 0.0 110.028 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 tt -120.22 120.13 35.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.536 -0.727 . . . . 0.0 109.531 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.403 ' HE3' ' CE1' ' A' ' 106' ' ' TYR . 43.6 tttt -93.79 147.91 22.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.116 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.6 OUTLIER -142.68 122.14 13.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 109.526 -179.768 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -129.97 168.18 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 O-C-N 121.249 -0.907 . . . . 0.0 108.908 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -94.51 131.29 40.39 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.533 -0.729 . . . . 0.0 109.487 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.453 HD21 HE21 ' A' ' 55' ' ' GLN . 15.8 mt -96.32 167.52 11.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 109.534 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.53 ' CG ' ' N ' ' A' ' 51' ' ' ASN . 4.6 ptm180 -47.93 -46.86 32.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.261 -0.899 . . . . 0.0 109.296 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.53 ' N ' ' CG ' ' A' ' 50' ' ' ARG . 98.6 m-20 -75.75 -27.48 58.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.316 -0.865 . . . . 0.0 109.199 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.85 28.96 7.95 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.497 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.4 t-20 -84.67 13.64 5.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.099 -1.236 . . . . 0.0 109.359 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.8 mt 47.31 100.26 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.527 0.68 . . . . 0.0 109.509 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.453 HE21 HD21 ' A' ' 49' ' ' LEU . 8.9 tt0 -68.85 117.77 10.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.534 -0.729 . . . . 0.0 109.214 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.515 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 96.7 m-85 -98.07 114.71 26.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.174 -0.954 . . . . 0.0 109.865 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.21 155.76 22.46 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.553 ' C ' ' CD2' ' A' ' 59' ' ' HIS . 5.2 mp -134.36 144.7 48.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.838 -1.164 . . . . 0.0 110.517 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.603 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.5 OUTLIER -141.97 126.55 17.89 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.566 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.701 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -105.94 131.13 53.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.1 -1.0 . . . . 0.0 109.593 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -104.94 123.94 48.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.422 -0.799 . . . . 0.0 109.331 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.9 mt -104.7 162.12 13.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.863 . . . . 0.0 109.595 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -117.37 162.69 12.81 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.485 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 0.6 OUTLIER -81.08 -12.57 59.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.302 -1.117 . . . . 0.0 109.614 -179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -106.24 26.98 9.13 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.3 m -130.75 97.61 4.4 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 122.2 1.0 . . . . 0.0 108.42 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 66' ' ' CYS . 31.4 m -49.71 -176.49 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.733 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 72' ' ' GLY . 13.7 pt20 -68.17 -17.5 64.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.4 -0.812 . . . . 0.0 109.561 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -63.48 -58.57 6.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.919 . . . . 0.0 109.652 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.449 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 3.8 mm-40 -62.32 -48.13 81.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.229 -0.919 . . . . 0.0 109.177 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.7 p -66.01 -27.53 68.19 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.338 -0.851 . . . . 0.0 109.231 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.89 -31.82 66.86 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.22 -51.22 18.53 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.278 -1.131 . . . . 0.0 109.342 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.92 -48.18 73.44 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.414 -0.804 . . . . 0.0 109.279 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.406 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -57.11 -48.38 78.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 109.303 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.4 mt -50.77 -47.28 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.204 -0.935 . . . . 0.0 109.319 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -58.06 -37.75 75.02 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.306 -0.871 . . . . 0.0 109.264 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 m -65.32 -46.22 81.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.33 -0.856 . . . . 0.0 109.266 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 75' ' ' ALA . 17.1 t -56.02 -36.41 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 0.0 109.451 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -64.89 -50.09 67.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.277 -0.889 . . . . 0.0 109.255 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.2 mt -53.13 -36.1 60.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.204 -0.935 . . . . 0.0 109.247 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 85' ' ' LEU . 40.6 m-20 -63.36 -58.34 7.42 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.247 -0.908 . . . . 0.0 109.109 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 82' ' ' ASP . 1.8 t70 -45.4 -34.0 2.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.212 -0.93 . . . . 0.0 108.54 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -73.7 -28.87 61.96 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 82' ' ' ASP . 6.4 mt -112.93 28.36 8.86 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.394 -0.816 . . . . 0.0 109.272 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 85' ' ' LEU . 9.6 t-20 43.56 37.22 1.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.397 -0.815 . . . . 0.0 109.429 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 48.72 32.95 11.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -89.09 30.96 0.9 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.192 -1.181 . . . . 0.0 109.22 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -129.76 179.14 6.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.423 -0.798 . . . . 0.0 109.347 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.7 128.23 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.15 -0.969 . . . . 0.0 109.5 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.586 ' NE2' ' N ' ' A' ' 91' ' ' GLN . 1.6 mp0 -88.98 144.33 26.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.932 . . . . 0.0 109.366 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.42 ' HB2' ' CG ' ' A' ' 59' ' ' HIS . 28.4 m-70 -131.31 107.27 8.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.94 . . . . 0.0 109.576 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -86.25 105.04 16.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 109.377 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.596 ' OE1' ' CD1' ' A' ' 103' ' ' PHE . 22.3 mt-10 -110.3 141.77 42.84 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.36 -0.837 . . . . 0.0 109.732 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 96' ' ' GLN . 12.0 t -144.38 163.3 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.342 -0.848 . . . . 0.0 109.147 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.426 ' N ' HG12 ' A' ' 95' ' ' VAL . 2.3 pt20 -56.89 120.52 8.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.939 . . . . 0.0 109.442 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.42 15.76 77.54 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.438 ' O ' ' C ' ' A' ' 99' ' ' GLU . 7.0 t80 -141.7 12.13 2.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -1.145 . . . . 0.0 109.443 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.6 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 30.2 mp0 -41.52 138.4 1.33 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.506 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.446 ' H ' ' HG2' ' A' ' 94' ' ' GLU . 4.1 m -72.29 -177.36 2.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 0.0 109.402 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.2 -65.21 0.98 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.187 -0.945 . . . . 0.0 109.505 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.6 m -47.64 -36.21 10.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 109.444 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.685 ' CZ ' ' CZ ' ' A' ' 107' ' ' PHE . 2.1 t80 -67.8 -47.16 69.87 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.259 -0.901 . . . . 0.0 109.442 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 104' ' ' LEU . 63.5 mt -66.83 -23.1 65.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.934 . . . . 0.0 109.508 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -93.32 -24.17 22.49 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.403 ' CE1' ' HE3' ' A' ' 45' ' ' LYS . 32.6 t80 -86.94 -33.62 19.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.225 -1.162 . . . . 0.0 109.51 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.685 ' CZ ' ' CZ ' ' A' ' 103' ' ' PHE . 24.2 m-85 -90.31 99.31 12.36 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.29 -0.881 . . . . 0.0 109.528 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.419 ' C ' ' H ' ' A' ' 110' ' ' GLY . 19.9 mtpp -99.74 -6.16 27.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.913 . . . . 0.0 109.365 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 26.0 m -77.75 22.29 0.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 109.426 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 111' ' ' LEU . . . 47.62 80.85 0.05 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.75 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.5 OUTLIER -43.01 118.33 1.25 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -1.145 . . . . 0.0 109.441 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -82.04 123.57 29.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.28 -0.887 . . . . 0.0 109.497 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -94.93 108.73 20.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.511 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -111.43 140.12 46.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.348 -0.845 . . . . 0.0 109.556 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 30.3 pttt . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.911 . . . . 0.0 109.397 179.983 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo . . . . . 0 N--CA 1.492 1.388 0 CA-C-O 121.296 0.457 . . . . 0.0 112.099 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.409 ' C ' ' N ' ' A' ' 6' ' ' LEU . 0.4 OUTLIER -82.25 -34.83 28.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 109.698 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.628 ' CE2' HG12 ' A' ' 42' ' ' VAL . 15.9 t80 -56.78 -8.87 0.66 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.184 -0.948 . . . . 0.0 109.291 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.409 ' N ' ' C ' ' A' ' 4' ' ' GLU . 51.1 mt -90.24 -45.73 8.88 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.227 -0.921 . . . . 0.0 109.385 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.455 ' O ' ' C ' ' A' ' 8' ' ' ALA . 43.6 mtpt -87.27 -2.08 58.37 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.292 -0.88 . . . . 0.0 109.439 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -41.48 150.46 0.1 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.42 -0.8 . . . . 0.0 109.581 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.54 68.83 0.29 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -134.64 9.69 3.66 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.373 -1.075 . . . . 0.0 109.539 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -172.67 139.37 0.93 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.148 -0.97 . . . . 0.0 109.451 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.38 86.3 1.17 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.547 2.165 . . . . 0.0 112.265 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -166.31 -107.58 0.2 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.6 tt -162.6 151.0 14.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.291 -1.123 . . . . 0.0 109.635 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.424 ' HB3' ' CZ3' ' A' ' 17' ' ' TRP . 32.7 mt-30 -146.66 140.25 25.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 109.403 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.582 ' HB ' HG11 ' A' ' 27' ' ' VAL . 3.4 mt -114.38 149.39 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.312 -0.867 . . . . 0.0 109.923 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.424 ' CZ3' ' HB3' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -145.27 135.23 23.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.302 -0.874 . . . . 0.0 109.122 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -92.27 142.83 27.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.164 -0.96 . . . . 0.0 109.381 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.634 ' O ' HG13 ' A' ' 19' ' ' VAL . 9.9 p -80.45 119.62 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.198 -0.939 . . . . 0.0 109.501 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.614 ' O ' ' N ' ' A' ' 22' ' ' PHE . 8.6 tm-20 -74.79 147.83 40.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.234 -0.916 . . . . 0.0 109.157 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.425 ' N ' ' CD ' ' A' ' 20' ' ' GLU . 23.8 mttp -45.19 -11.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.901 . . . . 0.0 109.833 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.614 ' N ' ' O ' ' A' ' 20' ' ' GLU . 7.6 t80 -165.71 29.75 0.05 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.126 -0.984 . . . . 0.0 109.797 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.463 ' N ' ' HB3' ' A' ' 20' ' ' GLU . 27.5 t70 -175.29 -116.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 109.597 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.6 tp -157.99 146.2 18.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.346 -0.846 . . . . 0.0 109.499 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -134.38 107.9 11.17 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.244 -0.91 . . . . 0.0 109.604 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.74 132.79 37.62 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.192 1.928 . . . . 0.0 111.843 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.582 HG11 ' HB ' ' A' ' 16' ' ' ILE . 2.2 p -75.7 121.57 85.35 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 109.572 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -78.17 166.84 24.14 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.4 2.067 . . . . 0.0 112.139 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.86 -6.25 43.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.332 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -87.19 -6.39 58.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 109.346 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 32' ' ' TYR . 56.6 mt -132.87 -11.4 3.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 109.778 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.528 ' CZ ' ' CD1' ' A' ' 16' ' ' ILE . 9.6 t80 -43.25 118.98 1.44 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 109.487 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.66 -11.91 56.45 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.514 ' C ' ' CG ' ' A' ' 35' ' ' PHE . 1.9 m-20 -110.52 150.52 28.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -1.154 . . . . 0.0 109.503 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.514 ' CG ' ' C ' ' A' ' 34' ' ' ASP . 5.2 m-85 -155.1 148.17 24.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 109.421 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.478 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 2.0 m-85 -102.34 135.96 43.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 109.536 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 44.7 p -67.13 -9.57 41.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.354 -0.841 . . . . 0.0 109.289 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.52 30.36 8.9 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 40' ' ' ALA . 3.1 t70 -161.36 159.44 28.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -1.154 . . . . 0.0 109.399 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.6 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -107.46 150.71 26.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 109.392 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -130.03 138.89 51.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.312 -0.867 . . . . 0.0 109.511 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.08 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -112.81 126.52 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.25 -0.906 . . . . 0.0 108.591 179.698 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.08 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -123.73 137.77 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 119.319 -0.952 . . . . 0.0 110.373 -178.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.6 tt -121.09 146.96 46.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.542 -0.724 . . . . 0.0 109.396 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 57' ' ' ASP . 1.8 ttmp? -123.67 139.34 54.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.417 -0.802 . . . . 0.0 109.259 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 13' ' ' GLY . 20.4 m -136.31 117.93 14.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.342 -0.849 . . . . 0.0 109.328 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -126.52 167.86 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.317 -0.864 . . . . 0.0 109.01 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -98.48 125.44 43.68 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.498 -0.752 . . . . 0.0 109.442 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.435 HD11 ' HB2' ' A' ' 55' ' ' GLN . 11.1 mt -87.9 154.43 20.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.27 -0.894 . . . . 0.0 109.673 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.432 ' CZ ' ' CB ' ' A' ' 50' ' ' ARG . 10.3 mtp-105 -48.24 -43.39 32.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -0.916 . . . . 0.0 109.255 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -68.41 -32.85 73.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.312 -0.868 . . . . 0.0 109.3 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.09 74.67 1.18 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.508 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.1 t-20 -143.69 13.77 1.73 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.203 -1.175 . . . . 0.0 109.336 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.708 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 31.4 mt 44.52 98.26 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.536 0.684 . . . . 0.0 109.496 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.435 ' HB2' HD11 ' A' ' 49' ' ' LEU . 9.7 tt0 -73.97 121.31 20.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.559 -0.713 . . . . 0.0 109.682 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -99.54 114.54 27.59 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.248 -0.908 . . . . 0.0 109.751 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 45' ' ' LYS . 0.9 OUTLIER -127.51 122.56 33.7 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.362 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.57 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 0.5 OUTLIER -126.16 150.37 48.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.114 -0.991 . . . . 0.0 110.71 -178.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.482 ' CB ' ' CE1' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -129.53 141.71 50.92 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.34 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.572 ' HE1' ' HB1' ' A' ' 40' ' ' ALA . 2.4 t80 -103.24 126.22 50.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.897 . . . . 0.0 109.56 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.457 ' N ' ' CD1' ' A' ' 60' ' ' TYR . 44.2 t90 -100.74 127.8 47.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.09 -1.006 . . . . 0.0 109.824 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.499 HD21 ' CE2' ' A' ' 60' ' ' TYR . 2.9 mp -112.53 157.0 21.68 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.491 -0.756 . . . . 0.0 109.412 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -104.78 161.68 14.99 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.514 HD21 ' NE2' ' A' ' 96' ' ' GLN . 0.5 OUTLIER -81.72 -12.05 58.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.333 -1.098 . . . . 0.0 109.474 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -106.66 29.59 6.82 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.552 ' SG ' ' OE2' ' A' ' 70' ' ' GLU . 1.6 m -130.78 97.51 4.36 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.591 ' OG ' ' N ' ' A' ' 68' ' ' GLN . 1.0 OUTLIER -58.67 -173.76 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.573 -179.829 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.591 ' N ' ' OG ' ' A' ' 67' ' ' SER . 8.6 pt20 -62.45 -17.97 60.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 109.66 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -65.35 -58.77 5.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.557 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.552 ' OE2' ' SG ' ' A' ' 66' ' ' CYS . 13.4 mt-10 -64.63 -43.1 94.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.336 -0.852 . . . . 0.0 109.139 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.7 t -69.33 -26.7 64.83 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.491 -0.756 . . . . 0.0 109.191 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.31 -38.89 71.18 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.02 -47.98 64.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.331 -1.1 . . . . 0.0 109.366 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.483 ' O ' ' OG1' ' A' ' 78' ' ' THR . . . -60.36 -42.22 95.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.366 -0.834 . . . . 0.0 109.311 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.487 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -62.95 -44.8 95.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.883 . . . . 0.0 109.598 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.2 mt -53.45 -51.53 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 0.0 109.341 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -61.36 -33.23 73.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 109.307 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -68.81 -44.77 72.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.382 -0.824 . . . . 0.0 109.374 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 75' ' ' ALA . 42.9 t -63.34 -31.2 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.293 -0.879 . . . . 0.0 109.409 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -66.9 -60.97 2.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.334 -0.854 . . . . 0.0 109.165 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.805 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -50.78 -31.09 15.84 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.046 -1.034 . . . . 0.0 108.708 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' A' ' 86' ' ' ASN . 29.2 t70 -63.64 -59.57 4.44 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.418 -0.802 . . . . 0.0 108.928 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.583 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 1.3 m-20 -46.03 -34.09 3.84 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.158 -0.964 . . . . 0.0 108.46 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -74.7 -32.79 62.28 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 82' ' ' ASP . 1.1 tt -121.48 35.67 4.82 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.369 -0.832 . . . . 0.0 109.532 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.609 ' N ' ' O ' ' A' ' 82' ' ' ASP . 1.7 p30 -76.89 27.03 0.14 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.125 -0.985 . . . . 0.0 109.092 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -69.9 -57.86 6.74 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -176.67 46.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.346 -1.091 . . . . 0.0 109.564 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.63 179.13 6.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 0.0 109.406 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.7 t -126.25 111.95 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 109.45 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -102.38 136.43 42.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.364 -0.835 . . . . 0.0 109.397 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.619 ' N ' ' CD2' ' A' ' 92' ' ' HIS . 0.6 OUTLIER -143.82 118.65 9.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.077 -1.014 . . . . 0.0 109.515 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.1 mtm180 -83.01 138.28 33.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 109.774 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' A' ' 100' ' ' SER . 5.4 mt-10 -131.37 155.98 46.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.304 -0.873 . . . . 0.0 109.283 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.698 HG12 ' N ' ' A' ' 96' ' ' GLN . 48.1 t -131.66 173.8 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.219 -0.925 . . . . 0.0 109.575 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.698 ' N ' HG12 ' A' ' 95' ' ' VAL . 3.3 tt0 -60.55 139.75 57.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.374 -0.829 . . . . 0.0 109.54 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 70.53 -18.55 0.75 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.517 ' H ' ' C ' ' A' ' 96' ' ' GLN . 7.9 t80 -106.59 4.7 28.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.301 -1.117 . . . . 0.0 109.452 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.54 ' OE2' HD22 ' A' ' 111' ' ' LEU . 27.7 mt-10 -42.69 148.26 0.24 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.903 . . . . 0.0 109.559 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.467 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 38.4 m -81.06 168.7 18.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.9 . . . . 0.0 109.529 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.93 -35.02 78.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.153 -0.967 . . . . 0.0 109.607 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.8 m -58.03 -61.03 2.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.568 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -57.78 -41.79 82.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.35 -0.844 . . . . 0.0 109.732 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.2 mt -66.28 -28.52 68.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.189 -0.944 . . . . 0.0 109.552 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -81.7 -19.22 66.29 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.43 ' CD1' ' CZ ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -81.37 -45.55 15.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -1.121 . . . . 0.0 109.431 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.43 ' CZ ' ' CD1' ' A' ' 106' ' ' TYR . 20.4 m-85 -139.41 87.21 2.17 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.352 -0.842 . . . . 0.0 109.496 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.35 -20.76 20.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.386 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.7 t -96.94 -12.39 23.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -0.939 . . . . 0.0 109.484 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.456 ' O ' ' C ' ' A' ' 111' ' ' LEU . . . -97.65 -107.15 2.53 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.54 HD22 ' OE2' ' A' ' 99' ' ' GLU . 14.5 mt 41.52 61.64 1.77 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.329 -1.1 . . . . 0.0 109.507 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tppt? -75.59 117.04 16.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.172 -0.955 . . . . 0.0 109.479 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -84.5 114.38 21.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.297 -0.877 . . . . 0.0 109.478 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -103.05 166.28 10.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 0.0 109.355 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.854 . . . . 0.0 109.465 179.881 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo . . . . . 0 N--CA 1.488 1.152 0 CA-C-O 121.22 0.425 . . . . 0.0 112.238 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.644 ' H ' HD22 ' A' ' 24' ' ' LEU . 1.2 tp10 -83.07 -29.35 28.86 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.26 -0.9 . . . . 0.0 109.563 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.616 ' CZ ' ' O ' ' A' ' 42' ' ' VAL . 2.9 m-85 -56.32 -4.59 0.14 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.951 . . . . 0.0 109.13 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.511 ' H ' ' C ' ' A' ' 4' ' ' GLU . 14.4 mt -84.54 -38.4 20.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.88 . . . . 0.0 109.279 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 8' ' ' ALA . 23.2 mttt -101.43 -3.37 28.79 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.393 -0.817 . . . . 0.0 109.358 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.503 ' HB3' HD13 ' A' ' 44' ' ' LEU . . . -42.01 137.52 1.81 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.31 -0.869 . . . . 0.0 109.637 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . 0.555 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 154.86 -37.45 0.66 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.623 ' CD ' ' H ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -70.78 19.83 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -1.152 . . . . 0.0 109.309 179.85 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.555 ' H ' ' C ' ' A' ' 9' ' ' GLY . 79.9 mt-10 -139.23 103.02 7.31 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.374 -0.829 . . . . 0.0 109.293 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -78.33 83.97 2.11 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.426 2.084 . . . . 0.0 112.157 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -174.22 -102.01 0.15 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -159.97 132.47 6.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.134 . . . . 0.0 109.427 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -115.23 135.93 53.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.276 -0.89 . . . . 0.0 109.478 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.58 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 6.3 mt -130.96 110.11 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.44 -0.787 . . . . 0.0 109.91 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.58 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 6.1 m0 -139.32 149.76 44.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.176 -0.953 . . . . 0.0 108.769 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.641 ' HE ' HG22 ' A' ' 27' ' ' VAL . 6.7 ptp180 -114.83 153.27 30.73 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.122 -0.986 . . . . 0.0 110.139 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.552 ' O ' HG13 ' A' ' 19' ' ' VAL . 7.3 p -89.26 125.68 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -0.843 . . . . 0.0 109.13 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.657 ' CB ' HG21 ' A' ' 25' ' ' VAL . 5.6 mt-10 -157.45 138.02 13.02 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.214 -0.929 . . . . 0.0 109.319 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 22' ' ' PHE . 12.8 mttt 72.97 48.21 0.18 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.501 -0.75 . . . . 0.0 109.458 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.428 ' C ' ' O ' ' A' ' 21' ' ' LYS . 20.5 m-85 43.74 36.93 1.41 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.541 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -169.01 166.75 10.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.28 -0.888 . . . . 0.0 109.405 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.644 HD22 ' H ' ' A' ' 4' ' ' GLU . 4.4 tp -68.15 146.16 53.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.246 -0.909 . . . . 0.0 109.431 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.657 HG21 ' CB ' ' A' ' 20' ' ' GLU . 44.1 t -138.5 97.67 9.25 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.371 -0.831 . . . . 0.0 109.071 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -50.31 168.99 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.771 2.314 . . . . 0.0 112.632 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.641 HG22 ' HE ' ' A' ' 18' ' ' ARG . 58.0 t -126.92 107.43 22.27 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.462 -0.774 . . . . 0.0 109.173 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -45.69 144.04 5.75 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.434 2.089 . . . . 0.0 112.492 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 31' ' ' LEU . 6.5 m -51.89 -50.19 61.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.266 -0.896 . . . . 0.0 109.39 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -48.11 -11.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.418 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' THR . 94.5 mt -114.96 -17.45 11.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 109.552 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.525 ' CE1' HD12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -38.74 122.4 1.15 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.325 -0.859 . . . . 0.0 109.352 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.2 -10.9 36.89 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.477 ' C ' ' CD2' ' A' ' 35' ' ' PHE . 4.3 m-20 -93.5 156.71 16.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.151 -1.205 . . . . 0.0 109.381 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.477 ' CD2' ' C ' ' A' ' 34' ' ' ASP . 77.2 m-85 -146.83 134.38 20.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.201 -0.937 . . . . 0.0 109.6 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.598 ' CD2' ' NZ ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -103.63 120.02 40.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 109.329 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.471 ' OG1' ' OE1' ' A' ' 65' ' ' GLU . 59.1 p -61.9 -23.05 66.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 109.44 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.451 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -88.33 24.97 9.85 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.511 ' OD1' ' CG ' ' A' ' 20' ' ' GLU . 7.1 m-20 -159.52 135.34 8.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.283 -1.128 . . . . 0.0 109.334 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.534 ' HB1' ' HE1' ' A' ' 60' ' ' TYR . . . -77.83 140.6 39.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -0.901 . . . . 0.0 109.318 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -116.33 135.04 54.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -0.859 . . . . 0.0 109.383 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.95 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -118.92 136.37 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.414 -0.804 . . . . 0.0 109.265 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.95 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -130.64 141.58 45.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.776 179.81 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.682 HD23 ' N ' ' A' ' 45' ' ' LYS . 4.6 tt -129.32 117.31 20.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.311 -0.868 . . . . 0.0 109.688 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.682 ' N ' HD23 ' A' ' 44' ' ' LEU . 4.6 ttmm -89.07 134.65 33.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.842 . . . . 0.0 109.38 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.6 OUTLIER -140.81 116.33 10.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.159 -0.963 . . . . 0.0 109.432 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.803 ' O ' HD23 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -125.58 168.44 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.18 -0.95 . . . . 0.0 109.183 -179.816 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.832 HE22 ' H ' ' A' ' 51' ' ' ASN . 1.0 OUTLIER -115.56 123.33 48.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.564 -0.71 . . . . 0.0 109.163 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.594 ' N ' ' OE1' ' A' ' 48' ' ' GLN . 0.5 OUTLIER -103.46 100.41 10.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.285 -0.885 . . . . 0.0 109.532 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.584 ' C ' ' O ' ' A' ' 49' ' ' LEU . 19.7 mtp180 25.89 58.99 0.06 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.654 -0.654 . . . . 0.0 110.032 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.832 ' H ' HE22 ' A' ' 48' ' ' GLN . 1.8 m-20 55.23 50.54 14.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.351 -0.843 . . . . 0.0 109.382 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . -93.53 -79.71 1.45 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.419 ' O ' ' O ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -164.61 22.06 0.06 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -1.171 . . . . 0.0 109.515 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.803 HD23 ' O ' ' A' ' 47' ' ' VAL . 11.4 mt 56.35 104.81 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.641 0.734 . . . . 0.0 109.359 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 46' ' ' THR . 4.5 tt0 -68.71 116.29 9.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.55 -0.719 . . . . 0.0 109.236 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.627 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 96.3 m-85 -104.39 115.24 30.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.364 -0.835 . . . . 0.0 109.964 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.89 155.05 36.25 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.439 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 4.3 tp -142.63 137.91 30.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.936 -1.102 . . . . 0.0 110.521 -179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.653 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -130.02 119.55 23.32 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.524 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.534 ' HE1' ' HB1' ' A' ' 40' ' ' ALA . 3.6 t80 -101.57 124.44 47.23 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.01 -1.056 . . . . 0.0 109.387 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -103.81 126.64 51.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.11 -0.994 . . . . 0.0 109.799 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.425 ' CD2' ' OH ' ' A' ' 60' ' ' TYR . 6.4 mt -97.28 162.07 13.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.449 -0.782 . . . . 0.0 109.657 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.97 154.59 16.87 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -74.62 -12.34 60.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.056 -1.261 . . . . 0.0 109.52 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.471 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 1.2 mt-10 -109.23 30.35 6.68 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 2.1 m -130.49 97.42 4.39 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 122.075 0.94 . . . . 0.0 108.586 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.2 p -73.27 -170.88 0.85 Allowed 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.665 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -55.49 -28.18 52.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.792 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.31 -58.87 4.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 0.0 109.571 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.451 ' OE2' ' O ' ' A' ' 65' ' ' GLU . 24.3 mt-10 -62.95 -43.02 99.93 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.264 -0.898 . . . . 0.0 108.998 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.0 t -64.69 -34.68 78.88 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.454 -0.779 . . . . 0.0 108.953 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.03 -43.15 99.81 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.23 -50.33 73.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -1.125 . . . . 0.0 109.116 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.479 ' O ' ' OG1' ' A' ' 78' ' ' THR . . . -61.63 -40.02 93.38 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.469 -0.769 . . . . 0.0 109.267 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.488 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -64.37 -42.7 96.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.866 . . . . 0.0 109.428 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.2 mt -55.4 -53.88 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.183 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -57.87 -32.19 67.44 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.187 -0.946 . . . . 0.0 109.228 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -69.44 -52.42 27.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.008 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 75' ' ' ALA . 37.7 t -56.92 -26.55 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.289 -0.882 . . . . 0.0 109.097 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -70.11 -55.9 8.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.383 -0.823 . . . . 0.0 109.295 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.695 ' C ' HD12 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -54.17 -29.82 47.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.035 -1.041 . . . . 0.0 109.04 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 85' ' ' LEU . 72.7 m-20 -68.94 -58.77 3.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.244 -0.91 . . . . 0.0 108.806 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 82' ' ' ASP . 52.9 t0 -46.86 -29.6 2.07 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.124 -0.985 . . . . 0.0 108.465 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -75.15 -33.79 61.55 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.9 tp -107.63 25.72 11.15 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.424 -0.797 . . . . 0.0 109.375 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 85' ' ' LEU . 2.9 m120 39.09 33.9 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.582 -0.699 . . . . 0.0 109.476 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . 53.98 84.6 0.03 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 45.0 mtp85 -140.22 43.08 1.91 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.318 -1.107 . . . . 0.0 109.391 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.627 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -150.67 170.68 18.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.858 . . . . 0.0 109.404 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.1 t -91.26 91.87 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 109.266 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.525 ' H ' ' CD ' ' A' ' 91' ' ' GLN . 2.3 mp0 -94.34 120.07 34.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -0.885 . . . . 0.0 109.49 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.602 ' NE2' ' ND1' ' A' ' 59' ' ' HIS . 3.9 p80 -127.94 134.09 49.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.359 -0.838 . . . . 0.0 109.381 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.496 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 0.8 OUTLIER -90.52 117.82 29.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.718 -179.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.477 ' OE2' ' OG ' ' A' ' 100' ' ' SER . 11.3 mt-10 -108.28 161.13 15.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 109.354 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.7 t -132.53 158.03 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.184 -0.947 . . . . 0.0 109.538 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.548 ' NE2' ' C ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -61.98 143.79 56.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 109.443 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.533 ' N ' HE21 ' A' ' 96' ' ' GLN . . . 73.95 7.71 76.51 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -151.39 22.01 0.73 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.316 -1.108 . . . . 0.0 109.322 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -51.62 171.21 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.569 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.477 ' OG ' ' OE2' ' A' ' 94' ' ' GLU . 67.5 p -101.11 165.77 11.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.328 -0.858 . . . . 0.0 109.488 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.47 -33.21 73.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 0.0 109.487 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.2 m -59.92 -42.81 94.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.479 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -66.21 -53.46 36.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.242 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.3 mt -62.58 -27.94 69.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.352 -0.843 . . . . 0.0 109.169 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -69.35 -35.65 76.73 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.522 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 1.9 m-85 -70.13 -54.92 10.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -1.101 . . . . 0.0 109.251 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.522 ' CD2' ' O ' ' A' ' 106' ' ' TYR . 10.0 m-85 -139.36 115.57 10.4 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.425 -0.797 . . . . 0.0 109.562 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.8 tttp -98.72 -52.02 3.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.313 -0.867 . . . . 0.0 109.52 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 m -92.61 23.11 4.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 109.467 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -119.16 -30.27 1.62 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.0 mt -63.8 123.39 18.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.221 -1.164 . . . . 0.0 109.509 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -137.12 102.65 4.9 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.305 -0.872 . . . . 0.0 109.448 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.69 136.42 35.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.905 . . . . 0.0 109.373 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.598 ' NZ ' ' CD2' ' A' ' 36' ' ' PHE . 9.5 pttp -131.54 147.38 52.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 109.464 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.417 ' HD3' ' H ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.353 -0.842 . . . . 0.0 109.433 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo . . . . . 0 N--CA 1.488 1.183 0 CA-C-O 121.248 0.437 . . . . 0.0 112.085 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 6' ' ' LEU . 75.8 mt-10 -83.11 -30.77 27.66 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.275 -0.89 . . . . 0.0 109.708 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.61 ' CE1' HG12 ' A' ' 42' ' ' VAL . 46.8 t80 -43.88 -18.31 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.134 -0.979 . . . . 0.0 109.233 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.565 ' N ' ' O ' ' A' ' 4' ' ' GLU . 4.6 mt -81.4 -39.96 24.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.337 -0.852 . . . . 0.0 109.53 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 8' ' ' ALA . 28.3 mtpt -86.93 -12.83 46.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 109.615 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.471 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -42.23 164.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.193 -0.942 . . . . 0.0 109.509 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.12 26.95 5.28 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -102.04 12.53 36.71 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.205 -1.173 . . . . 0.0 109.653 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -158.3 133.69 5.79 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.915 . . . . 0.0 109.466 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -74.58 86.02 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.499 2.133 . . . . 0.0 112.34 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -170.18 -105.59 0.18 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.3 tt -162.2 144.69 11.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.311 -1.111 . . . . 0.0 109.517 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -138.02 134.73 35.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 109.375 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.735 HG23 HD12 ' A' ' 43' ' ' ILE . 27.1 mt -106.92 147.38 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.338 -0.851 . . . . 0.0 110.167 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.08 141.94 36.15 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 25' ' ' VAL . 18.7 ttt180 -110.39 144.85 38.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.177 -0.952 . . . . 0.0 109.635 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.553 HG21 ' HB3' ' A' ' 40' ' ' ALA . 52.0 t -72.48 133.51 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.436 -0.79 . . . . 0.0 109.502 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.633 ' O ' ' N ' ' A' ' 22' ' ' PHE . 28.0 tt0 -81.08 86.85 6.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -0.966 . . . . 0.0 109.366 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.463 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 26.2 mmtp 61.05 -33.09 0.08 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.487 -0.758 . . . . 0.0 109.994 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.633 ' N ' ' O ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER 179.34 27.31 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -0.932 . . . . 0.0 109.394 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -145.15 -113.52 0.09 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.083 -1.01 . . . . 0.0 109.626 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.7 mt -143.66 136.37 27.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.066 -1.021 . . . . 0.0 109.799 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 18' ' ' ARG . 0.9 OUTLIER -149.16 140.37 14.18 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.302 -0.874 . . . . 0.0 108.759 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.49 149.42 68.59 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.551 2.167 . . . . 0.0 112.516 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.421 HG23 ' N ' ' A' ' 18' ' ' ARG . 71.6 t -117.94 101.82 51.56 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.492 -0.755 . . . . 0.0 109.207 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -80.84 167.91 18.0 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.655 2.237 . . . . 0.0 112.461 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.564 ' C ' ' H ' ' A' ' 31' ' ' LEU . 1.9 t -61.03 -173.91 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.546 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.464 ' N ' ' OG1' ' A' ' 29' ' ' THR . 8.1 t30 70.31 -27.71 0.17 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.861 . . . . 0.0 109.343 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.564 ' H ' ' C ' ' A' ' 29' ' ' THR . 43.5 mt -122.73 -33.41 3.39 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.392 -0.818 . . . . 0.0 109.369 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -48.59 165.13 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 0.0 109.319 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.468 ' N ' ' CD1' ' A' ' 32' ' ' TYR . . . 89.04 -24.08 14.85 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -96.71 150.76 20.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -1.182 . . . . 0.0 109.469 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -141.03 134.17 29.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.898 . . . . 0.0 109.418 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.484 ' C ' ' H ' ' A' ' 38' ' ' GLY . 25.6 m-85 -104.53 111.78 24.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.872 . . . . 0.0 109.482 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.469 ' OG1' ' OE1' ' A' ' 65' ' ' GLU . 19.6 p -51.55 -9.51 0.08 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.237 -0.915 . . . . 0.0 109.356 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.484 ' H ' ' C ' ' A' ' 36' ' ' PHE . . . -99.51 27.12 21.64 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.443 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 50.2 m-20 -161.01 146.76 14.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -1.086 . . . . 0.0 109.368 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.553 ' HB3' HG21 ' A' ' 19' ' ' VAL . . . -92.23 158.88 15.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.192 -0.942 . . . . 0.0 109.483 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.437 ' CD2' ' C ' ' A' ' 40' ' ' ALA . 36.4 m-85 -138.26 138.12 38.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 109.369 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.005 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -108.83 128.44 64.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.129 -0.982 . . . . 0.0 108.902 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 1.005 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.4 OUTLIER -125.76 136.97 59.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.242 -0.911 . . . . 0.0 110.023 -179.523 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 tt -124.55 128.85 49.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.545 -0.722 . . . . 0.0 109.582 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.447 ' NZ ' HG21 ' A' ' 102' ' ' THR . 30.3 ttpt -103.79 145.96 29.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.311 -0.868 . . . . 0.0 109.06 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 13' ' ' GLY . 1.0 OUTLIER -143.01 126.78 17.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 109.764 -179.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -131.94 168.09 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.29 -0.881 . . . . 0.0 109.16 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -96.82 131.86 43.13 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.597 -0.689 . . . . 0.0 109.497 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 50' ' ' ARG . 14.5 mt -96.92 166.93 11.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.301 -0.874 . . . . 0.0 109.538 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.48 ' H ' ' HD2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -45.18 -78.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.272 -0.892 . . . . 0.0 109.17 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -45.53 -28.97 1.04 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.291 -0.881 . . . . 0.0 109.252 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.55 69.07 1.03 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.499 ' O ' ' O ' ' A' ' 54' ' ' LEU . 63.5 m-20 -120.73 14.44 11.72 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.242 -1.152 . . . . 0.0 109.384 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.661 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 17.7 mt 44.1 97.05 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.509 0.671 . . . . 0.0 109.364 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -71.08 112.08 6.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.428 -0.795 . . . . 0.0 109.527 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.59 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 73.7 m-85 -95.74 114.54 26.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.136 -0.978 . . . . 0.0 109.701 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -115.78 155.38 27.92 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 58' ' ' LEU . 3.8 mp -132.3 141.1 48.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.815 -1.178 . . . . 0.0 110.884 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.484 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -136.7 112.43 9.46 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.233 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.735 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -94.38 126.93 39.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.086 -1.008 . . . . 0.0 109.458 -179.6 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.456 ' HE1' ' HG2' ' A' ' 99' ' ' GLU . 2.3 t90 -98.08 124.73 42.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.475 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 mt -107.64 145.86 32.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.532 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -95.01 158.87 22.59 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -76.23 -12.53 60.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.322 -1.105 . . . . 0.0 109.662 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.469 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 1.1 mt-10 -109.45 29.16 7.82 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 2.0 m -130.7 97.48 4.37 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.211 1.005 . . . . 0.0 108.579 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.8 t -57.35 -170.92 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.735 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.562 ' O ' ' N ' ' A' ' 72' ' ' GLY . 3.2 mm100 -68.99 -17.39 63.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -0.86 . . . . 0.0 109.647 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -61.02 -58.75 7.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 109.394 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -64.38 -49.08 73.0 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.237 -0.914 . . . . 0.0 108.884 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.3 m -64.43 -23.22 67.21 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.399 -0.813 . . . . 0.0 108.844 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -68.44 -47.09 59.62 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.433 ' O ' ' CE2' ' A' ' 77' ' ' PHE . . . -62.63 -49.25 75.92 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.293 -1.122 . . . . 0.0 109.138 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.62 -32.51 74.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.507 -0.746 . . . . 0.0 109.214 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.556 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -71.59 -43.96 65.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.264 -0.898 . . . . 0.0 109.376 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.496 ' O ' ' OE1' ' A' ' 80' ' ' GLN . 59.4 mt -55.09 -53.17 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.188 -0.945 . . . . 0.0 109.24 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.559 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -60.0 -36.57 77.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.134 179.784 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.1 m -69.2 -31.42 70.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.283 -0.886 . . . . 0.0 108.999 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 75' ' ' ALA . 55.1 t -64.83 -46.09 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.271 -0.893 . . . . 0.0 109.242 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . 0.552 ' OE1' ' N ' ' A' ' 80' ' ' GLN . 5.1 mp0 -60.97 -45.42 94.82 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.6 mt -53.27 -43.93 67.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.315 -0.866 . . . . 0.0 109.037 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.64 ' O ' ' N ' ' A' ' 86' ' ' ASN . 68.4 t0 -58.14 -58.23 9.37 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.396 -0.815 . . . . 0.0 109.145 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 82' ' ' ASP . 1.9 m-20 -44.73 -34.41 2.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.155 -0.966 . . . . 0.0 108.948 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -77.08 -30.94 55.69 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.299 -0.876 . . . . 0.0 108.98 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 82' ' ' ASP . 18.7 mt -121.56 32.39 5.91 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.315 -0.866 . . . . 0.0 109.486 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.64 ' N ' ' O ' ' A' ' 82' ' ' ASP . 60.8 t30 -81.08 28.28 0.37 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.207 -0.933 . . . . 0.0 109.097 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -110.45 -37.26 1.79 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -163.23 67.78 0.2 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.154 -1.204 . . . . 0.0 109.45 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.07 166.17 24.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.0 109.321 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.9 t -123.12 96.34 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.342 -0.849 . . . . 0.0 109.545 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.58 131.38 44.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.315 -0.865 . . . . 0.0 109.036 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.569 ' N ' ' CD2' ' A' ' 92' ' ' HIS . 1.6 p80 -150.55 157.36 42.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.006 -1.059 . . . . 0.0 110.037 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.71 121.34 40.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.407 -0.808 . . . . 0.0 109.666 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.447 ' N ' ' CD ' ' A' ' 94' ' ' GLU . 1.5 mp0 -104.69 120.93 42.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.296 -0.878 . . . . 0.0 109.407 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.556 HG12 ' N ' ' A' ' 96' ' ' GLN . 38.9 t -101.18 166.72 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.317 -0.865 . . . . 0.0 109.581 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . 0.556 ' N ' HG12 ' A' ' 95' ' ' VAL . 41.4 tt0 -76.17 140.87 41.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.493 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.424 ' O ' ' CG ' ' A' ' 98' ' ' PHE . . . 80.51 5.02 90.1 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.472 ' O ' ' O ' ' A' ' 99' ' ' GLU . 46.1 m-85 -157.64 22.42 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -1.126 . . . . 0.0 109.457 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' A' ' 98' ' ' PHE . 97.3 mt-10 -49.05 178.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.405 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.3 t -89.63 163.09 15.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.424 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.08 -26.73 67.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.404 -0.81 . . . . 0.0 109.433 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.447 HG21 ' NZ ' ' A' ' 45' ' ' LYS . 7.5 m -65.62 -41.72 92.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.485 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -75.26 -41.95 56.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.372 -0.83 . . . . 0.0 109.336 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.5 mt -62.46 -24.68 67.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.271 -0.893 . . . . 0.0 109.519 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -92.94 -24.02 23.87 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.11 -35.77 69.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.274 -1.133 . . . . 0.0 109.417 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -139.16 133.82 31.97 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.328 -0.858 . . . . 0.0 109.529 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -108.59 -55.45 2.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.436 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.4 t -105.56 15.36 27.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 109.532 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.45 -20.01 18.84 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.5 mt -72.61 70.66 0.94 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -1.18 . . . . 0.0 109.438 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -85.4 124.04 31.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.291 -0.881 . . . . 0.0 109.581 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -105.29 152.76 22.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.485 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.4 mttt -138.83 163.65 31.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.329 -0.857 . . . . 0.0 109.416 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.8 mttt . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.313 -0.867 . . . . 0.0 109.461 -179.949 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . 0.586 ' HA ' HD23 ' A' ' 24' ' ' LEU . 54.0 Cg_exo . . . . . 0 N--CA 1.492 1.42 0 CA-C-O 121.262 0.443 . . . . 0.0 112.116 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.497 ' OE2' ' CH2' ' A' ' 17' ' ' TRP . 19.6 tt0 -83.23 -44.03 15.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 109.982 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.464 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 5.4 m-85 -49.35 -28.73 5.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.185 -0.947 . . . . 0.0 109.435 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.5 mt -74.78 -29.22 61.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 109.597 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.6 mmtm -123.76 26.38 7.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -0.911 . . . . 0.0 109.523 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 4' ' ' GLU . . . -81.35 173.3 12.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.354 -0.841 . . . . 0.0 109.568 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.32 44.8 0.17 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.92 30.54 3.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.381 -1.07 . . . . 0.0 109.497 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.542 ' OE1' ' NE2' ' A' ' 15' ' ' GLN . 1.2 pm0 -164.14 117.17 1.01 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.173 -0.955 . . . . 0.0 109.367 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -77.67 89.47 1.33 Allowed 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.432 2.088 . . . . 0.0 112.088 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -177.98 -98.34 0.11 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -162.06 138.51 7.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -1.142 . . . . 0.0 109.638 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.542 ' NE2' ' OE1' ' A' ' 11' ' ' GLU . 19.1 mt-30 -114.99 135.89 53.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.435 -0.791 . . . . 0.0 108.974 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.62 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 13.1 mt -130.19 116.53 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.345 -0.847 . . . . 0.0 110.114 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TRP . . . . . 0.62 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 7.6 m0 -144.2 152.16 40.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.054 -1.029 . . . . 0.0 109.116 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.58 ' O ' ' N ' ' A' ' 25' ' ' VAL . 0.9 OUTLIER -101.84 153.29 19.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.93 . . . . 0.0 109.801 -179.283 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 23' ' ' ASP . 12.5 t -97.47 131.2 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.42 -0.8 . . . . 0.0 109.538 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.65 ' O ' ' N ' ' A' ' 22' ' ' PHE . 1.9 tm-20 -76.83 86.65 3.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.132 -0.98 . . . . 0.0 108.732 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.6 ' O ' ' CB ' ' A' ' 22' ' ' PHE . 25.2 mtmm 48.31 3.86 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.375 -0.828 . . . . 0.0 109.539 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.65 ' N ' ' O ' ' A' ' 20' ' ' GLU . 1.4 t80 155.59 -30.22 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.424 -0.797 . . . . 0.0 109.472 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.728 ' O ' HG13 ' A' ' 19' ' ' VAL . 1.7 t70 -81.62 -133.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.171 -0.956 . . . . 0.0 109.844 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.741 HD13 ' H ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -137.03 140.13 41.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -0.916 . . . . 0.0 109.607 -179.767 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.741 ' H ' HD13 ' A' ' 24' ' ' LEU . 9.4 t -137.79 91.6 13.47 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 108.999 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -52.42 159.35 4.56 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.654 2.236 . . . . 0.0 112.574 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.1 t -145.25 112.83 4.77 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.354 -0.841 . . . . 0.0 109.077 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 29' ' ' THR . 60.0 Cg_endo -77.88 168.14 22.66 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.44 2.093 . . . . 0.0 112.468 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -51.73 -174.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.389 -0.819 . . . . 0.0 109.361 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.573 ' N ' ' OG1' ' A' ' 29' ' ' THR . 0.3 OUTLIER 69.17 -36.76 0.35 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.17 -0.956 . . . . 0.0 109.222 -179.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.555 ' H ' ' C ' ' A' ' 29' ' ' THR . 14.4 mt -109.21 -36.36 6.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.442 -0.786 . . . . 0.0 109.198 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 31' ' ' LEU . 1.9 p90 -43.22 166.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.348 -0.845 . . . . 0.0 109.376 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.89 -12.88 15.38 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.3 158.81 18.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.212 -1.17 . . . . 0.0 109.481 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -144.99 108.42 4.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 109.56 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.474 ' C ' ' H ' ' A' ' 38' ' ' GLY . 2.8 m-85 -80.32 111.91 17.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 109.136 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.44 ' OG1' ' OE1' ' A' ' 65' ' ' GLU . 8.7 p -56.65 -4.97 0.18 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.185 -0.947 . . . . 0.0 109.618 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 36' ' ' PHE . . . -109.7 39.09 3.03 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.529 ' N ' ' SG ' ' A' ' 66' ' ' CYS . 8.2 m-20 -169.34 -176.38 2.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -1.173 . . . . 0.0 109.622 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.51 129.37 50.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.372 -0.83 . . . . 0.0 109.343 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -114.07 137.31 51.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 109.688 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.966 ' O ' HD13 ' A' ' 43' ' ' ILE . 0.4 OUTLIER -115.24 142.82 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.297 -0.877 . . . . 0.0 109.18 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.966 HD13 ' O ' ' A' ' 42' ' ' VAL . 0.7 OUTLIER -136.34 143.2 36.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.108 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.8 tt -128.05 118.97 24.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.484 -0.76 . . . . 0.0 109.238 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 50.2 tttt -88.85 138.74 31.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 109.426 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -141.64 114.37 8.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.93 . . . . 0.0 109.477 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.674 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -126.03 168.04 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 121.13 -0.981 . . . . 0.0 109.069 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -100.92 101.37 12.17 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.675 -0.641 . . . . 0.0 109.395 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.6 mt -57.04 163.86 1.87 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.933 . . . . 0.0 109.434 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.2 ptt85 -48.82 -47.65 42.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 0.0 109.308 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -70.65 -30.1 66.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.176 -0.952 . . . . 0.0 109.158 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.47 34.93 3.99 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.501 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.6 t-20 -89.97 13.39 14.85 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.183 -1.187 . . . . 0.0 109.325 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.674 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.4 mt 43.38 96.97 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.578 0.704 . . . . 0.0 109.456 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -71.17 116.16 11.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.551 -0.718 . . . . 0.0 109.581 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.54 ' CD1' ' O ' ' A' ' 54' ' ' LEU . 90.4 m-85 -100.7 114.7 28.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 0.0 109.858 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.428 ' HB3' ' HE2' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -120.7 155.16 34.48 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.064 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.449 ' C ' ' CG ' ' A' ' 59' ' ' HIS . 5.2 mp -132.62 147.79 52.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.967 -1.083 . . . . 0.0 110.466 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . 0.462 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 1.4 m-70 -150.34 127.17 11.03 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.628 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 1.1 p90 -115.18 132.69 56.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.045 -1.035 . . . . 0.0 109.941 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.458 ' CE3' ' O ' ' A' ' 62' ' ' LEU . 10.3 t90 -102.97 123.88 47.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.375 -0.828 . . . . 0.0 109.238 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.458 ' O ' ' CE3' ' A' ' 61' ' ' TRP . 22.7 mt -101.85 162.12 13.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 109.657 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.03 154.61 16.49 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -82.15 -12.09 58.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -1.128 . . . . 0.0 109.572 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.44 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 2.8 mt-10 -106.58 29.09 7.23 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 39' ' ' ASP . 1.6 m -130.64 97.55 4.4 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 122.15 0.976 . . . . 0.0 108.381 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 66' ' ' CYS . 9.9 m -39.03 161.57 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.707 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 72' ' ' GLY . 15.9 mm-40 -56.2 -17.41 7.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.389 -0.819 . . . . 0.0 109.661 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -63.98 -58.56 6.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 109.371 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.455 ' OE1' ' SG ' ' A' ' 66' ' ' CYS . 24.2 mt-10 -61.06 -54.26 46.95 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.345 -0.847 . . . . 0.0 108.987 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 p -64.13 -26.22 68.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.318 -0.864 . . . . 0.0 109.043 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.38 -41.77 66.75 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.14 -46.74 82.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -1.18 . . . . 0.0 109.28 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.12 -46.31 89.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.427 -0.795 . . . . 0.0 109.07 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.39 -41.53 80.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.345 -0.847 . . . . 0.0 109.26 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 51.0 mt -57.68 -46.24 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.278 -0.889 . . . . 0.0 109.279 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -59.03 -35.34 73.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 109.143 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.7 m -72.34 -25.55 61.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.183 -0.948 . . . . 0.0 109.038 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.4 t -72.77 -48.77 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.306 -0.871 . . . . 0.0 109.541 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -65.86 -35.94 82.07 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.141 -0.975 . . . . 0.0 108.85 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.85 -42.56 98.04 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.628 ' O ' ' N ' ' A' ' 86' ' ' ASN . 51.9 t0 -61.16 -57.35 12.85 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.315 -0.865 . . . . 0.0 109.214 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -48.43 -31.38 6.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.142 -0.974 . . . . 0.0 108.707 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -78.59 -31.12 47.06 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.423 -0.798 . . . . 0.0 108.882 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.484 ' C ' ' H ' ' A' ' 87' ' ' GLY . 9.9 mt -121.71 32.7 5.77 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.435 -0.79 . . . . 0.0 109.518 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASN . . . . . 0.628 ' N ' ' O ' ' A' ' 82' ' ' ASP . 17.8 t-20 -77.35 27.03 0.16 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.243 -0.91 . . . . 0.0 109.024 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.484 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -94.34 -48.41 2.6 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -152.21 45.61 0.74 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.168 -1.196 . . . . 0.0 109.638 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 56' ' ' TYR . . . -136.95 157.46 46.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.431 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 19.2 t -136.05 141.37 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 109.466 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.423 ' N ' ' CD ' ' A' ' 91' ' ' GLN . 6.8 mm-40 -88.95 142.47 27.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.212 -0.93 . . . . 0.0 109.37 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.492 ' O ' ' OE1' ' A' ' 94' ' ' GLU . 15.3 m-70 -118.29 115.24 24.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.268 -0.895 . . . . 0.0 109.461 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.84 104.92 15.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.233 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.589 ' OE2' ' CE2' ' A' ' 103' ' ' PHE . 1.5 mp0 -104.62 124.09 48.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.877 . . . . 0.0 109.65 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.1 t -125.76 155.56 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.312 -0.867 . . . . 0.0 109.17 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -55.54 115.98 2.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.19 -0.943 . . . . 0.0 109.624 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.519 ' O ' ' CD1' ' A' ' 98' ' ' PHE . . . 93.34 10.18 59.68 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 78.8 m-85 -152.94 25.37 0.56 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.179 -1.189 . . . . 0.0 109.669 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 2.1 mp0 -48.19 135.52 13.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.119 -0.988 . . . . 0.0 109.428 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.5 t -61.46 171.42 1.46 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.104 -0.998 . . . . 0.0 109.552 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.11 -65.06 0.82 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 109.593 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.0 m -50.55 -27.39 6.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 109.308 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . 0.589 ' CE2' ' OE2' ' A' ' 94' ' ' GLU . 32.0 t80 -74.82 -55.59 5.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 0.0 109.799 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.439 ' C ' HD12 ' A' ' 104' ' ' LEU . 1.6 pp -67.18 -22.08 65.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.057 -1.027 . . . . 0.0 109.372 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.76 -33.12 34.86 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -78.4 -43.82 26.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -1.127 . . . . 0.0 109.422 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.465 ' HB2' HD21 ' A' ' 111' ' ' LEU . 51.8 m-85 -102.21 105.83 16.57 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.397 -0.814 . . . . 0.0 109.579 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -111.65 -49.85 2.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.358 -0.839 . . . . 0.0 109.513 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.0 t -106.04 23.16 14.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.094 -1.003 . . . . 0.0 109.514 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.575 ' O ' ' N ' ' A' ' 112' ' ' LYS . . . -125.18 -15.41 3.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.465 HD21 ' HB2' ' A' ' 107' ' ' PHE . 95.2 mt -62.13 70.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -1.176 . . . . 0.0 109.508 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.575 ' N ' ' O ' ' A' ' 110' ' ' GLY . 29.4 tttt -93.25 108.49 20.11 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.202 -0.936 . . . . 0.0 109.565 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.66 143.79 27.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.369 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -133.54 115.99 15.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 0.0 109.426 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.87 . . . . 0.0 109.47 179.969 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.481 ' CE1' ' OD2' ' A' ' 23' ' ' ASP . 1.6 p-80 -146.2 78.35 11.34 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.212 -0.93 . . . . 0.0 109.526 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -76.84 97.06 1.12 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.747 2.298 . . . . 0.0 111.946 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.574 ' O ' ' N ' ' A' ' 8' ' ' ALA . 16.7 mt-10 -83.34 -39.68 20.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.898 . . . . 0.0 110.138 -179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.715 ' CE2' HG12 ' A' ' 42' ' ' VAL . 23.5 t80 -61.78 -46.81 87.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.133 -0.979 . . . . 0.0 109.866 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.579 ' H ' HD12 ' A' ' 6' ' ' LEU . 3.4 mp -71.84 -32.99 68.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.068 -1.02 . . . . 0.0 109.439 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.9 mmtm -94.78 0.88 55.3 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.257 -0.902 . . . . 0.0 109.459 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 4' ' ' GLU . . . -52.1 153.74 2.59 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 109.424 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 137.52 68.42 0.05 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.8 pttt -144.66 8.14 1.3 Allowed 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.24 -1.153 . . . . 0.0 109.567 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -166.61 126.76 1.19 Allowed Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.223 -0.923 . . . . 0.0 109.243 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -75.85 94.56 1.0 Allowed 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.405 2.07 . . . . 0.0 112.213 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.529 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -174.18 -104.18 0.17 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.6 tp -156.01 134.42 11.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.366 -1.079 . . . . 0.0 109.764 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -126.55 131.93 51.45 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.866 . . . . 0.0 109.357 179.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.6 mt -108.0 137.1 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.422 -0.799 . . . . 0.0 109.758 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -139.5 166.19 25.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.261 -0.899 . . . . 0.0 109.063 179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -144.96 142.16 29.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.126 -0.984 . . . . 0.0 109.725 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.506 ' O ' HG13 ' A' ' 19' ' ' VAL . 7.6 p -79.76 127.95 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.292 -0.88 . . . . 0.0 109.566 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.529 ' CB ' HG21 ' A' ' 25' ' ' VAL . 2.6 mm-40 -164.18 134.47 4.16 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.298 -0.876 . . . . 0.0 109.267 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 20' ' ' GLU . 29.4 tttm 75.99 41.62 0.23 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.369 -0.832 . . . . 0.0 109.56 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 48.33 43.62 19.39 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.173 -0.954 . . . . 0.0 109.444 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.481 ' OD2' ' CE1' ' A' ' 2' ' ' HIS . 26.3 t0 -173.33 -172.05 0.76 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.267 -0.896 . . . . 0.0 109.459 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.549 ' N ' HD22 ' A' ' 24' ' ' LEU . 3.9 mm? -88.49 138.15 31.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.249 -0.907 . . . . 0.0 109.503 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.529 HG21 ' CB ' ' A' ' 20' ' ' GLU . 5.0 t -138.83 128.36 14.45 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.219 -0.926 . . . . 0.0 109.253 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -74.95 166.36 29.39 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.36 2.04 . . . . 0.0 112.355 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.6 t -111.12 101.3 49.86 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.367 -0.833 . . . . 0.0 109.404 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -53.27 168.08 0.67 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.533 2.155 . . . . 0.0 112.363 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.559 HG22 ' N ' ' A' ' 30' ' ' ASN . 24.5 m -60.16 170.56 1.23 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.342 -0.849 . . . . 0.0 109.032 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.559 ' N ' HG22 ' A' ' 29' ' ' THR . 0.9 OUTLIER 69.69 -40.91 0.47 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.205 -0.934 . . . . 0.0 109.195 -179.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.502 ' H ' ' C ' ' A' ' 29' ' ' THR . 96.0 mt -81.79 -44.22 17.27 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.376 -0.828 . . . . 0.0 109.209 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.498 ' CD1' ' N ' ' A' ' 33' ' ' GLY . 0.3 OUTLIER -53.42 138.33 33.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.359 -0.838 . . . . 0.0 109.138 179.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.498 ' N ' ' CD1' ' A' ' 32' ' ' TYR . . . 109.43 -8.99 32.86 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -121.81 115.5 22.75 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.351 -1.088 . . . . 0.0 109.375 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -87.86 140.07 29.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 109.589 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -102.17 146.19 28.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.266 -0.896 . . . . 0.0 109.334 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.5 p -92.42 -8.93 43.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -0.896 . . . . 0.0 109.468 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.434 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -107.94 35.79 4.78 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.434 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 9.7 m-20 -167.57 171.98 9.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.333 -1.098 . . . . 0.0 109.497 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -117.94 141.2 48.71 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.231 -0.918 . . . . 0.0 109.546 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -116.24 134.75 54.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.392 -0.817 . . . . 0.0 109.472 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.034 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -114.13 124.47 70.81 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.21 -0.931 . . . . 0.0 108.603 179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.034 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -121.33 133.8 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.174 -0.954 . . . . 0.0 110.03 -178.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.0 tt -122.68 121.65 36.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.504 -0.747 . . . . 0.0 109.906 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 69.6 tttt -96.56 141.87 29.31 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.371 -0.831 . . . . 0.0 108.954 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.529 ' O ' ' N ' ' A' ' 13' ' ' GLY . 29.1 m -137.17 128.05 27.38 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.037 -1.039 . . . . 0.0 109.72 -179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.587 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -132.68 168.72 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 O-C-N 121.223 -0.923 . . . . 0.0 109.231 -179.938 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -102.82 103.57 13.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.574 -0.704 . . . . 0.0 109.464 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 7.8 mt -72.7 169.01 17.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.282 -0.886 . . . . 0.0 109.711 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.42 ' C ' ' N ' ' A' ' 52' ' ' GLY . 14.7 mtt180 -45.52 -72.83 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.322 -0.861 . . . . 0.0 109.265 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 50' ' ' ARG . 0.4 OUTLIER -44.97 -24.18 0.2 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.911 . . . . 0.0 109.255 179.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.42 ' N ' ' C ' ' A' ' 50' ' ' ARG . . . 84.62 32.96 20.57 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.488 ' O ' ' O ' ' A' ' 54' ' ' LEU . 1.0 OUTLIER -86.58 14.26 7.19 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.165 -1.197 . . . . 0.0 109.205 -179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.59 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 12.6 mt 47.15 100.27 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.544 0.688 . . . . 0.0 109.608 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.597 ' NE2' ' H ' ' A' ' 56' ' ' TYR . 3.2 tm0? -68.57 145.35 54.05 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.573 -0.704 . . . . 0.0 109.129 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.597 ' H ' ' NE2' ' A' ' 55' ' ' GLN . 91.3 m-85 -129.77 114.67 16.24 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.222 -0.923 . . . . 0.0 109.925 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.413 ' OD1' ' OE1' ' A' ' 55' ' ' GLN . 70.7 m-20 -123.93 155.48 38.06 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -150.35 142.76 24.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.683 -1.261 . . . . 0.0 110.983 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.615 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -120.71 133.91 55.32 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.277 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.649 ' CZ ' HD22 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -105.14 115.38 30.16 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.361 -0.837 . . . . 0.0 109.366 -179.653 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.539 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 36.0 t90 -106.9 135.38 48.56 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.212 -0.93 . . . . 0.0 109.939 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.649 HD22 ' CZ ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -124.27 162.18 24.28 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.379 -0.826 . . . . 0.0 109.501 179.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -96.31 161.77 22.45 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.734 -1.347 . . . . 0.0 109.734 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 64.7 m-20 -82.11 -11.88 58.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.277 -1.131 . . . . 0.0 109.614 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -104.26 30.83 4.99 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.516 ' SG ' ' CD ' ' A' ' 70' ' ' GLU . 1.2 m -130.73 97.53 4.38 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-O 122.162 0.982 . . . . 0.0 108.433 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 66' ' ' CYS . 1.5 m -47.09 178.05 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.335 0 CA-C-N 115.675 -0.693 . . . . 0.0 109.694 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.759 ' H ' ' NE2' ' A' ' 68' ' ' GLN . 1.4 mp0 -61.22 -18.07 56.45 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.235 -0.915 . . . . 0.0 109.534 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -64.42 -58.78 5.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.167 -0.958 . . . . 0.0 109.359 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.516 ' CD ' ' SG ' ' A' ' 66' ' ' CYS . 25.5 mt-10 -66.02 -44.5 84.54 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 108.824 179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.85 -25.69 66.54 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.523 -0.736 . . . . 0.0 109.03 179.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.07 -47.01 48.26 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.134 -1.586 . . . . 0.0 109.134 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.74 91.31 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.271 -1.135 . . . . 0.0 109.193 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.404 ' HB1' ' CE1' ' A' ' 60' ' ' TYR . . . -61.32 -49.47 76.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.401 -0.812 . . . . 0.0 109.195 179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.577 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -62.75 -34.73 77.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.273 -0.892 . . . . 0.0 109.537 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 14.2 mt -57.26 -54.63 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.205 -0.934 . . . . 0.0 109.418 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -60.51 -33.47 72.68 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.108 -0.995 . . . . 0.0 109.47 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.3 m -69.72 -40.18 76.41 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.228 -0.92 . . . . 0.0 109.244 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 75' ' ' ALA . 81.0 t -61.81 -42.12 93.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.417 -0.802 . . . . 0.0 109.319 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.4 HE21 ' HA ' ' A' ' 80' ' ' GLN . 6.1 mm-40 -60.31 -51.32 70.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.295 -0.878 . . . . 0.0 109.009 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.6 mt -49.29 -43.1 43.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.25 -0.906 . . . . 0.0 108.951 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.605 ' O ' ' N ' ' A' ' 86' ' ' ASN . 19.6 t0 -57.02 -60.32 3.77 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.222 -0.924 . . . . 0.0 109.389 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.467 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 30.7 t0 -45.0 -35.86 3.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.145 -0.972 . . . . 0.0 108.88 179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.505 ' CE1' HD21 ' A' ' 85' ' ' LEU . 18.1 t80 -75.89 -28.87 58.27 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.563 ' C ' ' H ' ' A' ' 87' ' ' GLY . 47.8 mt -121.49 33.46 5.52 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.432 -0.792 . . . . 0.0 109.424 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.605 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.4 OUTLIER -73.13 25.62 0.06 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.148 -0.97 . . . . 0.0 109.052 179.889 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -84.4 -58.24 2.21 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -174.98 35.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.293 -1.122 . . . . 0.0 109.545 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.589 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -78.55 179.28 7.18 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.26 -0.9 . . . . 0.0 109.269 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 14.9 t -114.4 91.48 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.17 -0.956 . . . . 0.0 109.37 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.454 ' O ' ' CD ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -96.93 125.45 41.37 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.336 -0.852 . . . . 0.0 109.206 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.482 ' N ' ' CD2' ' A' ' 92' ' ' HIS . 1.8 p80 -151.48 118.68 5.93 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.036 -1.04 . . . . 0.0 109.513 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 60' ' ' TYR . 8.5 ptt-85 -91.71 134.63 34.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.382 -0.824 . . . . 0.0 109.792 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -112.89 155.98 23.76 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.424 -0.797 . . . . 0.0 109.566 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.498 HG12 ' H ' ' A' ' 96' ' ' GLN . 3.7 t -121.41 169.51 12.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.335 -0.853 . . . . 0.0 109.486 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.498 ' H ' HG12 ' A' ' 95' ' ' VAL . 14.1 tt0 -78.31 129.35 34.92 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 109.425 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 87.4 5.21 79.61 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.48 ' O ' ' O ' ' A' ' 99' ' ' GLU . 20.2 m-85 -146.06 19.51 1.42 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.242 -1.152 . . . . 0.0 109.463 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.48 ' O ' ' O ' ' A' ' 98' ' ' PHE . 0.0 OUTLIER -51.68 -173.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.3 -0.875 . . . . 0.0 109.403 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 5.0 t -137.89 175.77 9.29 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.222 -0.924 . . . . 0.0 109.524 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.53 -34.53 72.76 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.221 -0.924 . . . . 0.0 109.424 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.5 m -53.57 -47.01 70.48 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.53 -56.81 7.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.319 -0.863 . . . . 0.0 109.328 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 12.6 mt -56.36 -24.23 42.83 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.25 -0.906 . . . . 0.0 109.509 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.1 -30.03 26.69 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -71.01 -30.26 66.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.184 -1.186 . . . . 0.0 109.273 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -139.14 103.57 4.8 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.28 -0.888 . . . . 0.0 109.451 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 9.7 ptmt -102.86 -2.72 27.38 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.173 -0.954 . . . . 0.0 109.52 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.5 p -66.47 -16.12 63.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.187 -0.946 . . . . 0.0 109.486 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.89 88.78 2.07 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.685 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -70.1 135.44 49.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.236 -1.155 . . . . 0.0 109.379 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -90.18 142.23 27.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.331 -0.856 . . . . 0.0 109.582 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.443 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 20.4 m-85 -106.23 111.78 24.53 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.228 -0.92 . . . . 0.0 109.442 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.3 mttm -94.12 145.23 24.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 109.43 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.4 mtmm -138.28 137.67 37.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.356 -0.84 . . . . 0.0 109.52 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.4 115.01 0.07 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -100.25 74.65 0.44 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 90.5 t -60.82 89.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -1.139 . . . . 0.0 109.507 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -176.47 117.18 0.12 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 0.0 109.439 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 68.6 m -90.13 21.16 3.87 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.454 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -70.83 90.25 0.4 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -174.8 124.75 0.27 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.191 -1.182 . . . . 0.0 109.491 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 11.0 pttm -131.93 154.96 48.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.351 -0.843 . . . . 0.0 109.425 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 12.8 t60 -97.61 125.38 42.33 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.299 -0.875 . . . . 0.0 109.492 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 64.2 t -64.59 125.56 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.894 . . . . 0.0 109.412 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.401 HG22 ' H ' ' A' ' 126' ' ' VAL . 0.3 OUTLIER -95.61 153.89 39.34 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.948 . . . . 0.0 109.465 -179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.44 ' O ' ' O ' ' A' ' 128' ' ' ASN . 41.5 Cg_endo -70.89 97.36 0.73 Allowed 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.673 2.249 . . . . 0.0 112.142 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.44 ' O ' ' O ' ' A' ' 127' ' ' PRO . 29.2 m-20 43.04 -164.04 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.257 -0.902 . . . . 0.0 109.512 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.433 ' H ' ' CD ' ' A' ' 129' ' ' GLU . 35.1 mp0 -77.22 163.76 26.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.376 -0.828 . . . . 0.0 109.48 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.603 ' O ' HG12 ' A' ' 130' ' ' VAL . 39.1 t -74.59 13.31 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.145 -0.972 . . . . 0.0 109.434 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.422 ' C ' ' O ' ' A' ' 130' ' ' VAL . 2.2 p -43.66 -42.08 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.203 -0.935 . . . . 0.0 109.439 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 37.1 t -73.52 142.93 14.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.183 -0.948 . . . . 0.0 109.341 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 38.4 tp60 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 117.958 -1.02 . . . . 0.0 109.448 179.964 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.492 ' O ' ' CG ' ' A' ' 2' ' ' HIS . 16.5 tm-20 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.492 ' CG ' ' O ' ' A' ' 1' ' ' GLU . 9.1 m80 -163.74 58.92 0.73 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.251 -0.906 . . . . 0.0 109.495 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -71.33 71.84 2.32 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 C-N-CA 122.845 2.363 . . . . 0.0 112.174 179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.442 ' O ' ' N ' ' A' ' 8' ' ' ALA . 13.5 mm-40 -83.34 -46.04 13.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.167 -0.958 . . . . 0.0 109.872 -179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.616 ' CE1' ' O ' ' A' ' 42' ' ' VAL . 2.8 m-85 -67.17 -35.32 79.42 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.212 -0.93 . . . . 0.0 109.312 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.51 ' H ' HD12 ' A' ' 6' ' ' LEU . 4.2 mp -64.97 -35.23 80.52 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.916 . . . . 0.0 109.293 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 8' ' ' ALA . 10.5 mttp -103.86 2.4 32.6 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.354 -0.842 . . . . 0.0 109.472 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.852 ' HB1' HE22 ' A' ' 15' ' ' GLN . . . -46.81 175.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.91 . . . . 0.0 109.533 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 110.67 10.47 21.31 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.75 6.06 9.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.27 -1.135 . . . . 0.0 109.496 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -173.28 132.89 0.62 Allowed Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.219 -0.926 . . . . 0.0 109.468 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.65 90.8 1.02 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.482 2.122 . . . . 0.0 112.2 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.602 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -164.33 -107.73 0.21 Allowed Glycine 0 N--CA 1.488 2.162 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 51.6 tp -157.83 142.24 16.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.295 -1.121 . . . . 0.0 109.67 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.852 HE22 ' HB1' ' A' ' 8' ' ' ALA . 2.7 mt-30 -126.58 136.45 52.56 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.422 -0.799 . . . . 0.0 109.296 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.557 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 7.1 mt -133.01 113.77 20.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.387 -0.821 . . . . 0.0 109.875 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.557 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 8.3 m0 -139.77 151.41 45.77 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.073 -1.017 . . . . 0.0 109.378 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.434 ' HB2' HH21 ' A' ' 18' ' ' ARG . 18.1 ttp-105 -99.17 153.11 19.17 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.339 -0.851 . . . . 0.0 109.564 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.8 p -89.29 135.68 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.263 -0.898 . . . . 0.0 109.577 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.6 ' O ' ' N ' ' A' ' 22' ' ' PHE . 17.3 tt0 -86.93 151.03 23.66 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.169 -0.957 . . . . 0.0 109.131 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.475 ' O ' ' CD2' ' A' ' 22' ' ' PHE . 3.5 pttm -41.35 -19.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.354 -0.842 . . . . 0.0 109.515 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.6 ' N ' ' O ' ' A' ' 20' ' ' GLU . 26.2 m-85 -161.22 35.38 0.14 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.953 . . . . 0.0 109.471 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -174.65 -131.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.178 -0.951 . . . . 0.0 109.572 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.7 tp -143.33 146.23 33.37 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 109.526 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 t -131.09 95.07 26.04 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.463 -0.773 . . . . 0.0 109.402 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -48.18 147.78 7.91 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.58 2.187 . . . . 0.0 112.176 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 45.7 t -110.72 101.59 49.72 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.32 -0.862 . . . . 0.0 109.579 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -52.89 163.14 2.17 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.536 2.158 . . . . 0.0 112.402 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.601 ' O ' ' N ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -64.55 175.99 1.24 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.267 -0.896 . . . . 0.0 109.042 179.641 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.452 ' N ' ' OG1' ' A' ' 29' ' ' THR . 0.8 OUTLIER 64.54 -39.26 0.24 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.411 -0.806 . . . . 0.0 109.386 -179.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.601 ' N ' ' O ' ' A' ' 29' ' ' THR . 21.0 mt -83.77 -42.63 16.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.21 -0.931 . . . . 0.0 109.277 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.411 ' C ' ' O ' ' A' ' 31' ' ' LEU . 4.1 p90 -42.66 140.35 1.32 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.36 -0.838 . . . . 0.0 109.448 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 117.33 -26.35 8.22 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -94.84 154.62 17.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.337 -1.096 . . . . 0.0 109.374 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -141.34 125.64 17.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.194 -0.941 . . . . 0.0 109.56 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.549 ' C ' ' H ' ' A' ' 38' ' ' GLY . 36.2 m-85 -84.54 115.97 22.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.932 . . . . 0.0 109.372 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.408 ' H ' HG23 ' A' ' 37' ' ' THR . 1.5 p -52.95 -4.86 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.245 -0.909 . . . . 0.0 109.516 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.549 ' H ' ' C ' ' A' ' 36' ' ' PHE . . . -111.06 32.27 6.64 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 109.611 -1.395 . . . . 0.0 109.611 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.442 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 30.6 m-20 -160.16 -173.46 4.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -1.159 . . . . 0.0 109.544 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -134.88 142.25 46.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.337 -0.852 . . . . 0.0 109.511 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.507 ' OH ' ' CD2' ' A' ' 36' ' ' PHE . 35.1 m-85 -121.45 138.53 54.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.331 -0.856 . . . . 0.0 109.699 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.988 ' C ' HD13 ' A' ' 43' ' ' ILE . 1.1 t -118.1 134.44 61.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.394 -0.816 . . . . 0.0 109.084 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.988 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -129.99 148.08 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.846 . . . . 0.0 110.206 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.484 ' CD2' ' OG1' ' A' ' 46' ' ' THR . 7.8 tt -139.33 115.87 10.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.471 -0.768 . . . . 0.0 109.597 179.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -93.87 120.86 34.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.435 -0.791 . . . . 0.0 109.371 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.602 ' O ' ' N ' ' A' ' 13' ' ' GLY . 2.0 m -120.6 127.56 52.23 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.276 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 1.4 t -134.29 168.82 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.163 -0.96 . . . . 0.0 109.394 -179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -105.5 115.63 30.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.709 -0.619 . . . . 0.0 109.44 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.579 HD21 ' OE1' ' A' ' 55' ' ' GLN . 86.5 mt -97.71 169.43 9.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.274 -0.891 . . . . 0.0 109.436 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.589 ' C ' ' H ' ' A' ' 52' ' ' GLY . 0.0 OUTLIER -38.37 151.04 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.326 -0.859 . . . . 0.0 109.368 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 34.0 t30 68.04 -32.22 0.2 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.16 -179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.589 ' H ' ' C ' ' A' ' 50' ' ' ARG . . . 95.55 54.34 1.45 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 54' ' ' LEU . 16.3 t30 -88.05 6.25 37.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.21 -1.171 . . . . 0.0 109.197 179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.665 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 14.5 mt 38.39 95.04 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.875 0 CA-C-O 121.608 0.718 . . . . 0.0 109.658 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.579 ' OE1' HD21 ' A' ' 49' ' ' LEU . 12.2 pt20 -70.0 149.17 48.0 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 109.065 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.497 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 38.1 m-85 -129.78 114.97 16.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.44 -0.788 . . . . 0.0 110.01 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.427 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -124.28 155.26 38.95 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 179.062 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.1 pp -151.22 150.07 30.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.822 -1.174 . . . . 0.0 110.713 -179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 22.6 m-70 -127.46 133.88 49.88 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.62 ' CE2' HD22 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -108.69 115.92 31.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.402 -0.811 . . . . 0.0 109.208 -179.651 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.59 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 17.4 t90 -109.31 133.49 52.98 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.268 -0.895 . . . . 0.0 109.988 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.62 HD22 ' CE2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -127.48 162.15 27.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.397 -0.814 . . . . 0.0 109.292 179.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.68 153.73 21.38 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -82.23 -11.78 58.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.24 -1.153 . . . . 0.0 109.529 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.11 35.15 3.25 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 179.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.683 ' SG ' ' O ' ' A' ' 66' ' ' CYS . 15.9 p -130.09 98.12 4.66 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 122.471 1.129 . . . . 0.0 108.891 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.489 ' O ' ' O ' ' A' ' 66' ' ' CYS . 18.4 m -37.0 159.28 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.259 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.045 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.553 ' O ' ' N ' ' A' ' 72' ' ' GLY . 39.4 mt-30 -52.11 -17.8 1.21 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.41 -0.806 . . . . 0.0 109.662 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -62.37 -58.56 7.22 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.308 -0.87 . . . . 0.0 109.386 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.68 -49.4 73.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.361 -0.837 . . . . 0.0 108.854 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.29 -22.55 66.3 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.303 -0.873 . . . . 0.0 108.947 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -73.11 -43.9 37.95 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.94 -44.84 91.64 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.216 -1.167 . . . . 0.0 109.231 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.14 -43.69 98.28 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.367 -0.833 . . . . 0.0 109.053 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.478 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -58.28 -44.91 88.68 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.254 -0.904 . . . . 0.0 109.046 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.9 mt -54.14 -50.84 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.391 -0.818 . . . . 0.0 109.074 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -53.79 -38.26 64.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.334 -0.853 . . . . 0.0 109.122 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.2 m -68.97 -48.92 61.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.407 -0.808 . . . . 0.0 108.978 179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 75' ' ' ALA . 42.2 t -57.63 -33.35 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.311 -0.868 . . . . 0.0 109.018 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.89 -42.2 81.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.358 -0.838 . . . . 0.0 108.929 179.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.77 -42.89 80.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 0.0 108.96 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.508 ' O ' ' N ' ' A' ' 85' ' ' LEU . 5.9 t0 -62.54 -56.94 13.32 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.105 -0.997 . . . . 0.0 108.904 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -47.3 -31.14 3.59 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.171 -0.956 . . . . 0.0 108.607 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -74.0 -30.92 62.72 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.315 -0.866 . . . . 0.0 108.7 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.508 ' N ' ' O ' ' A' ' 82' ' ' ASP . 78.3 mt -105.73 24.38 12.37 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.24 -0.913 . . . . 0.0 109.302 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.458 ' C ' ' O ' ' A' ' 85' ' ' LEU . 0.1 OUTLIER 39.75 33.44 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.437 -0.789 . . . . 0.0 109.463 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 65.82 73.68 0.59 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 81.9 mtm-85 -143.01 35.05 1.37 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.149 -1.207 . . . . 0.0 109.346 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.497 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -144.02 178.66 7.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.291 -0.88 . . . . 0.0 109.381 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.3 t -105.33 112.82 40.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.268 -0.895 . . . . 0.0 109.693 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -93.94 121.69 35.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.306 -0.871 . . . . 0.0 109.209 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -107.16 104.95 14.72 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.187 -0.946 . . . . 0.0 109.695 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 21.4 mtm105 -75.53 97.36 3.7 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.208 -0.933 . . . . 0.0 109.073 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.616 ' CD ' ' H ' ' A' ' 100' ' ' SER . 18.0 mm-40 -96.6 137.28 35.92 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.272 -0.893 . . . . 0.0 109.943 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.6 t -132.85 157.56 43.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.334 -0.854 . . . . 0.0 109.17 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.466 ' C ' ' OE1' ' A' ' 96' ' ' GLN . 1.0 OUTLIER -62.21 117.3 5.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.071 -1.018 . . . . 0.0 109.398 -179.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 85.74 13.52 69.64 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.83 24.0 0.76 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.146 -1.208 . . . . 0.0 109.625 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.634 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 0.9 OUTLIER -52.64 137.85 29.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.185 -0.947 . . . . 0.0 109.423 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.616 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 28.7 t -64.79 165.49 10.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.294 -0.879 . . . . 0.0 109.634 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.3 -58.13 4.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.235 -0.915 . . . . 0.0 109.517 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.2 m -46.89 -32.11 3.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.306 -0.871 . . . . 0.0 109.429 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.689 ' CE1' ' CE1' ' A' ' 107' ' ' PHE . 23.9 t80 -73.16 -43.3 61.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.271 -0.893 . . . . 0.0 109.366 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.2 mt -69.27 -19.68 63.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.166 -0.959 . . . . 0.0 109.504 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -102.71 -24.98 7.86 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -82.14 -36.18 27.71 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.177 -1.19 . . . . 0.0 109.525 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.689 ' CE1' ' CE1' ' A' ' 103' ' ' PHE . 49.1 m-85 -89.71 81.43 6.42 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.251 -0.906 . . . . 0.0 109.524 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 52.9 mttt -77.57 -5.43 50.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.475 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 7.4 t -63.96 -7.34 8.07 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.117 -0.99 . . . . 0.0 109.48 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.43 82.97 0.74 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.74 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -67.84 158.06 33.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -1.116 . . . . 0.0 109.379 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -158.38 135.06 9.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.242 -0.911 . . . . 0.0 109.437 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -95.2 153.19 17.78 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.261 -0.899 . . . . 0.0 109.261 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.9 tttm -133.62 112.75 11.71 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.247 -0.908 . . . . 0.0 109.423 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -76.87 147.34 37.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.187 -0.946 . . . . 0.0 109.367 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -56.08 115.03 5.59 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -79.09 56.6 4.35 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 31.7 m -55.68 -17.22 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.348 -1.09 . . . . 0.0 109.515 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -44.94 -67.24 0.3 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 109.478 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.2 p 63.13 -172.47 0.16 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.193 -0.942 . . . . 0.0 109.53 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 143.92 -37.02 1.46 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.509 ' O ' ' CG ' ' A' ' 122' ' ' PHE . 37.6 p90 -153.64 121.97 6.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -1.123 . . . . 0.0 109.462 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -169.16 8.83 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.275 -0.891 . . . . 0.0 109.456 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.422 ' O ' ' CG ' ' A' ' 124' ' ' HIS . 0.1 OUTLIER -157.31 41.92 0.32 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 109.54 -179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -79.7 68.19 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.298 -0.876 . . . . 0.0 109.464 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.8 t -143.59 65.02 14.18 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.168 -0.958 . . . . 0.0 109.585 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -73.81 179.5 5.6 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.757 2.304 . . . . 0.0 112.094 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -76.74 138.93 40.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.226 -0.921 . . . . 0.0 109.442 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -76.83 -171.91 2.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.328 -0.858 . . . . 0.0 109.404 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 69.7 t -63.09 146.58 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.301 -0.874 . . . . 0.0 109.408 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.649 HG13 ' O ' ' A' ' 131' ' ' VAL . 7.1 p -59.44 99.47 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.0 109.572 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 67.1 t -82.49 116.51 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.226 -0.921 . . . . 0.0 109.5 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.044 -0.979 . . . . 0.0 109.469 -179.997 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.56 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 10.7 tt0 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.493 ' CB ' ' O ' ' A' ' 1' ' ' GLU . 1.8 t-80 75.15 60.66 0.27 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.881 . . . . 0.0 109.554 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -72.18 74.37 2.5 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.773 2.316 . . . . 0.0 111.988 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.555 ' O ' ' N ' ' A' ' 6' ' ' LEU . 6.4 mt-10 -83.15 -31.67 27.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.192 -0.942 . . . . 0.0 109.72 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.686 ' CE1' HG12 ' A' ' 42' ' ' VAL . 13.7 t80 -50.08 -7.57 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.114 -0.991 . . . . 0.0 109.435 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.555 ' N ' ' O ' ' A' ' 4' ' ' GLU . 13.1 mt -85.79 -26.83 25.54 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.291 -0.88 . . . . 0.0 109.506 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.2 pttm -130.94 13.03 5.25 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.39 -0.819 . . . . 0.0 109.566 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.507 ' HB3' HD13 ' A' ' 44' ' ' LEU . . . -50.93 153.04 1.93 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.175 -0.953 . . . . 0.0 109.477 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 148.86 50.66 0.02 OUTLIER Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 15.7 pttm -150.15 31.36 0.68 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.127 -1.219 . . . . 0.0 109.649 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 13' ' ' GLY . 26.7 mt-10 -147.62 83.26 7.65 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.243 -0.911 . . . . 0.0 109.394 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -48.83 80.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.666 0 C-N-CA 122.693 2.262 . . . . 0.0 112.398 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 11' ' ' GLU . . . 177.36 -100.18 0.14 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.1 tp -159.37 119.94 3.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.33 -1.1 . . . . 0.0 109.537 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.479 ' OE1' ' OE2' ' A' ' 11' ' ' GLU . 19.0 mt-30 -108.22 127.67 54.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.866 . . . . 0.0 109.366 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.549 HG23 HD12 ' A' ' 43' ' ' ILE . 53.0 mt -101.1 144.88 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.312 -0.868 . . . . 0.0 110.042 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -142.85 159.49 42.13 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.357 -0.84 . . . . 0.0 108.835 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.9 ttp180 -127.15 143.68 51.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.139 -0.975 . . . . 0.0 109.729 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.9 p -78.54 146.09 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.244 -0.91 . . . . 0.0 109.53 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.6 ' O ' ' N ' ' A' ' 22' ' ' PHE . 44.4 tt0 -92.76 154.32 18.37 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.197 -0.939 . . . . 0.0 109.222 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -44.9 -13.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.314 -0.866 . . . . 0.0 109.496 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.6 ' N ' ' O ' ' A' ' 20' ' ' GLU . 74.3 t80 -162.94 28.16 0.1 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.673 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.666 ' O ' HD22 ' A' ' 24' ' ' LEU . 8.4 t70 -175.29 -136.02 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.172 -0.955 . . . . 0.0 109.616 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.666 HD22 ' O ' ' A' ' 23' ' ' ASP . 1.7 mm? -126.76 146.11 50.36 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.38 -0.825 . . . . 0.0 109.259 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.495 HG23 ' HB2' ' A' ' 20' ' ' GLU . 2.1 t -141.63 130.23 12.19 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 109.017 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -73.44 174.64 11.82 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.348 2.032 . . . . 0.0 112.313 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.8 t -139.85 121.45 9.71 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.28 -0.887 . . . . 0.0 109.246 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -76.76 157.79 35.36 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.296 1.997 . . . . 0.0 112.301 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -66.64 -11.77 55.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.16 -0.962 . . . . 0.0 109.358 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -74.28 -10.91 60.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 109.387 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 32' ' ' TYR . 91.8 mt -126.56 -20.48 4.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.356 -0.84 . . . . 0.0 109.471 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.51 ' CE2' ' CD1' ' A' ' 16' ' ' ILE . 11.1 t80 -43.16 131.02 4.58 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -0.914 . . . . 0.0 109.353 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 123.67 -14.16 8.12 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -101.61 148.18 25.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.193 -1.181 . . . . 0.0 109.627 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -142.09 116.63 9.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.259 -0.901 . . . . 0.0 109.376 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -94.24 125.19 38.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.923 . . . . 0.0 109.501 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 43.5 p -68.33 -4.84 15.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.171 -0.956 . . . . 0.0 109.301 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.454 ' O ' ' OD2' ' A' ' 39' ' ' ASP . . . -107.51 36.18 4.55 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.454 ' OD2' ' O ' ' A' ' 38' ' ' GLY . 2.1 m-20 -159.93 156.63 27.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.265 -1.138 . . . . 0.0 109.424 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.63 134.03 48.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.365 -0.834 . . . . 0.0 109.514 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.51 ' HB3' HD11 ' A' ' 43' ' ' ILE . 3.0 m-85 -113.43 134.95 54.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.42 -0.8 . . . . 0.0 109.188 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.015 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -111.24 126.12 68.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.295 0 O-C-N 121.217 -0.927 . . . . 0.0 108.892 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.015 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -126.2 134.55 66.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.197 -0.94 . . . . 0.0 110.417 -179.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.727 HD23 ' C ' ' A' ' 44' ' ' LEU . 6.9 tt -117.42 115.4 25.13 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 35.6 tttp -89.95 144.48 25.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 109.786 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.576 HG22 HD22 ' A' ' 54' ' ' LEU . 38.4 m -143.4 117.68 9.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.252 -0.905 . . . . 0.0 109.083 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.642 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -128.54 168.37 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.142 -0.974 . . . . 0.0 109.234 -179.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -96.32 126.91 41.85 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.545 -0.722 . . . . 0.0 109.451 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.469 HD21 ' OE1' ' A' ' 55' ' ' GLN . 79.2 mt -91.06 166.77 12.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 0.0 109.495 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.422 ' C ' ' O ' ' A' ' 49' ' ' LEU . 2.3 mtt-85 -44.67 -57.99 3.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.089 -1.007 . . . . 0.0 109.231 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -66.38 -20.51 66.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.295 -0.878 . . . . 0.0 109.188 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . 89.62 37.34 6.99 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.508 ' O ' ' O ' ' A' ' 54' ' ' LEU . 10.7 m-80 -88.62 14.37 10.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.118 -1.225 . . . . 0.0 109.403 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.642 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.7 mt 44.79 98.44 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 CA-C-O 121.621 0.724 . . . . 0.0 109.418 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.469 ' OE1' HD21 ' A' ' 49' ' ' LEU . 40.3 tt0 -73.9 110.23 8.03 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.39 -0.819 . . . . 0.0 109.697 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.512 ' CD2' ' O ' ' A' ' 54' ' ' LEU . 85.3 m-85 -95.91 114.3 26.0 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.186 -0.946 . . . . 0.0 109.546 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.28 155.35 24.2 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.694 HD11 HD11 ' A' ' 81' ' ' LEU . 10.6 mt -129.84 133.38 46.89 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.171 -0.956 . . . . 0.0 109.776 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.693 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.1 OUTLIER -133.43 115.11 14.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.396 -0.815 . . . . 0.0 109.075 179.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.725 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -99.95 120.58 40.02 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 0.0 109.258 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 4.4 t90 -93.26 127.03 38.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.892 . . . . 0.0 109.539 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.3 mt -106.12 161.65 14.32 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.261 -0.899 . . . . 0.0 109.396 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -109.55 150.9 17.33 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -69.23 -12.26 61.52 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -1.182 . . . . 0.0 109.461 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -108.86 26.63 10.35 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.538 ' SG ' ' OE2' ' A' ' 70' ' ' GLU . 5.4 m -130.59 97.44 4.37 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.021 0.915 . . . . 0.0 108.545 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 m -60.46 -170.91 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.327 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.782 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.636 ' H ' ' NE2' ' A' ' 68' ' ' GLN . 2.0 mp0 -65.38 -17.8 64.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.377 -0.827 . . . . 0.0 109.696 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.03 -58.84 5.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.112 -0.992 . . . . 0.0 109.481 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.538 ' OE2' ' SG ' ' A' ' 66' ' ' CYS . 22.8 mt-10 -64.07 -46.25 85.18 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.261 -0.899 . . . . 0.0 109.092 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.1 m -65.54 -26.81 68.05 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.347 -0.846 . . . . 0.0 108.826 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -65.87 -45.86 85.71 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.86 -48.98 74.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -1.157 . . . . 0.0 109.261 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.67 -39.82 92.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.34 -0.85 . . . . 0.0 109.179 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.454 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -65.84 -46.27 79.16 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.364 -0.835 . . . . 0.0 109.316 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.6 mt -51.47 -49.22 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.134 -0.979 . . . . 0.0 109.294 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -62.29 -35.25 78.42 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.29 -0.881 . . . . 0.0 109.325 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.3 m -69.53 -36.42 76.39 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.226 -0.921 . . . . 0.0 109.372 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 75' ' ' ALA . 63.8 t -68.14 -42.33 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.265 -0.897 . . . . 0.0 109.517 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -62.49 -60.59 3.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.239 -0.913 . . . . 0.0 109.26 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.728 ' C ' HD12 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -52.57 -29.18 24.31 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.215 -0.928 . . . . 0.0 108.835 179.688 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.626 ' O ' ' N ' ' A' ' 86' ' ' ASN . 55.2 t0 -67.47 -57.68 6.09 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.239 -0.913 . . . . 0.0 108.815 179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.469 ' O ' ' OD1' ' A' ' 86' ' ' ASN . 88.1 m-20 -45.25 -36.14 3.79 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.201 -0.937 . . . . 0.0 108.579 179.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.517 ' CD1' ' O ' ' A' ' 84' ' ' TYR . 1.8 t80 -73.66 -31.57 63.55 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 82' ' ' ASP . 96.2 mt -121.65 34.44 5.18 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.461 -0.774 . . . . 0.0 109.419 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.626 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.4 OUTLIER -82.82 27.81 0.52 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.207 -0.933 . . . . 0.0 109.371 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.77 -51.15 54.22 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.5 mtp180 -175.94 34.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.181 -1.188 . . . . 0.0 109.377 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.11 179.02 7.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -0.947 . . . . 0.0 109.529 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 78.9 t -130.39 102.98 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.313 -0.867 . . . . 0.0 109.505 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.66 ' H ' ' CD ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -97.04 134.83 39.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 109.145 179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.601 ' NE2' ' ND1' ' A' ' 59' ' ' HIS . 3.7 p80 -144.35 161.14 39.74 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.121 -0.987 . . . . 0.0 109.756 -179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -103.38 121.7 43.32 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.464 -0.772 . . . . 0.0 109.585 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.561 ' OE2' ' CD2' ' A' ' 103' ' ' PHE . 42.5 mt-10 -102.32 150.58 23.18 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.357 -0.84 . . . . 0.0 109.164 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.6 t -140.75 161.93 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.113 -0.992 . . . . 0.0 109.567 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -60.84 134.42 57.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.282 -0.886 . . . . 0.0 109.597 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.11 -26.23 5.04 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.547 ' CD1' ' O ' ' A' ' 98' ' ' PHE . 71.5 t80 -108.02 10.4 28.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -1.115 . . . . 0.0 109.442 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 98' ' ' PHE . 80.5 mt-10 -43.05 123.61 2.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.875 . . . . 0.0 109.508 179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.1 p -55.57 179.69 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.334 -0.854 . . . . 0.0 109.501 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -68.1 -41.31 82.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.344 -0.847 . . . . 0.0 109.501 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 17.7 m -48.68 -57.58 6.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.307 -0.87 . . . . 0.0 109.529 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.561 ' CD2' ' OE2' ' A' ' 94' ' ' GLU . 5.9 m-85 -59.18 -53.57 56.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.412 -0.805 . . . . 0.0 109.56 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.58 ' O ' ' CD1' ' A' ' 107' ' ' PHE . 25.7 mt -54.36 -14.66 1.27 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.227 -0.921 . . . . 0.0 109.56 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -104.98 -27.29 5.99 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 9.5 t80 -79.49 -15.29 58.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.261 -1.14 . . . . 0.0 109.636 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.58 ' CD1' ' O ' ' A' ' 104' ' ' LEU . 3.2 p90 -55.8 128.66 36.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.227 -0.92 . . . . 0.0 109.589 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 51.7 mttt -114.92 -55.6 2.46 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.298 -0.876 . . . . 0.0 109.417 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.5 p -103.74 -8.61 19.72 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.923 . . . . 0.0 109.466 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 103.63 109.07 3.33 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.737 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -53.37 120.03 5.54 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.276 -1.132 . . . . 0.0 109.469 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 35.3 mttm -81.42 125.06 29.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.292 -0.88 . . . . 0.0 109.47 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -95.28 144.09 26.14 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.2 -0.938 . . . . 0.0 109.425 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 35.5 mmtt -141.7 132.03 25.06 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.297 -0.877 . . . . 0.0 109.407 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 69.6 mttt -74.1 156.32 37.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 109.513 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -84.56 -64.92 1.53 Allowed Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -159.26 -130.52 1.15 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 46.1 t -103.14 -77.6 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.227 -1.16 . . . . 0.0 109.56 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -73.19 -152.39 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.464 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 18.9 t -144.2 64.09 1.32 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.263 -0.898 . . . . 0.0 109.427 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -177.73 -35.1 0.05 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 124' ' ' HIS . 8.6 m-85 -70.29 -83.86 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.227 -1.161 . . . . 0.0 109.504 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 18.2 ttpt 68.9 -62.72 0.39 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.342 -0.849 . . . . 0.0 109.51 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.425 ' N ' ' O ' ' A' ' 122' ' ' PHE . 3.0 t-160 -158.71 128.06 5.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.145 -0.972 . . . . 0.0 109.523 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.2 p -93.87 148.87 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 109.432 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.4 m -142.26 83.81 11.97 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 0.0 109.482 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.16 -70.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.649 0 C-N-CA 122.73 2.287 . . . . 0.0 112.321 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -75.54 168.51 19.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.182 -0.949 . . . . 0.0 109.515 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -90.11 104.21 16.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -0.956 . . . . 0.0 109.422 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.666 HG13 ' O ' ' A' ' 130' ' ' VAL . 14.0 p -105.06 112.48 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.333 -0.855 . . . . 0.0 109.572 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 7.3 t -75.45 127.69 37.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.303 -0.873 . . . . 0.0 109.479 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.6 p -45.15 148.44 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.192 -0.943 . . . . 0.0 109.44 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.96 -1.019 . . . . 0.0 109.494 -179.953 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.594 ' O ' ' N ' ' A' ' 4' ' ' GLU . 0.0 OUTLIER 176.0 -48.11 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.292 -0.88 . . . . 0.0 109.76 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.524 ' CD ' ' N ' ' A' ' 2' ' ' HIS . 50.8 Cg_exo -52.26 70.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.575 2.183 . . . . 0.0 112.167 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.594 ' N ' ' O ' ' A' ' 2' ' ' HIS . 34.1 mt-10 -83.27 -46.21 12.92 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.836 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.666 ' CE1' ' CD1' ' A' ' 81' ' ' LEU . 50.2 t80 -47.64 -16.12 0.06 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.235 -0.915 . . . . 0.0 109.391 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 4' ' ' GLU . 71.7 mt -84.05 -52.03 6.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 0.0 109.439 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.468 ' O ' ' O ' ' A' ' 8' ' ' ALA . 46.3 mtpt -91.08 5.97 46.82 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.354 -0.841 . . . . 0.0 109.553 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.468 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -44.43 169.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.231 -0.918 . . . . 0.0 109.632 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 114.75 70.75 0.51 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.46 6.63 2.54 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.17 -1.194 . . . . 0.0 109.647 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -172.13 141.97 1.2 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.899 . . . . 0.0 109.409 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -74.02 84.13 1.53 Allowed 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.675 2.25 . . . . 0.0 112.291 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -164.96 -108.02 0.21 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.3 tt -162.54 148.03 12.45 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -1.114 . . . . 0.0 109.553 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.421 ' NE2' ' HB1' ' A' ' 8' ' ' ALA . 1.0 OUTLIER -136.51 131.75 34.35 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.26 -0.9 . . . . 0.0 109.242 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.492 ' HA ' HG23 ' A' ' 43' ' ' ILE . 12.2 mt -102.28 157.63 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.215 -0.928 . . . . 0.0 110.22 -179.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.428 ' N ' HG22 ' A' ' 16' ' ' ILE . 1.0 OUTLIER -159.17 130.46 6.2 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.495 -0.753 . . . . 0.0 109.17 179.769 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -100.92 152.5 20.48 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.174 -0.954 . . . . 0.0 109.403 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 23' ' ' ASP . 41.4 t -77.03 129.02 37.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.255 -0.903 . . . . 0.0 109.532 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.711 ' O ' ' N ' ' A' ' 22' ' ' PHE . 27.6 tt0 -80.49 86.82 5.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.126 -0.984 . . . . 0.0 109.479 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.599 ' O ' ' CB ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER 39.35 15.48 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.574 -0.704 . . . . 0.0 110.081 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.711 ' N ' ' O ' ' A' ' 20' ' ' GLU . 1.4 t80 154.82 -39.53 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.391 -0.818 . . . . 0.0 109.134 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 20' ' ' GLU . 1.3 t0 -98.99 -146.56 0.33 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.251 -0.906 . . . . 0.0 109.341 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.43 ' CD2' ' H ' ' A' ' 5' ' ' PHE . 3.3 tp -116.1 138.83 50.9 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.196 -0.94 . . . . 0.0 109.714 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.533 HG23 ' CD ' ' A' ' 20' ' ' GLU . 1.2 t -137.98 144.6 44.48 Favored Pre-proline 0 N--CA 1.491 1.602 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -69.69 152.04 69.6 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 C-N-CA 122.527 2.151 . . . . 0.0 112.392 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.0 t -120.54 101.61 45.97 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.301 -0.874 . . . . 0.0 109.376 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -49.64 158.06 2.08 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.561 2.174 . . . . 0.0 112.128 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.503 ' O ' ' N ' ' A' ' 31' ' ' LEU . 5.9 m -59.54 -46.26 89.38 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.237 -0.915 . . . . 0.0 109.526 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.416 ' C ' ' O ' ' A' ' 29' ' ' THR . 3.0 m120 -43.05 -22.14 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.119 -0.988 . . . . 0.0 109.475 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 29' ' ' THR . 79.7 mt -105.63 -25.49 12.24 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -0.861 . . . . 0.0 109.451 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.454 ' C ' ' O ' ' A' ' 31' ' ' LEU . 2.0 t80 -42.18 129.49 3.72 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.328 -0.858 . . . . 0.0 109.371 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.443 ' N ' ' CD2' ' A' ' 32' ' ' TYR . . . 100.28 -20.88 46.79 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.43 ' C ' ' CD1' ' A' ' 35' ' ' PHE . 4.3 m-20 -97.83 155.62 16.96 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.222 -1.163 . . . . 0.0 109.501 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.43 ' CD1' ' C ' ' A' ' 34' ' ' ASP . 57.1 m-85 -146.65 136.05 22.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.274 -0.891 . . . . 0.0 109.457 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -97.42 162.83 13.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.922 . . . . 0.0 109.406 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 48.7 p -97.97 -4.87 35.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.269 -0.894 . . . . 0.0 109.383 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -87.91 -76.93 1.28 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -75.97 157.81 32.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.356 -1.085 . . . . 0.0 109.415 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.74 167.2 11.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.444 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -128.47 134.8 48.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 109.52 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.562 HG11 ' CD1' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -108.7 144.52 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.254 -0.903 . . . . 0.0 109.052 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.985 ' N ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -143.88 139.54 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.996 -1.065 . . . . 0.0 110.097 -179.837 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.661 HD23 ' N ' ' A' ' 45' ' ' LYS . 0.8 OUTLIER -123.52 126.09 46.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.408 -0.808 . . . . 0.0 109.149 179.256 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.661 ' N ' HD23 ' A' ' 44' ' ' LEU . 30.3 ttpt -104.46 130.37 52.38 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.326 -0.859 . . . . 0.0 109.6 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.513 ' O ' ' N ' ' A' ' 13' ' ' GLY . 99.8 m -131.83 125.66 32.35 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.293 -0.88 . . . . 0.0 109.294 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -133.09 168.46 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 121.175 -0.953 . . . . 0.0 109.357 -179.647 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -96.29 121.76 38.42 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.681 -0.637 . . . . 0.0 109.324 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 50' ' ' ARG . 11.1 mt -82.59 168.79 16.98 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.182 -0.949 . . . . 0.0 109.523 -179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.432 ' C ' ' O ' ' A' ' 49' ' ' LEU . 1.1 tpt180 -43.21 -67.14 0.3 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.251 -0.906 . . . . 0.0 109.261 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -60.18 -26.07 66.06 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 109.125 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.98 40.2 3.37 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.7 m120 -87.66 14.79 7.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.11 -1.229 . . . . 0.0 109.316 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.624 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 11.7 mt 43.79 96.83 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.511 0.672 . . . . 0.0 109.444 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -69.18 153.62 43.4 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.528 -0.732 . . . . 0.0 109.245 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.412 ' CD2' ' O ' ' A' ' 54' ' ' LEU . 70.7 m-85 -138.0 114.86 10.7 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.171 -0.956 . . . . 0.0 109.623 -179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -124.78 116.7 22.72 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.027 HD12 ' H ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -102.84 145.72 29.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.134 -0.979 . . . . 0.0 110.076 -179.021 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.532 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 3.1 m-70 -131.34 150.52 52.12 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.469 -0.769 . . . . 0.0 109.4 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.882 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -129.37 121.33 27.2 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.352 -0.843 . . . . 0.0 109.34 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.467 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 44.8 t90 -101.84 123.77 46.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.92 . . . . 0.0 109.59 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.467 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 18.4 mt -104.55 162.04 13.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.279 -0.888 . . . . 0.0 109.382 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.515 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -112.86 162.0 12.5 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -82.14 -11.62 58.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -1.168 . . . . 0.0 109.599 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -109.68 33.89 4.12 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.657 ' SG ' ' O ' ' A' ' 66' ' ' CYS . 18.0 p -130.58 97.91 4.51 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-O 122.478 1.133 . . . . 0.0 108.951 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.49 ' O ' ' O ' ' A' ' 66' ' ' CYS . 0.5 OUTLIER -46.57 177.18 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.731 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.555 ' O ' ' N ' ' A' ' 72' ' ' GLY . 4.6 pt20 -66.52 -17.78 65.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.476 -0.765 . . . . 0.0 109.553 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.463 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 1.1 p30 -62.85 -58.43 7.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.263 -0.898 . . . . 0.0 109.626 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.401 ' N ' ' OD1' ' A' ' 69' ' ' ASP . 2.6 mp0 -62.04 -51.93 65.99 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.301 -0.874 . . . . 0.0 109.129 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -66.43 -22.87 66.22 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.405 -0.809 . . . . 0.0 108.879 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.555 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -75.16 -46.26 16.74 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.79 -39.09 87.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.186 -1.185 . . . . 0.0 109.151 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.882 ' HB1' ' CE2' ' A' ' 60' ' ' TYR . . . -59.4 -59.49 5.36 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.394 -0.816 . . . . 0.0 108.968 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.775 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -48.25 -43.21 32.19 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.31 -0.869 . . . . 0.0 109.48 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.8 mt -56.67 -39.14 61.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.143 -0.973 . . . . 0.0 109.564 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -64.7 -50.48 66.81 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 109.704 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.483 ' OG1' ' CE1' ' A' ' 60' ' ' TYR . 2.7 m -63.72 -35.03 79.24 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.065 -1.022 . . . . 0.0 108.794 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 75' ' ' ALA . 74.5 t -59.59 -41.9 86.49 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.343 -0.848 . . . . 0.0 108.729 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -62.55 -43.75 98.03 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.666 ' CD1' ' CE1' ' A' ' 5' ' ' PHE . 0.6 OUTLIER -50.83 -45.47 59.62 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.403 -0.811 . . . . 0.0 108.921 179.5 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.568 ' O ' ' N ' ' A' ' 85' ' ' LEU . 1.6 m-20 -60.33 -60.42 3.85 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.294 -0.879 . . . . 0.0 108.967 179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 82' ' ' ASP . 39.6 t0 -46.94 -32.99 4.23 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.116 -0.99 . . . . 0.0 108.412 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.468 ' CD2' ' O ' ' A' ' 84' ' ' TYR . 2.8 t80 -74.49 -27.1 60.41 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.568 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.6 tp -110.24 26.47 10.64 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.475 -0.765 . . . . 0.0 109.306 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.403 ' C ' ' O ' ' A' ' 85' ' ' LEU . 0.2 OUTLIER 44.71 37.47 2.26 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.487 -0.758 . . . . 0.0 109.579 179.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 53.7 34.13 49.92 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 18.5 ttm180 -90.64 31.38 1.05 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -1.138 . . . . 0.0 109.138 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -145.24 179.22 7.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.434 -0.791 . . . . 0.0 109.31 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.686 ' O ' HD12 ' A' ' 58' ' ' LEU . 21.9 t -119.13 140.83 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.158 -0.964 . . . . 0.0 109.672 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.41 ' CD ' ' N ' ' A' ' 91' ' ' GLN . 0.2 OUTLIER -102.74 149.28 24.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.328 -0.857 . . . . 0.0 109.319 179.859 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 33.7 m-70 -124.49 121.78 35.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.212 -0.93 . . . . 0.0 109.553 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.43 ' H ' ' HD2' ' A' ' 93' ' ' ARG . 1.5 mpt_? -91.5 105.42 17.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.943 . . . . 0.0 109.063 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.417 ' OE2' ' CD1' ' A' ' 103' ' ' PHE . 35.8 mt-10 -113.12 148.06 36.08 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.285 -0.884 . . . . 0.0 109.764 -179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.713 HG12 ' N ' ' A' ' 96' ' ' GLN . 61.5 t -151.9 174.04 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.31 -0.869 . . . . 0.0 109.091 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.713 ' N ' HG12 ' A' ' 95' ' ' VAL . 10.2 tt0 -62.58 115.84 4.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.051 -1.031 . . . . 0.0 109.542 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.95 11.66 82.29 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.47 ' O ' ' C ' ' A' ' 99' ' ' GLU . 3.2 t80 -132.66 19.39 4.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.252 -1.146 . . . . 0.0 109.551 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.631 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 8.8 mp0 -39.63 137.6 0.84 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.549 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.85 166.91 16.71 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.18 -0.95 . . . . 0.0 109.654 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.27 -64.45 0.85 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.247 -0.908 . . . . 0.0 109.448 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.8 m -47.03 -54.86 9.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.207 -0.933 . . . . 0.0 109.198 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.417 ' CD1' ' OE2' ' A' ' 94' ' ' GLU . 3.3 t80 -50.81 -45.27 59.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.471 -0.768 . . . . 0.0 109.295 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.506 ' O ' ' CD1' ' A' ' 107' ' ' PHE . 5.8 mt -59.01 -30.81 68.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.913 . . . . 0.0 109.388 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -89.79 -19.27 48.5 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.423 ' O ' ' C ' ' A' ' 107' ' ' PHE . 35.4 t80 -76.35 -27.36 56.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.346 -1.091 . . . . 0.0 109.458 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.54 ' CD1' ' O ' ' A' ' 107' ' ' PHE . 1.3 p90 -42.42 125.83 3.31 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.183 -0.948 . . . . 0.0 109.494 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.2 mttp -110.87 -47.85 3.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.24 -0.913 . . . . 0.0 109.433 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.6 m -96.67 -28.55 14.27 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.241 -0.912 . . . . 0.0 109.493 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 124.24 112.5 1.98 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.2 mt -57.76 176.69 0.13 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.334 -1.098 . . . . 0.0 109.47 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 11.2 mttt -159.97 122.25 3.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.352 -0.842 . . . . 0.0 109.279 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -106.75 141.66 37.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -0.868 . . . . 0.0 109.414 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.5 mmtt -146.19 126.29 13.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.887 . . . . 0.0 109.387 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.2 pttp -114.02 131.39 56.37 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.346 -0.846 . . . . 0.0 109.47 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 166.79 -52.6 0.25 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 98.06 23.71 12.74 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 35.2 m -145.55 153.1 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.343 -1.093 . . . . 0.0 109.474 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -146.43 -80.55 0.15 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.321 -0.862 . . . . 0.0 109.471 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.5 m -147.05 -152.94 0.46 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.952 . . . . 0.0 109.423 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -175.53 169.61 42.42 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -94.11 151.8 19.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.337 -1.096 . . . . 0.0 109.446 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 13.5 ttmm -157.39 -48.57 0.07 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.366 -0.834 . . . . 0.0 109.318 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -66.54 119.1 11.11 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.239 -0.913 . . . . 0.0 109.302 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 71.1 t -87.46 -56.79 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.307 -0.87 . . . . 0.0 109.435 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 26.1 m -50.75 147.87 7.92 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.401 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.32 178.44 5.52 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.579 2.186 . . . . 0.0 112.136 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -70.95 -73.89 0.16 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.254 -0.904 . . . . 0.0 109.405 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -131.52 151.15 51.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.436 -0.79 . . . . 0.0 109.42 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' A' ' 131' ' ' VAL . 55.1 t -69.35 149.22 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.187 -0.945 . . . . 0.0 109.441 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.415 ' C ' ' O ' ' A' ' 130' ' ' VAL . 58.0 t -42.82 121.99 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.529 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 132' ' ' VAL . 12.6 p -49.22 130.54 6.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 109.448 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.536 ' H ' ' CD ' ' A' ' 133' ' ' GLN . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 118.097 -0.954 . . . . 0.0 109.39 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.54 ' C ' ' ND1' ' A' ' 2' ' ' HIS . 10.5 mm-40 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.282 0.563 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.54 ' ND1' ' C ' ' A' ' 1' ' ' GLU . 8.7 m80 -146.48 57.29 3.66 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.91 . . . . 0.0 109.398 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.517 ' HB3' HD12 ' A' ' 6' ' ' LEU . 36.2 Cg_endo -68.13 66.74 0.99 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 122.78 2.32 . . . . 0.0 112.077 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.542 ' OE1' ' NE1' ' A' ' 17' ' ' TRP . 74.7 mt-10 -83.15 -46.24 12.98 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -0.934 . . . . 0.0 109.756 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.519 ' CE2' ' CG1' ' A' ' 42' ' ' VAL . 22.8 t80 -66.95 -18.76 65.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.281 -0.887 . . . . 0.0 109.406 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.517 HD12 ' HB3' ' A' ' 3' ' ' PRO . 10.1 mt -76.61 -37.2 56.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.258 -0.901 . . . . 0.0 109.389 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.453 ' O ' ' C ' ' A' ' 8' ' ' ALA . 7.4 mtpm? -86.12 -15.6 40.63 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.334 -0.854 . . . . 0.0 109.335 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.453 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -40.94 142.36 0.49 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 109.567 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 131.26 42.32 0.2 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 ptpt -140.65 26.38 2.11 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.339 -1.095 . . . . 0.0 109.692 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -148.84 128.1 6.29 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.192 -0.943 . . . . 0.0 109.433 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -75.81 80.1 2.69 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.494 2.129 . . . . 0.0 112.272 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 173.32 -99.37 0.14 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.9 tt -162.25 152.26 16.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -1.131 . . . . 0.0 109.834 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.42 ' HB3' ' CZ3' ' A' ' 17' ' ' TRP . 42.1 mt-30 -135.74 141.31 44.83 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 109.367 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 28.5 mt -113.99 139.11 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.36 -0.838 . . . . 0.0 110.1 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.542 ' NE1' ' OE1' ' A' ' 4' ' ' GLU . 0.0 OUTLIER -142.75 156.77 45.05 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.535 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.811 ' O ' HD23 ' A' ' 24' ' ' LEU . 18.8 ttt180 -116.29 140.13 49.65 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.172 -0.955 . . . . 0.0 109.62 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.468 ' O ' HG13 ' A' ' 19' ' ' VAL . 8.4 p -85.33 131.72 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.232 -0.917 . . . . 0.0 109.409 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.606 ' O ' ' N ' ' A' ' 22' ' ' PHE . 20.4 tt0 -84.06 151.36 25.01 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.165 -0.96 . . . . 0.0 109.225 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.486 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 10.8 ttmm -45.25 -11.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.271 -0.893 . . . . 0.0 109.92 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.606 ' N ' ' O ' ' A' ' 20' ' ' GLU . 20.7 m-85 -162.96 20.97 0.09 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.961 -1.087 . . . . 0.0 110.065 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.474 ' CG ' ' O ' ' A' ' 22' ' ' PHE . 24.5 m-20 -166.38 -116.53 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.193 -0.942 . . . . 0.0 109.499 179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.811 HD23 ' O ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -158.19 138.6 12.65 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.272 -0.892 . . . . 0.0 109.296 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 t -119.98 132.62 24.01 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 0.0 109.282 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -74.1 136.87 23.07 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.428 2.085 . . . . 0.0 112.343 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.7 t -97.49 112.03 60.12 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.224 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -45.54 127.88 9.98 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.33 2.02 . . . . 0.0 112.104 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -71.64 -10.11 59.27 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.146 -0.971 . . . . 0.0 109.485 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -90.91 -3.06 57.62 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.237 -0.914 . . . . 0.0 109.113 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 38.4 mt -136.81 -1.93 2.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.288 -0.882 . . . . 0.0 109.801 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.426 ' O ' ' CG ' ' A' ' 32' ' ' TYR . 3.6 p90 -50.42 135.17 22.63 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.176 -0.952 . . . . 0.0 109.507 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 135.94 -25.44 3.21 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -100.8 105.29 16.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.238 -1.154 . . . . 0.0 109.43 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 48.6 m-85 -96.5 146.26 24.95 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.511 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -94.46 128.36 40.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.568 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.472 ' OG1' ' OE1' ' A' ' 65' ' ' GLU . 35.7 p -72.24 -4.78 31.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.307 -0.87 . . . . 0.0 109.426 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.44 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -109.67 38.25 3.4 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.44 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 22.6 m-20 -163.52 -169.38 1.92 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -1.122 . . . . 0.0 109.465 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -136.72 138.28 40.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.231 -0.918 . . . . 0.0 109.401 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -126.01 139.0 53.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.332 -0.855 . . . . 0.0 109.519 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.006 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -105.95 136.97 38.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 121.178 -0.951 . . . . 0.0 108.767 179.781 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.006 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.2 OUTLIER -127.84 137.17 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.269 -0.895 . . . . 0.0 110.369 -179.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.682 HD23 ' C ' ' A' ' 44' ' ' LEU . 6.9 tt -117.83 116.98 28.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.7 -0.625 . . . . 0.0 109.335 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.481 ' N ' HD23 ' A' ' 44' ' ' LEU . 4.8 ttpm? -98.9 118.24 35.22 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.544 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.41 ' CG2' HD22 ' A' ' 54' ' ' LEU . 8.4 m -118.62 131.33 56.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.34 -0.85 . . . . 0.0 109.201 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -132.01 168.46 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.193 -0.942 . . . . 0.0 109.569 -179.562 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.576 ' NE2' ' O ' ' A' ' 49' ' ' LEU . 8.4 tm0? -95.97 112.33 24.09 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.576 ' O ' ' NE2' ' A' ' 48' ' ' GLN . 63.8 mt -72.28 155.61 40.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.924 . . . . 0.0 109.748 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 49' ' ' LEU . 20.9 mtm105 -42.89 -77.1 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.267 -0.895 . . . . 0.0 109.388 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 50' ' ' ARG . 4.1 t-20 -43.33 -31.1 0.59 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.166 -0.959 . . . . 0.0 109.259 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.64 75.47 1.16 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.481 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.1 t-20 -132.76 14.09 4.39 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.251 -1.147 . . . . 0.0 109.199 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 11.9 mt 43.22 95.98 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.796 0 CA-C-O 121.386 0.612 . . . . 0.0 109.616 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.418 ' N ' ' O ' ' A' ' 47' ' ' VAL . 17.2 tt0 -68.85 154.48 41.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.549 -0.719 . . . . 0.0 109.144 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.614 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 97.6 m-85 -134.53 121.69 21.34 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 0.0 109.674 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.581 ' OD1' ' N ' ' A' ' 58' ' ' LEU . 1.5 t0 -133.0 155.44 49.17 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.581 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 0.1 OUTLIER -143.58 145.79 32.8 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.825 -1.172 . . . . 0.0 110.388 -179.629 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.477 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -141.06 131.93 25.94 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.401 -0.812 . . . . 0.0 108.957 179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.751 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -96.64 120.74 37.51 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.094 -1.004 . . . . 0.0 109.463 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.517 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 31.2 t90 -89.13 123.71 33.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.298 -0.876 . . . . 0.0 109.357 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.517 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 6.6 mt -106.36 162.18 13.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.321 -0.862 . . . . 0.0 109.423 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.93 156.59 15.46 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -75.79 -12.24 60.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.27 -1.135 . . . . 0.0 109.357 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 116' ' ' GLY . 2.7 mt-10 -106.47 26.25 10.13 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.5 m -130.85 97.51 4.35 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 122.136 0.969 . . . . 0.0 108.397 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.473 ' O ' ' O ' ' A' ' 66' ' ' CYS . 39.7 p -49.82 -177.18 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.589 -179.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.49 ' O ' ' N ' ' A' ' 72' ' ' GLY . 29.2 mt-30 -66.04 -17.82 64.94 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.304 -0.873 . . . . 0.0 109.5 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.503 ' OD2' ' N ' ' A' ' 69' ' ' ASP . 2.5 m-20 -63.75 -58.57 6.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.244 -0.91 . . . . 0.0 109.369 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -61.03 -51.02 70.98 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.288 -0.882 . . . . 0.0 109.131 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 58.0 m -64.23 -27.37 69.01 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.442 -0.786 . . . . 0.0 109.065 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -69.24 -43.05 72.96 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.04 -41.56 97.37 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.317 -1.108 . . . . 0.0 109.245 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.52 -47.03 87.96 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.398 -0.814 . . . . 0.0 109.25 179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.89 -46.44 81.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.173 -0.955 . . . . 0.0 109.345 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 55.2 mt -51.96 -49.82 36.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.214 -0.929 . . . . 0.0 109.207 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 8.4 m-85 -57.91 -33.92 69.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.866 . . . . 0.0 109.277 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.405 HG21 ' CE1' ' A' ' 60' ' ' TYR . 2.1 m -68.34 -46.79 69.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.231 -0.918 . . . . 0.0 109.263 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 31.6 t -57.26 -31.93 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.168 -0.957 . . . . 0.0 109.318 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 24.8 mm-40 -68.06 -54.44 18.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.913 . . . . 0.0 109.246 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.831 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -53.47 -29.46 35.98 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.285 -0.884 . . . . 0.0 108.981 179.873 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.591 ' O ' ' N ' ' A' ' 85' ' ' LEU . 3.4 m-20 -66.53 -59.32 3.74 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.272 -0.892 . . . . 0.0 108.913 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 82' ' ' ASP . 1.0 OUTLIER -45.62 -34.51 3.48 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.294 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.595 ' CD1' ' O ' ' A' ' 84' ' ' TYR . 0.6 OUTLIER -69.55 -32.56 71.44 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.591 ' N ' ' O ' ' A' ' 82' ' ' ASP . 5.6 mp -104.51 27.39 7.95 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.417 -0.802 . . . . 0.0 109.026 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 85' ' ' LEU . 13.1 m-80 42.7 35.03 0.64 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.449 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 86' ' ' ASN . . . 43.44 85.31 0.01 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -145.61 47.73 1.27 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.202 -1.175 . . . . 0.0 109.384 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.614 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -155.1 179.15 9.42 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.894 . . . . 0.0 109.505 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.505 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 8.7 t -94.58 116.13 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.284 -0.885 . . . . 0.0 109.625 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -109.7 125.36 52.56 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.268 -0.895 . . . . 0.0 109.193 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.574 ' N ' ' CD2' ' A' ' 92' ' ' HIS . 1.3 p80 -151.0 136.05 17.49 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.028 -1.045 . . . . 0.0 110.197 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 15.3 ptp180 -85.85 131.43 34.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.176 -0.953 . . . . 0.0 109.713 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -100.34 121.37 41.4 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.95 . . . . 0.0 109.359 179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.596 HG12 ' N ' ' A' ' 96' ' ' GLN . 44.4 t -89.64 167.71 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 0.0 109.615 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.686 ' NE2' ' N ' ' A' ' 97' ' ' GLY . 17.5 tp60 -88.03 136.12 33.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 0.0 109.394 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.686 ' N ' ' NE2' ' A' ' 96' ' ' GLN . . . 110.41 -26.91 12.26 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.487 ' O ' ' O ' ' A' ' 99' ' ' GLU . 2.9 t80 -133.21 -30.14 1.36 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.414 -1.051 . . . . 0.0 109.413 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' A' ' 98' ' ' PHE . 18.1 mp0 47.02 -176.11 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.264 -0.898 . . . . 0.0 109.477 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.6 t -100.92 143.88 30.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.247 -0.908 . . . . 0.0 109.53 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -47.65 -40.42 19.73 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.194 -0.941 . . . . 0.0 109.527 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.1 m -54.02 -44.5 71.02 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.899 . . . . 0.0 109.442 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.81 -55.35 8.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 109.268 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.443 ' O ' ' CD1' ' A' ' 107' ' ' PHE . 92.7 mt -48.15 -21.52 0.5 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.36 -0.838 . . . . 0.0 109.497 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -100.23 -24.29 9.74 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -84.61 -5.98 59.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -1.183 . . . . 0.0 109.549 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.578 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 5.0 p90 -54.03 118.0 3.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.223 -0.923 . . . . 0.0 109.492 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -114.88 -55.79 2.44 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.271 -0.893 . . . . 0.0 109.483 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.1 p -92.63 -14.08 28.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.541 -179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.15 75.62 1.23 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.087 HD23 ' H ' ' A' ' 111' ' ' LEU . 1.1 pt? -56.58 163.31 1.85 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -1.124 . . . . 0.0 109.608 -179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -141.38 179.75 6.6 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.374 -0.829 . . . . 0.0 109.432 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.99 111.43 7.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 0.0 109.333 -179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.7 tptp -75.5 110.04 9.55 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.43 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -77.44 114.86 16.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.334 -0.854 . . . . 0.0 109.452 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.549 ' N ' ' OE1' ' A' ' 65' ' ' GLU . . . -72.27 -125.12 0.07 OUTLIER Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -176.24 120.17 0.74 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.46 ' C ' ' H ' ' A' ' 120' ' ' SER . 16.5 m -88.05 -159.61 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.286 -1.126 . . . . 0.0 109.442 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -75.22 33.36 0.1 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.91 . . . . 0.0 109.392 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.46 ' H ' ' C ' ' A' ' 118' ' ' VAL . 3.5 t 56.15 178.57 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.423 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.597 ' O ' ' CG ' ' A' ' 122' ' ' PHE . . . -179.33 120.01 0.67 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 -179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.597 ' CG ' ' O ' ' A' ' 121' ' ' GLY . 4.9 m-85 -177.07 -165.87 0.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.265 -1.138 . . . . 0.0 109.374 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.499 ' O ' ' O ' ' A' ' 122' ' ' PHE . 3.3 mptp? 57.47 122.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.382 -0.824 . . . . 0.0 109.701 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.533 ' O ' ' C ' ' A' ' 125' ' ' VAL . 16.4 m170 -66.51 -151.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.3 -0.875 . . . . 0.0 109.45 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.533 ' C ' ' O ' ' A' ' 124' ' ' HIS . 1.3 p -34.48 105.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.574 -0.703 . . . . 0.0 109.73 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.624 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -83.66 -41.42 0.79 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.342 -0.849 . . . . 0.0 109.924 -179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.624 ' CD ' ' N ' ' A' ' 126' ' ' VAL . 73.1 Cg_endo -83.52 -102.38 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.513 2.142 . . . . 0.0 112.359 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.58 ' ND2' ' O ' ' A' ' 127' ' ' PRO . 14.9 m120 -160.12 -159.05 0.68 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.133 -0.98 . . . . 0.0 109.528 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.531 ' O ' HG23 ' A' ' 130' ' ' VAL . 2.8 tm-20 -173.87 100.51 0.11 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.357 -0.84 . . . . 0.0 109.312 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 129' ' ' GLU . 56.1 t -157.49 -61.44 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.168 -0.958 . . . . 0.0 109.596 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.434 ' C ' ' O ' ' A' ' 130' ' ' VAL . 11.6 t -42.61 113.37 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.208 -0.933 . . . . 0.0 109.506 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.02 51.01 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.885 . . . . 0.0 109.573 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 66.1 tt0 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.066 -0.969 . . . . 0.0 109.433 -179.985 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.662 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -100.38 -40.93 0.22 Allowed Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.32 -0.863 . . . . 0.0 109.572 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.662 ' CD ' ' N ' ' A' ' 2' ' ' HIS . 25.8 Cg_exo -59.82 86.03 0.07 OUTLIER 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 122.711 2.274 . . . . 0.0 111.965 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -83.24 -28.84 28.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.878 -179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.55 ' CE2' HG12 ' A' ' 42' ' ' VAL . 5.7 t80 -70.46 -16.05 62.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.185 -0.947 . . . . 0.0 109.785 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.0 mt -83.74 -38.28 21.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.208 -0.933 . . . . 0.0 109.446 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.45 ' O ' ' C ' ' A' ' 8' ' ' ALA . 48.2 mmtt -95.25 -2.59 49.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.343 -0.848 . . . . 0.0 109.388 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.484 ' HB3' HD13 ' A' ' 44' ' ' LEU . . . -42.12 139.27 1.4 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.283 -0.885 . . . . 0.0 109.529 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 136.23 56.83 0.06 OUTLIER Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 3.7 pttm -137.45 18.7 2.92 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.2 -1.177 . . . . 0.0 109.514 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.469 ' O ' ' OE1' ' A' ' 11' ' ' GLU . 1.7 pp20? -165.93 127.38 1.37 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.188 -0.945 . . . . 0.0 109.419 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.12 85.16 1.7 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.421 2.081 . . . . 0.0 112.148 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -174.62 -103.28 0.16 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.624 -1.39 . . . . 0.0 109.624 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.0 tp -153.2 146.73 25.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.356 -1.085 . . . . 0.0 109.608 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.401 ' HB3' ' CZ3' ' A' ' 17' ' ' TRP . 25.1 mt-30 -135.89 128.72 31.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.866 . . . . 0.0 109.367 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 23.5 mt -105.91 150.08 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.394 -0.816 . . . . 0.0 109.557 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.401 ' CZ3' ' HB3' ' A' ' 15' ' ' GLN . 0.0 OUTLIER -156.68 135.59 11.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.263 -0.898 . . . . 0.0 109.134 179.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.0 ttm180 -104.82 148.61 26.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.27 -0.894 . . . . 0.0 109.568 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.481 ' O ' ' OD1' ' A' ' 39' ' ' ASP . 9.5 p -83.44 146.0 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.286 -0.884 . . . . 0.0 109.42 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.595 ' O ' ' N ' ' A' ' 22' ' ' PHE . 22.8 tt0 -99.3 154.52 18.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.311 -0.868 . . . . 0.0 109.382 179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 20' ' ' GLU . 39.3 tttm -42.31 -18.77 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.272 -0.892 . . . . 0.0 109.599 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.595 ' N ' ' O ' ' A' ' 20' ' ' GLU . 53.5 t80 -163.42 32.67 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.186 -0.946 . . . . 0.0 109.647 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.544 ' OD2' ' N ' ' A' ' 24' ' ' LEU . 9.3 t0 -173.23 -122.84 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.22 -0.925 . . . . 0.0 109.431 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.544 ' N ' ' OD2' ' A' ' 23' ' ' ASP . 4.6 tp -152.44 146.04 24.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.57 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 t -128.62 134.03 25.83 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.398 -0.813 . . . . 0.0 109.17 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.77 146.8 49.1 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.378 2.052 . . . . 0.0 112.16 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.5 t -105.24 105.89 53.73 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.411 -0.806 . . . . 0.0 109.191 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_exo -47.85 127.9 15.22 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.463 2.109 . . . . 0.0 112.358 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 1.6 m -76.37 -3.6 37.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.32 -0.862 . . . . 0.0 109.285 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -77.75 -15.2 59.29 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.167 -0.958 . . . . 0.0 109.358 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.63 ' C ' HD12 ' A' ' 31' ' ' LEU . 0.9 OUTLIER -156.3 12.5 0.29 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 110.129 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.487 ' N ' HD12 ' A' ' 31' ' ' LEU . 20.6 p90 -43.35 163.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.127 -0.983 . . . . 0.0 109.377 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 112.25 -4.71 26.81 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -96.17 102.04 13.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.184 -1.186 . . . . 0.0 109.497 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -96.21 124.43 40.21 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.243 -0.911 . . . . 0.0 109.511 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -92.16 146.79 23.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.443 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.425 ' OG1' ' CD ' ' A' ' 65' ' ' GLU . 13.3 p -84.46 -15.79 44.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.213 -0.929 . . . . 0.0 109.436 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.21 22.91 32.17 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.481 ' OD1' ' O ' ' A' ' 19' ' ' VAL . 3.5 t70 -164.34 150.78 11.05 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.205 -1.174 . . . . 0.0 109.463 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.481 ' O ' ' OD2' ' A' ' 39' ' ' ASP . . . -92.55 153.08 19.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.391 -0.818 . . . . 0.0 109.528 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -125.01 134.79 52.44 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.366 -0.834 . . . . 0.0 109.32 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.55 HG12 ' CE2' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -109.93 144.39 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.269 -0.894 . . . . 0.0 109.018 -179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.072 ' N ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -143.32 121.83 7.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.932 -1.105 . . . . 0.0 109.852 -179.438 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.484 HD13 ' HB3' ' A' ' 8' ' ' ALA . 7.5 tt -111.35 124.58 52.53 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.593 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.543 ' CE ' ' OH ' ' A' ' 106' ' ' TYR . 23.2 tttm -101.33 140.47 35.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.288 -0.883 . . . . 0.0 109.225 179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.526 HG22 HD22 ' A' ' 54' ' ' LEU . 98.9 m -139.32 123.22 17.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.293 -0.88 . . . . 0.0 109.574 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -128.55 168.32 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.171 -0.955 . . . . 0.0 108.894 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 28.6 tt0 -103.64 108.88 20.35 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.58 -0.7 . . . . 0.0 109.411 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 50' ' ' ARG . 14.5 mt -72.8 169.06 17.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.226 -0.921 . . . . 0.0 109.564 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.416 ' C ' ' O ' ' A' ' 49' ' ' LEU . 8.9 tpp85 -43.25 -70.36 0.11 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.217 -0.927 . . . . 0.0 109.252 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -52.74 -31.22 36.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.258 -0.901 . . . . 0.0 109.207 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.35 36.74 4.53 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.818 -1.313 . . . . 0.0 109.818 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.495 ' O ' ' O ' ' A' ' 54' ' ' LEU . 5.8 t-20 -84.52 13.21 5.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.118 -1.225 . . . . 0.0 109.175 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.647 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.4 mt 44.37 97.63 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.573 0.701 . . . . 0.0 109.418 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -71.39 113.18 8.17 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.475 -0.766 . . . . 0.0 109.325 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.536 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 92.6 m-85 -98.89 114.38 26.96 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.239 -0.913 . . . . 0.0 109.849 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -118.28 154.98 31.39 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.421 HD13 HD11 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -142.68 144.59 32.79 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.964 -1.085 . . . . 0.0 110.674 -179.274 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.781 ' HB2' HD13 ' A' ' 43' ' ' ILE . 4.2 m-70 -129.62 150.21 51.05 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.614 ' CD1' ' O ' ' A' ' 60' ' ' TYR . 19.8 p90 -128.98 124.95 36.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.205 -0.934 . . . . 0.0 109.434 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.554 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 56.1 t90 -107.78 127.75 53.98 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.369 -0.832 . . . . 0.0 109.647 -179.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.554 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 24.2 mt -106.65 161.98 14.16 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.314 -0.866 . . . . 0.0 109.405 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.493 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -109.12 157.49 15.1 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 21.8 t-20 -82.29 -11.81 58.4 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -1.14 . . . . 0.0 109.545 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.425 ' CD ' ' OG1' ' A' ' 37' ' ' THR . 2.2 mt-10 -110.26 33.11 4.66 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.655 ' SG ' ' O ' ' A' ' 66' ' ' CYS . 18.8 p -130.44 97.66 4.46 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 122.432 1.11 . . . . 0.0 108.965 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.485 ' O ' ' OG ' ' A' ' 71' ' ' SER . 3.1 m -43.77 170.86 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.763 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.484 ' O ' ' N ' ' A' ' 72' ' ' GLY . 19.5 mt-30 -65.44 -17.78 64.81 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.422 -0.799 . . . . 0.0 109.584 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -65.07 -58.59 5.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.52 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -63.7 -47.07 82.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.378 -0.826 . . . . 0.0 109.196 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.485 ' OG ' ' O ' ' A' ' 67' ' ' SER . 0.2 OUTLIER -68.65 -24.21 64.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.386 -0.821 . . . . 0.0 109.074 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -71.46 -36.02 62.96 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.16 -42.7 62.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -1.152 . . . . 0.0 109.344 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.37 -46.59 88.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.363 -0.836 . . . . 0.0 109.234 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.513 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -59.48 -49.33 78.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.323 -0.861 . . . . 0.0 109.29 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 58.9 mt -49.26 -42.22 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.252 -0.905 . . . . 0.0 109.239 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 6.1 m-85 -61.75 -45.75 92.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.24 -0.913 . . . . 0.0 109.307 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 69.9 m -63.08 -40.12 96.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.296 -0.878 . . . . 0.0 109.413 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 75' ' ' ALA . 24.9 t -67.32 -31.9 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.269 -0.894 . . . . 0.0 109.667 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -67.65 -61.46 1.88 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.261 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.479 ' C ' HD12 ' A' ' 81' ' ' LEU . 1.5 pp -54.13 -28.15 38.02 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.107 -0.996 . . . . 0.0 108.821 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.638 ' O ' ' N ' ' A' ' 86' ' ' ASN . 8.3 t70 -62.83 -54.09 44.24 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.142 -0.974 . . . . 0.0 109.022 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -54.56 -34.53 62.01 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -77.92 -26.17 48.84 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.616 ' C ' ' H ' ' A' ' 87' ' ' GLY . 7.3 mt -121.49 33.28 5.58 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.535 -0.728 . . . . 0.0 109.484 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.638 ' N ' ' O ' ' A' ' 82' ' ' ASP . 4.6 t-20 -70.42 25.56 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.249 -0.907 . . . . 0.0 108.956 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.616 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -68.79 25.63 0.29 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.578 ' H ' ' C ' ' A' ' 86' ' ' ASN . 0.4 OUTLIER 80.87 35.94 0.1 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.427 -1.043 . . . . 0.0 109.704 179.843 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -73.25 179.46 3.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.0 109.123 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.8 t -116.2 121.65 67.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.217 -0.927 . . . . 0.0 109.874 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -97.65 143.26 28.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.3 -0.875 . . . . 0.0 109.107 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.659 ' CD2' ' CE1' ' A' ' 59' ' ' HIS . 33.8 m-70 -120.6 146.61 46.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.196 -0.94 . . . . 0.0 109.519 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.454 ' H ' ' HG2' ' A' ' 93' ' ' ARG . 5.5 ptm180 -116.6 103.01 9.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 0.0 109.617 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.548 ' OE2' ' CG ' ' A' ' 103' ' ' PHE . 42.1 mt-10 -113.78 144.64 42.64 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.459 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.721 HG12 ' N ' ' A' ' 96' ' ' GLN . 47.4 t -149.1 176.56 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.879 . . . . 0.0 109.368 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.721 ' N ' HG12 ' A' ' 95' ' ' VAL . 10.4 tp-100 -67.96 118.08 10.68 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.934 . . . . 0.0 109.453 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 79.13 11.6 84.93 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.441 ' O ' ' C ' ' A' ' 99' ' ' GLU . 0.3 OUTLIER -140.98 19.32 2.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.163 -1.198 . . . . 0.0 109.485 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 98' ' ' PHE . 22.0 mt-10 -43.27 163.07 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.14 -0.975 . . . . 0.0 109.532 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.0 m -100.12 167.79 10.23 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.302 -0.873 . . . . 0.0 109.418 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.73 -50.88 31.41 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.255 -0.903 . . . . 0.0 109.449 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.6 m -46.97 -59.69 2.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.147 -0.971 . . . . 0.0 109.381 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.548 ' CG ' ' OE2' ' A' ' 94' ' ' GLU . 5.4 t80 -53.69 -51.18 64.04 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.392 -0.818 . . . . 0.0 109.328 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.612 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 6.6 mt -53.35 -18.71 2.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.29 -0.881 . . . . 0.0 109.094 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.81 -21.98 24.62 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.543 ' OH ' ' CE ' ' A' ' 45' ' ' LYS . 3.0 m-85 -73.68 -33.74 64.58 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.273 -1.134 . . . . 0.0 109.247 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.691 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 1.0 OUTLIER -41.09 108.14 0.09 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.356 -0.84 . . . . 0.0 109.599 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.2 mttm -115.37 -47.43 2.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.146 -0.972 . . . . 0.0 109.378 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 58.7 m -86.11 -29.14 23.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.267 -0.896 . . . . 0.0 109.522 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 120.48 111.47 2.28 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.445 ' H ' ' HG ' ' A' ' 111' ' ' LEU . 2.4 pp -120.99 166.87 13.24 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.326 -1.103 . . . . 0.0 109.524 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -172.81 -178.17 1.81 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.638 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -93.52 139.7 30.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.286 -0.884 . . . . 0.0 109.44 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -146.46 105.05 3.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.48 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -88.95 150.97 22.58 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 0.0 109.402 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -59.06 150.1 37.11 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 74.52 87.81 0.23 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.505 ' O ' ' HB2' ' A' ' 119' ' ' ALA . 2.7 p -101.29 154.66 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.161 -1.199 . . . . 0.0 109.418 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.505 ' HB2' ' O ' ' A' ' 118' ' ' VAL . . . 174.87 -76.36 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.0 109.426 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -93.09 -61.55 1.55 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.304 -0.872 . . . . 0.0 109.494 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 48.45 -155.86 1.34 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -85.13 -34.56 22.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -1.159 . . . . 0.0 109.504 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.481 ' CG ' ' H ' ' A' ' 124' ' ' HIS . 23.0 tptt 54.22 -138.78 1.07 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.218 -0.926 . . . . 0.0 109.41 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.481 ' H ' ' CG ' ' A' ' 123' ' ' LYS . 33.4 m170 52.87 59.35 4.53 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.343 -0.848 . . . . 0.0 109.489 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.43 ' C ' ' O ' ' A' ' 124' ' ' HIS . 12.7 p -42.79 150.29 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.183 -0.948 . . . . 0.0 109.461 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.418 HG22 ' H ' ' A' ' 126' ' ' VAL . 0.7 OUTLIER -79.12 153.04 77.11 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.922 . . . . 0.0 109.433 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -70.52 -159.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.7 2.267 . . . . 0.0 112.096 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -134.96 84.58 2.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.9 . . . . 0.0 109.462 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -140.54 152.45 45.55 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.252 -0.905 . . . . 0.0 109.458 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.445 ' H ' HG23 ' A' ' 130' ' ' VAL . 2.1 t -72.69 -133.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.249 -0.907 . . . . 0.0 109.441 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.32 154.6 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 109.47 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 11.7 t -73.5 134.55 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.501 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 118.058 -0.972 . . . . 0.0 109.477 -179.991 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.477 ' C ' ' CG ' ' A' ' 2' ' ' HIS . 18.3 tt0 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.287 0.565 . . . . 0.0 109.533 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.477 ' CG ' ' C ' ' A' ' 1' ' ' GLU . 0.2 OUTLIER 171.71 81.24 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.24 -0.913 . . . . 0.0 109.52 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -49.21 89.89 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.702 2.268 . . . . 0.0 111.966 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -83.18 -38.0 22.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.905 . . . . 0.0 110.022 -179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.593 ' CE1' HG12 ' A' ' 42' ' ' VAL . 22.4 t80 -55.17 -19.85 8.88 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.101 -1.0 . . . . 0.0 109.519 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.626 HD23 HD11 ' A' ' 81' ' ' LEU . 9.0 mt -83.77 -35.38 24.39 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.183 -0.948 . . . . 0.0 109.466 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 8' ' ' ALA . 2.2 mmmp? -89.68 -0.96 57.87 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.197 -0.939 . . . . 0.0 109.511 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.479 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -42.88 166.93 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.882 . . . . 0.0 109.546 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 101.34 75.37 1.13 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.7 ptmt -142.99 5.49 1.52 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.19 -1.182 . . . . 0.0 109.622 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -172.34 143.27 1.26 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.239 -0.913 . . . . 0.0 109.342 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -74.38 88.45 1.15 Allowed 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.585 2.19 . . . . 0.0 112.295 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.447 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -172.37 -104.71 0.18 Allowed Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.622 -1.391 . . . . 0.0 109.622 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.8 tp -156.2 143.39 19.07 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.263 -1.14 . . . . 0.0 109.697 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -129.06 130.65 46.82 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.363 -0.835 . . . . 0.0 109.237 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 53.2 mt -113.37 137.66 45.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.263 -0.898 . . . . 0.0 109.958 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -141.61 136.51 31.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.368 -0.832 . . . . 0.0 108.82 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -98.03 150.71 21.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.148 -0.97 . . . . 0.0 109.671 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.626 ' O ' HG13 ' A' ' 19' ' ' VAL . 8.1 p -92.12 122.77 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.387 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.611 ' O ' ' N ' ' A' ' 22' ' ' PHE . 4.2 tm-20 -75.12 149.5 39.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.126 -0.984 . . . . 0.0 109.012 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 20' ' ' GLU . 57.9 mttt -40.3 -20.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.447 -0.783 . . . . 0.0 109.841 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.611 ' N ' ' O ' ' A' ' 20' ' ' GLU . 40.4 t80 -151.46 13.24 0.65 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.081 -1.012 . . . . 0.0 109.819 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.513 ' O ' ' N ' ' A' ' 20' ' ' GLU . 35.0 m-20 -160.81 -143.06 0.09 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.2 -0.938 . . . . 0.0 109.385 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.446 ' CD2' ' H ' ' A' ' 5' ' ' PHE . 0.8 OUTLIER -129.35 139.83 51.58 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.31 -0.869 . . . . 0.0 109.571 -179.756 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 t -119.76 133.06 23.85 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.361 -0.837 . . . . 0.0 108.947 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.62 150.75 45.9 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.431 2.088 . . . . 0.0 112.495 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.8 t -148.79 101.53 3.44 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.306 -0.871 . . . . 0.0 109.214 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -50.1 139.46 34.57 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.591 2.194 . . . . 0.0 112.262 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.475 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 12.4 t -67.53 -21.08 65.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.325 -0.86 . . . . 0.0 109.347 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -77.04 -2.74 35.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.365 -0.835 . . . . 0.0 109.415 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.486 ' O ' ' O ' ' A' ' 32' ' ' TYR . 50.1 mt -124.91 -18.87 5.4 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.339 -0.851 . . . . 0.0 109.5 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.486 ' O ' ' O ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -49.24 -178.61 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.123 -0.986 . . . . 0.0 109.51 179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 119.15 -41.01 2.09 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -98.47 102.37 14.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.238 -1.154 . . . . 0.0 109.495 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -90.33 136.43 33.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.187 -0.946 . . . . 0.0 109.461 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.439 ' CD2' ' OH ' ' A' ' 41' ' ' TYR . 25.1 m-85 -92.9 138.72 31.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 109.435 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.423 ' OG1' ' CD ' ' A' ' 65' ' ' GLU . 55.8 p -80.45 -4.83 55.27 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.31 -0.869 . . . . 0.0 109.48 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.7 -74.9 1.21 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.759 -1.337 . . . . 0.0 109.759 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -78.7 155.05 29.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -1.126 . . . . 0.0 109.601 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.528 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -90.69 165.44 13.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.257 -0.902 . . . . 0.0 109.335 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.439 ' OH ' ' CD2' ' A' ' 36' ' ' PHE . 11.1 m-85 -126.84 136.02 51.78 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.296 -0.878 . . . . 0.0 109.542 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.07 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -111.68 128.6 68.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.338 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.07 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -124.79 141.96 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.949 . . . . 0.0 110.494 -178.667 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.5 tt -128.21 120.6 27.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.55 -0.719 . . . . 0.0 109.081 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.559 ' HZ2' HG22 ' A' ' 47' ' ' VAL . 38.2 tttp -93.11 146.54 23.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.364 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.447 ' O ' ' N ' ' A' ' 13' ' ' GLY . 85.1 m -143.16 129.2 19.64 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.094 -1.004 . . . . 0.0 109.549 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.576 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -133.33 168.49 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 O-C-N 121.178 -0.951 . . . . 0.0 109.262 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -101.72 111.0 23.1 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.616 -0.677 . . . . 0.0 109.376 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.467 ' O ' ' N ' ' A' ' 52' ' ' GLY . 81.2 mt -74.92 158.28 33.59 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.227 -0.92 . . . . 0.0 109.572 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.713 ' CD ' ' H ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -44.85 -47.04 11.06 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.363 -0.836 . . . . 0.0 109.203 179.757 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.465 ' ND2' ' N ' ' A' ' 51' ' ' ASN . 0.9 OUTLIER -65.69 -28.82 69.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.279 -0.888 . . . . 0.0 109.203 179.741 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . 94.17 30.75 8.51 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.498 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.1 t-20 -89.89 12.78 16.34 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.085 -1.244 . . . . 0.0 109.373 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.576 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.1 mt 45.12 99.12 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.665 0.745 . . . . 0.0 109.554 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.547 ' CD ' ' N ' ' A' ' 56' ' ' TYR . 0.4 OUTLIER -68.56 152.83 44.83 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.476 -0.765 . . . . 0.0 109.118 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.547 ' N ' ' CD ' ' A' ' 55' ' ' GLN . 68.4 m-85 -133.05 114.25 13.73 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.223 -0.923 . . . . 0.0 109.806 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.63 155.72 26.03 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.458 ' C ' ' CD2' ' A' ' 59' ' ' HIS . 1.1 mp -130.41 146.44 51.98 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.884 -1.135 . . . . 0.0 110.664 -179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.461 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 6.9 m-70 -136.22 144.19 44.75 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.437 ' CE1' ' HG ' ' A' ' 62' ' ' LEU . 13.5 t80 -129.27 128.97 44.3 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.245 -0.909 . . . . 0.0 109.857 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -109.2 126.0 52.81 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.403 -0.811 . . . . 0.0 109.587 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.437 ' HG ' ' CE1' ' A' ' 60' ' ' TYR . 7.9 mt -104.06 162.18 13.37 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.423 -0.798 . . . . 0.0 109.906 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.536 ' O ' ' SG ' ' A' ' 66' ' ' CYS . . . -120.54 158.6 15.53 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 45.1 t30 -82.34 -11.95 58.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.158 -1.201 . . . . 0.0 109.957 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.423 ' CD ' ' OG1' ' A' ' 37' ' ' THR . 0.4 OUTLIER -109.73 35.17 3.45 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 179.447 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.649 ' SG ' ' O ' ' A' ' 66' ' ' CYS . 18.5 p -130.45 97.76 4.49 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 122.44 1.114 . . . . 0.0 108.916 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 66' ' ' CYS . 1.2 m -52.46 -170.91 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.645 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.518 ' O ' ' N ' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -76.54 -17.82 59.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 109.561 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 64.1 m-20 -64.18 -58.71 5.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.236 -0.915 . . . . 0.0 109.547 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -66.54 -40.1 88.91 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.375 -0.828 . . . . 0.0 109.123 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.7 t -73.81 -22.75 59.69 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.398 -0.813 . . . . 0.0 109.251 179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -75.1 -35.36 49.57 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.75 -46.78 34.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.284 -1.127 . . . . 0.0 109.297 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.15 -39.81 87.67 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.349 -0.844 . . . . 0.0 109.324 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -68.46 -49.58 58.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.31 -0.869 . . . . 0.0 109.425 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.413 HG22 ' OE1' ' A' ' 80' ' ' GLN . 39.3 mt -48.31 -42.18 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -0.912 . . . . 0.0 109.411 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 37.8 m-85 -70.06 -36.48 75.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.23 -0.919 . . . . 0.0 109.377 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.467 ' O ' ' OD2' ' A' ' 82' ' ' ASP . 5.7 m -68.68 -34.94 76.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.918 . . . . 0.0 109.265 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 87.5 t -70.37 -46.65 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.362 -0.836 . . . . 0.0 109.424 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.413 ' OE1' HG22 ' A' ' 76' ' ' ILE . 43.6 mt-30 -64.03 -46.27 85.18 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.295 -0.878 . . . . 0.0 109.192 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.626 HD11 HD23 ' A' ' 6' ' ' LEU . 2.5 mt -56.63 -36.61 69.69 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.261 -0.899 . . . . 0.0 108.88 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.589 ' O ' ' N ' ' A' ' 86' ' ' ASN . 0.7 OUTLIER -61.53 -58.12 9.41 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.298 -0.876 . . . . 0.0 109.154 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.49 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 10.8 m-20 -50.7 -33.11 21.47 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.993 -1.067 . . . . 0.0 108.355 179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -78.14 -25.87 47.57 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.569 ' C ' ' H ' ' A' ' 87' ' ' GLY . 8.5 mt -121.38 32.09 6.05 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.497 -0.752 . . . . 0.0 109.371 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.589 ' N ' ' O ' ' A' ' 82' ' ' ASP . 26.8 p30 -72.77 26.38 0.06 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.271 -0.893 . . . . 0.0 108.849 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.569 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -78.25 56.59 4.04 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 62.03 55.23 2.56 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.477 -1.014 . . . . 0.0 109.69 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -110.22 179.09 4.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.373 -0.83 . . . . 0.0 109.186 179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.1 t -134.68 151.52 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.151 -0.968 . . . . 0.0 109.607 -179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -115.75 136.63 52.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.383 -0.823 . . . . 0.0 109.416 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.485 ' O ' ' OE2' ' A' ' 94' ' ' GLU . 21.2 m-70 -107.22 110.4 22.44 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.159 -0.963 . . . . 0.0 109.55 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 23.1 mtp85 -86.39 92.93 8.98 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.248 -0.908 . . . . 0.0 109.142 179.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.485 ' OE2' ' O ' ' A' ' 92' ' ' HIS . 20.2 mp0 -99.87 140.46 34.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.266 -0.896 . . . . 0.0 109.871 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.6 t -132.61 157.35 43.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.417 -0.802 . . . . 0.0 109.123 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.456 ' O ' ' CD ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -56.99 115.98 2.94 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.232 -0.917 . . . . 0.0 109.499 -179.882 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 89.89 9.92 65.39 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.456 ' O ' ' C ' ' A' ' 99' ' ' GLU . 11.5 t80 -144.98 30.07 1.18 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.236 -1.156 . . . . 0.0 109.588 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.654 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 6.7 mp0 -41.82 157.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 0.0 109.497 179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.7 p -87.29 177.76 7.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -0.889 . . . . 0.0 109.564 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -71.35 -57.01 4.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.273 -0.892 . . . . 0.0 109.458 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.8 m -46.77 -51.18 16.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.189 -0.945 . . . . 0.0 109.269 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -55.76 -52.5 63.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.387 -0.821 . . . . 0.0 109.203 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.6 mt -49.09 -28.68 4.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -0.89 . . . . 0.0 109.424 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -94.56 -14.11 51.44 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.444 ' O ' ' C ' ' A' ' 107' ' ' PHE . 7.2 t80 -83.08 -20.29 35.19 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.269 -1.136 . . . . 0.0 109.564 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.545 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 3.3 p90 -42.31 122.97 2.36 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.163 -0.961 . . . . 0.0 109.549 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 8.8 ttpt -103.1 -57.12 2.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 109.427 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 72.8 m -106.15 -29.2 10.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -0.874 . . . . 0.0 109.413 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 132.49 107.9 1.09 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.697 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -76.42 160.27 29.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.211 -1.17 . . . . 0.0 109.449 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 12.1 mtpp -153.54 152.05 30.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -0.885 . . . . 0.0 109.511 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -98.28 138.68 35.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.242 -0.911 . . . . 0.0 109.421 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 18.1 tttp -142.5 154.36 44.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.269 -0.894 . . . . 0.0 109.604 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -94.91 139.29 31.52 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.429 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -95.47 87.61 1.03 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -155.24 -62.19 0.01 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 22.6 m -95.82 142.81 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -1.14 . . . . 0.0 109.547 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -96.65 100.92 12.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 109.442 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 31.1 t -89.83 79.89 6.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.396 -0.815 . . . . 0.0 109.508 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 148.58 105.15 0.36 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER 48.44 -140.63 0.64 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.261 -1.14 . . . . 0.0 109.435 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 30.0 tttp -158.47 123.98 4.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.898 . . . . 0.0 109.389 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.401 ' O ' HG23 ' A' ' 126' ' ' VAL . 1.1 t-80 -59.37 153.0 19.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.164 -0.96 . . . . 0.0 109.488 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 11.2 t -53.49 153.23 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.185 -0.947 . . . . 0.0 109.504 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 124' ' ' HIS . 91.7 t -145.07 83.21 9.43 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.88 . . . . 0.0 109.459 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.459 ' O ' ' O ' ' A' ' 128' ' ' ASN . 51.7 Cg_exo -50.59 -38.91 55.95 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.726 2.284 . . . . 0.0 112.28 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.459 ' O ' ' O ' ' A' ' 127' ' ' PRO . 5.3 t-20 61.04 133.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.383 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -92.6 95.43 9.6 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.261 -0.899 . . . . 0.0 109.489 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' A' ' 131' ' ' VAL . 96.8 t -151.91 107.91 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.174 -0.953 . . . . 0.0 109.426 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.478 HG13 ' N ' ' A' ' 132' ' ' VAL . 6.5 p -43.11 -40.84 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.323 -0.861 . . . . 0.0 109.482 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.478 ' N ' HG13 ' A' ' 131' ' ' VAL . 2.2 t -66.32 123.87 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.179 -0.951 . . . . 0.0 109.51 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.432 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.491 ' O ' ' N ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER -142.0 154.75 65.44 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.271 -0.893 . . . . 0.0 109.3 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -40.94 87.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.648 2.232 . . . . 0.0 112.086 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.688 ' H ' HD22 ' A' ' 24' ' ' LEU . 67.5 tt0 -83.21 -18.02 40.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.355 -0.841 . . . . 0.0 109.999 -179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.465 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 2.3 m-85 -74.09 -5.91 44.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.092 -1.005 . . . . 0.0 109.541 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.421 ' CD2' HE21 ' A' ' 80' ' ' GLN . 11.5 mt -85.49 -39.62 17.26 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.205 -0.934 . . . . 0.0 109.417 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.447 ' O ' ' O ' ' A' ' 8' ' ' ALA . 41.9 mtpt -97.67 -9.97 25.84 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.352 -0.843 . . . . 0.0 109.515 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.447 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -43.84 166.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 0.0 109.577 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 134.87 -29.9 2.91 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 33.4 mttt -78.94 23.7 0.34 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.245 -1.15 . . . . 0.0 109.377 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.437 ' O ' ' N ' ' A' ' 13' ' ' GLY . 55.3 mt-10 -137.01 76.77 44.84 Favored Pre-proline 0 C--N 1.305 -1.367 0 O-C-N 121.288 -0.882 . . . . 0.0 109.547 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -52.25 81.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.858 0 C-N-CA 122.867 2.378 . . . . 0.0 112.207 -179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' A' ' 46' ' ' THR . . . 179.65 -102.98 0.17 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 109.654 -1.379 . . . . 0.0 109.654 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.639 HD21 ' CG2' ' A' ' 43' ' ' ILE . 7.1 tt -162.53 127.53 3.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.196 -1.179 . . . . 0.0 109.81 -179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.59 ' N ' HD23 ' A' ' 14' ' ' LEU . 35.1 mt-30 -114.42 146.82 40.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.346 -0.846 . . . . 0.0 109.316 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.625 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 11.8 mt -130.68 123.86 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.502 -0.749 . . . . 0.0 110.284 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.625 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 11.3 m0 -143.88 158.94 43.36 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.043 -1.036 . . . . 0.0 108.528 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.504 ' NE ' ' CZ ' ' A' ' 41' ' ' TYR . 20.8 ttm180 -105.76 152.48 23.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.019 -1.051 . . . . 0.0 110.001 -179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.6 p -88.38 139.61 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.277 -0.889 . . . . 0.0 109.422 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.595 ' O ' ' N ' ' A' ' 22' ' ' PHE . 18.8 tt0 -88.69 152.61 21.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.23 -0.919 . . . . 0.0 109.203 179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.461 ' C ' ' O ' ' A' ' 20' ' ' GLU . 24.3 tttt -40.72 -20.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.307 -0.87 . . . . 0.0 109.555 -179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.595 ' N ' ' O ' ' A' ' 20' ' ' GLU . 7.2 t80 -160.14 32.1 0.17 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.175 -0.953 . . . . 0.0 109.492 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -170.71 -130.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.516 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.688 HD22 ' H ' ' A' ' 4' ' ' GLU . 5.9 tp -144.2 146.2 32.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.232 -0.917 . . . . 0.0 109.558 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 t -129.3 126.99 23.14 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.017 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -75.21 141.6 26.24 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.368 2.045 . . . . 0.0 112.383 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 75.5 t -104.35 122.84 42.56 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.379 -0.826 . . . . 0.0 109.242 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -76.32 162.08 34.14 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.514 2.143 . . . . 0.0 112.28 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.94 -24.64 67.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.216 -0.928 . . . . 0.0 109.428 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -64.02 -10.71 23.43 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.228 -0.92 . . . . 0.0 109.429 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 32' ' ' TYR . 94.9 mt -127.26 -13.16 5.62 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.289 -0.882 . . . . 0.0 109.531 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.531 ' CD1' ' C ' ' A' ' 32' ' ' TYR . 4.4 t80 -41.11 131.05 2.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.297 -0.877 . . . . 0.0 109.372 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.454 ' O ' ' N ' ' A' ' 112' ' ' LYS . . . 85.8 15.03 66.3 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 57.2 t0 -141.24 99.28 3.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -1.145 . . . . 0.0 109.48 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -97.04 164.94 12.31 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.276 -0.89 . . . . 0.0 109.494 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.7 t80 -105.2 136.08 45.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.206 -0.934 . . . . 0.0 109.449 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.449 ' OG1' ' CD ' ' A' ' 65' ' ' GLU . 4.1 p -73.35 -4.99 36.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.184 -0.948 . . . . 0.0 109.486 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.97 38.75 3.18 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 40' ' ' ALA . 5.9 t0 -171.23 171.01 5.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -1.189 . . . . 0.0 109.489 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.463 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -113.59 136.01 53.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.275 -0.89 . . . . 0.0 109.546 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.504 ' CZ ' ' NE ' ' A' ' 18' ' ' ARG . 27.7 m-85 -114.91 142.64 46.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.333 -0.854 . . . . 0.0 109.345 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.011 ' O ' HD13 ' A' ' 43' ' ' ILE . 0.3 OUTLIER -113.14 143.96 21.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.273 -0.892 . . . . 0.0 108.871 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.011 HD13 ' O ' ' A' ' 42' ' ' VAL . 1.2 mm -136.7 151.41 27.79 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 C-N-CA 119.359 -0.937 . . . . 0.0 110.091 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.706 HD23 ' N ' ' A' ' 45' ' ' LYS . 4.5 tt -135.27 121.14 19.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.554 -0.716 . . . . 0.0 109.207 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.706 ' N ' HD23 ' A' ' 44' ' ' LEU . 31.5 tttt -104.96 112.48 25.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.251 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 55' ' ' GLN . 39.1 m -119.78 135.54 54.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.418 -0.801 . . . . 0.0 109.484 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.535 ' O ' HD23 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -126.95 168.29 20.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 O-C-N 121.304 -0.872 . . . . 0.0 108.907 179.931 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 40.9 tp60 -106.9 98.49 8.14 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.611 -0.68 . . . . 0.0 109.422 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.61 ' O ' ' N ' ' A' ' 51' ' ' ASN . 9.3 mt -65.03 157.75 27.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.287 -0.883 . . . . 0.0 109.239 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -51.72 84.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.12 -0.988 . . . . 0.0 109.099 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.61 ' N ' ' O ' ' A' ' 49' ' ' LEU . 6.6 m-20 51.43 43.36 29.59 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.229 -0.92 . . . . 0.0 109.192 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -97.82 -79.9 1.49 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 54' ' ' LEU . 1.2 t30 -174.53 26.27 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.079 -1.248 . . . . 0.0 109.908 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.616 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 3.9 mt 58.51 106.7 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.763 0 CA-C-O 121.666 0.746 . . . . 0.0 109.118 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.593 ' O ' HG23 ' A' ' 46' ' ' THR . 32.1 tt0 -68.82 147.53 51.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.523 -0.735 . . . . 0.0 109.503 -179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.616 ' CE1' ' O ' ' A' ' 54' ' ' LEU . 97.7 m-85 -129.95 114.67 16.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.48 -0.762 . . . . 0.0 109.507 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.593 ' OD1' ' CE1' ' A' ' 59' ' ' HIS . 0.3 OUTLIER -123.1 154.94 37.92 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 179.176 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.5 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 1.8 mp -132.93 150.2 52.18 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.958 -1.089 . . . . 0.0 110.753 -179.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.704 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -141.96 116.93 9.93 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.36 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.667 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -103.8 121.89 43.98 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.023 -1.048 . . . . 0.0 109.52 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.553 ' NE1' ' OE1' ' A' ' 99' ' ' GLU . 71.4 t90 -98.99 136.25 39.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.314 -0.866 . . . . 0.0 109.725 -179.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.565 ' H ' HD12 ' A' ' 62' ' ' LEU . 0.5 OUTLIER -116.63 159.04 22.78 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.397 -0.814 . . . . 0.0 109.4 179.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -101.07 148.34 18.1 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -70.37 -12.25 61.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -1.16 . . . . 0.0 109.49 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.449 ' CD ' ' OG1' ' A' ' 37' ' ' THR . 1.7 mt-10 -106.6 31.37 5.29 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.467 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.3 m -130.48 97.57 4.43 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.091 0.948 . . . . 0.0 108.513 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 66' ' ' CYS . 94.3 p -52.57 -170.88 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.783 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 72' ' ' GLY . 44.2 tt0 -64.63 -17.95 64.49 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.367 -0.833 . . . . 0.0 109.537 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -63.29 -58.69 6.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 109.473 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -68.16 -39.46 82.57 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.396 -0.815 . . . . 0.0 108.898 179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.1 t -73.48 -20.98 60.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.515 -0.741 . . . . 0.0 109.064 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -75.66 -41.06 30.19 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.53 -42.16 71.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -1.121 . . . . 0.0 109.22 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.436 ' HB2' ' CB ' ' A' ' 40' ' ' ALA . . . -62.05 -42.04 98.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.328 -0.858 . . . . 0.0 109.285 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.513 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -64.91 -47.82 76.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.308 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.2 mt -52.76 -37.14 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.348 -0.845 . . . . 0.0 109.235 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -68.56 -41.34 79.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.342 -0.849 . . . . 0.0 109.293 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 21.9 m -68.28 -34.45 76.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.217 -0.927 . . . . 0.0 109.557 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 75' ' ' ALA . 61.8 t -68.06 -37.99 79.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.223 -0.923 . . . . 0.0 109.426 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.421 HE21 ' CD2' ' A' ' 6' ' ' LEU . 0.0 OUTLIER -68.39 -47.03 68.42 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.723 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.463 HD13 HD23 ' A' ' 58' ' ' LEU . 0.6 OUTLIER -55.43 -38.13 68.59 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.189 -0.945 . . . . 0.0 108.974 179.633 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.628 ' O ' ' N ' ' A' ' 86' ' ' ASN . 16.1 t70 -61.74 -58.33 8.45 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.318 -0.864 . . . . 0.0 109.109 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 82' ' ' ASP . 59.1 m-20 -45.43 -35.09 3.48 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.119 -0.988 . . . . 0.0 108.744 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -74.25 -32.66 63.04 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.361 -0.837 . . . . 0.0 108.834 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.577 ' C ' ' H ' ' A' ' 87' ' ' GLY . 7.7 mt -121.69 36.17 4.69 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.409 -0.807 . . . . 0.0 109.283 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.628 ' N ' ' O ' ' A' ' 82' ' ' ASP . 9.6 p30 -72.03 25.4 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.181 -0.95 . . . . 0.0 109.143 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.577 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -80.41 -75.65 1.06 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.409 ' HG3' HH21 ' A' ' 88' ' ' ARG . 12.7 mtt85 -152.32 50.65 0.77 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.262 -1.14 . . . . 0.0 109.458 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.536 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -96.87 179.14 5.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.214 -0.929 . . . . 0.0 109.404 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 59.0 t -135.99 96.36 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.282 -0.886 . . . . 0.0 109.532 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 58' ' ' LEU . 7.2 pt20 -95.87 143.92 26.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.905 . . . . 0.0 109.308 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.672 ' CE1' ' HD1' ' A' ' 59' ' ' HIS . 2.0 p80 -147.09 158.6 43.99 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.841 -1.162 . . . . 0.0 110.144 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.537 ' CG ' HD11 ' A' ' 62' ' ' LEU . 4.4 ttt180 -91.68 126.29 36.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.456 -0.778 . . . . 0.0 109.902 -179.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.441 ' O ' HD12 ' A' ' 62' ' ' LEU . 21.4 mt-10 -107.49 129.91 54.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.263 -0.898 . . . . 0.0 109.229 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.491 ' O ' ' OE1' ' A' ' 99' ' ' GLU . 3.4 t -127.57 161.41 35.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 109.66 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -62.44 145.21 54.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.328 -0.858 . . . . 0.0 109.551 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.69 4.18 6.71 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.447 ' O ' ' C ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -134.08 6.13 3.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.329 -1.101 . . . . 0.0 109.293 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.553 ' OE1' ' NE1' ' A' ' 61' ' ' TRP . 3.5 mp0 -42.64 158.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.417 -0.802 . . . . 0.0 109.351 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.1 m -80.32 147.44 31.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.313 -0.867 . . . . 0.0 109.369 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.71 -33.26 66.3 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -0.964 . . . . 0.0 109.432 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 99.4 m -68.68 -33.86 74.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -0.916 . . . . 0.0 109.481 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -68.74 -46.6 68.44 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.361 -0.837 . . . . 0.0 109.422 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 7.6 mt -69.36 -23.49 63.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.466 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -91.14 -26.24 22.04 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 50.6 t80 -77.33 -30.9 54.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.363 -1.081 . . . . 0.0 109.559 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -80.65 129.17 34.36 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.298 -0.876 . . . . 0.0 109.446 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.47 ' HB2' ' HZ3' ' A' ' 108' ' ' LYS . 1.9 mtmp? -103.21 -12.86 17.03 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.895 . . . . 0.0 109.457 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 5.9 t -97.05 -9.21 28.54 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.927 . . . . 0.0 109.511 -179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 80.59 104.48 0.3 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.766 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -63.27 179.82 0.39 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.29 -1.123 . . . . 0.0 109.32 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 33' ' ' GLY . 0.0 OUTLIER -164.54 167.13 19.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.204 -0.935 . . . . 0.0 109.459 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.5 103.24 5.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.254 -0.904 . . . . 0.0 109.316 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.9 ttmp? -79.51 124.06 28.14 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.264 -0.897 . . . . 0.0 109.536 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 28.4 ttpt -92.73 144.49 25.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.125 -0.985 . . . . 0.0 109.479 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -102.01 48.81 1.05 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -161.1 95.86 0.14 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 12.0 p -147.64 -13.62 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.276 -1.132 . . . . 0.0 109.416 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.419 ' C ' ' H ' ' A' ' 121' ' ' GLY . . . -159.42 -174.44 4.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.495 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 47.0 t -75.42 37.23 0.13 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.27 -0.894 . . . . 0.0 109.46 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.446 ' O ' ' O ' ' A' ' 122' ' ' PHE . . . 77.74 123.04 0.25 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.452 ' CD1' ' N ' ' A' ' 123' ' ' LYS . 55.6 t80 -47.66 -95.22 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.26 -1.141 . . . . 0.0 109.376 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.452 ' N ' ' CD1' ' A' ' 122' ' ' PHE . 14.8 ptpt -57.01 -169.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.23 -0.919 . . . . 0.0 109.492 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -94.97 94.67 8.14 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.237 -0.914 . . . . 0.0 109.437 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 6.0 p -120.48 1.06 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.245 -0.909 . . . . 0.0 109.409 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.717 HG13 ' O ' ' A' ' 126' ' ' VAL . 8.3 p -51.95 114.26 5.13 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.175 -0.953 . . . . 0.0 109.416 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -45.59 169.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.432 2.088 . . . . 0.0 112.237 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -99.19 55.22 0.99 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 0.0 109.566 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -56.68 158.25 4.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 109.477 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 49.0 t -69.46 72.81 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.247 -0.908 . . . . 0.0 109.533 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.2 t -151.12 113.05 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.245 -0.91 . . . . 0.0 109.429 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 61.4 t -150.85 79.36 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.29 -0.881 . . . . 0.0 109.445 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 25.3 mm-40 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.441 179.975 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.576 ' O ' ' CD2' ' A' ' 2' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.576 ' CD2' ' O ' ' A' ' 1' ' ' GLU . 20.2 m-70 -157.35 52.55 0.6 Allowed Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.201 -0.937 . . . . 0.0 109.551 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 2' ' ' HIS . 34.8 Cg_endo -68.08 75.05 0.7 Allowed 'Trans proline' 0 C--N 1.305 -1.753 0 C-N-CA 122.786 2.324 . . . . 0.0 111.994 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.425 ' HB3' ' CE2' ' A' ' 17' ' ' TRP . 6.0 mm-40 -83.42 -46.45 12.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -0.877 . . . . 0.0 109.993 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.804 ' CZ ' HG12 ' A' ' 42' ' ' VAL . 23.1 t80 -65.29 -32.66 74.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.207 -0.933 . . . . 0.0 109.058 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.509 HD23 HD11 ' A' ' 81' ' ' LEU . 12.2 mt -74.01 -35.85 64.43 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.31 -0.869 . . . . 0.0 109.314 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.497 ' O ' ' O ' ' A' ' 8' ' ' ALA . 12.4 mmmt -82.76 -9.88 59.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.435 -0.79 . . . . 0.0 109.307 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.497 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -45.58 173.07 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.346 -0.846 . . . . 0.0 109.595 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 115.4 32.57 1.77 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 13.8 pttt -150.25 35.61 0.66 Allowed 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.324 -1.103 . . . . 0.0 109.412 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -155.09 115.5 2.36 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.296 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.15 81.85 2.6 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.442 2.094 . . . . 0.0 112.354 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 46' ' ' THR . . . 175.44 -100.62 0.15 Allowed Glycine 0 N--CA 1.488 2.154 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 tt -161.44 145.06 12.76 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.217 -1.167 . . . . 0.0 109.652 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.42 ' HB3' ' CZ3' ' A' ' 17' ' ' TRP . 1.2 mt-30 -133.75 135.96 44.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.274 -0.891 . . . . 0.0 109.239 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.409 HG23 HD12 ' A' ' 43' ' ' ILE . 13.3 mt -106.83 135.65 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.349 -0.844 . . . . 0.0 110.067 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.425 ' CE2' ' HB3' ' A' ' 4' ' ' GLU . 0.6 OUTLIER -144.34 111.38 5.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.379 -0.825 . . . . 0.0 108.948 179.466 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.569 ' NH2' ' CD1' ' A' ' 36' ' ' PHE . 28.2 ttt180 -74.79 153.03 38.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.192 -0.942 . . . . 0.0 109.473 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.9 p -77.14 145.14 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 109.792 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.59 ' O ' ' N ' ' A' ' 22' ' ' PHE . 21.6 tt0 -108.08 154.58 21.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.405 -0.809 . . . . 0.0 109.187 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.591 ' O ' ' CD2' ' A' ' 22' ' ' PHE . 7.2 mtmp? -46.93 -10.86 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.287 -0.883 . . . . 0.0 109.513 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 21' ' ' LYS . 9.5 m-85 -169.53 28.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 109.529 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.675 ' C ' HD22 ' A' ' 24' ' ' LEU . 3.7 t70 -176.03 -154.17 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.918 . . . . 0.0 109.592 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.675 HD22 ' C ' ' A' ' 23' ' ' ASP . 4.5 mm? -117.83 146.01 44.17 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.312 -0.868 . . . . 0.0 109.425 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.423 ' O ' ' N ' ' A' ' 18' ' ' ARG . 2.1 t -125.08 130.65 24.12 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.323 -0.861 . . . . 0.0 109.048 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.56 137.61 20.71 Favored 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.344 2.029 . . . . 0.0 112.631 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.2 t -122.25 101.68 40.88 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.428 -0.795 . . . . 0.0 108.973 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -78.66 166.93 23.21 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.466 2.111 . . . . 0.0 112.478 -179.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -58.35 -17.8 22.73 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.22 -0.925 . . . . 0.0 109.31 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.723 HD22 ' N ' ' A' ' 30' ' ' ASN . 0.6 OUTLIER -44.45 -31.18 1.01 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.939 . . . . 0.0 109.361 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.487 ' O ' ' OD2' ' A' ' 34' ' ' ASP . 2.3 pp -160.45 16.64 0.13 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.247 -0.908 . . . . 0.0 109.837 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -56.33 161.4 2.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.992 -1.067 . . . . 0.0 109.423 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.57 -7.77 63.69 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.487 ' OD2' ' O ' ' A' ' 31' ' ' LEU . 11.3 p-10 -93.01 98.14 11.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -1.145 . . . . 0.0 109.373 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.485 ' CE1' HD23 ' A' ' 111' ' ' LEU . 51.1 m-85 -89.61 133.71 34.49 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.279 -0.888 . . . . 0.0 109.508 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.569 ' CD1' ' NH2' ' A' ' 18' ' ' ARG . 28.2 m-85 -96.52 127.4 42.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.259 -0.901 . . . . 0.0 109.525 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 28.5 p -68.83 -4.87 17.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.879 . . . . 0.0 109.576 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -118.22 43.82 1.54 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.631 -1.388 . . . . 0.0 109.631 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -167.99 -168.25 0.95 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.244 -1.15 . . . . 0.0 109.49 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -136.83 145.25 44.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.959 . . . . 0.0 109.497 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.574 ' HB3' HD11 ' A' ' 43' ' ' ILE . 1.7 m-85 -118.73 135.77 54.32 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.399 -0.813 . . . . 0.0 109.455 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.064 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -115.62 120.11 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.428 -0.795 . . . . 0.0 109.048 179.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.064 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -125.1 130.0 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.16 -0.962 . . . . 0.0 110.299 -179.211 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.613 HD12 ' O ' ' A' ' 57' ' ' ASP . 6.0 tp -104.79 121.0 42.73 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.565 -0.709 . . . . 0.0 109.166 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.554 ' N ' HD12 ' A' ' 44' ' ' LEU . 8.1 tptm -104.83 103.81 13.48 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.37 -0.831 . . . . 0.0 109.178 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.501 HG23 ' O ' ' A' ' 55' ' ' GLN . 16.9 m -117.22 139.1 51.21 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.331 -0.856 . . . . 0.0 109.521 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.561 ' O ' HD23 ' A' ' 54' ' ' LEU . 0.5 OUTLIER -131.65 168.39 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.246 -0.909 . . . . 0.0 109.491 -179.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.762 HE22 ' H ' ' A' ' 51' ' ' ASN . 0.0 OUTLIER -111.69 133.49 53.89 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.651 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.626 ' O ' ' C ' ' A' ' 50' ' ' ARG . 0.5 OUTLIER -116.06 100.33 7.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.202 -0.936 . . . . 0.0 109.554 179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.626 ' C ' ' O ' ' A' ' 49' ' ' LEU . 31.0 ttt85 21.23 72.54 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.68 -0.638 . . . . 0.0 110.235 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.762 ' H ' HE22 ' A' ' 48' ' ' GLN . 1.8 m120 45.87 52.04 10.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.246 -0.909 . . . . 0.0 109.381 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . -97.11 -81.74 1.6 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.48 ' O ' ' O ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -165.15 20.73 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.347 -1.09 . . . . 0.0 109.754 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.592 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 5.9 mt 53.77 104.65 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 O-C-N 121.489 -0.757 . . . . 0.0 109.306 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.501 ' O ' HG23 ' A' ' 46' ' ' THR . 32.1 tt0 -68.04 149.69 49.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.538 -0.726 . . . . 0.0 109.043 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.592 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 97.1 m-85 -131.47 114.89 15.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.195 -0.941 . . . . 0.0 109.94 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.613 ' O ' HD12 ' A' ' 44' ' ' LEU . 2.0 m-20 -120.29 155.03 34.11 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.465 HD13 ' HG3' ' A' ' 91' ' ' GLN . 4.8 mp -136.25 129.78 32.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.947 -1.095 . . . . 0.0 110.162 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.586 ' ND1' ' NE2' ' A' ' 92' ' ' HIS . 3.1 m-70 -115.62 109.65 18.05 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.658 ' CZ ' HD22 ' A' ' 62' ' ' LEU . 0.6 OUTLIER -99.55 115.81 30.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.22 -0.925 . . . . 0.0 109.317 -179.61 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 88.6 t90 -108.16 142.31 38.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.29 -0.881 . . . . 0.0 109.752 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.658 HD22 ' CZ ' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -133.52 162.21 32.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.306 -0.871 . . . . 0.0 109.526 179.904 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -87.24 154.41 26.3 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -82.07 -12.42 58.26 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -1.122 . . . . 0.0 109.564 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -106.81 32.79 4.3 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.498 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.3 m -130.23 97.67 4.5 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 122.261 1.029 . . . . 0.0 108.438 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 66' ' ' CYS . 1.2 t -44.32 173.87 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.575 -0.738 . . . . 0.0 109.855 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.596 ' O ' ' N ' ' A' ' 72' ' ' GLY . 3.3 pt20 -57.25 -17.45 11.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.483 -0.761 . . . . 0.0 109.732 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -61.22 -59.1 5.84 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.054 -1.029 . . . . 0.0 109.384 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.28 -50.75 66.69 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.281 -0.887 . . . . 0.0 108.691 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 25.2 m -64.98 -20.87 66.71 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.596 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.15 -43.83 62.55 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.198 -1.561 . . . . 0.0 109.198 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.69 -49.07 67.31 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.233 -1.157 . . . . 0.0 109.103 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -58.69 -43.9 90.13 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.393 -0.817 . . . . 0.0 109.211 179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.553 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -66.73 -47.2 73.03 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.353 -0.842 . . . . 0.0 109.478 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 15.9 mt -47.08 -44.12 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.28 -0.888 . . . . 0.0 109.091 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.458 ' O ' HD12 ' A' ' 81' ' ' LEU . 37.5 m-85 -65.77 -45.92 80.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 109.298 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.4 m -66.14 -22.58 66.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.245 -0.909 . . . . 0.0 109.009 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 75' ' ' ALA . 66.3 t -73.57 -50.28 31.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.288 -0.883 . . . . 0.0 109.459 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -61.66 -49.86 74.84 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.321 -0.862 . . . . 0.0 108.92 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.509 HD11 HD23 ' A' ' 6' ' ' LEU . 0.9 OUTLIER -55.15 -37.68 67.29 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.28 -0.888 . . . . 0.0 109.037 179.552 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 86' ' ' ASN . 64.5 t0 -58.07 -55.87 29.38 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.226 -0.921 . . . . 0.0 108.883 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.435 ' HA ' HD22 ' A' ' 86' ' ' ASN . 39.4 m-20 -50.32 -33.98 22.08 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.08 -1.012 . . . . 0.0 108.362 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -77.1 -24.27 51.8 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 82' ' ' ASP . 12.6 mt -121.4 30.45 6.76 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.326 -0.859 . . . . 0.0 109.419 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 82' ' ' ASP . 0.5 OUTLIER -80.13 27.99 0.31 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.309 -0.869 . . . . 0.0 108.974 179.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.431 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -83.17 -54.35 3.2 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.6 ptt-85 -175.81 42.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -1.112 . . . . 0.0 109.62 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.581 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -95.53 178.88 5.34 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.276 -0.89 . . . . 0.0 109.497 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 87.4 t -123.27 91.97 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.437 -0.789 . . . . 0.0 109.337 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.535 ' H ' ' CD ' ' A' ' 91' ' ' GLN . 3.9 mp0 -96.57 125.18 40.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.342 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.586 ' NE2' ' ND1' ' A' ' 59' ' ' HIS . 2.7 p80 -133.52 143.78 48.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.143 -0.973 . . . . 0.0 109.618 -179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -99.32 105.29 17.27 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.227 -0.92 . . . . 0.0 109.69 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.423 ' OE1' ' OG ' ' A' ' 100' ' ' SER . 41.0 mt-10 -87.11 148.16 25.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.321 -0.862 . . . . 0.0 109.391 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.3 t -135.28 163.46 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.196 -0.94 . . . . 0.0 109.487 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.548 ' OE1' ' N ' ' A' ' 97' ' ' GLY . 6.2 tp-100 -75.4 126.35 30.85 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.242 -0.911 . . . . 0.0 109.557 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.548 ' N ' ' OE1' ' A' ' 96' ' ' GLN . . . 121.19 4.58 10.03 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.459 ' O ' ' C ' ' A' ' 99' ' ' GLU . 35.9 t80 -174.0 -34.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.226 -1.161 . . . . 0.0 109.448 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.459 ' C ' ' O ' ' A' ' 98' ' ' PHE . 14.1 mt-10 41.64 -155.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.356 -0.84 . . . . 0.0 109.569 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.423 ' OG ' ' OE1' ' A' ' 94' ' ' GLU . 78.7 p -129.78 134.3 47.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 109.5 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 100' ' ' SER . . . -44.81 -37.66 3.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.292 -0.88 . . . . 0.0 109.38 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.4 m -55.54 -48.34 74.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.231 -0.918 . . . . 0.0 109.346 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -62.69 -55.64 25.01 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 0.0 109.194 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.3 mt -47.39 -26.67 1.38 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.877 . . . . 0.0 109.242 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.71 -40.16 7.83 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.5 ' OH ' ' NZ ' ' A' ' 45' ' ' LYS . 2.7 m-85 -51.87 -46.71 64.56 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.306 -1.114 . . . . 0.0 109.314 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -139.27 149.71 44.61 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.387 -0.821 . . . . 0.0 109.6 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.89 -56.82 2.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.302 -0.874 . . . . 0.0 109.286 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . 0.435 ' O ' ' C ' ' A' ' 110' ' ' GLY . 5.0 m -103.02 -26.81 12.94 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.496 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 109' ' ' SER . . . -42.44 -59.93 2.94 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.485 HD23 ' CE1' ' A' ' 35' ' ' PHE . 13.9 mt -44.87 134.28 5.78 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.257 -1.143 . . . . 0.0 109.445 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 13.3 mttp -151.23 121.56 7.31 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.224 -0.923 . . . . 0.0 109.406 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.448 ' CD2' ' N ' ' A' ' 113' ' ' TYR . 0.6 OUTLIER -98.0 127.8 44.17 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.302 -0.874 . . . . 0.0 109.443 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.9 mtpt -135.42 134.13 39.35 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.278 -0.889 . . . . 0.0 109.457 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 31.9 mtmt -66.2 143.84 57.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.146 -0.971 . . . . 0.0 109.506 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.494 ' C ' ' H ' ' A' ' 118' ' ' VAL . . . -66.98 -9.09 52.68 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 70.18 -39.4 0.44 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.494 ' H ' ' C ' ' A' ' 116' ' ' GLY . 60.2 t -96.41 69.31 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.241 -1.152 . . . . 0.0 109.416 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.424 ' O ' ' O ' ' A' ' 118' ' ' VAL . . . -60.38 -153.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.294 -0.879 . . . . 0.0 109.422 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.99 -73.8 0.33 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 47.73 -152.6 1.88 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -75.17 -168.43 0.77 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.269 -1.136 . . . . 0.0 109.418 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.6 ttpm? -166.5 128.12 1.77 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.26 -0.9 . . . . 0.0 109.519 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -128.29 124.78 37.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.351 -0.843 . . . . 0.0 109.443 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.427 ' C ' HG23 ' A' ' 126' ' ' VAL . 2.0 t -98.49 5.72 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.285 -0.884 . . . . 0.0 109.497 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.489 ' O ' ' O ' ' A' ' 127' ' ' PRO . 2.2 t 61.01 80.82 0.25 Allowed Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.329 -0.857 . . . . 0.0 109.515 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 126' ' ' VAL . 50.9 Cg_exo -51.44 -155.52 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.809 2.339 . . . . 0.0 112.239 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.525 ' N ' ' OD1' ' A' ' 128' ' ' ASN . 0.5 OUTLIER -89.29 179.18 6.16 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.324 -0.86 . . . . 0.0 109.466 -179.913 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 57.9 tt0 -157.02 68.19 0.55 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.207 -0.933 . . . . 0.0 109.47 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.5 t -65.19 82.46 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.291 -0.881 . . . . 0.0 109.583 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 131' ' ' VAL . 6.5 p -75.31 93.72 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.223 -0.923 . . . . 0.0 109.536 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 19.6 t -56.0 125.57 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.193 -0.942 . . . . 0.0 109.506 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.418 ' OXT' ' CD ' ' A' ' 133' ' ' GLN . 1.2 tm0? . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.507 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.449 ' N ' ' CD ' ' A' ' 1' ' ' GLU . 2.3 pm0 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -97.35 155.66 37.1 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.428 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -66.71 87.77 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.764 2.309 . . . . 0.0 112.007 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.585 ' H ' HD13 ' A' ' 24' ' ' LEU . 4.4 mm-40 -83.41 -37.4 23.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.295 -0.878 . . . . 0.0 109.973 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.592 ' CE1' ' CG1' ' A' ' 42' ' ' VAL . 23.5 t80 -70.07 -24.29 63.21 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.175 -0.953 . . . . 0.0 110.031 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.492 HD23 ' N ' ' A' ' 6' ' ' LEU . 4.1 mt -80.76 -40.34 25.33 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.081 -1.012 . . . . 0.0 109.677 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.493 ' O ' ' O ' ' A' ' 8' ' ' ALA . 4.2 pttm -96.51 3.45 52.7 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.294 -0.879 . . . . 0.0 109.587 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.493 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -54.03 -165.47 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.268 -0.895 . . . . 0.0 109.501 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 87.77 64.9 1.35 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.18 17.96 1.91 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.336 -1.097 . . . . 0.0 109.588 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.476 ' O ' ' OE1' ' A' ' 11' ' ' GLU . 1.9 pp20? -156.18 134.15 7.05 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.18 -0.95 . . . . 0.0 109.421 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -75.34 84.65 1.67 Allowed 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 122.526 2.151 . . . . 0.0 112.286 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 46' ' ' THR . . . 178.35 -100.55 0.14 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 tt -162.21 152.63 17.04 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.24 -1.153 . . . . 0.0 109.487 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 17.0 mt-30 -135.36 142.24 45.7 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.272 -0.892 . . . . 0.0 109.553 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.535 HG23 HD12 ' A' ' 43' ' ' ILE . 22.3 mt -117.22 133.16 64.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.32 -0.863 . . . . 0.0 109.801 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -139.26 119.37 13.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.313 -0.867 . . . . 0.0 109.085 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.479 HH11 ' CB ' ' A' ' 39' ' ' ASP . 15.3 ttt85 -85.47 153.62 22.35 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.235 -0.916 . . . . 0.0 109.647 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 22' ' ' PHE . 38.8 t -91.99 123.49 44.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.218 -0.926 . . . . 0.0 110.043 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.763 ' O ' ' N ' ' A' ' 22' ' ' PHE . 0.6 OUTLIER -71.02 85.82 0.72 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.982 -1.074 . . . . 0.0 108.482 179.405 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.652 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 48.8 tttt 43.63 6.38 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.361 -0.837 . . . . 0.0 109.415 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.763 ' N ' ' O ' ' A' ' 20' ' ' GLU . 0.7 OUTLIER 160.92 -30.68 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.342 -0.849 . . . . 0.0 109.292 -179.802 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -95.08 -129.52 0.14 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.179 -0.951 . . . . 0.0 110.076 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.585 HD13 ' H ' ' A' ' 4' ' ' GLU . 3.8 mt -139.99 142.65 36.28 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.127 -0.983 . . . . 0.0 110.265 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' A' ' 18' ' ' ARG . 3.4 t -142.11 110.29 5.97 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.371 -0.831 . . . . 0.0 108.96 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -46.27 151.59 1.63 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.067 1.845 . . . . 0.0 111.808 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.3 t -109.11 101.47 45.04 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.19 -0.944 . . . . 0.0 109.61 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.02 162.58 1.83 Allowed 'Trans proline' 0 N--CA 1.493 1.479 0 C-N-CA 122.506 2.138 . . . . 0.0 112.257 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 19.6 m -78.22 -34.79 49.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.274 -0.891 . . . . 0.0 109.348 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -56.63 -16.95 7.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.405 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.458 ' O ' ' C ' ' A' ' 32' ' ' TYR . 15.6 mt -112.35 -25.96 8.98 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.263 -0.898 . . . . 0.0 109.551 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.566 ' OH ' ' CE2' ' A' ' 107' ' ' PHE . 19.0 t80 -41.63 137.08 1.7 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.275 -0.891 . . . . 0.0 109.453 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.44 -16.71 48.27 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -100.18 121.96 42.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -1.189 . . . . 0.0 109.438 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -102.53 121.58 42.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.189 -0.945 . . . . 0.0 109.536 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -95.96 144.23 26.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.217 -0.927 . . . . 0.0 109.465 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 13.4 p -97.05 -10.22 26.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -0.905 . . . . 0.0 109.524 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -100.22 34.23 5.69 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.479 ' CB ' HH11 ' A' ' 18' ' ' ARG . 4.8 m-20 -163.78 -177.1 4.95 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.246 -1.149 . . . . 0.0 109.496 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.406 ' C ' ' CD2' ' A' ' 41' ' ' TYR . . . -140.46 146.9 38.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.256 -0.903 . . . . 0.0 109.405 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.585 ' OH ' ' CZ3' ' A' ' 61' ' ' TRP . 0.1 OUTLIER -142.56 137.88 30.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.121 -0.987 . . . . 0.0 109.793 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.945 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -101.29 144.23 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 108.704 -0.85 . . . . 0.0 108.704 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.945 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.6 OUTLIER -128.02 134.37 65.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 C-N-CA 119.466 -0.894 . . . . 0.0 110.512 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.668 HD23 ' C ' ' A' ' 44' ' ' LEU . 4.7 tt -109.66 116.2 31.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.627 -0.671 . . . . 0.0 109.397 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.649 ' N ' HD23 ' A' ' 44' ' ' LEU . 8.5 ttpt -92.43 139.48 30.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.219 -0.926 . . . . 0.0 109.44 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.525 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.6 OUTLIER -143.07 118.62 10.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.119 -0.988 . . . . 0.0 109.413 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.694 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -128.24 167.97 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.109 -0.995 . . . . 0.0 109.224 -179.934 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -95.37 120.25 35.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.571 -0.705 . . . . 0.0 109.433 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.511 ' O ' ' N ' ' A' ' 52' ' ' GLY . 82.2 mt -74.86 168.8 19.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -0.956 . . . . 0.0 109.487 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 49' ' ' LEU . 13.5 ttt-85 -43.31 -48.92 6.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.273 -0.892 . . . . 0.0 109.177 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.434 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 33.0 t-20 -81.49 -12.07 58.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.308 -0.87 . . . . 0.0 109.132 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.511 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . 88.77 31.85 12.09 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.499 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.8 m120 -78.65 13.92 1.48 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.13 -1.217 . . . . 0.0 109.206 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.694 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.0 mt 43.82 96.8 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 CA-C-O 121.438 0.637 . . . . 0.0 109.566 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.51 ' HB2' HD21 ' A' ' 49' ' ' LEU . 28.1 tp60 -77.67 118.09 19.71 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.386 -0.821 . . . . 0.0 109.465 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -96.16 114.14 25.81 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.137 -0.977 . . . . 0.0 109.585 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.602 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -113.43 150.2 33.09 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.189 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.587 HD22 ' O ' ' A' ' 57' ' ' ASP . 4.1 mm? -117.1 136.56 52.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.089 -1.007 . . . . 0.0 110.068 -179.319 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.578 ' CE1' ' CG ' ' A' ' 92' ' ' HIS . 27.2 m-70 -135.43 125.48 26.0 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.653 ' CE2' HD22 ' A' ' 62' ' ' LEU . 9.4 t80 -117.36 135.18 54.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.26 -0.9 . . . . 0.0 109.819 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.585 ' CZ3' ' OH ' ' A' ' 41' ' ' TYR . 27.9 t90 -120.2 124.24 45.22 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.413 -0.804 . . . . 0.0 109.289 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.653 HD22 ' CE2' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -112.86 162.31 15.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.359 -0.838 . . . . 0.0 109.523 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -100.02 156.1 19.62 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -78.12 -11.71 59.94 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.391 -1.064 . . . . 0.0 109.482 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -102.25 32.41 3.54 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.498 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.0 OUTLIER -130.79 97.56 4.38 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.181 0.991 . . . . 0.0 108.359 179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 66' ' ' CYS . 20.6 t -42.02 167.97 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.356 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.785 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.564 ' O ' ' N ' ' A' ' 72' ' ' GLY . 27.0 tt0 -56.59 -17.76 9.66 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.258 -0.901 . . . . 0.0 109.592 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -62.6 -58.65 6.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 109.376 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.557 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -63.07 -48.63 77.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.315 -0.866 . . . . 0.0 109.079 179.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.8 -21.62 64.31 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.311 -0.868 . . . . 0.0 109.055 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.564 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -75.65 -40.5 31.76 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.59 -39.2 77.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.194 -1.18 . . . . 0.0 109.162 179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.515 ' CB ' ' CZ ' ' A' ' 60' ' ' TYR . . . -65.81 -46.53 78.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.489 -0.757 . . . . 0.0 109.226 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -60.3 -37.52 80.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.311 -0.868 . . . . 0.0 109.337 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.8 mt -60.88 -49.25 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.41 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -65.56 -31.43 72.47 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.279 -0.888 . . . . 0.0 109.405 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.1 m -72.8 -41.95 64.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.225 -0.922 . . . . 0.0 109.278 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 75' ' ' ALA . 89.8 t -63.34 -35.83 73.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.243 -0.91 . . . . 0.0 109.297 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -65.67 -51.37 59.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.331 -0.856 . . . . 0.0 109.071 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 mt -51.72 -39.49 58.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.296 -0.878 . . . . 0.0 109.034 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 85' ' ' LEU . 13.4 t0 -60.16 -58.75 7.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.307 -0.87 . . . . 0.0 109.144 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 82' ' ' ASP . 24.0 t0 -45.14 -34.16 2.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.207 -0.933 . . . . 0.0 108.881 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 16.9 t80 -76.57 -28.25 56.17 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.309 -0.869 . . . . 0.0 108.868 179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.555 ' N ' ' O ' ' A' ' 82' ' ' ASP . 11.5 mt -121.69 32.14 5.99 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.354 -0.841 . . . . 0.0 109.736 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.542 ' N ' ' O ' ' A' ' 82' ' ' ASP . 24.2 t-20 -79.34 27.51 0.26 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.165 -0.959 . . . . 0.0 109.13 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.449 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -89.9 -49.22 3.4 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.434 ' CG ' ' O ' ' A' ' 87' ' ' GLY . 57.8 mtm-85 -158.41 41.61 0.26 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.248 -1.148 . . . . 0.0 109.462 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -127.63 165.25 20.32 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.399 -0.813 . . . . 0.0 109.226 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.623 HG12 ' N ' ' A' ' 91' ' ' GLN . 98.6 t -135.92 167.34 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.237 -0.914 . . . . 0.0 109.589 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.717 ' NE2' ' H ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -119.31 134.51 55.17 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.39 -0.819 . . . . 0.0 109.465 179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.578 ' CG ' ' CE1' ' A' ' 59' ' ' HIS . 20.2 m-70 -105.72 105.14 15.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.291 -0.881 . . . . 0.0 109.582 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 38.2 mtm180 -77.95 102.4 7.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.946 . . . . 0.0 109.309 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.558 ' OE2' ' CD2' ' A' ' 103' ' ' PHE . 50.2 mt-10 -102.33 134.09 46.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.189 -0.944 . . . . 0.0 109.747 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 96' ' ' GLN . 3.1 t -132.88 168.62 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.401 -0.812 . . . . 0.0 109.269 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.453 ' H ' HG12 ' A' ' 95' ' ' VAL . 4.5 tt0 -69.94 118.34 12.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.258 -0.901 . . . . 0.0 109.57 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.514 ' O ' ' CD1' ' A' ' 98' ' ' PHE . . . 91.0 11.29 61.67 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.514 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 24.8 m-85 -152.55 24.66 0.6 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -1.161 . . . . 0.0 109.665 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 98' ' ' PHE . 27.6 mt-10 -42.82 150.96 0.14 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.173 -0.955 . . . . 0.0 109.409 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.8 p -78.24 168.14 20.31 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.226 -0.921 . . . . 0.0 109.553 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -74.45 -61.68 1.78 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.25 -0.906 . . . . 0.0 109.485 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.4 m -47.25 -45.04 23.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.377 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.558 ' CD2' ' OE2' ' A' ' 94' ' ' GLU . 29.1 t80 -58.67 -53.49 57.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.294 -0.879 . . . . 0.0 109.38 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.7 mt -56.1 -28.83 59.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.277 -0.89 . . . . 0.0 109.386 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -78.0 -25.54 61.9 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -77.83 -30.08 50.91 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.232 -1.158 . . . . 0.0 109.338 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.566 ' CE2' ' OH ' ' A' ' 32' ' ' TYR . 54.3 m-85 -139.06 127.35 22.74 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.256 -0.902 . . . . 0.0 109.35 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.455 ' HB2' ' HZ3' ' A' ' 108' ' ' LYS . 12.6 ttmm -105.51 -57.01 2.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.0 109.51 -179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.0 t -106.03 15.2 26.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.497 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -106.33 28.42 13.68 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.406 HD23 ' N ' ' A' ' 111' ' ' LEU . 0.3 OUTLIER -140.69 54.78 1.59 Allowed 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.281 -1.129 . . . . 0.0 109.558 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 25.5 ttpt -73.87 135.67 43.39 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.317 -0.865 . . . . 0.0 109.486 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.496 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 0.9 OUTLIER -92.37 111.32 22.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.472 -179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 25.8 mtpt -107.99 121.14 44.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.313 -0.867 . . . . 0.0 109.582 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -56.97 122.08 11.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.504 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -87.51 138.76 15.51 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -151.95 -61.73 0.01 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.415 HG12 ' H ' ' A' ' 120' ' ' SER . 18.6 t -83.86 118.29 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.275 -1.132 . . . . 0.0 109.522 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -86.51 30.45 0.71 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.265 -0.897 . . . . 0.0 109.513 -180.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . 0.415 ' H ' HG12 ' A' ' 118' ' ' VAL . 94.4 p -172.77 107.1 0.17 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -0.913 . . . . 0.0 109.396 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -169.66 14.66 0.06 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 12.0 t80 -151.69 91.12 1.61 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.282 -1.128 . . . . 0.0 109.513 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.451 ' O ' ' C ' ' A' ' 124' ' ' HIS . 42.2 mttm -68.07 -156.25 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.184 -0.947 . . . . 0.0 109.422 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.451 ' C ' ' O ' ' A' ' 123' ' ' LYS . 0.1 OUTLIER -42.1 162.01 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.316 -0.865 . . . . 0.0 109.485 179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.597 HG22 ' N ' ' A' ' 126' ' ' VAL . 7.6 p -66.99 165.4 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.122 -0.986 . . . . 0.0 109.423 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.597 ' N ' HG22 ' A' ' 125' ' ' VAL . 2.3 m -117.89 87.4 27.55 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.331 -0.856 . . . . 0.0 109.424 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -50.66 -69.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.658 0 C-N-CA 122.704 2.27 . . . . 0.0 112.255 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -162.48 131.4 4.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 109.494 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -103.59 162.29 13.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.298 -0.876 . . . . 0.0 109.376 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.475 ' O ' ' N ' ' A' ' 132' ' ' VAL . 55.6 t -83.07 -33.95 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.254 -0.904 . . . . 0.0 109.543 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.775 HG13 ' O ' ' A' ' 131' ' ' VAL . 12.0 p -67.44 68.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.208 -0.932 . . . . 0.0 109.474 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.475 ' N ' ' O ' ' A' ' 130' ' ' VAL . 72.3 t -86.01 129.98 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.92 . . . . 0.0 109.514 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.549 -179.976 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.684 ' N ' ' CD ' ' A' ' 3' ' ' PRO . 0.0 OUTLIER -92.09 -38.53 0.36 Allowed Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.216 -0.927 . . . . 0.0 109.694 179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' A' ' 2' ' ' HIS . 16.7 Cg_exo -64.63 49.72 0.17 Allowed 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.756 2.304 . . . . 0.0 112.091 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.537 ' O ' ' N ' ' A' ' 8' ' ' ALA . 41.9 mt-10 -83.13 -45.74 13.6 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.126 -0.984 . . . . 0.0 109.703 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.537 ' CE1' ' CD1' ' A' ' 81' ' ' LEU . 68.2 t80 -48.67 -22.57 0.8 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -0.908 . . . . 0.0 109.287 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.569 HD23 HD11 ' A' ' 81' ' ' LEU . 85.1 mt -83.61 -40.52 18.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 109.484 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' ALA . 42.8 mmtm -101.24 7.15 43.1 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.39 -0.819 . . . . 0.0 109.549 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 4' ' ' GLU . . . -56.01 -164.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.421 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.464 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 104.86 -27.67 17.94 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 14.2 pttp -75.76 21.51 0.15 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -1.152 . . . . 0.0 109.4 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.464 ' H ' ' C ' ' A' ' 9' ' ' GLY . 26.9 mm-40 -135.12 115.43 11.95 Favored Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.259 -0.9 . . . . 0.0 109.356 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.86 73.85 5.5 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.376 2.051 . . . . 0.0 112.277 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.552 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -177.28 -103.34 0.17 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.767 HD23 ' C ' ' A' ' 14' ' ' LEU . 3.3 tt -162.26 146.98 12.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.239 -1.153 . . . . 0.0 109.581 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.566 ' N ' HD23 ' A' ' 14' ' ' LEU . 24.0 mt-30 -139.3 145.53 39.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.28 -0.887 . . . . 0.0 109.347 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.55 HD12 ' CE1' ' A' ' 32' ' ' TYR . 10.7 mt -114.18 146.52 18.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.396 -0.815 . . . . 0.0 110.198 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.451 ' CZ2' ' CB ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER -149.55 138.73 21.32 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.435 -0.791 . . . . 0.0 109.063 179.665 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.2 ttp180 -96.67 144.64 26.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 109.473 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.562 HG12 ' O ' ' A' ' 40' ' ' ALA . 12.4 p -81.02 143.82 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.198 -0.939 . . . . 0.0 109.494 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.58 ' O ' ' N ' ' A' ' 22' ' ' PHE . 39.9 tt0 -103.3 153.41 20.45 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.3 -0.875 . . . . 0.0 109.368 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 20' ' ' GLU . 7.6 mtmp? -41.48 -20.47 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.648 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.58 ' N ' ' O ' ' A' ' 20' ' ' GLU . 3.0 p90 -160.99 30.52 0.14 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.17 -0.956 . . . . 0.0 109.524 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.625 ' C ' HD12 ' A' ' 24' ' ' LEU . 9.8 t70 -174.07 -130.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.241 -0.912 . . . . 0.0 109.53 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.625 HD12 ' C ' ' A' ' 23' ' ' ASP . 5.5 mp -144.34 146.07 32.35 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.322 -0.861 . . . . 0.0 109.562 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.3 t -126.31 112.93 23.55 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.393 -0.817 . . . . 0.0 109.427 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.49 152.64 5.89 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.436 2.091 . . . . 0.0 112.313 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 88.9 t -110.39 101.89 49.81 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.898 . . . . 0.0 109.317 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -48.43 143.47 15.45 Favored 'Trans proline' 0 N--CA 1.493 1.441 0 C-N-CA 122.476 2.117 . . . . 0.0 112.319 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.528 ' C ' ' H ' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -55.96 -44.11 78.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.299 -0.876 . . . . 0.0 109.376 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.447 ' ND2' ' O ' ' A' ' 30' ' ' ASN . 1.4 t-20 -56.72 -2.6 0.08 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.307 -0.871 . . . . 0.0 109.481 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.528 ' H ' ' C ' ' A' ' 29' ' ' THR . 86.4 mt -129.23 -10.73 4.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.202 -0.936 . . . . 0.0 109.551 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.55 ' CE1' HD12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -41.84 124.37 2.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.276 -0.89 . . . . 0.0 109.453 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.39 -9.37 57.46 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.7 t0 -97.98 107.13 19.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.184 -1.186 . . . . 0.0 109.462 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -96.15 150.52 20.42 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.275 -0.89 . . . . 0.0 109.536 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -105.03 112.14 25.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.251 -0.906 . . . . 0.0 109.402 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 8.1 p -58.36 -17.07 17.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.244 -0.91 . . . . 0.0 109.586 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.447 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -88.15 10.71 69.88 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.447 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 46.6 m-20 -159.49 170.56 21.45 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.225 -1.162 . . . . 0.0 109.511 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.562 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -109.76 152.38 25.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.387 -0.821 . . . . 0.0 109.504 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -122.12 134.9 54.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.337 -0.852 . . . . 0.0 109.239 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.93 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -103.19 138.38 27.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.143 -0.973 . . . . 0.0 108.91 179.86 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.93 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.9 OUTLIER -131.25 145.62 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.516 -0.874 . . . . 0.0 110.615 -179.357 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.63 HD23 ' N ' ' A' ' 45' ' ' LYS . 3.9 tt -123.64 118.45 27.3 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.63 ' N ' HD23 ' A' ' 44' ' ' LEU . 35.0 tttp -103.94 103.77 13.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -0.889 . . . . 0.0 109.358 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.788 HG23 ' O ' ' A' ' 55' ' ' GLN . 33.8 m -112.63 137.15 51.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.267 -0.896 . . . . 0.0 109.423 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -133.03 168.58 23.93 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.277 0 O-C-N 121.158 -0.964 . . . . 0.0 109.586 -179.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -102.58 100.74 10.84 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 12.8 mt -69.19 168.34 14.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.315 -0.866 . . . . 0.0 109.739 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.594 ' CD ' ' H ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -48.23 -73.18 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.331 -0.855 . . . . 0.0 109.265 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.433 ' C ' ' O ' ' A' ' 50' ' ' ARG . 1.9 m120 -43.63 -25.9 0.2 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.303 -0.873 . . . . 0.0 109.16 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 50' ' ' ARG . . . 89.03 36.68 7.55 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.515 ' O ' ' O ' ' A' ' 54' ' ' LEU . 51.2 m-20 -87.61 12.81 11.63 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.15 -1.206 . . . . 0.0 109.361 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.598 ' O ' ' CE1' ' A' ' 56' ' ' TYR . 11.1 mt 42.56 97.3 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.815 0 CA-C-O 121.455 0.645 . . . . 0.0 109.443 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.788 ' O ' HG23 ' A' ' 46' ' ' THR . 7.4 tt0 -68.07 154.09 42.38 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.239 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.598 ' CE1' ' O ' ' A' ' 54' ' ' LEU . 95.6 m-85 -133.74 114.82 13.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.295 -0.878 . . . . 0.0 109.66 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -121.0 155.12 35.02 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.469 ' N ' HD12 ' A' ' 58' ' ' LEU . 3.2 mp -138.78 129.06 25.66 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.943 -1.098 . . . . 0.0 109.972 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -121.3 127.39 51.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.415 -0.803 . . . . 0.0 109.024 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.704 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -106.15 124.9 50.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.187 -0.946 . . . . 0.0 109.537 -179.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.498 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 39.2 t90 -102.88 123.89 47.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.216 -0.927 . . . . 0.0 109.354 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.498 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 20.1 mt -102.73 162.01 13.27 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.49 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.0 155.99 15.81 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -78.98 -11.97 60.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.188 -1.183 . . . . 0.0 109.448 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -106.44 24.37 12.67 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.496 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.7 m -130.95 97.56 4.35 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 122.163 0.982 . . . . 0.0 108.473 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 66' ' ' CYS . 9.9 m -51.48 -171.25 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.253 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.673 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.594 ' OE1' ' N ' ' A' ' 68' ' ' GLN . 0.0 OUTLIER -70.74 -17.6 62.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.349 -0.845 . . . . 0.0 109.516 -179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -62.29 -58.64 6.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.13 -0.981 . . . . 0.0 109.435 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.508 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 3.3 mp0 -65.87 -45.06 83.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.32 -0.863 . . . . 0.0 108.894 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.2 t -69.67 -20.97 63.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.331 -0.856 . . . . 0.0 109.041 179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.572 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -73.25 -41.01 47.96 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.92 -46.09 66.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.298 -1.119 . . . . 0.0 109.247 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.46 -44.58 92.97 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.349 -0.844 . . . . 0.0 109.23 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -61.12 -47.58 85.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.255 -0.903 . . . . 0.0 109.275 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 45.5 mt -49.62 -46.34 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 109.241 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -61.01 -40.53 93.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.289 -0.882 . . . . 0.0 109.345 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.4 m -67.02 -31.52 72.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.159 -0.963 . . . . 0.0 109.33 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 75' ' ' ALA . 91.2 t -66.0 -44.19 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.335 -0.853 . . . . 0.0 109.334 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 27.4 mm-40 -61.63 -50.92 70.6 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.281 -0.887 . . . . 0.0 109.192 179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.569 HD11 HD23 ' A' ' 6' ' ' LEU . 4.1 mt -54.55 -41.4 69.71 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.341 -0.849 . . . . 0.0 109.069 179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.627 ' O ' ' N ' ' A' ' 86' ' ' ASN . 27.1 t70 -61.69 -54.97 35.47 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.238 -0.914 . . . . 0.0 109.133 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -47.76 -32.21 5.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.081 -1.012 . . . . 0.0 108.858 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.676 ' CE2' HD21 ' A' ' 85' ' ' LEU . 10.1 t80 -77.64 -31.77 52.91 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.676 HD21 ' CE2' ' A' ' 84' ' ' TYR . 53.2 mt -121.59 33.49 5.5 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.369 -0.832 . . . . 0.0 109.427 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.627 ' N ' ' O ' ' A' ' 82' ' ' ASP . 38.4 t30 -79.71 27.7 0.28 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.211 -0.931 . . . . 0.0 109.16 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.434 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -78.12 -45.57 10.09 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.5 mtp85 -173.34 33.71 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -1.121 . . . . 0.0 109.299 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.53 179.1 7.9 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.182 -0.949 . . . . 0.0 109.433 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.5 t -127.11 128.03 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -0.843 . . . . 0.0 109.546 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -96.06 137.2 35.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.384 -0.823 . . . . 0.0 109.357 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.6 m-70 -126.59 126.85 44.31 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.156 -0.965 . . . . 0.0 109.662 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 25.0 ttt85 -100.74 95.99 7.02 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -0.874 . . . . 0.0 109.3 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.455 ' OE1' ' CD1' ' A' ' 103' ' ' PHE . 81.9 mt-10 -97.36 138.84 34.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.229 -0.919 . . . . 0.0 109.712 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 96' ' ' GLN . 15.4 t -145.01 163.75 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.344 -0.848 . . . . 0.0 109.305 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.455 ' N ' HG12 ' A' ' 95' ' ' VAL . 50.0 tt0 -53.28 117.9 3.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.271 -0.893 . . . . 0.0 109.43 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.09 13.88 81.38 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.439 ' O ' ' C ' ' A' ' 99' ' ' GLU . 6.4 t80 -135.54 17.49 3.35 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.243 -1.151 . . . . 0.0 109.443 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.651 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 11.1 mp0 -41.46 148.22 0.15 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.233 -0.917 . . . . 0.0 109.564 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 3.2 t -87.2 166.81 14.66 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.277 -0.889 . . . . 0.0 109.488 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.53 -65.1 0.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.533 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 51.4 m -47.55 -51.56 20.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.261 -0.899 . . . . 0.0 109.422 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.455 ' CD1' ' OE1' ' A' ' 94' ' ' GLU . 14.5 t80 -54.46 -44.79 72.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.417 -0.802 . . . . 0.0 109.437 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 5.9 mt -60.82 -34.16 74.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.171 -0.955 . . . . 0.0 109.415 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -77.07 -22.57 70.98 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -79.5 -29.21 41.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -1.12 . . . . 0.0 109.365 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -139.12 120.84 15.31 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.303 -0.873 . . . . 0.0 109.457 -179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -101.67 -56.65 2.24 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.287 -0.883 . . . . 0.0 109.512 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.5 t -103.3 -13.25 16.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.281 -0.887 . . . . 0.0 109.51 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -68.3 -12.82 64.02 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 30.4 mt -71.94 121.2 18.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.175 -1.191 . . . . 0.0 109.499 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 4.7 ttmt -148.55 154.7 40.13 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.188 -0.945 . . . . 0.0 109.417 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -135.97 134.59 38.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.365 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -103.89 105.87 16.2 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 109.338 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 116' ' ' GLY . 9.3 mtpm? -83.78 108.28 16.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.202 -0.936 . . . . 0.0 109.488 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 115' ' ' LYS . . . 44.06 -161.02 0.08 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 146.26 3.79 0.52 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.6 m -139.22 142.28 33.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.303 -1.116 . . . . 0.0 109.435 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -101.49 -76.05 0.58 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.306 -0.871 . . . . 0.0 109.537 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 5.5 m -90.25 169.48 11.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.18 -0.95 . . . . 0.0 109.556 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -160.91 81.13 0.14 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -92.05 -161.72 0.85 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.258 -1.143 . . . . 0.0 109.422 -179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 8.4 mtmp? -132.88 89.77 2.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.245 -0.91 . . . . 0.0 109.407 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -77.67 82.11 4.09 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.276 -0.89 . . . . 0.0 109.315 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 21.9 t -52.14 -25.19 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.183 -0.948 . . . . 0.0 109.541 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 11.7 m -145.06 145.83 28.62 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.149 -0.97 . . . . 0.0 109.439 179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -41.88 -65.88 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.543 2.162 . . . . 0.0 112.266 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -136.37 -122.91 0.15 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.203 -0.936 . . . . 0.0 109.471 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -105.06 130.24 53.3 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.344 -0.847 . . . . 0.0 109.503 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 2.4 t -80.08 4.36 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.237 -0.915 . . . . 0.0 109.539 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 64.6 t -46.93 126.72 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.192 -0.943 . . . . 0.0 109.459 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.466 ' O ' ' OXT' ' A' ' 133' ' ' GLN . 11.1 t -74.65 104.79 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.342 -0.849 . . . . 0.0 109.536 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.466 ' OXT' ' O ' ' A' ' 132' ' ' VAL . 48.0 mm-40 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.951 -1.023 . . . . 0.0 109.572 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.417 ' C ' ' ND1' ' A' ' 2' ' ' HIS . 20.5 mt-10 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.417 ' ND1' ' C ' ' A' ' 1' ' ' GLU . 8.8 m80 -142.01 57.33 6.64 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.584 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.422 ' HB2' HD12 ' A' ' 6' ' ' LEU . 55.4 Cg_endo -73.97 65.34 5.07 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.692 2.261 . . . . 0.0 112.043 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -83.08 -28.7 29.33 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.618 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.64 ' CE1' HG12 ' A' ' 42' ' ' VAL . 69.0 t80 -58.46 -16.55 15.56 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.142 -0.974 . . . . 0.0 109.354 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.422 HD12 ' HB2' ' A' ' 3' ' ' PRO . 3.3 mt -90.24 -34.88 15.61 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.218 -0.926 . . . . 0.0 109.553 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.444 ' O ' ' C ' ' A' ' 8' ' ' ALA . 30.8 mttm -87.59 -15.22 37.98 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.272 -0.892 . . . . 0.0 109.672 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -42.45 128.95 3.98 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 0.0 109.406 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.38 30.55 0.03 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.434 ' O ' ' CG ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -129.64 38.36 3.86 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.308 -1.113 . . . . 0.0 109.379 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.517 ' O ' ' N ' ' A' ' 13' ' ' GLY . 31.1 mt-10 -157.78 79.75 3.31 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.298 -0.876 . . . . 0.0 109.31 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -48.1 80.68 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 122.792 2.328 . . . . 0.0 112.148 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 11' ' ' GLU . . . 177.58 -99.87 0.13 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.751 HD23 ' C ' ' A' ' 14' ' ' LEU . 7.1 tt -156.94 125.7 5.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -1.138 . . . . 0.0 109.727 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.586 ' N ' HD23 ' A' ' 14' ' ' LEU . 11.8 mt-30 -112.66 133.45 54.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.384 -0.822 . . . . 0.0 109.239 179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.611 HG23 HD12 ' A' ' 43' ' ' ILE . 5.7 mt -101.25 146.68 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.365 -0.834 . . . . 0.0 110.16 -179.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -144.78 139.25 27.7 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -108.45 140.32 41.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.2 -0.938 . . . . 0.0 109.404 -179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.647 HG12 ' O ' ' A' ' 40' ' ' ALA . 8.9 p -84.01 138.33 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.237 -0.914 . . . . 0.0 109.495 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.609 ' O ' ' N ' ' A' ' 22' ' ' PHE . 18.5 tt0 -88.19 154.32 20.53 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.327 -0.858 . . . . 0.0 109.043 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.542 ' O ' ' CG ' ' A' ' 22' ' ' PHE . 39.9 mttp -40.39 -20.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.299 -0.876 . . . . 0.0 109.664 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.609 ' N ' ' O ' ' A' ' 20' ' ' GLU . 63.6 m-85 -160.09 21.82 0.16 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.167 -0.958 . . . . 0.0 109.679 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.432 ' N ' ' HB3' ' A' ' 20' ' ' GLU . 2.9 m-20 -160.23 -128.03 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.262 -0.899 . . . . 0.0 109.429 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.5 mt -145.53 146.09 31.29 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.208 -0.932 . . . . 0.0 109.584 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.5 t -131.31 133.81 24.97 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.316 -0.865 . . . . 0.0 108.963 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -72.63 146.9 44.53 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.367 2.045 . . . . 0.0 112.431 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 2.8 t -119.23 105.15 44.94 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.359 -0.838 . . . . 0.0 109.272 179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.473 ' C ' ' H ' ' A' ' 30' ' ' ASN . 61.3 Cg_endo -79.93 148.81 19.91 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.417 2.078 . . . . 0.0 112.469 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.632 ' O ' HG22 ' A' ' 29' ' ' THR . 14.7 m -63.32 1.32 0.52 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.2 -0.938 . . . . 0.0 109.368 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.473 ' H ' ' C ' ' A' ' 28' ' ' PRO . 14.8 m120 -76.09 -19.1 58.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.334 -0.854 . . . . 0.0 109.37 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.728 ' C ' HD12 ' A' ' 31' ' ' LEU . 2.6 pp -148.26 2.64 0.66 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 110.289 -179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.595 ' N ' HD12 ' A' ' 31' ' ' LEU . 1.6 p90 -55.58 173.5 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.87 -1.143 . . . . 0.0 109.366 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 95.76 -32.14 6.59 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -99.45 100.59 11.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.348 -1.089 . . . . 0.0 109.527 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.605 ' CZ ' ' CZ3' ' A' ' 61' ' ' TRP . 45.5 m-85 -86.93 137.51 32.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.482 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -88.34 131.21 34.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 109.441 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 20.4 p -73.99 -6.42 47.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.369 -0.832 . . . . 0.0 109.409 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.437 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -97.31 20.59 50.13 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.437 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 9.7 m-20 -167.35 146.15 4.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -1.112 . . . . 0.0 109.449 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.647 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -90.92 149.33 21.94 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.216 -0.928 . . . . 0.0 109.399 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -117.15 139.02 51.27 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -0.885 . . . . 0.0 109.351 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.01 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -105.58 129.36 58.66 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 O-C-N 121.177 -0.952 . . . . 0.0 108.623 179.829 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.01 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -126.21 134.25 66.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.231 -0.918 . . . . 0.0 110.421 -179.315 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.514 ' CD2' ' OG1' ' A' ' 46' ' ' THR . 7.7 tt -114.94 115.84 27.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.58 -0.7 . . . . 0.0 109.114 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -92.42 114.3 26.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.939 . . . . 0.0 109.534 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.514 ' OG1' ' CD2' ' A' ' 44' ' ' LEU . 1.0 OUTLIER -113.89 129.23 56.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.181 -0.949 . . . . 0.0 109.524 179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.592 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -132.18 168.48 23.97 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 O-C-N 121.071 -1.018 . . . . 0.0 109.252 -179.852 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -98.54 117.36 32.79 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.58 -0.7 . . . . 0.0 109.401 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 16.6 mt -81.05 160.83 24.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.242 -0.911 . . . . 0.0 109.609 -179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 25.0 mtt180 -51.44 -65.49 0.55 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.336 -0.852 . . . . 0.0 109.305 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.444 ' ND2' ' H ' ' A' ' 51' ' ' ASN . 1.4 p30 -48.27 -29.58 3.97 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.263 -0.898 . . . . 0.0 109.252 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 94.76 71.29 1.12 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 54' ' ' LEU . 4.3 t-20 -134.85 13.46 3.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.287 -1.125 . . . . 0.0 109.32 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.592 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 11.7 mt 45.71 99.69 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 CA-C-O 121.579 0.704 . . . . 0.0 109.535 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -68.6 152.1 45.83 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.498 ' O ' ' CB ' ' A' ' 89' ' ' ALA . 61.3 m-85 -129.49 116.56 19.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.217 -0.927 . . . . 0.0 109.866 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.626 ' O ' HD23 ' A' ' 58' ' ' LEU . 0.7 OUTLIER -122.36 155.17 36.58 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.427 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.626 HD23 ' O ' ' A' ' 57' ' ' ASP . 2.6 mt -132.83 150.18 52.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.913 -1.117 . . . . 0.0 110.172 -179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.545 ' CD2' ' C ' ' A' ' 58' ' ' LEU . 4.6 m-70 -143.26 123.09 13.43 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.71 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -100.62 129.57 46.56 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.082 -1.011 . . . . 0.0 109.641 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.605 ' CZ3' ' CZ ' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -102.85 123.83 47.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.345 -0.847 . . . . 0.0 109.314 179.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.7 mt -102.15 162.07 13.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.402 -0.811 . . . . 0.0 109.461 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -116.25 157.69 14.88 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 6.0 t-20 -75.68 -12.29 60.17 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.324 -1.104 . . . . 0.0 109.566 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -106.84 23.21 14.71 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.9 m -131.09 97.5 4.32 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 122.06 0.933 . . . . 0.0 108.514 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 m -59.6 -170.98 0.01 OUTLIER 'General case' 0 C--N 1.284 -2.257 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.593 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.524 ' O ' ' N ' ' A' ' 72' ' ' GLY . 37.2 tt0 -61.6 -17.95 57.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.293 -0.879 . . . . 0.0 109.559 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -63.87 -58.81 5.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.173 -0.955 . . . . 0.0 109.46 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -65.69 -42.5 91.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.446 -0.784 . . . . 0.0 108.987 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.2 m -71.08 -23.28 62.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.389 -0.82 . . . . 0.0 109.016 179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -71.53 -40.11 60.0 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.214 -1.555 . . . . 0.0 109.214 179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.38 -49.09 52.72 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.261 -1.141 . . . . 0.0 109.25 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.15 -45.66 83.39 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.374 -0.829 . . . . 0.0 109.058 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.443 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -58.54 -51.29 70.53 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.406 -0.809 . . . . 0.0 109.189 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.6 mt -48.9 -41.08 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.193 -0.942 . . . . 0.0 109.209 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.45 -43.24 99.21 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.222 -0.924 . . . . 0.0 109.101 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 86.3 m -61.05 -49.45 77.3 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.145 -0.972 . . . . 0.0 109.093 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 75' ' ' ALA . 10.6 t -51.06 -40.06 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.238 -0.913 . . . . 0.0 109.211 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.437 HE21 ' HA ' ' A' ' 80' ' ' GLN . 5.3 mm-40 -61.25 -48.21 82.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.36 -0.838 . . . . 0.0 109.082 179.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.521 ' CD1' ' CE1' ' A' ' 5' ' ' PHE . 0.7 OUTLIER -50.71 -40.17 53.52 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.32 -0.862 . . . . 0.0 108.929 179.63 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.562 ' O ' ' N ' ' A' ' 85' ' ' LEU . 10.3 m-20 -61.89 -61.8 2.24 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.16 -0.962 . . . . 0.0 109.069 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -47.31 -30.62 3.25 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.049 -1.032 . . . . 0.0 108.445 179.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 87.6 t80 -76.81 -27.06 55.04 Favored 'General case' 0 C--N 1.303 -1.413 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.562 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.9 mt -113.87 27.23 9.69 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.37 -0.831 . . . . 0.0 109.169 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 44.47 38.36 2.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.377 -0.827 . . . . 0.0 109.479 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 56.35 31.19 59.4 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.432 ' N ' ' O ' ' A' ' 85' ' ' LEU . 21.4 ttt-85 -92.69 31.92 1.3 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.204 -1.174 . . . . 0.0 109.38 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 56' ' ' TYR . . . -141.14 161.17 38.51 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.526 -0.734 . . . . 0.0 109.395 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 38.8 t -96.0 146.26 7.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.263 -0.898 . . . . 0.0 109.426 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.676 ' H ' ' CD ' ' A' ' 91' ' ' GLN . 0.0 OUTLIER -111.4 131.59 55.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.382 -0.824 . . . . 0.0 109.314 -179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.472 ' CG ' ' ND1' ' A' ' 59' ' ' HIS . 20.3 m-70 -115.68 136.35 53.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.315 -0.866 . . . . 0.0 109.414 -179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.431 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 3.9 ptp180 -102.71 92.92 4.83 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.22 -0.925 . . . . 0.0 109.309 179.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.499 ' OE1' ' CD2' ' A' ' 103' ' ' PHE . 13.6 mt-10 -92.88 128.94 38.92 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.148 -0.97 . . . . 0.0 109.538 -179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 96' ' ' GLN . 10.5 t -132.94 163.52 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.336 -0.852 . . . . 0.0 109.241 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.621 ' OE1' ' N ' ' A' ' 97' ' ' GLY . 0.8 OUTLIER -62.22 115.59 4.27 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.238 -0.914 . . . . 0.0 109.429 -179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.621 ' N ' ' OE1' ' A' ' 96' ' ' GLN . . . 90.38 5.74 69.31 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.475 ' O ' ' O ' ' A' ' 99' ' ' GLU . 5.1 t80 -143.26 32.6 1.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.366 -1.079 . . . . 0.0 109.526 179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.66 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 2.4 mp0 -41.51 164.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.305 -0.872 . . . . 0.0 109.537 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.62 161.69 19.16 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.464 -179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.09 -60.39 2.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.477 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 76.9 m -46.95 -41.35 15.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.145 -0.972 . . . . 0.0 109.355 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.499 ' CD2' ' OE1' ' A' ' 94' ' ' GLU . 1.6 m-85 -69.9 -41.1 75.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.352 -0.843 . . . . 0.0 109.383 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.5 mt -58.79 -23.67 60.59 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.175 -0.953 . . . . 0.0 109.451 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -105.43 -12.94 25.68 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -86.42 -37.67 18.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.18 -1.188 . . . . 0.0 109.602 -179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -84.37 117.78 23.82 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.309 -0.869 . . . . 0.0 109.638 -179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 mmtt -115.0 3.0 14.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.395 -0.815 . . . . 0.0 109.387 179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.0 m -89.31 -4.65 58.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 109.54 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.53 97.32 0.43 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.705 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -77.78 165.74 23.8 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.158 -1.201 . . . . 0.0 109.509 -179.942 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.442 ' CG ' ' O ' ' A' ' 111' ' ' LEU . 38.3 mtmt -158.41 152.2 23.59 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.246 -0.908 . . . . 0.0 109.475 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.445 ' OH ' ' CD ' ' A' ' 99' ' ' GLU . 53.8 m-85 -101.51 125.2 48.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.373 -0.83 . . . . 0.0 109.438 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.0 120.04 25.22 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.206 -0.934 . . . . 0.0 109.489 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 56.2 mmtt -82.02 140.07 34.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.42 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -96.07 22.89 37.13 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -94.82 -127.04 4.93 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.462 HG23 ' N ' ' A' ' 119' ' ' ALA . 9.1 m -93.53 -155.08 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.244 -1.151 . . . . 0.0 109.515 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.462 ' N ' HG23 ' A' ' 118' ' ' VAL . . . -146.88 -51.97 0.21 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.186 -0.946 . . . . 0.0 109.46 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 2.1 m -164.32 -65.72 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 93.95 24.31 20.39 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -48.93 -34.38 12.72 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.132 -1.217 . . . . 0.0 109.377 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 24.4 tptt -89.62 144.09 26.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.211 -0.931 . . . . 0.0 109.376 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.0 t-80 -136.65 -155.59 0.63 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.899 . . . . 0.0 109.488 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 126' ' ' VAL . 59.7 t -91.05 161.91 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.478 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.515 ' N ' HG12 ' A' ' 125' ' ' VAL . 10.0 t -148.34 99.17 3.66 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.26 -0.9 . . . . 0.0 109.456 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -79.62 0.76 9.76 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.586 2.19 . . . . 0.0 112.227 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -101.92 94.03 5.59 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 109.368 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 130' ' ' VAL . 6.7 mt-10 -129.31 -159.07 0.93 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.883 . . . . 0.0 109.441 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 130' ' ' VAL . 7.6 p -42.73 119.56 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.201 -0.937 . . . . 0.0 109.447 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 12.3 p -47.22 142.68 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.338 -0.851 . . . . 0.0 109.555 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.414 HG23 ' H ' ' A' ' 132' ' ' VAL . 12.3 t -48.32 99.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.594 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.442 -179.952 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.498 ' O ' ' O ' ' A' ' 2' ' ' HIS . 7.1 mm-40 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.498 ' O ' ' O ' ' A' ' 1' ' ' GLU . 2.8 m80 56.92 156.41 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.353 -0.842 . . . . 0.0 109.374 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.501 ' HB2' HD13 ' A' ' 6' ' ' LEU . 17.8 Cg_endo -62.21 90.34 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.726 2.284 . . . . 0.0 111.857 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -83.33 -43.43 15.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.296 -0.877 . . . . 0.0 110.071 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.593 ' CE2' ' CG1' ' A' ' 42' ' ' VAL . 21.6 t80 -50.94 -41.45 59.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.134 -0.979 . . . . 0.0 109.606 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.501 HD13 ' HB2' ' A' ' 3' ' ' PRO . 4.1 mp -69.4 -27.83 65.63 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.121 -0.987 . . . . 0.0 109.51 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 15.4 mttm -96.4 3.84 52.59 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.237 -0.914 . . . . 0.0 109.38 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.472 ' HB3' HD13 ' A' ' 44' ' ' LEU . . . -59.52 151.9 23.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.216 -0.928 . . . . 0.0 109.517 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 138.9 45.19 0.07 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -149.08 24.23 0.93 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.276 -1.132 . . . . 0.0 109.564 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -146.55 117.65 4.76 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.278 -0.889 . . . . 0.0 109.338 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.7 91.25 1.2 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.387 2.058 . . . . 0.0 112.221 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 166.07 -95.38 0.12 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 tp -160.23 130.35 5.36 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.318 -1.107 . . . . 0.0 109.627 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -113.88 135.71 53.68 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.0 109.355 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 25.2 mt -115.56 136.01 53.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.345 -0.847 . . . . 0.0 109.99 -179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.44 134.67 31.09 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.425 -0.797 . . . . 0.0 108.969 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.434 ' O ' ' N ' ' A' ' 25' ' ' VAL . 33.5 ttt180 -98.38 153.54 18.49 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.201 -0.937 . . . . 0.0 109.444 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.1 t -106.13 123.49 60.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.18 -0.95 . . . . 0.0 109.593 -179.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.635 ' O ' ' N ' ' A' ' 22' ' ' PHE . 5.2 tt0 -72.06 87.04 1.05 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.107 -0.996 . . . . 0.0 108.915 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.579 ' O ' ' CB ' ' A' ' 22' ' ' PHE . 16.5 tttm 49.04 2.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.359 -0.838 . . . . 0.0 109.85 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.635 ' N ' ' O ' ' A' ' 20' ' ' GLU . 2.1 t80 158.01 -29.34 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.289 -0.882 . . . . 0.0 109.422 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.76 -157.83 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.21 -0.932 . . . . 0.0 109.584 -179.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.26 132.75 56.56 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.287 -0.883 . . . . 0.0 109.344 -179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.545 ' CG2' ' N ' ' A' ' 20' ' ' GLU . 0.5 OUTLIER -129.9 120.81 19.58 Favored Pre-proline 0 N--CA 1.487 1.387 0 O-C-N 121.311 -0.868 . . . . 0.0 109.227 -179.686 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.88 132.0 11.52 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.303 2.002 . . . . 0.0 112.238 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.7 t -110.34 101.57 48.65 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.335 -0.853 . . . . 0.0 109.394 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -51.22 156.56 5.25 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.434 2.089 . . . . 0.0 112.208 179.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.3 m -66.89 -12.2 58.57 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.328 -0.857 . . . . 0.0 109.488 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.481 ' O ' ' OD1' ' A' ' 30' ' ' ASN . 23.9 t-20 -75.98 -10.03 59.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.357 -0.839 . . . . 0.0 109.522 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.445 ' O ' ' C ' ' A' ' 32' ' ' TYR . 96.3 mt -122.83 -23.35 5.07 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -0.847 . . . . 0.0 109.417 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 33' ' ' GLY . 1.7 t80 -42.88 138.33 2.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.301 -0.874 . . . . 0.0 109.464 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.617 ' N ' ' CD1' ' A' ' 32' ' ' TYR . . . 125.95 -28.68 4.83 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -107.19 148.19 29.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -1.152 . . . . 0.0 109.531 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -142.06 114.16 8.15 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 109.424 -179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -79.39 159.05 27.25 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.249 -0.907 . . . . 0.0 109.529 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.1 p -97.74 -4.77 36.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.262 -0.899 . . . . 0.0 109.447 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.445 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -88.28 16.4 52.72 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 7.6 m-20 -159.23 164.07 35.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -1.163 . . . . 0.0 109.544 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -108.29 151.98 25.23 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.31 -0.869 . . . . 0.0 109.406 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.575 ' N ' ' CD1' ' A' ' 41' ' ' TYR . 4.0 m-85 -130.21 134.61 47.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.285 -0.884 . . . . 0.0 109.667 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.991 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -105.4 139.44 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 121.182 -0.949 . . . . 0.0 108.596 179.202 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.991 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.4 OUTLIER -128.01 134.72 64.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.27 -0.894 . . . . 0.0 110.213 -179.421 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.472 HD13 ' HB3' ' A' ' 8' ' ' ALA . 7.2 tt -115.86 109.57 17.81 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.7 ttpt -82.42 144.31 30.58 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.363 -0.835 . . . . 0.0 109.098 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.2 m -143.24 129.01 19.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.09 -1.006 . . . . 0.0 109.725 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.573 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.7 OUTLIER -134.18 168.56 23.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 O-C-N 121.143 -0.973 . . . . 0.0 109.208 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -99.31 118.04 35.08 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.68 -0.638 . . . . 0.0 109.422 179.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 93.4 mt -81.9 165.08 21.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 109.605 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 16.6 mtm180 -45.35 -58.39 3.35 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.195 -0.94 . . . . 0.0 109.145 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -61.52 -27.03 68.31 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.915 . . . . 0.0 109.151 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.01 33.29 6.68 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.5 ' O ' ' O ' ' A' ' 54' ' ' LEU . 5.8 t30 -85.58 12.67 8.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.182 -1.187 . . . . 0.0 109.304 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.578 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 12.3 mt 44.91 98.38 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 121.563 0.697 . . . . 0.0 109.468 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.407 ' HG3' ' N ' ' A' ' 56' ' ' TYR . 3.3 tp-100 -68.56 155.84 39.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.505 -0.747 . . . . 0.0 109.072 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.578 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 79.6 m-85 -138.16 114.35 10.17 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.163 -0.96 . . . . 0.0 109.803 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.424 ' O ' HD23 ' A' ' 58' ' ' LEU . 0.2 OUTLIER -114.38 155.25 26.65 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 179.136 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.85 HD13 HD21 ' A' ' 81' ' ' LEU . 11.2 mt -125.16 150.29 47.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.023 -1.048 . . . . 0.0 110.372 -179.141 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -145.18 130.43 18.57 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.741 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -111.69 138.87 47.68 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.951 -1.093 . . . . 0.0 110.063 -179.297 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -111.41 123.55 50.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.392 -0.817 . . . . 0.0 108.987 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 49.6 mt -104.18 145.92 29.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.386 -0.821 . . . . 0.0 109.413 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -97.9 152.2 19.84 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -80.21 -12.02 59.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.295 -1.121 . . . . 0.0 109.478 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -107.93 31.87 5.18 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.533 ' SG ' ' OE2' ' A' ' 70' ' ' GLU . 2.1 m -130.56 97.5 4.4 Favored 'General case' 0 C--N 1.301 -1.535 0 CA-C-O 122.043 0.925 . . . . 0.0 108.533 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.496 ' O ' ' O ' ' A' ' 66' ' ' CYS . 30.0 m -45.63 175.89 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.366 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.78 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.48 ' O ' ' N ' ' A' ' 72' ' ' GLY . 39.0 tt0 -64.63 -17.7 64.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -0.889 . . . . 0.0 109.621 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -63.14 -58.59 6.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 109.344 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.533 ' OE2' ' SG ' ' A' ' 66' ' ' CYS . 11.5 mt-10 -64.84 -44.31 90.19 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.356 -0.84 . . . . 0.0 109.034 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -66.55 -26.85 67.33 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.429 -0.795 . . . . 0.0 109.02 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.15 -48.17 40.8 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.18 -35.36 76.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.342 -1.093 . . . . 0.0 109.098 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.741 ' HB1' ' CZ ' ' A' ' 60' ' ' TYR . . . -61.28 -51.95 66.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.418 -0.801 . . . . 0.0 109.211 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.424 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -52.94 -46.93 68.36 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 109.232 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.3 mt -51.9 -47.92 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.282 -0.886 . . . . 0.0 109.271 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 18.2 m-85 -54.61 -44.06 72.75 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.31 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.426 ' O ' ' OD1' ' A' ' 82' ' ' ASP . 0.9 OUTLIER -54.08 -50.97 65.59 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.3 -0.875 . . . . 0.0 109.507 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.481 HG23 ' H ' ' A' ' 79' ' ' VAL . 1.5 t -61.18 -35.39 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.361 -0.837 . . . . 0.0 109.63 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -64.57 -58.83 5.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.898 . . . . 0.0 109.302 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.954 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -53.81 -33.51 56.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 108.911 179.828 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 85' ' ' LEU . 0.9 OUTLIER -65.73 -55.13 18.93 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.22 -0.925 . . . . 0.0 108.891 179.531 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.437 ' C ' ' O ' ' A' ' 82' ' ' ASP . 8.7 t70 -45.87 -37.47 6.3 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -68.53 -33.39 74.02 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.551 ' N ' ' O ' ' A' ' 82' ' ' ASP . 4.8 tp -105.81 28.15 7.82 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.496 -0.752 . . . . 0.0 109.268 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.423 ' C ' ' O ' ' A' ' 85' ' ' LEU . 26.6 m-20 42.49 36.25 0.76 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.459 -0.776 . . . . 0.0 109.436 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 46.29 35.12 6.65 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 19.7 mmm-85 -86.46 29.97 0.74 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.137 -1.213 . . . . 0.0 109.106 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.426 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -144.13 166.9 23.71 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.565 -0.71 . . . . 0.0 109.376 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.4 t -100.62 153.9 4.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.44 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -117.57 130.29 56.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.313 -0.867 . . . . 0.0 109.392 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 15.5 m-70 -105.5 104.93 14.75 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 109.521 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -79.84 97.99 6.9 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.253 -0.904 . . . . 0.0 109.229 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.476 ' OE1' ' CG ' ' A' ' 103' ' ' PHE . 39.3 mt-10 -100.47 148.76 24.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.348 -0.845 . . . . 0.0 109.722 -179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 96' ' ' GLN . 6.2 t -137.68 166.12 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.327 -0.858 . . . . 0.0 109.27 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.5 ' OE1' ' O ' ' A' ' 96' ' ' GLN . 1.4 tm0? -59.86 116.81 4.37 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.255 -0.903 . . . . 0.0 109.481 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.2 12.24 81.09 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.445 ' O ' ' C ' ' A' ' 99' ' ' GLU . 2.4 t80 -137.51 20.79 2.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.216 -1.167 . . . . 0.0 109.569 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.445 ' C ' ' O ' ' A' ' 98' ' ' PHE . 7.5 mm-40 -42.16 156.26 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.232 -0.918 . . . . 0.0 109.469 179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.2 p -88.01 174.29 8.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -0.961 . . . . 0.0 109.491 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -76.09 -53.69 7.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.914 . . . . 0.0 109.492 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.1 m -47.07 -46.78 22.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.322 -0.861 . . . . 0.0 109.459 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' A' ' 106' ' ' TYR . 0.2 OUTLIER -67.46 -54.07 23.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.391 -0.818 . . . . 0.0 109.397 179.998 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.405 ' C ' ' O ' ' A' ' 103' ' ' PHE . 29.5 mt -44.57 -26.36 0.36 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.228 -0.92 . . . . 0.0 109.462 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -99.95 -17.09 26.37 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.492 ' N ' ' O ' ' A' ' 103' ' ' PHE . 14.4 t80 -81.73 -13.43 57.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.292 -1.122 . . . . 0.0 109.559 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.534 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 8.7 p90 -45.95 122.48 3.84 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.137 -0.977 . . . . 0.0 109.589 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 15.4 mtpt -111.19 -56.41 2.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 0.0 109.349 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 29.4 t -90.88 0.38 57.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.891 . . . . 0.0 109.501 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 111' ' ' LEU . . . 87.3 68.96 1.31 Allowed Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.434 ' C ' ' O ' ' A' ' 110' ' ' GLY . 2.3 pp -42.96 155.24 0.06 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.305 -1.115 . . . . 0.0 109.453 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 72.0 tttt -154.23 135.99 14.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.455 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' A' ' 113' ' ' TYR . 0.0 OUTLIER -104.21 140.02 38.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.318 -0.864 . . . . 0.0 109.47 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 19.2 mmtt -108.26 120.93 43.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.853 . . . . 0.0 109.333 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -76.81 138.34 39.79 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.198 -0.939 . . . . 0.0 109.396 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -142.99 -97.69 0.26 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 48.86 65.4 2.68 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.406 ' O ' ' C ' ' A' ' 119' ' ' ALA . 24.5 m -95.8 152.7 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.303 -1.116 . . . . 0.0 109.49 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 118' ' ' VAL . . . 45.34 75.93 0.1 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.244 -0.91 . . . . 0.0 109.479 179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 10.9 t -62.87 -159.89 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.149 -0.97 . . . . 0.0 109.453 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.534 ' O ' ' N ' ' A' ' 123' ' ' LYS . . . 174.24 -160.83 30.66 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -50.16 90.09 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.301 -1.117 . . . . 0.0 109.467 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 121' ' ' GLY . 4.7 mmtp -141.25 -59.15 0.49 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.191 -0.943 . . . . 0.0 109.492 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 3.8 m80 -83.17 99.26 9.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 1.7 t -114.14 100.25 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.4 -0.813 . . . . 0.0 109.435 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 47.5 t -139.96 74.13 32.0 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.447 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.95 170.21 19.26 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.82 2.347 . . . . 0.0 112.24 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.445 ' O ' ' O ' ' A' ' 129' ' ' GLU . 1.0 OUTLIER -85.63 131.19 34.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.0 109.494 -179.922 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.447 ' OE1' ' C ' ' A' ' 130' ' ' VAL . 0.2 OUTLIER 53.0 101.42 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.429 179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.622 HG13 ' O ' ' A' ' 130' ' ' VAL . 8.3 p -66.28 120.19 12.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.225 -0.922 . . . . 0.0 109.533 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.553 HG12 ' N ' ' A' ' 132' ' ' VAL . 82.8 t -73.32 164.46 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.175 -0.953 . . . . 0.0 109.497 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.553 ' N ' HG12 ' A' ' 131' ' ' VAL . 27.4 t -146.89 59.52 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.224 -0.923 . . . . 0.0 109.483 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 5.2 tp60 . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.957 -1.02 . . . . 0.0 109.422 -179.911 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.542 ' NE2' ' O ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -159.22 76.32 3.16 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.528 ' HB3' HD13 ' A' ' 6' ' ' LEU . 32.5 Cg_exo -58.0 93.21 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.813 0 C-N-CA 122.953 2.435 . . . . 0.0 112.007 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.489 ' O ' ' N ' ' A' ' 8' ' ' ALA . 61.5 mm-40 -83.45 -46.71 12.19 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.104 -0.998 . . . . 0.0 110.259 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.508 ' CZ ' ' O ' ' A' ' 42' ' ' VAL . 21.7 m-85 -66.94 -43.35 83.44 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.078 -1.014 . . . . 0.0 109.151 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 1.035 ' H ' HD12 ' A' ' 6' ' ' LEU . 3.0 mp -62.36 -33.9 75.62 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.343 -0.848 . . . . 0.0 109.628 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -106.35 9.1 31.97 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.248 -0.907 . . . . 0.0 109.605 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.576 ' HB1' ' NE2' ' A' ' 15' ' ' GLN . . . -62.73 -162.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.194 -0.941 . . . . 0.0 109.395 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.45 58.02 1.31 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 18.9 pttm -146.63 10.88 1.09 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.267 -1.137 . . . . 0.0 109.452 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -161.92 124.32 1.73 Allowed Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.258 -0.901 . . . . 0.0 109.282 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.87 82.28 2.19 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.396 2.064 . . . . 0.0 112.348 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.605 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -164.61 -108.05 0.21 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.6 tt -162.71 143.5 9.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.326 -1.102 . . . . 0.0 109.439 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.576 ' NE2' ' HB1' ' A' ' 8' ' ' ALA . 1.3 mt-30 -129.48 144.0 51.07 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.235 -0.916 . . . . 0.0 109.523 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.604 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 9.2 mt -126.58 125.85 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.418 -0.801 . . . . 0.0 109.992 -179.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.604 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 8.1 m0 -145.22 155.85 43.5 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.205 -0.934 . . . . 0.0 109.061 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.439 ' N ' HG23 ' A' ' 27' ' ' VAL . 7.8 ttp180 -95.94 153.17 17.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.063 -1.023 . . . . 0.0 109.386 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 40' ' ' ALA . 7.0 p -94.48 133.35 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.212 -0.93 . . . . 0.0 109.739 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.636 ' O ' ' N ' ' A' ' 22' ' ' PHE . 17.9 tt0 -82.0 154.71 25.55 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.338 -0.851 . . . . 0.0 108.768 179.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.481 ' C ' ' O ' ' A' ' 20' ' ' GLU . 39.7 mttt -38.35 -22.98 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.394 -0.816 . . . . 0.0 109.683 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.636 ' N ' ' O ' ' A' ' 20' ' ' GLU . 3.4 t80 -158.75 21.05 0.21 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.258 -0.901 . . . . 0.0 109.394 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.657 ' O ' HD22 ' A' ' 24' ' ' LEU . 0.3 OUTLIER -155.58 -147.37 0.2 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.135 -0.978 . . . . 0.0 109.749 -179.834 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.657 HD22 ' O ' ' A' ' 23' ' ' ASP . 2.9 mm? -123.29 146.4 47.92 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.352 -0.843 . . . . 0.0 109.447 -179.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -131.42 99.26 17.51 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.341 -0.849 . . . . 0.0 109.173 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_exo -47.64 132.96 21.3 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.557 2.172 . . . . 0.0 112.42 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.439 HG23 ' N ' ' A' ' 18' ' ' ARG . 61.0 t -104.51 106.2 53.3 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.317 -0.864 . . . . 0.0 109.482 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -46.64 145.89 5.98 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.484 2.123 . . . . 0.0 112.32 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 6.4 t -61.7 -25.63 67.54 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.289 -0.882 . . . . 0.0 109.554 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -69.04 -10.98 60.3 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.278 -0.889 . . . . 0.0 109.509 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.467 ' O ' ' C ' ' A' ' 32' ' ' TYR . 57.7 mt -110.14 -28.25 8.75 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.345 -0.847 . . . . 0.0 109.572 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.467 ' C ' ' O ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -40.33 143.85 0.27 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.288 -0.883 . . . . 0.0 109.458 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.05 -32.02 7.58 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -101.89 104.53 15.26 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.256 -1.144 . . . . 0.0 109.398 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -102.67 140.91 36.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.239 -0.913 . . . . 0.0 109.53 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.595 ' CD2' ' OH ' ' A' ' 41' ' ' TYR . 0.7 OUTLIER -101.67 161.12 13.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.393 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.9 p -94.89 -4.88 46.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.238 -0.914 . . . . 0.0 109.614 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -101.56 34.75 5.41 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -171.52 151.53 3.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.196 -1.179 . . . . 0.0 109.51 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.469 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -100.23 139.25 36.17 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.282 -0.886 . . . . 0.0 109.598 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.595 ' OH ' ' CD2' ' A' ' 36' ' ' PHE . 44.2 m-85 -121.38 144.36 48.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.365 -0.834 . . . . 0.0 109.359 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.923 ' O ' HD13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -118.76 144.82 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 O-C-N 121.286 -0.884 . . . . 0.0 109.216 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.923 HD13 ' O ' ' A' ' 42' ' ' VAL . 1.0 OUTLIER -134.18 146.49 31.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.98 179.859 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 45' ' ' LYS . 15.7 tp -129.5 118.07 21.51 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.46 -0.775 . . . . 0.0 109.467 179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.539 ' CE ' ' CE2' ' A' ' 106' ' ' TYR . 36.3 tttt -97.39 133.96 41.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.41 -0.806 . . . . 0.0 109.046 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.608 HG22 HD22 ' A' ' 54' ' ' LEU . 88.8 m -142.74 118.4 10.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.099 -1.001 . . . . 0.0 109.401 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.676 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -125.98 168.2 19.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.29 0 O-C-N 121.226 -0.921 . . . . 0.0 109.122 -179.933 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -102.88 112.41 25.2 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.512 -0.742 . . . . 0.0 109.331 179.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.9 mt -77.3 169.22 18.71 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.438 -0.789 . . . . 0.0 109.59 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.517 ' CG ' ' N ' ' A' ' 51' ' ' ASN . 5.7 ptp85 -47.69 -49.33 28.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.285 -0.884 . . . . 0.0 109.299 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.517 ' N ' ' CG ' ' A' ' 50' ' ' ARG . 5.0 m120 -70.75 -27.24 63.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.271 -0.893 . . . . 0.0 109.157 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 93.65 28.52 11.17 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.0 t-20 -80.66 12.59 3.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.072 -1.252 . . . . 0.0 109.21 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.676 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 13.8 mt 43.88 97.72 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.852 0 CA-C-O 121.535 0.683 . . . . 0.0 109.562 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 19.5 tt0 -74.3 111.45 9.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.491 -0.756 . . . . 0.0 109.538 -179.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.779 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 96.2 m-85 -96.55 114.75 26.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.933 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.578 ' OD1' ' NE2' ' A' ' 92' ' ' HIS . 0.4 OUTLIER -115.99 120.8 40.31 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 179.022 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.424 ' N ' HD23 ' A' ' 58' ' ' LEU . 0.3 OUTLIER -97.77 150.61 21.04 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.921 -1.112 . . . . 0.0 110.778 -178.467 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.454 ' HE2' ' HB2' ' A' ' 45' ' ' LYS . 6.1 m-70 -149.19 122.19 8.82 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.408 ' CD2' ' N ' ' A' ' 60' ' ' TYR . 10.5 p90 -113.39 131.43 55.99 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.117 -0.989 . . . . 0.0 109.846 -179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.565 ' CZ3' ' O ' ' A' ' 62' ' ' LEU . 55.6 t90 -103.44 124.01 47.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.488 -0.758 . . . . 0.0 109.356 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.565 ' O ' ' CZ3' ' A' ' 61' ' ' TRP . 62.8 mt -102.76 162.12 13.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.329 -0.857 . . . . 0.0 109.591 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.92 162.96 12.33 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -82.07 -12.37 58.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -1.168 . . . . 0.0 109.576 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.51 28.95 7.32 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.3 m -130.84 97.57 4.37 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.115 0.959 . . . . 0.0 108.54 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 64.6 m -56.19 -170.87 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.674 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.526 ' O ' ' N ' ' A' ' 72' ' ' GLY . 0.2 OUTLIER -64.87 -17.81 64.61 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.247 -0.908 . . . . 0.0 109.562 -179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -63.13 -58.7 6.37 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.118 -0.989 . . . . 0.0 109.405 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -66.81 -41.59 87.29 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.15 -23.06 62.94 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.401 -0.812 . . . . 0.0 108.995 179.506 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -71.64 -44.24 49.73 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 179.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.97 -43.94 86.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.343 -1.092 . . . . 0.0 109.172 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -57.9 -49.28 77.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.415 -0.803 . . . . 0.0 109.304 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -56.67 -48.62 77.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.328 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 53.7 mt -50.09 -42.39 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.386 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -63.77 -37.15 86.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.198 -0.939 . . . . 0.0 109.328 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 76.6 m -65.52 -46.96 77.58 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.366 -0.834 . . . . 0.0 109.362 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 20.5 t -56.09 -39.85 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 0.0 109.163 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -61.52 -47.39 85.82 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.304 -0.873 . . . . 0.0 109.041 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 81' ' ' LEU . 34.1 mt -50.59 -46.05 57.66 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.309 -0.869 . . . . 0.0 109.001 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.588 ' O ' ' N ' ' A' ' 85' ' ' LEU . 0.8 OUTLIER -56.59 -59.01 5.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.232 -0.918 . . . . 0.0 109.177 179.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 82' ' ' ASP . 9.1 t0 -45.26 -30.05 1.14 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.108 -0.995 . . . . 0.0 108.611 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -75.44 -29.7 59.76 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.588 ' N ' ' O ' ' A' ' 82' ' ' ASP . 11.6 mt -116.0 30.91 7.05 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.389 -0.819 . . . . 0.0 109.412 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 46.32 34.5 2.27 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.293 -0.879 . . . . 0.0 109.507 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 51.29 22.2 6.89 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 9.8 ptt180 -90.34 30.93 1.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.102 -1.234 . . . . 0.0 109.228 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.779 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -123.49 177.1 5.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.542 -0.724 . . . . 0.0 109.306 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 95.1 t -113.32 115.45 49.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 109.477 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.93 157.87 18.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.264 -0.898 . . . . 0.0 109.374 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.578 ' NE2' ' OD1' ' A' ' 57' ' ' ASP . 27.6 m-70 -132.4 131.56 41.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.338 -0.851 . . . . 0.0 109.201 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.715 ' CD ' ' H ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER -98.66 103.19 15.11 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.112 -0.992 . . . . 0.0 109.54 -179.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.521 ' N ' ' CD ' ' A' ' 94' ' ' GLU . 3.9 mp0 -101.91 143.44 31.79 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.244 -0.91 . . . . 0.0 109.403 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.525 HG12 ' N ' ' A' ' 96' ' ' GLN . 13.8 t -141.81 169.91 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.298 -0.876 . . . . 0.0 109.62 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.665 ' CD ' ' H ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -82.11 118.95 23.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.261 -0.9 . . . . 0.0 109.384 -179.843 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 96.83 13.07 48.09 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.446 ' O ' ' O ' ' A' ' 99' ' ' GLU . 37.5 m-85 -150.93 -37.57 0.13 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.221 -1.164 . . . . 0.0 109.37 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.446 ' O ' ' O ' ' A' ' 98' ' ' PHE . 40.7 mt-10 40.61 -160.87 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.0 109.561 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.4 ' O ' HD12 ' A' ' 104' ' ' LEU . 1.8 m -139.09 159.79 41.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.176 -0.953 . . . . 0.0 109.422 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -64.95 -65.12 0.71 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.243 -0.911 . . . . 0.0 109.648 -179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.1 m -48.56 -54.51 14.17 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.159 -0.963 . . . . 0.0 109.464 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -53.78 -41.87 67.7 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.445 -0.784 . . . . 0.0 109.534 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.4 HD12 ' O ' ' A' ' 100' ' ' SER . 7.3 mt -69.54 -31.82 70.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.17 -0.956 . . . . 0.0 109.484 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.68 -21.14 67.01 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.539 ' CE2' ' CE ' ' A' ' 45' ' ' LYS . 8.2 t80 -76.79 -54.49 6.54 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.262 -1.14 . . . . 0.0 109.477 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -96.77 79.65 2.98 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.39 -0.819 . . . . 0.0 109.607 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -78.38 1.43 22.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.245 -0.909 . . . . 0.0 109.383 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.7 p -67.5 -22.04 65.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 109.493 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 111' ' ' LEU . . . 92.59 64.19 1.11 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.744 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER -49.23 178.7 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.338 -1.095 . . . . 0.0 109.546 -179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.48 155.32 43.03 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.226 -0.921 . . . . 0.0 109.329 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -126.47 143.68 51.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.212 -0.93 . . . . 0.0 109.451 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 44.3 mttt -140.18 134.75 31.61 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -0.875 . . . . 0.0 109.392 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 21.5 mtmm -68.28 151.75 46.46 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.275 -0.891 . . . . 0.0 109.523 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -143.33 63.15 0.5 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -73.67 127.11 10.26 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 11.5 p -155.81 151.4 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -1.127 . . . . 0.0 109.488 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -144.38 -90.77 0.11 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.296 -0.878 . . . . 0.0 109.472 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.4 m -174.57 137.81 0.49 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.297 -0.877 . . . . 0.0 109.576 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -142.85 135.42 6.5 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 4.8 t80 -72.13 49.42 0.19 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.228 -1.16 . . . . 0.0 109.424 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -96.12 -84.03 0.36 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.262 -0.899 . . . . 0.0 109.371 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -62.04 98.84 0.11 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.217 -0.927 . . . . 0.0 109.441 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 20.2 t -75.44 -72.61 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.658 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 126' ' ' VAL . 5.7 p -157.58 80.0 3.34 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.17 -0.956 . . . . 0.0 109.421 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -49.98 -9.91 0.19 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.846 2.364 . . . . 0.0 112.281 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 24.3 m120 -96.62 110.74 23.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.237 -0.914 . . . . 0.0 109.54 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.477 ' O ' HG23 ' A' ' 131' ' ' VAL . 36.6 mt-10 -72.29 -162.97 0.1 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 51.9 t -68.52 76.43 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.27 -0.894 . . . . 0.0 109.472 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 129' ' ' GLU . 2.0 t -72.57 -137.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.292 -0.88 . . . . 0.0 109.503 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.573 HG13 ' O ' ' A' ' 132' ' ' VAL . 7.3 p -73.15 117.49 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.169 -0.957 . . . . 0.0 109.474 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.046 -0.978 . . . . 0.0 109.414 179.986 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.55 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 67.2 tt0 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 121.303 0.573 . . . . 0.0 109.498 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.601 ' N ' ' OD1' ' A' ' 23' ' ' ASP . 33.0 m80 -159.52 53.35 0.54 Allowed Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.22 -0.925 . . . . 0.0 109.644 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.535 ' HB2' HD11 ' A' ' 6' ' ' LEU . 46.7 Cg_endo -71.33 91.74 0.66 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.758 2.305 . . . . 0.0 111.893 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.43 ' C ' ' N ' ' A' ' 6' ' ' LEU . 20.3 mm-40 -83.6 -25.71 30.63 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.222 -0.923 . . . . 0.0 110.035 -179.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.529 ' CE1' HG12 ' A' ' 42' ' ' VAL . 43.6 t80 -51.65 -11.96 0.16 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.036 -1.04 . . . . 0.0 109.747 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.535 HD11 ' HB2' ' A' ' 3' ' ' PRO . 0.3 OUTLIER -93.94 -29.97 14.99 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.146 -0.971 . . . . 0.0 109.032 179.582 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.506 ' O ' ' O ' ' A' ' 8' ' ' ALA . 17.0 mtpp -87.94 -6.63 57.93 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.391 -0.818 . . . . 0.0 109.264 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.506 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -43.71 170.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.351 -0.843 . . . . 0.0 109.568 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 105.04 76.68 1.09 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -136.04 -1.26 2.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.226 -1.161 . . . . 0.0 109.694 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -171.46 149.58 2.54 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.152 -0.968 . . . . 0.0 109.419 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.4 89.34 1.09 Allowed 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.727 2.285 . . . . 0.0 112.193 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -170.29 -106.15 0.19 Allowed Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.7 tt -162.33 149.17 13.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.222 -1.163 . . . . 0.0 109.665 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.3 mt-30 -135.77 132.97 37.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.368 -0.832 . . . . 0.0 109.309 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.428 HG22 ' N ' ' A' ' 17' ' ' TRP . 42.7 mt -102.96 159.7 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.276 -0.89 . . . . 0.0 109.767 -179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.428 ' N ' HG22 ' A' ' 16' ' ' ILE . 0.0 OUTLIER -157.87 162.17 38.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.313 -0.867 . . . . 0.0 109.047 179.917 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -129.03 147.29 50.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.355 -0.84 . . . . 0.0 109.555 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.536 ' CG1' ' OD1' ' A' ' 39' ' ' ASP . 8.1 p -81.03 145.98 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.32 -0.862 . . . . 0.0 109.548 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.58 ' O ' ' N ' ' A' ' 22' ' ' PHE . 22.3 tt0 -100.52 153.93 18.97 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.343 -0.848 . . . . 0.0 109.344 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 20' ' ' GLU . 18.7 tptm -40.32 -22.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.348 -0.845 . . . . 0.0 109.509 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.58 ' N ' ' O ' ' A' ' 20' ' ' GLU . 58.6 t80 -160.86 33.97 0.15 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 109.416 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.601 ' OD1' ' N ' ' A' ' 2' ' ' HIS . 25.9 t0 -173.89 -127.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.305 -0.872 . . . . 0.0 109.526 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.459 HD22 ' H ' ' A' ' 5' ' ' PHE . 4.7 tp -148.43 146.06 28.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.178 -0.951 . . . . 0.0 109.572 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.4 t -129.5 133.36 25.02 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.28 -0.888 . . . . 0.0 109.225 179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -74.26 140.91 28.27 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.453 2.102 . . . . 0.0 112.138 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.9 t -99.76 133.74 21.54 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.218 -0.926 . . . . 0.0 109.241 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -72.7 133.14 19.78 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.525 2.15 . . . . 0.0 112.308 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.508 ' C ' ' H ' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -68.25 176.01 2.98 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.239 -0.913 . . . . 0.0 109.431 179.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 29' ' ' THR . 3.1 t-20 69.91 -39.1 0.43 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.406 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.508 ' H ' ' C ' ' A' ' 29' ' ' THR . 31.6 mt -96.94 -32.75 11.87 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.287 -0.883 . . . . 0.0 109.414 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.456 ' C ' ' O ' ' A' ' 31' ' ' LEU . 14.6 p90 -41.58 160.6 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 0.0 109.58 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 128.82 -19.15 5.57 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -98.26 124.33 42.82 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -1.136 . . . . 0.0 109.604 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 12.7 m-85 -105.31 131.44 52.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -0.876 . . . . 0.0 109.335 179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 27.6 m-85 -96.5 135.67 38.07 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.211 -0.931 . . . . 0.0 109.582 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 69.7 p -83.71 -16.58 44.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.241 -0.912 . . . . 0.0 109.383 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.02 30.14 8.44 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.536 ' OD1' ' CG1' ' A' ' 19' ' ' VAL . 32.8 t0 -165.03 171.66 13.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.273 -1.133 . . . . 0.0 109.518 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.4 145.56 38.7 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.308 -0.87 . . . . 0.0 109.396 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -122.62 134.96 54.49 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.28 -0.888 . . . . 0.0 109.421 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.529 HG12 ' CE1' ' A' ' 5' ' ' PHE . 0.1 OUTLIER -108.71 144.16 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.345 0 O-C-N 121.324 -0.86 . . . . 0.0 109.018 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.082 ' N ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -144.34 125.12 8.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.049 -1.032 . . . . 0.0 109.738 -179.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.0 tt -113.22 124.12 51.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.282 -0.886 . . . . 0.0 109.53 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 29.6 tttm -97.69 145.81 25.96 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.316 -0.865 . . . . 0.0 109.515 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 13' ' ' GLY . 85.0 m -142.96 128.33 18.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.292 -0.88 . . . . 0.0 109.276 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -131.98 168.45 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 O-C-N 120.986 -1.071 . . . . 0.0 109.535 -179.626 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -99.66 98.46 9.3 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.556 HD13 HH11 ' A' ' 88' ' ' ARG . 10.1 mt -60.84 168.65 2.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.328 -0.858 . . . . 0.0 109.594 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 51' ' ' ASN . 34.0 ttm180 -48.95 -77.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.276 -0.89 . . . . 0.0 109.394 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 50' ' ' ARG . 1.2 m120 -42.84 -27.89 0.21 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.24 -0.912 . . . . 0.0 109.214 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 50' ' ' ARG . . . 96.03 44.17 3.13 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.3 t-20 -95.35 14.05 23.74 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.983 -1.304 . . . . 0.0 109.288 179.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.574 ' O ' ' CE2' ' A' ' 56' ' ' TYR . 11.5 mt 43.68 97.22 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.649 0.738 . . . . 0.0 109.377 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.412 ' HB2' HD11 ' A' ' 49' ' ' LEU . 9.3 tt0 -68.86 151.89 46.0 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.497 -0.752 . . . . 0.0 109.156 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.574 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 90.7 m-85 -136.08 114.31 11.54 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.318 -0.864 . . . . 0.0 109.419 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -119.73 153.94 34.89 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.3 137.62 40.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.934 -1.104 . . . . 0.0 110.324 -179.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.716 ' HB2' HD13 ' A' ' 43' ' ' ILE . 1.0 OUTLIER -122.5 150.11 42.98 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.447 -0.783 . . . . 0.0 109.138 179.545 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.707 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -124.78 116.42 22.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -0.851 . . . . 0.0 109.122 179.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.404 ' CE3' ' O ' ' A' ' 62' ' ' LEU . 16.7 t90 -97.77 123.93 41.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.294 -0.879 . . . . 0.0 109.61 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.404 ' O ' ' CE3' ' A' ' 61' ' ' TRP . 0.7 OUTLIER -104.54 161.49 14.06 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.316 -0.865 . . . . 0.0 109.394 179.861 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -106.26 157.83 15.75 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.408 ' HB2' HE21 ' A' ' 96' ' ' GLN . 6.6 t-20 -77.52 -12.25 59.94 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.286 -1.126 . . . . 0.0 109.389 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -107.16 24.36 12.96 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.484 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.8 m -130.97 97.5 4.33 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-O 122.105 0.955 . . . . 0.0 108.496 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 66' ' ' CYS . 1.4 m -50.85 -173.52 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.315 0 CA-C-O 121.378 0.609 . . . . 0.0 109.569 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.439 ' O ' ' N ' ' A' ' 72' ' ' GLY . 54.9 mt-30 -71.49 -17.8 62.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.19 -0.944 . . . . 0.0 109.598 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -63.82 -58.5 6.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.235 -0.916 . . . . 0.0 109.463 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.32 -46.99 84.1 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.369 -0.832 . . . . 0.0 109.053 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 18.6 m -63.79 -29.18 70.41 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.493 -0.755 . . . . 0.0 108.968 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -65.1 -45.92 90.21 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.22 -49.97 74.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -1.146 . . . . 0.0 109.326 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -61.83 -45.43 93.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -0.84 . . . . 0.0 109.252 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.641 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -62.21 -38.54 89.53 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.159 -0.963 . . . . 0.0 109.425 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 25.1 mt -58.84 -44.56 90.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.189 -0.945 . . . . 0.0 109.468 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -61.75 -42.0 98.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.247 -0.908 . . . . 0.0 109.37 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 82.2 m -68.0 -39.96 83.14 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.333 -0.854 . . . . 0.0 109.232 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 75' ' ' ALA . 68.2 t -67.87 -27.41 37.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 121.402 -0.811 . . . . 0.0 109.372 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.486 ' O ' ' OD2' ' A' ' 83' ' ' ASP . 40.8 mm-40 -70.4 -61.47 1.76 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.254 -0.904 . . . . 0.0 109.285 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.8 pp -58.03 -24.06 56.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.943 . . . . 0.0 108.645 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' A' ' 86' ' ' ASN . 13.9 t70 -72.25 -54.96 8.04 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.39 -0.819 . . . . 0.0 108.912 179.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.486 ' OD2' ' O ' ' A' ' 80' ' ' GLN . 1.1 p30 -48.33 -35.42 12.37 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.113 -0.992 . . . . 0.0 108.368 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.457 ' N ' ' OD1' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -72.93 -32.07 65.03 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.297 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 82' ' ' ASP . 4.6 tp -121.56 35.29 4.93 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.327 -0.858 . . . . 0.0 109.415 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.615 ' N ' ' O ' ' A' ' 82' ' ' ASP . 42.6 t30 -87.71 30.16 0.84 Allowed 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.193 -0.942 . . . . 0.0 109.205 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -107.41 -21.3 8.05 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.556 HH11 HD13 ' A' ' 49' ' ' LEU . 25.3 ttt85 -159.53 64.81 0.38 Allowed 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.282 -1.128 . . . . 0.0 109.41 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -153.13 174.43 14.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.924 . . . . 0.0 109.379 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 16.9 t -136.11 142.51 38.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -0.888 . . . . 0.0 109.641 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -103.24 147.71 26.71 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.328 -0.858 . . . . 0.0 109.077 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.401 ' HB2' ' ND1' ' A' ' 59' ' ' HIS . 38.4 m-70 -132.1 119.16 20.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.226 -0.921 . . . . 0.0 109.655 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.524 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 11.0 ptp180 -91.97 109.32 20.66 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.367 -0.833 . . . . 0.0 109.299 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.407 ' HG2' ' H ' ' A' ' 100' ' ' SER . 86.6 mt-10 -113.32 144.19 43.16 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 109.43 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 96' ' ' GLN . 37.5 t -148.55 166.59 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.299 -0.876 . . . . 0.0 109.37 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.541 ' N ' HG12 ' A' ' 95' ' ' VAL . 12.7 tt0 -59.16 115.99 3.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.245 -0.91 . . . . 0.0 109.388 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.06 9.79 85.75 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.48 ' O ' ' O ' ' A' ' 99' ' ' GLU . 0.2 OUTLIER -143.17 24.71 1.78 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -1.147 . . . . 0.0 109.305 179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.538 ' OE1' HD21 ' A' ' 104' ' ' LEU . 9.7 pt-20 -44.53 170.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.276 -0.89 . . . . 0.0 109.556 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.407 ' H ' ' HG2' ' A' ' 94' ' ' GLU . 4.3 t -91.51 167.8 11.99 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.279 -0.888 . . . . 0.0 109.573 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -73.66 -59.89 2.51 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.295 -0.878 . . . . 0.0 109.527 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 10.0 m -46.85 -35.59 6.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.355 -0.841 . . . . 0.0 109.373 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -68.87 -46.49 68.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.347 -0.846 . . . . 0.0 109.292 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.58 ' O ' ' CD1' ' A' ' 107' ' ' PHE . 12.0 mt -61.15 -20.57 62.85 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.252 -0.905 . . . . 0.0 109.436 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -93.74 -24.85 19.5 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.414 ' O ' ' C ' ' A' ' 107' ' ' PHE . 7.8 t80 -80.0 -21.42 43.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -1.133 . . . . 0.0 109.461 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.583 ' CG ' ' O ' ' A' ' 107' ' ' PHE . 1.6 p90 -44.97 121.67 2.91 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.234 -0.916 . . . . 0.0 109.456 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.8 ttmp? -108.98 -50.67 2.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.133 -0.979 . . . . 0.0 109.536 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 94.9 p -101.42 -9.79 20.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 109.539 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 96.29 108.48 2.44 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.735 HD23 ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -67.6 177.06 2.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.239 -1.153 . . . . 0.0 109.512 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 9.2 ttmm -146.88 143.7 28.74 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.288 -0.883 . . . . 0.0 109.436 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.61 ' N ' ' CD2' ' A' ' 113' ' ' TYR . 0.2 OUTLIER -112.41 124.67 53.0 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.312 -0.868 . . . . 0.0 109.485 179.969 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 17.0 mtpt -97.42 160.62 14.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.172 -0.955 . . . . 0.0 109.531 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.5 mtmp? -125.35 123.98 40.56 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.364 -0.835 . . . . 0.0 109.364 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -78.69 -109.53 0.21 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 89.85 145.46 12.88 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.82 -156.43 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -1.179 . . . . 0.0 109.433 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.437 ' C ' ' N ' ' A' ' 121' ' ' GLY . . . -139.65 -0.31 1.75 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.288 -0.882 . . . . 0.0 109.466 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 13.1 m 53.33 10.29 0.19 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 109.44 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.437 ' N ' ' C ' ' A' ' 119' ' ' ALA . . . 59.79 -128.84 47.41 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.579 ' CD2' ' N ' ' A' ' 122' ' ' PHE . 0.1 OUTLIER -85.57 -78.67 0.26 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.243 -1.151 . . . . 0.0 109.419 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.459 ' HE3' ' H ' ' A' ' 124' ' ' HIS . 6.0 ttpp -78.95 -152.95 0.07 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.18 -0.95 . . . . 0.0 109.324 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.459 ' H ' ' HE3' ' A' ' 123' ' ' LYS . 4.9 t-80 59.11 35.96 23.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.206 -0.934 . . . . 0.0 109.549 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.1 t -116.92 24.8 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.321 -0.862 . . . . 0.0 109.35 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 2.5 t -144.11 69.33 16.14 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.269 -0.894 . . . . 0.0 109.39 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.482 ' C ' ' H ' ' A' ' 129' ' ' GLU . 55.4 Cg_endo -74.71 6.47 3.25 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.708 2.272 . . . . 0.0 112.226 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -74.3 20.43 0.11 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.187 -0.946 . . . . 0.0 109.36 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.482 ' H ' ' C ' ' A' ' 127' ' ' PRO . 6.2 pt-20 -141.01 64.2 1.43 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.228 -0.92 . . . . 0.0 109.453 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.451 ' C ' ' O ' ' A' ' 129' ' ' GLU . 42.7 t -40.72 125.25 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.312 -0.868 . . . . 0.0 109.64 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.498 HG13 ' O ' ' A' ' 131' ' ' VAL . 15.0 p -72.24 127.73 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.438 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 14.8 p -73.92 -27.84 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.873 . . . . 0.0 109.433 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.453 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.581 ' O ' ' ND1' ' A' ' 2' ' ' HIS . 60.1 mm-40 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.601 ' O ' ' N ' ' A' ' 4' ' ' GLU . 13.8 m-70 -156.53 81.61 3.51 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.168 -0.957 . . . . 0.0 109.627 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -54.13 67.0 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.774 2.316 . . . . 0.0 111.974 179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.601 ' N ' ' O ' ' A' ' 2' ' ' HIS . 57.2 mm-40 -83.06 -46.02 13.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 109.972 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.553 ' CE2' ' CG1' ' A' ' 42' ' ' VAL . 34.8 t80 -69.74 -12.54 61.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.111 -0.993 . . . . 0.0 109.558 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.415 ' N ' HD23 ' A' ' 6' ' ' LEU . 9.4 mt -90.34 -33.71 15.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.216 -0.927 . . . . 0.0 109.381 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 8' ' ' ALA . 25.1 mttp -91.17 -11.34 38.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.229 -0.919 . . . . 0.0 109.494 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -42.73 166.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.177 -0.952 . . . . 0.0 109.47 -179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.542 ' H ' ' NE2' ' A' ' 15' ' ' GLN . . . 106.24 68.27 0.69 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.8 pttt -135.97 -0.87 2.49 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.211 -1.17 . . . . 0.0 109.576 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -159.02 142.48 10.81 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.273 -0.892 . . . . 0.0 109.326 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -74.35 89.88 1.04 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.594 2.196 . . . . 0.0 112.256 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.495 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -169.14 -105.92 0.19 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.5 tt -162.38 144.82 11.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -1.15 . . . . 0.0 109.472 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.542 ' NE2' ' H ' ' A' ' 9' ' ' GLY . 9.0 mt-30 -134.6 144.39 47.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.253 -0.904 . . . . 0.0 109.629 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.505 HG23 HD12 ' A' ' 43' ' ' ILE . 7.8 mt -122.89 143.96 34.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.455 -0.778 . . . . 0.0 109.812 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.423 ' CE2' ' HB3' ' A' ' 4' ' ' GLU . 0.1 OUTLIER -146.68 136.07 22.83 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.307 -0.87 . . . . 0.0 109.019 179.738 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.552 ' O ' ' N ' ' A' ' 25' ' ' VAL . 51.5 ttt180 -94.11 153.17 18.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.124 -0.985 . . . . 0.0 109.645 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.737 HG13 ' O ' ' A' ' 23' ' ' ASP . 28.3 t -96.45 133.31 38.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.92 . . . . 0.0 109.722 -179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.774 ' O ' ' N ' ' A' ' 22' ' ' PHE . 6.0 tt0 -80.09 85.58 5.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.132 -0.98 . . . . 0.0 108.774 179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.648 ' O ' ' CD2' ' A' ' 22' ' ' PHE . 7.5 mtpm? 40.43 9.86 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.548 -0.72 . . . . 0.0 109.792 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.774 ' N ' ' O ' ' A' ' 20' ' ' GLU . 0.7 OUTLIER 160.22 -32.35 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.225 -0.922 . . . . 0.0 109.167 -179.723 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.737 ' O ' HG13 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -94.49 -142.38 0.24 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.273 -0.892 . . . . 0.0 110.257 -179.214 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.52 HD13 ' H ' ' A' ' 4' ' ' GLU . 8.9 mt -125.95 146.12 49.99 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.341 -0.849 . . . . 0.0 109.942 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.552 ' N ' ' O ' ' A' ' 18' ' ' ARG . 7.8 t -142.05 132.29 12.66 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 0.0 109.15 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -76.3 144.67 26.37 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.39 2.06 . . . . 0.0 112.26 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.2 t -110.96 101.51 50.09 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.346 -0.846 . . . . 0.0 109.437 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -51.19 161.6 1.58 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.508 2.139 . . . . 0.0 112.153 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.7 m -68.64 -22.15 64.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.389 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -67.0 -11.83 58.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.256 -0.903 . . . . 0.0 109.433 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 32' ' ' TYR . 15.3 mt -122.93 -17.11 6.87 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.268 -0.895 . . . . 0.0 109.52 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.55 ' C ' ' CD2' ' A' ' 32' ' ' TYR . 4.4 t80 -42.46 133.12 3.4 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.907 . . . . 0.0 109.348 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.83 22.26 16.36 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -143.02 151.37 40.76 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.174 -1.192 . . . . 0.0 109.444 179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -141.83 137.48 31.5 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.231 -0.918 . . . . 0.0 109.549 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -102.04 137.63 40.07 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.322 -0.861 . . . . 0.0 109.325 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.4 p -78.2 -4.79 49.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.29 -0.882 . . . . 0.0 109.48 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.35 30.94 8.92 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.699 -1.361 . . . . 0.0 109.699 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.447 ' OD1' ' N ' ' A' ' 40' ' ' ALA . 8.8 t70 -173.66 156.13 2.86 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.188 -1.184 . . . . 0.0 109.521 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.447 ' N ' ' OD1' ' A' ' 39' ' ' ASP . . . -97.77 147.68 24.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.246 -0.909 . . . . 0.0 109.279 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.44 ' N ' ' CD2' ' A' ' 41' ' ' TYR . 17.1 m-85 -128.72 134.82 48.57 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.324 -0.86 . . . . 0.0 109.46 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.918 ' O ' HD13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -105.44 140.94 21.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 O-C-N 121.213 -0.929 . . . . 0.0 109.06 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.918 HD13 ' O ' ' A' ' 42' ' ' VAL . 1.1 mm -131.22 134.89 60.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.37 -0.831 . . . . 0.0 110.028 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.7 tt -120.22 120.13 35.23 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.536 -0.727 . . . . 0.0 109.531 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.403 ' HE3' ' CE1' ' A' ' 106' ' ' TYR . 43.6 tttt -93.79 147.91 22.61 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.116 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.495 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.6 OUTLIER -142.68 122.14 13.2 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 109.526 -179.768 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.622 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -129.97 168.18 23.57 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 O-C-N 121.249 -0.907 . . . . 0.0 108.908 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 42.7 tt0 -94.51 131.29 40.39 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.533 -0.729 . . . . 0.0 109.487 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.453 HD21 HE21 ' A' ' 55' ' ' GLN . 15.8 mt -96.32 167.52 11.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.289 -0.882 . . . . 0.0 109.534 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.53 ' CG ' ' N ' ' A' ' 51' ' ' ASN . 4.6 ptm180 -47.93 -46.86 32.51 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.261 -0.899 . . . . 0.0 109.296 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.53 ' N ' ' CG ' ' A' ' 50' ' ' ARG . 98.6 m-20 -75.75 -27.48 58.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.316 -0.865 . . . . 0.0 109.199 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 97.85 28.96 7.95 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.497 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.4 t-20 -84.67 13.64 5.49 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.099 -1.236 . . . . 0.0 109.359 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.622 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.8 mt 47.31 100.26 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.83 0 CA-C-O 121.527 0.68 . . . . 0.0 109.509 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.453 HE21 HD21 ' A' ' 49' ' ' LEU . 8.9 tt0 -68.85 117.77 10.95 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.534 -0.729 . . . . 0.0 109.214 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.515 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 96.7 m-85 -98.07 114.71 26.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.174 -0.954 . . . . 0.0 109.865 -179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.21 155.76 22.46 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.553 ' C ' ' CD2' ' A' ' 59' ' ' HIS . 5.2 mp -134.36 144.7 48.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.838 -1.164 . . . . 0.0 110.517 -179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.603 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.5 OUTLIER -141.97 126.55 17.89 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.566 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.701 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 0.1 OUTLIER -105.94 131.13 53.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.1 -1.0 . . . . 0.0 109.593 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 13.6 t90 -104.94 123.94 48.63 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.422 -0.799 . . . . 0.0 109.331 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.9 mt -104.7 162.12 13.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.863 . . . . 0.0 109.595 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -117.37 162.69 12.81 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.607 -1.397 . . . . 0.0 109.607 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.485 ' O ' ' ND2' ' A' ' 64' ' ' ASN . 0.6 OUTLIER -81.08 -12.57 59.26 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.302 -1.117 . . . . 0.0 109.614 -179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -106.24 26.98 9.13 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.485 ' O ' ' O ' ' A' ' 67' ' ' SER . 1.3 m -130.75 97.61 4.4 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-O 122.2 1.0 . . . . 0.0 108.42 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.485 ' O ' ' O ' ' A' ' 66' ' ' CYS . 31.4 m -49.71 -176.49 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.284 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.733 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 72' ' ' GLY . 13.7 pt20 -68.17 -17.5 64.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.4 -0.812 . . . . 0.0 109.561 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 62.3 t0 -63.48 -58.57 6.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.919 . . . . 0.0 109.652 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.449 ' CD ' ' N ' ' A' ' 70' ' ' GLU . 3.8 mm-40 -62.32 -48.13 81.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.229 -0.919 . . . . 0.0 109.177 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.7 p -66.01 -27.53 68.19 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.338 -0.851 . . . . 0.0 109.231 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.89 -31.82 66.86 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.22 -51.22 18.53 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.278 -1.131 . . . . 0.0 109.342 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -54.92 -48.18 73.44 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.414 -0.804 . . . . 0.0 109.279 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.406 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -57.11 -48.38 78.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 109.303 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.4 mt -50.77 -47.28 29.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.204 -0.935 . . . . 0.0 109.319 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -58.06 -37.75 75.02 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.306 -0.871 . . . . 0.0 109.264 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 m -65.32 -46.22 81.19 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.33 -0.856 . . . . 0.0 109.266 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 75' ' ' ALA . 17.1 t -56.02 -36.41 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.224 -0.923 . . . . 0.0 109.451 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -64.89 -50.09 67.92 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.277 -0.889 . . . . 0.0 109.255 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.2 mt -53.13 -36.1 60.43 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.204 -0.935 . . . . 0.0 109.247 179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.576 ' O ' ' N ' ' A' ' 85' ' ' LEU . 40.6 m-20 -63.36 -58.34 7.42 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.247 -0.908 . . . . 0.0 109.109 179.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 82' ' ' ASP . 1.8 t70 -45.4 -34.0 2.85 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.212 -0.93 . . . . 0.0 108.54 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -73.7 -28.87 61.96 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.576 ' N ' ' O ' ' A' ' 82' ' ' ASP . 6.4 mt -112.93 28.36 8.86 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.394 -0.816 . . . . 0.0 109.272 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 85' ' ' LEU . 9.6 t-20 43.56 37.22 1.4 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.397 -0.815 . . . . 0.0 109.429 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 48.72 32.95 11.65 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 34.0 ttt180 -89.09 30.96 0.9 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.192 -1.181 . . . . 0.0 109.22 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -129.76 179.14 6.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.423 -0.798 . . . . 0.0 109.347 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 21.3 t -110.7 128.23 67.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.15 -0.969 . . . . 0.0 109.5 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.586 ' NE2' ' N ' ' A' ' 91' ' ' GLN . 1.6 mp0 -88.98 144.33 26.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.932 . . . . 0.0 109.366 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.42 ' HB2' ' CG ' ' A' ' 59' ' ' HIS . 28.4 m-70 -131.31 107.27 8.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.197 -0.94 . . . . 0.0 109.576 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -86.25 105.04 16.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.198 -0.939 . . . . 0.0 109.377 179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.596 ' OE1' ' CD1' ' A' ' 103' ' ' PHE . 22.3 mt-10 -110.3 141.77 42.84 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.36 -0.837 . . . . 0.0 109.732 -179.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.426 HG12 ' N ' ' A' ' 96' ' ' GLN . 12.0 t -144.38 163.3 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 121.342 -0.848 . . . . 0.0 109.147 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.426 ' N ' HG12 ' A' ' 95' ' ' VAL . 2.3 pt20 -56.89 120.52 8.06 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.197 -0.939 . . . . 0.0 109.442 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.42 15.76 77.54 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.438 ' O ' ' C ' ' A' ' 99' ' ' GLU . 7.0 t80 -141.7 12.13 2.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -1.145 . . . . 0.0 109.443 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.6 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 30.2 mp0 -41.52 138.4 1.33 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.506 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.446 ' H ' ' HG2' ' A' ' 94' ' ' GLU . 4.1 m -72.29 -177.36 2.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.879 . . . . 0.0 109.402 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -77.2 -65.21 0.98 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.187 -0.945 . . . . 0.0 109.505 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.6 m -47.64 -36.21 10.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.244 -0.91 . . . . 0.0 109.444 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.685 ' CZ ' ' CZ ' ' A' ' 107' ' ' PHE . 2.1 t80 -67.8 -47.16 69.87 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.259 -0.901 . . . . 0.0 109.442 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 104' ' ' LEU . 63.5 mt -66.83 -23.1 65.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.206 -0.934 . . . . 0.0 109.508 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -93.32 -24.17 22.49 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.403 ' CE1' ' HE3' ' A' ' 45' ' ' LYS . 32.6 t80 -86.94 -33.62 19.61 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.225 -1.162 . . . . 0.0 109.51 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.685 ' CZ ' ' CZ ' ' A' ' 103' ' ' PHE . 24.2 m-85 -90.31 99.31 12.36 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.29 -0.881 . . . . 0.0 109.528 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.419 ' C ' ' H ' ' A' ' 110' ' ' GLY . 19.9 mtpp -99.74 -6.16 27.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.913 . . . . 0.0 109.365 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 26.0 m -77.75 22.29 0.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 109.426 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.434 ' O ' ' C ' ' A' ' 111' ' ' LEU . . . 47.62 80.85 0.05 OUTLIER Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.75 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.5 OUTLIER -43.01 118.33 1.25 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.254 -1.145 . . . . 0.0 109.441 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.8 mttm -82.04 123.57 29.04 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.28 -0.887 . . . . 0.0 109.497 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -94.93 108.73 20.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.306 -0.871 . . . . 0.0 109.511 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -111.43 140.12 46.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.348 -0.845 . . . . 0.0 109.556 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 30.3 pttt -137.57 139.91 40.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.243 -0.911 . . . . 0.0 109.397 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -81.87 112.55 3.5 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 177.1 0.04 0.03 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 72.5 t -96.04 -48.56 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -1.122 . . . . 0.0 109.433 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . 53.31 -117.88 1.25 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.162 -0.961 . . . . 0.0 109.384 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 1.4 t -93.67 111.96 23.74 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.182 -0.948 . . . . 0.0 109.422 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -155.22 19.29 0.54 Allowed Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 19.7 t80 -151.66 -31.6 0.16 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.33 -1.1 . . . . 0.0 109.487 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.416 ' O ' ' CG ' ' A' ' 124' ' ' HIS . 28.6 mtmt -67.67 -29.32 68.58 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.256 -0.903 . . . . 0.0 109.413 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . 0.416 ' CG ' ' O ' ' A' ' 123' ' ' LYS . 80.1 m80 -153.87 100.63 2.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.29 -0.881 . . . . 0.0 109.401 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.482 ' O ' ' C ' ' A' ' 126' ' ' VAL . 2.1 t -69.64 66.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 109.532 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.482 ' C ' ' O ' ' A' ' 125' ' ' VAL . 1.2 m -38.92 103.35 0.28 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.435 -0.791 . . . . 0.0 109.574 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.99 119.58 5.03 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.461 2.107 . . . . 0.0 112.187 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.808 HD22 ' H ' ' A' ' 128' ' ' ASN . 0.0 OUTLIER -102.55 -12.7 17.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.263 -0.898 . . . . 0.0 109.499 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -163.2 84.61 0.5 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.317 -0.864 . . . . 0.0 109.508 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.435 ' H ' HG23 ' A' ' 130' ' ' VAL . 2.4 t -71.25 139.53 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.164 -0.96 . . . . 0.0 109.43 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 131' ' ' VAL . 13.3 p -72.25 124.86 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.895 . . . . 0.0 109.474 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 4.4 t -69.15 77.5 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.247 -0.908 . . . . 0.0 109.428 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.012 -0.994 . . . . 0.0 109.427 -179.951 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 . . . . . 0 N--CA 1.491 1.575 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.618 ' N ' ' ND1' ' A' ' 2' ' ' HIS . 0.0 OUTLIER -144.07 173.28 4.56 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.372 -179.983 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -49.39 73.86 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.688 0 C-N-CA 122.73 2.287 . . . . 0.0 112.099 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.592 ' N ' ' O ' ' A' ' 2' ' ' HIS . 0.4 OUTLIER -82.25 -34.83 28.63 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.26 -0.9 . . . . 0.0 109.698 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.628 ' CE2' HG12 ' A' ' 42' ' ' VAL . 15.9 t80 -56.78 -8.87 0.66 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.184 -0.948 . . . . 0.0 109.291 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.409 ' N ' ' C ' ' A' ' 4' ' ' GLU . 51.1 mt -90.24 -45.73 8.88 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.227 -0.921 . . . . 0.0 109.385 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.455 ' O ' ' C ' ' A' ' 8' ' ' ALA . 43.6 mtpt -87.27 -2.08 58.37 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.292 -0.88 . . . . 0.0 109.439 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 7' ' ' LYS . . . -41.48 150.46 0.1 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.42 -0.8 . . . . 0.0 109.581 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 120.54 68.83 0.29 Allowed Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -134.64 9.69 3.66 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.373 -1.075 . . . . 0.0 109.539 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -172.67 139.37 0.93 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.148 -0.97 . . . . 0.0 109.451 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.38 86.3 1.17 Allowed 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.547 2.165 . . . . 0.0 112.265 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -166.31 -107.58 0.2 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.6 tt -162.6 151.0 14.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.291 -1.123 . . . . 0.0 109.635 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.424 ' HB3' ' CZ3' ' A' ' 17' ' ' TRP . 32.7 mt-30 -146.66 140.25 25.85 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.252 -0.905 . . . . 0.0 109.403 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.582 ' HB ' HG11 ' A' ' 27' ' ' VAL . 3.4 mt -114.38 149.39 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.312 -0.867 . . . . 0.0 109.923 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.424 ' CZ3' ' HB3' ' A' ' 15' ' ' GLN . 0.1 OUTLIER -145.27 135.23 23.72 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.302 -0.874 . . . . 0.0 109.122 179.748 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 -92.27 142.83 27.03 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.164 -0.96 . . . . 0.0 109.381 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.634 ' O ' HG13 ' A' ' 19' ' ' VAL . 9.9 p -80.45 119.62 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.198 -0.939 . . . . 0.0 109.501 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.614 ' O ' ' N ' ' A' ' 22' ' ' PHE . 8.6 tm-20 -74.79 147.83 40.88 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.234 -0.916 . . . . 0.0 109.157 179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.425 ' N ' ' CD ' ' A' ' 20' ' ' GLU . 23.8 mttp -45.19 -11.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.901 . . . . 0.0 109.833 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.614 ' N ' ' O ' ' A' ' 20' ' ' GLU . 7.6 t80 -165.71 29.75 0.05 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.126 -0.984 . . . . 0.0 109.797 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.463 ' N ' ' HB3' ' A' ' 20' ' ' GLU . 27.5 t70 -175.29 -116.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 0.0 109.597 179.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.6 tp -157.99 146.2 18.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.346 -0.846 . . . . 0.0 109.499 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -134.38 107.9 11.17 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.244 -0.91 . . . . 0.0 109.604 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.74 132.79 37.62 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.192 1.928 . . . . 0.0 111.843 179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.582 HG11 ' HB ' ' A' ' 16' ' ' ILE . 2.2 p -75.7 121.57 85.35 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 109.572 -179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -78.17 166.84 24.14 Favored 'Trans proline' 0 N--CA 1.491 1.366 0 C-N-CA 122.4 2.067 . . . . 0.0 112.139 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.86 -6.25 43.74 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.332 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -87.19 -6.39 58.63 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.906 . . . . 0.0 109.346 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 32' ' ' TYR . 56.6 mt -132.87 -11.4 3.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.317 -0.864 . . . . 0.0 109.778 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.528 ' CZ ' ' CD1' ' A' ' 16' ' ' ILE . 9.6 t80 -43.25 118.98 1.44 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 109.487 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.66 -11.91 56.45 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.514 ' C ' ' CG ' ' A' ' 35' ' ' PHE . 1.9 m-20 -110.52 150.52 28.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -1.154 . . . . 0.0 109.503 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.514 ' CG ' ' C ' ' A' ' 34' ' ' ASP . 5.2 m-85 -155.1 148.17 24.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.279 -0.888 . . . . 0.0 109.421 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.478 ' N ' ' CD1' ' A' ' 36' ' ' PHE . 2.0 m-85 -102.34 135.96 43.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.207 -0.933 . . . . 0.0 109.536 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 44.7 p -67.13 -9.57 41.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.354 -0.841 . . . . 0.0 109.289 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.52 30.36 8.9 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.483 ' OD1' ' N ' ' A' ' 40' ' ' ALA . 3.1 t70 -161.36 159.44 28.35 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.239 -1.154 . . . . 0.0 109.399 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.6 ' O ' HG12 ' A' ' 19' ' ' VAL . . . -107.46 150.71 26.47 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.276 -0.89 . . . . 0.0 109.392 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -130.03 138.89 51.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.312 -0.867 . . . . 0.0 109.511 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.08 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -112.81 126.52 70.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.25 -0.906 . . . . 0.0 108.591 179.698 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.08 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -123.73 137.77 55.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 C-N-CA 119.319 -0.952 . . . . 0.0 110.373 -178.862 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 5.6 tt -121.09 146.96 46.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.542 -0.724 . . . . 0.0 109.396 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 57' ' ' ASP . 1.8 ttmp? -123.67 139.34 54.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.417 -0.802 . . . . 0.0 109.259 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.518 ' O ' ' N ' ' A' ' 13' ' ' GLY . 20.4 m -136.31 117.93 14.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.342 -0.849 . . . . 0.0 109.328 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.708 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -126.52 167.86 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 O-C-N 121.317 -0.864 . . . . 0.0 109.01 -179.896 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -98.48 125.44 43.68 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.498 -0.752 . . . . 0.0 109.442 179.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.435 HD11 ' HB2' ' A' ' 55' ' ' GLN . 11.1 mt -87.9 154.43 20.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.27 -0.894 . . . . 0.0 109.673 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.432 ' CZ ' ' CB ' ' A' ' 50' ' ' ARG . 10.3 mtp-105 -48.24 -43.39 32.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.235 -0.916 . . . . 0.0 109.255 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -68.41 -32.85 73.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.312 -0.868 . . . . 0.0 109.3 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.09 74.67 1.18 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.508 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.1 t-20 -143.69 13.77 1.73 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.203 -1.175 . . . . 0.0 109.336 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.708 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 31.4 mt 44.52 98.26 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.536 0.684 . . . . 0.0 109.496 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.435 ' HB2' HD11 ' A' ' 49' ' ' LEU . 9.7 tt0 -73.97 121.31 20.81 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.559 -0.713 . . . . 0.0 109.682 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -99.54 114.54 27.59 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.248 -0.908 . . . . 0.0 109.751 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.477 ' O ' ' N ' ' A' ' 45' ' ' LYS . 0.9 OUTLIER -127.51 122.56 33.7 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 179.362 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.57 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 0.5 OUTLIER -126.16 150.37 48.33 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.114 -0.991 . . . . 0.0 110.71 -178.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.482 ' CB ' ' CE1' ' A' ' 92' ' ' HIS . 0.0 OUTLIER -129.53 141.71 50.92 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.34 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.572 ' HE1' ' HB1' ' A' ' 40' ' ' ALA . 2.4 t80 -103.24 126.22 50.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.266 -0.897 . . . . 0.0 109.56 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.457 ' N ' ' CD1' ' A' ' 60' ' ' TYR . 44.2 t90 -100.74 127.8 47.02 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.09 -1.006 . . . . 0.0 109.824 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.499 HD21 ' CE2' ' A' ' 60' ' ' TYR . 2.9 mp -112.53 157.0 21.68 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.491 -0.756 . . . . 0.0 109.412 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -104.78 161.68 14.99 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.514 HD21 ' NE2' ' A' ' 96' ' ' GLN . 0.5 OUTLIER -81.72 -12.05 58.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.333 -1.098 . . . . 0.0 109.474 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -106.66 29.59 6.82 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.552 ' SG ' ' OE2' ' A' ' 70' ' ' GLU . 1.6 m -130.78 97.51 4.36 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.591 ' OG ' ' N ' ' A' ' 68' ' ' GLN . 1.0 OUTLIER -58.67 -173.76 0.02 OUTLIER 'General case' 0 C--N 1.283 -2.309 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.573 -179.829 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.591 ' N ' ' OG ' ' A' ' 67' ' ' SER . 8.6 pt20 -62.45 -17.97 60.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 109.66 -179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -65.35 -58.77 5.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.265 -0.897 . . . . 0.0 109.557 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.552 ' OE2' ' SG ' ' A' ' 66' ' ' CYS . 13.4 mt-10 -64.63 -43.1 94.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.336 -0.852 . . . . 0.0 109.139 179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.7 t -69.33 -26.7 64.83 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.491 -0.756 . . . . 0.0 109.191 179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.31 -38.89 71.18 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.02 -47.98 64.11 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.331 -1.1 . . . . 0.0 109.366 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.483 ' O ' ' OG1' ' A' ' 78' ' ' THR . . . -60.36 -42.22 95.3 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.366 -0.834 . . . . 0.0 109.311 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.487 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -62.95 -44.8 95.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.286 -0.883 . . . . 0.0 109.598 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 47.2 mt -53.45 -51.53 40.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.221 -0.924 . . . . 0.0 109.341 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -61.36 -33.23 73.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.902 . . . . 0.0 109.307 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.483 ' OG1' ' O ' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -68.81 -44.77 72.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.382 -0.824 . . . . 0.0 109.374 179.837 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 75' ' ' ALA . 42.9 t -63.34 -31.2 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.293 -0.879 . . . . 0.0 109.409 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 63.8 mt-30 -66.9 -60.97 2.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.334 -0.854 . . . . 0.0 109.165 179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.805 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -50.78 -31.09 15.84 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.046 -1.034 . . . . 0.0 108.708 179.655 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.609 ' O ' ' N ' ' A' ' 86' ' ' ASN . 29.2 t70 -63.64 -59.57 4.44 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.418 -0.802 . . . . 0.0 108.928 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.583 ' O ' ' ND2' ' A' ' 86' ' ' ASN . 1.3 m-20 -46.03 -34.09 3.84 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.158 -0.964 . . . . 0.0 108.46 179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -74.7 -32.79 62.28 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 82' ' ' ASP . 1.1 tt -121.48 35.67 4.82 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.369 -0.832 . . . . 0.0 109.532 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.609 ' N ' ' O ' ' A' ' 82' ' ' ASP . 1.7 p30 -76.89 27.03 0.14 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.125 -0.985 . . . . 0.0 109.092 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.491 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -69.9 -57.86 6.74 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.2 ptm180 -176.67 46.54 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.346 -1.091 . . . . 0.0 109.564 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.63 179.13 6.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.874 . . . . 0.0 109.406 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 49.7 t -126.25 111.95 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 109.45 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -102.38 136.43 42.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.364 -0.835 . . . . 0.0 109.397 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.619 ' N ' ' CD2' ' A' ' 92' ' ' HIS . 0.6 OUTLIER -143.82 118.65 9.91 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.077 -1.014 . . . . 0.0 109.515 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 11.1 mtm180 -83.01 138.28 33.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.3 -0.875 . . . . 0.0 109.774 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' A' ' 100' ' ' SER . 5.4 mt-10 -131.37 155.98 46.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.304 -0.873 . . . . 0.0 109.283 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.698 HG12 ' N ' ' A' ' 96' ' ' GLN . 48.1 t -131.66 173.8 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.219 -0.925 . . . . 0.0 109.575 -179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.698 ' N ' HG12 ' A' ' 95' ' ' VAL . 3.3 tt0 -60.55 139.75 57.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.374 -0.829 . . . . 0.0 109.54 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 70.53 -18.55 0.75 Allowed Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.517 ' H ' ' C ' ' A' ' 96' ' ' GLN . 7.9 t80 -106.59 4.7 28.31 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.301 -1.117 . . . . 0.0 109.452 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.54 ' OE2' HD22 ' A' ' 111' ' ' LEU . 27.7 mt-10 -42.69 148.26 0.24 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.903 . . . . 0.0 109.559 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.467 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 38.4 m -81.06 168.7 18.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.259 -0.9 . . . . 0.0 109.529 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.93 -35.02 78.72 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.153 -0.967 . . . . 0.0 109.607 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.8 m -58.03 -61.03 2.85 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.568 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -57.78 -41.79 82.78 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.35 -0.844 . . . . 0.0 109.732 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 13.2 mt -66.28 -28.52 68.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.189 -0.944 . . . . 0.0 109.552 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -81.7 -19.22 66.29 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.43 ' CD1' ' CZ ' ' A' ' 107' ' ' PHE . 0.2 OUTLIER -81.37 -45.55 15.95 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -1.121 . . . . 0.0 109.431 -179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.43 ' CZ ' ' CD1' ' A' ' 106' ' ' TYR . 20.4 m-85 -139.41 87.21 2.17 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.352 -0.842 . . . . 0.0 109.496 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.35 -20.76 20.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.386 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 11.7 t -96.94 -12.39 23.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -0.939 . . . . 0.0 109.484 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.456 ' O ' ' C ' ' A' ' 111' ' ' LEU . . . -97.65 -107.15 2.53 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.54 HD22 ' OE2' ' A' ' 99' ' ' GLU . 14.5 mt 41.52 61.64 1.77 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.329 -1.1 . . . . 0.0 109.507 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 3.1 tppt? -75.59 117.04 16.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.172 -0.955 . . . . 0.0 109.479 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -84.5 114.38 21.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.297 -0.877 . . . . 0.0 109.478 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 21.0 mmtp -103.05 166.28 10.53 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.282 -0.886 . . . . 0.0 109.355 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 49.7 mmtt -127.8 156.59 42.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.854 . . . . 0.0 109.465 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -161.04 -162.46 12.69 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -176.04 -176.32 44.15 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 2.4 p -156.76 139.21 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.097 -1.237 . . . . 0.0 109.541 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -98.39 84.34 3.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.293 -0.879 . . . . 0.0 109.507 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 43.1 t -70.92 -59.96 2.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.243 -0.911 . . . . 0.0 109.395 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -160.08 26.38 0.32 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -65.75 -73.08 0.14 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.226 -1.161 . . . . 0.0 109.488 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -95.97 -64.72 1.03 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.301 -0.874 . . . . 0.0 109.607 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -140.3 -174.41 3.94 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.297 -0.877 . . . . 0.0 109.502 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 125' ' ' VAL . 14.5 p -103.4 3.45 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.22 -0.925 . . . . 0.0 109.56 -179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 3.7 t 57.21 66.91 2.76 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.132 -0.98 . . . . 0.0 109.458 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -73.32 -172.58 1.06 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.73 2.287 . . . . 0.0 112.185 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.421 ' O ' ' O ' ' A' ' 129' ' ' GLU . 56.9 m-80 -85.47 -64.67 1.12 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.499 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.421 ' O ' ' O ' ' A' ' 128' ' ' ASN . 28.5 tt0 61.65 145.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.405 -0.809 . . . . 0.0 109.442 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 21.5 t -146.65 -78.04 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.22 -0.925 . . . . 0.0 109.458 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.42 ' C ' ' N ' ' A' ' 133' ' ' GLN . 2.0 t -71.76 146.97 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.292 -0.88 . . . . 0.0 109.481 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.436 ' O ' ' OXT' ' A' ' 133' ' ' GLN . 75.3 t -51.55 -14.38 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.216 -0.927 . . . . 0.0 109.515 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.436 ' OXT' ' O ' ' A' ' 132' ' ' VAL . 24.6 mm-40 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.066 -0.969 . . . . 0.0 109.534 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.281 0.562 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.579 ' O ' ' N ' ' A' ' 4' ' ' GLU . 0.4 OUTLIER -176.46 145.44 0.7 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.246 179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.404 ' HD2' ' CG ' ' A' ' 2' ' ' HIS . 84.3 Cg_exo -39.4 81.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.65 2.234 . . . . 0.0 112.238 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.644 ' H ' HD22 ' A' ' 24' ' ' LEU . 1.2 tp10 -83.07 -29.35 28.86 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.26 -0.9 . . . . 0.0 109.563 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.616 ' CZ ' ' O ' ' A' ' 42' ' ' VAL . 2.9 m-85 -56.32 -4.59 0.14 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.951 . . . . 0.0 109.13 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.511 ' H ' ' C ' ' A' ' 4' ' ' GLU . 14.4 mt -84.54 -38.4 20.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.293 -0.88 . . . . 0.0 109.279 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 8' ' ' ALA . 23.2 mttt -101.43 -3.37 28.79 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.393 -0.817 . . . . 0.0 109.358 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.503 ' HB3' HD13 ' A' ' 44' ' ' LEU . . . -42.01 137.52 1.81 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.31 -0.869 . . . . 0.0 109.637 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . 0.555 ' C ' ' H ' ' A' ' 11' ' ' GLU . . . 154.86 -37.45 0.66 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.623 ' CD ' ' H ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -70.78 19.83 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -1.152 . . . . 0.0 109.309 179.85 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.555 ' H ' ' C ' ' A' ' 9' ' ' GLY . 79.9 mt-10 -139.23 103.02 7.31 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.374 -0.829 . . . . 0.0 109.293 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -78.33 83.97 2.11 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.426 2.084 . . . . 0.0 112.157 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -174.22 -102.01 0.15 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -159.97 132.47 6.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.134 . . . . 0.0 109.427 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -115.23 135.93 53.65 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.276 -0.89 . . . . 0.0 109.478 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.58 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 6.3 mt -130.96 110.11 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.44 -0.787 . . . . 0.0 109.91 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.58 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 6.1 m0 -139.32 149.76 44.59 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.176 -0.953 . . . . 0.0 108.769 178.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.641 ' HE ' HG22 ' A' ' 27' ' ' VAL . 6.7 ptp180 -114.83 153.27 30.73 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.122 -0.986 . . . . 0.0 110.139 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.552 ' O ' HG13 ' A' ' 19' ' ' VAL . 7.3 p -89.26 125.68 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.352 -0.843 . . . . 0.0 109.13 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.657 ' CB ' HG21 ' A' ' 25' ' ' VAL . 5.6 mt-10 -157.45 138.02 13.02 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.214 -0.929 . . . . 0.0 109.319 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.428 ' O ' ' C ' ' A' ' 22' ' ' PHE . 12.8 mttt 72.97 48.21 0.18 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.501 -0.75 . . . . 0.0 109.458 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.428 ' C ' ' O ' ' A' ' 21' ' ' LYS . 20.5 m-85 43.74 36.93 1.41 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.541 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -169.01 166.75 10.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.28 -0.888 . . . . 0.0 109.405 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.644 HD22 ' H ' ' A' ' 4' ' ' GLU . 4.4 tp -68.15 146.16 53.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.246 -0.909 . . . . 0.0 109.431 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.657 HG21 ' CB ' ' A' ' 20' ' ' GLU . 44.1 t -138.5 97.67 9.25 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.371 -0.831 . . . . 0.0 109.071 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -50.31 168.99 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.771 2.314 . . . . 0.0 112.632 -179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.641 HG22 ' HE ' ' A' ' 18' ' ' ARG . 58.0 t -126.92 107.43 22.27 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.462 -0.774 . . . . 0.0 109.173 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -45.69 144.04 5.75 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.434 2.089 . . . . 0.0 112.492 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.531 ' O ' ' N ' ' A' ' 31' ' ' LEU . 6.5 m -51.89 -50.19 61.51 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.266 -0.896 . . . . 0.0 109.39 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -48.11 -11.97 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.223 -0.923 . . . . 0.0 109.418 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.531 ' N ' ' O ' ' A' ' 29' ' ' THR . 94.5 mt -114.96 -17.45 11.5 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 109.552 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.525 ' CE1' HD12 ' A' ' 16' ' ' ILE . 0.2 OUTLIER -38.74 122.4 1.15 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.325 -0.859 . . . . 0.0 109.352 179.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.2 -10.9 36.89 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.477 ' C ' ' CD2' ' A' ' 35' ' ' PHE . 4.3 m-20 -93.5 156.71 16.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.151 -1.205 . . . . 0.0 109.381 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.477 ' CD2' ' C ' ' A' ' 34' ' ' ASP . 77.2 m-85 -146.83 134.38 20.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.201 -0.937 . . . . 0.0 109.6 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.598 ' CD2' ' NZ ' ' A' ' 114' ' ' LYS . 0.1 OUTLIER -103.63 120.02 40.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -0.934 . . . . 0.0 109.329 -179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.471 ' OG1' ' OE1' ' A' ' 65' ' ' GLU . 59.1 p -61.9 -23.05 66.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 109.44 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.451 ' O ' ' CG ' ' A' ' 39' ' ' ASP . . . -88.33 24.97 9.85 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.511 ' OD1' ' CG ' ' A' ' 20' ' ' GLU . 7.1 m-20 -159.52 135.34 8.64 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.283 -1.128 . . . . 0.0 109.334 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.534 ' HB1' ' HE1' ' A' ' 60' ' ' TYR . . . -77.83 140.6 39.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.258 -0.901 . . . . 0.0 109.318 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -116.33 135.04 54.23 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.326 -0.859 . . . . 0.0 109.383 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.95 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -118.92 136.37 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.414 -0.804 . . . . 0.0 109.265 -179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.95 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -130.64 141.58 45.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.776 179.81 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.682 HD23 ' N ' ' A' ' 45' ' ' LYS . 4.6 tt -129.32 117.31 20.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.311 -0.868 . . . . 0.0 109.688 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.682 ' N ' HD23 ' A' ' 44' ' ' LEU . 4.6 ttmm -89.07 134.65 33.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.352 -0.842 . . . . 0.0 109.38 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.539 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.6 OUTLIER -140.81 116.33 10.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.159 -0.963 . . . . 0.0 109.432 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.803 ' O ' HD23 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -125.58 168.44 18.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.18 -0.95 . . . . 0.0 109.183 -179.816 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.832 HE22 ' H ' ' A' ' 51' ' ' ASN . 1.0 OUTLIER -115.56 123.33 48.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.564 -0.71 . . . . 0.0 109.163 179.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.594 ' N ' ' OE1' ' A' ' 48' ' ' GLN . 0.5 OUTLIER -103.46 100.41 10.27 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.285 -0.885 . . . . 0.0 109.532 -179.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.584 ' C ' ' O ' ' A' ' 49' ' ' LEU . 19.7 mtp180 25.89 58.99 0.06 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.654 -0.654 . . . . 0.0 110.032 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.832 ' H ' HE22 ' A' ' 48' ' ' GLN . 1.8 m-20 55.23 50.54 14.87 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.351 -0.843 . . . . 0.0 109.382 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 49' ' ' LEU . . . -93.53 -79.71 1.45 Allowed Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.419 ' O ' ' O ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -164.61 22.06 0.06 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.21 -1.171 . . . . 0.0 109.515 -179.951 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.803 HD23 ' O ' ' A' ' 47' ' ' VAL . 11.4 mt 56.35 104.81 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 121.641 0.734 . . . . 0.0 109.359 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 46' ' ' THR . 4.5 tt0 -68.71 116.29 9.04 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.55 -0.719 . . . . 0.0 109.236 -179.797 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.627 ' O ' ' HB1' ' A' ' 89' ' ' ALA . 96.3 m-85 -104.39 115.24 30.03 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.364 -0.835 . . . . 0.0 109.964 -179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -121.89 155.05 36.25 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.439 ' O ' ' CD2' ' A' ' 92' ' ' HIS . 4.3 tp -142.63 137.91 30.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.936 -1.102 . . . . 0.0 110.521 -179.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.653 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -130.02 119.55 23.32 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 179.524 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.534 ' HE1' ' HB1' ' A' ' 40' ' ' ALA . 3.6 t80 -101.57 124.44 47.23 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.01 -1.056 . . . . 0.0 109.387 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 7.1 t90 -103.81 126.64 51.08 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.11 -0.994 . . . . 0.0 109.799 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.425 ' CD2' ' OH ' ' A' ' 60' ' ' TYR . 6.4 mt -97.28 162.07 13.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.449 -0.782 . . . . 0.0 109.657 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -113.97 154.59 16.87 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -74.62 -12.34 60.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.056 -1.261 . . . . 0.0 109.52 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.471 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 1.2 mt-10 -109.23 30.35 6.68 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 179.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 2.1 m -130.49 97.42 4.39 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 122.075 0.94 . . . . 0.0 108.586 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.2 p -73.27 -170.88 0.85 Allowed 'General case' 0 C--N 1.283 -2.3 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.665 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -55.49 -28.18 52.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.35 -0.844 . . . . 0.0 109.792 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -66.31 -58.87 4.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.243 -0.911 . . . . 0.0 109.571 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.451 ' OE2' ' O ' ' A' ' 65' ' ' GLU . 24.3 mt-10 -62.95 -43.02 99.93 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.264 -0.898 . . . . 0.0 108.998 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.0 t -64.69 -34.68 78.88 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.454 -0.779 . . . . 0.0 108.953 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -61.03 -43.15 99.81 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -61.23 -50.33 73.52 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.287 -1.125 . . . . 0.0 109.116 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.479 ' O ' ' OG1' ' A' ' 78' ' ' THR . . . -61.63 -40.02 93.38 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.469 -0.769 . . . . 0.0 109.267 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.488 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -64.37 -42.7 96.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.315 -0.866 . . . . 0.0 109.428 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 49.2 mt -55.4 -53.88 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.319 -0.863 . . . . 0.0 109.183 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -57.87 -32.19 67.44 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.187 -0.946 . . . . 0.0 109.228 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -69.44 -52.42 27.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 109.008 179.752 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 75' ' ' ALA . 37.7 t -56.92 -26.55 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.289 -0.882 . . . . 0.0 109.097 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -70.11 -55.9 8.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.383 -0.823 . . . . 0.0 109.295 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.695 ' C ' HD12 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -54.17 -29.82 47.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.035 -1.041 . . . . 0.0 109.04 179.934 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 85' ' ' LEU . 72.7 m-20 -68.94 -58.77 3.68 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.244 -0.91 . . . . 0.0 108.806 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.404 ' C ' ' O ' ' A' ' 82' ' ' ASP . 52.9 t0 -46.86 -29.6 2.07 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.124 -0.985 . . . . 0.0 108.465 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -75.15 -33.79 61.55 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.495 ' N ' ' O ' ' A' ' 82' ' ' ASP . 3.9 tp -107.63 25.72 11.15 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.424 -0.797 . . . . 0.0 109.375 179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.475 ' C ' ' O ' ' A' ' 85' ' ' LEU . 2.9 m120 39.09 33.9 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.582 -0.699 . . . . 0.0 109.476 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 85' ' ' LEU . . . 53.98 84.6 0.03 OUTLIER Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 45.0 mtp85 -140.22 43.08 1.91 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.318 -1.107 . . . . 0.0 109.391 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.627 ' HB1' ' O ' ' A' ' 56' ' ' TYR . . . -150.67 170.68 18.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.858 . . . . 0.0 109.404 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 55.1 t -91.26 91.87 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.23 -0.919 . . . . 0.0 109.266 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.525 ' H ' ' CD ' ' A' ' 91' ' ' GLN . 2.3 mp0 -94.34 120.07 34.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.284 -0.885 . . . . 0.0 109.49 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.602 ' NE2' ' ND1' ' A' ' 59' ' ' HIS . 3.9 p80 -127.94 134.09 49.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.359 -0.838 . . . . 0.0 109.381 179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.496 ' O ' ' CG ' ' A' ' 93' ' ' ARG . 0.8 OUTLIER -90.52 117.82 29.5 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.888 . . . . 0.0 109.718 -179.753 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.477 ' OE2' ' OG ' ' A' ' 100' ' ' SER . 11.3 mt-10 -108.28 161.13 15.29 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 109.354 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.7 t -132.53 158.03 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.184 -0.947 . . . . 0.0 109.538 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.548 ' NE2' ' C ' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -61.98 143.79 56.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.26 -0.9 . . . . 0.0 109.443 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.533 ' N ' HE21 ' A' ' 96' ' ' GLN . . . 73.95 7.71 76.51 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -151.39 22.01 0.73 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.316 -1.108 . . . . 0.0 109.322 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -51.62 171.21 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.569 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.477 ' OG ' ' OE2' ' A' ' 94' ' ' GLU . 67.5 p -101.11 165.77 11.14 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.328 -0.858 . . . . 0.0 109.488 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.47 -33.21 73.38 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 0.0 109.487 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.2 m -59.92 -42.81 94.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.479 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -66.21 -53.46 36.93 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.289 -0.882 . . . . 0.0 109.242 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.3 mt -62.58 -27.94 69.54 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.352 -0.843 . . . . 0.0 109.169 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -69.35 -35.65 76.73 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.522 ' O ' ' CD2' ' A' ' 107' ' ' PHE . 1.9 m-85 -70.13 -54.92 10.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -1.101 . . . . 0.0 109.251 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.522 ' CD2' ' O ' ' A' ' 106' ' ' TYR . 10.0 m-85 -139.36 115.57 10.4 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.425 -0.797 . . . . 0.0 109.562 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 22.8 tttp -98.72 -52.02 3.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.313 -0.867 . . . . 0.0 109.52 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 m -92.61 23.11 4.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 109.467 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -119.16 -30.27 1.62 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.0 mt -63.8 123.39 18.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.221 -1.164 . . . . 0.0 109.509 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -137.12 102.65 4.9 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.305 -0.872 . . . . 0.0 109.448 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -94.69 136.42 35.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.905 . . . . 0.0 109.373 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.598 ' NZ ' ' CD2' ' A' ' 36' ' ' PHE . 9.5 pttp -131.54 147.38 52.53 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.258 -0.901 . . . . 0.0 109.464 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.417 ' HD3' ' H ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -107.74 153.25 23.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.353 -0.842 . . . . 0.0 109.433 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . 0.404 ' O ' ' C ' ' A' ' 117' ' ' GLY . . . -163.67 143.54 8.71 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.416 ' O ' ' C ' ' A' ' 118' ' ' VAL . . . -42.96 -55.24 4.91 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.416 ' C ' ' O ' ' A' ' 117' ' ' GLY . 32.4 t 44.21 -105.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -1.123 . . . . 0.0 109.417 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . 0.408 ' N ' HG12 ' A' ' 118' ' ' VAL . . . -81.44 54.52 2.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.172 -0.955 . . . . 0.0 109.508 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 26.9 p -58.42 -78.0 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.293 -0.88 . . . . 0.0 109.533 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 158.59 100.48 0.17 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -46.16 -63.88 0.88 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.285 -1.127 . . . . 0.0 109.539 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -93.09 -133.68 0.15 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.371 -0.831 . . . . 0.0 109.492 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -148.17 35.15 0.81 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 109.392 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.661 HG22 ' H ' ' A' ' 126' ' ' VAL . 0.9 OUTLIER -110.37 -171.82 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.237 -0.914 . . . . 0.0 109.342 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.661 ' H ' HG22 ' A' ' 125' ' ' VAL . 7.4 p -174.32 118.17 0.35 Allowed Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.168 -0.958 . . . . 0.0 109.307 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -76.94 83.5 2.11 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 C-N-CA 122.274 1.983 . . . . 0.0 112.268 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.579 ' OD1' ' N ' ' A' ' 128' ' ' ASN . 4.9 p-10 -90.27 149.87 22.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -0.902 . . . . 0.0 109.473 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -172.42 62.08 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.867 . . . . 0.0 109.337 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.632 HG13 ' O ' ' A' ' 130' ' ' VAL . 6.3 p -79.11 87.35 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.276 -0.89 . . . . 0.0 109.638 -179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 131' ' ' VAL . 9.5 p -83.49 118.0 30.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.318 -0.864 . . . . 0.0 109.477 179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 58.1 t -77.33 -96.47 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.192 -0.943 . . . . 0.0 109.582 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.056 -0.974 . . . . 0.0 109.466 179.981 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.59 ' CE1' ' OE1' ' A' ' 20' ' ' GLU . 0.3 OUTLIER -85.87 -51.3 0.49 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.941 . . . . 0.0 109.58 -179.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 2' ' ' HIS . 65.3 Cg_endo -79.44 72.85 6.3 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.607 2.205 . . . . 0.0 112.085 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.565 ' O ' ' N ' ' A' ' 6' ' ' LEU . 75.8 mt-10 -83.11 -30.77 27.66 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.275 -0.89 . . . . 0.0 109.708 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.61 ' CE1' HG12 ' A' ' 42' ' ' VAL . 46.8 t80 -43.88 -18.31 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.134 -0.979 . . . . 0.0 109.233 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.565 ' N ' ' O ' ' A' ' 4' ' ' GLU . 4.6 mt -81.4 -39.96 24.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.337 -0.852 . . . . 0.0 109.53 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.471 ' O ' ' O ' ' A' ' 8' ' ' ALA . 28.3 mtpt -86.93 -12.83 46.46 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.239 -0.913 . . . . 0.0 109.615 -179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.471 ' O ' ' O ' ' A' ' 7' ' ' LYS . . . -42.23 164.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.193 -0.942 . . . . 0.0 109.509 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 108.12 26.95 5.28 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -102.04 12.53 36.71 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.205 -1.173 . . . . 0.0 109.653 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -158.3 133.69 5.79 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.235 -0.915 . . . . 0.0 109.466 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -74.58 86.02 1.4 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.499 2.133 . . . . 0.0 112.34 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -170.18 -105.59 0.18 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.3 tt -162.2 144.69 11.31 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.311 -1.111 . . . . 0.0 109.517 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -138.02 134.73 35.17 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.288 -0.883 . . . . 0.0 109.375 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.735 HG23 HD12 ' A' ' 43' ' ' ILE . 27.1 mt -106.92 147.38 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.338 -0.851 . . . . 0.0 110.167 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -140.08 141.94 36.15 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.441 ' O ' ' N ' ' A' ' 25' ' ' VAL . 18.7 ttt180 -110.39 144.85 38.54 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.177 -0.952 . . . . 0.0 109.635 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.553 HG21 ' HB3' ' A' ' 40' ' ' ALA . 52.0 t -72.48 133.51 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.436 -0.79 . . . . 0.0 109.502 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.633 ' O ' ' N ' ' A' ' 22' ' ' PHE . 28.0 tt0 -81.08 86.85 6.08 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -0.966 . . . . 0.0 109.366 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.463 ' C ' ' CG ' ' A' ' 22' ' ' PHE . 26.2 mmtp 61.05 -33.09 0.08 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.487 -0.758 . . . . 0.0 109.994 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.633 ' N ' ' O ' ' A' ' 20' ' ' GLU . 0.1 OUTLIER 179.34 27.31 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.209 -0.932 . . . . 0.0 109.394 -179.866 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -145.15 -113.52 0.09 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.083 -1.01 . . . . 0.0 109.626 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.7 mt -143.66 136.37 27.31 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.066 -1.021 . . . . 0.0 109.799 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.441 ' N ' ' O ' ' A' ' 18' ' ' ARG . 0.9 OUTLIER -149.16 140.37 14.18 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.302 -0.874 . . . . 0.0 108.759 179.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.49 149.42 68.59 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.551 2.167 . . . . 0.0 112.516 -179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.421 HG23 ' N ' ' A' ' 18' ' ' ARG . 71.6 t -117.94 101.82 51.56 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.492 -0.755 . . . . 0.0 109.207 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -80.84 167.91 18.0 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.655 2.237 . . . . 0.0 112.461 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.564 ' C ' ' H ' ' A' ' 31' ' ' LEU . 1.9 t -61.03 -173.91 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.274 -0.891 . . . . 0.0 109.546 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.464 ' N ' ' OG1' ' A' ' 29' ' ' THR . 8.1 t30 70.31 -27.71 0.17 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.323 -0.861 . . . . 0.0 109.343 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.564 ' H ' ' C ' ' A' ' 29' ' ' THR . 43.5 mt -122.73 -33.41 3.39 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.392 -0.818 . . . . 0.0 109.369 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 33' ' ' GLY . 0.1 OUTLIER -48.59 165.13 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -0.912 . . . . 0.0 109.319 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.468 ' N ' ' CD1' ' A' ' 32' ' ' TYR . . . 89.04 -24.08 14.85 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -96.71 150.76 20.32 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -1.182 . . . . 0.0 109.469 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -141.03 134.17 29.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.264 -0.898 . . . . 0.0 109.418 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.484 ' C ' ' H ' ' A' ' 38' ' ' GLY . 25.6 m-85 -104.53 111.78 24.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.872 . . . . 0.0 109.482 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.469 ' OG1' ' OE1' ' A' ' 65' ' ' GLU . 19.6 p -51.55 -9.51 0.08 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.237 -0.915 . . . . 0.0 109.356 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.484 ' H ' ' C ' ' A' ' 36' ' ' PHE . . . -99.51 27.12 21.64 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.443 ' CG ' ' O ' ' A' ' 38' ' ' GLY . 50.2 m-20 -161.01 146.76 14.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -1.086 . . . . 0.0 109.368 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.553 ' HB3' HG21 ' A' ' 19' ' ' VAL . . . -92.23 158.88 15.9 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.192 -0.942 . . . . 0.0 109.483 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.437 ' CD2' ' C ' ' A' ' 40' ' ' ALA . 36.4 m-85 -138.26 138.12 38.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 109.369 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.005 ' C ' HD13 ' A' ' 43' ' ' ILE . 0.1 OUTLIER -108.83 128.44 64.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 O-C-N 121.129 -0.982 . . . . 0.0 108.902 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 1.005 HD13 ' C ' ' A' ' 42' ' ' VAL . 0.4 OUTLIER -125.76 136.97 59.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.242 -0.911 . . . . 0.0 110.023 -179.523 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 2.0 tt -124.55 128.85 49.56 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.545 -0.722 . . . . 0.0 109.582 -179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.447 ' NZ ' HG21 ' A' ' 102' ' ' THR . 30.3 ttpt -103.79 145.96 29.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.311 -0.868 . . . . 0.0 109.06 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.516 ' O ' ' N ' ' A' ' 13' ' ' GLY . 1.0 OUTLIER -143.01 126.78 17.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.176 -0.953 . . . . 0.0 109.764 -179.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.5 OUTLIER -131.94 168.09 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.29 -0.881 . . . . 0.0 109.16 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -96.82 131.86 43.13 Favored 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.597 -0.689 . . . . 0.0 109.497 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.401 ' O ' ' C ' ' A' ' 50' ' ' ARG . 14.5 mt -96.92 166.93 11.38 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.301 -0.874 . . . . 0.0 109.538 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.48 ' H ' ' HD2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -45.18 -78.94 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.272 -0.892 . . . . 0.0 109.17 179.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 42.0 m-80 -45.53 -28.97 1.04 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.291 -0.881 . . . . 0.0 109.252 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 95.55 69.07 1.03 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.499 ' O ' ' O ' ' A' ' 54' ' ' LEU . 63.5 m-20 -120.73 14.44 11.72 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.242 -1.152 . . . . 0.0 109.384 179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.661 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 17.7 mt 44.1 97.05 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 121.509 0.671 . . . . 0.0 109.364 179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -71.08 112.08 6.95 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.428 -0.795 . . . . 0.0 109.527 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.59 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 73.7 m-85 -95.74 114.54 26.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.136 -0.978 . . . . 0.0 109.701 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -115.78 155.38 27.92 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 179.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.453 ' N ' HD12 ' A' ' 58' ' ' LEU . 3.8 mp -132.3 141.1 48.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.815 -1.178 . . . . 0.0 110.884 -179.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.484 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 0.0 OUTLIER -136.7 112.43 9.46 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.233 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.735 ' CD1' ' N ' ' A' ' 60' ' ' TYR . 0.0 OUTLIER -94.38 126.93 39.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.086 -1.008 . . . . 0.0 109.458 -179.6 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.456 ' HE1' ' HG2' ' A' ' 99' ' ' GLU . 2.3 t90 -98.08 124.73 42.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.295 -0.878 . . . . 0.0 109.475 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.0 mt -107.64 145.86 32.77 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.254 -0.904 . . . . 0.0 109.532 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -95.01 158.87 22.59 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -76.23 -12.53 60.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.322 -1.105 . . . . 0.0 109.662 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.469 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 1.1 mt-10 -109.45 29.16 7.82 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 2.0 m -130.7 97.48 4.37 Favored 'General case' 0 C--N 1.303 -1.438 0 CA-C-O 122.211 1.005 . . . . 0.0 108.579 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 15.8 t -57.35 -170.92 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 115.702 -0.681 . . . . 0.0 109.735 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.562 ' O ' ' N ' ' A' ' 72' ' ' GLY . 3.2 mm100 -68.99 -17.39 63.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -0.86 . . . . 0.0 109.647 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -61.02 -58.75 7.11 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.22 -0.925 . . . . 0.0 109.394 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -64.38 -49.08 73.0 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.237 -0.914 . . . . 0.0 108.884 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.3 m -64.43 -23.22 67.21 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.399 -0.813 . . . . 0.0 108.844 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.562 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -68.44 -47.09 59.62 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.433 ' O ' ' CE2' ' A' ' 77' ' ' PHE . . . -62.63 -49.25 75.92 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.293 -1.122 . . . . 0.0 109.138 179.668 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.62 -32.51 74.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.507 -0.746 . . . . 0.0 109.214 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.556 ' O ' HG23 ' A' ' 79' ' ' VAL . . . -71.59 -43.96 65.32 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.264 -0.898 . . . . 0.0 109.376 179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.496 ' O ' ' OE1' ' A' ' 80' ' ' GLN . 59.4 mt -55.09 -53.17 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.188 -0.945 . . . . 0.0 109.24 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.559 ' N ' ' CD1' ' A' ' 77' ' ' PHE . 0.8 OUTLIER -60.0 -36.57 77.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.292 -0.88 . . . . 0.0 109.134 179.784 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.1 m -69.2 -31.42 70.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.283 -0.886 . . . . 0.0 108.999 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 75' ' ' ALA . 55.1 t -64.83 -46.09 93.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.271 -0.893 . . . . 0.0 109.242 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . 0.552 ' OE1' ' N ' ' A' ' 80' ' ' GLN . 5.1 mp0 -60.97 -45.42 94.82 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.6 mt -53.27 -43.93 67.83 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.315 -0.866 . . . . 0.0 109.037 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.64 ' O ' ' N ' ' A' ' 86' ' ' ASN . 68.4 t0 -58.14 -58.23 9.37 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.396 -0.815 . . . . 0.0 109.145 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.43 ' C ' ' O ' ' A' ' 82' ' ' ASP . 1.9 m-20 -44.73 -34.41 2.25 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.155 -0.966 . . . . 0.0 108.948 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.7 t80 -77.08 -30.94 55.69 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.299 -0.876 . . . . 0.0 108.98 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 82' ' ' ASP . 18.7 mt -121.56 32.39 5.91 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.315 -0.866 . . . . 0.0 109.486 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.64 ' N ' ' O ' ' A' ' 82' ' ' ASP . 60.8 t30 -81.08 28.28 0.37 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.207 -0.933 . . . . 0.0 109.097 179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -110.45 -37.26 1.79 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.6 ttm180 -163.23 67.78 0.2 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.154 -1.204 . . . . 0.0 109.45 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -138.07 166.17 24.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.248 -0.907 . . . . 0.0 109.321 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 7.9 t -123.12 96.34 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.342 -0.849 . . . . 0.0 109.545 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.58 131.38 44.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.315 -0.865 . . . . 0.0 109.036 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.569 ' N ' ' CD2' ' A' ' 92' ' ' HIS . 1.6 p80 -150.55 157.36 42.91 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.006 -1.059 . . . . 0.0 110.037 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -98.71 121.34 40.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.407 -0.808 . . . . 0.0 109.666 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.447 ' N ' ' CD ' ' A' ' 94' ' ' GLU . 1.5 mp0 -104.69 120.93 42.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.296 -0.878 . . . . 0.0 109.407 179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.556 HG12 ' N ' ' A' ' 96' ' ' GLN . 38.9 t -101.18 166.72 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.317 -0.865 . . . . 0.0 109.581 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.556 ' N ' HG12 ' A' ' 95' ' ' VAL . 41.4 tt0 -76.17 140.87 41.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 109.493 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.424 ' O ' ' CG ' ' A' ' 98' ' ' PHE . . . 80.51 5.02 90.1 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.472 ' O ' ' O ' ' A' ' 99' ' ' GLU . 46.1 m-85 -157.64 22.42 0.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -1.126 . . . . 0.0 109.457 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.472 ' O ' ' O ' ' A' ' 98' ' ' PHE . 97.3 mt-10 -49.05 178.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.233 -0.917 . . . . 0.0 109.405 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 11.3 t -89.63 163.09 15.3 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.316 -0.865 . . . . 0.0 109.424 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -66.08 -26.73 67.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.404 -0.81 . . . . 0.0 109.433 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.447 HG21 ' NZ ' ' A' ' 45' ' ' LYS . 7.5 m -65.62 -41.72 92.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.228 -0.92 . . . . 0.0 109.485 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -75.26 -41.95 56.14 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.372 -0.83 . . . . 0.0 109.336 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 11.5 mt -62.46 -24.68 67.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.271 -0.893 . . . . 0.0 109.519 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -92.94 -24.02 23.87 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -72.11 -35.77 69.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.274 -1.133 . . . . 0.0 109.417 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -139.16 133.82 31.97 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.328 -0.858 . . . . 0.0 109.529 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 1.8 pttp -108.59 -55.45 2.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.436 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.4 t -105.56 15.36 27.14 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 109.532 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -99.45 -20.01 18.84 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.5 mt -72.61 70.66 0.94 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -1.18 . . . . 0.0 109.438 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt -85.4 124.04 31.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.291 -0.881 . . . . 0.0 109.581 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -105.29 152.76 22.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.485 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 54.4 mttt -138.83 163.65 31.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.329 -0.857 . . . . 0.0 109.416 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 55.8 mttt -116.38 126.75 53.91 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.313 -0.867 . . . . 0.0 109.461 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 60.51 -100.36 0.22 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 145.2 173.25 16.29 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 4.3 m -144.54 140.9 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -1.127 . . . . 0.0 109.426 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -157.54 134.77 10.29 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.184 -0.947 . . . . 0.0 109.481 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 4.4 m -174.69 -27.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.194 -0.942 . . . . 0.0 109.519 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -71.34 66.24 0.98 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 16.8 m-85 -53.01 -44.51 67.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.277 -1.131 . . . . 0.0 109.496 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 19.6 mtpp -101.69 -84.39 0.44 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -0.859 . . . . 0.0 109.454 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -142.14 104.32 4.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.889 . . . . 0.0 109.544 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 125' ' ' VAL . 7.3 p -72.98 -13.06 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.268 -0.895 . . . . 0.0 109.467 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.59 HG13 ' O ' ' A' ' 126' ' ' VAL . 6.2 p -149.7 76.67 8.91 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.299 -0.875 . . . . 0.0 109.407 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.484 ' O ' ' O ' ' A' ' 128' ' ' ASN . 50.5 Cg_exo -49.19 -69.59 0.07 OUTLIER 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.792 2.328 . . . . 0.0 112.192 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . 0.484 ' O ' ' O ' ' A' ' 127' ' ' PRO . 15.6 t30 53.43 105.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.29 -0.881 . . . . 0.0 109.38 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -138.47 -166.56 2.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.193 -0.942 . . . . 0.0 109.397 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 3.9 t -65.53 -56.63 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.286 -0.884 . . . . 0.0 109.506 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.62 HG13 ' O ' ' A' ' 131' ' ' VAL . 6.5 p -46.23 104.46 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.471 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . 0.418 ' O ' ' C ' ' A' ' 133' ' ' GLN . 7.6 p -76.47 -15.71 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.209 -0.932 . . . . 0.0 109.461 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 132' ' ' VAL . 3.6 tp-100 . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 117.891 -1.052 . . . . 0.0 109.534 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 24' ' ' LEU . 29.3 mt-10 . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.4 ' H ' ' HB3' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -176.53 96.15 0.25 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.374 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.586 ' HA ' HD23 ' A' ' 24' ' ' LEU . 54.0 Cg_exo -48.61 90.34 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.563 2.176 . . . . 0.0 112.116 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.497 ' OE2' ' CH2' ' A' ' 17' ' ' TRP . 19.6 tt0 -83.23 -44.03 15.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -0.892 . . . . 0.0 109.982 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.464 ' CD1' ' HB ' ' A' ' 42' ' ' VAL . 5.4 m-85 -49.35 -28.73 5.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.185 -0.947 . . . . 0.0 109.435 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.5 mt -74.78 -29.22 61.04 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.228 -0.92 . . . . 0.0 109.597 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.6 mmtm -123.76 26.38 7.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -0.911 . . . . 0.0 109.523 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.437 ' N ' ' O ' ' A' ' 4' ' ' GLU . . . -81.35 173.3 12.6 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.354 -0.841 . . . . 0.0 109.568 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 130.32 44.8 0.17 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.92 30.54 3.06 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.381 -1.07 . . . . 0.0 109.497 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.542 ' OE1' ' NE2' ' A' ' 15' ' ' GLN . 1.2 pm0 -164.14 117.17 1.01 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.173 -0.955 . . . . 0.0 109.367 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -77.67 89.47 1.33 Allowed 'Trans proline' 0 C--N 1.311 -1.401 0 C-N-CA 122.432 2.088 . . . . 0.0 112.088 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 46' ' ' THR . . . -177.98 -98.34 0.11 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -162.06 138.51 7.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.259 -1.142 . . . . 0.0 109.638 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.542 ' NE2' ' OE1' ' A' ' 11' ' ' GLU . 19.1 mt-30 -114.99 135.89 53.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.435 -0.791 . . . . 0.0 108.974 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.62 ' O ' ' CD1' ' A' ' 17' ' ' TRP . 13.1 mt -130.19 116.53 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.345 -0.847 . . . . 0.0 110.114 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TRP . . . . . 0.62 ' CD1' ' O ' ' A' ' 16' ' ' ILE . 7.6 m0 -144.2 152.16 40.48 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.054 -1.029 . . . . 0.0 109.116 178.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.58 ' O ' ' N ' ' A' ' 25' ' ' VAL . 0.9 OUTLIER -101.84 153.29 19.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.213 -0.93 . . . . 0.0 109.801 -179.283 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.728 HG13 ' O ' ' A' ' 23' ' ' ASP . 12.5 t -97.47 131.2 44.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.42 -0.8 . . . . 0.0 109.538 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.65 ' O ' ' N ' ' A' ' 22' ' ' PHE . 1.9 tm-20 -76.83 86.65 3.41 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.132 -0.98 . . . . 0.0 108.732 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.6 ' O ' ' CB ' ' A' ' 22' ' ' PHE . 25.2 mtmm 48.31 3.86 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.375 -0.828 . . . . 0.0 109.539 -179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.65 ' N ' ' O ' ' A' ' 20' ' ' GLU . 1.4 t80 155.59 -30.22 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.424 -0.797 . . . . 0.0 109.472 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.728 ' O ' HG13 ' A' ' 19' ' ' VAL . 1.7 t70 -81.62 -133.46 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.171 -0.956 . . . . 0.0 109.844 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.741 HD13 ' H ' ' A' ' 25' ' ' VAL . 0.2 OUTLIER -137.03 140.13 41.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.235 -0.916 . . . . 0.0 109.607 -179.767 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.741 ' H ' HD13 ' A' ' 24' ' ' LEU . 9.4 t -137.79 91.6 13.47 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 108.999 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -52.42 159.35 4.56 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.654 2.236 . . . . 0.0 112.574 -179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 23.1 t -145.25 112.83 4.77 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.354 -0.841 . . . . 0.0 109.077 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 29' ' ' THR . 60.0 Cg_endo -77.88 168.14 22.66 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.44 2.093 . . . . 0.0 112.468 -179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -51.73 -174.28 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.389 -0.819 . . . . 0.0 109.361 -179.985 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.573 ' N ' ' OG1' ' A' ' 29' ' ' THR . 0.3 OUTLIER 69.17 -36.76 0.35 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.17 -0.956 . . . . 0.0 109.222 -179.788 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.555 ' H ' ' C ' ' A' ' 29' ' ' THR . 14.4 mt -109.21 -36.36 6.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.442 -0.786 . . . . 0.0 109.198 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.458 ' O ' ' O ' ' A' ' 31' ' ' LEU . 1.9 p90 -43.22 166.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.348 -0.845 . . . . 0.0 109.376 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 77.89 -12.88 15.38 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.3 158.81 18.98 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.212 -1.17 . . . . 0.0 109.481 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -144.99 108.42 4.62 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 109.56 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.474 ' C ' ' H ' ' A' ' 38' ' ' GLY . 2.8 m-85 -80.32 111.91 17.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 109.136 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.44 ' OG1' ' OE1' ' A' ' 65' ' ' GLU . 8.7 p -56.65 -4.97 0.18 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.185 -0.947 . . . . 0.0 109.618 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.474 ' H ' ' C ' ' A' ' 36' ' ' PHE . . . -109.7 39.09 3.03 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.529 ' N ' ' SG ' ' A' ' 66' ' ' CYS . 8.2 m-20 -169.34 -176.38 2.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.206 -1.173 . . . . 0.0 109.622 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -124.51 129.37 50.49 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.372 -0.83 . . . . 0.0 109.343 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 37.9 m-85 -114.07 137.31 51.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.0 109.688 -179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.966 ' O ' HD13 ' A' ' 43' ' ' ILE . 0.4 OUTLIER -115.24 142.82 26.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.297 -0.877 . . . . 0.0 109.18 179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.966 HD13 ' O ' ' A' ' 42' ' ' VAL . 0.7 OUTLIER -136.34 143.2 36.36 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 C-N-CA 119.702 -0.799 . . . . 0.0 110.108 179.863 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 7.8 tt -128.05 118.97 24.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.484 -0.76 . . . . 0.0 109.238 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 50.2 tttt -88.85 138.74 31.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.242 -0.911 . . . . 0.0 109.426 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 13' ' ' GLY . 0.9 OUTLIER -141.64 114.37 8.45 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.211 -0.93 . . . . 0.0 109.477 -179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.674 ' O ' ' HA ' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -126.03 168.04 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 O-C-N 121.13 -0.981 . . . . 0.0 109.069 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -100.92 101.37 12.17 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.675 -0.641 . . . . 0.0 109.395 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.6 mt -57.04 163.86 1.87 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.933 . . . . 0.0 109.434 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 21.2 ptt85 -48.82 -47.65 42.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 0.0 109.308 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -70.65 -30.1 66.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.176 -0.952 . . . . 0.0 109.158 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 102.47 34.93 3.99 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.501 ' O ' ' O ' ' A' ' 54' ' ' LEU . 2.6 t-20 -89.97 13.39 14.85 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.183 -1.187 . . . . 0.0 109.325 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.674 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 12.4 mt 43.38 96.97 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.752 0 CA-C-O 121.578 0.704 . . . . 0.0 109.456 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -71.17 116.16 11.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.551 -0.718 . . . . 0.0 109.581 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.54 ' CD1' ' O ' ' A' ' 54' ' ' LEU . 90.4 m-85 -100.7 114.7 28.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.31 -0.869 . . . . 0.0 109.858 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.428 ' HB3' ' HE2' ' A' ' 59' ' ' HIS . 0.2 OUTLIER -120.7 155.16 34.48 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.064 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.449 ' C ' ' CG ' ' A' ' 59' ' ' HIS . 5.2 mp -132.62 147.79 52.35 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.967 -1.083 . . . . 0.0 110.466 -179.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . 0.462 ' CD2' ' N ' ' A' ' 59' ' ' HIS . 1.4 m-70 -150.34 127.17 11.03 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.628 ' N ' ' CD2' ' A' ' 60' ' ' TYR . 1.1 p90 -115.18 132.69 56.53 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.045 -1.035 . . . . 0.0 109.941 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.458 ' CE3' ' O ' ' A' ' 62' ' ' LEU . 10.3 t90 -102.97 123.88 47.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.375 -0.828 . . . . 0.0 109.238 179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.458 ' O ' ' CE3' ' A' ' 61' ' ' TRP . 22.7 mt -101.85 162.12 13.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 109.657 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -110.03 154.61 16.49 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.674 -1.37 . . . . 0.0 109.674 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -82.15 -12.09 58.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.283 -1.128 . . . . 0.0 109.572 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.44 ' OE1' ' OG1' ' A' ' 37' ' ' THR . 2.8 mt-10 -106.58 29.09 7.23 Favored 'General case' 0 C--N 1.304 -1.409 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 39' ' ' ASP . 1.6 m -130.64 97.55 4.4 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 122.15 0.976 . . . . 0.0 108.381 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.484 ' O ' ' O ' ' A' ' 66' ' ' CYS . 9.9 m -39.03 161.57 0.01 OUTLIER 'General case' 0 C--N 1.283 -2.316 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.707 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.541 ' O ' ' N ' ' A' ' 72' ' ' GLY . 15.9 mm-40 -56.2 -17.41 7.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.389 -0.819 . . . . 0.0 109.661 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -63.98 -58.56 6.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.222 -0.924 . . . . 0.0 109.371 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.455 ' OE1' ' SG ' ' A' ' 66' ' ' CYS . 24.2 mt-10 -61.06 -54.26 46.95 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.345 -0.847 . . . . 0.0 108.987 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 p -64.13 -26.22 68.44 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.318 -0.864 . . . . 0.0 109.043 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.541 ' N ' ' O ' ' A' ' 68' ' ' GLN . . . -70.38 -41.77 66.75 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.14 -46.74 82.8 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -1.18 . . . . 0.0 109.28 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.12 -46.31 89.59 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.427 -0.795 . . . . 0.0 109.07 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -57.39 -41.53 80.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.345 -0.847 . . . . 0.0 109.26 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 51.0 mt -57.68 -46.24 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.278 -0.889 . . . . 0.0 109.279 179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -59.03 -35.34 73.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.265 -0.897 . . . . 0.0 109.143 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.7 m -72.34 -25.55 61.58 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.183 -0.948 . . . . 0.0 109.038 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.4 t -72.77 -48.77 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.306 -0.871 . . . . 0.0 109.541 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -65.86 -35.94 82.07 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.141 -0.975 . . . . 0.0 108.85 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.85 -42.56 98.04 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.628 ' O ' ' N ' ' A' ' 86' ' ' ASN . 51.9 t0 -61.16 -57.35 12.85 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.315 -0.865 . . . . 0.0 109.214 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -48.43 -31.38 6.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.142 -0.974 . . . . 0.0 108.707 179.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -78.59 -31.12 47.06 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.423 -0.798 . . . . 0.0 108.882 179.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.484 ' C ' ' H ' ' A' ' 87' ' ' GLY . 9.9 mt -121.71 32.7 5.77 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.435 -0.79 . . . . 0.0 109.518 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.628 ' N ' ' O ' ' A' ' 82' ' ' ASP . 17.8 t-20 -77.35 27.03 0.16 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.243 -0.91 . . . . 0.0 109.024 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.484 ' H ' ' C ' ' A' ' 85' ' ' LEU . . . -94.34 -48.41 2.6 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 29.0 mtp180 -152.21 45.61 0.74 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.168 -1.196 . . . . 0.0 109.638 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.422 ' CB ' ' O ' ' A' ' 56' ' ' TYR . . . -136.95 157.46 46.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.431 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 19.2 t -136.05 141.37 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.242 -0.911 . . . . 0.0 109.466 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.423 ' N ' ' CD ' ' A' ' 91' ' ' GLN . 6.8 mm-40 -88.95 142.47 27.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.212 -0.93 . . . . 0.0 109.37 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.492 ' O ' ' OE1' ' A' ' 94' ' ' GLU . 15.3 m-70 -118.29 115.24 24.33 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.268 -0.895 . . . . 0.0 109.461 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.84 104.92 15.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.233 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.589 ' OE2' ' CE2' ' A' ' 103' ' ' PHE . 1.5 mp0 -104.62 124.09 48.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.298 -0.877 . . . . 0.0 109.65 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.1 t -125.76 155.56 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.312 -0.867 . . . . 0.0 109.17 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -55.54 115.98 2.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.19 -0.943 . . . . 0.0 109.624 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.519 ' O ' ' CD1' ' A' ' 98' ' ' PHE . . . 93.34 10.18 59.68 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.614 -1.395 . . . . 0.0 109.614 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.519 ' CD1' ' O ' ' A' ' 97' ' ' GLY . 78.8 m-85 -152.94 25.37 0.56 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.179 -1.189 . . . . 0.0 109.669 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.467 ' CD ' ' H ' ' A' ' 99' ' ' GLU . 2.1 mp0 -48.19 135.52 13.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.119 -0.988 . . . . 0.0 109.428 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 1.5 t -61.46 171.42 1.46 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.104 -0.998 . . . . 0.0 109.552 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -72.11 -65.06 0.82 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.931 . . . . 0.0 109.593 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.0 m -50.55 -27.39 6.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.143 -0.973 . . . . 0.0 109.308 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.589 ' CE2' ' OE2' ' A' ' 94' ' ' GLU . 32.0 t80 -74.82 -55.59 5.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.323 -0.861 . . . . 0.0 109.799 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.439 ' C ' HD12 ' A' ' 104' ' ' LEU . 1.6 pp -67.18 -22.08 65.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.057 -1.027 . . . . 0.0 109.372 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -79.76 -33.12 34.86 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -78.4 -43.82 26.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -1.127 . . . . 0.0 109.422 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.465 ' HB2' HD21 ' A' ' 111' ' ' LEU . 51.8 m-85 -102.21 105.83 16.57 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.397 -0.814 . . . . 0.0 109.579 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 2.0 tpmt? -111.65 -49.85 2.96 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.358 -0.839 . . . . 0.0 109.513 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 9.0 t -106.04 23.16 14.47 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.094 -1.003 . . . . 0.0 109.514 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.575 ' O ' ' N ' ' A' ' 112' ' ' LYS . . . -125.18 -15.41 3.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.465 HD21 ' HB2' ' A' ' 107' ' ' PHE . 95.2 mt -62.13 70.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.201 -1.176 . . . . 0.0 109.508 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.575 ' N ' ' O ' ' A' ' 110' ' ' GLY . 29.4 tttt -93.25 108.49 20.11 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.202 -0.936 . . . . 0.0 109.565 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.66 143.79 27.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.263 -0.898 . . . . 0.0 109.369 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 36.8 tttp -133.54 115.99 15.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.26 -0.9 . . . . 0.0 109.426 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 26.2 mtmt -75.04 163.13 27.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.87 . . . . 0.0 109.47 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -85.08 -162.04 35.02 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.576 -1.409 . . . . 0.0 109.576 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -175.41 -74.45 0.05 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.655 ' O ' HG13 ' A' ' 118' ' ' VAL . 7.6 p -79.1 116.83 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.27 -1.136 . . . . 0.0 109.427 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ALA . . . . . . . . . . . . . . . -61.75 -75.24 0.07 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.308 -0.87 . . . . 0.0 109.484 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' SER . . . . . . . . . . . . . 70.2 m -65.69 -107.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.218 -0.926 . . . . 0.0 109.409 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . 140.26 -109.65 0.63 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -166.39 3.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.386 -1.067 . . . . 0.0 109.388 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -66.81 -62.28 1.53 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 0.0 109.507 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -97.21 97.74 9.43 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.0 109.489 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' VAL . . . . . . . . . . . . . 2.3 t -104.23 79.92 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.341 -0.849 . . . . 0.0 109.449 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.611 ' O ' HG23 ' A' ' 126' ' ' VAL . 30.6 m -143.67 81.17 12.27 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 109.433 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.512 ' O ' ' O ' ' A' ' 126' ' ' VAL . 48.5 Cg_exo -52.16 -145.72 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.747 2.298 . . . . 0.0 112.318 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 62.76 24.85 14.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.186 -0.946 . . . . 0.0 109.256 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -51.1 161.24 0.42 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.325 -0.859 . . . . 0.0 109.515 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.437 HG22 ' N ' ' A' ' 131' ' ' VAL . 9.1 p -75.46 165.25 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.342 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 131' ' ' VAL . 9.2 p -64.19 116.13 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.166 -0.959 . . . . 0.0 109.466 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' VAL . . . . . . . . . . . . . 69.8 t -83.17 -25.2 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.196 -0.94 . . . . 0.0 109.505 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.082 -0.961 . . . . 0.0 109.382 179.997 . . . . . . . . 0 0 . 1 stop_ save_